e6vk
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN ISSUER
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
February 23, 2009
KONINKLIJKE PHILIPS ELECTRONICS N.V.
(Exact name of registrant as specified in its charter)
Royal Philips Electronics
(Translation of registrants name into English)
The Netherlands
(Jurisdiction of incorporation or organization)
Breitner Center, Amstelplein 2, 1096 BC Amsterdam, The Netherlands
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form
20-F or Form 40-F.
Form 20-F þ Form 40-F o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule101(b)(1):___
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule101(b)(7):___
Indicate by check mark whether the registrant by furnishing the information contained in this Form
is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.
Yes o No þ
Name and address of person authorized to receive notices
and communications from the Securities and Exchange Commission:
E.P. Coutinho
Koninklijke Philips Electronics N.V.
Amstelplein 2
1096 BC Amsterdam The Netherlands
This report comprises a copy of the Annual Report of the Philips Group for the year ended December
31, 2008, dated February 23, 2009, as well as a copy of the
press release entitled Philips publishes 2008 Annual
Report.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf, by the undersigned, thereunto duly authorized at Amsterdam,
on the 23rd day of February 2009.
KONINKLIJKE PHILIPS ELECTRONICS N.V.
/s/ E.P. Coutinho
(General Secretary)
Annual Report 2008
Financial, social and environmental performance
2008 Welcome to the Philips Annual Report
... their needs drive our actions
At Philips, we seek to improve peoples lives with timely innovations that enhance their health and
well-being. We want to help people live a healthy, fulfilled life.
Our health and well-being focus also extends beyond the individual, reflecting a commitment to the
sustainability of our communities, our societies, our world.
This report
Simplifying our external annual reporting in order to better meet the needs of our stakeholders,
this years Annual Report covers both our financial and our social and environmental performance in a single volume. This
reflects the fact that sustainability is no mere adjunct to, but rather embedded in the very fabric of our business operations. Our Annual Report 2008 will also
be the last to be based on both US GAAP (Generally Accepted Accounting Principles in the United
States) and IFRS (International Financial Reporting Standards): as of 2009 we will apply IFRS only.
www.philips.com/annualreport2008
We care about our performance
We remain tightly focused on our financial and sustainability performance.
We care about our customers needs
We integrate technology and design into people-centric solutions based on fundamental end-user
insights and the brand promise of sense and simplicity.
We care about global challenges
We believe we can make a difference in enabling efficient energy use and in making healthcare
available and affordable turning global challenges into business opportunities.
We care about our people, our planet and our partners
Improving the quality of life of people inside and outside our company, as well as the quality of
the world we live in, is vital if we are to realize our ambitions for sustainable growth.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 Performance highlights
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance
|
Performance highlights
The years performance at a glance
Message from the President
Gerard Kleisterlee looks to the challenges and opportunities ahead
Our group performance
Analysis of our 2008 performance fi nancial, social and environmental
www.philips.com/annualreport2008
This
Annual Report is available online in dynamic interactive form
at the address above. Key financial data are available as Excel downloads. The Report can also be downloaded in full or per
chapter in PDF.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
70 Our sector performance
|
|
94 Risk management
|
|
110 Our leadership
|
|
114 Supervisory Board report
|
|
122 Performance statements
|
|
|
|
Contents |
|
|
|
Performance highlights |
|
|
Message from the President |
14
|
|
Who we are |
18
|
|
We care about |
|
|
The global healthcare challenge |
|
|
Helping consumers to enjoy a healthy lifestyle |
|
|
The energy efficiency imperative |
|
|
Capturing opportunities in emerging markets |
|
|
Our people, our planet, our partners |
42
|
|
Our group performance |
|
|
Management discussion and analysis |
|
|
Liquidity and capital resources |
|
|
Sustainability |
|
|
Proposed distribution to shareholders |
|
|
Outlook |
|
|
Our sector performance |
|
|
Healthcare |
|
|
Consumer Lifestyle |
|
|
Lighting |
|
|
Innovation & Emerging Businesses |
|
|
Group Management & Services |
|
|
Risk management |
|
|
Our leadership |
|
|
Supervisory Board report |
Performance statements |
|
|
Notes overview |
|
|
US GAAP financial statements |
|
|
Sustainability performance |
|
|
IFRS financial statements |
|
|
Company financial statements |
|
|
Reconciliation of non-US GAAP information |
|
|
Corporate governance |
|
|
Ten-year overview |
|
|
Investor information |
Please refer to page 44 for more information about forward-looking
statements, third-party market share data, fair value information, US GAAP
basis of preparation, use of non-US GAAP information, statutory financial
statements and management report, and revisions and reclassifi cations.
Statutory financial statements and management report
The chapters IFRS financial statements and Company financial statements
contain the statutory financial statements. The introduction to the chapter
IFRS financial statements sets out which parts of this Annual Report form
the management report within the meaning of Section 2:391 of the Dutch
Civil Code (and related Decrees).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 Performance highlights
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance
|
Performance highlights
Financial table
|
|
|
|
|
|
|
|
|
|
|
|
|
all amounts in millions of euros unless otherwise stated |
|
2006 |
1) |
|
2007 |
1) |
|
2008 |
|
Sales |
|
|
26,682 |
|
|
|
26,793 |
|
|
|
26,385 |
|
EBITA2) |
|
|
1,383 |
|
|
|
2,054 |
|
|
|
931 |
|
as a % of sales |
|
|
5.2 |
|
|
|
7.7 |
|
|
|
3.5 |
|
EBIT |
|
|
1,198 |
|
|
|
1,841 |
|
|
|
317 |
|
as a % of sales |
|
|
4.5 |
|
|
|
6.9 |
|
|
|
1.2 |
|
Financial income and expenses |
|
|
28 |
|
|
|
2,613 |
|
|
|
(225 |
) |
Results relating to equity-
accounted investees |
|
|
(157 |
) |
|
|
763 |
|
|
|
19 |
|
Income (loss) from continuing
operations |
|
|
899 |
|
|
|
4,593 |
|
|
|
(178 |
) |
Income (loss) from discontinued
operations |
|
|
4,482 |
|
|
|
(433 |
) |
|
|
(8 |
) |
Net income (loss) per common share in euros |
|
|
5,381 |
|
|
|
4,160 |
|
|
|
(186 |
) |
- basic |
|
|
4.58 |
|
|
|
3.83 |
|
|
|
(0.19 |
) |
- diluted |
|
|
4.55 |
|
|
|
3.79 |
|
|
|
(0.19 |
) |
Net operating capital2) |
|
|
8,473 |
|
|
|
10,529 |
|
|
|
14,867 |
|
Free cash flows2) |
|
|
(358 |
) |
|
|
821 |
|
|
|
773 |
|
Stockholders equity |
|
|
22,963 |
|
|
|
21,642 |
|
|
|
16,243 |
|
Net debt : group equity ratio2) |
|
|
(10):110 |
|
|
|
(32):132 |
|
|
|
3:97 |
|
Employees at December 313) |
|
|
121,732 |
|
|
|
123,801 |
|
|
|
121,398 |
|
|
|
|
1) |
|
Revised to reflect immaterial adjustments of intercompany profit eliminations on inventories
in the Healthcare sector |
|
2) |
|
For a reconciliation to the most directly comparable US GAAP measures, see the chapter
Reconciliation of non-US GAAP information |
|
3) |
|
Includes discontinued operations 6,640 at December 31, 2006 and 5,703 at December 31, 2007 |
|
4) |
|
Comprises of Western Europe, North America, Japan, Korea, Israel, Australia and New Zealand |
|
5) |
|
Comprises of Asia Pacific (excluding Japan, Korea, Australia and New Zealand), Latin America,
Central & Eastern Europe, Middle East and Africa |
6 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
70 Our sector performance
|
|
94 Risk management
|
|
110 Our leadership
|
|
114 Supervisory Board report
|
|
122 Performance statements
|
773 million
free cash flow
12%
comparable sales growth for Healthcare in emerging markets
0.70
per share proposed distribution to shareholders in 2009
Philips Annual Report 2008 7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 Performance highlights
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance
|
Message from the President
Dear stakeholder
2008 was not exactly the year of progress that you and I had envisaged for Philips 12 months ago.
Our companys transformation over the last few years has definitely produced a balanced, stronger
and more resilient set of businesses active in the field of health and well-being, and these
continued to improve their position in the market in 2008. But the acceleration of the economic
downturn in the course of the year, particularly in the fourth quarter, took an increasing toll on
several of our businesses that are sensitive to early cycle effects, especially those with direct
or indirect consumer market exposure, requiring us to take decisive action.
Nevertheless there has been progress on several fronts. With the successful integration of the two
largest acquisitions in Philips history Respironics and Genlyte more than 50% of our revenue
is generated from businesses with global leadership positions; up from less than 40% in 2007. And a
steady 31% of our sales continues to come from emerging markets. All that supported by a quality
brand that gained 8% in value in 2008 alone and a workforce reaching high-performance benchmark
engagement levels.
Performance
The increased strength and resilience of our business portfolio was particularly evident in
Healthcare, which, in a very challenging operating environment, achieved excellent results higher
comparable sales and an improvement in underlying EBITA and is on the way to becoming our largest
sector.
The strong downturn in the latter part of 2008 affected the Groups top line, particularly at
Consumer Lifestyle and in our OEM businesses in Lighting, partly offset by continued healthy growth
at Healthcare, leading to a moderate overall sales decline of 2.7%.
EBITA was down on 2007, largely due to a decline in sales-driven earnings at Consumer Lifestyle and
Lighting, as well as an asbestos-related settlement charge. We also extended and accelerated the
restructuring and change programs across our Healthcare, Consumer Lifestyle and Lighting sectors,
further impacting EBITA. These programs are on track to deliver cost savings of approximately EUR
400 million on an annual basis, with effect from the second half of 2009.
We also moved quickly to extend our cash management initiatives, including rigorous management of
working capital. This enabled us to end the year with a robust balance sheet supported by strong
operating cash flows of almost EUR 1.5 billion.
Furthermore, we continued with the responsible sell-down of our non-core financial holdings by
divesting our final holding in TSMC, as well as further reducing our stake in LG Display. The
economic malaise affected the market value of our remaining financial stakes, causing us to write
down EUR 1.4 billion on the value of our current financial holdings.
The road ahead
We remain fully committed to our primary financial objective of doubling EBITA per share, and will
continue to drive forward our plans in this respect. However, the rapid and severe deterioration in
the business environment means we no longer expect to be able to realize this goal in 2010.
We
remain fully committed to our primary financial objective to double EBITA per share
For the mature markets in Western Europe and the US and most emerging markets we foresee very
difficult conditions throughout 2009. Nonetheless, I firmly believe that the overall strength of
our business portfolio, coupled with our strong balance sheet and tight focus on cost and cash
management, will enable us to weather the current turmoil and make the most of the economic upturn
when it comes.
69%
Employee Engagement Index
8 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
70 Our sector performance
|
|
94 Risk management
|
|
110 Our leadership
|
|
114 Supervisory Board report
|
|
122 Performance statements
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 Performance highlights
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance
|
Return to shareholders
We completed EUR 3.3 billion of the current EUR 5 billion share repurchase program announced in
December 2007. However, in view of the risks and opportunities presented by the economic downturn
and the turbulence on the financial markets, we decided that the most responsible course of action
was to stop the share repurchase program until further notice and to maintain our financial
flexibility.
In common with many in our peer group, our share price followed the downward trend of the market in
2008. Disappointing as this is, I remain confident that when better economic times return our share
price will respond to reflect the intrinsic quality of our health and well-being portfolio.
At our General Meeting of Shareholders in March 2008 we increased the dividend for the fourth year
in a row. We are proposing to the upcoming General Meeting of Shareholders to make a distribution
of EUR 0.70 per common share equal to last years dividend resulting in an increased yield (as
of December 31, 2008) of 5.1% for shareholders.
How did we do against our Management Agenda 2008?
Let me update you on how we performed on the objectives we set ourselves last year.
Integrate and leverage recent acquisitions, delivering anticipated return on investment
The two main integration processes concerned Respironics in our Healthcare sector and Genlyte in
Lighting. Both contributed positively to sales and earnings, in line with expectation.
... positive contribution from integrated acquisitions ...
The acquisition of leading North American luminaire manufacturer Genlyte not only gives us the
leading position in the US market for professional lighting applications, but also makes us the
only player with a truly global platform for its lighting applications and solutions.
The acquisition of Respironics a leading US-based global provider of innovative respiratory and
sleep therapy solutions for hospital and home use is part of our strategy to create a global
leadership position in the fast-growing home healthcare solutions market. In December, we further
solidified this position with the acquisition of the aerosol therapy business of Medel SpA in
Italy. The hospital activities of Respironics are now part of our integrated offering of Clinical
Care Solutions, and we are well on our way with the creation of an integrated approach to sleep
care involving our Lifestyle sector.
10 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
70 Our sector performance
|
|
94 Risk management
|
|
110 Our leadership
|
|
114 Supervisory Board report
|
|
122 Performance statements
|
Take decisive steps to structurally deal with unsatisfactory EBITA margins in Connected Displays
(Television)
In North America we entered into a five-year minimum brand licensing agreement with Funai Electric
Company of Japan, under which Funai will assume responsibility for all Philips-branded consumer
television activities in the United States and Canada. Toward the end of the year this agreement
was extended, adding audio-video categories in the US and TV and audio-video categories in Mexico.
... decisive action to address profitability ...
We drove further portfolio reductions around the world, for instance in Australia, New Zealand and
South Africa, and announced our withdrawal from plasma-based TVs. We also signed a letter of intent
regarding our PC Monitors business, creating a brand licensing agreement with TPV Technology for
the global distribution and marketing of IT Display products.
Given the current economic turmoil, we will continue to evaluate whether more action is required in
2009. Going forward, we have a solid TV business with leadership positions in selected geographic
markets that is driven by innovation and margin rather than volume.
Improve productivity as a driver for margin expansion
Our progress on this point was limited as our efficiency programs were mitigated by lower earnings
in our operational sectors due to the economic downturn. The restructuring and change programs
across our sectors will put us in a stronger position, but productivity remains a key focus point
for management.
Step up resource investment in developing markets to accelerate growth in excess of 2x GDP
In 2008, we further increased our talent, marketing and R&D investments towards the emerging
markets. In addition, we made a number of acquisitions in Brazil, China and India, designed to
strengthen our position in healthcare in emerging markets.
... emerging market sales growth of 12% and 8% in Healthcare and Lighting respectively ...
Excluding Television, which we manage for margin instead of volume, our sales growth in emerging
markets amounted to 6%, approximately in line with the latest 2x world GDP growth estimates. I am
particularly pleased with the way our Healthcare and Lighting businesses weathered the economic
downturn, with comparable sales growth of 12% and 8% respectively in the emerging markets for the
year.
Increase innovation focus in support of Philips growth ambition
In 2008, sales of innovative products i.e. products introduced within the last year (for B2C
products) or three years (for B2B products) amounted to 58% of total sales, again up 2 percentage
points and more than double the 2003 level, but still not giving us the amount of new business we
are looking for.
In difficult economic times like these, innovation is more crucial than ever to provide a
competitive edge. In 2009 we will therefore notwithstanding our focus on cash management
sustain our spending levels on R&D and marketing, while intensifying our efforts to increase the
speed and productivity of innovation.
Sustainability continues to be a key driver of innovation. Sales of Green Products rose to 23% of
overall sales, up from 20% in 2007, representing an important, growing part of our revenue stream.
Our investment in Green Innovations amounted to over EUR 280 million in 2008, on track for a
cumulative amount of EUR 1 billion to be invested by 2012.
Continue to drive a culture of superior customer experience
Ensuring a superior customer experience is absolutely crucial to the realization of our ambitions.
The Net Promoter Score (NPS) is our single key metric of customer experience. NPS measures the
answer to one simple question: How likely is it that you would recommend this company/product to a
friend or colleague? Compared to 2007, we achieved NPS leadership in an additional 4% of our
businesses on a comparable basis. During 2008, we also expanded the NPS measurement to now cover
all our strategic areas, and at present 47% of our key businesses have industry-leading scores.
Especially notable is our strong performance in the emerging markets such as Brazil, Russia, India
and China. We are still committed to reach our 2010 NPS target and to this end we will drive
customer experience improvement and execute strategic moves to continue to secure leading NPS
positions.
We also realized 8% growth of our total brand value in the annual ranking of the top-100 global
brands compiled by Interbrand the fifth increase in a row. In 2004, when we launched our sense
and simplicity brand campaign, Philips total brand value was USD 4.4 billion. This has steadily
increased to a total value of USD 8.3 billion in 2008. Such consistent improvement clearly
illustrates that our sense and simplicity brand promise, founded on deep, validated insights into
customer and end-user needs, continues to resonate with customers.
23%
of sales came from Green Products
58%
of sales came from innovative products introduced in the last three years
Philips Annual Report 2008 11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 Performance highlights
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance
|
Bring employee engagement to high-performance benchmark
I am very pleased to report that we have made significant advances in Employee Engagement our
measure of the progress of our people initiatives.
... strong progress in employee engagement ...
The results of our 2008 survey exceeded expectations. Our overall Philips score leaped from 64% to
69% favorable two points above our target for the year, and closing in on the high-performance
benchmark. Our People Leadership Index, which measures the effectiveness of our leaders in engaging
people, also rose by five points to a score of 69%.
because health and well-being matters to people
Peoples needs remain the starting point for everything we do. By tracking trends in society and
obtaining deep insights into the issues confronting people in their daily lives, we are able to
identify opportunities and develop innovative solutions that are easy to access and relevant to
peoples needs and aspirations.
Philips must continue to stand for sense and simplicity. That is what our customers should
experience, each and every day, in dealing with us. Now more than ever, we need to redouble efforts
to fully understand our customers and markets, so that we can identify and compete boldly and
successfully for new opportunities as they arise.
... further grow Philips as the leading brand in health and well-being ...
We aim to further grow Philips as the leading brand in the health and well-being market space.
Health and well-being is a theme that is becoming increasingly relevant for society around the
world, and it will be a major driver of growth when the financial and economic turbulence has
subsided. It is also the glue that bonds our businesses within Healthcare, Consumer Lifestyle and
Lighting.
Our Healthcare sector is a great example of how we are building growth-orientated businesses with
strong leadership positions in both clinical and home healthcare, as well as a growing presence in
emerging markets.
In Consumer Lifestyle, we are focusing the business on innovative lifestyle solutions for personal
well-being. We will continue to build upon existing market-leading positions based on
differentiation and profitability, rather than scale. In addition, we will enter new, higher-margin
value spaces with a particular focus on platforms such as healthy living, personal care and home
life.
In Lighting, we have established leading positions in fast-growing areas such as LEDs and
energy-efficient lighting with a segment-based marketing approach. Our task now is to strengthen
our global leadership by driving the transition to application-based solutions to fuel future
growth. Our strong IP position across the solid-state lighting value chain and the licensing
opportunities it brings will further reinforce this leadership.
... continue to embed sustainability throughout our operations ...
We will also continue to embed sustainability throughout our operations. Moving to this integrated
financial, social and environmental annual report clearly illustrates this unified approach.
Staying the course
We are convinced that the strategic choices we have made are the right ones. Our goals are
ambitious and they have become more challenging with the deterioration in the macro-economic
climate. However, these difficult times call at most for a change of tactic, not a change of
strategy.
Therefore, our Management Agenda 2009 is all about staying the course through this downturn. Its
three themes Drive performance, Accelerate change and Implement strategy reflect the current
reality, where the prime focus will be on managing cash flow and cost, while continuing to capture
opportunities to strengthen our position in the market. Pursuing these goals with a heightened
sense of urgency will ensure the long-term health, growth and profitability of our company. We
have the strategy, portfolio, financial strength and talent to succeed.
12 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
70 Our sector performance
|
|
94 Risk management
|
|
110 Our leadership
|
|
114 Supervisory Board report
|
|
122 Performance statements
|
Final thoughts
I would like to thank our employees, including our many new employees from our acquisitions, for
their hard work over the past 12 months. Time and again, they have demonstrated the resilience and
drive to rise to a challenge. And I know I can count on their continued dedication and effort in
the face of this latest hurdle.
I would also like to thank our other stakeholders, and in particular our customers, for the loyalty
and confidence they have shown toward us in 2008.
Finally, on behalf of my colleagues on the Board of Management, let me thank our shareholders for
their continued support in these difficult times. We remain wholly committed to increasing the
value of the company.
Gerard Kleisterlee
President
Management Agenda 2009
Drive performance
|
|
Relentlessly manage cash |
|
|
|
Proactively align cost structure with market conditions and increase productivity |
|
|
|
Manage risks and opportunities in a balanced way to strengthen our market positions |
Accelerate change
|
|
Organize around customers and markets, thereby improving Net Promoter Score |
|
|
|
Increase Employee Engagement to high-performance level and implement Leading to Win |
|
|
|
Accelerate sector transformation programs |
Implement strategy
|
|
Further build the brand in the Health and Well-being space |
|
|
|
Continue to re-allocate resources to growth opportunities and emerging markets, including
selective mergers and acquisitions |
|
|
|
Increase revenue derived from leadership positions |
Philips Annual Report 2008 13
|
|
|
|
|
|
|
|
|
6 Performance
highlights
|
|
8 Message from the
President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance |
Our company
Our company was founded in Eindhoven (Netherlands) in 1891 by Anton and Gerard Philips to
manufacture incandescent lamps and other electrical products. Ever since then, our innovations have
been making peoples lives simpler, more enjoyable and more productive.
Based on a deep understanding of what people really need and want, and delivering on our promise of
simplicity, we empower our customers both healthcare and lighting professionals and end-consumers
with solutions that are advanced, yet designed around them and easy to experience.
We see exciting opportunities in both mature and emerging markets and apply our competence in
marketing, design and technology to capture value from major economic, social and demographic
trends, for example the growing demand for better healthcare at lower cost, consumer empowerment,
the rise of emerging markets and the need for energy efficiency.
At the same time, we are committed to enhancing economic prosperity, environmental quality and
social equity wherever we operate.
Our mission
We improve the quality of peoples lives through the timely introduction of meaningful innovations.
Our vision
In a world where complexity increasingly touches every aspect of our daily lives, we will lead in
bringing sense and simplicity to people.
Our brand promise
We empower people to benefit from innovation by delivering on our brand promise of sense and
simplicity. This brand promise encapsulates our commitment to deliver solutions that are advanced,
easy to use, and designed around the needs of all our users.
Our organization
Headquartered in Amsterdam, Netherlands
|
|
Healthcare |
|
|
|
Consumer Lifestyle |
|
|
|
Lighting |
14 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector
performance
|
|
94 Risk
management
|
|
110 Our leadership
|
|
114 Supervisory
Board report
|
|
122 Performance
statements |
Our strategy
Through our strategy, we aim to fuel growth by making Philips the leading brand in health and
well-being. Our strategy further positions Philips as a market-driven, people-centric company with
a structure that reflects the needs of its customer base, while also increasing shareholder value.
Our ways of working
1
We are a people-centric company that organizes around customers and markets
2
We invest in a strong brand and consistently deliver on our brand promise of sense and
simplicity, in our actions, products and services
3
We deliver innovation by investing in world-class strengths in end-user insights, technology,
design and superior supplier networks
4
We develop our peoples leadership, talent and engagement and align ourselves with high-performance
benchmarks
5
We invest in high-growth and profitable businesses and emerging geographies to achieve market
leadership positions
6
We are committed to sustainability and focus on making the difference in efficient energy use
7
We drive operational excellence and quality to best-in-class levels, allowing us the
above-mentioned strategic investments in our businesses
Vision 2010
On December 4, 2008, we confirmed that we continue to execute on our Vision 2010 strategy.
However, given the current economic environment, the financial targets set as part of Vision 2010
are not expected to be met by the end of 2010, as originally planned, due to the continuing
economic slowdown and resulting declining demand in key markets. We remain fully committed to our
strategy, and will update the market on the realization of our financial objectives when economic
visibility improves.
Our ambitions
Our financial targets
|
|
Double EBITA per common share from 2007 level |
|
|
|
Group EBITA margin of 10-11%
Sector EBITA targets:
Healthcare 15-17%
Consumer Lifestyle 8-10%
Lighting 12-14% |
|
|
|
Comparable sales growth of 6% average per year |
|
|
|
Return on invested capital of 12-13% |
Our EcoVision4 targets
over the period 2007 2012
|
|
Double revenues from Green Products to 30% of total sales |
|
|
|
Double investment in Green Innovations to a cumulative EUR 1 billion |
|
|
|
Improve our operational energy efficiency
by 25% and reduce CO2 emissions by 25% |
Philips Annual Report 2008 15
|
|
|
|
|
|
|
|
|
6 Performance
highlights
|
|
8 Message from the
President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance |
16 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector
performance
|
|
94 Risk
management
|
|
110 Our leadership
|
|
114 Supervisory
Board report
|
|
122 Performance
statements |
Philips Annual Report 2008 17
|
|
|
|
|
|
|
|
|
6 Performance
highlights
|
|
8 Message from the
President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance |
The global healthcare challenge
Healthcare is one of the most pressing issues of our time. The global population is aging and there
are more and more people living with chronic disease. This is causing costs to continue to rise and
increasing the demand for advanced healthcare, particularly in developing countries.
At Philips we see these challenges as opportunities. We focus on the needs of patients and their
care providers throughout the care cycle, wherever that care occurs. And we apply our insights and
innovation to improve healthcare quality and reduce cost.
For some patients, this means faster, more accurate diagnosis and greater comfort and satisfaction,
for others access to healthcare for the first time. For care providers, it means improved patient
care and more time to focus on disease management.
We work to simplify and improve healthcare for people
Our people-focused approach brings meaningful innovation to simplify healthcare and to give people
the best care possible. This includes new ways to empower patients to manage their own health for
more independent living at home.
Steve Rusckowski, CEO Philips Healthcare
18 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector
performance
|
|
94 Risk
management
|
|
110 Our leadership
|
|
114 Supervisory
Board report
|
|
122 Performance
statements |
Philips Annual Report 2008 19
|
|
|
|
|
|
|
|
|
6 Performance
highlights
|
|
8 Message from the
President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance |
$100 billion
economic impact of sleep disorders in the US
Sleep well, live well
Recognizing the importance of a good nights rest, the 19th century philosopher Ralph Waldo Emerson
wrote, Health is the first muse, and sleep is the condition to produce it. Todays medical
science proves him right.
Research in recent years has shown that those who suffer from the sleep disorder Obstructive Sleep
Apnea (OSA) characterized by the repeated cessation of breathing during sleep are at possible
increased risk of high blood pressure, heart disease and heart attack, stroke, diabetes as well as
fatigue-related motor vehicle and work accidents.
I was depressed so I talked to my doctor.
One womans story
Denise, a 55 year-old former bank employee from the United States, didnt know anything about OSA,
but she did know that her heavy snoring drove her husband of 35 years to sleep in the guest room.
Loud snoring may be a sign of sleep apnea, which can be a life-threatening condition.
I was depressed so I talked to my doctor, she explains. He prescribed anti-depressants, which
didnt help at all. Thats when doctors suggested
an overnight sleep study. The results were startling. They told me I had stopped breathing 46
times an hour while I was asleep! This caused low blood oxygen levels, which meant her heart had
to work harder, and Denise felt sleepy during the day.
Sleep therapy
That all changed when Denise began using Philips Respironics continuous positive airway pressure
(CPAP) therapy when she sleeps. The CPAP machine and mask for her face increase air pressure in
Denises throat so that her airway does not collapse when she breathes in.
Philips Respironics products are designed to be simple to use and natural and easy to live with -
providing Denise with the essential treatment she needs, and allowing her and her husband, Russ, a
restful nights sleep.
Home Healthcare
It is estimated that in the United States alone there are 18-20 million sufferers of moderate or
severe OSA, of which only 15-20% have been diagnosed. Our acquisition of Respironics is a
significant step in strengthening our Home Healthcare business, giving us a leading position in the
fast-growing areas of sleep management, respiratory care and non-invasive ventilation.
Left: Obstructive Sleep Apnea
Right: normal breathing
20 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector
performance
|
|
94 Risk
management
|
|
110 Our leadership
|
|
114 Supervisory
Board report
|
|
122 Performance
statements |
Designed for emerging markets
Our series of new portable, compact patient monitors provides a reliable and affordable means to
observe and care for patients. Introduced in India, the new Philips SureSigns VM3 is the first
Philips patient monitor designed for emerging markets.
Rapidly changing healthcare services
With a growing per capita income and the adoption of new lifestyles, healthcare services in India
are rapidly changing. To meet the increasing demand for quality care, people in urban areas have
seen the construction of new, state-of-the-art hospitals and associated satellite facilities, while
others are increasingly seeking care at smaller nursing homes and clinics. This has fueled demand
for healthcare equipment including patient monitors. Our objective is to garner a market share of
40% by 2010 through our diverse range of patient monitoring equipment.
Access to more affordable equipment
High-end patient monitors are out of reach for many small to mid-sized clinics, forcing doctors and
nurses to decide upon treatment only based on visible symptoms. Sometimes this means they must wait
for a patients condition to deteriorate before changing treatment. With access to more affordable
patient monitoring equipment, clinicians are able to observe a patients vital signs and make more
informed, timely decisions about patient care.
Versatile, cost-effective solutions
In 2008, Philips introduced the latest additions to its HD ultrasound family of products, the
Philips HD7 and Philips HD15.
The HD7 was introduced to Europe in March at the European Congress of Radiology (ECR) in Vienna. It
draws upon an array of features and capabilities available on high-end Philips systems and puts
them into an affordable, mobile unit that is well-suited for a wide variety of clinical settings.
Now it no longer requires a major investment for a medical office, clinic or small hospital to get
the same kind of key capabilities, performance features and high-definition imaging found in
higher-priced ultrasound systems.
Anne LeGrand, senior vice president, Ultrasound, Philips Healthcare
Developed with clinicians in mind, the ergonomic, easy-to-use system can meet the demands for
high-volume use in a wide range of clinical applications.
Superb imaging and workflow performance in a cost-effective system
The Philips HD15 ultrasound system is a new platform designed to deliver an advanced level of image
clarity and broad application support for everyday use in small hospitals, clinics and private
practices.
The system may be used as a primary system for some users, particularly those in emerging markets
who require a feature-rich system but may not need all of the features of a high-end ultrasound
solution.
>450
products and services offered in over 100 countries
Philips Annual Report 2008 21
|
|
|
|
|
|
|
|
|
6 Performance
highlights
|
|
8 Message from the
President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance |
Helping consumers to enjoy a healthy lifestyle
The design of our products and services reflects the fact that consumer choices are increasingly
driven by emotional and social factors rather than simply functionality.
Andrea Ragnetti, CEO Philips Consumer Lifestyle
The pursuit of personal well-being is a universal trend we all want to feel and look our best,
and to enjoy a healthy life balance. This trend also represents a significant and fast-growing
segment of total global consumer spend.
Our Consumer Lifestyle sector illustrates Philips evolution from a technology business to one that
improves the quality of peoples lives by focusing on their health and well-being.
Starting from validated consumer insights, and guided by our brand promise of sense and
simplicity, we offer consumers lifestyle experiences that are enjoyable and fulfilling.
We focus on consumer experiences
22 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector
performance
|
|
94 Risk
management
|
|
110 Our leadership
|
|
114 Supervisory
Board report
|
|
122 Performance
statements |
Philips Annual Report 2008 23
|
|
|
|
|
|
|
|
|
6 Performance highlights
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We care about
|
|
42 Our group performance |
Wide awake the natural way
Sleep can play a positive role in consumers lifestyles, and in enhancing well-being in particular.
We can all identify with the benefit of a good nights sleep, but also the feel good factor of
waking naturally, feeling refreshed, says Ena Voute, leader of the Beauty & Vita-Light category
within Consumer Lifestyle. We took this as the starting point for developing the Philips Wake-up
Light, which is designed to gently wake the body the way nature intended with light.
Most of us know that getting a good nights sleep is a good thing, but we now know a lot more about
the benefits of enabling the kind of sleep pattern nature intended us to have.
Half an hour before the required wake-up time, the Wake-up Light switches on with a very low level
of light intensity, gradually increasing it over the following 30 minutes to simulate the rising
sun. A choice of ambient noises like bird song can add to the experience, as well as more
conventional early morning stimuli, like a conventional alarm or radio.
Most people will agree that being woken abruptly especially during winter, when its cold and
dark outside is not a pleasant way to come-to in the morning, notes Ena. We know that light
stimulates the senses, energizing the body and helping in making us feel less lethargic. The
Wake-up Light gently prepares the body for waking. As a result, you not only feel refreshed but
also more alert.
Founded on fact
Philips own insights have been underpinned by scientific research, which has revealed more about
the natural clock within us all. Our ancestors would sleep according to the availability of
natural light, says Ena. The introduction of artificial light changed that, as people were
effectively able to control sunrise and sunset themselves. However, research has made direct links
between sleep cycles and other physiological factors, such as our metabolism, blood pressure,
cardiovascular system, and the release of stress hormones.
Before launching the Wake-up Light, Philips applied a rigorous process of consumer validation to
underpin the insight behind the product. Consumer testing resulted in extremely positive feedback.
I have more energy and get up without any stress, wrote one consumer.
My boyfriend and I noticed that, since we have the Wake up Light, we have more energy throughout
the day. Our productivity is higher and we feel that our daily rhythm is smoother.
Following the success of its first-generation Wake-up Light, Philips introduced a new model in
2008. Nine out of ten customers who bought our first model said they found it a more pleasant
method of waking than traditional alarms on clocks, radios or mobile phones, says Christophe
Melle, Consumer Marketing Director for Vita-Light. These results were highly encouraging, and also
gave us a lot of positive end-user experience to draw on in developing our second-generation
model.
24 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector performance
|
|
94 Risk management
|
|
110 Our leadership
|
|
114 Supervisory Board report
|
|
122 Performance statements |
SimplicityLabs a virtual lab for people-focused innovation
In August 2008, Philips Research presented its new online research environment SimplicityLabs.
This virtual environment allows people worldwide to experiment with new software-based product
concepts in the comfort of their own homes. An extension of Philips consumer-focused research,
SimplicityLabs enables Philips Research to harness end-user feedback at a very early stage in the
innovation process and validate new concepts in a way that is fast, efficient and cost-effective.
Whats new about SimplicityLabs is that people can join in the experiments at any time, from
anywhere. We expect this will boost take-up rates and provide faster and richer consumer feedback
in the early phases of product concept development.
This feedback is both explicit (people fill in a questionnaire about the concept) and implicit (the
system records how people actually interact with the mock-up or prototype). Once weve gathered
and interpreted this data, we can make all the improvements necessary to turn the online product
concept into a real, consumer-focused product that, we expect, people will love, says Fred
Boekhorst, Senior Vice-President Philips Research and Program Manager Lifestyle.
The next step in experience research
Like Philips Researchs ExperienceLab, SimplicityLabs places the consumer at the very heart of the
innovation process. In the longer term, we expect SimplicityLabs will make a significant
contribution to steering our innovation process and to ensuring that products in our portfolio are
based on existing, wide-ranging consumer needs, says Boekhorst.
One million and counting
Our conscious decision to make peoples needs the starting point for everything we do is clearly
resonating with consumers, as evidenced by the fact that supported by our Healthy living
initiative we sold our one millionth whole-fruit juicer in 2008.
With this product, we took a fundamental insight that parents the world over want their children
to get all the nutritional goodness they need and applied our development and design competence
to produce an innovative solution that fulfilled this universal aspiration.
Fantastically healthy
There is nothing more delicious and healthy than freshly squeezed juice it is one of the staples
of a healthy breakfast and a great way to enjoy the delicious taste of fruit and vegetables.
Drinking juice also cleanses, flushes, alkalizes and revitalizes the body. But juicing can often be
messy and ineffective and rather than an ideal way to get your recommended daily allowance of
vital vitamins and minerals, it can become a hassle and a chore.
The Philips Juicer changes this forever. With its powerful motor, this innovative appliance can
instantly turn any fruit or vegetable chopped or whole into juice, with no pips or unwanted
pulp.
#1
power toothbrush recommended by dental professionals Philips Sonicare
Philips Annual Report 2008 25
|
|
|
|
|
|
|
|
|
6 Performance highlights
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We care about
|
|
42 Our group performance |
|
|
|
|
|
|
|
|
|
70 Our sector performance
|
|
94 Risk management
|
|
110 Our leadership
|
|
114 Supervisory Board report
|
|
122 Performance statements |
The energy efficiency imperative
Global climate change and rising energy costs these are major issues that people really care
about. At Philips, we embraced the energy challenge early on, seeing it as a business opportunity
that could benefit society at large.
With lighting, for instance, accounting for 19% of all electricity consumed throughout the world,
we can make a significant impact. As the global market leader, we are committed to meeting peoples
lighting needs by promoting and supplying energy-efficient and sustainable solutions and
applications based on innovative new technologies, such as solid-state lighting.
Its a simple switch ...
with benefits all round
Philips Annual Report 2008 27
|
|
|
|
|
|
|
|
|
6 Performance highlights
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We care about
|
|
42 Our group performance |
>3.5 million
people pledge to change to energy-efficient lighting via our website
Partnering for sustainability
In 2008, Philips and UK-based Gazeley Ltd announced a partnership agreement under which they will
join forces to realize the most sustainable warehouse facilities by applying state-of-the-art
energy-efficient lighting solutions.
Gazeley is a global provider of sustainable logistics space. It is committed to delivering
environmental initiatives as part of its standard specification, at no extra cost to its customers.
...working with Philips will enable us to significantly reduce our global footprint ...
Significant benefits
By applying Philips energy-efficient lighting solutions across its operations, Gazeley will cut
energy consumption and CO2 emissions by up to 45% and reduce waste by as much as 83%.
This will also yield cost-reduction benefits for occupiers thanks to lower energy bills and the
need for less maintenance activity while the superior light quality will provide employees with a
more pleasant working environment.
Smaller footprint, lower costs
At the signing of the partnership agreement, Jonathan Fenton-Jones, Global Procurement &
Sustainability Director for Gazeley commented: This partnership marks a major step forward in our
strategy to deliver cutting-edge sustainability standards to our customers worldwide. To be able to
work with a recognized partner such as Philips, which is at the forefront of environmental change,
is an important business development for Gazeley and will enable us to significantly reduce our
global footprint whilst providing customers with increased operational cost savings.
Sustainable energy solutions for Africa
In 2008, Philips and the Dutch Government signed a public/private partnership agreement, which will
see the development of a new generation of sustainable solar-powered lighting solutions for
Sub-Saharan Africa.
Entitled Sustainable Energy Solutions for Africa (SESA), this project is linked to the UN
Millennium Development Goals. It aims to provide 10 million people in Sub-Saharan Africa with
affordable, appropriate and sustainable energy solutions for lighting, cooking and water
purification by 2015.
A brighter future
Today an estimated 500 million Africans live without electricity. For them, night-time means either
darkness or the flickering light of a candle or kerosene lamp. However, very few can afford the
kerosene they need. As a result, at sundown life simply comes to a halt for hundreds of millions of
people.
Lighting solutions like our solar-powered Solar Uday lantern and self-powered Dynamo Multi LED
flashlight can really make a difference. The Solar Uday, for example, is cheaper to run than
kerosene lamps and provides far more and higher quality light. It is also safer, as there is no
fire risk, and better for health, as smoke is avoided.
There are economic and social benefits to being able to undertake activities in the evening hours.
And these products also offer an environmental benefit, as they use a sustainable natural commodity
sunlight or manpower to generate electricity.
28 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70
Our sector performance
|
|
94 Risk management
|
|
110 Our leadership
|
|
114
Supervisory Board report
|
|
122
Performance statements |
Lighting the National dramatic impact
Philips and the National Theatre in London are some 20 months into a five-year lighting partnership
program to replace the landmark venues lighting scheme with a state-of-the-art dynamic and
energy efficient design.
...offering Londoners and visitors the chance to see world-class theatre, whilst lowering the carbon
impact...
Londoners and tourists have already seen a dramatic enhancement of the exterior of the iconic
Thames-side building. Our LED lighting solution provides an endless color palette with which to
paint the building, creating a spectacular and welcoming aura. New, smaller light fittings will
help maintain the architectural integrity of the Grade 2 listed building.
Easy on the eye, easy on the environment
In addition to the immediate visual enhancements, upon completion Philips lighting technology will
deliver a 70% reduction in the energy needed to illuminate the buildings iconic flytowers and
ultimately an estimated £100,000 annual saving for the National Theatre!
After the initial phase concentrating on the exterior, the focus switched to the interior and
backstage areas of the theater. The public areas front-of-house have been fitted with lower-energy,
higher-efficiency fittings. Here, the National Theatre believes this has reduced their lighting
electricity consumption by more than 130,000 kWh every year! Similar fittings have been installed
in the vast corridors, workshops and rehearsal rooms.
The Mayor of London at the time of the announcement of the partnership, Ken Livingstone, said:
Tackling climate change doesnt mean we have to stop enjoying ourselves, but it does mean that
every sector of London life has to consider its impact on global warming. The work the National
Theatre and Philips are doing is the perfect example of the kind of leadership we need right across
London, continuing to offer Londoners and visitors the chance to see world-class theater, whilst
lowering its carbon impact.
Lasting contribution
The partnership between Philips and the National Theatre is not a fit and forget operation. As
Philips introduces new lighting technology, improvements will be installed to deliver ever-greater
energy savings and further enhance the environment for everyone coming into contact with one of
Londons most recognizable buildings.
This partnership will enable us to spend more on putting on plays and performances and less on
electricity and maintenance. Its an investment that would be justified on economic grounds, but
its hard for arts organizations to find the money. Thanks to this partnership we can do so. We are
immensely grateful for Philips far-sighted approach.
Nick Starr, Executive Director of the National Theatre
Philips Annual Report 2008 29
|
|
|
|
|
|
|
|
|
6 Performance highlights
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We care about
|
|
42 Our group performance |
30 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
70 Our sector performance
|
|
94 Risk management
|
|
110 Our leadership
|
|
114 Supervisory Board report
|
|
122 Performance statements |
Capturing opportunities in emerging markets
Through our technology, know-how, products and services, we are capturing growth
opportunities by providing sustainable solutions to the challenges and needs of
people in emerging markets.
Gottfried Dutiné, Member of the Board of Management
Within the emerging markets there is a fast-growing middle class, but
also the majority of the world population who live on less than $2 a
day. For both groups, smart products and solutions tailored to their
needs can really improve their lives.
We have a long-established presence, strong brand awareness and a large
workforce in the emerging economies. Together with our increasing
resource investment, this gives us the home-grown insights needed to
produce appropriate and relevant solutions. We have developed
innovative technologies and approaches to address particular healthcare
and lighting issues, for instance our SureSigns patient monitors and
Uday solar-powered lanterns. And we provide market-specific consumer
products in response to unique customer needs. For example, the rice
cooker range for the Asian market, the water purifier for India and the
Maté kettle in countries such as Brazil and Argentina.
THE
potential is tremendous
Philips Annual Report 2008 31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 Performance highlights
|
|
8 Message from
the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance |
1.6 billion
invested in R&D in 2008
Addressing indoor air quality
While the effects of outdoor air pollution have been well
documented, relatively little attention has been paid to
the quality of indoor air. Figures released by the World
Health Organization in 2007 claimed that in a number of
countries including several emerging economies indoor
air pollution is responsible for a total of 1.2 million
deaths a year. Children, WHO noted, were impacted even
more than adults in succumbing to acute respiratory
conditions attributed to indoor air pollution.
These alarming statistics played a significant part in
the creation of Philips new Water & Air category.
More than 70% of consumers feel that the air quality
will impact their long-term health, says Sridhar
Kumaraswamy, the Water & Air category leader. This same
research also indicated that about half of households are
not satisfied with their indoor air quality. We have
chosen to address its provision with a very
market-specific approach for our Clean Air Systems range,
based on different priorities in each market.
European air quality under threat
Philips insight has shown that Europeans are mostly
concerned about the amount of dust and especially
allergens in indoor air. 55% say they have a problem
with it, even though only 5% of European households own
an air cleaner, says Sridhar. Europes growing city
populations two-thirds of Europeans will be city
dwellers by 2050 are being increasingly exposed to a
whole range of pollutants, from harmful gases, viruses
and bacteria, to fine dust, pollen and cooking waste. The
design and construction of modern homes is also less
effective in dispersing indoor pollutants.
With more people than ever before living in cities in
both the developed world and in emerging markets, there
is greater concern about the impact city living has on
health and well-being.
Emerging markets facing environmental challenges
In emerging markets like China, the situation is somewhat
different: People living in Chinas cities face the same
indoor air pollution issues as anywhere else like dust,
chemical emissions, pollen, tobacco smoke, bacteria and
viruses, says Sridhar. However, the expanding economy
has created additional environmental challenges as a
result of things like construction projects and increased
car ownership.
Awareness of domestic air quality in China is growing,
and interest in buying an air cleaner is high (around 85%
of households). In China, Philips has focused on
addressing family health with its Clean Air Systems. In
a big city like Shanghai, notes Sridhar, people might
be inhaling over 50 million particles with every breath.
Since children breathe even more air than adults up to
twice as much they will inhale even higher levels of
airborne contaminants. So, every breath that a child
takes, at home and outdoors, can affect his or her growth
and development.
32 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
70 Our sector performance
|
|
94 Risk management
|
|
110 Our leadership
|
|
114 Supervisory Board report
|
|
122 Performance statements |
Providing a sustainable healthcare infrastructure
2008 marked the completion of the installation phase of a
six-year program to modernize the healthcare
infrastructure of the Republic of Zambia. Part of the
Dutch governments ORET international development
initiative, the project has seen substantial improvements
made to 71 hospitals across the country. It also has
included the training of over 200 local hospital staff,
creating a sustainable skills base to ensure a brighter
future for the provision of healthcare in the country.
The EUR 25 million project included the installation and
maintenance of diagnostic imaging equipment including
mobile X-ray, fluoroscopy, ultrasound scanners,
operating theaters and dental treatment systems. Funding
was provided by the Dutch and Zambian governments, each
contributing 50% of the projects costs.
Working with partners
With overall responsibility for project implementation,
we partnered with education provider Fontys to train a
local workforce of radiologists, laboratory technicians,
nurses, midwives and other medical staff. We partnered
with Simed, a provider of turnkey healthcare solutions,
to provide surgical and dental solutions for the project.
We will continue to maintain the equipment we installed,
and with Fontys we have implemented a train-the-trainer
program to ensure that the projects benefits continue to
be realized for years to come.
Healthy people, healthy living, healthy planet
At the Philips Simplicity Event 2008 held on Moscows Red
Square, Philips unveiled a range of innovative concepts
addressing peoples need to be healthy and to live a
healthy lifestyle while maintaining a sustainable
environment.
The concepts presented at this fourth edition focused on
the responsible domestic use of resources, harnessing
renewable energy and the responsible consumption of
goods.
Ongoing co-creation
The simplicity-led design concepts are not intended for
introduction to the market in exactly the form seen at
the Event. Instead, as part of our innovation enrichment
strategy, they exist to promote dialogue, to allow people
to experience our ideas, to trigger reactions, and to
test the water for potential products.
The Simplicity Event brings into sharp focus the
positive impact that Philips can have on peoples lives
on their health, environment, security and sense of
well-being.
Geert van Kuyck, Chief Marketing Officer
All are technologically viable within a three- to
five-year time frame and are designed to address the
needs and aspirations of people and society.
Philips Annual Report 2008 33
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 Performance highlights
|
|
8 Message from
the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance |
Our people, our planet, our partners
We work to improve the health and well-being of people inside and outside our
company, as well as the quality of the world we live in.
Gerard Kleisterlee, President
We do this both through what we do the products and services we bring to
the market as well as the way we work: engaging our employees; focusing
our social investment in communities on education in energy efficiency
and healthy lifestyles; reducing the environmental impact of our products
and processes; and driving sustainability throughout our supply chain.
We develop our peoples talents and encourage them to make the most of
themselves both at work and in their personal lives.
With a set of measurable targets, we are driving revenues from Green
Products, increasing investment in Green Innovations, and raising the
energy efficiency of our operations. Green Product development and
innovation also means reducing the chemical content of our products and
designing them more effectively for collection and recycling.
And we consider our suppliers as partners in our sustainability
initiatives, taking care of the environment and of workers lives.
Its
about all of us and the environment
34 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
70 Our sector performance
|
|
94 Risk management
|
|
110 Our leadership
|
|
114 Supervisory Board report
|
|
122 Performance statements |
Philips
Annual Report 2008 35
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 Performance highlights
|
|
8 Message from
the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance |
121,000
Philips employees focus on improving
peoples lives through timely
innovations
Engaging for success
Engaged people with a winning spirit are essential if we
are to achieve our growth ambitions. Our aim is to
develop our business further by creating products that
improve peoples lives. At the same time, we believe in
improving our own peoples lives by creating a fulfilling
and exciting work environment.
We believe engagement is about creating an
inclusive and high-energy working environment.
Empowering people
We are committed to enabling our people to grow,
empowering them to be creative in a culture of trust and
confidence. Thats why we continue to focus on boosting
engagement and improving talent development.
At Philips, we believe engagement is about creating an
inclusive and high-energy working environment, where all
employees are aligned and energized to contribute to our
business success. An engaged workforce delivers a
competitive advantage our people are highly motivated
to give their best every day.
Our engagement process
Engagement can be stimulated but it cannot be mandated.
Getting there is a journey and like every journey to
reach our destination we need a road map. Our engagement
process is just that a foundation for a road map that
allows us to check where we are and where we are headed.
On a regular basis, we measure where we are in our
engagement journey. Through the Engagement Survey, we
ask our employees to give confidential feedback on 44
items. This enables us to continually strive for even
higher levels of employee satisfaction and loyalty as
well as referral to and pride in the company.
Taking action
Results are distributed throughout the organization, and
teams are encouraged to get together to talk about the
results in Deep Dive sessions. Strengths and weaknesses
are discussed in an open and honest dialogue; the root
causes of any issues that have arisen from the survey are
addressed and corrective actions put in place.
Action can be taken at various levels company,
sector, country, function, business, team and even at
individual manager level.
Responsible restructuring
In 2008 the global economy took an unforeseen, unprecedented downturn. Unfortunately this
has necessitated job cuts throughout the entire Philips organization. In this regard we
follow one principle: we first inform and consult works councils and employees before making
public announcements on specific programs and details on a case by case basis. As a
people-centric organization we are doing everything within our power to support those
affected with the utmost responsibility and respect. This includes looking for alternative
employment within the company for colleagues who face being laid off, providing social plans
where applicable, organizing work-to-work trajectories and assigning outplacement coaches.
These measures may vary depending on local work conditions and regulations.
36 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
70 Our sector performance
|
|
94 Risk management
|
|
110 Our leadership
|
|
114 Supervisory Board report
|
|
122 Performance statements |
Diversity and inclusion initiative evolves
We recognize and appreciate the wide variety of people
who work for us. Each individual is unique, with his or
her own background, culture, characteristics, skills and
ambitions. Our customers are equally unique, and thanks
to our diversity we can better understand them and meet
their needs.
Achieving our target for 2008, women now comprise nearly
10% of executives across the company. Thats more than
double the figure of 5% in 2005. Next we want to increase
that number to 15% by 2012. Further, we want to get more
talented local people into key positions in our growth
markets.
Understanding female customers
Since it was founded in 2004 our womens network,
WINergy, has focused on support and mentoring. WINergys
scope expanded in 2008 as the network took steps to
evolve into an in-house consultancy to reach out to
female customers.
Thanks to our diversity we can better understand
our customers and meet their needs.
Women representing our sectors and various functional
areas attended workshops in the Netherlands and the
United States to learn more about our end-users. Now
marketers can reach out to WINergy members to help them
generate consumer insights during the product creation
process.
GLBT
We have been working with a GLBT (gay, lesbian, bisexual
and transgender) focus group to decide if we should
create a network, and if so what kind of activities we
should develop on behalf of and driven by our GLBT
community. We have established Philips Pride, our network
for gays and lesbians. Additionally, we joined the
Company Pride Platform in 2008 with a number of other
multinational companies and co-sponsored its annual
conference in Amsterdam.
Philips General Business Principles
The Philips General Business Principles (GBP) are
defined to ensure integrity and transparency in our
activities and to our stakeholders. Our work on business
ethics is dynamic, featuring ongoing communications and
updates of our GBP Directives.
Increasing awareness
We launched a communications program to strengthen
employees awareness of the principles, as well as their
importance and how they underpin business integrity.
Targeting all employees, the program consists of modules
that enable sector and regional leaders to deliver the
message, illustrating managerial commitment at the local
level. The communications package features a range of
tools from simple e-mails and printed media to online
messaging including intranet videos.
Our work on business ethics is dynamic.
A thorough updating process
Our mid-2008 update of the GBP Directives is based on
many factors. It takes into account experience gained
with the previous GBP Directives, trends in legislation
and society, and developments in major codes of conduct
like the Electronics Industry Code of Conduct. Also
included are demands of key accounts and business ethics
issues that experience shows require further elaboration
into concrete directives to ensure adequate compliance.
15%
women executives by 2012
Philips Annual Report 2008 37
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 Performance highlights
|
|
8 Message from
the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance |
Reducing our environmental footprint
We continuously work on improving the environmental
performance of our products across their entire lifespan
by investing in EcoDesign, green technologies and
measures to further reduce our environmental footprint.
We make these investments because we recognize the
importance of considering, as architect and designer
William McDonough says, all children, all species, for
all time. We believe that our products will not only
become increasingly environmentally friendly but also
even more useful and attractive for our customers.
The global warming challenge
Climate change has been recognized globally as one of
the most serious human-made threats to our
civilization. Today, however, as author George Monbiot
puts it, the risk is not that climate change is not a
subject of debate anymore but rather that we keep on
talking.
Commitment and action is required by all parts of society
including authorities, business and consumers. In Tokyo
in July 2008, the G8 leaders pledged to move to a
carbon-free society through cutting global emissions by
50% in 2050.
At Philips we are convinced that we can contribute to the
required transition to a low-carbon world, not only with
environmentally sound products, services and
technologies, but also by actively seeking the dialogue
with all stakeholders including our customers and
suppliers.
With the launch of our latest EcoVision program in
2007, we have therefore committed to reduce CO2
emissions with a sharp focus on energy-efficient
products, green innovation and energy efficient
day-to-day operations.
38 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
70 Our sector performance
|
|
94 Risk management
|
|
110 Our leadership
|
|
114 Supervisory Board report
|
|
122 Performance statements |
EcoVision4
Green Products
We use the Philips Green logo to identify an increasing
number of our Green Products, making it simple for our
customers and end-users to make responsible choices.
With increasing concern about the impact of CO2
emissions on the climate, we will continue to ensure that
our products offer superior energy efficiency. We also
remain committed to giving our full attention to all
relevant environmental and social dimensions, including
the chemical content of products and reliable as well as
effective collection and recycling.
In 1994 we were at the forefront when we developed
procedures for Environmentally Conscious Product Design
what we call EcoDesign. To support this process, we
introduced our Green Focal Areas (shown far right) in
1998.
Today Green Products represent a significant share of
our revenues in all of the markets we serve.
Green Innovations
Sustainability is recognized as a strategic driver for
innovation at Philips. With our commitment to Green
Innovations we are looking at today and tomorrow what
we can simply categorize as now (roadmap development),
soon (adjacencies, which can also be outside the scope of
our current portfolio) and later (breakaway innovations).
Our research portfolio is regularly reviewed from a
sustainability angle to ensure that we are on track to
deliver on our EcoVision commitments.
Operational energy efficiency
Focusing on operational energy efficiency is not only
essential to reduce our greenhouse-gas emissions,
including CO2, it also drives overall efficiency and savings.
In this context we have identified a number of strategic
initiatives driven by dedicated teams to further
strengthen the energy efficiency of our operations and
reduce our greenhouse-gas emissions
including CO2. All initiatives are sponsored by senior
executives and progress is closely monitored.
Examples include systematic energy scans at our
manufacturing sites globally, Green IT, Green Logistics,
Green Facility management and Green Supply Chain. While
some of these initiatives may primarily have a financial
impact, others engage our employees, influencing them to
make simple switches that have a big impact, and some,
like the examples below, offer both.
We have identified a number of strategic initiatives to
further strengthen the energy efficiency of our
operations and reduce our greenhouse-gas emissions.
Our Green IT initiative addresses our use of computers and
accompanying peripherals, as well as IT infrastructure.
Elements of the project include providing employees with
green computing tips and allowing them to submit their
ideas, as well as encouraging them to be energy educators.
Green IT power scan results are published weekly,
illustrating the declining percentage of PCs online at
night in each region.
To reduce business travel, we have introduced a new
video-conferencing system available via the intranet that
is as easy as face-to-face and is available for virtual
team-gatherings around the world.
Philips Annual Report 2008 39
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 Performance highlights
|
|
8 Message from
the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance |
Product stewardshipm
With a deep understanding that our influence on the
environmental performance of our products does not end
at the time of sale, we are committed to continuously
improve their ecological impact throughout their
lifespan. We believe that this also will make our
products truly better, creating value for people, the
planet and the company.
Cradle to Cradle
Our engineers, marketers and designers are inspired by
the concept of Cradle to Cradle. This paradigm encourages
a mindset shift from being less bad to doing good for
the environment. It sets a vision of a world based on
renewable energy, full of materials continually recycled
and applied with safety and health in mind.
For Philips, the ongoing exploration of Cradle to Cradle
means the search for innovative products, processes and
services that use materials and energy effectively. Eight
project teams from Consumer Lifestyle have conducted
feasibility studies, and pilots are now in progress.
We featured the Circle of Life at our Simplicity Day
Event in Moscow. This concept for delivering
responsible goods invites people to co-create and make
choices based on the entire chain of the products
life, including the phases before purchase and after
disposal.
We are committed to manage our collection and
recycling initiatives to continuously advance in
this area.
Collection and recycling
Society increasingly expects companies to take action
for products at their end-of-life. In areas where
regulation is in place, such as Europe or the United
States, people look to companies to step up their
efforts to increase collection ratios. Similar
expectations are surfacing in countries where
legislation is still in development.
To do just that, we are working to:
|
|
minimize environmental impact through EcoDesign of our products, which includes design for
recycling |
|
|
|
support the development of legislation to create a level playing field, also enabling
collection and recycling of old products whose brand has disappeared from the market |
|
|
|
drive
expansion of collection and recycling services, for example by starting up voluntary activities in
India and Brazil in 2008 |
|
|
|
drive the development of environmentally friendly recycling systems and
technologies with sufficient economies of scale |
|
|
|
support the education of consumers on the subject
of collection and recycling, and communicating clearly and consistently to all stakeholders. |
Chemical content of products
The European REACH legislation is concerned with the
Registration, Evaluation, Authorization and Restriction
of Chemical substances. Underpinned by the precautionary
principle, the aim of REACH is to further improve the
protection of human health and the environment through
the better and earlier identification of certain chemical
substances.
To ensure compliance and no interruption in the supply
flow, we have asked our chemicals suppliers to
pre-register chemicals supplied to us. The limited number
of chemicals that we produce ourselves have been
pre-registered with the European Chemicals Agency (ECHA).
Additionally, we have requested information on relevant
chemicals from our component or finished products
suppliers.
40 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
70 Our sector performance
|
|
94 Risk management
|
|
110 Our leadership
|
|
114 Supervisory Board report
|
|
122 Performance statements |
Supplier sustainability
We believe achieving a sustainable supply base is a
matter of taking care of workers lives and the
environment. As a member company of the Electronic
Industry Citizenship Coalition (EICC) we share the
organizations goal to improve conditions in the
electronics supply chain.
Our approach
The Philips Supplier Sustainability Program is built on
five pillars. We clearly set out our requirements, build
understanding and agreement, and monitor identified risk
suppliers through audits, nearly 60% of which are now
conducted by specialized external auditing bodies. We
work with suppliers to resolve issues quickly and engage
stakeholders in the chain.
We seek constructive dialogue and the opportunity to
engage in specific projects with all relevant
stakeholders in the chain.
To determine where to focus our efforts, we have developed
an approach based on a risk profile related to spend,
country of production, business risk and type of supplier
relationship. In 2008, the integration of new acquisitions
included training their Supply Management staff and then
analyzing their supply bases with regard to sustainability
risk. Where risk has been identified we conduct awareness
training with suppliers to prepare for third-party audits.
Resolving issues quickly is a key component of our
approach. Corrective action plans are agreed upon within
one month of an audit. One of our sustainability officers follows up monthly and will escalate the issue to
the responsible purchasing manager as necessary to ensure
zero-tolerance issues are resolved within three months.
In this way all zero-tolerances from 2007 and those from
the first three quarters of 2008 have been resolved.
With three years of audit experience we have developed a
list of topics that need to be addressed with our
suppliers. Continual conformance audits show that a
multi-year approach to training and auditing is
essential to engrain sustainability in the supply chain.
Sustainable NPR procurement and supply
As part of our ongoing efforts to minimize our
environmental impacts, as well as meet our EcoVision4
targets, our commodity teams have a number of projects
under way. These projects include the previously
mentioned Green Supply Chain initiative, as well as
continuing sustainable procurement in marketing and
sales.
Working with stakeholders
We seek constructive dialogue and the opportunity to
engage in specific projects with all relevant
stakeholders in the chain. Much of this work is done via
the EICC and bilateral meetings with investors and NGOs.
One example is a project in Dongguan, China, focusing on
working hours, which is the most frequent labor issue
found during audits. We believe that cooperation with the
EICC and local governments is the only way to truly
achieve sustainable change.
Philips is also an active member of other EICC working
groups to resolve specific issues at industry level,
including the Global e-Sustainability Initiative on the
health and well-being of people working in the mining
industry.
Philips Annual Report 2008 41
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 Performance highlights
|
|
8 Message from
the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance
Management discussion
and analysis |
42 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector performance
|
|
94 Risk management
|
|
110 Our leadership
|
|
114 Supervisory Board report
|
|
122 Performance statements |
Management discussion and analysis
Management summary
The year
2008...
|
|
2008 was impacted by the most globally significant economic downturn in many years. For
Philips, this led to a 3% decline in comparable sales and lower earnings. In response, we
proactively expanded and accelerated restructuring programs across all sectors and stepped up
our focus on costs and cash management. |
|
|
2008 was nevertheless a year of strategic progress. We continued the reshaping of our
portfolio by investing EUR 5.3 billion in high-growth, high-margin businesses such as
Respironics and Genlyte, and divesting unprofitable activities such as Television in North
America and non-core businesses such as Set-Top Boxes and PC Monitors. |
|
|
Healthcare sales grew by 6% on a comparable basis; all businesses contributed to this growth.
Lighting achieved 3% comparable sales growth, driven by energy-efficient lighting solutions.
Consumer Lifestyle sales on a comparable basis, declined 8% compared to 2007, reflecting the
severe economic downturn in consumer markets in the second half of 2008. |
|
|
Emerging markets remained a major focal point and delivered 4% comparable growth in 2008
with Healthcare and Lighting growing by 12% and 8% respectively. Additionally, we announced
and/or finalized five strategic Healthcare acquisitions in China, Brazil and India. |
|
|
EBIT included EUR 1.1 billion of charges related to restructuring and change programs across
all sectors (EUR 520 million), an asbestos-related settlement charge (EUR 239 million), a
non-cash goodwill impairment charge for Lumileds (EUR 232 million) and acquisition-related
charges, mainly in Healthcare and Lighting (EUR 146 million), which were partially offset by
EUR 164 million of gains on the sale of businesses and real estate. |
Key data
in millions of euros unless otherwise stated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20061) |
|
|
20071) |
|
|
2008 |
|
Sales |
|
|
26,682 |
|
|
|
26,793 |
|
|
|
26,385 |
|
EBITA2) |
|
|
1,383 |
|
|
|
2,054 |
|
|
|
931 |
|
as a % of sales |
|
|
5.2 |
|
|
|
7.7 |
|
|
|
3.5 |
|
EBIT |
|
|
1,198 |
|
|
|
1,841 |
|
|
|
317 |
|
as a % of sales |
|
|
4.5 |
|
|
|
6.9 |
|
|
|
1.2 |
|
Financial income and expenses |
|
|
28 |
|
|
|
2,613 |
|
|
|
(225 |
) |
Income tax expense |
|
|
(166 |
) |
|
|
(619 |
) |
|
|
(286 |
) |
Results of equity-accounted
investees |
|
|
(157 |
) |
|
|
763 |
|
|
|
19 |
|
Minority interests |
|
|
(4 |
) |
|
|
(5 |
) |
|
|
(3 |
) |
Income (loss) from continuing
operations |
|
|
899 |
|
|
|
4,593 |
|
|
|
(178 |
) |
Income (loss) from discontinued
operations |
|
|
4,482 |
|
|
|
(433 |
) |
|
|
(8 |
) |
Net income (loss) |
|
|
5,381 |
|
|
|
4,160 |
|
|
|
(186 |
) |
Per common share basic |
|
|
4.58 |
|
|
|
3.83 |
|
|
|
(0.19 |
) |
Per common share diluted |
|
|
4.55 |
|
|
|
3.79 |
|
|
|
(0.19 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net operating capital (NOC)2) |
|
|
8,473 |
|
|
|
10,529 |
|
|
|
14,867 |
|
Cash flows before financing
activities |
|
|
(2,472 |
) |
|
|
5,449 |
|
|
|
(1,606 |
) |
Employees (FTEs) |
|
|
121,732 |
|
|
|
123,801 |
|
|
|
121,398 |
|
of which discontinued
operations |
|
|
6,640 |
|
|
|
5,703 |
|
|
|
|
|
|
|
|
1) |
|
Revised to reflect immaterial adjustments of intercompany profit eliminations on inventories |
|
2) |
|
For a reconciliation to the most directly comparable US GAAP measures, see Reconciliation of
non-US GAAP information that begins on page 250 of this Annual Report |
|
|
We generated strong cash flows from operations of EUR 1,495 million despite lower earnings,
driven by rigorous working capital management. In addition, in March we structurally
refinanced our debt prior to the collapse of the financial markets providing Philips with
a strong balance sheet and a solid liquidity position to help weather the turbulent economic
situation. |
|
|
We reduced our shareholding in LG Display and sold our remaining stake in TSMC, generating
EUR 2.5 billion in cash proceeds and realizing a gain of just under EUR 1.2 billion. The
economic downturn led us to take a non-cash value adjustment of EUR 1.4 billion on the majority
of our remaining financial holdings. |
|
|
We completed EUR 3.3 billion of the EUR 5 billion share buy-back program announced in 2007,
which was subsequently stopped in January 2009 until further notice. Additionally, we returned
EUR 720 million to shareholders in the form of our annual dividend payment. |
Philips Annual Report 2008 43
|
|
|
|
|
|
|
|
|
6 Performance
highlights |
|
8 Message from the President |
|
14 Who we are |
|
18 We care about.... |
|
42 Our group performance
Management discussion and analysis |
Forward-looking statements
This document contains certain forward-looking statements with respect to the financial condition,
results of operations and business of Philips and certain of the plans and objectives of Philips
with respect to these items, in particular the Outlook section of the chapter Our group performance
in this Annual Report. Examples of forward-looking statements include statements made about our
strategy, estimates of sales growth, future EBITA and future developments in our organic business.
By their nature, forward-looking statements involve risk and uncertainty because they relate to
future events and circumstances and there are many factors that could cause actual results and
developments to differ materially from those expressed or implied by these forward-looking
statements.
These factors include, but are not limited to, domestic and global economic and business
conditions, particularly in light of the ongoing recessionary condition prevailing in many markets,
the successful implementation of our strategy and our ability to realize the benefits of this
strategy, our ability to develop and market new products, changes in legislation, legal claims,
changes in exchange and interest rates, changes in tax rates, pension costs, raw materials and
employee costs, our ability to identify and complete successful acquisitions and to integrate those
acquisitions into our business, our ability to successfully exit certain businesses or restructure
our operations, the rate of technological changes, political, economic and other developments in
countries where Philips operates, industry consolidation and competition. As a result, Philips
actual future results may differ materially from the plans, goals and expectations set forth in
such forward-looking statements. For a discussion of factors that could cause future results to
differ from such forward-looking statements, see also the chapter Risk management.
Third-party market share data
Statements regarding market share, including those regarding Philips competitive position,
contained in this document are based on outside sources such as specialized research institutes,
industry and dealer panels in combination with management estimates. Where full-year information
regarding 2008 is not yet available to Philips, those statements may also be based on estimates and
projections prepared by outside sources or management. Rankings are based on sales unless otherwise
stated.
Fair value information
In presenting the Philips Groups financial position, fair values are used for the measurement of
various items in accordance with the applicable accounting standards. These fair values are based
on market prices, where available, and are obtained from sources that are deemed to be reliable.
Readers are cautioned that these values are subject to changes over time and are only valid at the
balance sheet date. When an observable market value does not exist, fair values are estimated using
valuation models, which we believe are appropriate for their purpose. They require management to
make significant assumptions with respect to future developments which are inherently uncertain and
may therefore deviate from actual developments. Critical assumptions used are disclosed in the
financial statements. In certain cases, independent valuations are obtained to support managements
determination of fair values.
US GAAP basis of presentation
The financial information included in this document is based on US GAAP, unless otherwise
indicated. As used in this document, the term EBIT has the same meaning as Income from operations
(IFO).
Use of non-US GAAP information
In presenting and discussing the Philips Groups financial position, operating results and cash
flows, management uses certain non-US GAAP financial measures like: comparable growth; EBITA; NOC;
net debt (cash); free cash flow; and cash flow before financing activities. These non-US GAAP
financial measures should not be viewed in isolation as alternatives to the equivalent US GAAP
measures.
Further information on non-US GAAP information and a reconciliation of such measures to the most
directly comparable US GAAP measures can be found in the chapter Reconciliation of non-US GAAP
information.
Statutory financial statements and management report The chapters IFRS financial statements and
Company financial statements contain the statutory financial statements. The introduction to the
chapter IFRS financial statements sets out which parts of this Annual Report form the management
report within the meaning of Section 2:391 of the Dutch Civil Code (and related Decrees).
Revision and reclassifications
Philips has revised prior-year financials to reflect immaterial adjustments of intercompany profit
eliminations on inventories in the Healthcare sector. Philips has determined that those adjustments
were not material for each of the individual prior years. Further information is provided in the
chapter Significant accounting policies in the section Revisions and reclassifications.
As of January 1, 2008, Philips activities are organized on a sector basis, with each operating
sector Healthcare, Consumer Lifestyle and Lighting being responsible for the management of its
businesses worldwide. The Healthcare sector brings together the former Medical Systems division and
Home Healthcare Solutions (formerly Consumer Healthcare Solutions) which has been transferred from
Innovation & Emerging Businesses. The former Consumer Electronics and Domestic Appliances and
Personal Care divisions have been integrated in the Consumer Lifestyle sector. In addition, key
financials of the segment Television, part of the sector Consumer Lifestyle, have been disclosed
separately. As a consequence of the aforementioned, prior-year financials have been restated.
Analyses of 2007 compared to 2006
The analysis of the 2007 financial results compared to 2006, and the discussion of the critical
accounting policies, have not been included in this Annual Report. These sections are included in
Philips Form 20-F for the financial year 2008, which is filed electronically with the US
Securities and Exchange Commission.
44 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector
performance |
|
94 Risk management |
|
110 Our leadership |
|
114 Supervisory Board
report |
|
122 Performance statements |
Sales
In percentage terms, the composition of sales growth in 2008, compared to 2007, was as shown in the
table on the right.
Group sales totaled EUR 26,385 million in 2008, a 2% decline compared to 2007. Adjusted for
unfavorable currency effects of 3% and a positive net impact from portfolio changes, mainly due to
the acquisition of Genlyte and Respironics, comparable sales were 3% lower than 2007. Excluding the
Television business which we manage for margin rather than scale Group comparable sales were in
line with 2007.
The decline in comparable sales was mainly due to the severe economic downturn, particularly in the
consumer markets. This was predominantly felt within Consumer Lifestyle, which reported an 8%
decline in comparable sales, led by a 12% sales decrease at Television, as well as lower sales in
Audio & Video Multimedia and Peripherals & Accessories.
This decline was partly tempered by 6% comparable sales growth at Healthcare, with higher sales
visible in emerging markets and across all businesses, notably Customer Services, Clinical Care
Systems, and Healthcare Informatics and Patient Monitoring. Additionally, Lighting saw a 3%
comparable sales increase, mainly attributable to strong growth in energy-efficient lighting
solutions, partly offset by lower sales in OEM automotive and consumer-related lighting markets.
Sales growth composition 2008 versus 2007
in %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
com- |
|
|
|
|
|
|
consoli- |
|
|
|
|
|
|
parable |
|
|
currency |
|
|
dation |
|
|
nominal |
|
|
|
growth |
|
|
effects |
|
|
changes |
|
|
growth |
|
Healthcare |
|
|
5.6 |
|
|
|
(4.5 |
) |
|
|
14.1 |
|
|
|
15.2 |
|
Consumer Lifestyle |
|
|
(8.5 |
) |
|
|
(2.7 |
) |
|
|
(5.2 |
) |
|
|
(16.4 |
) |
Lighting |
|
|
2.6 |
|
|
|
(3.8 |
) |
|
|
17.8 |
|
|
|
16.6 |
|
I&EB |
|
|
(26.6 |
) |
|
|
(0.9 |
) |
|
|
(9.6 |
) |
|
|
(37.1 |
) |
GM&S |
|
|
(24.2 |
) |
|
|
(0.5 |
) |
|
|
|
|
|
|
(24.7 |
) |
Philips Group |
|
|
(2.7 |
) |
|
|
(3.3 |
) |
|
|
4.5 |
|
|
|
(1.5 |
) |
Sales, EBIT and EBITA 2008
in millions of euros unless otherwise stated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
sales |
|
|
EBIT |
|
|
% |
|
|
EBITA1) |
|
|
% |
|
Healthcare |
|
|
7,649 |
|
|
|
638 |
|
|
|
8.3 |
|
|
|
863 |
|
|
|
11.3 |
|
Consumer Lifestyle |
|
|
11,145 |
|
|
|
265 |
|
|
|
2.4 |
|
|
|
281 |
|
|
|
2.5 |
|
Lighting |
|
|
7,106 |
|
|
|
165 |
|
|
|
2.3 |
|
|
|
538 |
|
|
|
7.6 |
|
I&EB |
|
|
337 |
|
|
|
(226 |
) |
|
|
(67.1 |
) |
|
|
(226 |
) |
|
|
(67.1 |
) |
GM&S |
|
|
148 |
|
|
|
(525 |
) |
|
|
|
|
|
|
(525 |
) |
|
|
|
|
Philips Group |
|
|
26,385 |
|
|
|
317 |
|
|
|
1.2 |
|
|
|
931 |
|
|
|
3.5 |
|
Sales, EBIT and EBITA 20072)
in millions of euros unless otherwise stated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
sales |
|
|
EBIT |
|
|
% |
|
|
EBITA1) |
|
|
% |
|
Healthcare |
|
|
6,638 |
|
|
|
713 |
|
|
|
10.7 |
|
|
|
862 |
|
|
|
13.0 |
|
Consumer Lifestyle |
|
|
13,330 |
|
|
|
832 |
|
|
|
6.2 |
|
|
|
848 |
|
|
|
6.4 |
|
Lighting |
|
|
6,093 |
|
|
|
675 |
|
|
|
11.1 |
|
|
|
722 |
|
|
|
11.9 |
|
I&EB |
|
|
535 |
|
|
|
(82 |
) |
|
|
(15.3 |
) |
|
|
(81 |
) |
|
|
(15.1 |
) |
GM&S |
|
|
197 |
|
|
|
(297 |
) |
|
|
|
|
|
|
(297 |
) |
|
|
|
|
Philips Group |
|
|
26,793 |
|
|
|
1,841 |
|
|
|
6.9 |
|
|
|
2,054 |
|
|
|
7.7 |
|
|
|
|
1) |
|
For a reconciliation to the most directly comparable US GAAP measures, see Reconciliation of
non-US GAAP information that begins on page 250 of this Annual Report |
|
2) |
|
Revised to reflect immaterial adjustments of intercompany profit eliminations on inventories |
Philips Annual Report 2008 45
|
|
|
|
|
|
|
|
|
6 Performance
highlights |
|
8 Message from
the President |
|
14 Who we are |
|
18 We care about.... |
|
42 Our group performance
Management discussion
and analysis |
Natural office lighting
Philips DayWave is the first LED-based luminaire for functional office lighting. Incorporating cool
and warm-white LEDs and an innovative optical system, this graceful, curving fixture has been
specifically conceived to create a more natural, inspiring ambience, in order to enhance staff
well-being and performance. Subtle variations and nuances of light level and tone create an effect
more in tune with peoples natural rhythms, contributing to their feeling of well-being.
No other form could better express the flexibility of LED technology.
Architectenkrant, April 2008, issue 216
Earnings
In 2008, Philips gross margin was EUR 8,495 million, or 32.2% of sales, compared to EUR 9,223
million, or 34.4% of sales, in 2007. Adjusted for the 2008 asbestos-related settlement charge of
EUR 239 million, gross margin declined from 34.4% of sales to 33.1%. The majority of this decline
was due to EUR 275 million restructuring and asset impairment charges, attributable to most
sectors.
Selling expenses increased from EUR 4,980 million in 2007 to EUR 5,501 million in 2008, largely due
to additional acquisition-related selling expenses at Healthcare and Lighting, as well as EUR 154
million of restructuring charges across all sectors. These increases were partly offset by lower
selling expenses at Group Management & Services. As a percentage of sales, selling expenses
increased from 18.6% in 2007 to 20.8% in 2008, mainly due to the aforementioned restructuring
charges and the impact of lower sales at Consumer Lifestyle.
General and administrative expenses amounted to EUR 1,016 million, an increase of EUR 97 million
compared to 2007, mainly due to EUR 51 million of restructuring charges, primarily within Lighting
and Consumer Lifestyle, and higher costs in Consumer Lifestyle. As a percentage of sales, G&A
expenses increased from 3.4% in 2007 to 3.9% in 2008, largely due to the lower sales in Consumer
Lifestyle and higher restructuring charges across most sectors.
Research and development costs declined slightly from EUR 1,629 million in 2007 to EUR 1,622
million in 2008 as EUR 40 million of restructuring charges and higher spend in Lighting and
Healthcare were offset by lower expenditures at Consumer Lifestyle. At 6.1% of sales, 2008 R&D
expenditures were in line with 2007.
The overview on the previous page shows sales, EBIT and EBITA according to the 2008 sector
classification.
In 2008, EBIT declined by EUR 1,524 million compared to 2007, to EUR 317 million, or 1.2% of sales.
EBIT included a EUR 232 million non-cash goodwill impairment for Lumileds as well as EUR 15 million
write-off of acquired in-process R&D charges. EBIT and EBITA were both impacted by EUR 520 million
restructuring charges and EUR 131 million of acquisition-related charges, as well as a EUR 239
million asbestos-related settlement charge. 2007 included EUR 37 million of restructuring charges
and EUR 41 million of acquisition-related charges.
Adjusted for the aforementioned charges, EBITA declined from 8.0% of sales to 6.9% in 2008, largely
due to lower sales at Consumer Lifestyle and lower license income at Innovation & Emerging
Businesses.
46 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector
performance |
|
94 Risk management |
|
110 Our leadership |
|
114 Supervisory Board
report |
|
122 Performance
statements |
Healthcares EBITA of EUR 863 million was in line with 2007 and included EUR 69 million of
restructuring charges and EUR 90 million of acquisition-related costs, partially offset by a EUR 45
million gain on the sale of Philips Speech Recognition Services. In 2007, acquisition-related
charges were EUR 11 million. As a percentage of sales, EBITA declined from 13.0% in 2007 to 11.3%
in 2008. However, adjusted for the aforementioned items, EBITA profitability was 12.8% in relation
to sales, broadly in line with 2007.
Consumer Lifestyles EBITA declined from EUR 848 million in 2007 to EUR 281 million in 2008,
largely due to lower sales-driven earnings in all businesses except Health & Wellness and Domestic
Appliances, deteriorating margins within Television, and restructuring charges of EUR 195 million.
The sectors 2008 EBITA included a EUR 63 million gain on the sale of the Set-Top Boxes activity.
EBITA at Lighting declined from EUR 722 million, or 11.9% of sales, in 2007 to EUR 538 million, or
7.6% of sales, in 2008. Additional earnings from acquisitions were offset by EUR 221 million of
restructuring charges, EUR 41 million of acquisition-related charges and margin compression in
mature markets. In 2007, restructuring and acquisition-related charges were EUR 55 million.
The EBITA loss at Innovation & Emerging Businesses amounted to EUR 226 million, compared to a loss
of EUR 81 million in 2007. The decline was mainly due to EUR 81 million lower license income, EUR
18 million restructuring charges at Assembléon, a EUR 13 million loss on the sale of the High Tech
Plastics Optics business, and higher investments in the Healthcare and Lighting & Cleantech
incubator activities.
EBITA at Group Management and Services declined EUR 228 million in 2008 to a loss of EUR 525
million, mainly due to a EUR 239 million asbestos-related settlement charge. Adjusted for this
settlement, GM&S costs saw a year-on-year decline due to lower brand campaign spending.
For further information regarding the performance of the sectors, see the Our sector performance
chapter, starting on page 70 of this Annual Report.
Pensions
The net periodic pension costs of defined-benefit pension plans amounted to EUR 10 million in 2008
compared to EUR 27 million in 2007. The payments to defined-contribution pension plans amounted to
EUR 96 million, EUR 12 million higher than in 2007, largely due to acquisitions and a gradual shift
from defined-benefit to defined-contribution pension plans.
Restructuring and impairment charges
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Restructuring: |
|
|
|
|
|
|
|
|
|
|
|
|
Healthcare |
|
|
14 |
|
|
|
1 |
|
|
|
68 |
|
Consumer Lifestyle |
|
|
25 |
|
|
|
8 |
|
|
|
171 |
|
Lighting |
|
|
43 |
|
|
|
24 |
|
|
|
132 |
|
I&EB |
|
|
|
|
|
|
1 |
|
|
|
18 |
|
GM&S |
|
|
|
|
|
|
4 |
|
|
|
17 |
|
Reduction of excess provisions |
|
|
(5 |
) |
|
|
(5 |
) |
|
|
(2 |
) |
Total restructuring |
|
|
77 |
|
|
|
33 |
|
|
|
404 |
|
Asset impairment: |
|
|
|
|
|
|
|
|
|
|
|
|
Healthcare |
|
|
|
|
|
|
|
|
|
|
1 |
|
Consumer Lifestyle |
|
|
|
|
|
|
|
|
|
|
24 |
|
Lighting |
|
|
5 |
|
|
|
4 |
|
|
|
91 |
|
I&EB |
|
|
|
|
|
|
|
|
|
|
|
|
GM&S |
|
|
|
|
|
|
|
|
|
|
|
|
Total asset impairment |
|
|
5 |
|
|
|
4 |
|
|
|
116 |
|
Goodwill impairment: |
|
|
|
|
|
|
|
|
|
|
|
|
Lighting |
|
|
|
|
|
|
|
|
|
|
234 |
|
Total goodwill impairment |
|
|
|
|
|
|
|
|
|
|
234 |
|
Total restructuring and impairment |
|
|
82 |
|
|
|
37 |
|
|
|
754 |
|
Restructuring and impairment charges
In 2008, EBIT included net charges totaling EUR 520 million for restructuring and related asset
impairments. Besides the annual goodwill impairment tests for Philips, due to the economic
circumstances, trigger-based impairment tests were performed in the latter half of the year,
resulting in goodwill impairment charges of EUR 234 million, mainly related to Lumileds.
The most significant restructuring projects in 2008 were related to Lighting, Consumer Lifestyle
and Healthcare. Restructuring projects in Lighting aimed at further increasing organizational
effectiveness and reducing the fixed cost base mainly centered on Lamps (principally North
America and Poland), Professional Luminaires (notably Germany), Special Lighting Applications
(primarily the Netherlands and Belgium), Automotive (mainly Korea and Germany) and Lighting
Electronics (primarily the Netherlands).
Consumer Lifestyles restructuring projects were concentrated on the integration of the former
Domestic Appliances and Consumer Electronics businesses, the exit of Television from North America,
restructuring of the Television factory in Juarez (Mexico) and restructuring charges taken to
re-align the European industrial footprint. Healthcare restructuring projects undertaken to
reduce operating costs and simplify the organization spanned many locations, including sites in
Hamburg (Germany), Helsinki (Finland) and Andover (USA).
Philips Annual Report 2008 47
|
|
|
|
|
|
|
|
|
6 Performance
highlights |
|
8 Message from the President |
|
14 Who we are |
|
18 We care about.... |
|
42 Our group performance
Management discussion
and analysis |
Financial income and expenses
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Interest expense (net) |
|
|
(189 |
) |
|
|
(43 |
) |
|
|
(106 |
) |
Sale of securities |
|
|
|
|
|
|
2,549 |
|
|
|
1,197 |
|
Value adjustments on securities |
|
|
(77 |
) |
|
|
(36 |
) |
|
|
(1,296 |
) |
Other |
|
|
294 |
|
|
|
143 |
|
|
|
(20 |
) |
|
|
|
28 |
|
|
|
2,613 |
|
|
|
(225 |
) |
Sale of securities
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Gain on sale of TSMC shares |
|
|
|
|
|
|
2,528 |
|
|
|
1,082 |
|
Gain on sale of LG Display shares |
|
|
|
|
|
|
|
|
|
|
83 |
|
Gain on sale of D&M shares |
|
|
|
|
|
|
|
|
|
|
16 |
|
Gain on sale of Nuance shares |
|
|
|
|
|
|
31 |
|
|
|
|
|
Loss on sale of JDS Uniphase shares |
|
|
|
|
|
|
(10 |
) |
|
|
|
|
Others |
|
|
|
|
|
|
|
|
|
|
16 |
|
|
|
|
|
|
|
|
2,549 |
|
|
|
1,197 |
|
Value adjustments on securities
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
NXP |
|
|
|
|
|
|
|
|
|
|
(599 |
) |
LG Display |
|
|
|
|
|
|
|
|
|
|
(596 |
) |
TPO Display |
|
|
(77 |
) |
|
|
|
|
|
|
(71 |
) |
Pace Micro Technology |
|
|
|
|
|
|
|
|
|
|
(30 |
) |
JDS Uniphase |
|
|
|
|
|
|
(36 |
) |
|
|
|
|
|
|
|
(77 |
) |
|
|
(36 |
) |
|
|
(1,296 |
) |
Results of equity-accounted investees
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Companys participation in
income (loss) |
|
|
(180 |
) |
|
|
271 |
|
|
|
81 |
|
Results on sale of shares |
|
|
79 |
|
|
|
514 |
|
|
|
(2 |
) |
Gains arising from dilution effects |
|
|
14 |
|
|
|
|
|
|
|
12 |
|
Investment impairment and
guarantee charges |
|
|
(70 |
) |
|
|
(22 |
) |
|
|
(72 |
) |
|
|
|
(157 |
) |
|
|
763 |
|
|
|
19 |
|
Other restructuring projects included the restructuring of Assembléon within Innovation & Emerging
Businesses and smaller projects at Group & Management Services.
The most significant restructuring projects in 2007 were related to the Lighting sector and
consisted mainly of the exit from the fluorescent lamp-based LCD backlighting business and several
projects in the Lamps business.
For further details of restructuring charges, see note 4 of the US GAAP financial statements.
Financial income and expenses
A breakdown of the financial income and expenses is shown in the table on the left.
The net interest expense in 2008 was EUR 63 million higher than in 2007, mainly as a result of the
lower average cash position of the Group, partly offset by lower interest costs on derivatives
related to the hedging of Philips foreign currency funding positions.
In 2008, a total gain of EUR 1,197 million was recognized on the sale of stakes, mainly in TSMC, LG
Display and D&M Holdings. Also, a EUR 23 million cash dividend was received from TSMC. However,
these gains were more than offset by non-cash value adjustments amounting to EUR 1,296 million,
notably for NXP and LG Display, as well as a EUR 37 million loss related to the revaluation of the
convertible bond received from TPV Technology.
2007 included a gain of EUR 2,549 million on the sale of shares in TSMC, Nuance and JDS Uniphase,
as well as a EUR 128 million cash dividend from TSMC and a EUR 12 million gain related to the
revaluation of the convertible bond received from TPV Technology, partly offset by a EUR 36 million
value adjustment of JDS Uniphase.
Income taxes
Income taxes amounted to EUR 286 million, compared to EUR 619 million in 2007.
The tax burden in 2008 corresponded to an effective tax rate of 311% on pre-tax income, compared to
14% in 2007. The 2008 effective tax rate was affected by non-deductible impairment and value
adjustments, increased valuation allowances, higher provisions for uncertain tax positions and
foreign withholding taxes for which a credit could not be realized. These were partially offset by
non-taxable gains resulting from the sale of securities.
48 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector
performance |
|
94 Risk management |
|
110 Our leadership |
|
114 Supervisory Board
report |
|
122 Performance
statements |
For 2009, the effective tax rate excluding non-taxable items is expected to be around 30%.
For further information, please refer to note 6 of the US GAAP financial statements.
Results of equity-accounted investees
The results relating to equity-accounted investees declined by EUR 744 million in 2008 to EUR 19
million.
Philips participation in the net income of equity-accounted investees declined from EUR 271
million in 2007 to EUR 81 million in 2008, which included EUR 66 million from earnings at LG
Display. These earnings were partly offset by a EUR 59 million non-cash value adjustment on the
equity stake in TPV Technology.
During 2008, as a result of the reduction in both Philips shareholding and the number of Philips
board members, Philips lost significant influence, and LG Display was accounted for as an
available-for-sale security instead of an equity investment.
In 2007, the EUR 514 million proceeds from the sale of shares were mainly due to the EUR 508
million non-taxable gain on the sale of a 13% stake in LG Display. The proceeds from the sale of
stakes in 2008 were recorded under Financial income and expenses.
Minority interests
The share of minority interests in companies within the income of the Group reduced income by EUR 3
million in 2008, compared to EUR 5 million in 2007.
Discontinued operations
Philips reports the results of Semiconductors and the MedQuist business separately as discontinued
operations. Consequently, the related results, including transaction gains and losses, are shown
separately in the financial statements under Discontinued operations.
The loss from discontinued operations of EUR 8 million in 2008 was mainly due to final results
related to MedQuist, which was sold in 2008 to CBAY Inc.
The power to do more
Every day, radiologists and cardiologists are asked to do more in less time, meeting heightened
expectations across a wider range of patients and conditions. Philips brings much-needed simplicity
to this complex process. The latest innovation in computed tomography, Philips Brilliance iCT
offers an impressive combination of speed, power and coverage to improve image quality while
incorporating the latest dose-reduction technology.
In 2007, discontinued operations recorded a loss of EUR 433 million, primarily attributable to a
EUR 360 million impairment charge for MedQuist, taking into account EUR 325 million in cumulative
foreign currency translation differences, which had previously been accumulated under equity since
the date of the acquisition in 2000. In addition, a EUR 43 million loss related to the 2006 sale of
a majority stake in the Semiconductors division was recognized, mainly due to pension settlements.
Net income
Income from continuing operations declined from EUR 4,593 million in 2007 to a loss of EUR 178
million in 2008. The decline was attributable to lower EBIT in 2008 and lower results in financial
income and expenses.
Net income for the Group including discontinued operations amounted to a loss of EUR 186 million,
or EUR 0.19 per common share, in 2008, compared to a profit of EUR 4,160 million, or EUR 3.83 per
common share, in 2007.
Philips Annual Report 2008 49
|
|
|
|
|
|
|
|
|
6 Performance
highlights |
|
8 Message from
the President |
|
14 Who we are |
|
18 We care about.... |
|
42 Our group performance
Management discussion
and analysis |
Saving energy with style
Our new range of sleek, stylish kettles is designed to help you reduce energy consumption by
boiling only the water you actually need. The water-level indicators clearly show when the kettle
has just enough water for either one or two cups, enabling you to cut your kettles energy usage by
up to 66% (boiling 250 ml. vs. 1 liter each time).
Acquisitions and divestments
In 2008, Philips continued its journey to become a health and well-being company by investing in
high-growth, high-margin businesses that are leaders in their respective fields. In line with this
vision, Philips acquired, or announced the intention to acquire, 10 strategic companies during the
year while divesting several non-core, or unprofitable, business interests. This further increased
the proportion of overall sales generated by businesses leading in their markets and increased
sales in emerging markets.
Acquisitions
Within Healthcare, we acquired nine notable companies. In February, Philips acquired VISICU, a
clinical IT system maker which enables critical-care medical staff to actively monitor patients in
hospital intensive care units (ICUs) from remote locations. In March, we acquired Respironics in
what is the companys largest acquisition to date. Respironics is a global leader in the treatment
of Obstructive Sleep Apnea (OSA), and its acquisition has helped form a solid foundation for the
Home Healthcare Solutions business. Furthermore, TOMCAT and Medel SpA were acquired later in 2008,
complementing our Healthcare IT and Home Healthcare Solutions businesses respectively.
Additionally, within emerging markets, five strategic acquisitions were made and/or
announced: Dixtal Biomédica e Tecnologia in Brazil; Shenzhen Goldway in China; within India, Alpha
X-Ray Technologies was acquired while the intention to acquire Meditronics was announced; and in an
acquisition related to the Medel acquisition, Philips acquired a strategically important
manufacturing facility in Guangdong, China for nebulizer compressor systems.
Within Lighting, Philips completed the acquisition of North American luminaires company Genlyte, a
leader in the North American construction luminaires market. This has further solidified Philips
position as the global leader in lighting, with touch-points across the entire global value chain.
In 2008, acquisitions led to integration and purchase accounting charges totaling EUR 146 million,
of which EUR 131 million impacted EBITA. Within the operating sectors, Healthcare incurred charges
totaling EUR 95 million, of which EUR 90 million impacted EBITA, and Lighting incurred EUR 51
million of charges, EUR 41 million of which impacted EBITA.
In 2007, acquisitions led to integration and purchase accounting charges totaling EUR 54 million,
EUR 41 million of which impacted EBITA, primarily at Lighting and Healthcare.
Divestments
In 2008, Philips also sold, or decided to sell, several non-core business interests. These
divestments included the sale of the Set-Top Boxes and Connectivity Solutions activities; the brand
license agreement with respect to the North America television, audio and video businesses; the
sale of Philips Speech Recognition Services (PSRS); the divestment of High Tech Plastic Optics;
the sale of Philips approximate 70% ownership stake in MedQuist; and a brand licensing agreement,
expected to close in the first half of 2009, with regard to the PC Monitors and digital signage business.
In total, net gains from the sale of businesses amounted to EUR 106 million in 2008. There were no
significant net proceeds from the sale of businesses in 2007.
50 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector
performance |
|
94 Risk management |
|
110 Our leadership |
|
114 Supervisory Board
report |
|
122 Performance
statements |
Performance by market cluster
Philips monitors its performance on a geographical axis based on the following market clusters:
|
|
Key emerging markets, including China, India, and Latin America |
|
|
Other emerging markets, including emerging markets in Central and Eastern Europe, Russia,
Ukraine and Central Asia, the Middle East and Africa, Turkey and ASEAN zone |
|
|
Mature markets, including Western Europe, North America, Japan, Korea, Israel, Australia, and
New Zealand. |
In 2008, sales declined 3% comparably as growth in key emerging markets, and relatively stable
sales in other emerging markets were more than offset by a decline in mature markets, largely as a
result of the economic downturn in the second half of the year in Western Europe and North America.
Overall, emerging markets grew 4% on a comparable basis and accounted for 31% of total sales in
2008, a slight increase over 2007.
Key emerging markets saw single-digit sales growth, mainly attributable to double-digit growth in
India (principally Healthcare and Lighting) and Latin America (largely Healthcare and Consumer
Lifestyle), as well as single-digit growth in China.
Other emerging markets comparable sales in 2008 were broadly in line with 2007, as solid growth in
Lighting and Healthcare was partially offset by a decline in Consumer Lifestyle, mainly due to
Television.
The comparatively lower sales in mature markets were largely due to lower Consumer Lifestyle sales
within Western Europe, mainly Television, which more than offset growth in both Healthcare and
Lighting. In North America, lower comparable sales were mainly seen in Consumer Lifestyle and
Lighting, partially offset by sales growth at Healthcare, particularly in Imaging Systems and
Healthcare Informatics and Patient Monitoring.
EBITA in key emerging markets improved EUR 7 million compared to 2007. However, this was more than
offset by a EUR 965 million decline in mature markets, mainly due to lower sales-driven earnings
and higher restructuring charges in Consumer Lifestyle. In addition, a EUR 239 million
asbestos-related settlement charge was recorded in North America. Other emerging markets were also
EUR 165 million below 2007, mainly due to lower sales-driven earnings within Consumer Lifestyle.
EBITA per
market cluster1)
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20062) |
|
|
20072) |
|
|
2008 |
|
Western Europe |
|
|
953 |
|
|
|
1,281 |
|
|
|
439 |
|
North America |
|
|
20 |
|
|
|
304 |
|
|
|
233 |
|
Other mature markets |
|
|
32 |
|
|
|
41 |
|
|
|
(11 |
) |
Total mature markets |
|
|
1,005 |
|
|
|
1,626 |
|
|
|
661 |
|
Key emerging markets |
|
|
125 |
|
|
|
209 |
|
|
|
216 |
|
Other emerging markets |
|
|
253 |
|
|
|
219 |
|
|
|
54 |
|
|
|
|
1,383 |
|
|
|
2,054 |
|
|
|
931 |
|
EBIT per market cluster
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20062) |
|
|
20072) |
|
|
2008 |
|
Western Europe |
|
|
944 |
|
|
|
1,215 |
|
|
|
414 |
|
North America |
|
|
(154 |
) |
|
|
160 |
|
|
|
(288 |
) |
Other mature markets |
|
|
32 |
|
|
|
41 |
|
|
|
(11 |
) |
Total mature markets |
|
|
822 |
|
|
|
1,416 |
|
|
|
115 |
|
Key emerging markets |
|
|
123 |
|
|
|
206 |
|
|
|
209 |
|
Other emerging markets |
|
|
253 |
|
|
|
219 |
|
|
|
(7 |
) |
|
|
|
1,198 |
|
|
|
1,841 |
|
|
|
317 |
|
|
|
|
1) |
|
For a reconciliation to the most directly comparable US GAAP measures, see Reconciliation of
non-US GAAP information that begins on page 250 of this Annual Report |
|
2) |
|
Revised to reflect immaterial adjustments of intercompany profit eliminations on inventories |
Philips Annual Report 2008 51
|
|
|
|
|
|
|
|
|
6 Performance
highlights |
|
8 Message from
the President |
|
14 Who we are |
|
18 We care about.... |
|
42 Our group performance
Management discussion
and analysis |
Research and
development expenditures per sector 1)2)
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Healthcare |
|
|
572 |
|
|
|
592 |
|
|
|
642 |
|
Consumer Lifestyle |
|
|
553 |
|
|
|
492 |
|
|
|
407 |
|
Lighting |
|
|
269 |
|
|
|
276 |
|
|
|
305 |
|
I&EB |
|
|
265 |
|
|
|
269 |
|
|
|
268 |
|
Philips Group |
|
|
1,659 |
|
|
|
1,629 |
|
|
|
1,622 |
|
|
|
|
1) |
|
Includes the write-off of acquired in-process research and development of EUR 15 million in
2008 (2007: EUR 13 million, 2006: EUR 33 million) |
|
2) |
|
Total R&D expenditures include costs related to external contract research, accounting for
3%, 5% and 3% of the Companys R&D expenditures for the years 2006, 2007 and 2008,
respectively. |
Performance by key function
Marketing
Philips brand promise of sense and simplicity continues to drive innovation and customer
experience across all customer touch-points. As a result, in 2008 Philips again achieved
significant growth in its total brand value. Interbrand reported an estimated value of USD 8.3
billion, an 8% increase over 2007. The Interbrand measurement also confirmed the important role the
Philips brand continues to play in the purchase decision of customers across Philips businesses.
In 2008, total worldwide Philips marketing expenses as percentage of sales were 3.6%, just below
the 2007 level, largely as a result of the planned ramp-down of the now largely complete global
brand campaign. Investments in this campaign declined by EUR 47 million in 2008 to EUR 64 million.
On a geographic basis, Philips is shifting a significant portion of its commercial investment from
mature to higher- growth markets, while also increasing the focus and effectiveness of these
investments.
As part of the 2008/9 marketing campaign, Philips is running a major advertising and thought
leadership program on health and well-being issues with A Level media owners such as CNN, CNBC,
FT and The Economist Group. The ultimate aim is to become the brand of first choice among
influencers, professionals and consumers, a brand which stands for sense and simplicity in the
area of health and well-being.
Developing solutions and products based on best- in-class insight into the real needs and wants of
our customer and consumers is increasingly becoming a competitive advantage for Philips. Over half
of our value propositions score above industry benchmarks, with over 30% rated in the top 20% of
all products in their class, giving us confidence that our final solutions will be highly
competitive in the marketplace.
52 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector
performance |
|
94 Risk management |
|
110 Our leadership |
|
114 Supervisory Board
report |
|
122 Performance
statements |
Research & development
The ability of our Research & Development teams to create innovative, meaningful products and
solutions for customers is a critical driver of Philips competitiveness in its markets. Through
substantial R&D investments, Philips has created a vast knowledge and intellectual property base.
Early involvement of customers in new technologies, as well as in product and business concepts,
ensures deep insight into their needs the foundation for our innovations. Starting in 2009, in an
effort to generate more profitable growth and new product and market development from our R&D
investments, Philips will redirect EUR 250 million of innovation spending from mature to emerging
market areas. The redirection of innovation is guided by the newly-formed Philips Innovation board,
chaired by Philips CEO, and the Companys chief officers of Technology, Strategy, Marketing and
Design.
In 2008, Philips investment in R&D activities amounted to EUR 1,622 million (6.1% of sales),
compared with EUR 1,629 million (6.1% of sales) in 2007. Higher expenditures at Healthcare and
Lighting were fully offset by lower expenditures at Consumer Lifestyle. Also, investments in
innovative technologies increased in areas such as energy-efficient and solid-state lighting
solutions as well as in the areas of health and wellness. These increases were offset by lower
expenditures in more mature technologies, such as lamps and television.
Healthcare R&D expenditures increased in 2008, mainly due to the acquisition of Respironics.
Lightings expenditures were also above 2007 as a result of the acquisition of Genlyte and higher
investments in energy-efficient and solid-state lighting solutions. The lower R&D expenditures
within Consumer Lifestyle were mainly due to lower expenditures in maturing product categories,
such as Television. Furthermore, R&D investments at Innovation & Emerging Businesses were on par
with 2007, as higher investments in the Incubator activities were offset by lower external contract
research.
Philips strong innovation pipeline contributed positively to the Companys sales in 2008, as 58%
of Group sales came from newly introduced products products introduced within the last year (for
B2C products) or three years (for B2B products). Compared to last year, a 2% improvement was seen
thanks to above-average contributions from Healthcare and Consumer Lifestyle. Philips aims to
maintain its new-product-to-sales ratio above 50%, while at the same time focusing on the
profitability of new products and reallocating innovation spend more towards new business creation.
Meeting the needs of the city
UrbanLine is a flexible, energy-efficient LED urban lighting solution that delivers a visually
comfortable white light for the residential outdoor market. Urban-Line enables energy savings of up
to 50% compared with conventional street lighting solutions thanks to efficient LED technology
and smart street lighting optics while preventing light pollution. The longer-life LEDs also
reduce maintenance costs.
In 2008, Amsterdam became the first major city to install UrbanLine along the path outside the
town hall/Muziektheater opera house.
Philips Annual Report 2008 53
|
|
|
|
|
|
|
|
|
6 Performance
highlights |
|
8 Message from
the President |
|
14 Who we are |
|
18 We care about.... |
|
42 Our group performance
Management discussion
and analysis |
Employees per sector
in FTEs at year-end
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Healthcare |
|
|
27,223 |
|
|
|
29,191 |
|
|
|
35,551 |
|
Consumer Lifestyle |
|
|
24,419 |
|
|
|
23,397 |
|
|
|
17,346 |
|
Lighting |
|
|
47,739 |
|
|
|
54,323 |
|
|
|
57,166 |
|
I&EB |
|
|
8,832 |
|
|
|
5,888 |
|
|
|
5,324 |
|
GM&S |
|
|
6,879 |
|
|
|
5,299 |
|
|
|
6,011 |
|
|
|
|
115,092 |
|
|
|
118,098 |
|
|
|
121,398 |
|
Discontinued operations |
|
|
6,640 |
|
|
|
5,703 |
|
|
|
|
|
|
|
|
121,732 |
|
|
|
123,801 |
|
|
|
121,398 |
|
Supply management
The Supply Management function has been designed to create value for Philips by leveraging the
scale of the company, thereby creating a single point of management and accountability for our
supply base.
Our approach in turbulent markets
Given the turbulent global economic climate in 2008, proactive risk management and mitigation
strategies aimed at ensuring continuity of supply and competitiveness of sourcing were essential.
Initiatives included enhanced monitoring of the financial stability of the key supplier base and,
where necessary, early intervention to reduce Philips exposure.
Supply Management also assisted in managing the sourcing risk through a pro-active approach towards
key and sole source suppliers, as well as supporting sector-specific initiatives such as a
dual-sourcing strategy for LCD panels and electronic manufacturing services (EMS) in the Consumer
Lifestyle sector.
Additionally, Supply Management teams protected Philips from significant raw material price
fluctuations in 2008, mainly through the use of forward commodity contracts. Also, 2008 saw
progress towards further outsourcing of bill-of-material (BOM) spending: over 50% of Philips BOM
spending is now outsourced, albeit to a smaller, but more focused, number of suppliers.
Our supplier network
The Global Supplier Rating System (GSRS) was further deployed in 2008, providing structured
measurement of supplier performance and rigorous tracking of improvement actions. GSRS covered 85%
of Philips total spend in 2008. Key supplier scores improved 9% in the year to reach a solid
overall rating of 78%.
In 2008, Philips continued to develop the Partners for Growth strategic supplier network, bringing
together its top 30 suppliers to identify and exploit joint business opportunities. This initiative
was combined with our supplier sustainability initiative, which ensures mandatory auditing of all
suppliers with spend above EUR 100,000 in risk areas. This involves tracking all sustainability
issues in risk areas and, where necessary, a highly accelerated resolution of identified issues.
54 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector
performance |
|
94 Risk management |
|
110 Our leadership |
|
114 Supervisory Board
report |
|
122 Performance
statements |
Employment
Excluding discontinued operations (MedQuist in 2007), the total number of employees of the Philips
Group was 121,398 at the end of 2008, compared to 118,098 at the end of 2007. Approximately 47%
were employed in the Lighting sector, due to the still relatively strong vertical integration in
this business. Some 29% were employed in the Healthcare sector and approximately 14% of the
workforce was employed in the Consumer Lifestyle sector.
The main increase in employee numbers in 2008 was due to acquisitions, which added 12,673
employees. The main acquisition-related increases were within Healthcare (mainly Respironics) and
Lighting (Genlyte).
This increase was partially reduced by the divestments in Consumer Lifestyle, primarily the North
America television activities and the sale of Set-Top Boxes. Additionally, restructuring and
business optimization projects resulted in personnel reductions across all sectors, mainly within
Consumer Lifestyle and Lighting.
Approximately 58% of Philips workforce is located in mature markets, with 42% in emerging markets.
In 2008, the number of employees in mature markets increased, largely as a result of the Genlyte
and Respironics acquisitions. This increase was partly offset by restructuring programs across all
sectors. Key emerging markets saw a reduction in employee numbers as additional headcount from the
Healthcare acquisitions in China, India and Brazil was offset by the divestment of HTP Optics, the
sale of the Television factory in Juarez (Mexico) and a reduction of employees due to lower factory
production. The employee decrease in other emerging markets was largely due to low year-end
production volumes in Hungary and the Lamps and Lighting Electronics factory in Poland.
Sales per employee decreased from EUR 224,000 in 2007 to EUR 209,000 in 2008, affected by 3%
unfavorable currency movements compared to 2007.
Adjusted for the 3% adverse foreign currency impact in 2008, sales per employee declined 4%,
largely due to Consumer Lifestyle, caused by a sharp decline in sales in the second half of the
year, as well as Healthcare and Innovation & Emerging Businesses. The decline was partly mitigated
by increases in Lighting and Group Management & Services.
Employees per market cluster
in FTEs at year-end
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Western Europe |
|
|
39,722 |
|
|
|
40,244 |
|
|
|
37,452 |
|
North America |
|
|
22,169 |
|
|
|
21,682 |
|
|
|
31,336 |
|
Other mature markets |
|
|
1,831 |
|
|
|
1,850 |
|
|
|
1,633 |
|
Total mature markets |
|
|
63,722 |
|
|
|
63,776 |
|
|
|
70,421 |
|
Key emerging markets |
|
|
31,893 |
|
|
|
33,377 |
|
|
|
32,084 |
|
Other emerging markets |
|
|
19,477 |
|
|
|
20,945 |
|
|
|
18,893 |
|
|
|
|
115,092 |
|
|
|
118,098 |
|
|
|
121,398 |
|
Discontinued operations |
|
|
6,640 |
|
|
|
5,703 |
|
|
|
|
|
|
|
|
121,732 |
|
|
|
123,801 |
|
|
|
121,398 |
|
Employment
in FTEs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Position at beginning of year |
|
|
159,226 |
|
|
|
121,732 |
|
|
|
123,801 |
|
Consolidation changes: |
|
|
|
|
|
|
|
|
|
|
|
|
- new consolidations |
|
|
4,834 |
|
|
|
6,654 |
|
|
|
12,673 |
|
- deconsolidations |
|
|
(44,085 |
) |
|
|
(3,535 |
) |
|
|
(1,571 |
) |
Comparable change |
|
|
1,757 |
|
|
|
(1,050 |
) |
|
|
(13,505 |
) |
Position at year-end |
|
|
121,732 |
|
|
|
123,801 |
|
|
|
121,398 |
|
of which: |
|
|
|
|
|
|
|
|
|
|
|
|
continuing operations |
|
|
115,092 |
|
|
|
118,098 |
|
|
|
121,398 |
|
discontinued operations |
|
|
6,640 |
|
|
|
5,703 |
|
|
|
|
|
Philips Annual Report 2008 55
|
|
|
|
|
|
|
|
|
6 Performance
highlights |
|
8 Message from
the President |
|
14 Who we are
|
|
18 We care about....
|
|
42 Our group performance
Liquadity and
capital resources |
Condensed consolidated cash flow statements
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
|
5,381 |
|
|
|
4,160 |
|
|
|
(186 |
) |
(Income) loss from discontinued
operations |
|
|
(4,482 |
) |
|
|
433 |
|
|
|
8 |
|
Adjustments to reconcile net income
to net cash provided by operating
activities |
|
|
(569 |
) |
|
|
(3,074 |
) |
|
|
1,673 |
|
Net cash provided by operating
activities |
|
|
330 |
|
|
|
1,519 |
|
|
|
1,495 |
|
Net cash (used for) provided by
investing activities |
|
|
(2,802 |
) |
|
|
3,930 |
|
|
|
(3,101 |
) |
Cash flows before financing activities |
|
|
5,449 |
|
|
|
(1,606 |
) |
|
|
|
|
Net cash used for financing activities |
|
|
(3,715 |
) |
|
|
(2,368 |
) |
|
|
(3,575 |
) |
Cash (used for) provided by continuing
operations |
|
|
(6,187 |
) |
|
|
3,081 |
|
|
|
(5,181 |
) |
Net cash provided by (used for)
discontinued operations |
|
|
7,114 |
|
|
|
(115 |
) |
|
|
(37 |
) |
Effect of changes in exchange rates
on cash and cash equivalents |
|
|
(197 |
) |
|
|
(112 |
) |
|
|
(39 |
) |
Total change in cash and cash equivalents |
|
|
730 |
|
|
|
2,854 |
|
|
|
(5,257 |
) |
Cash and cash equivalents at the
beginning of year |
|
|
5,293 |
|
|
|
6,023 |
|
|
|
8,877 |
|
Less cash and cash equivalents at the
end of year discontinued operations |
|
|
137 |
|
|
|
108 |
|
|
|
|
|
Cash and cash equivalents at the end
of year continuing operations |
|
|
5,886 |
|
|
|
8,769 |
|
|
|
3,620 |
|
Please refer to the consolidated statements of cash flows which are part of the chapter US
GAAP financial statements.
Liquidity and capital resources
Cash flows provided by continuing operations
Condensed consolidated statements of cash flows for the years ended December 31, 2006, 2007 and
2008 are presented on the left.
Cash flows from operating activities
Net cash from operating activities amounted to EUR 1,495 million in 2008, slightly lower than the
EUR 1,519 million cash flows generated in 2007. A decline in sales-driven earnings in Consumer
Lifestyle was largely offset by lower working capital requirements in most sectors and the positive
cash contributions from acquisitions.
Cash flows from investing activities
Cash flows from investing activities were an outflow of EUR 3,101 million in 2008, due to EUR 5,316
million cash used for acquisitions and EUR 722 million used for net capital expenditures, partly
offset by EUR 2,937 million of inflows received mainly from the sale of other non-current financial
assets (mainly TSMC).
2007 cash flows from investing activities amounted to an inflow of EUR 3,930 million as a result of
EUR 6,130 million of proceeds, mainly from the sale of other non-current financial assets (notably
TSMC) and businesses (notably LG Display), partly offset by cash used for acquisitions (EUR 1,502
million) and net capital expenditures (EUR 698 million).
Net capital expenditures
Net capital expenditures totaled EUR 722 million in 2008, EUR 24 million higher than in 2007,
mainly due to acquisition-driven investment increases in Healthcare, as well as higher investments
in solid-state lighting at Lighting. These higher investments were partly offset by higher proceeds
from the sale of real estate within Group Management & Services.
56 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector
performance |
|
94 Risk management |
|
110 Our leadership |
|
114 Supervisory Board
report |
|
122 Performance
statements |
Acquisitions
In 2008, a total of EUR 5,316 million cash was used for acquisitions, mainly for Respironics (EUR
3,196 million), Genlyte (EUR 1,805 million) and VISICU (EUR 198 million).
In 2007, cash disbursements amounting to EUR 1,502 million were used for acquisitions, notably for
PLI (EUR 561 million) and Color Kinetics (EUR 515 million), as well as for DLO, Health Watch, TIR
Systems, Raytel Cardiac Services and Emergin.
Divestments and derivatives
Cash proceeds of EUR 1,831 million and EUR 37 million were received from the final sale of stakes
in TSMC and D&M Holdings respectively. Additionally, the sale of shares in LG Display generated EUR
670 million cash. The maturing of derivatives led to a net cash inflow of EUR 337 million.
In 2007, EUR 4,105 million in cash was received from the sale of other non-current financial
assets, primarily related to TSMC, while EUR 1,640 million cash was generated by the sale of
interests in businesses, including the sale of 46.4 million shares in LG Display. The maturing of
currency hedges led to a net cash inflow of EUR 385 million.
Cash flows from financing activities
Net cash used for financing activities in 2008 was EUR 3,575 million. The impact of changes in debt
was an increase of EUR 380 million, including the issuance of EUR 2,053 million of bonds, offset by
bond repayments amounting to EUR 1,691 million. Also, Philips shareholders were paid EUR 720
million in the form of a dividend payment. Additionally, net cash outflows for share repurchases
totaled EUR 3,257 million. This included a total of EUR 3,298 million related to the repurchases of
shares for cancellation. The cash outflows were partially offset by a net cash inflow of EUR 41
million due to the exercise of stock options.
In 2007, net cash used for financing activities totaled EUR 2,368 million. The impact of changes in
debt was a reduction of EUR 281 million, including a EUR 113 million repayment of long-term bank
borrowings. Furthermore, Philips shareholders were paid EUR 659 million as a dividend payment. Net
cash outflows for share repurchases totaled EUR 1,448 million. This included EUR 810 million
related to hedging of obligations under the long-term employee incentive and employee stock
purchase programs and a total of EUR 823 million related to the repurchases of the shares for
cancellation. These cash outflows were partially offset by a net cash inflow of EUR 161 million due
to the exercise of stock options.
Condensed consolidated balance sheet information
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Intangible assets |
|
|
5,536 |
|
|
|
6,289 |
|
|
|
11,676 |
|
Property, plant and equipment |
|
|
3,084 |
|
|
|
3,180 |
|
|
|
3,484 |
|
Inventories |
|
|
2,834 |
|
|
|
3,146 |
|
|
|
3,371 |
|
Receivables |
|
|
9,651 |
|
|
|
9,500 |
|
|
|
9,275 |
|
Accounts payable and other
liabilities |
|
|
(8,129 |
) |
|
|
(7,799 |
) |
|
|
(8,625 |
) |
Provisions |
|
|
(3,281 |
) |
|
|
(3,089 |
) |
|
|
(3,969 |
) |
Other non-current financial
assets |
|
|
8,055 |
|
|
|
3,183 |
|
|
|
1,331 |
|
Equity-accounted investees |
|
|
2,974 |
|
|
|
1,886 |
|
|
|
284 |
|
Assets of discontinued
operations |
|
|
431 |
|
|
|
333 |
|
|
|
|
|
Liabilities of discontinued
operations |
|
|
(169 |
) |
|
|
(157 |
) |
|
|
|
|
|
|
|
20,986 |
|
|
|
16,472 |
|
|
|
16,827 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
|
5,886 |
|
|
|
8,769 |
|
|
|
3,620 |
|
Debt |
|
|
(3,869 |
) |
|
|
(3,557 |
) |
|
|
(4,158 |
) |
Net cash (debt) |
|
|
2,017 |
|
|
|
5,212 |
|
|
|
(538 |
) |
Minority interests |
|
|
(40 |
) |
|
|
(42 |
) |
|
|
(46 |
) |
Stockholders equity |
|
|
(22,963 |
) |
|
|
(21,642 |
) |
|
|
(16,243 |
) |
|
|
|
(20,986 |
) |
|
|
(16,472 |
) |
|
|
(16,827 |
) |
Please refer to the consolidated balance sheets for 2007 and 2008 which are part of the
chapter US GAAP financial statements.
Changes in debt
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
New borrowings |
|
|
(106 |
) |
|
|
(29 |
) |
|
|
(2,088 |
) |
Repayments |
|
|
543 |
|
|
|
310 |
|
|
|
1,708 |
|
Consolidation and currency effects |
|
|
181 |
|
|
|
31 |
|
|
|
(221 |
) |
Total changes in debt |
|
|
618 |
|
|
|
312 |
|
|
|
(601 |
) |
Cash flows from discontinued operations
In 2008, EUR 37 million cash was used by discontinued operations, the majority of which related to
tax payments in connection with the 2006 sale of Philips majority stake in the Semiconductors
business.
In 2007, EUR 115 million cash was used by discontinued operations, the majority of which was due to
tax payments related to the Semiconductors business and operating cash flows of MedQuist in 2007.
Financing
Consolidated balance sheet information for the years 2008, 2007 and 2006 is presented above.
Philips Annual Report 2008 57
|
|
|
|
|
|
|
|
|
6 Performance
highlights |
|
8 Message from
the President |
|
14 Who we are
|
|
18 We care about....
|
|
42 Our group performance
Liquidity and
capitla resources |
|
|
|
1) |
|
Includes the sale of stakes in mainly TSMC and LG Display |
|
2) |
|
For a reconciliation to the most directly comparable US GAAP measures, see the chapter
Reconciliation of non-US GAAP information |
|
3) |
|
Includes the acquisitions of mainly Respironics, Genlyte and VISICU |
Cash and cash equivalents
In 2008, cash and cash equivalents declined by EUR 5,149 million to EUR 3,620 million at year-end.
The share buyback program led to a cash outflow of EUR 3,298 million while a dividend of EUR 720
million was paid. Furthermore, cash outflows for acquisitions were EUR 5,316 million, partially
compensated by EUR 2,600 million in cash proceeds from divestments. In addition, cash flow from
operations amounted to EUR 1,495 million, partly offset by unfavorable currency changes within cash
and cash equivalents of EUR 39 million.
In 2007, cash and cash equivalents increased by EUR 2,883 million to EUR 8,769 million at the end
of the year. The share buyback program led to a cash outflow of EUR 1,609 million. Furthermore a
dividend of EUR 659 million was paid. Cash outflows for acquisitions amounted to EUR 1,502 million,
partially offset by cash proceeds received from divestments of EUR 5,745 million. The cash flows
from operations amounted to EUR 1,519 million, partly compensated by an unfavorable impact from
currency changes of EUR 112 million which impacted cash and cash equivalents.
Debt position
Total debt outstanding at the end of 2008 was EUR 4,158 million, compared with EUR 3,557 million at
the end of 2007.
In 2008, total debt increased by EUR 601 million. During the year, Philips repaid EUR 1,691 million
of bonds. Repayments under capital leases amounted to EUR 28 million, while EUR 5 million was used
to reduce other long-term debt. These reductions were more than offset by new borrowings which
totaled EUR 2,088 million.
In March, Philips issued EUR 2,053 million of corporate bonds, thereby significantly extending the
overall maturity profile. New borrowings under capital leases totaled EUR 31 million in the year.
Other changes resulting from consolidation and currency effects led to an increase of EUR 221
million.
In 2007, total debt decreased by EUR 312 million. Philips repaid EUR 113 million of bank
facilities; repayments under capital leases amounted to EUR 24 million; and EUR 15 million resulted
from reductions in other long-term debt. Repayments under short-term debt totaled EUR 158 million.
New borrowings totaled EUR 29 million. Other changes resulting from consolidation and currency
effects led to a reduction of EUR 31 million.
Long-term debt as a proportion of the total debt stood at 83% at the end of 2008 with average
remaining term of 10.9 years, compared to 34% at the end of 2007.
Net debt to group equity
Philips ended 2008 in a net debt position (cash and cash equivalents, net of debt) of EUR 538
million, compared to a net cash position of EUR 5,212 million at the end of 2007.
58 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector
performance |
|
94 Risk management |
|
110 Our leadership |
|
114 Supervisory Board
report |
|
122 Performance
statements |
Stockholders equity
Stockholders equity declined by EUR 5,399 million in 2008 to EUR 16,243 million at December 31,
2008. The decrease was mainly attributable to share repurchase programs for capital reduction
purposes, as well as the hedging of long-term incentive and employee stock purchase programs,
reducing equity by EUR 3,298 million. The dividend payment to shareholders in 2008 further reduced
equity by EUR 720 million. Additionally a EUR 1,539 million decrease related to total changes in
comprehensive income, net of tax. The decrease was partially offset by EUR 158 million related to
re-issuance of treasury stock and share-based compensation plans.
Stockholders equity decreased by EUR 1,321 million in 2007 to EUR 21,642 million at December 31,
2007. Share repurchase programs for capital reduction purposes and the hedging of long-term
incentive and employee stock purchase programs resulted in a EUR 1,633 million reduction of equity.
The dividend payment to shareholders in 2007 further reduced equity by EUR 659 million. The
decrease was partially offset by EUR 305 million related to re-issuance of treasury stock and
share-based compensation plans and a further EUR 666 million increase, related to total changes in
comprehensive income, net of tax.
The number of outstanding common shares of Royal Philips Electronics at December 31, 2008, was 923
million (2007: 1,065 million).
At the end of 2008, the Company held 47.6 million shares in treasury to cover the future delivery
of shares. This was in connection with the 65.5 million rights outstanding at the end of 2008 under
the Companys long-term incentive plan and convertible personnel debentures. At the end of 2008,
the Company held 1.9 million shares for cancellation.
At the end of 2007, the Company held 52.1 million shares in treasury to cover the future delivery
of shares. This was in connection with the 61.4 million rights outstanding at year-end 2007 under
the Companys long-term incentive plans and convertible personnel debentures. At the end of 2007,
the Company held 25.8 million shares for cancellation. Treasury shares are accounted for as a
reduction of stockholders equity.
Liquidity position
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Cash and cash equivalents |
|
|
5,886 |
|
|
|
8,769 |
|
|
|
3,620 |
|
Trading securities |
|
|
192 |
|
|
|
|
|
|
|
|
|
Commited revolving credit facility
/ CP program |
|
|
1,898 |
|
|
|
1,698 |
|
|
|
2,274 |
|
Short-term debt |
|
|
(863 |
) |
|
|
(2,345 |
) |
|
|
(717 |
) |
Short-term available liquidity |
|
|
7,113 |
|
|
|
8,122 |
|
|
|
5,177 |
|
Available-for-sale securities at
market value |
|
|
6,529 |
|
|
|
1,776 |
|
|
|
599 |
|
Main listed investments in equity-
accounted investees at market value |
|
|
2,803 |
|
|
|
2,688 |
|
|
|
60 |
|
Long-term debt |
|
|
(3,006 |
) |
|
|
(1,212 |
) |
|
|
(3,441 |
) |
Net available liquidity resources |
|
|
13,439 |
|
|
|
11,374 |
|
|
|
2,395 |
|
|
|
|
1) |
|
Stockholders equity and minority interests |
|
2) |
|
For a reconciliation to the most directly comparable US GAAP measures, see the chapter
Reconciliation of non-US GAAP information |
Liquidity position
Including the companys net debt (cash) position (cash and cash equivalents, net of debt), listed
available for-sale securities, listed equity-accounted investees, as well as its USD 2.5 billion
commercial paper program supported by the revolving credit facility, the company had access to net
available liquidity resources of EUR 2,395 million as of December 31, 2008, compared to EUR 11,374
million one year earlier.
The fair value of the Companys listed available-for-sale securities, based on quoted market prices
at December 31, 2008, amounted to EUR 599 million, of which EUR 558 million related to LG Display
and EUR 29 million related to Pace Micro Technology.
Philips Annual Report 2008 59
|
|
|
|
|
|
|
|
|
6 Performance
highlights |
|
8 Message from
the President |
|
14 Who we are |
|
18 We care about.... |
|
42 Our group performance
Liquidity and
Capital resources |
Lighting the road ahead in Asia
Philips officially opened its Automotive Lighting Application Center at the Philips Innovation
Campus in Shanghai, China. This center studies local needs in automotive lighting to provide
customized support and speed up the introduction of the latest
lighting technologies into the fast-growing local markets.
The Company has a lock-up period associated with the sale
of shares in Pace Micro Technology that expires on April 21, 2009. The sale of TSMC shares
contributed the majority of the decrease in available-for-sale securities.
Philips shareholdings in its main listed equity-accounted investees had a fair value of EUR 60
million based on quoted market prices at December 31, 2008, and consisted primarily of the
Companys holdings in TPV Technology. The Company transferred LG Display from equity-accounted
investees to available-for-sale securities effective March 1, 2008 as Philips was no longer able to
exercise significant influence. The decline in the value of LG Display holding was due to the sale
of 24 million shares, as well as the sharp decline in the stock price in 2008.
Philips has a USD 2.5 billion commercial paper program, under which it can issue commercial paper
up to 364 days in tenor, both in the US and in Europe, in any major freely convertible currency.
There is a panel of banks, in Europe and in the US, which service the program. When Philips wants
to fund through the commercial paper program, it contacts the panel of banks. The interest is at
market rates prevailing at the time of issuance of the commercial paper. There is no collateral
requirement in the commercial paper program. Also, there are no limitations on Philips use of the
program, save for market considerations, such as that the commercial paper market itself is not
open.
If this were to be the case, Philips USD 2.5 billion committed revolving credit facilities could
act as back-up for short-term financing requirements that normally would be satisfied through the
commercial paper program. The USD 2.5 billion revolving credit facility does not have a material
adverse change clause, has no financial covenants and does not have credit-rating-related
acceleration possibilities. The revolving credit facility is allocated among 26 banks headquartered
in Organization for Economic Co-operation and Development (OECD) countries. As of December 31,
2008, Philips did not have any commercial paper outstanding.
In addition to the USD 2.5 billion revolving credit facility, Philips has a EUR 500 million standby
roll-over loan agreement in place. The availability of EUR 450 million out of this EUR 500 million
is committed until April 29, 2010. As of December 31, 2008, Philips did not have any loans
outstanding under these facilities.
As of December 31, 2008 Philips had an undrawn committed bilateral loan of EUR 250 million in place
which was fully drawn in January 2009.
Outstanding long-term bonds, including the ones issued in March 2008, do not have a material
adverse change clause, financial covenants nor credit-rating-related acceleration possibilities.
As at December 31, 2008, Philips had total cash and cash equivalents of EUR 3,620 million; Philips
pools cash from subsidiaries to the extent legally and economically feasible. Cash in subsidiaries
is not necessarily freely available for alternative uses due to possible legal or economic
restrictions. The amount of cash not immediately available is not considered material for Philips
to meet its cash obligations. Philips had a total debt position of EUR 4,158 million at year-end
2008.
Contractual cash obligations, other cash commitments and guarantees
Contractual cash obligations
Presented opposite is a summary of the Groups contractual cash obligations and commitments at
December 31, 2008
Philips has no material commitments for capital expenditures.
Philips has a number of commercial agreements, such as supply agreements, which provide that
certain penalties may be charged to the company if the company does not fulfill its commitments.
60 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector
performance |
|
94 Risk management |
|
110 Our leadership |
|
114 Supervisory Board
report |
|
122 Performance
statements |
The table on the right excludes any potential uncertain income tax liabilities that may become
payable upon examination of the Groups income tax returns by taxing authorities. Such amounts and
periods of payment cannot be reliably estimated. Refer to note 6 of the notes to the Group
financial statements for further explanation of the Groups uncertain tax positions.
Other cash commitments
Under the terms of a proposed Plan of Reorganization filed by a US subsidiary of the Company
which is subject to Court approval an amount of USD 900 million (EUR 639 million) would be
required to be contributed to an Asbestos Personal Injury Trust. EUR 121 million is currently held
in a restricted trust account and will be used in the settlement of this contingent obligation. For
further information with respect to this and other contingent liabilities, refer to note 27 of the
US GAAP financial statements.
The Company and its subsidiaries sponsor pension plans in many countries in accordance with legal
requirements, customs and the local situation in the countries involved. Additionally, certain
postretirement benefits are provided in certain countries. Refer to notes 20 and 21 of the notes to
the Group financial statements for a discussion of the plans and expected cash outflows.
The Company announced the acceleration of restructuring and change programs across all sectors in
2008, which is expected to lead to a cash payment amounting to EUR 235 million in 2009. For further
information, refer to note 4 of the notes to the Group financial statements.
A distribution for 2009 of EUR 0.70 per common share will be proposed to the 2009 Annual General
Meeting of Shareholders. Assuming the distribution is approved, it is expected to amount to
approximately EUR 646 million.
In light of current economic environment, in January 2009, Philips has stopped the EUR 5 billion
share buy-back program until futher notice.
Guarantees
Guarantees issued or modified after December 31, 2003, having characteristics defined in FASB
Interpretation No. 45 Guarantors Accounting and Disclosure Requirements for Guarantees, including
Indirect Guarantees of Indebtedness of Others (FIN 45), are measured at fair value and recognized
on the balance sheet. At the end of 2008, the total fair value of guarantees recognized by the
company was EUR 10 million.
Contractual cash obligations at December 31, 20083)
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
payments due by period |
|
|
|
|
|
|
|
less |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
than 1 |
|
|
1-3 |
|
|
3-5 |
|
|
after 5 |
|
|
|
total |
|
|
year |
|
|
years |
|
|
years |
|
|
years |
|
Long-term debt1) |
|
|
3,437 |
|
|
|
127 |
|
|
|
1,027 |
|
|
|
456 |
|
|
|
1,827 |
|
Finance lease
obligations1) |
|
|
135 |
|
|
|
4 |
|
|
|
68 |
|
|
|
17 |
|
|
|
46 |
|
Short-term debt1) |
|
|
586 |
|
|
|
586 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating leases1) |
|
|
715 |
|
|
|
171 |
|
|
|
229 |
|
|
|
137 |
|
|
|
178 |
|
Interest on debt2) |
|
|
2,533 |
|
|
|
209 |
|
|
|
391 |
|
|
|
278 |
|
|
|
1,655 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,406 |
|
|
|
1,097 |
|
|
|
1,715 |
|
|
|
888 |
|
|
|
3,706 |
|
|
|
|
1) |
|
Short-term debt, long-term debt and capital lease obligations are included in the Companys
consolidated balance sheet; please refer to note 23, note 24 and note 26 of the US GAAP
financial statements |
|
2) |
|
Approximately 24% of the debt bears interest at a variable rate. Interest on debt has been
estimated based upon average rates in 2008. |
|
3) |
|
For further details about uncertain tax positions, amounting to EUR 559 million, see note 6
of the US GAAP financial statements. |
Expiration per period 2008
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
|
less |
|
|
|
|
|
|
|
|
|
amounts |
|
|
than 1 |
|
|
1-5 |
|
|
after 5 |
|
|
|
committed |
|
|
year |
|
|
years |
|
|
years |
|
Business-related
guarantees |
|
|
443 |
|
|
|
205 |
|
|
|
78 |
|
|
|
160 |
|
Credit-related
guarantees |
|
|
42 |
|
|
|
18 |
|
|
|
7 |
|
|
|
17 |
|
|
|
|
485 |
|
|
|
223 |
|
|
|
85 |
|
|
|
177 |
|
Expiration per period 2007
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
total |
|
|
less |
|
|
|
|
|
|
|
|
|
amounts |
|
|
than 1 |
|
|
1-5 |
|
|
after 5 |
|
|
|
committed |
|
|
year |
|
|
years |
|
|
years |
|
Business-related
guarantees |
|
|
432 |
|
|
|
142 |
|
|
|
95 |
|
|
|
195 |
|
Credit-related
guarantees |
|
|
45 |
|
|
|
5 |
|
|
|
16 |
|
|
|
24 |
|
|
|
|
477 |
|
|
|
147 |
|
|
|
111 |
|
|
|
219 |
|
Guarantees issued before December 31, 2003, and
not modified afterwards, and guarantees issued
after December 31, 2003, which do not have
characteristics defined in FIN 45, remain
off-balance sheet.
Philips policy is to provide only guarantees
and other letters of support, in writing.
Philips does not stand by other forms of
support. The above table outlines the total
outstanding off-balance sheet credit-related
guarantees and business-related guarantees
provided by Philips for the benefit of
unconsolidated companies and third parties as
at December 31, 2008.
Philips Annual Report 2008 61
|
|
|
|
|
|
|
|
|
6 Performance highlights
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance Sustainability |
Low energy consumption
Our focus on sustainability has resulted in our PowerSave feature in all our MRI systems. Not only
does this save energy, but the customer saves substantially on energy costs compared with
competitors. With smart power management our MRI systems only consume energy when really needed.
Key to achieving this is making the right choices in power amplifier technology.
The Achieva 1.5T product line reduces energy consumption by 28% and offers a life cycle assessment
improvement of about 10% compared to its predecessor.
Sustainability
Management summary
In 2008 we made progress against our Sustainability Management Agenda, focusing on:
|
|
driving the implementation of our EcoVision programs |
|
|
|
strengthening the energy-efficient and Green Product approach at both Healthcare and Consumer
Lifestyle, leveraging the experience of our Lighting sector |
|
|
|
making our supply chain fully compliant with the Electronic Industry Code of Conduct standard,
and |
|
|
|
continuing to engage employees on energy efficiency and carbon footprint awareness. |
We also focused on achieving the targets defined by our Key Performance Indicators, which are set
yearly to track our progress on the major issues regarding sustainability. These KPIs include
targets related to our EcoVision4 program; diversity and inclusion; engagement; health and safety;
supplier performance and communication.
Results are detailed on the following pages.
EcoVision III
Our EcoVision III environmental action program began in 2006 and will run through 2009. EcoVision
III calls for improvements in all major environmental parameters in manufacturing, compared to the
base year 2005.
EcoVision III covers the contributors to climate change (energy, PFCs and other greenhouse gases),
water, waste and a selection of the most relevant restricted and hazardous substances. For nine out
of the 13 defined parameters, we realized or exceeded the reduction targets by year-end 2008. To
achieve the defined targets in the four remaining parameters one restricted and three hazardous
substances we will work to realize further reductions in 2009. However, due to certain production
processes, for some parameters it may not be possible to achieve the stated targets.
62 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector performance
|
|
94 Risk Management
|
|
110 Our leadership
|
|
114 Supervisory Board report
|
|
122 Performance statements |
EcoVision4
With our latest environmental action program, EcoVision4, we have committed to:
|
|
generate 30% of total revenues from Green Products by 2012, compared with 15% in 2006 |
|
|
|
double our investment in Green Innovations to a cumulative EUR 1 billion, and |
|
|
|
further increase the energy efficiency of our operations by 25% by 2012, as well as reduce our
total operational carbon footprint by 25%, both compared with the base year of 2007. |
Results for each target are highlighted on the following pages.
Green Product sales
Sales from Green Products increased 12.5% in 2008, contributing significantly to the total revenue
stream. As a percentage of the Group total, Green Product sales rose to 22.6%, up from 19.8% in
2007. Excluding the major acquisitions in 2008 (Genlyte and Respironics), the percentage increased
to 24.9%.
Consumer Lifestyle contributed most to the overall increase with the introduction of 61 Green
Products in 2008. Further progress was also achieved in the Lighting sector, where the share of
Green Products increased.
Overall, improvements have been predominantly realized in our energy efficiency Green Focal Area.
Green Innovations
In 2008 Philips invested approximately EUR 282 million in Green Innovations the Research &
Development spend related to the development of new generations of Green Products and breakthrough
Green Technologies.
Philips Healthcare innovation projects consider all of the Green Focal Areas and aim to reduce
total life cycle impact. In particular the sector focuses on reducing energy consumption, weight
and hazardous substances.
Consumer Lifestyles investment in Green Innovations is dedicated to the development of new Green
Products, focusing on further enhancing energy efficiency and on closing material loops.
The Lighting sector accounts for more than half of the total spend on Green Innovations. The focus
is on developing new energy-efficient lighting solutions, further enhancing current Green Products
and driving toward technological breakthroughs, such as solid-state lighting.
Philips Annual Report 2008 63
|
|
|
|
|
|
|
|
|
6 Performance highlights
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance Sustainability |
Reducing our operational carbon footprint
Our Roosendaal facility is the first Philips location in the Netherlands to run completely on green
electricity from renewable sources. The lamps produced at Roosendaal are mainly Green Products
energy-efficient solutions that reduce energy costs and CO2 emissions.
In 2008 the facility started an adoption plan, donating energy-efficient lighting to all primary
schools in the town. That cut their electricity consumption annually by an average of 18% and
stopped 33 tons of CO2 from entering the atmosphere. The project involved more than 100 employees, 26 schools and more
than 9,500 lamps.
Within Corporate Technologies, Philips Research invested approximately EUR 41 million, spread over
Green Innovation projects focused on meeting global challenges related to water, air, waste and
energy.
Operational energy efficiency
In absolute terms, total CO2 emissions in 2008 remained virtually flat at 2.1 million
tons CO2
equivalents, mainly due to the major acquisitions (Genlyte and Respironics). Without these
additions, the footprint would have decreased by nearly 5%. CO2 emissions from
manufacturing increased 2% in absolute terms, but decreased 4% on a comparable basis (excluding the
acquisitions). We doubled the percentage of electricity purchased from renewable sources and
optimized production. Because we reduced facility space, CO2 emissions from non-
industrial operations (offices, warehouses, etc.) decreased 7% in absolute terms, and 15% on a
comparable basis.
CO2 emissions related to business travel decreased 8% in absolute terms and 11% on a
comparable basis, due to our strict air travel policy, strong promotion of videoconferencing and
our green lease car policy. CO2 emissions from distribution increased 6% nominally and
1% on a comparable basis. Half of these emissions are attributable to air transport, which was up
1% nominally but down 2% on a comparable basis. Sea transport increased 19%, due to various reasons
like a targeted shift from air to sea transport, new acquisitions and shipments moving into our
scope definition. Road transport increased 2%, but decreased 7% on a comparable basis, among other
things due to improved truck utilization.
64 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector performance
|
|
94 Risk Management
|
|
110 Our leadership
|
|
114 Supervisory Board report
|
|
122 Performance statements |
Social performance
Employee engagement
In 2008, 90% of our employees took the Engagement Survey. The Employee Engagement Index the
single measure of the overall level of employee engagement at Philips rose to 69% in 2008, from
64% in the previous year.
Equally important is the insight we gained into ways we can improve. For example, employees
confidence in the companys future decreased. To reverse this we are placing emphasis on connecting
all of our people with the long-term ambition of Philips.
Diversity and inclusion
We reached our diversity and inclusion target for 2008, significantly increasing the percentage of
women in executive positions. Women now comprise nearly 10% of executives across the global Philips
organization double the figure of 5% in 2005.
In 2008 the percentage of women in the top potential pool reached 23%, up from 20% in 2007.
Further, the percentage of executives from Asia Pacific stood at 8% at year-end 2008, versus 7% the
previous year. The percentage of top potentials from Asia Pacific was 14%, a decrease from 16% in
2007.
Developing our people
With nearly 10,000 employees participating in programs in our Core Curriculum during 2008,
enrollment decreased compared with 12,000 the previous year. Functional Core Curricula enrollment
was some 7,600 in 2008, a slight decrease from 8,000 in 2007.
In 2008, our Inspire program for high potentials facilitated the completion of seven project
assignments, and seven more are expected to be completed during the first quarter of 2009. Top
potentials in the Octagon program completed eight projects.
Even in the face of the economic downturn, participation in our curriculum of internal and external
programs for executives remained at the same levels as 2007. Approximately 9% of executives and top
potentials attended external business school programs.
In 2008, 13 new executives went through the executive induction program for newly hired or recently
appointed executives.
Talent creating value
At Philips we all work together to achieve our goal of providing meaningful solutions to human
needs. It is therefore crucial that we communicate properly among ourselves and that everyone is
given full opportunity to use their individual talents.
We believe it is important that employees feel part of a team, experience that their ideas and
suggestions count, develop themselves and know diverse perspectives are valued.
Philips Annual Report 2008 65
|
|
|
|
|
|
|
|
|
6 Performance highlights
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance Sustainability |
Switching to a brighter world
The EcoClassic 50 is the first ever energy-saving lamp purposely designed to suit decorative
fixtures where existing energy savers could not be used. The lamp starts instantly, is dimmable and
comes in a retrofit design, which means that consumers can use the halogen energy savers in all
traditional lamp sockets.
Importantly, the EcoClassic 50 combines high-quality light with a 50% energy saving.
General Business Principles
In 2008 a total of 361 complaints were raised, compared with 389 in 2007; 392 in 2006; and 318 in
2005.
All alleged GBP violations (and the status of the investigations) are considered by the Board of
Management and the Audit Committee of the Supervisory Board, which assess any possible impact on
Philips businesses and compliance with applicable laws.
There was a sharp rise in the number of complaints relating to the general commitment towards
employees principle (GBP 4.0). To a large extent these originated from employees of a number of
recently acquired companies, where the pre-acquisition style of management was in many respects
inconsistent with the underlying principles of business conduct defined in the Philips GBP.
In 2008 the GBP most associated with alleged violations was again GBP 4.3 (Equal and fair
treatment). As in the previous two years, almost half of all reported complaints related to this
principle.
Business integrity issues
With regard to reporting of the typical business integrity issues, the number of complaints
remained fairly stable in 2008 compared to 2007.
Use and protection of assets
After having been the second most frequent GBP complaint received in 2007 at 15.5% of the total,
there was a sharp fall in the number of complaints relating to GBP 6.1 (Use and protection of
assets), with only 7.7% in 2008. A lot of attention has been devoted to this issue, both in recent
editions of the GBP directives and the latest corporate IT directives.
Supply management
The number of complaints relating to supply management was virtually the same in 2008 and 2007.
Only eight complaints were lodged in 2008 in the GBP Complaints database as alleged violations of
GBP 5 (Commitment to Suppliers and Business Partners), compared with nine in 2007.
Breakdown of alleged violations GBP
as a % of total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 |
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
1 General commitment |
|
|
4.3 |
|
|
|
7.2 |
|
|
|
7.0 |
|
|
|
5.2 |
|
2 Commitment to customers |
|
|
|
|
|
|
1.2 |
|
|
|
0.7 |
|
|
|
1.9 |
|
3 Commitment to shareholders |
|
|
|
|
|
|
0.3 |
|
|
|
|
|
|
|
|
|
4 Commitment to employees |
|
|
48.1 |
|
|
|
58.8 |
|
|
|
55.8 |
|
|
|
62.9 |
|
5 Commitment to suppliers and
business partners |
|
|
8.9 |
|
|
|
5.7 |
|
|
|
2.3 |
|
|
|
2.2 |
|
6 Assets and information |
|
|
24.2 |
|
|
|
15.6 |
|
|
|
17.0 |
|
|
|
9.9 |
|
7 Business integrity |
|
|
13.7 |
|
|
|
10.9 |
|
|
|
17.2 |
|
|
|
16.3 |
|
8 Observance of the General
Business Principles |
|
|
0.8 |
|
|
|
0.3 |
|
|
|
|
|
|
|
1.6 |
|
|
|
|
100 |
|
|
|
100 |
|
|
|
100 |
|
|
|
100 |
|
Health and safety
In 2008 we recorded 650 Lost Workday Injuries cases, occupational injury cases where the injured
person is unable to work the day after the injury. This is an 18% decrease compared with 2007. The
rate of Lost Workday Injuries also decreased substantially to 0.68 per 100 FTEs, compared with 0.81
in 2007.
Reductions were particularly realized in the Lighting sector, which initiated a dedicated action
program two years ago to drive down injury levels. Consumer Lifestyle also achieved a lower injury
rate.
66 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector performance
|
|
94 Risk Management
|
|
110 Our leadership
|
|
114 Supervisory Board report
|
|
122 Performance statements |
Supplier performance
We continued to drive progress in our Supplier Sustainability Involvement Program in 2008. A total
of 572 audits of Bill of Material (BOM) and non-product related (NPR) identified risk suppliers
were carried out in 2008, comprised of:
|
|
244 initial audits of new suppliers, including those from acquisitions, new sites or spend growth
exceeding EUR 100,000 |
|
|
|
33 continual conformance audits at suppliers audited in 2005, and |
|
|
|
295 resolution audits focusing on zero-tolerance issues (for example: child labor, continual
seven-day work weeks, immediate life-threatening situations, slave labor conditions and banned
substances). |
The majority (80%) of BOM-related audits were conducted in China, where the vast majority of
non-compliances (89%) were found.
2008 supplier audit results
The most frequently identified issues coming out of the 277 initial and continual conformance
audits were as follows:
|
|
Zero-tolerance emergency preparedness (blocked fire exits); occupational safety (immediate
threat to health and safety); working conditions (exposure to hazardous substances); working hours
(continual seven-day work weeks); and lack of environmental permits. |
|
|
|
Limited-tolerance improper handling/processing of chemical waste; working hours (above legal
limits/60 hours a week); wages and benefits (below minimum wages and absence of legal overtime
payment); environmental performance objectives do not meet legal requirements; lack of industrial
hygiene (lack of personal protective equipment); occupational injury and illness (no medical
treatment facility). |
Increased speed of resolution
During 2008 we focused on resolving zero-tolerance issues, leading to a 60% improvement in
resolution speed. During the last four months of the year all zero-tolerance issues were resolved
within 105 days, down significantly from the average resolution time of 250 days in 2007. At
year-end there were no zero-tolerance issues older than three months.
The most frequently identified zero-tolerance issues related to occupational health and safety
risks and continual seven-day work weeks. Health and safety issues can be resolved quickly. Dealing
with working hours often entails installing extra shifts with additional personnel, which can take
at least a month.
Where no improvement could be established, 25 suppliers were phased out.
Philips Annual Report 2008 67
|
|
|
|
|
|
|
|
|
6 Performance highlights
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We care about
|
|
42 Our group performance Sustainability |
Proposed distribution to shareholders
Pursuant to article 34 of the articles of association of Royal Philips Electronics, a dividend will
first be declared on preference shares out of net income. The remainder of the net income, after
reservations made with the approval of the Supervisory Board, shall be available for distribution
to holders of common shares subject to shareholder approval after year-end. As of December 31,
2008, the issued share capital consists only of common shares; no preference shares have been
issued. Article 33 of the articles of association of Royal Philips Electronics gives the Board of
Management the power to determine what portion of the net income shall be retained by way of
reserve, subject to the approval of the Supervisory Board.
Pursuant to article 35 of the articles of association of Royal Philips Electronics, a proposal will
be submitted to the 2009 Annual General Meeting of Shareholders to declare a distribution in cash
of EUR 0.70 per common share from the retained earnings. Such distribution is expected to result in
a payment of EUR 646 million.
In 2008, a dividend was paid of EUR 0.70 per common share (EUR 720 million) in respect of the
financial year 2007. The remainder of the net income for the financial year 2007 has been retained
by way of reserve.
The balance sheet presented in this report, as part of the Company financial statements for the
period ended December 31, 2008, is before appropriation of the result for the financial year 2008.
68 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector performance
|
|
94 Risk Management
|
|
110 Our leadership
|
|
114 Supervisory Board report
|
|
122 Performance statements |
Outlook
Our fourth-quarter results confirm the expectation we expressed early December that the short-term
economic outlook is worsening and that 2009 is likely to be a very challenging year. Construction
and automotive markets look set to remain contracted and the latest consumer confidence numbers
also in most emerging markets leave little room for optimism. Although Healthcare has been less
directly affected by the economic downturn, the limited availability of capital financing in North
America is expected to continue for the foreseeable future.
Anticipating this environment, we proactively extended our restructuring plans and sharpened our
cash management initiatives last year to further drive down (fixed) costs and ensure we start this
year with a strong balance sheet position. In line with our prudent financial management, we will
stop the share repurchase program until further notice. During 2009, we will continue to closely
manage our businesses relative to both the market and the competition.
We are confident that this stringent approach to cost and cash management, together with our strong
brand and our balanced portfolio of leading businesses, will enable us to weather the current
economic turmoil and will result in an even stronger company able to deliver on its targets once
economic conditions recover.
Amsterdam, February 23, 2009
Board of Management
Philips Annual Report 2008 69
|
|
|
|
|
|
|
|
|
6 Performance highlights
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance Sustainability |
Our sector performance
Imaging Systems Clinical Care Systems Healthcare Informatics and Patient Monitoring Home
Healthcare Solutions Customer Services
Television Shaving & Beauty Audio & Video Multimedia Domestic Appliances Health & Wellness
· Peripherals & Accessories
Lamps Professional Luminaires Consumer Luminaires Lighting Electronics Automotive Special
Lighting Applications Solid-State Lighting Components & Modules
Innovation & Emerging Businesses
Research Intellectual Property & Standards Applied Technologies Healthcare, Lifestyle and
Lighting & Cleantech Incubators New Venture Integration Design
Group Management & Sevices
Corporate center Countries and regions Global service units Shared service centers Pensions
70 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector
performance
|
|
94 Risk Management
|
|
110 Our leadership
|
|
114 Supervisory Board report
|
|
122 Performance
statements |
Our structure
Koninklijke Philips Electronics N.V. (the Company) is the parent company of the Philips Group
(Philips or the Group). Its shares are listed on the stock markets of Euronext Amsterdam and
the New York Stock Exchange. The management of the Company is entrusted to the Board of Management
under the supervision of the Supervisory Board.
Philips activities in the field of health and well-being are organized on a sector basis, with
each operating sector Healthcare, Consumer Lifestyle and Lighting being responsible for the
management of its businesses worldwide.
The Company aims, through the Innovation & Emerging Businesses sector, to invest in projects that
are not currently part of the operating sectors, but which will lead to additional organic growth
or create value through future spin-offs.
The Group Management & Services sector provides the sectors with support through shared service
centers. Furthermore, country management supports the creation of value, connecting Philips with
key stakeholders, especially our employees, customers, government and society. This sector also
includes the global service units, pensions and global brand campaign activities.
At the end of 2008, Philips had approximately 155 production sites in 29 countries, sales and
service outlets in approximately 100 countries, and some 121,000 employees.
Philips Annual Report 2008 71
|
|
|
|
|
|
|
|
|
6
Performance
highlights
|
|
8 Message from
the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our
group performance |
A helping hand
Designed to meet the needs of cardiologists for clear
diagnostic data at the bedside, our new Philips CX50
CompactXtreme handheld ultrasound system combines the image
quality expected of a premium full-size system with the
convenience of portability. The CX50 system also offers
significant environmental benefits: 10% less packaging
weight, 22% improvement in system weight, 31% less operating
power and 30% reduction in impact over the life cycle.
Healthcare
® Healthcare challenges present major opportunities |
|
® Addressing
care cycles
cardiology, oncology and
womens health |
|
® Home healthcare a core part
of our healthcare strategy |
|
® Acquisition and integration of Respironics |
|
® Strengthened presence in emerging markets |
The future of healthcare is one of the most
pressing global issues of our time. Around the
globe, societies are facing the growing reality
and burden of increasing and in some cases
aging populations, as well as the upward
spiraling costs of keeping us in good health.
Worldwide, many more people live longer with
chronic disease such as cardiovascular
diseases, cancer, diabetes than in the past.
Aging and unhealthy lifestyles are also
contributing to the rise of chronic diseases,
putting even more pressure on our healthcare
systems. At the same time, we are facing a
global and growing deficit of healthcare
professionals.
These challenges present us with an enormous
opportunity. We focus our business on
addressing the evolving needs of the
healthcare market by developing innovative
products and technologies that contribute to
improved healthcare, at lower cost, around the
world.
72 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70
Our sector performance Healthcare
|
|
94 Risk management
|
|
110 Our leadership
|
|
114
Supervisory Board report
|
|
122
Performance statements |
Healthcare landscape
The global healthcare market is dynamic and
growing. Over the past three decades, the
healthcare industry has grown faster than
Western world GDP, and has also experienced
high rates of growth in emerging markets such
as China and India. Rising healthcare costs
present a major challenge to society. The
industry is looking to address this through
continued innovation, both in traditional care
settings and also in the field of home
healthcare. This approach will not only help to
reduce the burden on health systems, but will
also help to provide a more comforting and
therapeutic environment for patient care.
The healthcare market is not, however, immune
from developments in the macro-economic
environment. The recent global downturn has had
a significant impact on the healthcare
industry. Hospitals and other healthcare
providers are struggling with reimbursement
pressures and reduced direct government
spending due to budgetary constraints. At the
same time, tighter credit markets have resulted
in greater scrutiny on capital purchases. These
rapidly changing market dynamics adversely
affected us and our competitors in 2008 and
will continue to have an impact in 2009. In
North America, for example, the availability of
capital financing is expected to remain limited
for the foreseeable future.
How we make a difference
Philips distinctive approach to healthcare
starts by looking beyond the technology to the
people patients and care providers and the
medical problems they face. By gaining deep
insights into how patients and clinicians
experience healthcare, we are able to identify
market and clinical needs. In response, we can
develop more intuitive, more affordable, and in
the end better technology solutions to help
take some of the complexity out of healthcare.
This results in better diagnosis, more
appropriate treatment planning, faster patient
recovery and long-term health. We try to
simplify healthcare through combining our
clinical expertise with human insights to
develop meaningful innovations that ultimately
help to improve the quality of peoples lives.
With a growing presence in cardiology,
oncology, and womens health, we focus on the
fundamental health problems with which people
are confronted, such as congestive heart
failure, lung and breast cancers and coronary
artery disease. Our focus is to deliver value
across the complete cycle of care: from disease
prevention to screening and diagnosis through
to treatment, monitoring and health management.
Philips is dedicated to making an impact
wherever care happens, within the hospital -
critical care, emergency care and surgery -
and, as importantly, in the home.
The high-growth sector of home healthcare is a
core part of Philips healthcare strategy.
Philips Home Healthcare Solutions provides
innovative products and services for the home
that connect patients to their healthcare
providers and support individuals at risk in
the home through better awareness, diagnosis,
treatment, monitoring, and management of their
conditions. We provide solutions that improve
the quality of life for aging adults, for
people with chronic illnesses and for their
caregivers, by enabling healthier, independent
living at home.
About Philips Healthcare
Philips is one of the top-tier players in the
healthcare technology market (based on sales)
alongside General Electric (GE) and Siemens.
Our new Healthcare sector brings together our
former Medical Systems division and our growing
Home Healthcare Solutions business.
Consolidating these businesses, combined with
additional acquisitions of complementary,
high-growth healthcare companies, has created a
Healthcare sector with sales in 2008 of more
than EUR 7.6 billion. It has also created
global leadership positions in areas such as
cardiac care, acute care and home healthcare.
#1
provider of
personal emergency
response
services in the US
Philips Annual Report 2008 73
|
|
|
|
|
|
|
|
|
6
Performance
highlights
|
|
8 Message from
the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our
group performance |
Peace of mind
Philips Lifeline part of Philips
growing home healthcare activities is
the leading medical alert system in North
America. It supports independent living
for seniors and the chronically ill by
giving them and their care givers peace of
mind.
Lifelines Medication Management System is
a simple-to-use solution that helps address
forgetfulness and confusion, which are
among the top reasons seniors do not adhere
to their medication routine. The system
helps to ensure that the correct medication
is taken at the right time, reducing the
risk of under- or over-dosing.
Philips Healthcares current activities are
organized across five businesses:
|
|
Imaging Systems x-ray, computed
tomography (CT), magnetic resonance (MR)
imaging, and nuclear medicine imaging
equipment |
|
|
|
Clinical Care Systems ultrasound
imaging, hospital respiratory systems,
cardiac care systems and childrens
medical ventures |
|
|
|
Home Healthcare Solutions sleep
management and respiratory care, medical
alert services, remote cardiac services,
remote patient management |
|
|
|
Healthcare Informatics and Patient
Monitoring healthcare informatics,
patient monitoring systems and image
management services |
|
|
|
Customer Services consultancy,
clinical services, education, equipment
financing, asset management and
equipment maintenance and repair. |
We are continually striving to improve the
organizational structure of our Healthcare
businesses, particularly in light of the
current economic climate. In late 2008, we set
forth a plan to help reduce complexity in the
organization, streamlining the management
structure and increasing our speed of
execution. This will position us for a
stronger future as we pursue our ambitious
strategic targets.
Products and services are sold to healthcare
providers around the world, including academic,
enterprise and stand-alone institutions,
clinics, physicians, home healthcare agencies
and consumer retailers. Marketing, sales and
service channels are mainly direct.
The United States is the largest healthcare
market, currently representing close to 50%
of the global market, followed by Japan and
Germany.
The healthcare market is subject to some
seasonality as a relatively large proportion of
revenue is recognized in the fourth quarter (on
a calendar basis), mainly reflecting
public/governmental budget spending.
Philips Healthcare employs approximately
36,000 employees worldwide.
With regard to sourcing, please refer to the
section Supply management on page 54 of this
Annual Report.
Progress against targets
The Annual Report 2007 set out a number of
key targets for Philips Healthcare in 2008.
The advances made in addressing these are
outlined below.
Extract value from acquisitions
through successful integration
In 2008, Philips took a significant step in
strengthening its Home Healthcare Solutions
business by acquiring Respironics, a provider
of innovative respiratory and sleep therapy
solutions for hospital and home use. This
acquisition, the largest in Philips history,
gives us a leading position in the fast-growing
areas of sleep management, respiratory care and
non-invasive ventilation. The integration
process will continue in 2009, yet we have
already been able to extract value, e.g. in the
form of positive contributions to sales and
earnings.
Philips also finalized the acquisition of
VISICU Inc., a provider of remote critical care
monitoring, in 2008, as well as acquiring
Northern Ireland-based TOMCAT Systems Ltd., a
company that offers a software solution to
collect and aggregate data relating to cardiac
care. Leveraging the TOMCAT platform, the
Philips Cardiovascular Information System
launched in the fourth quarter of 2008 helps
hospitals achieve a high standard of patient
care throughout the cardiovascular care
continuum.
74 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70
Our sector performance Healthcare
|
|
94 Risk management
|
|
110 Our leadership
|
|
114
Supervisory
Board report
|
|
122
Performance statements |
Expand presence in emerging markets
In 2008, Philips strengthened its presence in
emerging markets by acquiring the following
businesses: India-based Alpha X-Ray
Technologies, a leading manufacturer of
cardiovascular X-Ray systems targeting the
economy segment of the Indian market;
Brazil-based Dixtal Biomédica e Tecnologia, a
manufacturer of in-hospital patient monitoring,
anesthesia, ventilation equipment and
electrocardiographs (ECG) as well as other
sensors for vital sign measurements; and
Chinese patient monitoring company Shenzhen
Goldway, Inc., which brings a strong portfolio
of economy- and mid-range patient monitors.
Toward the end of the year, Philips announced
the acquisition of India-based Meditronics, a
leading manufacturer of
general X-ray systems for the economy segment
in India.
Cultivate leadership talent and
recognize and reward top talent
In 2008, we further strengthened our focus on
developing key leadership talent within Philips
Healthcare. We have achieved our objective to
identify and attract more than 30 new top
potentials to our talent pool. We also
continued to enable personal development
through stretch assignments and broadening
experiences (86% of all moves of top potentials
in 2008 were to a new function, new business or
new country). In addition, Healthcare launched
the new career compass which transparently lays
out the career paths for our key leadership
talent depending on a choice to grow in either
a functional area or develop on a general
management track.
We have also achieved our 2008 target of having
15% of the Philips Healthcare executive pool
comprised of females, up from 9% in 2004 when
this goal was set. Furthermore, we have
strengthened our focus on talent inflow and
leadership development in our emerging markets,
which will be one of the main focus areas to
successfully enable our growth plans.
Healthcare also continued year-over-year
improvement in employee engagement and
leadership. Employee engagement improved to 67%
favorable, from 64% in 2007, only three points
off the external benchmark for high-performing
companies. Our index measuring the leadership
effectiveness of managers as perceived by
employees also showed another year of strong
improvement with 68% favorable, up five points
from 2007.
Childrens hospital of the future
In 2008 Disney Childrens Hospital at
Florida Hospital announced its intention to
be a model for patient experience that is
truly dedicated to the well-being of
children. One of the keystones of this
visionary plan is the creation of a
dedicated childrens emergency department,
the first of its kind in the United States
to feature Ambient Experience Design
solutions from Philips.
Areas throughout the department will
incorporate captivating and comforting
lighting and design elements to provide
calming,
positive assurances to young patients and
their families. Patient treatment rooms
will offer animation selections on the
ceiling accompanied by soft lighting and
music, allowing escapes to areas such as
the beach or mountains.
Deliver on care cycle solutions from the
hospital to the home
Cardiology
Philips cardiology solutions help simplify
diagnosis, treatment and monitoring of a range
of cardiac conditions. We simplify and reduce
time to treatment for heart-attack victims,
with innovative, time-saving offerings that
span from discovery whether in the field by a
paramedic or in the emergency department by a
clinician to treatment in the catheterization
lab. With our advanced 16-lead ECG, unique 3D
ultrasound visualization, vivid computed
tomography (CT) scans, and IT workflow
solutions we provide efficient and timely
triage for chronic cardiac patients. And by
enabling surgeons to view live 3D ultrasound
scans of the beating heart, we assist in
procedure planning and help reduce the need for
invasive valve replacement.
15
years in a row leadership in ultrasound service
Philips Annual Report 2008 75
|
|
|
|
|
|
|
|
|
6
Performance highlights
|
|
8
Message from the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our
group performance |
Our multi-purpose catheterization labs provide
advanced solutions for a wide range of
minimally-invasive procedures, ranging from
balloon angioplasty and stenting to structural
heart repair and electrophysiology. Lastly, our
remote monitoring tools and services make it
possible to monitor and support chronic cardiac
patients in the convenience of their own homes.
Oncology
One of the areas of focus for our Oncology
segment is colorectal cancer, one of the
leading causes of death globally. Death from
colorectal cancer can largely be prevented;
however, the central issue is that too few
patients receive screening. In the US, optical
colonoscopy is an approved and reimbursed
procedure recommended for anyone over the age
of 50, but since it is such an invasive
procedure, only about one-third of people who
are eligible actually have it done. Leveraging
computed tomography (CT) for virtual
colonoscopy, Philips is seeking to make this
procedure accurate and patient-friendly, with a
goal to increase screening participation. A
more comfortable exam for patients, virtual
colonoscopy avoids the need for sedation -
meaning patients can return to work immediately
after the procedure.
Womens health
Philips is committed to developing technologies
to enhance solutions for womens specific
conditions and diseases, such as breast cancer.
Breast imaging, for example, benefits from a
multi-modality approach. Clinicians are
increasingly relying on multiple imaging
technologies to screen for, diagnose and treat
breast cancer. In addition to unveiling a new
MRI scanner, the Achieva 3.0T TX, in 2008
Philips showcased its comprehensive portfolio
of Breast Health solutions, including
MammoDiagnost DR, iU22 Breast Ultrasound, MR
Elite Breast and GEMINI TF Big Bore PET/CT.
Key data
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20061) |
|
|
20071) |
|
|
2008 |
|
Sales |
|
|
6,562 |
|
|
|
6,638 |
|
|
|
7,649 |
|
|
Sales growth
|
|
|
|
|
|
|
|
|
|
|
|
|
% increase, nominal |
|
|
9 |
|
|
|
1 |
|
|
|
15 |
|
% increase, comparable |
|
|
8 |
|
|
|
4 |
|
|
|
6 |
|
|
EBITA |
|
|
857 |
|
|
|
862 |
|
|
|
863 |
|
as a % of sales |
|
|
13.1 |
|
|
|
13.0 |
|
|
|
11.3 |
|
|
EBIT |
|
|
713 |
|
|
|
713 |
|
|
|
638 |
|
as a % of sales |
|
|
10.9 |
|
|
|
10.7 |
|
|
|
8.3 |
|
Net operating capital (NOC) |
|
|
4,699 |
|
|
|
4,802 |
|
|
|
8,830 |
|
Cash flows before financing activities |
|
|
(1,003 |
) |
|
|
236 |
|
|
|
(2,418 |
) |
Employees (FTEs) |
|
|
27,223 |
|
|
|
29,191 |
|
|
|
35,551 |
|
|
|
|
1) |
|
Revised to reflect immaterial adjustments of intercompany profit
eliminations on inventories. |
For a reconciliation to the most directly comparable US GAAP measures,
see the chapter Reconciliation of non-US GAAP information
2008 financial performance
In 2008, sales amounted to EUR 7,649 million,
15% higher than in 2007 on a nominal basis,
largely thanks to the contributions from
acquired companies, notably Respironics.
Excluding the 14% positive impact of portfolio
changes and the 5% unfavorable impact of
currency effects, comparable sales grew 6%. All
businesses showed positive growth, led by solid
sales growth in Customer Services, Clinical
Care Systems, and Healthcare Informatics and
Patient Monitoring. Higher sales within Imaging
Systems were supported by X-Ray and Nuclear
Medicine, partly tempered by lower sales at
Computed Tomography. Green Product sales
amounted to EUR 1,527 million in 2008, up from
EUR 1,452 million in 2007, representing 20% of
sector sales.
Geographically, double-digit comparable sales
growth was achieved in the key emerging
markets, notably in China and Latin America,
driven by growth in all businesses. Also,
single-digit sales growth was recognized in the
mature markets, across all businesses, notably
Imaging Systems and Clinical Care Systems.
EBITA of EUR 863 million, or 11.3% of sales,
was in line with 2007 earnings of EUR 862
million. Earnings included EUR 90 million of
acquisition-related charges and EUR 69 million
of restructuring charges, which were partly
offset by a EUR 45 million gain on the sale of
Philips Speech Recognition Systems. EBITA also
included additional income from Respironics
and higher earnings at Clinical Care Systems
and Healthcare Informatics and Patient
Monitoring, partly offset by lower earnings at
Imaging Systems.
76 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70
Our sector performance
Healthcare
|
|
94 Risk
management
|
|
110 Our leadership
|
|
114
Supervisory
Board report
|
|
122 Performance
statements |
Compared to 2007, EBIT declined EUR 75
million to EUR 638 million.
Cash flow before financing activities included
net payments totaling EUR 3,456 million, mainly
for the
acquisitions of Respironics, VISICU, TOMCAT,
Dixtal Biomédica, Shenzhen Goldway, Medel SpA
and Alpha X-Ray Technologies. In 2007,
acquisition-related outflows amounted to EUR
245 million, mainly for the acquisitions of
Health Watch, Raytel Cardiac Services, Emergin
and VMI Sistemas Medicos. Excluding these
acquisition-related outflows, cash flow before
financing activities was EUR 557 million higher
than in 2007, largely thanks to improved
working capital requirements, notably lower
inventory.
Regulatory requirements
Philips Healthcare is subject to extensive
regulation. It strives for full compliance with
regulatory product approval and quality system
requirements in every market it serves by
addressing specific terms and conditions of
local ministry of health or federal regulatory
authorities, including agencies like the US
FDA, EU Competent Authorities and Japanese
MLHW. Environmental and sustainability
requirements like the European Unions Waste
from Electrical and Electronic Equipment (WEEE)
and Restriction of Hazardous Substances (RoHS)
directives are met with comprehensive EcoDesign
and manufacturing programs to reduce the use of
hazardous materials.
Strategy and 2009 objectives
Philips Healthcare will play an important
role in the realization of Philips strategic
ambitions. For 2009 and beyond, Healthcare
has put in place a number of specific
value-creating initiatives which it will
drive via the axes Drive performance,
Accelerate change and Implement strategy:
|
|
Improve margins through acceleration of
operational improvements |
|
|
Grow faster than our markets through
investments in key market segments |
|
|
Deliver value to our customers and
shareholders by effective integration
of acquisitions |
|
|
Enhance engagement of our workforce. |
Philips Annual Report 2008 77
|
|
|
|
|
|
|
|
|
6 Performance highlights
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group
performance |
Simply sensational
In 2008, Philips extended its highly successful Senseo
range of coffee machines with the introduction of the
Senseo Latte Select, which offers delicious coffee
specialties made with fresh frothed milk. Consumers can
choose from Cappuccino, Latte Macchiato, Café Latte and
regular black Senseo coffee all at the touch of a
button.
Consumer Lifestyle
®
|
|
Consumer markets heavily impacted by downturn |
|
® |
|
Integration of former CE and DAP |
|
® |
|
Refocused approach to Television based on differentiation |
|
® |
|
Market and customer-driven portfolio choices |
Todays consumers want to enjoy a healthy life balance to look and feel good, and to benefit
emotionally from rich, pleasurable technology experiences, both at home and on the move.
The pursuit of personal health and well-being is a universal trend. It represents a significant
proportion of the total global consumer spend and the broad consumer lifestyle market in
particular, which is itself nearly three times larger than the market for our existing consumer
businesses. It is creating a market in both developed and emerging economies, is growing at a
faster pace than the overall consumer goods market, and therefore represents a formidable platform
for sustainable growth.
78 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70
Our sector performance
|
|
94 Risk management
|
|
110 Our leadership
|
|
114 Supervisory Board report
|
|
122 Performance statements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consumer Lifestyle |
Lifestyle retail landscape
The lifestyle retail landscape continues to evolve, with Brazil, China and India emerging as major
retail markets and retailers driving their expansion, both into new geographies, as well as into
the online segment.
Our new Consumer Lifestyle sector, launched on January 1, 2008, reflects Philips evolution from a
technology business to one that focuses on peoples health and well-being. Through the application
of design and validated consumer insight, we develop innovative solutions that help to fulfill
peoples lifestyle needs and desires.
Clearly, markets around the world both mature and emerging were hit hard by the steep downturn
in the second half of the year, with its sharp decline in consumer confidence and consumer
spending, a situation that is expected to continue in 2009. This had a heavy impact on our Consumer
Lifestyle sector. Now more than ever, focus, flexibility and differentiation remain key to gaining
and maintaining market leadership.
About Philips Consumer Lifestyle
The Philips Consumer Lifestyle sector was launched following the integration of the former Domestic
Appliances & Personal Care and Consumer Electronics divisions. The sector is organized around its
markets, customers and consumers, with its businesses focused on value creation through category
development, and its functions concentrating on value delivery through operational excellence,
albeit with a lower fixed-cost base. A delayered management structure has increased the span of
control of the sectors leadership, creating greater employee empowerment to help drive Consumer
Lifestyle forward.
The market-driven approach is applied with particular emphasis at local level, enabling the sales
organizations to operate with shorter lines of communication with the sectors six businesses. This
also promotes customer- centricity in day-to-day operations. The grouping of local sales activities
within three sales clusters Western Europe & North America, Growth (including the emerging
markets of China, India, Russia, Latin America, Poland, Turkey and Ukraine) and International
with each cluster defined by the individual market characteristics, enables Consumer Lifestyle to
address a variety of dynamics in both its mature and emerging markets.
In 2008 the sector consisted of the
following areas of business:
|
|
Television experience television (including the new Aurea II, Ambilight and ultra-thin Essence
TV ranges), lifestyle television, professional and business display solutions |
|
|
|
Shaving & Beauty electric shavers, female depilation appliances, haircare and male grooming
products, vitality solutions (including the Wake-Up light) |
|
|
|
Audio & Video Multimedia home and portable audio and video entertainment, including Blu-ray
Disc playback, MP3 and MP4 players, and docking stations for portable entertainment devices |
|
|
|
Domestic Appliances kitchen appliances, floor care, garment care, water and air purifiers,
beverage appliances |
|
|
|
Health & Wellness oral healthcare, mother and childcare, relationship care |
|
|
|
Peripherals & Accessories mobility accessories (including headphones, portable audio
accessories), remote controls, PC peripherals, digital picture frames, audio and video
communications (including DECT and VoIP digital cordless phones). |
We also partner with leading companies from other fields, such as Sara Lee/Douwe Egberts, Nivea
Beiersdorf and Swarovski, in order to deliver customer-focused appliance/consumable combinations.
Consumer Lifestyle has continued its business with international key accounts, particularly in
emerging markets. The introduction of flagship online stores for Consumer Lifestyle products has
added a key touch-point to the consumer brand experience.
With our extensive product portfolio, we are able to service traditional and emerging distribution
channels, e.g. general retailers, electronic retailers, mass merchants, retail specialists, online
retailers, and distributors/ wholesalers. We offer a broad range of products from high to low
price/value quartiles, necessitating a diverse distribution model that includes mass merchants,
retail chains, independents and small specialty stores often represented by buying groups.
Under normal economic conditions, the Consumer Lifestyle business experiences seasonality, with
higher sales in the fourth quarter resulting from the holiday sales.
>20
million
Senseo coffee
makers sold
since 2001
Philips Annual Report 2008 79
|
|
|
|
|
|
|
|
|
6 Performance highlights
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group
performance |
Directors cut
During IFA 2008, Philips introduced the
compact CinemaOne home theater system, the
worlds first cinema-proportioned LCD
television. With its 56 screen shaped in
the 21:9 aspect ratio, Cinema 21:9 lets
you enjoy movies as you would in the
cinema and just as the director intended.
Ambilight technology combines with the
on-screen action to completely immerse you
in the movie and deliver an uncompromised
and absorbing cinematic viewing experience
never before available in the home.
Consumer Lifestyle employs approximately 17,000
people worldwide down by some 6,000 compared
with 2007 following the integration of the
former CE and DAP businesses and subsequent
rebalancing of the portfolio and industrial
footprint. Our global sales and service
organization embraces more than 50 mature and
emerging markets. In addition, we operate
manufacturing and business creation
organizations in the Netherlands, France,
Belgium, Austria, Hungary, Singapore,
Argentina, Brazil and China.
Consumer Lifestyle strives for full
compliance with relevant regulatory
requirements, including the European Unions
WEEE (Waste from Electrical and Electronic
Equipment) directive.
With regard to sourcing, please refer to the
section Supply management on page 54 of this
Annual Report.
Transformation program
Throughout 2008, Consumer Lifestyle has
undergone a process of integration and
optimization. This has involved right-sizing
the two complementary business operations from
the start of the year into one that is focused
on profitability and business stability with
synergies and lower fixed costs. Within this
framework, the sector has applied itself to
making focused choices on the categories and
markets in which it operates in order to create
a stronger and more profitable foundation for
growth.
The sector has also placed particular emphasis
on ensuring the right product/market
combinations exist across its portfolio, making
bold choices in
many markets regarding which categories to
pursue and grow. For example, Television has
shifted from a business based on scale to one
driven by differentiation, especially in its
channel/market mix. Traditional world-class
competences in areas like picture quality and
technical performance have been maintained,
while additional focus has been placed on
differentiated design and experiences.
Across many of our businesses, we tightened our
focus in Europe and North America, while
expanding our presence in emerging markets like
Brazil, India, China and Russia. Within the
North American market, Philips entered into a
five-year minimum brand licensing agreement
with Funai Electric Company of Japan, under
which Funai will assume responsibility for all
Philips-branded consumer television activities
in the United States and Canada. Toward the end
of the year this agreement was extended, adding
audio-video categories in the US and TV and
audio-video categories in Mexico. Consumer
Lifestyle took a similar approach to its PC
monitors and digital signage business, IT
Displays, entering into a brand licensing
agreement with TPV Technology Ltd for the
global distribution and marketing of products
in these categories. This transaction is
expected to be completed in the first quarter
of 2009.
80 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector performance
|
|
94 Risk management
|
|
110 Our leadership
|
|
114 Supervisory Board report
|
|
122 Performance statements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consumer Lifestyle |
Progress against targets
The Annual Report 2007 set out a number of key
targets for Philips Consumer Lifestyle in
2008. The advances made in addressing these
are outlined below.
Leverage post-integration synergies
Best practices from the former Domestic
Appliances & Personal Care and Consumer
Electronics divisions have been implemented
across the new Consumer Lifestyle sector.
Marketing expertise from the previous DAP
organization, for example, has been applied in
the higher-volume electronics categories, and
the supply chain competences of CE have been
leveraged across the sector.
Open up new value spaces
Consumer Lifestyles application of insight and
innovation has helped it open up new and
emerging value spaces. With the stronger focus
on consumer health and well- being, categories
such as the Sonicare oral healthcare and
Philips-Avent mother and child ranges have
already given Consumer Lifestyle a foothold in
this area. With the 2007 launch of the Water &
Air category, the sector started to focus on
new opportunities. In this category, the
Philips brand is applied to the very basic
necessities of life in emerging and mature
markets where the provision of clean drinking
water or purer indoor air can improve the
quality of life. In 2008 the Relationship Care
category was created as a platform to address a
different aspect of well-being and initially,
in particular, the intimate needs and interests
of committed couples in the 35 to 55-year age
group.
Create a unified, engaged and high-performance
organization
Consumer Lifestyle brought together highly
engaged employees from the former DAP and CE
organizations. Integration-related
communications focused on driving a
single-sector mindset, an initiative running in
step with the operational transition of
activities into the new sector.
The sector has focused strongly on creating the
right kind of empowered leadership to take it
forward, with an increased span of control and
greater diversity in terms of both gender and
nationality. Consumer Lifestyle has recorded an
increase in employee engagement levels related
to its leadership, with the Philips Leadership
Index
reflecting leadership effectiveness and
engagement capabilities rising by 4% over the
year.
Whiter, healthier teeth
Consumer Lifestyle strengthened the scope
of its health and well-being portfolio for
consumers with several key product
launches, such as the new Philips Sonicare
HealthyWhite whitening toothbrush in
Europe. This rechargeable sonic toothbrush
lets the natural whiteness of your teeth
shine through.
Maximize our structure to be fully market-driven
Consumer Lifestyles structure in
particular, its clustered sales organization
has reinforced the sectors market-driven
approach, both geographically and in terms of
applying consumer insight, relevant innovation
and design to drive positions of strength,
such as its Shaving & Beauty, Domestic
Appliances and Peripherals & Accessories
businesses.
Philips Annual Report 2008 81
|
|
|
|
|
|
|
|
|
6
Performance highlights
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance |
Key data
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Sales |
|
|
13,108 |
|
|
|
13,330 |
|
|
|
11,145 |
|
of which Television |
|
|
6,559 |
|
|
|
6,270 |
|
|
|
4,980 |
|
Sales growth |
|
|
|
|
|
|
|
|
|
|
|
|
% increase (decrease), nominal |
|
|
4 |
|
|
|
2 |
|
|
|
(16 |
) |
% increase (decrease), comparable |
|
|
6 |
|
|
|
4 |
|
|
|
(8 |
) |
Sales growth excl. Television
|
|
|
|
|
|
|
|
|
|
|
|
|
% increase (decrease), nominal |
|
|
|
|
|
|
8 |
|
|
|
(13 |
) |
% increase (decrease), comparable |
|
|
(3 |
) |
|
|
10 |
|
|
|
(6 |
) |
EBITA |
|
|
692 |
|
|
|
848 |
|
|
|
281 |
|
of which Television |
|
|
155 |
|
|
|
(68 |
) |
|
|
(413 |
) |
as a % of sales |
|
|
5.3 |
|
|
|
6.4 |
|
|
|
2.5 |
|
EBIT |
|
|
683 |
|
|
|
832 |
|
|
|
265 |
|
of which Television |
|
|
155 |
|
|
|
(68 |
) |
|
|
(413 |
) |
as a % of sales |
|
|
5.2 |
|
|
|
6.2 |
|
|
|
2.4 |
|
Net operating capital (NOC) |
|
|
910 |
|
|
|
890 |
|
|
|
728 |
|
of which Television |
|
|
(185 |
) |
|
|
(255 |
) |
|
|
(245 |
) |
Cash flows before financing activities |
|
|
(39 |
) |
|
|
772 |
|
|
|
253 |
|
of which Television |
|
|
207 |
|
|
|
(41 |
) |
|
|
(489 |
) |
Employees (FTEs) 24,419 |
|
|
|
|
|
|
23,397 |
|
|
|
17,346 |
|
of which Television |
|
|
7,262 |
|
|
|
6,855 |
|
|
|
4,943 |
|
For a reconciliation to the most directly
comparable US GAAP measures, see the
chapter Reconciliation of non-US GAAP
information
2008 financial performance
2008 presented very challenging market
conditions for Consumer Lifestyle. Sales
amounted to EUR 11,145 million, a nominal
decline of 16% compared to 2007. Adjusted for
unfavorable currency effects of 3% and
portfolio changes, mainly the divestment of
Television in North America and the sale of the
Set-Top Boxes and Mobile Phones businesses,
comparable sales declined by 8%.
Year-on-year declines were seen in all
businesses, except for 4% comparable growth in
Domestic Appliances and Health & Wellness.
Television and Audio & Video Multimedia
suffered comparable double-digit declines.
Green Product sales totaled 1,478 million in
2008, a nominal increase of 41% compared to
2007, amounting to 13% of sector sales.
From a geographical perspective, Western Europe
and North America, which account for more than
half of the sectors sales, were heavily
impacted by the economic downturn as well as by
selective portfolio and margin management.
Sales growth
was strong in the key emerging markets, led by
double-digit growth in Brazil. Growth in Asia
was driven by solid double-digit growth across
the countries in most businesses, mostly offset
by a decline in Television. European emerging
markets declined 14%.
EBITA as a percentage of sales decreased from
6.4% in 2007 to 2.5% in 2008, due to declines
in nearly all businesses, mainly as a result
of lower sales. EBITA was impacted by EUR 195
million of restructuring charges, partially
offset by the EUR 63 million gain on the sale
of Set-Top Boxes.
EBIT declined from EUR 832 million (6.2% of
sales) in 2007 to EUR 265 million (2.4% of
sales) in 2008.
Net operating capital was reduced by EUR 162
million at the end of 2008 and amounted to EUR
728 million.
Cash flows before financing activities
declined from EUR 772 million in 2007 to an
inflow of EUR 253 million, primarily driven
by lower earnings.
82 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector performance
|
|
94 Risk management
|
|
110 Our leadership
|
|
114 Supervisory Board report
|
|
122 Performance statements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consumer Lifestyle |
Strategy and 2009 objectives
Philips Consumer Lifestyle will play an
important role in the realization of Philips
strategic ambitions. For 2009 and beyond,
Consumer Lifestyle has put in place a number
of specific value-creating initiatives which
it will drive via the axes Drive performance,
Accelerate change and Implement strategy:
|
|
Further optimize the business portfolio
to focus on higher growth, higher-margin
product categories and to build on global
and regional leadership positions |
|
|
|
Selectively strengthen the portfolio
through opening up new values spaces,
including pursuing external opportunities
such as strategic acquisitions and
alliances |
|
|
|
Focus on geographic areas in
particular emerging markets with the
highest return on marketing investment |
|
|
|
Increase effectiveness and investment
in advertising and promotion as well as
research and development |
|
|
|
Maintain rigorous cost and
organizational discipline, measured
against external and internal benchmarks. |
Philips Annual Report 2008 83
|
|
|
|
|
|
|
|
|
6
Performance highlights
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance |
EcoMoods consumer luminaries
The Philips EcoMoods luminaire range allows people to save
energy without compromising their personal taste. With
EcoMoods the lights and fittings are chic and elegant, with a
contemporary feel, providing warm and welcoming light that
can be tailored to any mood. A variety of ceiling, wall and
floor fittings offers endless possibilities to complement any
room in any home.
EcoMoods is a product of Philips business group Consumer
Luminaires, which grew out of PLI, the leading European
home luminaires company acquired in 2007.
Lighting
® |
|
Transition to energy-efficient
lighting, solid-state lighting
and applications |
|
® |
|
Slowdown in automotive and construction sectors |
|
® |
|
Acquisition and integration of Genlyte |
|
® |
|
Major transformation program |
|
® |
|
Strengthened position in emerging markets |
Around the world, people are increasingly
concerned about the effects of climate change
and rising energy costs. In many countries a
substantial body of green legislation is
imminent, if not already in place much of
which has a direct impact on the future of
lighting. Indeed, the European Union has
decided to phase out incandescent lamps by
2012, in line with our December 2006 appeal to
accelerate the switch to energy-efficient
solutions. Understanding these imperatives and
addressing these challenges presents us with a
tremendous opportunity to help shape the
future of lighting on a global scale.
Lighting accounts for 19% of global electricity
consumption. Innovative lighting solutions can
realistically reduce the energy consumption of
todays installed base by at least 40% (and
even up to 70%, e.g. in offices), while also
improving the quality of the light. We can play
a significant role in encouraging and enabling
the switch to energy-efficient lighting and
helping combat climate change.
84 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector performance
|
|
94 Risk management
|
|
110 Our leadership
|
|
114 Supervisory Board report
|
|
122 Performance statements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lighting |
Lighting landscape
Overall, we see three main transitions that
will affect the lighting industry in the years
to come. The first is from incandescent lamps
to energy-efficient light sources. Rising
energy prices and increased awareness of
climate change are creating a greater demand
for energy-saving lighting. As a result, the
market for innovative, efficient and
sustainable lighting solutions is growing.
The second transition is the move from
traditional vacuum-based technologies to
solid-state lighting technology. Solid-state
or LED lighting is the most significant
development in lighting since the invention
of electric light well over a century ago.
Offering unprecedented freedom in terms of
color, dynamics, miniaturization,
architectural integration and energy
efficiency, solid-state lighting is opening
up exciting new possibilities.
The third transition is from the bulb and
components as the point of value creation in
the lighting industry to applications and
solutions. Lighting expertise based on end-user
insights is integrated into the application,
system or solution. Increasingly, these
applications and solutions will include
controls, and so a key differentiator in the
future will be the innovative strength to
create systems and solutions that are truly
customer-centric.
Like other industries, however, the lighting
industry is not immune to macro-economic
developments. The slowdown in the automotive
and construction sectors, tighter availability
of credit and weaker spending on public
infrastructure projects had an impact in 2008
and the continuation of these trends in 2009
could slow the above transitions for us and
many of the players in the industry.
Solutions for peoples needs
Philips Lighting is dedicated to improving
peoples lives through the introduction of
innovative and energy-efficient solutions or
applications for lighting. Our approach is
based on obtaining direct input both from
customers and from end-users/consumers. Through
a segment-based approach, we can assess
customer needs in a targeted way, track changes
over time and define new insights that fuel our
innovation process and ultimately increase the
success rate of new propositions introduced
onto the market.
We aim to be the true front-runner in
design-led, market- and consumer-driven
innovation both in conventional lighting and
in solid-state lighting while continuing to
contribute to responsible energy use and
sustainable growth.
Elegance meets efficiency
Offering up to 80% energy saving compared
with standard dichroic low-wattage halogen
lamps and incandescent spot lamps and
45,000 hours of high-quality light, the
Philips MASTER LED range opens up a whole
new world of spot and general lighting
solutions. The energy efficiency and long
lifetime of LEDs have now been applied to
meet the need for a long-lasting,
cost-efficient lamp in functional
applications. MASTER LED particularly
benefits hospitality and retail sector
owners and managers who want to reduce the
energy consumption of their hotels,
restaurants and clubs but will not
compromise on perceived quality of light.
About Philips Lighting
Philips Lighting is the global market
leader, with recognized expertise in the
development, manufacturing and application
of innovative lighting solutions. We have
pioneered many of the key breakthroughs in
lighting over the past 100 years, laying
the basis for our current position.
We address peoples lighting needs across a
full range of environments. Indoors, we offer
specialized lighting solutions for homes,
shops, offices, schools, hotels, factories and
hospitals. Outdoors, we provide lighting for
public spaces, residential areas and sports
arenas. We also meet peoples needs on the
road, by providing safe lighting for traffic
(car lights and street lighting) and elsewhere.
In addition, we address peoples desire for
light-inspired experiences through
architectural projects. Finally, we offer
specific applications of lighting in
specialized areas, such as horticulture,
refrigeration lighting and signage, as well as
heating, air and water purification, and
healthcare.
1 in 3
cars worldwide uses
Philips automotive
lighting
Philips Annual Report 2008 85
|
|
|
|
|
|
|
|
|
6 Performance highlights
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance |
Win-win in Lesotho
In 2008 Philips announced plans to
participate in a joint venture to set up a
manufacturing facility, as well as a
recycling plant, for energy-saving Compact
Fluorescent Lamp integrated (CFLi) light
bulbs in Lesotho, Southern Africa. The
facility will be set up jointly with CEF, a
company that focuses on opportunities in
the energy sector in the region, and Karebo
Systems, a company specialized in energy
efficiency programs in the lighting and
energy sectors. With this joint venture
Philips will be able to help stimulate
economic growth while accelerating the
uptake of energy-efficient light bulbs in
general.
In our efforts to significantly reduce
energy consumption in South Africa,
switching to energy-efficient lighting
is the quickest and easiest way to make
a significant contribution. With
Philips expertise in this field, we
bring the high-quality energy-saving
light bulbs this country desperately
needs, says Peter Kgame, managing
director of Karebo Systems.
In short, our lighting business spans the
entire lighting value chain from lighting
sources, electronics and controls to full
applications and solutions via the following
businesses:
|
|
Lamps: incandescent, halogen, (compact)
fluorescent, high-intensity discharge |
|
|
|
Consumer Luminaires: functional,
decorative, lifestyle,
scene-setting |
|
|
|
Professional Luminaires: city
beautification, road lighting,
sports lighting, office lighting,
shop/hospitality lighting,
industry lighting |
|
|
|
Lighting Electronics and Controls:
electronic gear, electromagnetic gear,
controls |
|
|
|
Automotive Lighting: car headlights,
car signaling, interior |
|
|
|
Special Lighting Applications:
projection, entertainment,
purification, comfort heating,
light & health |
|
|
|
Solid-State Lighting components:
LUXEON, SnapLED, SuperFlux |
|
|
|
Solid-State Lighting modules:
modules, retrofits, new applications |
Our customers are mainly in the professional
market. The Lamps business conducts its sales
and marketing activities through the wholesale,
OEM and consumer channels, the latter also
being used by our Consumer Luminaires business.
Professional Luminaires is organized in a Trade
business (commodity products) and a Project
solutions business (project luminaires and
solutions). For the latter, the main focus is
on specifiers, lighting designers, architects
and urban planners. Automotive Lighting is
organized in two businesses: OEM and After-
market. Lighting Electronics and Controls,
Special Lighting Applications and Solid-State
Lighting components and modules conduct their
sales and marketing through both the OEM and
wholesale channels.
Regarding competition, our current global
structure is centered on our Lamps and
Luminaires businesses. The lamps industry is
highly consolidated, with GE and Siemens/Osram
as key competitors. The luminaires industry is
more fragmented. Our competition varies per
region and per segment. Our lighting
electronics business and our automotive
lighting business are again more consolidated
businesses. Chinese companies are entering
Western markets with energy-saving solutions,
and there are a range of companies active in
the transition to solid-state lighting as well
as in the transition to applications and
solutions.
86 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector performance
|
|
94 Risk management
|
|
110 Our leadership
|
|
114 Supervisory Board report
|
|
122 Performance statements |
|
|
|
|
|
|
|
|
Lighting |
Driving transformation
As we are the market leader in both solid-state
lighting and energy-efficient solutions, the
radical changes in the lighting industry give
us ample opportunities to shape our own future.
Our acquisition of Genlyte, completed in 2008,
is particularly important in strengthening our
position in professional luminaires and in the
North American lighting market. Following our
recent acquisitions, we are well positioned
across the entire solid-state lighting value
chain.
Furthermore, we implemented a major
transformation program in 2008. This has helped
streamline the organization, simplify the
structure, and shape our Lighting sector around
future opportunities. It has involved reducing
complexity as well as reallocating and
reinvesting resources in R&D and marketing,
with a stronger emphasis on the application
side of the business as well as on emerging
markets. It has also helped us accelerate the
shift from traditional technologies to
energy-efficient and solid-state lighting
technologies, as well as to project sales.
Philips Lighting has manufacturing facilities
in some 25 countries in all regions of the
world and sales organizations in more than
60. Commercial activities in other countries
are handled via dealers working with our
International Sales organization. Lighting
has approximately 57,000 employees worldwide.
Lighting strives for full compliance with
relevant regulatory requirements, including
the European Unions WEEE (Waste from
Electrical and Electronic Equipment) and RoHS
(Restriction of Hazardous Substances)
directives.
With regard to sourcing, please refer to the
section Supply management on page 54 of this
Annual Report.
Progress against targets
In the 2007 Annual Report, Lighting
identified a number of key objectives for
2008. The progress made in addressing
these is discussed below.
Emerging markets and energy-efficient lighting
In 2008 we continued to strengthen our position
in emerging markets, with double-digit
comparable
sales growth. Among a large number of
high-profile projects in emerging markets, we
provided a state-of-the-art lighting solution
for the major bridge in Sao Paulo, Brazil,
reducing energy consumption by 53%. In the SESA
(Sustainable Energy Solutions for Africa)
project, we partnered with the UN and national
governments on a renewable energy for lighting
project for 14 countries in Sub-Saharan Africa.
Philips to create Guanajuato City of Light
Philips in Mexico has signed an agreement
with the Government of Guanajuato City to
turn this UNESCO World Heritage site into
Guanajuato Ciudad Luz (City of Light).
The plan will be implemented in
collaboration with a multidisciplinary
team (government, urbanists, designers,
architects, technicians, etc) coordinated
by Philips.
This first city lighting masterplan to
be deployed in Latin America will bring
many benefits to Guanajuato enhancing
the architecture, monuments, churches,
streets and plazas, making the public
and decorative lighting
energy-efficient, increasing safety and
boosting tourism.
We have continued strongly promoting our Green
value propositions and the enhanced energy
savings that are possible through our systems
approach and renovation focus.
Energy-efficient lighting now accounts for
over 53% of Lighting sales, excluding the
acquired Partners in Lighting International
(PLI) and Genlyte, up from just under 50% in
2007.
System solutions professional
and consumer luminaries
We have continued expanding in the direction of
system solutions, especially incorporating
solid-state lighting. We completed the
acquisition of Genlyte, a leader in the North
American professional luminaires market, in
early 2008. Integration is well under way and
significant synergies are being realized. The
integration of PLI (acquired in 2007) is on
schedule; its activities are being expanded
outside Europe and it has launched major new
LED-based product ranges for the home. Our
other major recent acquisition, Color Kinetics,
the solid-state lighting solutions company also
acquired in 2007, has been fully embedded and
leveraged across the value chain.
Philips Annual Report 2008 87
|
|
|
|
|
|
|
|
|
6 Performance highlights
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance |
This systems approach, building on the strong
position we have gained in luminaires following
our recent acquisitions, is illustrated by new
lighting solutions we have introduced in 2008
in all our application segments, such as shops,
offices, homes, streets and hospitality.
Leadership bench
Our 2008 People Leadership Index, which
measures the effectiveness of our leaders in
engaging and managing people, showed a major
improvement from 63% to 71%. We have increased
our annual recruitment of top potentials to
24 (up 20%).
Excellence and learning
Our 2008 Employee Engagement score also showed
a significant improvement from 64% to 72%
surpassing our benchmark index and reflecting
our efforts to build a winning culture in our
organization. And more than 40% of our
employees are learning and developing their
competences in our Quality Improvement
Competition.
Streamline ways of working
The transformation program outlined above
reinforced our segment marketing approach and
strengthened our customer focus. We have
significantly simplified the way we are
organized by setting up regional commercial
organizations covering the whole product
portfolio. Both our sourcing and supply chain
functions now have global transparency and
harmonized ways of working, which has enabled
us to offset a major part of the commodity
price inflation in 2008.
Key data
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Sales |
|
|
5,466 |
|
|
|
6,093 |
|
|
|
7,106 |
|
Sales growth |
|
|
|
|
|
|
|
|
|
|
|
|
% increase, nominal |
|
|
14 |
|
|
|
11 |
|
|
|
17 |
|
% increase, comparable |
|
|
8 |
|
|
|
6 |
|
|
|
3 |
|
EBITA |
|
|
608 |
|
|
|
722 |
|
|
|
538 |
|
as a % of sales |
|
|
11.1 |
|
|
|
11.9 |
|
|
|
7.6 |
|
EBIT |
|
|
577 |
|
|
|
675 |
|
|
|
165 |
|
as a % of sales |
|
|
10.6 |
|
|
|
11.1 |
|
|
|
2.3 |
|
Net operating capital (NOC) |
|
|
2,527 |
|
|
|
3,886 |
|
|
|
5,648 |
|
Cash flows before |
|
|
451 |
|
|
|
(648 |
) |
|
|
(1,139 |
) |
financing activities |
|
|
|
|
|
|
|
|
|
|
|
|
Employees (FTEs) |
|
|
47,739 |
|
|
|
54,323 |
|
|
|
57,166 |
|
For a reconciliation to the most directly comparable US GAAP measures,
see the chapter Reconciliation of non-US GAAP information
2008 financial performance
Sales in 2008 grew by 17% in nominal terms,
mainly supported by the acquired companies:
Genlyte and Color Kinetics. Adjusted for
portfolio changes of 18% and unfavorable
currency effects of 4%, comparable sales grew
by 3% compared to 2007. This growth was driven
by continued sales growth in energy-efficient
lighting solutions, notably within the Lamps
and Professional Luminaires businesses. Sales
were broadly in line with 2007 in the remaining
businesses as a result of the deteriorating
economic climate in the latter part of 2008
within the automotive, consumer and
construction industries. Green sales grew by
12% in 2008 compared to 2007, reaching EUR
2,970 million. This growth was supported by
increased sales of solid-state lighting
applications, which grew by 6% to EUR 470
million, as well as innovative product design
and strong growth in application-based
solutions.
Geographically, comparable sales in the mature
markets slightly declined compared to 2007, as
higher sales in energy-efficient lighting
solutions were more than offset by the
deteriorating economic climate in the
automotive, consumer and construction segments
in North America and Western Europe. Emerging
market sales increased 8%, with growth in all
businesses except Special Lighting
Applications, led by strong double-digit sales
growth in India, Eastern Europe and the ASEAN
countries.
EBITA of EUR 538 million, or 7.6% of sales,
declined EUR 184 million compared to 2007 and
included EUR 221 million restructuring charges
and EUR 41 million of acquisition-related
charges. 2008 earnings were also impacted by
margin compression in mature markets as a
result of slowing demand, particularly
88 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector performance
|
|
94 Risk management
|
|
110 Our leadership
|
|
114 Supervisory Board report
|
|
122 Performance statements |
|
|
|
|
|
|
|
|
Lighting |
in the automotive and construction segments,
partly offset by positive contributions from
acquisitions. 2007 included EUR 55 million of
restructuring and acquisition-related
charges.
EBIT amounted to EUR 165 million, compared to
EUR 675 million in 2007. In 2008, a EUR 232
million non-cash goodwill impairment charge
for Lumileds was recorded, primarily due to
weaker demand in the automotive, displays and
mobile phone segments.
Cash flow before financing activities included
cash disbursements of EUR 1,826 million, mainly
related to the acquisition of Genlyte, whereas
in 2007 acquisition- related disbursements
amounted to EUR 1,162 million, mainly in
connection with the acquisitions of PLI and
Color Kinetics. Excluding these
acquisition-related payments, cash flow before
financing activities increased by EUR 173
million compared to 2007 thanks to improved
working capital requirements. Net capital
expenditures increased by EUR 54 million
compared to 2007, largely due to higher
investments in solid-state lighting solutions.
Strategy and 2009 objectives
Philips Lighting will play an important role in
the realization of Philips strategic
ambitions. For 2009 and beyond, Lighting has
put in place a number of specific
value-creating initiatives which it will drive
via the axes
Drive performance, Accelerate change and Implement strategy.
The five value drivers that we believe will
strengthen our competitive advantage and help
safeguard our leading position in lighting
are:
|
|
growth driven by acquisitions, Green value propositions, innovative solutions, LEDs/solid-state
lighting and emerging markets |
|
|
|
segment leadership by driving the development of our market segments through channels and
multi-stakeholder partnerships |
|
|
|
brand franchise by leveraging category management and our brand equity |
|
|
|
new business models by creating new ways of working and new forms of revenue generation |
|
|
|
intellectual property in particular by developing the solid-state lighting market through a
dedicated IP licensing program. |
Philips Annual Report 2008 89
|
|
|
|
|
|
|
|
|
6 Performance highlights
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance |
LED IP licensing to accelerate market development
In 2008, Philips introduced a patent licensing program for LED-based luminaires used in the general
illumination, architectural and theatrical markets and also concluded a patent licensing agreement
with Osram for key LED technology. Both events are next steps in making basic Philips LED
intellectual property broadly available to the industry, accelerating the development of the
LED-based lighting market.
Innovation & Emerging Business
Introduction
The Innovation and Emerging Businesses sector is designed to stimulate growth by leveraging
Philips brand, technology and intellectual property (IP) base. Through this sector, Philips
invests in innovation and new business activities that are not currently part of the operating
sectors, but which have potential to create additional organic growth or value through future
spin-offs. The sector comprises Corporate Technologies, Corporate Investments, New Venture
Integration and Philips Design.
Corporate Technologies
Corporate Technologies feeds the innovation pipeline, enabling its business partners principally
the three Philips operating sectors to create new business options through new technologies,
venturing and intellectual property development, to improve time-to-market efficiency and to
increase innovation effectiveness via focused research and development activities. Corporate
Technologies encompasses Philips Corporate Research, the Philips Incubators, Philips Intellectual
Property & Standards (IP&S), the Philips Innovation Campus as well as Philips Applied Technologies.
In total, Corporate Technologies employs about 4,100 professionals around the globe.
Corporate Technologies actively participates in open innovation through relationships with
academic and industrial partners, as well as via European and regional projects, in order to
improve innovation efficiency and share the related financial exposure. The High Tech Campus in
Eindhoven, the Philips Innovation Campus in Bangalore India, Research Shanghai China and InnoHub
are prime examples of eco-systems enabling open innovation.
90 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector performance
Innovation & Emerging Businesses
|
|
94 Risk management
|
|
110 Our leadership
|
|
114 Supervisory Board report
|
|
122 Performance statements
|
Philips Research is a key innovation partner for Philips business sectors. It has three main
roles. Firstly, it creates new technologies that help to spur the growth of the Philips
businesses. Secondly, it develops unique IP, which will enable longer-term business and creates
standardization opportunities for Philips. Lastly, it sets up ventures that can grow into new
adjacent businesses for the sectors.
In 2008, Research started to develop a novel ultrasound- based drug delivery technology that could
potentially increase the effectiveness of chemotherapy treatment and reduce its side effects.
Research is also working on, among other things, improved water purification technology for home
use. It is compact, powerful and cost-effective, bringing clean, safe drinking water within
everyones reach.
Philips has established three corporate venturing organizations: the Healthcare, Lifestyle and
Lighting & Cleantech Incubators. The main purpose of venturing is to create strategic growth
opportunities for Philips. In some cases spin-out or technology licensing will be considered. In
2008, Philips, together with Prime Technology Ventures (PTV III), arranged for the spin-out of five
technology companies from the Incubators: amBX, Civolution, Intrinsic-ID, priv-ID and Serious
Toys.
Philips IP&S proactively pursues the creation of new intellectual property. Its portfolio
currently consists of about 55,000 patent rights, 33,000 trademarks, 49,000 design rights and
2,600 domain name registrations. Philips filed approximately 1,640 patents in 2008. Over the past
five years Philips has reshaped its intellectual property portfolio in line with its new strategic
focus on health and well-being. Philips believes its business as a whole is not materially
dependent on any particular patent or license, or any particular group of patents and licenses.
Philips Applied Technologies supports customers both inside and outside Philips through new
technologies, new business ideas, consultancy and new product introduction services. In 2008, it
announced the commercial roll-out of the Ambient Experience for Hospitality concept, with the first
implementation by the citizenM hotel chain, in Amsterdam which went on to win the European Hotel
Design Award as the most innovative hotel of 2008.
Localized delivery of cancer drugs
Philips is developing an ultrasound-based drug delivery technology designed to increase the
effectiveness and reduce the side effects of chemotherapy treatment for certain types of cancer.
The system proposes the use of drug-loaded microbubbles, no larger than red blood cells, which
can be injected into the bloodstream, tracked via ultrasound imaging, and then ruptured by a
focused ultrasound pulse to release their drug payload when they reach the desired spot. Because
the drugs would only be released at the site of the diseased tissue, the patients total body
exposure to them could be limited.
Corporate Investments
The remaining business within Corporate Investments Assembléon is a wholly owned subsidiary
that develops, assembles, markets and distributes a diverse range of surface-mount technology
placement equipment.
In line with Philips strategy to reduce its portfolio of non-core, strategically unaligned
activities, the High Tech Plastics Optics business was sold to Triumph Pan-Pacific in 2008.
New Venture Integration
The New Venture Integration group became fully operational in 2008 and focuses on the integration
of newly acquired companies across all sectors.
Philips Annual Report 2008 91
|
|
|
|
|
|
|
|
|
6 Performance highlights
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance |
Philips Design
Philips Design is one of the longest-established design organizations of its kind in the world. It
is headquartered in Eindhoven, Netherlands, with eight branch studios in Europe, the USA and Asia
Pacific. Its creative force of some 550 professionals representing more than 30 nationalities
embraces disciplines as diverse as psychology, cultural sociology, anthropology and trend research,
in addition to the more conventional design-related skills.
Philips Designs people-centric design approach, known as High Design, is human-focused and
research-based, and uses a deep understanding of peoples needs as the starting point for the
design process. It also provides the framework for taking these insights and translating them into
imaginative yet feasible solutions.
2008 financial performance
In 2008, EBITA amounted to a loss of EUR 226 million, compared to a loss of EUR 81 million in 2007,
which included a EUR 6 million gain on the sale of TASS. The higher loss was mainly due to EUR 18
million restructuring charges at Assembléon, a EUR 13 million loss from the sale of High Tech
Plastics Optics, as well as higher investments in the Lighting & Cleantech and Healthcare
Incubator activities and lower income from an intellectual property transaction in 2007.
Cash flow before financing activities improved by EUR 38 million to an outflow of EUR 126 million,
largely thanks to higher license income receipts and lower net capital expenditures, partly offset
by lower proceeds from the sale of businesses.
Key data
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Sales |
|
|
1,379 |
|
|
|
535 |
|
|
|
337 |
|
|
Sales growth |
|
|
|
|
|
|
|
|
|
|
|
|
% decrease, nominal |
|
|
(28 |
) |
|
|
(61 |
) |
|
|
(37 |
) |
% increase (decrease), comparable |
|
|
(9 |
) |
|
|
38 |
|
|
|
(27 |
) |
|
EBITA Corporate Technologies |
|
|
(91 |
) |
|
|
(76 |
) |
|
|
(172 |
) |
|
EBITA Corporate Investments/ Other |
|
|
16 |
|
|
|
(5 |
) |
|
|
(54 |
) |
|
EBITA |
|
|
(75 |
) |
|
|
(81 |
) |
|
|
(226 |
) |
as a % of sales |
|
|
(5.4 |
) |
|
|
(15.1 |
) |
|
|
(67.1 |
) |
|
EBIT |
|
|
(76 |
) |
|
|
(82 |
) |
|
|
(226 |
) |
as a % of sales |
|
|
(5.5 |
) |
|
|
(15.3 |
) |
|
|
(67.1 |
) |
|
Net operating capital (NOC) |
|
|
128 |
|
|
|
246 |
|
|
|
153 |
|
|
Cash flows before financing activities |
|
|
(49 |
) |
|
|
(164 |
) |
|
|
(126 |
) |
|
Employees (FTEs) |
|
|
8,832 |
|
|
|
5,888 |
|
|
|
5,324 |
|
For a reconciliation to the most directly comparable US GAAP measures, see the chapter
Reconciliation of non-US GAAP information
92 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector performance
Group Management & Services
|
|
94 Risk management
|
|
110 Our leadership
|
|
114 Supervisory Board report
|
|
122 Performance statements
|
Group Management & Services
2008 financial performance
The sector Group Management & Services comprises the activities of the corporate center including
Philips global management and sustainability programs, as well as country and regional overhead
costs, and costs of pension and other postretirement benefit plans. Additionally, the global service
units such as Philips General Purchasing, real estate, and shared financial services are reported in
this sector.
In 2008, the EBITA of corporate & regional overheads was EUR 15 million lower than 2007, mainly due
to higher restructuring charges.
Brand campaign investments in 2008 were EUR 47 million lower than 2007 due to lower spending and
higher cost reduction initiatives.
The EBITA of service units, pensions, and other was impacted by a EUR 239 million asbestos-related
settlement charge and higher restructuring costs. Pension and other postretirement benefit costs
were in line with 2007.
Cash flows before financing activities resulted in a EUR 1,824 million inflow in 2008, compared to an
inflow of EUR 5,253 million in 2007. 2008 included cash receipts related to the sale of shares in
TSMC (EUR 1,831 million) and LG Display (EUR 670 million) whereas 2007 saw EUR 5.4 billion of cash
proceeds from the sale of TSMC and LG Display.
Key data
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Sales |
|
|
167 |
|
|
|
197 |
|
|
|
148 |
|
|
Sales growth
|
|
|
|
|
|
|
|
|
|
|
|
|
% increase (decrease), nominal |
|
|
23 |
|
|
|
18 |
|
|
|
(25 |
) |
% increase (decrease), comparable |
|
|
14 |
|
|
|
31 |
|
|
|
(24 |
) |
|
EBITA Corporate & regional costs |
|
|
(226 |
) |
|
|
(156 |
) |
|
|
(171 |
) |
|
EBITA Brand campaign |
|
|
(126 |
) |
|
|
(111 |
) |
|
|
(64 |
) |
|
EBITA Services Units Pensions,
Other |
|
|
(347 |
) |
|
|
(30 |
) |
|
|
(290 |
) |
|
EBITA |
|
|
(699 |
) |
|
|
(297 |
) |
|
|
(525 |
) |
|
EBIT |
|
|
(699 |
) |
|
|
(297 |
) |
|
|
(525 |
) |
|
Net operating capital (NOC) |
|
|
209 |
|
|
|
705 |
|
|
|
(492 |
) |
|
Cash flows before financing activities |
|
|
(1,832 |
) |
|
|
5,253 |
|
|
|
1,824 |
|
|
Employees (FTEs) |
|
|
6,879 |
|
|
|
5,299 |
|
|
|
6,011 |
|
For a reconciliation to the most directly comparable US GAAP measures, see the chapter
Reconciliation of non-US GAAP information
Philips Annual Report 2008 93
|
|
|
|
|
|
|
|
|
6 Performance highlights
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance |
Risk Management
Introduction
The following sections present an overview of Philips approach to risk management and business
control and a description of the nature and the extent of its exposure to risks. Philips recognizes
different risk categories, namely Strategic risks, Market risks, Operational risks, Compliance
risks, and Financial risks. These are further described in the section Risk categories and factors
of this Annual Report. The risk overview highlights the main risks that may hinder Philips in
achieving its strategic objectives. The risk overview may, however, not include all the risks that
may ultimately affect Philips. Some risks not yet known to Philips, or currently believed not to be
material, could later turn out to have a major impact on Philips businesses, objectives, revenues,
income, assets, liquidity or capital resources.
All oral and written forward-looking statements made on or after the date of this Annual Report and
attributable to Philips are expressly qualified in their entirety by the factors described in the
cautionary statement on forward-looking statements that begins on page 44 of this Annual Report and
the risk factors described in the section below entitled Risk categories and factors.
Our approach to risk management and business control
Risk management forms an integral part of business management. The companys risk and control
policy is designed to provide reasonable assurance that objectives are met by integrating
management control into the daily operations, by ensuring compliance with legal requirements and by
safeguarding the integrity of the companys financial reporting and its related disclosures. It
makes management responsible for identifying the critical business risks and for the implementation
of fit-for-purpose risk responses. Philips risk management approach is embedded in the areas of
corporate governance, Philips Business Control Framework and Philips General Business Principles,
and in the actual periodic business planning and review cycles.
Corporate governance
Corporate governance is the system by which a company is directed and controlled. Philips believes
that good corporate governance is a critical factor in achieving business success. Good corporate
governance derives from, amongst other things, solid internal controls and high ethical standards.
Risk management is a well-established part of Philips corporate governance structure.
The quality of Philips systems of business controls and the findings of internal and external
audits are reported to and discussed in the Audit Committee of the Supervisory Board. Internal
auditors monitor the quality of the business controls through risk-based operational audits,
inspections of financial reporting controls and compliance audits. Audit committees at corporate and
sector levels meet on a quarterly basis to address weaknesses in the business control
infrastructure as reported by the auditors or revealed by self-assessments, and to take corrective
action where necessary. These audit committees are also involved in determining the desired
company-wide internal audit coverage as approved by the Audit Committee of the Supervisory Board.
An in-depth description of Philips corporate governance structure can be found in the chapter
Corporate governance that begins on page 254 of this Annual Report.
Philips Business Control Framework
The Philips Business Control Framework (BCF), derived from the Committee of Sponsoring
Organizations of the Treadway Commission (COSO) framework on internal control, sets the standard
for risk management and business control in Philips. The objectives of the BCF are to maintain
integrated management control of the companys operations, in order to ensure integrity of the
financial reporting, as well as compliance with laws and regulations.
Philips has reviewed and further strengthened the fundamentals of its BCF over recent years. The
first of these developments was the drive to harmonize enterprise resource planning systems, with
SAP as the leading standard, enabling Philips to replace time-consuming manual controls with
embedded, automated controls. Thereafter, Philips introduced a program to systematically certify
the critical IT systems against an internal control standard which is based on the generally
accepted standard Control Objectives for Information and related Technology.
94 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector performance
|
|
94 Risk management
|
|
110 Our leadership
|
|
114 Supervisory Board report
|
|
122 Performance statements
|
Furthermore, as part of BCF, Philips implemented a global standard for internal control over
financial reporting (ICS). The ICS together with Philips established accounting procedures are
designed to provide reasonable assurance that assets are safeguarded, that the books and records
properly reflect transactions necessary to permit preparation of financial statements, that policies
and procedures are carried out by qualified personnel, and that published financial statements are
properly prepared and do not contain any material misstatements. ICS has been deployed in all main
reporting units, where business process owners perform an extensive number of controls, document
the results each quarter, and take corrective action where necessary. ICS supports sector and
functional management in a quarterly cycle of assessment and monitoring of its control
environment. Findings of managements evaluation are reported to the Board of Management.
As part of the Annual Report process, managements accountability for business controls is
enforced through the formal issuance of a Statement on Business Controls and a Letter of
Representation by sector and functional management to the Board of Management. Any deficiencies
noted in design and operating effectiveness of controls over financial reporting which were not
completely remediated are evaluated at year-end by the Board of Management. The Board of
Managements report, including its conclusions, regarding the effectiveness of its internal
control over US GAAP financial reporting, can be found in the chapter US GAAP financial statements
of this Annual Report as required by section 404 of the US Sarbanes-Oxley Act.
Philips General Business Principles
The Philips General Business Principles (GBP) govern Philips business decisions and actions
throughout the world, applying equally to corporate actions and the behavior of individual
employees. They incorporate the fundamental principles within Philips for doing business. The
intention of the GBP is to ensure compliance with laws and regulations, as well as with Philips
norms and values.
The GBP are available in most of the local languages and are an integral part of the labor
contracts in virtually all countries where Philips has business activities. Responsibility for
compliance with the principles rests primarily with the management of each business. Every country
organization and each main production site has a compliance officer. Confirmation of compliance with
the GBP is an integral part of the annual Statement on Business Controls that has to be issued by
the management of each business unit. The GBP incorporate a whistleblower policy, standardized
complaint reporting and a formal escalation procedure.
The global implementation of the One Philips Ethics hotline ensures that alleged violations are
registered and dealt with consistently within one company-wide system.
To drive the practical deployment of the GBP, a set of directives has been published, which are
applicable to all employees. There are also separate directives which apply to specific categories
of employees, e.g. the Supply Management Code of Ethics and Financial Code of Ethics
(www.philips.com/gbp). In 2008, an updated and extended version of the GBP directives was approved
and adopted, reflecting ongoing developments in codes of conduct and business integrity
legislation. New elements in this edition include: a completely new GBP directive on anti-trust,
an extensive update of the GBP directive on protection of information and use of information and
communication assets, and a number of changes
Philips Annual Report 2008 95
|
|
|
|
|
|
|
|
|
6 Performance highlights
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We care about
|
|
42 Our group performance |
designed to further clarify the existing GBP directives. To ensure compliance with the highest
standards of transparency and accountability by all employees performing important financial
functions, the Financial Code of Ethics contains, amongst other things, standards to promote
honest and ethical conduct, as well as full, accurate and timely disclosure procedures in order to
avoid conflicts of interest. Philips did not grant any waivers of the Financial Code of Ethics in
2008.
In order to further strengthen the employees awareness of the existence and importance of the
Philips GBP, and the new GBP directives in particular, an internal communications program tailored
to the respective businesses was developed in 2008.
To ensure that GBP compliance officers are better able to carry out their compliance function,
their roles and responsibilities profile and its organizational embedding were clarified further in
2008. In particular, a more clearly structured procedure for appointment (responsibilities and
authority, hierarchical structure and organizational mandate/independence) was implemented.
Furthermore, the functional job assessment of compliance officers is now mandatorily included in
their annual People Performance Management appraisal.
To reinforce awareness of the need for compliance with the GBP, a web-based GBP training tool has
been rolled out throughout the Group in 22 different languages, covering more than 95% of the
employees with on-line access. In the course of 2008 an updated version of this web-based training
was developed, which will be rolled out in 2009. The new GBP directives are an important part of
this web-based training.
In 2008, the global train-the-trainer program for compliance awareness was expanded with regional/
area tailor-made GBP training programs for compliance officers (which also provide for an annual
refresher). In addition, a GBP e-Learning tool for middle and senior management was developed and
rolled out in 2008.
Risk categories and factors
Taking risks is an inherent part of entrepreneurial behavior. A structured risk management process
encourages management to take risks in a controlled manner. Philips has a structured risk
management process that recognizes different risk categories, namely Strategic, Market,
Operational, Compliance and Financial risks.
Strategic risks comprise threats and opportunities that influence Philips strategic ambitions. The
Market risks cover the effect that changes in the market may have on Philips. Risks related to
areas such as economic and political developments are likely to affect all market participants in
a similar manner. Operational risks include adverse unexpected developments resulting from
internal processes, people and systems, or from external events that are linked to the actual
running of each business (examples are solution and product creation, and supply chain
management). Compliance risks cover unanticipated failures to enact, or comply with, appropriate
policies and procedures. Within the area of Financial risks, Philips identifies risks related to
Treasury, Pensions, Legal and Fiscal.
96 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector performance
|
|
94 Risk management
|
|
110 Our leadership
|
|
114 Supervisory Board report
|
|
122 Performance statements
|
Philips describes the risk factors within each risk category in order of expected significance to
give stakeholders an insight into which risks it considers more prominent than others at present.
Describing risk factors in their order of expected significance within each risk category does not
mean that any risk factor may not have a material and adverse impact on Philips business,
strategic objectives, revenues, income, assets, liquidity or capital resources. Furthermore, a
risk factor described after other risk factors may ultimately prove to have more significant
adverse consequences than a more prominent risk factor. Over time Philips may change its view as
to the relative significance of each risk factor. Philips does not order the risk categories
themselves in order of importance.
Strategic risks
Failure to deliver the Philips strategy may adversely affect results and negatively impact
shareholder value. Through its strategy, Philips aims to achieve profitable growth. Philips
inability to transform this strategy into action and to meet the financial targets as planned, may
cause its share price to drop.
Philips may be unable to adapt swiftly to changes in industry or market circumstances, which could
have a material adverse impact on its financial condition and results.
Paradigmatic shifts in the industry or market, like the transition from traditional lighting to
energy-saving and LED lighting, may drastically change the business environment. If Philips is
unable to recognize these changes in good time, or is too inflexible to rapidly adjust its business
models, growth ambitions and financial results could be affected materially.
Philips performs cost-cutting initiatives, including streamlining product portfolios, capacity
adjustments and headcount reduction. These measures impact its results, and any future
contribution of these measures to its profitability will be influenced by actual savings achieved
and by its ability to sustain these ongoing efforts.
Acquisitions could expose Philips to integration risks and challenge management in continuing to
reduce the complexity of the company.
Philips has recently completed acquisitions, and may continue to do so in the future, exposing
Philips to integration risks in areas such as sales and service force integration, logistics,
regulatory compliance, information technology and finance. Integration difficulties and complexity
may adversely impact
the realization of an increased contribution from acquisitions. Philips may incur significant
acquisition, administrative and other costs in connection with these transactions, including costs
related to the integration of acquired businesses.
Furthermore, organizational simplification and resulting cost savings may be difficult to achieve.
Acquisitions may also lead to a substantial increase in long-lived assets, including goodwill.
Write-downs of these assets due to unforeseen business developments may materially and adversely
affect Philips earnings, particularly in Healthcare and Lighting which have significant amounts of
intangible assets.
Philips inability to secure and retain intellectual property rights for products, whilst
maintaining overall competitiveness, could have a material adverse effect on its results.
Philips is dependent on its ability to obtain and retain licenses and other intellectual property
(IP) rights covering its products and its design and manufacturing processes. The IP portfolio
results from an extensive patenting process that could be influenced by, amongst other things,
innovation. The value of the IP portfolio is dependent on the successful promotion and market
acceptance of standards developed or co-developed by Philips. This is particularly applicable for
Consumer Lifestyle where third-party licenses are important and a loss or impairment could
negatively impact Philips results.
Philips ongoing investments in the sense and simplicity brand campaign, with a focus on
simplifying the interaction with its customers, translating awareness into preference and
improving its international brand recognition, could have less impact than anticipated. Philips
has made large investments in the reshaping of the Group into a more market-driven company
focusing on delivering advanced and easy-to-use products and easy relationships with Philips for
its customers. The brand promise of sense and simplicity is important for both external and
internal development. If Philips fails to deliver on its sense and simplicity concept, its
growth opportunities may be hampered, which could have a material adverse effect on Philips
revenue and income.
Philips Annual Report 2008 97
|
|
|
|
|
|
|
|
|
6 Performance highlights
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance |
Market risks
As Philips business is global, its operations are exposed to economic and political developments
in countries across the world that could adversely impact its revenues and income.
Philips business environment is influenced by economic conditions globally and in individual
countries where Philips conducts business. During 2008, the capital and credit markets experienced
extended volatility and disruption that have reached unprecedented levels and have negatively
impacted both consumer borrowing and spending and economic growth globally. If these levels of
market volatility and disruption continue or worsen, or the current global economic downturn
continues to worsen, Philips revenues, results of operations, and financial condition may continue
to be affected materially and adversely. For example, the current tightening of credit in the
financial markets may make it more difficult for Philips customers to obtain financing and as a
result, they may modify, delay or cancel plans to purchase Philips products and services or a
slowdown in the automobile and construction industry could impact the results of our Lighting
sector. All Philips sectors are affected by these market conditions.
Numerous other factors, such as fluctuation of energy and raw material prices as well as global
political conflicts, including the Middle East and other regions, could continue to impact
macroeconomic factors and the international capital and credit markets. Economic and political
uncertainty may have a material adverse impact on Philips financial condition or results of
operations and can also make Philips budgeting and forecasting more difficult.
Philips may encounter difficulty in planning and managing operations due to unfavorable political
factors, including unexpected legal or regulatory changes such as foreign exchange import or export
controls, nationalization of assets or restrictions on the repatriation of returns from foreign
investments and the lack of adequate infrastructure. As emerging markets are becoming increasingly
important in Philips operations, the above-mentioned risks are also expected to grow and could
have an adverse impact on Philips financial condition and operating results.
Philips overall performance in the coming years is dependent on realizing its growth ambitions in
emerging markets.
Emerging markets are becoming increasingly important in the global market. In addition, Asia is an
important production, sourcing and design center for Philips.
Philips faces strong competition to attract the best talent in tight labor markets and intense
competition from local companies as well as other global players for market share in emerging
markets. Philips needs to be part of the growth of emerging markets, invest in local talents,
understand developments in end-user preferences and localize the portfolio in order to stay
competitive. If Philips fails to achieve this, its growth ambition and financial results could be
affected materially.
Philips is exposed to markets with high complexity, and is facing continued competition.
Philips continually faces competitive challenges such as speed of innovation, fast-moving market
trends, rapid technological change, evolving standards, shortening product life cycles, the
cyclical nature of certain sectors and price erosion. Earnings improvement is highly exposed to
these increased competitive challenges, which requires margin management through measures such as
price management, cost reduction and/or efficiency increase.
Philips produces consumer products that compete against products sold by an increasing number of
competitors on the basis of many factors including price. Therefore, Philips must continue to
develop superior technology, anticipate consumer tastes and continue to rapidly develop attractive
products that appeal to changing and increasingly diverse consumer preferences. In the Consumer
Lifestyle sector, Philips faces increasingly intense pricing pressure and shorter product cycles in
a variety of consumer product categories. If Philips is unable to effectively anticipate and
counter the price erosion that frequently accompanies its products, or if the average selling
prices of Philips products decrease faster than it is able to reduce its manufacturing costs,
Philips gross margins will decrease and its results of operations and financial condition may be
negatively impacted materially.
Philips is exposed to governmental investigations and legal proceedings with regard to increased
scrutiny of possible anti-competitive market practices. Philips is facing increased scrutiny of
possible anti-competitive market practices by national and European authorities, especially in
product segments where Philips has significant market shares. For example, Philips and certain of
its (former) affiliates are involved in investigations by competition law authorities in several
jurisdictions into possible anti-competitive activities in the Cathode-Ray Tubes, or CRT, industry
and are engaged in litigation in this respect. Philips financial position and results could be
materially affected by an adverse final outcome of these investigations and litigation, as well as
any potential claims in this respect. Furthermore, increased scrutiny may hamper planned growth
opportunities provided by potential acquisitions.
98 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70
Our sector
performance
|
|
94
Risk management
|
|
110
Our leadership
|
|
114
Supervisory Board report
|
|
122
Performance statements
|
Philips global presence exposes the company to regional and local regulatory rules which may
interfere with the realization of business opportunities and investments in the countries in
which Philips operates.
Philips has established subsidiaries in over 60 countries. These subsidiaries are exposed to
changes in governmental regulations and unfavorable political developments, which may limit the
realization of business opportunities or impair Philips local investments. An increased focus on
medical and health care increases the exposure to highly regulated markets, where obtaining
clearances or approvals for new products is of great importance, and the dependency on the
funding available for healthcare systems. In addition, changes in reimbursement policies may
affect spending on healthcare.
Operational risks
Failure to achieve improvements in Philips solution and product creation process and/or
increased speed in innovation-to-market may hamper Philips profitable growth ambitions.
Further improvements in Philips solution and product creation process, ensuring timely delivery
of new solutions and products at lower cost and upgrading of customer service levels to create
sustainable competitive advantages, are important in realizing Philips profitable growth
ambitions. The emergence of new low-cost players, particularly in Asia, further underlines the
importance of improvements in the product creation process. The success of new solution and
product creation, however, depends on a number of factors, including timely and successful
completion of development efforts, market acceptance, Philipss ability to manage the risks
associated with new products and production ramp-up issues, the availability of products in
appropriate quantities and costs to meet anticipated demand, and the risk that new products and
services may have quality or other defects in the early stages of introduction. Accordingly,
Philips cannot determine in advance the ultimate effect that new solutions and product creations
will have on its financial condition and operating results. If Philips fails to accelerate its
innovation-to-market processes and fails to ensure that end-user insights are fully captured and
translated into solution and product creations that improve product mix and consequently
contribution, it may face an erosion of its market share and competitiveness.
If Philips is unable to ensure effective supply chain management, it may be unable to sustain its
competitiveness in its markets.
Philips is continuing the process of creating a leaner supply base with fewer suppliers, while
maintaining dual sourcing strategies where possible. This strategy strongly supports close
cooperation with suppliers to enhance, amongst others, time to market and quality. In addition,
Philips is continuing its initiatives to reduce assets through outsourcing. These processes may
result in increased dependency. Although Philips works closely with its suppliers to avoid
supply-related problems, there can be no assurance that it will not encounter supply problems in
the future or that it will be able to replace a supplier that is not able to meet its demand.
Shortages or delays could materially harm its business. Philips maintains a regular review of its
strategic and critical suppliers to assess financial stability.
Philips supply chain is also exposed to fluctuations in energy and raw material prices. In recent
times, commodities such as oil have been subject to volatile markets and subject to significant
price increases from time to time. If Philips is not able to compensate for or pass on its
increased costs to customers, such price increases could have a material adverse impact on its
financial results.
Most of Philips activities are conducted outside of the Netherlands, and international
operations bring challenges. For example, production and procurement of products and parts in
Asian countries are increasing, and this creates a risk that production and shipping of products
and parts could be interrupted by a natural disaster in that region.
A setback in global account management could hamper expected growth.
Integral global key account management is important for maintaining a sustainable competitive
advantage. An example of this is the provision of category management solutions to key retailers
for supporting consumers in their decision-making. A setback in the management of international
key retail accounts could hamper growth and damage Philips reputation and brand image.
Due to the fact that Philips is dependent on its personnel for leadership and specialized skills,
the loss of its ability to attract and retain such personnel would have an adverse effect on its
business. The retention of talented employees in sales and marketing, research and development,
finance and general management, as well as of highly specialized technical personnel, especially
in transferring technologies to low-cost countries, is critical to Philips success. The loss of
specialized skills could also result in business interruptions.
Philips Annual Report 2008 99
|
|
|
|
|
|
|
|
|
6
Performance
highlights
|
|
8
Message from the President
|
|
14
Who we are
|
|
18
We care about...
|
|
42
Our group performance |
Diversity in information technology (IT) could result in ineffective or inefficient business
management. IT outsourcing and off-shoring strategies could result in complexities in service
delivery and contract management. Furthermore, we observe a global increase in IT security
threats and higher levels of professionalism in computer crime, posing a risk to the
confidentiality, availability and integrity of data and information.
Philips is engaged in a continuous drive to create a more open, standardized and, consequently,
more cost-effective IT landscape. This is leading to an approach involving further outsourcing,
off-shoring, commoditization and ongoing reduction in the number of IT systems. The global
increase in security threats and higher levels of professionalism in computer crime have raised
the Companys awareness of the importance of effective IT security measures, including proper
identity management processes to protect against unauthorized systems access. The integration of
new companies and successful outsourcing of business processes are highly dependent on secure and
well- controlled IT systems.
Warranty and product liability claims against Philips could cause Philips to incur significant
costs and affect Philips results as well as its reputation and relationships with key customers.
Philips is from time to time subject to warranty and product liability claims with regard to
product performance and effects. Philips could incur product liability losses as a result of
repair and replacement costs in response to customer complaints or in connection with the
resolution of contemplated or actual legal proceedings relating to such claims. In addition to
potential losses arising from claims and related legal proceedings, product liability claims
could affect Philips reputation and its relationships with key customers, both customers for end
products and customers that use Philips products in their production process. As a result,
product liability claims could materially impact Philips financial position and results.
Any damage to Philips reputation could have an adverse effect on its businesses.
Philips is exposed to developments which could affect its reputation. Such developments could be
of an environmental or social nature, or related to individual behavior of employees.
Compliance risks
Exposure to non-compliance with general business principles.
Philips attempts to realize its growth targets could expose it to the risk of non-compliance
with Philips General Business Principles. This risk is heightened in emerging markets as
corporate governance systems, including information structures and the monitoring of ethical
standards, are less developed in emerging markets compared to mature markets. Examples include
commission payments to third parties, remuneration payments to agents, distributors,
commissioners and the like (Agents), or the acceptance of gifts, which may be considered in
some markets to be normal local business practice.
Reliability of reporting and disclosures, and safeguarding of assets.
The reliability of reporting is important in ensuring that management decisions for steering the
businesses and managing both top-line and bottom-line growth are based on top-quality data. Flaws
in internal control systems could adversely affect the financial position and results and hamper
expected growth.
The correctness of disclosures provides investors and other market professionals with significant
information for a better understanding of Philips businesses. Imperfections or lack of clarity
in the disclosures could create market uncertainty regarding the reliability of the data
presented and may have a negative impact on the Philips share price.
Compliance procedures have been adopted by management to ensure that the use of resources is
consistent with laws, regulations and policies, and that resources are safeguarded against waste,
loss and misuse. Ineffective compliance procedures relating to the safeguarding of assets could
have an adverse effect on the financial results.
Non-compliance with data privacy and product security laws.
Philips brand image and reputation will be adversely impacted by non-compliance with the various
(patient) data privacy and (medical) product security laws. Privacy and product security issues
may arise with respect to remote access or monitoring of patient data or loss of data on
customers systems.
100 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70
Our sector
performance
|
|
94
Risk management
|
|
110
Our leadership
|
|
114
Supervisory Board report
|
|
122
Performance statements
|
Financial risks
Philips is exposed to a variety of treasury risks including liquidity risk, currency risk, interest
rate risk, equity price risk, commodity price risk, credit risk, country risk and other insurable
risk. During 2008 Philips re-financed a significant proportion of its long-term debt commitments,
thereby significantly extending the overall maturity profile of its funding. Furthermore, additional
credit lines were arranged to act as additional back-up for the liquidity needs of the group.
Nevertheless, if further negative developments impact the global liquidity markets this may affect
the ability to raise or re-finance debt in the capital markets, or could also lead to significant
increases in the cost of such borrowing in the future. Expected or actual downgrades by rating
agencies may increase our cost of borrowing, may reduce our potential investor base and may
negatively affect our businesses.
Philips is a global company and as a direct result the financial results of the group may be
impacted through currency fluctuations. The majority of the currency risk to which Philips is
exposed relates to transaction exposure within the business of on-balance and forecast foreign
currency purchases or sales and translation exposure of foreign currency denominated financing
positions.
Philips is also exposed to interest rate risk particularly in relation to its long-term debt
position; this risk can take the form of either fair value or cash flow risk. Failure to effectively
hedge this risk can impact Philips financial results.
Philips is exposed to equity price risk through holdings in publicly listed and other companies. A
downturn in equity markets can materially impact the realizable value of such securities and can
lead to material financial losses and impairment charges for the Group.
Credit risk of counterparties that have outstanding payment obligations creates exposure for
Philips, particularly in relation to accounts receivable and liquid assets and insurance contracts
with financial counterparties. A default by counterparties in such transactions can have a material
and adverse effect on Philips financial condition.
For further analysis, please refer to the section Details of treasury risks that begins on page 102
of this Annual Report.
Philips has defined-benefit pension plans in a number of countries. The funded status and the cost of
maintaining these plans are influenced by financial market and demographic developments, creating
volatility in Philips financials.
The majority of employees in Europe and North America are covered by defined-benefit pension plans.
The accounting for defined-benefit pension plans requires management to determine discount rates,
expected rates of compensation and expected returns on plan assets. Changes in these variables can
have a significant impact on the projected benefit obligations and net periodic pension costs. A
negative performance of the financial markets could have a material impact on funding requirements
and net periodic pension costs and also affect the value of certain financial assets or liabilities
of the company.
For further analysis of pension-related exposure to changes in financial markets, please refer to
the section Details of pension risks that begins on page 106 of this Annual Report and for
quantitative and qualitative disclosure of pensions, please refer to note 20.
Legal proceedings covering a range of matters are pending in various jurisdictions against Philips
and its current and former group companies. Due to the uncertainty inherent in legal proceedings,
it is difficult materially to predict the final outcome. Adverse outcomes might impact Philips
financial position and results.
Philips, including a certain number of its current and former group companies, is involved in legal
proceedings relating to such matters as competition issues, commercial transactions, product
liability, participations and environmental pollution. Since the ultimate outcome of asserted
claims and proceedings, or the impact of any claims that may be asserted in the future, cannot be
predicted with certainty, Philips financial position and results of operations could be affected
materially by adverse outcomes.
Please refer to note 27 for additional disclosure relating to specific legal proceedings.
Philips Annual Report 2008 101
|
|
|
|
|
|
|
|
|
6 Performance
highlights
|
|
8
Message from the President
|
|
14
Who we are
|
|
18
We care about...
|
|
42
Our group performance |
Estimated transaction exposure and related
hedges
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
maturity 0-60 days |
|
|
maturity over 60 days |
|
|
|
exposure |
|
|
hedges |
|
|
exposure |
|
|
hedges |
|
Receivables |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
USD vs AED |
|
|
14 |
|
|
|
(10 |
) |
|
|
44 |
|
|
|
(23 |
) |
USD vs CNY |
|
|
15 |
|
|
|
(14 |
) |
|
|
48 |
|
|
|
(20 |
) |
GBP vs EUR |
|
|
23 |
|
|
|
(12 |
) |
|
|
53 |
|
|
|
(27 |
) |
PLN vs EUR |
|
|
40 |
|
|
|
(27 |
) |
|
|
105 |
|
|
|
(38 |
) |
USD vs EUR |
|
|
298 |
|
|
|
(361 |
) |
|
|
1,021 |
|
|
|
(1,161 |
) |
EUR vs GBP |
|
|
8 |
|
|
|
(5 |
) |
|
|
46 |
|
|
|
(24 |
) |
EUR vs USD |
|
|
145 |
|
|
|
(78 |
) |
|
|
561 |
|
|
|
(265 |
) |
JPY vs EUR |
|
|
22 |
|
|
|
(34 |
) |
|
|
51 |
|
|
|
(95 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payables |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
USD vs CAD |
|
|
(20 |
) |
|
|
19 |
|
|
|
(36 |
) |
|
|
25 |
|
PLN vs EUR |
|
|
(44 |
) |
|
|
27 |
|
|
|
(235 |
) |
|
|
100 |
|
USD vs EUR |
|
|
(518 |
) |
|
|
309 |
|
|
|
(899 |
) |
|
|
537 |
|
EUR vs GBP |
|
|
(20 |
) |
|
|
19 |
|
|
|
(98 |
) |
|
|
87 |
|
MXN vs USD |
|
|
(14 |
) |
|
|
12 |
|
|
|
(68 |
) |
|
|
48 |
|
MYR vs USD |
|
|
(10 |
) |
|
|
6 |
|
|
|
(63 |
) |
|
|
32 |
|
The first currency displayed is the exposure that is being hedged followed by the functional
currency of the hedging entity.
Philips is exposed to a number of different fiscal uncertainties which could have a significant
impact on local tax results.
Philips is exposed to a number of different tax uncertainties which could result in double
taxation, penalties and interest payments. These include, amongst others, transfer pricing
uncertainties on internal cross-border deliveries of goods and services, tax uncertainties
related to acquisitions and divestments, tax uncertainties related to the use of tax credits and
permanent establishments, and tax uncertainties due to losses carried forward and tax credits
carried forward. Those uncertainties may have a significant impact on local tax results.
For further details, please refer to the section Details of fiscal risks that begins on page 108
of this Annual Report
Details of treasury risks
Philips is, as mentioned before, exposed to several types of financial risk. This section further
analyzes financial risks. Philips does not purchase or hold derivative instruments for speculative
purposes. Information regarding financial instruments is included in note 36 and note 69.
This Treasury section up to Other insurable risks forms an integral part of the IFRS financial
statements.
Liquidity risk
The rating of the Companys debt by major rating services may improve or deteriorate. As a
result, Philips borrowing capacity may be influenced and its
financing costs may fluctuate. Philips
has various sources to mitigate the liquidity risk for the group, including EUR 3,620 million in
cash and cash equivalents, a USD 2,500 million Commercial Paper Program, and a USD 2,500 million
committed revolving facility that could serve as back-up for short-term financing requirements
that would normally be satisfied through the Commercial Paper Program. Additionally EUR 659
million of investments in its available-for-sale securities and listed equity-accounted investees
(market value at December 31, 2008) are available. Furthermore, Philips has a EUR 500 million
standby roll-over loan agreement in place, with EUR 450 million of the EUR 500 million committed
until May 2010. As of December 31, 2008 Philips did not have any loans outstanding under these
facilities.
In addition, as of December 31, 2008 Philips has an undrawn committed bilateral loan of EUR 250
million in place which will be fully drawn in January 2009.
Currency risk
Currency fluctuations may impact Philips financial results. Philips is exposed to currency risk in
the following areas:
|
|
Transaction exposures, such as forecasted sales and purchases and on-balance-sheet
receivables/payables resulting from such transactions; |
|
|
|
Translation exposure of net income in foreign entities; |
|
|
|
Translation exposure of foreign-currency intercompany and external debt and deposits; |
|
|
|
Translation exposure of equity invested in consolidated foreign entities; |
|
|
|
Exposure to equity interests in non-functional-currency equity-accounted investees and
available-for-sale investments. |
It is Philips policy that significant transaction exposures are hedged by the businesses.
Accordingly, all businesses are required to identify and measure their exposures resulting from
material transactions denominated in currencies other than their own functional currency.
Philips policy generally requires committed foreign currency exposures to be fully hedged using
forwards. Anticipated transactions may be hedged using forwards or options or a combination
thereof. The hedge tenor varies per business and is
102 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector
performance
|
|
94 Risk management
|
|
110 Our leadership
|
|
114 Supervisory Board
report
|
|
122 Performance statements
|
a function of the ability to forecast cash flows and the way in which the businesses can adapt to
changed levels of foreign-currency exchange rates. As a result, hedging activities may not
eliminate all currency risks for these transaction exposures. Generally, the maximum tenor of
these hedges is 18 months.
The table on the opposite page outlines the estimated nominal value in millions of euros for
transaction exposure and related hedges for Philips most significant currency exposures as of
December 31, 2008. The derivatives related to transactions are, for hedge accounting purposes,
split into hedges of on-balance-sheet accounts receivable/payable and forecasted sales and
purchases. Changes in the value of on-balance-sheet foreign-currency accounts receivable/payable,
as well as the changes in the fair value of the hedges related to these exposures, are reported
in the income statement under cost of sales. Hedges related to forecasted transactions are
accounted for as cash flow hedges. The results from such hedges are deferred in other
comprehensive income within equity to the extent that the hedge is effective. Currently, a loss
of EUR 17 million is deferred in equity as a result of these hedges. The result deferred in
equity will mostly be released to earnings during 2009 at the time when the related hedged
transactions affect the income statement. During 2008, a net loss of EUR 3 million was recorded
in the income statement as a result of ineffectiveness of transaction hedges.
The total net fair value of hedges related to transaction exposure as of December 31, 2008 was an
unrealized loss of EUR 21 million. An instantaneous 10% increase in the value of the euro against
all currencies would lead to an increase in the value of the derivatives of EUR 26 million,
including a EUR 12 million increase related to deals of the euro against the pound sterling, a
EUR 10 million increase related to deals of the euro against the Japanese yen and a EUR 3 million
increase related to deals of the euro against the US dollar. This EUR 26 million includes a loss
of EUR 11 million that would impact the income statement, which is offset by an equal and
opposite effect on the underlying accounts receivable and payable, and a gain of EUR 37 million
that would be recognized in equity to the extent that the cash flow hedges are effective. The net
change in value in other derivatives would be an increase of EUR 1 million.
The change in fair value of the hedges of transactions in the case of a 10% appreciation in the
euro for deals of the euro against the US dollar and the euro against the pound sterling has been
further broken down in the above tables.
Sensitivity to a 10% increase in euro versus
USD
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
maturity 0-12 |
|
|
maturity > 12 |
|
|
|
months |
|
|
months |
|
Change in fair value of forwards |
|
|
|
|
|
|
2 |
|
Change in fair value of options |
|
|
1 |
|
|
|
|
|
Sensitivity to a 10% increase in euro versus GBP
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
maturity 0-12 |
|
|
maturity > 12 |
|
|
|
months |
|
|
months |
|
Change in fair value of forwards |
|
|
11 |
|
|
|
1 |
|
Philips does not hedge the translation exposure of net income in foreign entities.
Foreign exchange exposure also arises as a result of inter-company loans and deposits. Where the
Company enters into such arrangements the financing is generally provided in the functional
currency of the subsidiary entity. The currency of the Companys external funding and liquid
assets is matched with the required financing of subsidiaries either directly through external
foreign currency loans and deposits, or synthetically by using foreign exchange derivatives. In
certain cases where group companies may also have external foreign currency debt or liquid assets,
these exposures are also hedged through the use of foreign exchange derivatives. Changes in the
fair value of hedges related to this translation exposure are recognized within financial income
and expenses in the income statement and are largely offset by the revaluation of the hedged
items. The total net fair value of these derivatives as of December 31, 2008, was an unrealized
loss of EUR 216 million. An instantaneous 10% increase in the value of the euro against all
currencies would lead to an increase in the value of the derivatives of EUR 339 million, including
a EUR 318 million increase due to the US dollar.
Translation exposure of equity invested in consolidated foreign entities is partially hedged. If a
hedge is entered into, it is accounted for as a net investment hedge. As at December 31, 2008,
Philips had no outstanding derivatives accounted for as net investment hedges. During 2008,
Philips recorded a gain of EUR 11 million in other comprehensive income under currency translation
differences as a result of net investment hedges.
Philips Annual Report 2008 103
|
|
|
|
|
|
|
|
|
6 Performance
highlights
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We
care about...
|
|
42 Our group performance |
Philips does not currently hedge the foreign exchange exposure arising from equity interests in
non-functional currency equity-accounted investees and available-for-sale financial assets.
Interest rate risk
Philips has outstanding debt of EUR 4,158 million, which creates an inherent interest rate risk.
Failure to effectively hedge this risk could negatively impact financial results. At year-end,
Philips held EUR 3,620 million in cash and cash equivalents and had total long-term debt of EUR
3,441 million and total short-term debt of EUR 717 million. At December 31, 2008, Philips had a
ratio of fixed-rate long-term debt to total outstanding debt of approximately 76%, compared to 34%
one year earlier.
A sensitivity analysis shows that if long-term interest rates were to decrease instantaneously by
1% from their level of December 31, 2008, with all other variables (including foreign exchange
rates) held constant, the fair value of the long-term debt would increase by approximately EUR
208 million. If there was an increase of 1% in long-term interest rates, this would reduce the
market value of the long-term debt by approximately EUR 207 million.
If interest rates were to increase instantaneously by 1% from their level of December 31, 2008,
with all other variables held constant, the annualized net interest expense would increase by
approximately EUR 24 million. This impact is based on the outstanding net debt position at
December 31, 2008.
Equity price risk
Philips is a shareholder in several publicly listed companies, including LG Display and TPV
Technology Ltd. As a result, Philips is exposed to potential financial loss through movements in
the share prices. The aggregate equity price exposure of publicly listed investments in its main
available-for-sale securities, trading securities and listed equity-accounted investees amounted
to approximately EUR 659 million at year-end 2008 (2007: EUR 4,464 million including shares that
were sold during 2008). Philips also holds options on the shares of TPV through a convertible
bond issued to Philips in September 2005, the face value of the bond being the USD equivalent of
EUR 149 million and the fair value of the option at year-end EUR 10 million. Furthermore, Philips
also holds options on the shares of CBay through a convertible bond issued to Philips in August
2008, the face value of the bond being the USD equivalent of EUR 65 million and the fair value of
the option at year-end less than EUR 1 million. Philips does not hold derivatives in its own
stock or in the above-mentioned listed companies
except for the embedded derivatives in the convertible bond already mentioned.
Philips is also a shareholder in several privately is owned companies including NXP. As a result,
Philips is exposed to potential value adjustments.
Commodity price risk
Philips is a purchaser of certain base metals, precious metals and energy. Philips hedges certain
commodity price risks using derivative instruments to minimize significant, unanticipated earnings
fluctuations caused by commodity price volatility. The commodity price derivatives that Philips
enters into are accounted for as cash flow hedges to offset forecasted purchases. Currently, a
loss of EUR 11 million is deferred in equity as a result of these hedges. A 10% increase in the
market price of all commodities as at December 31, 2008, would increase the fair value of the
derivatives by EUR 1 million.
Credit risk
Credit risk represents the loss that would be recognized at the reporting date if counterparties
failed completely to perform their payment obligations as contracted. Credit risk is present
within Philips trade receivables. To reduce exposure to credit risk, Philips performs ongoing
evaluations of the financial condition of its customers and adjusts payment terms and credit
limits when appropriate.
Philips invests available cash and cash equivalents with various financial institutions and is
exposed to credit risk with these counterparties. Philips is also exposed to credit risks in the
event of non-performance by counterparties with respect to financial derivative instruments.
Philips actively manages concentration risk and on a daily basis measures the potential loss
under certain stress scenarios, should a financial counterparty default. These worst-case scenario
losses are monitored and limited by the company. As of December 31, 2008 Philips had credit risk
exceeding EUR 25 million with the following number of counterparties:
104 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector
performance
|
|
94 Risk management
|
|
110 Our leadership
|
|
114 Supervisory Board
report
|
|
122 Performance statements
|
Credit risk with number of counterparties
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25-100 |
|
|
100-500 |
|
|
500-2,000 |
|
|
|
million |
|
|
million |
|
|
million |
|
AAA-rated governments |
|
|
|
|
|
|
1 |
|
|
|
1 |
|
AAA-rated government banks |
|
|
|
|
|
|
1 |
|
|
|
1 |
|
AAA-rated bank
counterparties |
|
|
|
|
|
|
|
|
|
|
1 |
|
AA-rated bank
counterparties |
|
|
1 |
|
|
|
|
|
|
|
|
|
A-rated bank counterparties |
|
|
3 |
|
|
|
1 |
|
|
|
|
|
The company does not enter into any financial derivative instruments to protect against default by
financial counterparties. However, where possible the company requires all financial counterparties
with whom it deals in derivative transactions to complete legally enforceable netting agreements
under an International Swap Dealers Association master agreement or otherwise prior to trading,
and whenever possible, to have a strong credit rating from Standard & Poors and Moodys Investor
Services. Philips also regularly monitors the development of credit default swap prices of its
financial counterparties. Wherever possible, cash is invested and financial transactions are
concluded with financial institutions with strong credit ratings or with governments or
government-backed institutions.
Country risk
Philips is exposed to country risk by the very nature of running a global business. Country risk
is the risk that political, legal, or economic developments in a single country could adversely
impact our performance. The country risk per country is defined as the sum of the equity of all
subsidiaries and associated companies in country cross-border transactions, such as intercompany
loans, accounts receivable from third parties and intercompany accounts receivable. The country
risk is monitored on a regular basis.
As of December 31, 2008, the company had country risk exposure in the Netherlands of EUR 9
billion and in the United States of EUR 10 billion. Other countries exceeding EUR 1 billion but
less than EUR 5 billion included Belgium and China (including Hong Kong). Countries where the
risk exceeded EUR 200 million but was less than EUR 1 billion included Germany, Korea, United
Kingdom, Russia, Poland, France, Canada, Austria, Japan, Taiwan and Italy . The degree of risk of
a country is taken into account when new investments are considered. The company does not,
however, use financial derivative instruments to hedge country risk.
Other insurable risks
Philips is covered for a range of different kinds of losses by global insurance policies in the
areas of property damage, business interruption, general and product liability, transport,
directors and officers liability, employment practice liability, fraud, and aviation product
liability.
To lower exposures and to avoid potential losses, Philips has a worldwide Risk Engineering
program in place. The main focus in this program is on property damage and business interruption
risks, which also include interdependencies. Philips sites, and also a limited number of sites of
key suppliers, are inspected on a regular basis by the Risk Engineering personnel of the insurer.
Inspections are carried out against predefined Risk Engineering standards which are agreed between
Philips and the insurers. Recommendations are made in a Risk Management report and are reviewed
centrally. This is the basis for decision-making by the local management of the business as to
which recommendations will be implemented. For all policies, deductibles are in place, which vary
from EUR 250,000 to EUR 500,000 per occurrence and this variance is designed to differentiate
between the existing risk categories within Philips. Above this first layer of working
deductibles, Philips operates its own re-insurance captive, which during 2008 retained EUR 2.5
million per occurrence for the property damage and business interruption losses and EUR 5 million
in the aggregate per year. For general and product liability claims, the captive retained EUR 1.5
million per claim and EUR 6 million in the aggregate. New contracts were signed on December 31,
2008 for the coming year, whereby the reinsurance captive retentions remained unchanged.
Philips Annual Report 2008 105
|
|
|
|
|
|
|
|
|
6 Performance
highlights
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We
care about...
|
|
42 Our group performance |
Figure 1
Figure 2
Figure 3
Figure 4
Details of pension risks
This section further analyzes the pension exposure and possible risks thereof.
Pension-related exposure to changes in financial markets
With pension obligations in more than thirty countries, Philips has devoted considerable attention
and resources to ensuring disclosure, awareness and control of the resulting exposures.
Depending on the investment policies and the membership composition of the respective pension
funds, developments in financial markets and changes in life expectancy may have significant effects
on the Funded Status and net periodic pension costs (NPPC) of Philips pension plans. To monitor
their exposure to the respective risk factors, Philips uses a stochastic model that covers
approximately 95% of the companys total pension liabilities and contains separate modules for
Germany, the Netherlands, the UK and the US. Amongst other things, it allows both sensitivity
analysis and stochastic simulations of the pension accounting figures of Philips.
Sensitivity analysis
An indication of Philips risk exposures can be obtained by a sensitivity analysis of the Funded
Status and NPPC for the above-mentioned countries. The bar charts in figures 1 and 2 show the
sensitivities of the Funded Status to changes in equity valuations, interest rates, inflation
expectations and longevity. Figures 3 and 4 show the same sensitivities for the NPPC. The risk
numbers show the extent to which the Funded Status and NPPC deviate from their (expected) levels as
per year-end 2009 if equity price levels, interest rates, inflation and longevity deviate one
standard deviation from their (expected) values at the end of 2009.
The aggregate Funded Status is particularly sensitive to changes in inflation expectations. This is
attributable to the inflation sensitivity of the projected pension obligations (PBO) for the
Netherlands, which is not matched by inflation-sensitive assets. The sensitivity to changes in
equity valuations is also dominated by the sensitivity in the Netherlands, even though in relative
terms there is a bigger exposure in the US. There is no sensitivity to equity prices left in
Germany, where equity holdings were swapped for cash and fixed income assets in 2008 in anticipation
of the implementation of a liability-driven investment (LDI) strategy in 2009.
106 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector
performance
|
|
94 Risk management
|
|
110 Our leadership
|
|
114 Supervisory Board
report
|
|
122 Performance statements
|
The aggregate Funded Status is least sensitive to interest rate risk. This relaect the LDI
strategies in the Netherlands and the UK and the relatively large fixed income allocations in
Germany. The biggest sensitivity to interest rates exists in the US plan. This is attributable to
the interest rate mismatch between its assets and liabilities. The overall sensitivity to
longevity is comparable to the sensitivity to equity prices. The Dutch fund contributes most,
which is due to its size.
The aggregate NPPC is particularly sensitive to changes in interest rates and inflation
expectations. This can be explained by the interest and inflation sensitivity of NPPC in the
Netherlands. NPPC is less sensitive to changes in equity valuations and longevity. Due to its
absolute exposure to equities, the biggest sensitivity to equities still exists in the
Netherlands. The biggest sensitivity to longevity also exists in the Netherlands.
Stochastic analysis
The sensitivities described
above reflect the impacts of separate changes in equity prices,
interest rates, etc. As such changes are unlikely to happen simultaneously, a simple summation of
the above-mentioned sensitivities would overestimate the total risk exposure. The difference
between the total risk and that summation represents the so-called diversification effect. It
results from the less than perfect (or even negative) correlation between the respective risk
factors. The diversification effect may be captured by a stochastic analysis, i.e. by analyzing
the outcomes of a large number of simulations.
These simulations are based on the volatility of and correlations between the respective risk
factors over the past 30 years. The bar charts on the right show the maximum deviations from the
expected aggregate Funded Status as per year-end 2008 and year-end 2009, and the expected NPPC
for 2009 and 2010, if the 5% worst possible outcomes are excluded. These Funded-Status-at-Risk
and NPPC-at-Risk measures are based on the valuations of plan assets and liabilities on
December 31, 2007 and December 31, 2008, respectively, and may therefore be seen as indicators of
the risks on these same dates. Figure 5 shows both the contribution of the separate risk factors
and the diversification effect. Contrary to figures 1 and 2, it excludes the impact of longevity
risk, but it includes the impact of credit risk (for 2008 only) and foreign exchange risk.
Figures 6 and 7 show both the contributions of the risk exposures in the four biggest pension
countries and the diversification between them.
Figure 5
Figure 6
Figure 7
Philips Annual Report 2008 107
|
|
|
|
|
|
|
|
|
6 Performance highlights
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance |
The differences between the first and second bars in
figures 5, 6 and 7 reflect plan changes, changes in
assumptions for discounting future liabilities and
changes in financial market conditions during 2008.
The Funded-Status-at-Risk has decreased compared to 2007.
The additional steps taken during 2008 in the Netherlands
and the US to fully implement their new investment
strategies have led to lower contributions of interest
rate and equity risk. The contribution of equity risk has
also decreased due to the lower absolute exposure that
resulted from negative market returns in 2008.
Nevertheless, equity risk is still a major source of
risk. It results from the relatively large strategic
allocation to equities in the US and the large absolute
exposure to equities in the Dutch fund. The contribution
of interest rate risk results from the remaining interest
rate mismatch between assets and liabilities. Both in
absolute and relative terms, it is biggest in the US.
Credit risk results mainly from the mismatch between the
credit spread risk exposure of (the discount rate curve
used for valuing) liabilities and the credit exposure of
assets (through defaults, downgrades and changing credit
spreads). The Dutch fund contributes most to inflation
risk, due to its size and its indexation policy. Foreign
exchange risk has increased compared to 2007, as the
increased deficits in the UK and especially the US lead to
higher translation risks. The diversification effect is
largely attributable to the positive correlation between
inflation and interest rates and the negative correlation
between bonds and equities.
The Dutch fund still contributes most to NPPC-at-Risk.
This is a reflection of its size.
Details of fiscal risks
Philips is, as mentioned before, exposed to fiscal
uncertainties. This section further describes this
exposure. Please refer to note 6 and note 42 for
additional disclosure relating to income taxes.
Transfer pricing uncertainties
Philips has issued transfer pricing directives, which are
in accordance with guidelines of the Organization of
Economic Co-operation and Development. As transfer
pricing has a cross-border effect, the focus of local tax
authorities on implemented transfer pricing procedures in
a country may have an impact on results in another
country. In order to mitigate the transfer pricing
uncertainties, audits are executed on a regular basis to
safeguard the correct implementation of the transfer
pricing directives.
Tax uncertainties on general service agreements and
specific allocation contracts
Due to the centralization of
certain activities in a limited number of countries (such
as research and development, centralized IT, and
corporate functions and head office), costs are also
centralized. As a consequence, for tax reasons these
costs and/or revenues must be allocated to the
beneficiaries, i.e. the various Philips entities. For that
purpose, apart from specific allocation contracts for
costs and revenues, general service agreements (GSAs) are
signed with a large number of entities. Tax authorities
review the implementation of GSAs, apply benefit tests for
particular countries or audit the use of tax credits
attached to GSAs and royalty payments, and may reject the
implemented procedures. Furthermore, buy in/out
situations in the case of (de)mergers could affect the
tax allocation of GSAs between countries. The same
applies to the specific allocation contracts.
Tax uncertainties due to disentanglements and
acquisitions
When a subsidiary of Philips is
disentangled, or a new company is acquired, related tax
uncertainties arise. Philips creates merger and
acquisition (M&A) teams for these disentanglements or
acquisitions. These teams consist of specialists from
various corporate functions and are formed, amongst other
things, to identify hidden tax uncertainties that could
subsequently surface when companies are acquired and to
avoid tax claims related to disentangled entities. These
tax uncertainties are investigated and assessed to
mitigate tax uncertainties in the future as much as
possible. Several tax uncertainties may surface from M&A
activities. Examples of uncertainties are: applicability
of the participation exemption, allocation issues, and
non-deductibility of parts of the purchase price.
108 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector performance
|
|
94 Risk management
|
|
110 Our leadership
|
|
114 Supervisory Board report
|
|
122 Performance statements
|
Tax uncertainties due to permanent establishments
In
countries where Philips starts new operations, the issue
of permanent establishment may arise. This is due to the
fact that when operations in new countries are led from
other countries, there is a risk that tax claims will
arise in the new country as well as in the initial
country. Philips assesses these uncertainties before the
new activities are started in a particular country.
Tax uncertainties of losses carried forward and tax
credits carried forward
The value of the losses carried
forward is not only subject to having sufficient profits
available within the loss-carried-forward period, but
also subject to having sufficient profits within the
foreseeable future in the case of losses carried forward
with an indefinite carry-forward period. Valuation
allowances of deferred tax asset positions are in place
where considered necessary. There is no absolute
assurance that all (net) tax losses and tax credits
carried forward can be realized as this is dependent on
estimated future taxable profits.
Philips Annual Report 2008 109
|
|
|
|
|
|
|
|
|
6 Performance highlights
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance |
Our leadership
Board of Management
The Board of Management operates under the chairmanship
of the President/Chief Executive Officer. The members of
the Board of Management have collective powers and
responsibilities. They share responsibility for the
management of Koninklijke Philips Electronics N.V. (the
Company), the deployment of its strategy and policies,
and the achievement of its objectives and results. The
Board of Management has, for practical purposes, adopted
a division of responsibilities reflecting the functional
and business areas monitored and reviewed by the
individual members. In accordance with the Companys
corporate objectives and Dutch law, the Board of
Management is guided by the interests of the Company and
its affiliated enterprises within the Group, taking into
consideration the interests of the Companys
stakeholders, and is accountable for the performance of
its assignment to the Supervisory Board and the General
Meeting of Shareholders. The Rules of Procedure of the
Board of Management are published on the Companys
website (www.philips.com/investor).
Corporate governance
A full description of the Companys corporate
governance structure is published in the chapter
Corporate governance of this Annual Report.
Gerard Kleisterlee
1946, Dutch
President/Chief Executive Officer (CEO) and Chairman of
the Board of Management and the Group Management
Committee President/CEO and Chairman of the Board of
Management since April 2001, member of the Board of
Management since April 2000 and member of the Group
Management Committee since January 1999
Corporate responsibilities: Communications, Internal
Audit, Legal/Compliance/GBP, Human Resources
Management, Marketing, Technology Management
Pierre-Jean Sivignon
1956, French
Executive Vice-President and Chief Financial Officer (CFO)
CFO and member of the Board of Management and the Group
Management Committee since June 2005
Corporate responsibilities: Control, Treasury, Fiscal,
Mergers & Acquisitions, Investor Relations,
Information Technology, Pensions, Real Estate,
Corporate Investments, Supply Management, New Venture
Integration
110 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector performance
|
|
94 Risk management
|
|
110 Our leadership
|
|
114 Supervisory Board report
|
|
122 Performance statements
|
Gottfried Dutiné
1952, German
Executive Vice-President
Member of the Board of Management since April 2002 and
member of the Group Management Committee since
February 2002
Corporate responsibilities: Areas and Countries,
Government Relations, Strategic Initiatives, Emerging
Markets
Andrea Ragnetti
1960, Italian
Executive Vice-President and Chief Executive Officer of
Philips Consumer Lifestyle
Member of the Board of
Management since April 2006, member of the Group
Management Committee since January 2003 and CEO of
Consumer Lifestyle since 2008
Corporate responsibilities: Consumer Lifestyle Sector, Design
Rudy Provoost
1959, Belgian
Executive Vice-President and Chief Executive Officer
of Philips Lighting
Member of the Board of Management
since April 2006, member of the Group Management
Committee since August 2003 and CEO of Philips
Lighting since April 2008
Corporate responsibilities: Lighting Sector, Sales
Leadership Board, Sustainability
Steve Rusckowski
1957, American
Executive Vice-President and Chief Executive Officer
of Philips Healthcare
Member of the Board of
Management since April 2007 and CEO of Philips
Healthcare since November 2006
Corporate responsibilities: Healthcare Sector
Philips Annual Report 2008 111
|
|
|
|
|
|
|
|
|
6 Performance highlights
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance |
Group Management Committee
The Group Management Committee consists
of the members of the Board of
Management and certain key officers.
Members other than members of the Board
of Management are appointed by the
Supervisory Board.
Rick Harwig
1949, Dutch
Member of the GMC and Chief Technology
Officer since April 2006
Corporate responsibilities: Technology
Management, Research, Applied
Technologies, Incubators, Intellectual
Property & Standards. Molecular
Diagnostics, PIC Bangalore
Gerard Ruizendaal
1958, Dutch
Member of the GMC since February 2007
and Chief Strategy Officer since May 2005
Corporate responsibilities: Strategy &
Alliances and Business Development
Maarten de Vries
1962, Dutch
Member of the GMC and Chief Information
Officer since September 2007 and Global
Head of Purchasing since September 2008
Corporate responsibilities:
Information Technology, Purchasing
Hayko Kroese
1955, Dutch
Member of the GMC since February 2007;
responsible for Human Resources
Management since 2007
Corporate responsibilities: Human
Resources Management
Eric Coutinho
1951, Dutch
Member of the GMC since February 2007,
Secretary to the Board of Management and
Chief Legal Officer since May 2006
Corporate responsibilities: Legal,
Company Secretary, Company Manual,
General Business Principles
112 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector performance
|
|
94 Risk management
|
|
110 Our leadership
|
|
114 Supervisory Board report
|
|
122 Performance statements
|
Supervisory Board
The Supervisory Board supervises the
policies of the executive management (the
Board of Management) and the general
course of affairs of Philips and advises
the executive management thereon. The
Supervisory Board, in the two-tier
corporate structure under Dutch law, is a
separate and independent body from the
Board of Management. The Rules of
Procedure of the Supervisory Board are
published on the Companys website.
For more details on the activities of
the Supervisory Board, see the chapter
Supervisory Board report of this Annual
Report.
C.J.A. van Lede
1942, Dutch**
Member of the Supervisory Board since
2003; second term expires in 2011
Former Chairman of the Board of Management
of Akzo Nobel and currently Chairman of
the Supervisory Board of Heineken, member
of the Boards of AirFrance/KLM, Sara Lee
Corporation, Air Liquide, member of the
Board of Directors of INSEAD and Senior
Advisor JP Morgan Plc
J.J. Schiro
1946, American* ***
Member of the Supervisory Board since
2005; first term expires in 2009
CEO of Zurich Financial Services and
Chairman of the Group Management Board.
Also serves on various boards of private
and listed companies including PepsiCo as
Chairman of the Audit Committee and member
of the Supervisory Board
J-M. Hessels
1942, Dutch** ***
Chairman
Member of the Supervisory Board since
1999; third term expires in 2011
Former CEO of Royal Vendex KBB and
currently Chairman of the Board of NYSE
Euronext Inc. member of the Supervisory
Board of Heineken
J.M. Thompson
1942, Canadian** ***
Vice-Chairman and Secretary Member of
the Supervisory Board since 2003;
second term expires in 2011
Former Vice-Chairman of the Board of
Directors of IBM, and director of Hertz
and Robert Mondavi; currently Chairman
of the Board of Toronto Dominion Bank
and a Director of Thomson Reuters
Corporation
H. von Prondzynski
1949, German*
Member of the Supervisory Board since
2007; first term expires in 2011
Former member of the Corporate Executive
Committee of the F. Hofmann-La Roche
Group and former CEO of Roche
Diagnostics, currently member of the
Supervisory Board of Qiagen and
Epigenomics and chairman of BB Medtech AG
Sir Richard Greenbury
1936, British**
Member of the Supervisory Board since
1998; third term expires in 2010
Former Chairman and CEO of Marks &
Spencer and former Director of Lloyds
TSB, British Gas, ICI, Zeneca and
Electronics Boutique Plc
E. Kist
1944, Dutch*
Member of the Supervisory Board since
2004; second term expires in 2012
Former Chairman of the Executive Board
of ING Group and currently member of the
Supervisory Boards of the Dutch Central
Bank, DSM, Moodys Investor Service and
Stage Entertainment
Prof. K.A.L.M. van Miert
1942, Belgian*
Member of the Supervisory Board since
2000; third term expires in 2012
Former Vice-President of the European
Commission and former President of
Nyenrode University, member of the
Supervisory Boards of RWE, Agfa Gevaert,
De Persgroep, Munich Re, Anglo American,
Vivendi Universal, Sibelco and Solvay
and member of the Advisory Board of
Goldman Sachs, Uni-Credito and Eli Lilly
Wong Ngit Liong
1941, Singaporean
Member of the Supervisory Board since
2005; first term expires in 2009
Chairman and CEO of the Venture Group of
companies. Also a board member of DBS
Bank and DBS Group Holdings Ltd, Chairman
of the National University of Singapore
Board of Trustee, and a member of the
Research Innovation and Enterprise
Council
* Member of the Audit Committee
** Member of the Remuneration Committee
*** Member of the Corporate Governance
and Nomination & Selection Committee
Philips Annual Report 2008 113
|
|
|
|
|
|
|
|
|
6 Performance highlights
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance |
Supervisory Board report
General
The supervision of the policies and actions of the
executive management (the Board of Management) of
Koninklijke Philips Electronics N.V. (the Company) is
entrusted to the Supervisory Board, which, in the
two-tier corporate structure under Dutch law, is a
separate body and fully independent of the Board of
Management. This independence is also reflected in the
requirement that members of the Supervisory Board be
neither a member of the Board of Management nor an
employee of the Company. The Supervisory Board considers
all its members to be independent under the applicable US
standards and pursuant to the Dutch Corporate Governance
Code of December 9, 2003 (the Dutch Corporate Governance
Code).
While retaining overall responsibility, the Supervisory
Board assigns certain of its tasks to three permanent
committees: the Corporate Governance and Nomination &
Selection Committee, the Remuneration Committee and the
Audit Committee. The separate reports of these committees
are part of this report and are published below. The
members (of the committees) of the Supervisory Board are
listed in the chapter Our leadership that begins on page
110 of this Annual Report.
For further information on the Companys corporate
governance structure and a more detailed description of
the duties and functioning of the Supervisory Board see
the chapter Corporate governance that begins on page 254
of this Annual Report.
Activities of the Supervisory Board
During 2008 the Supervisory Board devoted considerable
time to discussing the Companys strategy. In particular
the performance and integration of recent acquisitions,
such as Genlyte and Respironics, and the economic
situation and impact thereof on Philips and Vision 2010
were discussed extensively. The Supervisory Board also
discussed the capital and financing structure of the
Philips Group and approved the sale of some or all of the
Companys remaining shares in TSMC and LG Display. In
June the strategy of the Company and the sectors,
including various risks and opportunities scenarios, were
discussed during a one and a half day meeting.
Other discussion topics included:
|
|
financial performance of the Philips Group and the sectors |
|
|
|
status of merger and acquisition projects |
|
|
|
rebranding of products of acquired companies |
|
|
|
management agenda of the Board of Management and
especially the steps taken to deal with the
unsatisfactory EBITA margins in the TV business |
|
|
|
remuneration policy |
|
|
|
management development and succession planning |
|
|
|
evaluation of the Board of Management and its members |
|
|
|
geographic performance and growth opportunities in
Emerging Markets and particularly the shift of resources
from mature to emerging markets |
|
|
|
the shift of R&D spend from existing product categories
to new product categories |
|
|
|
the situation and improvement measures at some
businesses that did not perform according to plan |
|
|
|
the results of the Employee Engagement Score and the
implementation and impact of the Net Promoter Score |
|
|
|
financial scenarios for 2009 |
|
|
|
the situation at Philips Pension Fund in the Netherlands |
|
|
|
restructuring in various sectors |
|
|
|
the system of internal business controls and risk management |
|
|
|
the investigations into possible anticompetitive activities in the CRT industry. |
The Supervisory Board visited Lighting and Healthcare to
further familiarize itself with the business and the
respective management teams. Also, the yearly Corporate
Research Exhibition was visited, at which event the
latest technological projects and inventions of the
Company are presented. The members spent two days in
Boston/ Andover where they discussed the Philips
businesses in the United States of America and visited,
amongst others, the head office of Healthcare and attended
presentations of various businesses, including the
recently acquired business of Respironics, Colour
Kinetics, Genlyte, Emergin and VISICU. Finally, several
members of the Supervisory Board also attended external
training programs, which are often dedicated to specific
topics.
114 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our sector performance
|
|
94 Risk management
|
|
110 Our leadership
|
|
114 Supervisory Board report
|
|
122 Performance statements |
Composition and evaluation of the Supervisory Board
The Supervisory Board currently consists of nine members.
The Supervisory Board aims for an appropriate combination
of knowledge and experience among its members in relation
to the global and multi-product character of Philips
businesses. Consequently the Supervisory Board aims for
an appropriate level of experience in marketing,
technological, manufacturing, financial, economic, social
and legal aspects of international business and
government and public administration. The full profile is
described in the chapter Corporate governance. Members
are appointed for fixed terms of four years and may be
re-appointed for two additional four-year terms.
All members of the Supervisory Board completed a
questionnaire to verify compliance in 2008 with
applicable corporate governance rules and the Rules of
Procedure of the Supervisory Board. The Chairman of the
Supervisory Board discussed the functioning of the
Supervisory Board and its members in private discussions
with all members. He shared common themes and conclusions
in a private session of the Supervisory Board; items
discussed include the follow-up to the evaluation
regarding 2007, the composition and competencies of the
Board, the set-up and content of meetings and meeting
materials. In the same meeting the relationship with the
Board of Management was discussed. The three committees
of the Supervisory Board reviewed their charters and
their functioning and reported thereon to the full
Supervisory Board.
Report of the Corporate Governance and Nomination and
Selection Committee
The Corporate Governance and Nomination & Selection
Committee currently consists of three members. In line
with the New York Stock Exchange listing rules and other
developments in the field of corporate governance, the
committee reviews the corporate governance principles
applicable to the Company at least once a year, and
advises the Supervisory Board on any changes to these
principles as it deems appropriate.
As in prior years, the committee discussed developments
in the area of corporate governance and legislative
changes as well as further steps the Company could take
to improve its corporate governance structure. It also
discussed possible agenda items for the upcoming 2009
General Meeting of Shareholders.
Meetings 2008
|
|
Six regular meetings were held in 2008. |
|
|
|
All members were frequently present at the
regular meetings of the Supervisory Board. Four
members could not attend one or two regular
meetings due to agenda conflicts. In 2008, one
meeting took place by means of a conference call
to discuss a specific matter. |
|
|
|
The Audit Committee met nine times. |
|
|
|
The Remuneration Committee met six times. |
|
|
|
The Corporate Governance and Nomination &
Selection Committee met four times. |
Changes Supervisory Board and committees 2008
|
|
Messrs Kist and Van Miert have been reappointed as members of the Supervisory Board. |
|
|
|
Mr Hessels has succeeded Mr De Kleuver as Chairman of the Supervisory Board. |
|
|
|
Mr Schweitzer has resigned as a member of the Supervisory Board. |
|
|
|
Mr Kist has succeeded Mr Hessels as Chairman of the Audit Committee. |
|
|
|
Mr Von Prondzynski has become a member of the Audit Committee. |
|
|
|
Mr Schiro has become a member of the Corporate
Governance Nomination & Selection Committee. |
(Re)appointments Supervisory Board 2009
|
|
It is proposed to reappoint Mr Schiro.1) |
|
|
|
Mr Wong has expressed his wish to relinquish
his position as a member of the Supervisory
Board.2) |
1) |
|
Subject to approval by the General Meeting of Shareholders |
|
2) |
|
As from the closing of the 2009 General Meeting of Shareholders |
Changes Board of Management and Group Management
Committee 2008
|
|
Mr Van Deursen has retired as a member of the Board of Management. |
|
|
|
Mr Hartert and Mrs Kux have resigned as members of the Group Management Committee. |
(Re)appointments Board of Management 2009
|
|
It is proposed to reappoint Mr Sivignon.1) |
1) |
|
Subject to approval by the General Meeting of Shareholders |
Remuneration 20081)
in euros per year
|
|
|
|
|
|
|
|
|
|
|
Chairman |
|
|
Member |
|
Supervisory Board |
|
|
110,000 |
|
|
|
65,000 |
|
Audit Committee |
|
|
15,000 |
|
|
|
10,000 |
|
Remuneration Committee |
|
|
12,500 |
|
|
|
8,000 |
|
Corporate Governance and Nomination
& Selection Committee |
|
|
12,500 |
|
|
|
6,000 |
|
Fee for intercontinental traveling per trip |
|
|
3,000 |
|
|
|
3,000 |
|
|
|
|
1) |
|
Details are disclosed in note 34 Information on remuneration |
Philips Annual Report 2008 115
|
|
|
|
|
|
|
|
|
6 Performance highlights
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance |
In accordance with its charter, the Corporate Governance
and Nomination & Selection Committee consulted in 2008
with the President/CEO and other members of the Board of
Management on the appointment or reappointment of
candidates to fill current and future vacancies on the
Board of Management and the Group Management Committee,
prepared decisions and advised the Supervisory Board on
the candidates for appointment, and supervised the policy
of the Board of Management on the selection criteria and
appointment procedures for Philips senior management.
The committee devoted specific attention to the
composition and diversity of the Supervisory Board and
the search for a female member with knowledge of the
healthcare industry.
Report of the Remuneration Committee
The Remuneration Committee, currently consisting of four
members, is responsible for preparing decisions of the
Supervisory Board on the remuneration of individual
members of the Board of Management and the Group
Management Committee. In performing its duties and
responsibilities the Remuneration Committee is assisted
by a remuneration expert acting on the basis of a
protocol ensuring that the expert acts on the
instructions of the Remuneration Committee and on an
independent basis in which conflicts of interest are
avoided. The Remuneration Committees tasks are laid down
in the Charter of the Remuneration Committee that forms
part of the Rules of Procedure of the Supervisory Board.
Currently, no member of the Remuneration Committee is a
member of the management board of another listed company.
General remuneration policy
The objective of the remuneration policy for members of
the Board of Management is in line with that for Philips
executives throughout the Philips Group: to focus on
improving the performance of the company and enhancing
the value of the Philips Group, to motivate and retain
them, and to be able to attract highly qualified
executives, when required.
For the Board of Management, Philips benchmarks with
companies in the general industry in Europe and aims
at the median market position.
In order to link executive remuneration to the companys
performance, the remuneration package includes a
significant variable part in the form of an annual cash
incentive and a long-term incentive in the form of
restricted share rights and stock options.
Scenario analyses are conducted annually and serve as an
input for the review of the remuneration policy.
Contracts of employment
Members of the Board of Management have a 4-year
contract of employment with the Company.
Contract terms for current members1)
|
|
|
|
|
|
|
end of term |
|
G.J. Kleisterlee |
|
April 1, 2011 |
P-J. Sivignon |
|
June 15, 2009 |
G.H.A. Dutiné |
|
April 1, 2011 |
R.S. Provoost |
|
April 1, 2010 |
A. Ragnetti |
|
April 1, 2010 |
S.H. Rusckowski |
|
April 1, 2011 |
|
|
|
1) |
|
Reference date for board membership is December 31, 2008 |
The main elements of the contracts are made public no
later than the date of the notice calling the General
Meeting of Shareholders where the appointment of the
member of the Board of Management will be proposed.
The severance payment is set at a maximum of one years
salary, or in case this is manifestly unreasonable for
a member of the Board of Management in his first
appointment period, the amount shall not exceed twice the
annual salary.
Information on the individual remuneration of the
members of the Board of Management is shown in the
tables below as well as in the tables in note 34.
116 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our
sector performance
|
|
94 Risk
management
|
|
110 Our
leadership
|
|
114 Supervisory
Board report
|
|
122 Performance
statements |
Remuneration costs
The tables below give an overview of the costs incurred by the Company in the financial year in
relation to the remuneration of the Board of Management. Costs related to stock option and
restricted share rights grants are taken by the
Company over a number of years. As a consequence, the costs mentioned below in the columns stock
options and restricted share rights are the accounting cost of multi-year grants given to board
members during their board membership.
Remuneration costs Board of Management 20081)
in euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
realized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
annual |
|
|
stock |
|
|
restricted |
|
|
pension |
|
|
other |
|
|
|
base salary |
|
|
incentive2) |
|
|
options |
|
|
share rights |
|
|
costs |
|
|
compensation |
|
G.J. Kleisterlee |
|
|
1,100,000 |
|
|
|
490,512 |
|
|
|
491,878 |
|
|
|
645,155 |
|
|
|
(314,893 |
)3) |
|
|
324,346 |
|
P-J. Sivignon |
|
|
687,500 |
|
|
|
217,386 |
|
|
|
326,729 |
|
|
|
382,268 |
|
|
|
250,951 |
|
|
|
8,738 |
|
G.H.A. Dutiné |
|
|
618,750 |
|
|
|
200,664 |
|
|
|
284,446 |
|
|
|
365,531 |
|
|
|
192,153 |
|
|
|
135,673 |
|
R.S. Provoost |
|
|
620,000 |
|
|
|
247,607 |
|
|
|
265,791 |
|
|
|
343,011 |
|
|
|
192,003 |
|
|
|
26,406 |
|
A. Ragnetti |
|
|
613,750 |
|
|
|
329,571 |
|
|
|
255,997 |
|
|
|
338,156 |
|
|
|
202,281 |
|
|
|
37,665 |
|
S.H. Rusckowski |
|
|
620,000 |
|
|
|
103,164 |
4) |
|
|
177,629 |
|
|
|
307,685 |
|
|
|
235,852 |
|
|
|
66,356 |
|
|
|
|
1) |
|
Reference date for board membership is December 31, 2008 |
|
2) |
|
Annual incentive amount paid relates to performance in the previous year |
|
3) |
|
No further accrual of pension benefits after having reached the age of 60 in September 2006,
leading to a negative cost |
|
4) |
|
Pay-out related to period April 1 December 31, 2007 |
Remuneration costs Board of Management 20071)
in euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
realized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
annual |
|
|
stock |
|
|
restricted |
|
|
pension |
|
|
other |
|
|
|
base salary |
|
|
incentive2) |
|
|
options |
|
|
share rights |
|
|
costs |
|
|
compensation |
|
G.J. Kleisterlee |
|
|
1,087,500 |
|
|
|
1,186,618 |
|
|
|
467,467 |
|
|
|
612,844 |
|
|
|
(323,687 |
)3) |
|
|
304,047 |
|
P-J. Sivignon |
|
|
637,500 |
|
|
|
508,550 |
|
|
|
284,166 |
|
|
|
373,969 |
|
|
|
243,940 |
|
|
|
25,218 |
|
G.H.A. Dutiné |
|
|
587,500 |
|
|
|
513,691 |
|
|
|
284,033 |
|
|
|
354,526 |
|
|
|
192,549 |
|
|
|
140,116 |
|
R.S. Provoost |
|
|
562,500 |
|
|
|
335,551 |
4) |
|
|
184,050 |
|
|
|
295,059 |
|
|
|
176,867 |
|
|
|
22,007 |
|
A. Ragnetti |
|
|
531,250 |
|
|
|
354,893 |
4) |
|
|
174,256 |
|
|
|
284,860 |
|
|
|
178,611 |
|
|
|
37,031 |
|
S.H. Rusckowski5) |
|
|
431,250 |
|
|
|
|
|
|
|
93,489 |
|
|
|
209,370 |
|
|
|
184,633 |
|
|
|
137,741 |
|
|
|
|
1) |
|
Reference date for board membership is December 31, 2008 |
|
2) |
|
Annual incentive paid relates to performance in the previous year |
|
3) |
|
No further accrual of pension benefits after having reached the age of 60 in September 2006,
leading to a negative cost |
|
4) |
|
Pay-out related to period April 1 December 31, 2006 |
|
5) |
|
All amounts mentioned relate to the period of board membership (April 1 December 31, 2007),
therefore no amount is mentioned under annual incentive |
Remuneration
costs Board of Management 20061)
in euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
realized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
annual |
|
|
stock |
|
|
restricted |
|
|
pension |
|
|
other |
|
|
|
base salary |
|
|
incentive2) |
|
|
options |
|
|
share rights |
|
|
costs |
|
|
compensation |
|
G.J. Kleisterlee |
|
|
1,042,500 |
|
|
|
1,500,560 |
3) |
|
|
415,054 |
|
|
|
409,106 |
|
|
|
(52,145 |
)4) |
|
|
300,064 |
|
P-J. Sivignon |
|
|
568,750 |
|
|
|
519,191 |
3)5) |
|
|
163,797 |
|
|
|
247,408 |
|
|
|
224,481 |
|
|
|
60,671 |
|
G.H.A. Dutiné |
|
|
540,750 |
|
|
|
433,998 |
|
|
|
271,824 |
|
|
|
264,427 |
|
|
|
194,309 |
|
|
|
99,373 |
|
R.S. Provoost6) |
|
|
393,750 |
|
|
|
|
|
|
|
73,319 |
|
|
|
124,835 |
|
|
|
138,802 |
|
|
|
34,632 |
|
A. Ragnetti6) |
|
|
356,250 |
|
|
|
|
|
|
|
65,974 |
|
|
|
112,329 |
|
|
|
121,358 |
|
|
|
13,971 |
|
S.H. Rusckowski7) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1) |
|
Reference date for board membership is December 31, 2008 |
|
2) |
|
The annual incentive paid relates to performance in the previous year |
|
3) |
|
The annual incentive amount mentioned includes the special payment made in relation to the
divestment of the Semiconductors division |
|
4) |
|
No further accrual of pension benefits after having reached the age of 60 in September 2006,
leading to a negative cost |
|
5) |
|
Pay-out related to period June 15 December 31, 2005 |
|
6) |
|
All amounts mentioned relate to period of board membership (April 1 December 31, 2006),
therefore no amount mentioned under annual incentive |
|
7) |
|
Date of appointment as member of the Board of Management April 1, 2007, therefore no amounts
mentioned |
Philips Annual Report 2008 117
|
|
|
|
|
|
|
|
|
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance |
Base salary
In 2008 base salaries have been increased in line with the policy, with the exception of the
President/CEO for whom the salary is fixed for the duration of his contract of employment.
Annual Incentive
Each year, a variable cash incentive (Annual Incentive) can be earned, based on the achievement of
specific and challenging targets. The Annual Incentive criteria are for 80% the financial
indicators of the Company (net income, comparable sales growth and free cash flow) and for 20% team
targets in the areas of responsibility monitored by the (individual) members of the Board of
Management.
The Supervisory Board determines whether performance conditions are met, and has the ability to
adjust the pay-out upward or downward if the predetermined performance criteria would produce an
unfair result due to extraordinary circumstances. The related targets for the members of the Board
of Management are determined annually at the beginning of the year.
The on-target Annual Incentive percentage is set at 60% of the base salary for members of the Board
of Management and 80% of the base salary for the President/CEO, and the maximum Annual Incentive
achievable is 120% of the annual base salary for members of the Board of Management and for the
President/CEO it is 160% of the annual base salary.
The Annual Incentive pay-out in any year relates to the achievements of the preceding financial
year in relation to agreed targets. As a result, Annual Incentives paid in 2009 relate to the
salary levels and the performance in the year 2008.
Based upon the 2008 results as published in this Annual Report, the realized Annual Incentive
amounts mentioned in the table below will be paid to members of the Board of Management in April
2009.
Pay-out in 20091)
in euros
|
|
|
|
|
|
|
|
|
|
|
realized annual |
|
|
as a % of base |
|
|
|
incentive |
|
|
salary (2008) |
|
G.J. Kleisterlee |
|
|
220,000 |
|
|
|
20.0 |
% |
P-J. Sivignon |
|
|
105,000 |
|
|
|
15.0 |
% |
G.H.A. Dutiné |
|
|
93,750 |
|
|
|
15.0 |
% |
R.S. Provoost |
|
|
95,250 |
|
|
|
15.0 |
% |
A. Ragnetti |
|
|
95,250 |
|
|
|
15.0 |
% |
S.H Rusckowski |
|
|
221,470 |
|
|
|
34.9 |
% |
|
|
|
1) |
|
Reference date for board membership is December 31, 2008 |
Long-Term Incentive Plan (LTIP)
The LTIP consists of a mix of stock options and restricted share rights and serves to align the
interests of the participating employees with the shareholders interest and to attract, motivate
and retain participating employees.
The actual number of stock options and restricted share rights that will be granted to members of
the Board of Management is performance-related and depends on Philips Total Shareholder Return
(TSR) and the team targets of the Board of Management.
The 2007 General Meeting of Shareholders approved a new list of peer group companies and a new
simplified TSR-based LTI multiplier based on the ranking table below:
|
|
|
|
|
Philips position compared to peer companies |
|
LTI multiplier |
|
|
Top 4 |
|
|
1.2 |
|
Middle 4 |
|
|
1.0 |
|
Bottom 4 |
|
|
0.8 |
|
The peer group contains the following companies: Electrolux, Emerson Electric, General Electric,
Hitachi, Honeywell International, Johnson & Johnson, Matsushita (Panasonic), Philips, Schneider,
Siemens, Toshiba, 3M.
For 2008, the Supervisory Board has applied a multiplier of 1.0, based on the Philips share
performance over the period from December 2004 to December 2007.
The stock option plan has a three-year vesting term (vesting dependent on employment upon the
vesting date), and a 10-year total option term.
Restricted share rights grants apply a vesting term of respectively 1, 2 and 3 years after grant,
and vest based on employment upon vesting. Through the granting of additional (premium) shares
after the grantees have held the restricted shares for three years after delivery, provided they
are still in service, grantees will be more stimulated to focus on the longer term as shareholders
of the Company.
To further align the interests of the members of the Board of Management and shareholders,
restricted shares granted to the Board of Management members shall be retained for a period of at
least five years or until at least the end of their employment, if this period is shorter.
Similarly, for other Philips Senior Executives compulsory share ownership was introduced in 2004.
118 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our
sector performance
|
|
94 Risk
management
|
|
110 Our
leadership
|
|
114 Supervisory
Board report
|
|
122 Performance
statements |
In 2008, 9,979,902 stock options and 2,321,634 restricted share rights were granted under the LTIP
(excluding the 20% premium shares to be delivered after a three-year holding period).
For more details of the LTIP, see note 33.
Pensions
Eligible members of the Board of Management participate in the Executives Pension Plan in the
Netherlands consisting of a combination of a defined-benefit (career average) and
defined-contribution plan. The target retirement age under the plan is 62.5. The plan does not
require employee contributions.
Additional arrangements
In addition to the main conditions of employment, a number of additional arrangements apply to
members of the Board of Management. These additional arrangements, such as expense and relocation
allowances, medical insurance, accident insurance and company car arrangements are broadly in line
with those for Philips executives in the Netherlands. In the event of disablement, members of the
Board of Management are entitled to benefits in line with those for other Philips executives in the
Netherlands.
In line with regulatory requirements, the Companys policy forbids personal loans to members of the
Board of Management and Supervisory Board or to the other members of the Group Management
Committee, and consequently no loans were granted to such members in 2008, nor were such loans
outstanding as of December 31, 2008.
Unless the law provides otherwise, the members of the Board of Management and of the Supervisory
Board shall be reimbursed by the Company for various costs and expenses, like reasonable costs of
defending claims, as formalized in the articles of association. Under certain circumstances,
described in the articles of association, such as an act or failure to act by a member of the Board
of Management or a member of the Supervisory Board that can be characterized as intentional
(opzettelijk), intentionally reckless (bewust roekeloos) or seriously culpable (ernstig
verwijtbaar), there will be no entitlement to this reimbursement. The Company has also taken out
liability insurance (D&O Directors & Officers) for the persons concerned.
2009
In view of the current economic circumstances, salaries
of the members of the Board of Management will not be
increased in 2009 and Philips will be restrictive in the
salary review for all employees.
After extensive consultation with important stakeholders,
Philips will propose to the General Meeting of
Shareholders in 2009 the introduction of a new TSR
multiplier range for restricted share rights. If adopted,
the new multiplier will be applied starting with the
grant in April 2009. The new multiplier range has more
down side and more upside than previously: minimum is
zero (from 0.8), and maximum is 2 (from 1.2). As the
multiplier is applied to determine grant numbers, this
means that grants can be zero at minimum, or double the
target number at maximum. In this way, the link between
pay and performance is further enhanced.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proposed TSR |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TSR Ranking |
|
|
1 |
|
|
|
2 |
|
|
|
3 |
|
|
|
4 |
|
|
|
5 |
|
|
|
6 |
|
Multiplier
(current) |
|
|
1.2 |
|
|
|
1.2 |
|
|
|
1.2 |
|
|
|
1.2 |
|
|
|
1 |
|
|
|
1 |
|
Multiplier
(proposed) |
|
|
2 |
|
|
|
1.8 |
|
|
|
1.6 |
|
|
|
1.4 |
|
|
|
1.2 |
|
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proposed TSR |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TSR Ranking |
|
|
7 |
|
|
|
8 |
|
|
|
9 |
|
|
|
10 |
|
|
|
11 |
|
|
|
12 |
|
Multiplier
(current) |
|
|
1 |
|
|
|
1 |
|
|
|
0.8 |
|
|
|
0.8 |
|
|
|
0.8 |
|
|
|
0.8 |
|
Multiplier
(proposed) |
|
|
1 |
|
|
|
0.8 |
|
|
|
0.6 |
|
|
|
0.4 |
|
|
|
0.2 |
|
|
|
0 |
|
The current multiplier range for stock options will be
maintained (ranging from 0.8 1.2).
The so-called ultimum remedium clause and claw back
clause of best practice provisions II.2.10 and II.2.11 of
the new Dutch Corporate Governance Code, as presented by
the Corporate Governance Code Monitoring Committee in its
report of December 2008, is applicable to Annual
Incentive payments and LTIP grants over the year 2009
onwards to all members of the Board of Management.
Philips Annual Report 2008 119
|
|
|
|
|
|
|
|
|
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance |
Report of the Audit Committee
The Audit Committee, currently consisting of four members, assists the Supervisory Board in
fulfilling its supervisory responsibilities for the integrity of the Companys financial
statements, the financial reporting process, the system of internal business controls and risk
management, the internal and external audit process, the internal and external auditors findings
and recommendations, independence and performance, as well as the Companys process for monitoring
compliance with laws and regulations and the General Business Principles (GBP).
The Audit Committee met 9 times in 2008 and reported its findings periodically to the plenary
Supervisory Board. The President, the Chief Financial Officer, the Internal Auditor, the Group
Controller and the External Auditor attended all regular meetings. Furthermore, the Audit Committee
met each quarter separately with each of the President, the Chief Financial Officer, the Internal
Auditor and the External Auditor. In accordance with its charter, which is part of the Rules of
Procedure of the Supervisory Board, the Audit Committee in 2008 reviewed the Companys annual and
interim financial statements, including non-financial information, prior to publication thereof. It
also assessed in its quarterly meetings the adequacy and appropriateness of internal control
policies and internal audit programs and their findings.
In its 2008 meetings, the Audit Committee periodically reviewed matters relating to accounting
policies and compliance with accounting standards. Compliance with statutory and legal requirements
and regulations, particularly in the financial domain, was also reviewed. Important findings
identified risks and follow-up actions were examined thoroughly in order to allow appropriate
measures to be taken. With regard to the internal audit, the Audit Committee reviewed, and if
required approved, the internal audit charter, audit plan, audit scope and its coverage in relation
to the scope of the external audit, as well as the staffing, independence and organizational
structure of the internal audit function. An assessment by an independent auditor of the
effectiveness of the Internal Audit Function, including various recommendations, was discussed.
With regard to the external audit, the Audit Committee reviewed the proposed audit scope, approach
and fees, the independence of the external auditors, non-audit services provided by the external
auditors in conformity with the Philips Policy on Auditor Independence, as well as any changes to
this policy. Within the framework of the Philips policy on auditor independence, the evaluation of
the performance of the external auditor takes place every three years. On the basis thereof,
the Supervisory Board has recommended to reappoint KPMG
as auditor of the Company (which was resolved by the 2008
General Meeting of Shareholders).
Fees KPMG
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Audit fees |
|
|
20.6 |
|
|
|
17.6 |
|
|
|
17.3 |
|
- consolidated financial statements |
|
|
7.0 |
|
|
|
7.2 |
|
|
|
7.6 |
|
- statutory financial statements |
|
|
5.0 |
|
|
|
4.7 |
|
|
|
4.8 |
|
- internal controls over financial reporting |
|
|
8.6 |
|
|
|
5.7 |
|
|
|
4.9 |
|
Audit-related fees |
|
|
9.8 |
|
|
|
3.9 |
|
|
|
4.4 |
|
- acquisitions and divestments |
|
|
4.4 |
|
|
|
2.3 |
|
|
|
2.3 |
|
- other |
|
|
5.4 |
|
|
|
1.6 |
|
|
|
2.1 |
|
Tax fees |
|
|
0.9 |
|
|
|
1.2 |
|
|
|
1.2 |
|
- tax compliance services |
|
|
0.9 |
|
|
|
1.2 |
|
|
|
1.2 |
|
Other fees |
|
|
2.4 |
|
|
|
2.3 |
|
|
|
2.5 |
|
- royalty investigation |
|
|
1.9 |
|
|
|
1.9 |
|
|
|
1.8 |
|
- sustainability and other services |
|
|
0.5 |
|
|
|
0.4 |
|
|
|
0.7 |
|
|
|
|
33.7 |
|
|
|
25.0 |
|
|
|
25.4 |
|
In 2008, the Audit Committee periodically discussed the companys policy on business controls, the
GBP including the deployment thereof and amendments thereto, and the companys major areas of risk,
including the internal auditors reporting thereon. The Audit Committee was informed on, discussed
and monitored closely the companys internal control certification processess, in particular
compliance with section 404 of the US Sarbanes-Oxley Act and its requirements regarding assessment,
review and monitoring of internal controls. It also discussed tax issues, IT strategy, litigation
(including asbestos) and related provisions, environmental exposures and financing and liquidity of
the company, dividend, pensions (including the situation at Philips Pension Fund in the Netherlands
and the governance of the other major pension funds), valuation of financial holdings (and related
impairments), the investigations into possible anticompetitive activities in the CRT industry, as
well as a financial evaluation of the investments made in 2005.
120 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our
sector performance
|
|
94 Risk
management
|
|
110 Our
leadership
|
|
114 Supervisory
Board report
|
|
122 Performance
statements |
Financial statements 2008
The financial statements of Koninklijke Philips Electronics N.V. for 2008, as presented by the
Board of Management, have been audited by KPMG Accountants N.V., independent auditors. Their
reports have been included in the chapter IFRS financial statements on page 243 and the chapter
Company financial statements on page 249 of this Annual Report. We have approved these financial
statements, and all individual members of the Supervisory Board (together with the members of the
Board of Management) have signed these documents.
We recommend to shareholders that they adopt the 2008 financial statements. We likewise recommend
to shareholders that they adopt the proposal of the Board of Management to make a distribution of
EUR 0.70 per common share from the retained earnings.
Finally, we would like to express our thanks to the members of the Board of Management, the Group
Management Committee and all other employees for their continued contribution during the year.
February 23, 2009
The Supervisory Board
Philips Annual Report 2008 121
|
|
|
|
|
|
|
|
|
|
|
8 Message from the President
|
|
14 Who we are
|
|
18 We care about...
|
|
42 Our group performance |
Performance statements
|
|
|
|
|
|
|
|
|
|
|
|
|
US GAAP financial statements |
|
|
|
124 |
|
|
Managements report |
|
|
|
125 |
|
|
Auditors report |
|
|
|
126 |
|
|
Consolidated statements of income |
|
|
|
128 |
|
|
Consolidated balance sheets |
|
|
|
130 |
|
|
Consolidated statements of cash flows |
|
|
|
132 |
|
|
Consolidated statements of stockholders equity |
|
|
|
133 |
|
|
Information by sector and main country |
|
|
|
136 |
|
|
Significant accounting policies |
|
|
|
142 |
|
|
Notes to the US GAAP financial statements |
|
|
|
|
|
|
|
|
|
|
|
|
|
Sustainability performance |
|
|
|
180 |
|
|
Approach to sustainability reporting |
|
|
|
182 |
|
|
Economic indicators |
|
|
|
182 |
|
|
Environmental indicators |
|
|
|
186 |
|
|
Social indicators |
|
|
|
188 |
|
|
Supplier indicators |
|
|
|
189 |
|
|
Assurance report |
|
|
|
190 |
|
|
GRI performance indicators |
|
|
|
|
|
|
|
|
|
|
|
|
|
IFRS financial statements |
|
|
|
193 |
|
|
IFRS management commentary |
|
|
|
198 |
|
|
Consolidated statements of income |
|
|
|
200 |
|
|
Consolidated balance sheets |
|
|
|
202 |
|
|
Consolidated statements of cash flows |
|
|
|
204 |
|
|
Consolidated statements of equity |
|
|
|
206 |
|
|
Information by sector and main country |
|
|
|
209 |
|
|
Significant IFRS accounting policies |
|
|
|
216 |
|
|
Notes to the IFRS financial statements |
|
|
|
243 |
|
|
Auditors report |
|
|
|
|
|
|
|
|
|
|
|
|
|
Company financial statements |
|
|
|
244 |
|
|
Balance sheets |
|
|
|
245 |
|
|
Statements of income |
|
|
|
245 |
|
|
Statements of equity |
|
|
|
246 |
|
|
Notes to the Company financial statements |
|
|
|
249 |
|
|
Auditors report |
122 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
70 Our
sector performance
|
|
94 Risk
management
|
|
110 Our
leadership
|
|
114 Supervisory
Board report
|
|
122 Performance
statements |
Notes overview
|
|
|
|
|
|
|
|
|
|
|
|
|
US GAAP financial statements |
142
|
|
|
1 |
|
|
Discontinued operations |
143
|
|
|
2 |
|
|
Acquisitions and divestments |
148
|
|
|
3 |
|
|
Income from operations |
149
|
|
|
4 |
|
|
Restructuring and impairment |
151
|
|
|
5 |
|
|
Financial income and expenses |
152
|
|
|
6 |
|
|
Income taxes |
153
|
|
|
7 |
|
|
Investments in equity-accounted investees |
155
|
|
|
8 |
|
|
Earnings per share |
155
|
|
|
9 |
|
|
Receivables |
155
|
|
|
10 |
|
|
Inventories |
155
|
|
|
11 |
|
|
Other current assets |
156
|
|
|
12 |
|
|
Other non-current financial assets |
157
|
|
|
13 |
|
|
Non-current receivables |
157
|
|
|
14 |
|
|
Other non-current assets |
157
|
|
|
15 |
|
|
Property, plant and equipment |
158
|
|
|
16 |
|
|
Intangible assets excluding goodwill |
158
|
|
|
17 |
|
|
Goodwill |
159
|
|
|
18 |
|
|
Accrued liabilities |
159
|
|
|
19 |
|
|
Provisions |
160
|
|
|
20 |
|
|
Pensions |
163
|
|
|
21 |
|
|
Postretirement benefits other than pensions |
166
|
|
|
22 |
|
|
Other current liabilities |
166
|
|
|
23 |
|
|
Short-term debt |
167
|
|
|
24 |
|
|
Long-term debt |
168
|
|
|
25 |
|
|
Other non-current liabilities |
168
|
|
|
26 |
|
|
Contractual obligations |
168
|
|
|
27 |
|
|
Contingent liabilities |
170
|
|
|
28 |
|
|
Stockholders equity |
170
|
|
|
29 |
|
|
Cash from derivatives |
170
|
|
|
30 |
|
|
Proceeds from other non-current financial assets |
170
|
|
|
31 |
|
|
Assets received in lieu of cash from the sale of businesses |
171
|
|
|
32 |
|
|
Related-party transactions |
171
|
|
|
33 |
|
|
Share-based compensation |
173
|
|
|
34 |
|
|
Information on remuneration |
177
|
|
|
35 |
|
|
Fair value of financial assets and liabilities |
178
|
|
|
36 |
|
|
Other financial instruments |
178
|
|
|
37 |
|
|
Subsequent events |
|
|
|
|
|
|
|
|
|
|
|
|
|
IFRS financial statements |
216
|
|
|
38 |
|
|
Discontinued operations |
217
|
|
|
39 |
|
|
Acquisitions and divestments |
222
|
|
|
40 |
|
|
Income from operations |
223
|
|
|
41 |
|
|
Financial income and expenses |
224
|
|
|
42 |
|
|
Income taxes |
226
|
|
|
43 |
|
|
Investments in equity-accounted investees |
228
|
|
|
44 |
|
|
Earnings per share |
228
|
|
|
45 |
|
|
Receivables |
228
|
|
|
46 |
|
|
Inventories |
229
|
|
|
47 |
|
|
Other current assets |
229
|
|
|
48 |
|
|
Other non-current financial assets |
230
|
|
|
49 |
|
|
Non-current receivables |
230
|
|
|
50 |
|
|
Other non-current assets |
230
|
|
|
51 |
|
|
Property, plant and equipment |
231
|
|
|
52 |
|
|
Intangible assets excluding goodwill |
231
|
|
|
53 |
|
|
Goodwill |
232
|
|
|
54 |
|
|
Accrued liabilities |
232
|
|
|
55 |
|
|
Provisions |
233
|
|
|
56 |
|
|
Pensions and postretirement benefits |
237
|
|
|
57 |
|
|
Other current liabilities |
237
|
|
|
58 |
|
|
Short-term debt |
238
|
|
|
59 |
|
|
Long-term debt |
238
|
|
|
60 |
|
|
Other non-current liabilities |
238
|
|
|
61 |
|
|
Contractual obligations |
239
|
|
|
62 |
|
|
Contingent liabilities |
240
|
|
|
63 |
|
|
Stockholders equity |
241
|
|
|
64 |
|
|
Cash from derivatives |
241
|
|
|
65 |
|
|
Proceeds from other non-current financial assets |
241
|
|
|
66 |
|
|
Assets in lieu of cash from sale businesses |
241
|
|
|
67 |
|
|
Related-party transactions |
242
|
|
|
68 |
|
|
Fair value of financial assets and liabilities |
242
|
|
|
69 |
|
|
Other financial instruments |
243
|
|
|
70 |
|
|
Subsequent events |
|
|
|
|
|
|
|
|
|
|
|
|
|
Company financial statements |
246
|
|
|
A |
|
|
Receivables |
246
|
|
|
B |
|
|
Investments in affiliated companies |
247
|
|
|
C |
|
|
Other non-current financial assets |
247
|
|
|
D |
|
|
Other current liabilities |
247
|
|
|
E |
|
|
Short-term debt |
247
|
|
|
F |
|
|
Provisions |
248
|
|
|
G |
|
|
Long-term debt |
248
|
|
|
H |
|
|
Stockholders equity |
249
|
|
|
I |
|
|
Net income |
249
|
|
|
J |
|
|
Employees |
249
|
|
|
K |
|
|
Obligations not appearing in balance sheet |
249
|
|
|
L |
|
|
Audit fees |
249
|
|
|
M |
|
|
Subsequent events |
Philips Annual Report 2008 123
|
|
|
|
|
|
|
124 US GAAP financial statements
|
|
180 Sustainability performance
|
|
192 IFRS financial statements
|
|
244 Company financial statements |
- Managements report
- Auditors report
US GAAP financial statements
Managements report on internal control over financial
reporting pursuant to section 404 of the US
Sarbanes-Oxley Act
The Board of Management of Koninklijke Philips
Electronics N.V. (the Company) is responsible for
establishing and maintaining an adequate system of
internal control over financial reporting (as such term
is defined in Rule 13a-15(f) under the US Securities
Exchange Act). Internal control over financial reporting
is a process to provide reasonable assurance regarding
the reliability of our financial reporting for external
purposes in accordance with accounting principles
generally accepted in the United States of America (US
GAAP).
Internal control over financial reporting includes
maintaining records that, in reasonable detail,
accurately and fairly reflect our transactions; providing
reasonable assurance that transactions are recorded as
necessary for preparation of our financial statements;
providing reasonable assurance that receipts and
expenditures of company assets are made in accordance
with management authorization; and providing reasonable
assurance that unauthorized acquisition, use or
disposition of company assets that could have a material
effect on our financial statements would be prevented or
detected on a timely basis. Because of its inherent
limitations, internal control over financial reporting is
not intended to provide absolute assurance that a
misstatement of our financial statements would be
prevented or detected.
The Board of Management conducted an assessment of the
Companys internal control over financial reporting based
on the Internal Control-Integrated Framework established
by the Committee of Sponsoring Organizations of the
Treadway Commission (COSO). Based on that assessment, the
Board of Management concluded that, as of December 31,
2008, the Companys internal control over US GAAP
financial reporting is considered effective.
The Board of Managements assessment of the effectiveness
of the Companys internal control over financial
reporting as of December 31, 2008, excluded the following
companies acquired by the Company after January 1, 2008:
VISICU Inc., Philips Healthcare Informatics Limited
(formally known as TOMCAT Ltd.), Shenzhen Goldway
Industrial Inc., Dixtal Biomédica Indústria e Comércio
Ltda., Dixtal Tecnologia Indústria e Comércio Ltda.,
Alpha X-Ray Technologies, and Melhk Ltd. These
acquisitions are wholly-owned subsidiaries of the Company
of which total assets represented 1.0% of consolidated
total assets and net sales represented less than 0.5% of
consolidated net sales of the Company as of and for the
year ended December 31, 2008. If adequately disclosed,
companies are allowed to exclude acquisitions from their
assessment of internal control over financial reporting
during the year of acquisition while integrating the
acquired company under guidelines established by the US
Securities and Exchange Commission.
The effectiveness of the Companys internal control over
US GAAP financial reporting as of December 31, 2008, as
included in this chapter US GAAP financial statements,
has been audited by KPMG Accountants N.V., an
independent registered public accounting firm, as stated
in their report which follows hereafter.
Board of Management
February 23, 2009
124 Philips Annual Report 2008
|
|
|
|
|
|
|
250 Reconciliation of non-US GAAP information
|
|
254 Corporate governance
|
|
262 Ten-year overview
|
|
266 Investor information |
Report of independent registered public accounting firm
To the Supervisory Board and Shareholders of Koninklijke Philips Electronics N.V.:
We have audited the accompanying consolidated balance sheets of Koninklijke Philips Electronics
N.V. and subsidiaries as of December 31, 2008 and 2007, and the related consolidated statements of
income, changes in stockholders equity and cash flows for each of the years in the three-year
period ended December 31, 2008 appearing on page 126 to 178. We also have audited Koninklijke
Philips Electronics N.V. and subsidiaries internal control over financial reporting as of December
31, 2008, based on criteria established in Internal Control Integrated Framework issued by the
Committee of Sponsoring Organizations of the Treadway Commission (COSO). Koninklijke Philips
Electronics N.V. and subsidiaries management is responsible for these consolidated financial
statements, for maintaining effective internal control over financial reporting, and for its
assessment of the effectiveness of internal control over financial reporting, included in the
accompanying Managements report on internal control over financial reporting appearing on page
124. Our responsibility is to express an opinion on these consolidated financial statements and an
opinion on the companys internal control over financial reporting based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight
Board (United States). Those standards require that we plan and perform the audits to obtain
reasonable assurance about whether the financial statements are free of material misstatement and
whether effective internal control over financial reporting was maintained in all material
respects. Our audits of the consolidated financial statements included examining, on a test basis,
evidence supporting the amounts and disclosures in the financial statements, assessing the
accounting principles used and significant estimates made by management, and evaluating the overall
financial statement presentation. Our audit of internal control over financial reporting included
obtaining an understanding of internal control over financial reporting, assessing the risk that a
material weakness exists, and testing and evaluating the design and operating effectiveness of
internal control based on the assessed risk. Our audits also included performing such other
procedures as we considered necessary in the circumstances. We believe that our audits provide a
reasonable basis for our opinions.
A companys internal control over financial reporting is a process designed to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting principles. A
companys internal control over financial reporting includes those policies and procedures that (1)
pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the
transactions and dispositions of the assets of the company; (2) provide reasonable assurance that
transactions are recorded as necessary to permit preparation of financial statements in accordance
with generally accepted accounting principles, and that receipts and expenditures of the company
are being made only in accordance with authorizations of management and directors of the company;
and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized
acquisition, use, or disposition of the companys assets that could have a material effect on the
financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or
detect misstatements. Also, projections of any evaluation of effectiveness to future periods are
subject to the risk that controls may become inadequate because of changes in conditions, or that
the degree of compliance with the policies or procedures may deteriorate.
Koninklijke Philips Electronics N.V. and subsidiaries acquired VISICU Inc., Philips Healthcare
Informatics Limited (formally known as TOMCAT Ltd.), Shenzhen Goldway Industrial Inc., Dixtal
Biomédica Indústria e Comércio Ltda., Dixtal Tecnologia Indústria e Comércio Ltda., Alpha X-Ray
Technologies, and Melhk Ltd. (together the Acquired Companies) during 2008. Management excluded
from its assessment of the effectiveness of Koninklijke Philips Electronics N.V. and subsidiaries
internal control over financial reporting as of December 31, 2008, the Acquired Companies internal
control over financial reporting of which total assets represented 1.0% of consolidated total
assets and net sales represented less than 0.5% of consolidated net sales included in the
consolidated financial statements of Koninklijke Philips Electronics N.V. and subsidiaries as of
and for the year ended December 31, 2008. Our audit of internal control over financial reporting of
Koninklijke Philips Electronics N.V. and subsidiaries also excluded an evaluation of the internal
control over financial reporting of the Acquired Companies.
In our opinion, the consolidated financial statements referred to above present fairly, in all
material respects, the financial position of Koninklijke Philips Electronics N.V. and subsidiaries
as of December 31, 2008 and 2007, and the results of their operations and their cash flows for each
of the years in the three-year period ended December 31, 2008, in conformity with accounting
principles generally accepted in the United States of America. Also in our opinion, Koninklijke
Philips Electronics N.V. and subsidiaries maintained, in all material respects, effective internal
control over financial reporting as of December 31, 2008, based on criteria established in Internal
Control Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway
Commission.
As discussed in note 20 to the consolidated financial statements, effective December 31, 2006,
Koninklijke Philips Electronics N.V. and subsidiaries adopted the provisions of SFAS No. 158,
Employers Accounting for Defined Benefit Pension and Other Postretirement Plans.
KPMG Accountants N.V.
Amsterdam, February 23, 2009
Philips Annual Report 2008 125
|
|
|
|
|
|
|
124 US GAAP financial statements
|
|
180 Sustainability performance
|
|
192 IFRS financial statements
|
|
244 Company financial statements |
Consolidated statements of income
Consolidated statements of income of the Philips Group for the years ended December 31
in millions of euros unless otherwise stated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
|
|
|
|
Sales |
|
|
26,682 |
|
|
|
26,793 |
|
|
|
26,385 |
|
|
|
|
|
Cost of sales |
|
|
(18,435 |
) |
|
|
(17,570 |
) |
|
|
(17,890 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin |
|
|
8,247 |
|
|
|
9,223 |
|
|
|
8,495 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling expenses |
|
|
(4,655 |
) |
|
|
(4,980 |
) |
|
|
(5,501 |
) |
|
|
|
|
General and administrative expenses |
|
|
(969 |
) |
|
|
(919 |
) |
|
|
(1,016 |
) |
|
|
|
|
Research and development expenses |
|
|
(1,659 |
) |
|
|
(1,629 |
) |
|
|
(1,622 |
) |
|
|
|
|
Impairment of goodwill |
|
|
|
|
|
|
|
|
|
|
(234 |
) |
|
|
|
|
Other business income and expenses |
|
|
234 |
|
|
|
146 |
|
|
|
195 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 4 |
|
|
Income from operations |
|
|
1,198 |
|
|
|
1,841 |
|
|
|
317 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 |
|
|
Financial income and expenses |
|
|
28 |
|
|
|
2,613 |
|
|
|
(225 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before taxes |
|
|
1,226 |
|
|
|
4,454 |
|
|
|
92 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 |
|
|
Income tax expense |
|
|
(166 |
) |
|
|
(619 |
) |
|
|
(286 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) after taxes |
|
|
1,060 |
|
|
|
3,835 |
|
|
|
(194 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7 |
|
|
Results relating to equity-accounted investees |
|
|
(157 |
) |
|
|
763 |
|
|
|
19 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Minority interests |
|
|
(4 |
) |
|
|
(5 |
) |
|
|
(3 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations |
|
|
899 |
|
|
|
4,593 |
|
|
|
(178 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
|
Discontinued operations |
|
|
4,482 |
|
|
|
(433 |
) |
|
|
(8 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8 |
|
|
Net income (loss) |
|
|
5,381 |
|
|
|
4,160 |
|
|
|
(186 |
) |
Prior-period amounts have been revised to reflect immaterial adjustments of intercompany
profit elimination on inventory (see Significant accounting policies, Reclassifications and
revisions). The accompanying notes are an integral part of these consolidated financial
statements.
126 Philips Annual Report 2008
|
|
|
|
|
|
|
250 Reconciliation of non-US GAAP information
|
|
254 Corporate governance
|
|
262 Ten-year overview
|
|
266 Investor information |
Earnings per share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Weighted average number of common shares outstanding (after deduction of treasury stock)
during the year (in thousands) |
|
|
1,174,925 |
|
|
|
1,086,128 |
|
|
|
991,420 |
|
Adjusted weighted average number of shares (after deduction of treasury stock)
during the year (in thousands) |
|
|
1,182,784 |
|
|
|
1,097,435 |
|
|
|
997,720 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per common share in euros |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations |
|
|
0.77 |
|
|
|
4.23 |
|
|
|
(0.18 |
) |
Income (loss) from discontinued operations |
|
|
3.81 |
|
|
|
(0.40 |
) |
|
|
(0.01 |
) |
Net income (loss) |
|
|
4.58 |
|
|
|
3.83 |
|
|
|
(0.19 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per common share in euros |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations |
|
|
0.76 |
|
|
|
4.19 |
|
|
|
(0.18 |
)1) |
Income (loss) from discontinued operations |
|
|
3.79 |
|
|
|
(0.40 |
) |
|
|
(0.01 |
)1) |
Net income (loss) |
|
|
4.55 |
|
|
|
3.79 |
|
|
|
(0.19 |
)1) |
Dividend paid per common share in euros |
|
|
0.44 |
|
|
|
0.60 |
|
|
|
0.70 |
|
|
|
|
1) |
|
In 2008, the incremental shares from assumed conversion are not taken into account as the
effect would be antidilutive. |
Philips Annual Report 2008 127
|
|
|
|
|
|
|
124 US GAAP financial statements
|
|
180 Sustainability performance
|
|
192 IFRS financial statements
|
|
244 Company financial statements |
Consolidated balance sheets
Consolidated balance sheets of the Philips Group as of December 31
in millions of euros unless otherwise stated
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
2008 |
|
|
|
|
|
Current assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
|
|
|
|
|
8,769 |
|
|
|
|
|
|
|
3,620 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9 32 |
|
|
Receivables: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- Accounts receivable net |
|
|
4,209 |
|
|
|
|
|
|
|
3,813 |
|
|
|
|
|
|
|
|
|
- Accounts receivable from related parties |
|
|
26 |
|
|
|
|
|
|
|
24 |
|
|
|
|
|
|
|
|
|
- Other receivables |
|
|
435 |
|
|
|
|
|
|
|
452 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,670 |
|
|
|
|
|
|
|
4,289 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
|
Current assets of discontinued operations |
|
|
|
|
|
|
169 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10 |
|
|
Inventories net |
|
|
|
|
|
|
3,146 |
|
|
|
|
|
|
|
3,371 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11 |
|
|
Other current assets |
|
|
|
|
|
|
1,020 |
|
|
|
|
|
|
|
1,586 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets |
|
|
|
|
|
|
17,774 |
|
|
|
|
|
|
|
12,866 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-current assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7 |
|
|
Investments in equity-accounted investees |
|
|
|
|
|
|
1,886 |
|
|
|
|
|
|
|
284 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12 |
|
|
Other non-current financial assets |
|
|
|
|
|
|
3,183 |
|
|
|
|
|
|
|
1,331 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13 |
|
|
Non-current receivables |
|
|
|
|
|
|
84 |
|
|
|
|
|
|
|
50 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
|
Non-current assets of discontinued operations |
|
|
|
|
|
|
164 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14 |
|
|
Other non-current assets |
|
|
|
|
|
|
3,726 |
|
|
|
|
|
|
|
3,350 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15 26 |
|
|
Property, plant and equipment: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- At cost |
|
|
7,874 |
|
|
|
|
|
|
|
8,043 |
|
|
|
|
|
|
|
|
|
- Less accumulated depreciation |
|
|
(4,694 |
) |
|
|
|
|
|
|
(4,559 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,180 |
|
|
|
|
|
|
|
3,484 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16 |
|
|
Intangible assets excluding goodwill: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- At cost |
|
|
3,244 |
|
|
|
|
|
|
|
5,486 |
|
|
|
|
|
|
|
|
|
- Less accumulated amortization |
|
|
(1,090 |
) |
|
|
|
|
|
|
(1,511 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,154 |
|
|
|
|
|
|
|
3,975 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17 |
|
|
Goodwill |
|
|
|
|
|
|
4,135 |
|
|
|
|
|
|
|
7,701 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total non-current assets |
|
|
|
|
|
|
18,512 |
|
|
|
|
|
|
|
20,175 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
36,286 |
|
|
|
|
|
|
|
33,041 |
|
Prior-period amounts have been revised to reflect immaterial adjustments of
intercompany profit elimination on inventory (see Significant accounting policies,
Reclassifications and revisions). The accompanying notes are an integral
part of these consolidated financial statements.
128 Philips Annual Report 2008
|
|
|
|
|
|
|
250 Reconciliation of
non-US GAAP
information |
|
254 Corporate governance |
|
262 Ten-year overview
|
|
266 Investor information |
Liabilities and stockholders equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
2008 |
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts and notes payable: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32 |
|
- Trade creditors |
|
|
3,083 |
|
|
|
|
|
|
|
2,880 |
|
|
|
|
|
|
|
|
|
- Accounts payable to related parties |
|
|
289 |
|
|
|
|
|
|
|
112 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,372 |
|
|
|
|
|
|
|
2,992 |
|
|
|
|
|
Current liabilities of discontinued operations |
|
|
|
|
|
|
46 |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
Accrued liabilities |
|
|
|
|
|
|
2,984 |
|
|
|
|
|
|
|
3,636 |
|
|
|
18 |
|
Short-term provisions |
|
|
|
|
|
|
377 |
|
|
|
|
|
|
|
1,060 |
|
|
|
27 21 20 19 |
|
Other current liabilities |
|
|
|
|
|
|
509 |
|
|
|
|
|
|
|
523 |
|
|
|
22 |
|
Short-term debt |
|
|
|
|
|
|
2,345 |
|
|
|
|
|
|
|
717 |
|
|
|
24 23 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
|
|
|
|
9,633 |
|
|
|
|
|
|
|
8,928 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-current liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term debt |
|
|
|
|
|
|
1,212 |
|
|
|
|
|
|
|
3,441 |
|
|
|
26 24 |
|
Long-term provisions |
|
|
|
|
|
|
2,712 |
|
|
|
|
|
|
|
2,909 |
|
|
|
27 21 20 19 |
|
Non-current liabilities and minority interests of discontinued operations |
|
|
|
|
|
|
111 |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
Other non-current liabilities |
|
|
|
|
|
|
934 |
|
|
|
|
|
|
|
1,474 |
|
|
|
25 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total non-current liabilities |
|
|
|
|
|
|
4,969 |
|
|
|
|
|
|
|
7,824 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contractual obligations and contingent liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27 26 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Minority interests |
|
|
|
|
|
|
42 |
|
|
|
|
|
|
|
46 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28 |
|
Preference shares, par value EUR 0.20 per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- Authorized: 2,000,000,000 shares (2007: 2,500,000,000 shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- Issued: none |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common shares, par value EUR 0.20 per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- Authorized: 2,000,000,000 shares (2007: 2,500,000,000 shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- Issued and fully paid: 972,411,769 shares (2007: 1,142,826,763 shares) |
|
|
228 |
|
|
|
|
|
|
|
194 |
|
|
|
|
|
|
|
|
|
Capital in excess of par value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retained earnings |
|
|
25,517 |
|
|
|
|
|
|
|
20,577 |
|
|
|
|
|
|
|
|
|
Accumulated other comprehensive income (loss) |
|
|
(1,887 |
) |
|
|
|
|
|
|
(3,240 |
) |
|
|
|
|
|
|
|
|
Treasury shares, at cost 49,429,913 shares (2007: 77,933,509 shares) |
|
|
(2,216 |
) |
|
|
|
|
|
|
(1,288 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21,642 |
|
|
|
|
|
|
|
16,243 |
|
|
|
|
|
|
|
|
|
|
|
|
36,286 |
|
|
|
|
|
|
|
33,041 |
|
|
|
|
|
Philips Annual Report 2008 129
|
|
|
|
|
|
|
124 US GAAP financial statements
|
|
180 Sustainability performance |
|
192 IFRS financial statements
|
|
244 Company financial statements |
Consolidated statements of cash flows
|
|
|
|
|
Consolidated statements of cash flows of the Philips Group for the years ended December 31
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
|
|
|
|
Cash flows from operating activities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
|
5,381 |
|
|
|
4,160 |
|
|
|
(186 |
) |
|
|
|
|
(Income) loss from discontinued operations |
|
|
(4,482 |
) |
|
|
433 |
|
|
|
8 |
|
|
|
|
|
Adjustments to reconcile net income (loss) to net cash provided by operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
810 |
|
|
|
851 |
|
|
|
1,190 |
|
|
|
|
|
Impairment of goodwill, equity-accounted investees and available-for-sale securities |
|
|
8 |
|
|
|
39 |
|
|
|
1,590 |
|
|
|
|
|
Net gain on sale of assets |
|
|
(289 |
) |
|
|
(3,159 |
) |
|
|
(1,369 |
) |
|
|
|
|
Loss (income) from equity-accounted investees |
|
|
228 |
|
|
|
(249 |
) |
|
|
(91 |
) |
|
|
|
|
Dividends received from equity-accounted investees |
|
|
|
|
|
|
48 |
|
|
|
65 |
|
|
|
|
|
Minority interests (net of dividends paid) |
|
|
3 |
|
|
|
5 |
|
|
|
3 |
|
|
|
|
|
(Increase) decrease in receivables and other current assets |
|
|
(1,354 |
) |
|
|
(439 |
) |
|
|
276 |
|
|
|
|
|
Decrease (increase) in inventories |
|
|
5 |
|
|
|
(378 |
) |
|
|
41 |
|
|
|
|
|
(Decrease) increase in accounts payable, accrued and other liabilities |
|
|
(20 |
) |
|
|
186 |
|
|
|
(165 |
) |
|
|
|
|
(Increase) in non-current receivables/other assets |
|
|
(55 |
) |
|
|
(143 |
) |
|
|
(331 |
) |
|
|
|
|
Increase (decrease) in provisions |
|
|
82 |
|
|
|
(68 |
) |
|
|
406 |
|
|
|
|
|
Proceeds from sales of trading securities |
|
|
|
|
|
|
196 |
|
|
|
|
|
|
|
|
|
Other items |
|
|
13 |
|
|
|
37 |
|
|
|
58 |
|
|
|
|
|
Net cash provided by operating activities |
|
|
330 |
|
|
|
1,519 |
|
|
|
1,495 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase of intangible assets |
|
|
(101 |
) |
|
|
(118 |
) |
|
|
(121 |
) |
|
|
|
|
Capital expenditures on property, plant and equipment |
|
|
(694 |
) |
|
|
(661 |
) |
|
|
(771 |
) |
|
|
|
|
Proceeds from disposals of property, plant and equipment |
|
|
107 |
|
|
|
81 |
|
|
|
170 |
|
|
29 |
|
|
Cash from derivatives |
|
|
62 |
|
|
|
385 |
|
|
|
337 |
|
|
|
|
|
Purchase of other non-current financial assets |
|
|
(31 |
) |
|
|
(17 |
) |
|
|
|
|
|
30 |
|
|
Proceeds from other non-current financial assets |
|
|
4 |
|
|
|
4,105 |
|
|
|
2,576 |
|
|
|
|
|
Purchase of businesses, net of cash acquired |
|
|
(2,467 |
) |
|
|
(1,485 |
) |
|
|
(5,316 |
) |
|
|
|
|
Proceeds from sale of interests in businesses |
|
|
318 |
|
|
|
1,640 |
|
|
|
24 |
|
|
|
|
|
Net cash (used for) provided by investing activities |
|
|
(2,802 |
) |
|
|
3,930 |
|
|
|
(3,101 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase (decrease) in short-term debt |
|
|
97 |
|
|
|
(158 |
) |
|
|
18 |
|
|
|
|
|
Principal payments on short-term portion of long-term debt |
|
|
(543 |
) |
|
|
(152 |
) |
|
|
(1,726 |
) |
|
|
|
|
Proceeds from issuance of long-term debt |
|
|
9 |
|
|
|
29 |
|
|
|
2,088 |
|
|
|
|
|
Treasury stock transactions |
|
|
(2,755 |
) |
|
|
(1,448 |
) |
|
|
(3,257 |
) |
|
|
|
|
Dividends paid |
|
|
(523 |
) |
|
|
(639 |
) |
|
|
(698 |
) |
|
|
|
|
Net cash used for financing activities |
|
|
(3,715 |
) |
|
|
(2,368 |
) |
|
|
(3,575 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used for) provided by continuing operations |
|
|
(6,187 |
) |
|
|
3,081 |
|
|
|
(5,181 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from discontinued operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used for) operating activities |
|
|
524 |
|
|
|
(153 |
) |
|
|
(49 |
) |
|
|
|
|
Net cash provided by investing activities |
|
|
6,590 |
|
|
|
38 |
|
|
|
12 |
|
|
|
|
|
Net cash provided by (used for) financing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used for) discontinued operations |
|
|
7,114 |
|
|
|
(115 |
) |
|
|
(37 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used for) continuing and discontinued operations |
|
|
927 |
|
|
|
2,966 |
|
|
|
(5,218 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of changes in exchange rates on cash and cash equivalents |
|
|
(197 |
) |
|
|
(112 |
) |
|
|
(39 |
) |
|
|
|
|
Cash and cash equivalents at the beginning of the year |
|
|
5,293 |
|
|
|
6,023 |
|
|
|
8,877 |
|
|
|
|
|
Cash and cash equivalents at the end of the year |
|
|
6,023 |
|
|
|
8,877 |
|
|
|
3,620 |
|
|
|
|
|
Less cash and cash equivalents at the end of the year discontinued operations |
|
|
137 |
|
|
|
108 |
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at the end of the year continuing operations |
|
|
5,886 |
|
|
|
8,769 |
|
|
|
3,620 |
|
Prior-period amounts have been revised to reflect immaterial adjustments of
intercompany profit elimination on inventory (see Significant accounting
policies, Reclassifications and revisions). The accompanying notes are an
integral part of these consolidated financial statements. For a number of
reasons, principally the effects of translation differences and consolidation
changes, certain items in the statements of cash flows do not correspond to the
differences in the respective balance sheet amounts.
130 Philips Annual Report 2008
|
|
|
|
|
|
|
250 Reconciliation of
non-US GAAP
information |
|
254 Corporate governance |
|
262 Ten-year overview
|
|
266 Investor information |
Supplemental disclosures to the consolidated statements of cash flows
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
|
|
|
|
Net cash paid during the year for |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pensions |
|
|
1,144 |
|
|
|
449 |
|
|
|
379 |
|
|
|
|
|
Interest |
|
|
211 |
|
|
|
49 |
|
|
|
123 |
|
|
|
|
|
Income taxes |
|
|
632 |
|
|
|
493 |
|
|
|
352 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net gain on sale of assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash proceeds from the sale of assets |
|
|
429 |
|
|
|
5,826 |
|
|
|
2,770 |
|
|
|
|
|
Book value of these assets |
|
|
(193 |
) |
|
|
(2,765 |
) |
|
|
(1,508 |
) |
|
|
|
|
Deferred results on sale-and-leaseback transactions |
|
|
27 |
|
|
|
11 |
|
|
|
|
|
|
|
|
|
Non-cash gains |
|
|
26 |
|
|
|
87 |
|
|
|
107 |
|
|
|
|
|
|
|
|
289 |
|
|
|
3,159 |
|
|
|
1,369 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-cash investing and financing information |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets received in lieu of cash from the sale of businesses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31 |
|
- Shares/share options/convertible bonds |
|
|
188 |
|
|
|
|
|
|
|
148 |
|
|
|
|
|
- Receivables/loans |
|
|
6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of convertible personnel debentures |
|
|
26 |
|
|
|
38 |
|
|
|
9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Treasury stock transactions |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares acquired |
|
|
(2,899 |
) |
|
|
(1,609 |
) |
|
|
(3,298 |
) |
|
|
|
|
Exercise of stock options |
|
|
144 |
|
|
|
161 |
|
|
|
41 |
|
|
|
|
|
The accompanying notes are an integral part of these consolidated financial statements. For a
number of reasons, principally the effects of translation differences and consolidation changes,
certain items in the statements of cash flows do not correspond to the differences between the
balance sheet amounts for the respective items.
Philips Annual Report 2008 131
|
|
|
|
|
|
|
124 US GAAP financial statements
|
|
180 Sustainability performance |
|
192 IFRS financial statements
|
|
244 Company financial statements |
|
- Stockholders equity - Sectors and main countries
|
|
|
|
|
Consolidated statements of changes in stockholders equity of the Philips Group
in millions of euros unless otherwise stated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
accumulated other comprehensive income (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
unrealized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
out- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
gain (loss) |
|
|
|
|
|
|
|
|
|
change in |
|
|
|
|
|
|
|
|
|
|
|
|
standing |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
on |
|
additional |
|
|
|
|
|
fair value |
|
|
|
|
|
|
|
|
|
total |
|
|
number of |
|
|
|
|
|
capital in |
|
|
|
|
|
currency |
|
available- |
|
minimum |
|
pensions |
|
of cash |
|
|
|
|
|
treasury |
|
stock- |
|
|
shares in |
|
common |
|
excess of |
|
retained |
|
translation |
|
for-sale |
|
pension |
|
(SFAS |
|
flow |
|
|
|
|
|
shares at |
|
holders |
|
|
thousands |
|
stock |
|
par value |
|
earnings |
|
differences |
|
securities |
|
liability |
|
No. 158) |
|
hedges |
|
total |
|
cost |
|
equity |
Balance as of Dec. 31, 2005 |
|
|
1,201,358 |
|
|
|
263 |
|
|
|
82 |
|
|
|
21,710 |
|
|
|
(1,886 |
) |
|
|
(10 |
) |
|
|
(545 |
) |
|
|
|
|
|
|
(29 |
) |
|
|
(2,470 |
) |
|
|
(2,919 |
) |
|
|
16,666 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revision1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(32 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(32 |
) |
Revised balance as of Dec. 31, 2005 |
|
|
1,201,358 |
|
|
|
263 |
|
|
|
82 |
|
|
|
21,678 |
|
|
|
(1,886 |
) |
|
|
(10 |
) |
|
|
(545 |
) |
|
|
|
|
|
|
(29 |
) |
|
|
(2,470 |
) |
|
|
(2,919 |
) |
|
|
16,634 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,381 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,381 |
|
Net current period change |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(304 |
) |
|
|
4,389 |
|
|
|
298 |
|
|
|
|
|
|
|
72 |
|
|
|
4,455 |
|
|
|
|
|
|
|
4,455 |
|
Income tax on net current
period change |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(72 |
) |
|
|
|
|
|
|
(84 |
) |
|
|
|
|
|
|
(15 |
) |
|
|
(171 |
) |
|
|
|
|
|
|
(171 |
) |
Reclassifications into income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
388 |
|
|
|
(98 |
) |
|
|
|
|
|
|
|
|
|
|
(20 |
) |
|
|
270 |
|
|
|
|
|
|
|
270 |
|
Total comprehensive income net of tax |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,381 |
|
|
|
12 |
|
|
|
4,291 |
|
|
|
214 |
|
|
|
|
|
|
|
37 |
|
|
|
4,554 |
|
|
|
|
|
|
|
9,935 |
|
Adoption of SFAS No. 158 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
331 |
|
|
|
(808 |
) |
|
|
|
|
|
|
(477 |
) |
|
|
|
|
|
|
(477 |
) |
Dividend paid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(523 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(523 |
) |
Cancellation of treasury shares |
|
|
|
|
|
|
(35 |
) |
|
|
|
|
|
|
(4,332 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,367 |
|
|
|
|
|
Purchase of treasury stock |
|
|
(105,949 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,899 |
) |
|
|
(2,899 |
) |
Re-issuance of treasury stock |
|
|
11,484 |
|
|
|
|
|
|
|
(204 |
) |
|
|
(153 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
528 |
|
|
|
171 |
|
Share-based compensation plans |
|
|
|
|
|
|
|
|
|
|
122 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
122 |
|
Balance as of Dec. 31, 2006 |
|
|
1,106,893 |
|
|
|
228 |
|
|
|
|
|
|
|
22,051 |
|
|
|
(1,874 |
) |
|
|
4,281 |
|
|
|
|
|
|
|
(808 |
) |
|
|
8 |
|
|
|
1,607 |
|
|
|
(923 |
) |
|
|
22,963 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,160 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,160 |
|
Net current period change |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(830 |
) |
|
|
(618 |
) |
|
|
|
|
|
|
223 |
|
|
|
19 |
|
|
|
(1,206 |
) |
|
|
|
|
|
|
(1,206 |
) |
Income tax on net current
period change |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(10 |
) |
|
|
|
|
|
|
|
|
|
|
(56 |
) |
|
|
(3 |
) |
|
|
(69 |
) |
|
|
|
|
|
|
(69 |
) |
Reclassifications into income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
341 |
|
|
|
(2,615 |
) |
|
|
|
|
|
|
51 |
|
|
|
4 |
|
|
|
(2,219 |
) |
|
|
|
|
|
|
(2,219 |
) |
Total comprehensive income net of tax |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,160 |
|
|
|
(499 |
) |
|
|
(3,233 |
) |
|
|
|
|
|
|
218 |
|
|
|
20 |
|
|
|
(3,494 |
) |
|
|
|
|
|
|
666 |
|
Dividend paid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(659 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(659 |
) |
Purchase of treasury stock |
|
|
(53,141 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,633 |
) |
|
|
(1,633 |
) |
Re-issuance of treasury stock |
|
|
11,141 |
|
|
|
|
|
|
|
(106 |
) |
|
|
(35 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
340 |
|
|
|
199 |
|
Share-based compensation plans |
|
|
|
|
|
|
|
|
|
|
104 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
104 |
|
Income tax share-based
compensation plans |
|
|
|
|
|
|
|
|
|
|
2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 |
|
Balance as of Dec. 31, 2007 |
|
|
1,064,893 |
|
|
|
228 |
|
|
|
|
|
|
|
25,517 |
|
|
|
(2,373 |
) |
|
|
1,048 |
|
|
|
|
|
|
|
(590 |
) |
|
|
28 |
|
|
|
(1,887 |
) |
|
|
(2,216 |
) |
|
|
21,642 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(186 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(186 |
) |
Net current period change |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
69 |
|
|
|
(493 |
) |
|
|
|
|
|
|
(520 |
) |
|
|
(24 |
) |
|
|
(968 |
) |
|
|
|
|
|
|
(968 |
) |
Income tax on net current
period change |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
184 |
|
|
|
18 |
|
|
|
207 |
|
|
|
|
|
|
|
207 |
|
Reclassifications into income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9 |
|
|
|
(582 |
) |
|
|
|
|
|
|
31 |
|
|
|
(50 |
) |
|
|
(592 |
) |
|
|
|
|
|
|
(592 |
) |
Total comprehensive income net of tax |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(186 |
) |
|
|
83 |
|
|
|
(1,075 |
) |
|
|
|
|
|
|
(305 |
) |
|
|
(56 |
) |
|
|
(1,353 |
) |
|
|
|
|
|
|
(1,539 |
) |
Cancellation of treasury stock |
|
|
|
|
|
|
(34 |
) |
|
|
|
|
|
|
(4,062 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,096 |
|
|
|
|
|
Dividend paid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(720 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(720 |
) |
Purchase of treasury stock |
|
|
(146,453 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3,298 |
) |
|
|
(3,298 |
) |
Re-issuance of treasury stock |
|
|
4,542 |
|
|
|
|
|
|
|
(106 |
) |
|
|
28 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
130 |
|
|
|
52 |
|
Share-based compensation plans |
|
|
|
|
|
|
|
|
|
|
106 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
106 |
|
Balance as of Dec. 31, 2008 |
|
|
922,982 |
|
|
|
194 |
|
|
|
|
|
|
|
20,577 |
|
|
|
(2,290 |
) |
|
|
(27 |
) |
|
|
|
|
|
|
(895 |
) |
|
|
(28 |
) |
|
|
(3,240 |
) |
|
|
(1,288 |
) |
|
|
16,243 |
|
|
|
|
1) |
|
Prior-period amounts have been revised to reflect immaterial adjustments of intercompany profit
elimination on inventory (see Significant accounting policies, Reclassifications and revisions).
The accompanying notes are an integral part of these consolidated financial statements. |
132 Philips Annual Report 2008
|
|
|
|
|
|
|
250 Reconciliation of
non-US GAAP
information |
|
254 Corporate governance |
|
262 Ten-year overview
|
|
266 Investor information |
Information by sector and main country
in millions of euros unless otherwise stated
Sectors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
relating to |
|
cash flow |
|
|
|
|
|
|
research and |
|
|
|
|
|
income from |
|
equity- |
|
before |
|
|
|
|
|
|
development |
|
income from |
|
operations as a |
|
accounted |
|
financing |
|
|
sales |
|
expenses |
|
operations |
|
% of sales |
|
investees |
|
activities |
2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Healthcare |
|
|
7,649 |
|
|
|
(642 |
) |
|
|
638 |
|
|
|
8.3 |
|
|
|
6 |
|
|
|
(2,418 |
) |
Consumer Lifestyle |
|
|
11,145 |
|
|
|
(407 |
) |
|
|
265 |
|
|
|
2.4 |
|
|
|
|
|
|
|
253 |
|
of which Television |
|
|
4,980 |
|
|
|
(51 |
) |
|
|
(413 |
) |
|
|
(8.3 |
) |
|
|
|
|
|
|
(489 |
) |
Lighting |
|
|
7,106 |
|
|
|
(305 |
) |
|
|
165 |
|
|
|
2.3 |
|
|
|
1 |
|
|
|
(1,139 |
) |
Innovation & Emerging Businesses |
|
|
337 |
|
|
|
(268 |
) |
|
|
(226 |
) |
|
|
(67.1 |
) |
|
|
(2 |
) |
|
|
(126 |
) |
Group Management & Services |
|
|
148 |
|
|
|
|
|
|
|
(525 |
) |
|
|
|
|
|
|
14 |
|
|
|
1,824 |
|
|
|
|
26,385 |
|
|
|
(1,622 |
) |
|
|
317 |
|
|
|
1.2 |
|
|
|
19 |
|
|
|
(1,606 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Healthcare |
|
|
6,638 |
|
|
|
(592 |
) |
|
|
713 |
|
|
|
10.7 |
|
|
|
7 |
|
|
|
236 |
|
Consumer Lifestyle |
|
|
13,330 |
|
|
|
(492 |
) |
|
|
832 |
|
|
|
6.2 |
|
|
|
2 |
|
|
|
772 |
|
of which Television |
|
|
6,270 |
|
|
|
(119 |
) |
|
|
(68 |
) |
|
|
(1.1 |
) |
|
|
|
|
|
|
(41 |
) |
Lighting |
|
|
6,093 |
|
|
|
(276 |
) |
|
|
675 |
|
|
|
11.1 |
|
|
|
|
|
|
|
(648 |
) |
Innovation & Emerging Businesses |
|
|
535 |
|
|
|
(269 |
) |
|
|
(82 |
) |
|
|
(15.3 |
) |
|
|
(9 |
) |
|
|
(164 |
) |
Group Management & Services |
|
|
197 |
|
|
|
|
|
|
|
(297 |
) |
|
|
|
|
|
|
763 |
|
|
|
5,253 |
|
|
|
|
26,793 |
|
|
|
(1,629 |
) |
|
|
1,841 |
|
|
|
6.9 |
|
|
|
763 |
|
|
|
5,449 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Healthcare |
|
|
6,562 |
|
|
|
(572 |
) |
|
|
713 |
|
|
|
10.9 |
|
|
|
9 |
|
|
|
(1,003 |
) |
Consumer Lifestyle |
|
|
13,108 |
|
|
|
(553 |
) |
|
|
683 |
|
|
|
5.2 |
|
|
|
3 |
|
|
|
(39 |
) |
of which Television |
|
|
6,559 |
|
|
|
(114 |
) |
|
|
155 |
|
|
|
2.4 |
|
|
|
|
|
|
|
207 |
|
Lighting |
|
|
5,466 |
|
|
|
(269 |
) |
|
|
577 |
|
|
|
10.6 |
|
|
|
(4 |
) |
|
|
451 |
|
Innovation & Emerging Businesses |
|
|
1,379 |
|
|
|
(265 |
) |
|
|
(76 |
) |
|
|
(5.5 |
) |
|
|
(12 |
) |
|
|
(49 |
) |
Group Management & Services |
|
|
167 |
|
|
|
|
|
|
|
(699 |
) |
|
|
|
|
|
|
(153 |
) |
|
|
(1,832 |
) |
|
|
|
26,682 |
|
|
|
(1,659 |
) |
|
|
1,198 |
|
|
|
4.5 |
|
|
|
(157 |
) |
|
|
(2,472 |
) |
As of January 2008, Philips activities are organized on a sector basis, with each operating
sector, Healthcare, Lighting and Consumer Lifestyle being responsible for the management of its
business worldwide. The Healthcare sector brings together the former Medical Systems division and
Home Healthcare Solutions (formerly Consumer Healthcare Solutions) which has been transferred
from Innovation & Emerging Businesses. The former Consumer Electronics and Domestic Appliances
and Personal Care divisions have been integrated in the Consumer Lifestyle sector. As a
consequence of the aforementioned, prior-year financials have been restated. Prior-period Group
and Healthcare financials have been revised to reflect immaterial adjustments of intercompany
profit elimination on inventory (see Significant accounting policies, Reclassifications and
revisions).
The following sectors are included in the table above: Healthcare, Consumer Lifestyle,
Lighting, Innovation & Emerging Businesses (I&EB) and Group Management & Services (GM&S). A
short description of these sectors is as follows:
Healthcare: Consists of the following businesses Imaging Systems, Clinical Care systems, Home
Healthcare Solutions, Healthcare Informatics and Patient Monitoring, and Customer Services.
Consumer Lifestyle: Consists of the following businesses Television, Shaving & Beauty,
Audio & Video Multimedia, Domestic Appliances, Peripherals & Accessories, Health & Wellness,
and Licenses.
Lighting: Consists of the following businesses Lamps, Professional Luminaires, Consumer
Luminaires, Lighting Electronics, Automotive, Special Lighting Applications, and Lumileds.
I&EB: Consists of various activities and businesses which mainly support, but are not
allocated to, a specific sector. This includes Corporate Technologies (such as Research,
Intellectual Property & Standards, Molecular Healthcare, the Healthcare, Lifestyle and
Lighting & Cleantech Incubators as well as Applied Technologies), Corporate Investments, New
Venture Integration, and Design.
GM&S: Consists of the corporate center, as well as the overhead expenses of regional and
country organizations. Also included are the costs of Philips global brand campaign and
pension and other postretirement benefit costs not directly allocated to the other sectors.
Philips Annual Report 2008 133
|
|
|
|
|
|
|
124 US GAAP financial statements
|
|
180 Sustainability performance |
|
192 IFRS financial statements
|
|
244 Company financial statements |
Information by sectors and main countries
|
|
|
|
|
Sectors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
depreciation of |
|
|
|
|
|
|
net operating |
|
total liabilities |
|
long-lived |
|
capital |
|
property, plant |
|
|
total assets |
|
capital |
|
excl. debt |
|
assets |
|
expenditures |
|
and equipment |
2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Healthcare |
|
|
11,325 |
|
|
|
8,830 |
|
|
|
2,427 |
|
|
|
8,141 |
|
|
|
206 |
|
|
|
139 |
|
Consumer Lifestyle |
|
|
3,521 |
|
|
|
728 |
|
|
|
2,791 |
|
|
|
1,113 |
|
|
|
174 |
|
|
|
170 |
|
of which Television |
|
|
1,002 |
|
|
|
(245 |
) |
|
|
1,247 |
|
|
|
51 |
|
|
|
64 |
|
|
|
68 |
|
Lighting |
|
|
7,156 |
|
|
|
5,648 |
|
|
|
1,490 |
|
|
|
5,113 |
|
|
|
303 |
|
|
|
328 |
|
Innovation & Emerging Businesses |
|
|
504 |
|
|
|
153 |
|
|
|
221 |
|
|
|
217 |
|
|
|
6 |
|
|
|
31 |
|
Group Management & Services |
|
|
10,535 |
|
|
|
(492 |
) |
|
|
5,665 |
|
|
|
576 |
|
|
|
82 |
|
|
|
57 |
|
|
|
|
33,041 |
|
|
|
14,867 |
|
|
|
12,594 |
|
|
|
15,160 |
|
|
|
771 |
|
|
|
725 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Healthcare |
|
|
6,779 |
|
|
|
4,802 |
|
|
|
1,909 |
|
|
|
4,025 |
|
|
|
166 |
|
|
|
91 |
|
Consumer Lifestyle |
|
|
4,313 |
|
|
|
890 |
|
|
|
3,423 |
|
|
|
1,292 |
|
|
|
164 |
|
|
|
156 |
|
of which Television |
|
|
1,303 |
|
|
|
(255 |
) |
|
|
1,558 |
|
|
|
68 |
|
|
|
58 |
|
|
|
53 |
|
Lighting |
|
|
5,133 |
|
|
|
3,886 |
|
|
|
1,238 |
|
|
|
3,307 |
|
|
|
249 |
|
|
|
217 |
|
Innovation & Emerging Businesses |
|
|
606 |
|
|
|
246 |
|
|
|
250 |
|
|
|
240 |
|
|
|
52 |
|
|
|
39 |
|
Group Management & Services |
|
|
19,122 |
|
|
|
705 |
|
|
|
4,068 |
|
|
|
605 |
|
|
|
30 |
|
|
|
59 |
|
|
|
|
35,953 |
|
|
|
10,529 |
|
|
|
10,888 |
|
|
|
9,469 |
|
|
|
661 |
|
|
|
562 |
|
Discontinued operations |
|
|
333 |
|
|
|
|
|
|
|
157 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
36,286 |
|
|
|
|
|
|
|
11,045 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Healthcare |
|
|
6,695 |
|
|
|
4,699 |
|
|
|
1,935 |
|
|
|
4,126 |
|
|
|
83 |
|
|
|
77 |
|
Consumer Lifestyle |
|
|
4,284 |
|
|
|
910 |
|
|
|
3,365 |
|
|
|
1,353 |
|
|
|
156 |
|
|
|
140 |
|
of which Television |
|
|
1,306 |
|
|
|
(185 |
) |
|
|
1,491 |
|
|
|
68 |
|
|
|
40 |
|
|
|
43 |
|
Lighting |
|
|
3,719 |
|
|
|
2,527 |
|
|
|
1,185 |
|
|
|
2,244 |
|
|
|
343 |
|
|
|
205 |
|
Innovation & Emerging Businesses |
|
|
786 |
|
|
|
128 |
|
|
|
487 |
|
|
|
251 |
|
|
|
7 |
|
|
|
66 |
|
Group Management & Services |
|
|
22,536 |
|
|
|
209 |
|
|
|
4,438 |
|
|
|
646 |
|
|
|
105 |
|
|
|
66 |
|
|
|
|
38,020 |
|
|
|
8,473 |
|
|
|
11,410 |
|
|
|
8,620 |
|
|
|
694 |
|
|
|
554 |
|
Discontinued operations |
|
|
431 |
|
|
|
|
|
|
|
169 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
38,451 |
|
|
|
|
|
|
|
11,579 |
|
|
|
|
|
|
|
|
|
|
|
|
|
As of January 2008, Philips activities are organized on a sector basis, with each operating
sector, Healthcare, Lighting and Consumer Lifestyle being responsible for the management of its
business worldwide. The Healthcare sector brings together the former Medical Systems division and
Home Healthcare Solutions (formerly Consumer Healthcare Solutions) which has been transferred
from Innovation & Emerging Businesses. The former Consumer Electronics and Domestic Appliances
and Personal Care divisions have been integrated in the Consumer Lifestyle sector. As a
consequence of the aforementioned, prior-year financials have been restated. Prior-period Group
and Healthcare financials have been revised to reflect immaterial adjustments of intercompany
profit elimination on inventory (see Significant accounting policies, Reclassifications and
revisions).
Goodwill assigned to sectors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
carrying value at |
|
|
|
|
|
|
|
|
|
translation differences |
|
carrying value at |
|
|
January 1 |
|
acquisitions |
|
impairment |
|
and other changes |
|
December 31 |
2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Healthcare |
|
|
2,446 |
|
|
|
2,405 |
|
|
|
|
|
|
|
320 |
|
|
|
5,171 |
|
Consumer Lifestyle |
|
|
444 |
|
|
|
5 |
|
|
|
|
|
|
|
(66 |
) |
|
|
383 |
|
Lighting |
|
|
1,244 |
|
|
|
1,036 |
|
|
|
(234 |
) |
|
|
100 |
|
|
|
2,146 |
|
Innovation & Emerging Businesses |
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
Group Management & Services |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,135 |
|
|
|
3,446 |
|
|
|
(234 |
) |
|
|
354 |
|
|
|
7,701 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Healthcare |
|
|
2,605 |
|
|
|
108 |
|
|
|
|
|
|
|
(267 |
) |
|
|
2,446 |
|
Consumer Lifestyle |
|
|
481 |
|
|
|
7 |
|
|
|
|
|
|
|
(44 |
) |
|
|
444 |
|
Lighting |
|
|
636 |
|
|
|
695 |
|
|
|
|
|
|
|
(87 |
) |
|
|
1,244 |
|
Innovation & Emerging Businesses |
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
Group Management & Services |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,723 |
|
|
|
810 |
|
|
|
|
|
|
|
(398 |
) |
|
|
4,135 |
|
134 Philips Annual Report 2008
|
|
|
|
|
|
|
250 Reconciliation of
non-US GAAP
information |
|
254 Corporate governance |
|
262 Ten-year overview
|
|
266 Investor information |
Main countries
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
depreciation of |
|
|
|
|
|
|
|
|
|
|
net operating |
|
long-lived |
|
capital |
|
property, plant |
|
|
sales |
|
total assets |
|
capital |
|
assets |
|
expenditures |
|
and equipment |
2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Netherlands |
|
|
1,012 |
|
|
|
9,564 |
|
|
|
3,699 |
|
|
|
1,271 |
|
|
|
157 |
|
|
|
152 |
|
United States |
|
|
7,027 |
|
|
|
14,310 |
|
|
|
9,293 |
|
|
|
10,905 |
|
|
|
192 |
|
|
|
162 |
|
Germany |
|
|
2,048 |
|
|
|
970 |
|
|
|
(328 |
) |
|
|
282 |
|
|
|
50 |
|
|
|
53 |
|
France |
|
|
1,692 |
|
|
|
531 |
|
|
|
(81 |
) |
|
|
132 |
|
|
|
55 |
|
|
|
30 |
|
United Kingdom |
|
|
1,016 |
|
|
|
731 |
|
|
|
415 |
|
|
|
526 |
|
|
|
13 |
|
|
|
9 |
|
China |
|
|
1,754 |
|
|
|
1,319 |
|
|
|
(178 |
) |
|
|
236 |
|
|
|
60 |
|
|
|
47 |
|
Other countries |
|
|
11,836 |
|
|
|
5,616 |
|
|
|
2,047 |
|
|
|
1,808 |
|
|
|
244 |
|
|
|
272 |
|
|
|
|
26,385 |
|
|
|
33,041 |
|
|
|
14,867 |
|
|
|
15,160 |
|
|
|
771 |
|
|
|
725 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Netherlands |
|
|
1,159 |
|
|
|
14,008 |
|
|
|
1,969 |
|
|
|
1,200 |
|
|
|
163 |
|
|
|
151 |
|
United States |
|
|
6,725 |
|
|
|
8,068 |
|
|
|
6,709 |
|
|
|
5,172 |
|
|
|
118 |
|
|
|
103 |
|
Germany |
|
|
2,014 |
|
|
|
1,364 |
|
|
|
(219 |
) |
|
|
305 |
|
|
|
50 |
|
|
|
46 |
|
France |
|
|
1,784 |
|
|
|
694 |
|
|
|
(131 |
) |
|
|
103 |
|
|
|
23 |
|
|
|
26 |
|
United Kingdom |
|
|
1,250 |
|
|
|
1,037 |
|
|
|
692 |
|
|
|
720 |
|
|
|
13 |
|
|
|
8 |
|
China |
|
|
1,707 |
|
|
|
1,231 |
|
|
|
(516 |
) |
|
|
168 |
|
|
|
36 |
|
|
|
42 |
|
Other countries |
|
|
12,154 |
|
|
|
9,551 |
|
|
|
2,025 |
|
|
|
1,801 |
|
|
|
258 |
|
|
|
186 |
|
|
|
|
26,793 |
|
|
|
35,953 |
|
|
|
10,529 |
|
|
|
9,469 |
|
|
|
661 |
|
|
|
562 |
|
Discontinued operations |
|
|
|
|
|
|
333 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
36,286 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Netherlands |
|
|
1,088 |
|
|
|
10,646 |
|
|
|
3,479 |
|
|
|
1,132 |
|
|
|
242 |
|
|
|
162 |
|
United States |
|
|
7,153 |
|
|
|
7,820 |
|
|
|
4,394 |
|
|
|
5,162 |
|
|
|
211 |
|
|
|
98 |
|
Germany |
|
|
1,985 |
|
|
|
1,170 |
|
|
|
(449 |
) |
|
|
296 |
|
|
|
57 |
|
|
|
51 |
|
France |
|
|
1,626 |
|
|
|
608 |
|
|
|
301 |
|
|
|
107 |
|
|
|
18 |
|
|
|
32 |
|
United Kingdom |
|
|
1,186 |
|
|
|
1,194 |
|
|
|
717 |
|
|
|
792 |
|
|
|
4 |
|
|
|
6 |
|
China |
|
|
1,740 |
|
|
|
1,115 |
|
|
|
(112 |
) |
|
|
176 |
|
|
|
31 |
|
|
|
42 |
|
Other countries |
|
|
11,904 |
|
|
|
15,467 |
|
|
|
143 |
|
|
|
955 |
|
|
|
131 |
|
|
|
163 |
|
|
|
|
26,682 |
|
|
|
38,020 |
|
|
|
8,473 |
|
|
|
8,620 |
|
|
|
694 |
|
|
|
554 |
|
Discontinued operations |
|
|
|
|
|
|
431 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
38,451 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prior-period amounts have been revised to reflect immaterial adjustments of intercompany
profit elimination on inventory (see Significant accounting policies, Reclassifications and
revisions).
Philips Annual Report 2008 135
|
|
|
|
|
|
|
124 US GAAP financial statements
|
|
180 Sustainability performance |
|
192 IFRS financial statements
|
|
244 Company financial statements |
Significant accounting policies
|
|
|
|
|
Significant accounting policies
The consolidated financial statements are prepared in accordance with generally accepted accounting
principles in the United States (US GAAP). Historical cost is used as the measurement basis unless
otherwise indicated.
Consolidation principles
The consolidated financial statements include the accounts of Koninklijke Philips Electronics N.V.
(the Company) and all entities in which a direct or indirect controlling interest exists through
voting rights or qualifying variable interests. All intercompany balances and transactions have
been eliminated in the consolidated financial statements. Net income is reduced by the portion of
the earnings of subsidiaries applicable to minority interests. The minority interests are disclosed
separately in the consolidated statements of income and in the consolidated balance sheets.
Unrealized losses are eliminated in the same way as unrealized gains, but only to the extent that
there is no evidence of impairment.
Foreign currencies
The consolidated financial statements are presented in euros, which is the Companys functional
currency and presentation currency. The financial statements of entities that use a functional
currency other than the euro, are translated into euros. Assets and liabilities are translated
using the exchange rates on the respective balance sheet dates. Items in the income statement and
cash flow statement are translated into euros using the average rates of exchange for the periods
involved. The resulting translation adjustments are recorded as a separate component of other
comprehensive income (loss) within stockholders equity. Cumulative translation adjustments are
recognized as income or expense upon partial or complete disposal or substantially complete
liquidation of a foreign entity.
The functional currency of foreign entities is generally the local currency, unless the primary
economic environment requires the use of another currency. When foreign entities conduct their
business in economies considered to be highly inflationary, they record transactions in the
Companys reporting currency (the euro) instead of their local currency.
Gains and losses arising from the translation or settlement of foreign- currency-denominated
monetary assets and liabilities into the functional currency are recognized in income in the period
in which they arise. However, currency differences on intercompany loans that have the nature of a
permanent investment are accounted for as translation differences as a separate component of other
comprehensive income (loss) within stockholders equity.
Use of estimates
The preparation of financial statements requires management to make estimates and assumptions that
affect amounts reported in the consolidated financial statements in order to conform to generally
accepted accounting principles. These estimates and assumptions affect the reported amounts of
assets and liabilities, the disclosure of contingent liabilities at the date of the consolidated
financial statements, and the reported amounts of revenues and expenses during the reporting
period. We evaluate these estimates and judgments on an ongoing basis and base our estimates on
experience, current and expected future conditions, third-party evaluations and various other
assumptions that we believe are reasonable under the circumstances. The results of these estimates
form the basis for making judgments about the carrying values of assets and liabilities as well as
identifying and assessing the accounting treatment with respect to commitments and contingencies.
Actual results could differ materially from those estimates. Assumptions used are further explained
in the related notes.
Estimates significantly impact goodwill and intangibles acquired, tax on activities disposed,
impairments, financial instruments, liabilities from employee benefit plans, various provisions
including tax and other contingencies such as asbestos product liability. The fair values of
acquired identifiable intangibles are based on an assessment of future cash flows. Impairment
analyses of goodwill and indefinite-lived intangible assets are performed annually and whenever a
triggering event has occurred, in order to determine whether the carrying value exceeds the
recoverable amount. These calculations are based on estimates of future cash flows.
The estimated fair value of financial instruments that are not traded in an active market is
determined using observable inputs such as quoted prices for similar assets and liabilities in
active markets; quoted prices for identical or similar instruments in the markets that are not
active and model-derived valuations whose inputs are observable or whose significant value drivers
are observable. The estimated fair value of financial instruments that do not have observable
inputs or are supported by little or no market activity is determined using valuation techniques.
The Company uses its judgment to select a variety of methods including the discounted cash flow
method and option valuation models and make assumptions that are mainly based on market conditions
existing at each balance sheet date.
Actuarial assumptions are established to anticipate future events and are used in calculating
pension and other postretirement benefit expense and liability. These factors include assumptions
with respect to interest rates, expected investment returns on plan assets, rates of increase in
health care costs, rates of future compensation increases, turnover rates, and life expectancy.
Accounting changes
The Company applies the retrospective method for reporting a change in accounting principle in the
absence of explicit transition requirements for new accounting pronouncements.
Reclassifications and revisions
Certain items previously reported under specific financial statement captions have been
reclassified to conform to the current year presentation.
Prior-period amounts have been revised to adjust for certain intercompany profit eliminations on
inventories in Healthcare related to prior years. These adjustments are not material to the
consolidated financial statements in any of the prior periods. The table below outlines the impact
of these adjustments:
|
|
|
|
|
|
|
|
|
in millions of euros unless otherwise stated |
|
2006 |
|
2007 |
Decrease in income before taxes |
|
|
(3 |
) |
|
|
(11 |
) |
Decrease in income tax expense |
|
|
1 |
|
|
|
3 |
|
Decrease in net income |
|
|
(2 |
) |
|
|
(8 |
) |
Decrease in net income per common share
in euros |
|
|
|
|
|
|
|
|
- basic |
|
|
(0.00 |
) |
|
|
(0.01 |
) |
- diluted |
|
|
(0.00 |
) |
|
|
(0.01 |
) |
The effect on retained earnings as of December 31, 2005 is a decrease of EUR 32 million.
Discontinued operations and non-current assets held for sale
The Company has determined that the level of a reporting unit is the component for which operations
and cash flows can be clearly distinguished from the rest of the Company and qualifies as a
discontinued operation in the event of disposal of the component. A component of Philips qualified
as a reporting unit is usually one level below the Sector level. Any gain or loss from disposal of
a reporting unit, together with the results of these operations until the date of disposal, is
reported separately as discontinued operations. The financial information of a discontinued
reporting unit is excluded from the respective captions in the consolidated financial statements
and related notes and is reported separately.
Cash flow statements
Cash flow statements have been prepared using the indirect method. Cash flows in foreign currencies
have been translated into euros using the average rates of exchange for the periods involved.
Cash flows from derivative instruments that are accounted for as fair value hedges or cash flow
hedges are classified in the same category as the cash flows from the hedged items. Cash flows from
other derivative instruments are classified consistent with the nature of the instrument.
136 Philips Annual Report 2008
|
|
|
|
|
|
|
250 Reconciliation of
non-US GAAP
information |
|
254 Corporate governance |
|
262 Ten-year overview
|
|
266 Investor information |
Segments
Operating segments are components of the Companys business activities about which separate
financial information is available that is evaluated regularly by the chief operating
decision-maker (the Board of Management of the Company). The Board of Management decides how to
allocate resources and assesses performance. Reportable segments comprise: Healthcare, Consumer
Lifestyle, Lighting, and Television. Segment accounting policies are the same as the accounting
policies as described in this note.
Earnings per share
The Company presents basic and diluted earnings per share (EPS) data for its common shares. Basic
EPS is calculated by dividing the profit or loss attributable to common shareholders of the Company
by the weighted average number of common shares outstanding during the period. Diluted EPS is
determined by adjusting the profit or loss attributable to common shareholders and the weighted
average number of common shares outstanding for the effects of all potential dilutive common
shares, which comprise convertible personnel debentures, restricted shares and share options
granted to employees.
Revenue recognition
The Company recognizes revenue when persuasive evidence of an arrangement exists, delivery has
occurred or the service has been provided, the sales price is fixed or determinable, and
collectibility is reasonably assured. For consumer-type products in the segments Lighting and
Consumer Lifestyle, these criteria are generally met at the time the product is shipped and
delivered to the customer and, depending on the delivery conditions, title and risk have passed to
the customer and acceptance of the product, when contractually required, has been obtained, or, in
cases where such acceptance is not contractually required, when management has established that all
aforementioned conditions for revenue recognition have been met and no further post-shipment
obligations exist other than obligations under warranty. Examples of the above-mentioned delivery
conditions are Free on Board point of delivery and Costs, Insurance Paid point of delivery,
where the point of delivery may be the shipping warehouse or any other point of destination as
agreed in the contract with the customer and where title and risk in the goods pass to the
customer.
In accordance with EITF Issue No. 00-21, Revenue Arrangements with Multiple Deliverables,
revenues of transactions that have separately identifiable components are recognized based on their
relative fair values. These transactions mainly occur in the Healthcare Sector and include
arrangements that require subsequent installation and training activities in order to become
operable for the customer. However, since payment for the equipment is typically contingent upon
the completion of the installation process, revenue recognition is deferred until the installation
has been completed and the product is ready to be used by the customer in the way contractually
agreed.
Revenues are recorded net of sales taxes, customer discounts, rebates and similar charges.
For products for which a right of return exists during a defined period, revenue recognition is
determined based on the historical pattern of actual returns, or in cases where such information is
lacking, revenue recognition is postponed until the return period has lapsed. Return policies are
typically based on customary return arrangements in local markets.
For products for which a residual value guarantee has been granted or a buy-back arrangement has
been concluded, revenue recognition takes place in accordance with the requirements for lease
accounting of SFAS No.13, Accounting for Leases.
Shipping and handling costs billed to customers are recognized as revenues. Expenses incurred for
shipping and handling costs of internal movements of goods are recorded as cost of sales. Shipping
and handling costs related to sales to third parties are reported as selling expenses and disclosed
separately. Service revenue related to repair and maintenance activities for sold goods is
recognized ratably over the service period or as services are rendered.
A provision for product warranty is made at the time of revenue recognition and reflects the
estimated costs of replacement and free-of-charge services that will be incurred by the Company
with respect to the sold products. In cases where the warranty period is extended and the customer
has the option to purchase such an extension, which is subsequently billed to the customer, revenue
recognition occurs on a straight-line basis over the contract period.
Royalty income, which is generally earned based upon a percentage of sales or a fixed amount per
product sold, is recognized on an accrual basis. Government grants, other than those relating to
purchases of assets, are recognized as income as qualified expenditures are made.
Benefit accounting
The Company accounts for the cost of pension plans and postretirement benefits other than pensions
in accordance with SFAS No. 87, Employers Accounting for Pensions, and SFAS No. 106,
Postretirement Benefits other than Pensions, respectively.
Most of the Companys defined-benefit pension plans are funded with plan assets that have been
segregated and restricted in a trust or foundation to provide for the pension benefits to which the
Company has committed itself.
The Company also sponsors certain defined-benefit pension plans, which are funded as benefit
payments are made.
The net pension asset or liability recognized in the balance sheet in respect of defined pension
plans is the fair value of plan assets less the present value of the projected defined-benefit
obligation at the balance sheet date. The projected defined-benefit obligation is calculated
annually by qualified actuaries using the projected unit of credit method.
For the Companys major plans, a full discount rate curve of high quality corporate bonds
(Bloomberg AA Composite) is used to determine the defined-benefit obligation whereas for other
plans a single point discount rate is used based on the plans maturity. Plans in countries without
a deep corporate bond market, use a discount rate based on the local sovereign curve and the plans
maturity.
Pension costs in respect of defined-benefit pension plans primarily represent the increase in the
actuarial present value of the obligation for pension benefits based on employee service during the
year and the interest on this obligation in respect of employee service in previous years, net of
the expected return on plan assets.
Actuarial gains and losses arise mainly from changes in actuarial assumptions and differences
between actuarial assumptions and what has actually occurred. They are recognized in the income
statement, over the expected average remaining service periods of the employees, only to the extent
that their net cumulative amount exceeds 10% of the greater of the present value of the obligation
or of the fair value of plan assets at the end of the previous year (the corridor).
Unrecognized gains and losses in the Netherlands, France and Thailand are amortized using the
straight-line method over the expected average remaining service period without applying the
corridor.
The funded status of the Companys defined-benefit pension plans and postretirement benefits other
than pensions is reflected on the balance sheet in accordance with SFAS No. 158, Employers
Accounting for Defined Benefit Pension and Other Postretirement Benefit plans. The funded status
is measured as the difference between plan assets at fair value and the benefit obligation. For a
defined-benefit pension plan, the benefit obligation is the projected benefit obligation; for any
other postretirement benefit plan it is the accumulated postretirement benefit obligation.
Actuarial gains and losses, prior-service costs or credits and the transition obligation remaining
from the initial application of SFAS 106 that are not yet recognized as components of net periodic
benefit cost are recognized, net of tax, as a component of accumulated other comprehensive income.
Amounts recognized in accumulated other comprehensive income are adjusted as they are subsequently
recognized as components of net periodic pension cost.
In certain countries, the Company also provides postretirement benefits other than pensions. The
cost relating to such plans consists primarily of the present value of the benefits attributed on
an equal basis to each year of service, interest cost on the accumulated postretirement benefit
obligation, which is a discounted amount, and amortization of the unrecognized transition
obligation. This transition obligation is being amortized through charges to earnings over a
twenty-year period beginning in 1993 in the USA and in 1995 for all other plans.
Unrecognized prior-service costs related to pension plans and postretirement benefits other than
pensions are being amortized by assigning a proportional amount to the statements of income of a
number of years, reflecting the average remaining service period of the active employees.
Obligations for contributions to defined-contribution and multi-employer pension plans are
recognized as an expense in the statements of income as incurred.
Philips Annual Report 2008 137
|
|
|
|
|
|
|
124 US GAAP financial statements
|
|
180 Sustainability performance |
|
192 IFRS financial statements
|
|
244 Company financial statements |
Significant accounting policies
|
|
|
|
|
Share-based payment
The Company applies SFAS No. 123(R), Share-Based Payment, using the modified prospective method.
Under the provisions of SFAS No. 123(R), the Company recognizes the estimated fair value of equity
instruments granted to employees as compensation expense over the vesting period on a straight-line
basis, taking into account estimated forfeitures.
The fair value of the amount payable to employees in respect of share-based payments which are
settled in cash is recognized as an expense, with a corresponding increase in liabilities, over the
vesting period. The liability is remeasured at each reporting date and at settlement date. Any
changes in fair value of the liability are recognized as compensation expense in the income
statement.
Research and development
Costs of research and development are expensed in the period in which they are incurred.
Advertising
Advertising costs are expensed as incurred.
Leases
Leases in which a significant portion of the risks and rewards of ownership are retained by the
lessor are classified as operating leases. Payments made under operating leases are recognized in
the income statement on a straight-line basis over the term of the lease.
Leases in which the Company has substantially all the risk and rewards of ownership are classified
as finance leases. Finance leases are capitalized at the leases commencement at the lower of the
fair value of the leased property and the present value of the minimum lease payments.
Each lease payment is allocated between the liability and finance charges so as to achieve a
constant rate of interest on the recorded capital lease obligations. The property, plant and
equipment acquired under finance leases is depreciated over the shorter of the useful life of the
assets and the lease term.
Income taxes
Income taxes are accounted for using the asset and liability method. Income tax is recognized in
the income statement except to the extent that it relates to an item recognized directly within
stockholders equity, including other comprehensive income (loss), in which case the related tax
effect is also recognized within stockholders equity. Current-year deferred taxes related to
prior-year equity items which arise from changes in tax rates or tax laws are included in income.
Current tax is the expected tax payable on the taxable income for the year, using tax rates enacted
at the balance sheet date, and any adjustment to tax payable in respect of previous years. Deferred
tax assets and liabilities are recognized for the expected tax consequences of temporary
differences between the tax bases of assets and liabilities and their reported amounts. Measurement
of deferred tax assets and liabilities is based on the enacted tax rates expected to apply to
taxable income in the years in which those temporary differences are expected to be recovered or
settled. Deferred tax assets, including assets arising from loss carry-forwards, are recognized,
net of a valuation allowance, if it is more likely than not that the asset or a portion thereof
will not be realized. Deferred tax assets and liabilities are not discounted.
Deferred tax liabilities for withholding taxes are recognized for subsidiaries in situations where
the income is to be paid out as dividends in the foreseeable future, and for undistributed earnings
of unconsolidated companies to the extent that these withholding taxes are not expected to be
refundable and deductible.
Changes in tax rates are reflected in the period in which such change is enacted.
Uncertain tax positions
Income tax benefit from an uncertain tax position is recognized only if it is more likely than not
that the tax position will be sustained upon examination by the relevant taxing authorities, based
on the technical merits of the position. The income tax benefit recognized in the financial
statements from such position is measured based on the largest benefit that is more than 50% likely
to be realized upon settlement with a taxing authority that has full knowledge of all relevant
information. The liability for unrecognized tax benefits, including related interest and penalties,
is recorded as other non-current liabilities. Interest is presented as part of financial expenses
while penalty is classified as part of current tax expense in the statements of income.
Derivative financial instruments
The Company uses derivative financial instruments principally for the management of its foreign
currency risks and to a more limited extent for interest rate and commodity price risks. All
derivative financial instruments are classified as assets or liabilities and are accounted for at
trade date. The Company measures all derivative financial instruments based on fair values derived
from market prices of the instruments or from option pricing models, as appropriate. Changes in the
fair value of a derivative that is highly effective and that is designated and qualifies as a fair
value hedge, along with the loss or gain on the hedged asset, liability or unrecognized firm
commitment of the hedged item that is attributable to the hedged risk, are recorded in the income
statement. Gains or losses arising from changes in fair value of derivatives are recognized in the
statements of income, except for derivatives that qualify for cash flow or net investment hedge
accounting to the extent that the hedge is effective. The ineffective part is recognized in the
statements of income.
Changes in the fair value of a derivative that is designated and qualifies as a cash flow hedge are
recorded in accumulated other comprehensive income to the extent that the hedge is effective, until
earnings are affected by the variability in cash flows of the designated hedged item.
Changes in the fair value of derivatives that are designated and qualify as foreign currency hedges
are recorded in either earnings or accumulated other comprehensive income, depending on whether the
hedge transaction is a fair value hedge or a cash flow hedge and to the extent that the hedge is
effective.
The Company formally assesses, both at the hedges inception and on an ongoing basis, whether the
derivatives that are used in hedging transactions are highly effective in offsetting changes in
fair values or cash flows of hedged items. When it is established that a derivative is not highly
effective as a hedge or that it has ceased to be a highly effective hedge, the Company discontinues
hedge accounting prospectively. When hedge accounting is discontinued because it has been
established that the derivative no longer qualifies as an effective fair value hedge, the Company
continues to carry the derivative on the balance sheet at its fair value, and no longer adjusts the
hedged asset or liability for changes in fair value. When hedge accounting is discontinued because
it is probable that a forecasted transaction will not occur within a period of two months from the
originally forecasted transaction date, the Company continues to carry the derivative on the
balance sheet at its fair value, and gains and losses that were accumulated in other comprehensive
income are recognized immediately in the income statement. In all other situations in which hedge
accounting is discontinued, the Company continues to carry the derivative at its fair value on the
balance sheet, and recognizes any changes in its fair value in the income statement.
Foreign currency differences arising from the translation of a financial liability designated as a
hedge of a net investment in a foreign operation are recognized directly as a separate component of
equity, to the extent that the hedge is effective. To the extent that the hedge is ineffective,
such differences are recognized in the income statement.
For interest rate swaps designated as a fair value hedge of an interest-bearing asset or liability
that are unwound, the amount of the fair value adjustment to the asset or liability for the risk
being hedged is released to the income statement over the remaining life of the asset or liability
based on the recalculated effective yield.
138 Philips Annual Report 2008
|
|
|
|
|
|
|
250 Reconciliation of
non-US GAAP
information |
|
254 Corporate governance |
|
262 Ten-year overview
|
|
266 Investor information |
Non-derivative financial instruments
Non-derivative financial instruments are recognized initially at cost or fair value. Financial
assets transferred to another party are derecognized to the extent that the Company surrenders
control over those assets in exchange for a consideration other than beneficial exchange for
interest in the transferred assets. Financial liabilities are derecognized if and only if they are
extinguished. Non-derivative financial instruments are accounted for as a sale to the extent that a
consideration other than beneficial interests in the transferred assets is received in exchange.
The Company has surrendered control over transferred assets if and only if: (i) the transferred
assets have been isolated from the Company beyond its reach and its creditor even in bankruptcy or
other receivership, (ii) the transferree has the right to pledge or exchange the assets it
received, and no condition both constrains the transferee from taking advantage of its right to
pledge or exchange and provides more than a trivial benefit to the Company, and (iii) the Company
does not maintain effective control over the transferred assets.
Regular way purchases and sales of financial instruments are accounted for at trade date, i.e., the
date that the Company commits itself to purchase or sell the instrument. Dividend and interest
income are recognized when earned. Gains or losses, if any, are recorded in financial income and
expenses.
Cash and cash equivalents
Cash and cash equivalents include all cash balances and short-term highly liquid investments with
an original maturity of three months or less that are readily convertible into cash. They are
stated at face value, which approximates their fair value.
Receivables
Trade accounts receivable are carried at face value, net of allowances for doubtful accounts. As
soon as trade accounts receivable can no longer be collected in the normal way and are expected to
result in a loss, they are designated as doubtful trade accounts receivable and valued at the
expected collectible amounts. They are written off when they are deemed to be uncollectible due to
bankruptcy or other forms of receivership of the debtors.
The allowance for the risk of non-collection of trade accounts receivable takes into account
credit-risk concentration, collective debt risk based on average historical losses and specific
circumstances such as serious adverse economic conditions in a specific country or region.
In the events of sale of receivables and factoring, the Company derecognizes the receivables and
accounts for them as a sale only to the extent that the Company has surrended control over the
receivables in exchange for a consideration other than beneficial interest in the transferred
receivables.
Long-term receivables are initially recognized at their net present value using an appropriate
interest rate. Any discount is amortized to income over the life of the receivable using the
effective yield.
Debt and other liabilities
Debt and liabilities other than provisions are stated at amortized cost. However, loans that are
hedged under a fair value hedge are remeasured for the changes in the fair value that are
attributable to the risk that is being hedged.
Investments in equity-accounted investees
Investments in companies in which the Company does not have the ability to directly or indirectly
control the financial and operating decisions, but does possess the ability to exercise significant
influence, are accounted for using the equity method. In the absence of demonstrable proof of
significant influence, it is presumed to exist if at least 20% of the voting stock is owned. The
Companys share of the net income of these companies is included in results relating to
equity-accounted investees in the Consolidated statements of income. When the Companys share of
losses exceeds the carrying amount of an investment accounted for by the equity method, the
Companys carrying amount of that investment is reduced to zero and recognition of further losses
is discontinued unless the Company has guaranteed obligations of the investee or is otherwise
committed to provide further financial support to the investee.
Investments in equity-accounted investees include goodwill and loans from the Company to these
investees.
Accounting for capital transactions of a consolidated subsidiary or an equity-accounted investee
The Company recognizes dilution gains or losses arising from the sale or issuance of stock by a
consolidated subsidiary or an equity- accounted investee in the income statement, unless the
Company or the subsidiary either has reacquired or has plans to reacquire such shares. In such
instances, the result of the transaction will be recorded directly in stockholders equity.
The dilution gains or losses are presented on a separate line in the consolidated statement of
income if they relate to consolidated subsidiaries. Dilution gains and losses related to
equity-accounted investees are presented under Results relating to equity-accounted investees in
the consolidated statements of income.
Other non-current financial assets
Other non-current financial assets include available-for-sale securities, held-to-maturity
securities, loans and cost-method investments.
The Company classifies its investments in equity securities that have readily determinable fair
values as either available-for-sale or for trading purposes. Trading securities acquired and held
principally for the purpose of selling them in the short term are presented as Other current
assets. Trading securities are recorded at fair value; changes in the fair value are recognized as
financial income and expense. All securities not included in trading or held-to-maturity are
classified as available-for-sale. Available-for-sale equity securities are recorded at fair value;
changes in the fair value are recognized in other comprehensive income in stockholders equity.
Unrealized holding gains and losses, net of the related tax effect, on available-for-sale
securities are reported as a separate component of other comprehensive income within stockholders
equity until realized. Realized gains and losses from the sale of available-for-sale securities are
determined on a first-in, first-out basis. For available-for-sale securities hedged under a fair
value hedge, the changes in the fair value that are attributable to the risk which is being hedged
are recognized in earnings rather than in other comprehensive income.
Held-to-maturity securities are those debt securities which the Company has the ability and intent
to hold until maturity. Held-to-maturity debt securities are recorded at amortized cost, adjusted
for the accretion of discounts or amortization of premiums using the effective interest method.
Loans receivable are stated at amortized cost, less the related allowance for impaired loans
receivable.
Investments in privately-held companies are carried at cost, or estimated fair value, if an
other-than-temporary decline in value has occurred.
Dividend and interest income are recognized when earned. Gains or losses, if any, are recorded in
financial income and expenses.
Impairments of financial assets
A financial asset is considered to be impaired if objective evidence indicates that one or more
events have had a negative effect on the estimated future cash flows of that asset. The Company
assesses its long-term investments accounted for as available-for-sale on a quarterly basis to
determine whether declines in market value below cost are other-than-temporary, the cost basis for
the individual security is reduced and a loss is realized in the period in which it occurs. When
the decline is determined to be temporary, the unrealized losses are included in other
comprehensive income.
If objective evidence indicates that cost-method investments needs to be tested for impairment,
calculation was based on unobservable inputs which include certain pricing models, discounted cash
flows methodologies and similar techniques that use significant unobservable inputs.
Philips Annual Report 2008 139
|
|
|
|
|
|
|
124 US GAAP financial statements
|
|
180 Sustainability performance |
|
192 IFRS financial statements
|
|
244 Company financial statements |
Significant accounting policies
|
|
|
|
|
Inventories
Inventories are stated at the lower of cost or market, less advance payments on work in progress.
The cost of inventories comprises all costs of purchase, costs of conversion and other costs
incurred in bringing the inventories to their present location and condition. The costs of
conversion of inventories include direct labor and fixed and variable production overheads, taking
into account the stage of completion and the normal capacity of the production facilities. Costs of
idle facility and waste are expensed. The cost of inventories is determined using the first-in,
first-out (FIFO) method. Inventory is reduced for the estimated losses due to obsolescence, which
establishes a new cost basis. This reduction is determined for groups of products based on
purchases in the recent past and/or expected future demand.
Property, plant and equipment
Property, plant and equipment is stated at cost, less accumulated depreciation. Assets manufactured
by the Company include direct manufacturing costs, production overheads and interest charges
incurred during the construction period. Government grants are deducted from the cost of the
related asset. Depreciation is calculated using the straight-line method over the useful life of
the asset. Gains and losses on the sale of property, plant and equipment are included in other
business income. Costs related to repair and maintenance activities are expensed in the period in
which they are incurred unless they lead to an extension of the economic life or capacity of the
asset. Plant and equipment under capital leases and leasehold improvements are amortized using the
straight-line method over the shorter of the lease term or the estimated useful life of the asset.
The Company recognizes the fair value of an asset retirement obligation in the period in which it
is incurred, while an equal amount is capitalized as part of the carrying amount of the long-lived
asset and subsequently depreciated over the useful life of the asset.
Intangible assets
Intangible assets are amortized using the straight-line method over their estimated useful lives.
Remaining useful lives are evaluated every year to determine whether events and circumstances
warrant a revision to the remaining period of amortization. Intangible assets that are expected to
generate cash inflows during a period without a foreseeable limit, are regarded as intangibles with
an indefinite useful life. These assets are not amortized, but tested for impairment annually and
whenever an impairment trigger indicates that the asset may be impaired. In-process research and
development with no alternative use is written off immediately upon acquisition. Patents,
trademarks and other intangibles acquired from third parties are capitalized at cost and amortized
over their remaining useful lives.
Certain costs relating to the development and purchase of software for internal use are capitalized
and subsequently amortized over the estimated useful life of the software.
Eligible costs relating to the production of software intended to be sold, leased or otherwise
marketed are capitalized and subsequently amortized over the estimated useful life of the software.
Impairment or disposal of long-lived assets other than goodwill and indefinite-lived intangibles
The Company accounts for long-lived assets in accordance with the provisions of SFAS No. 144,
Accounting for the Impairment or Disposal of Long-Lived Assets. This Statement requires that
long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate
that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held
and used is measured by a comparison between the carrying amount of an asset and the future
undiscounted net cash flows expected to be generated by the asset. If the carrying amount of an
asset exceeds its estimated future undiscounted net cash flows, an impairment charge is recognized
in the amount by which the carrying amount of the asset exceeds the fair value of the asset. The
Company determines the fair value based on discounted projected cash flows. The review for
impairment is carried out at the level where discrete cash flows occur that are largely independent
of other cash flows. Assets held for sale are reported at the lower of the carrying amount or fair
value, less cost to sell.
Goodwill and indefinite lived intangibles
The Company accounts for goodwill and indefinite lived intangibles in accordance with the
provisions of SFAS No. 141 Business Combinations and SFAS No. 142 Goodwill and Other Intangible
Assets. Accordingly, goodwill and indefinite lived intangibles are not amortized but tested for
impairment annually and whenever impairment indicators require so. An impairment loss is recognized
to the extent that the carrying amount exceeds the assets fair value. This determination is made
at the reporting unit level, which has been determined by the Company to be the level of an entity
that reports discrete financial information to the Board of Management, which is usually one level
below the sector level.
The goodwill impairment test consists of two steps. First, the Company determines the carrying
value of each reporting unit by assigning the assets and liabilities, including the goodwill and
intangible assets, to those reporting units. Furthermore, the Company determines the fair value of
each reporting unit and compares it to the carrying amount of the reporting unit. If the carrying
amount of a reporting unit exceeds the fair value of the reporting unit, the Company performs the
second step of the impairment test. In the second step, the Company compares the implied fair value
of the reporting units goodwill with the carrying amount of the reporting units goodwill. The
implied fair value of goodwill is determined by allocating the fair value of the reporting unit to
all of the assets (recognized and unrecognized) and liabilities of the reporting unit in a manner
similar to a purchase price allocation upon a business combination in accordance with SFAS No. 141.
The residual fair value after this allocation is the implied fair value of the reporting units
goodwill. The Company generally determines the fair value of the reporting units based on
discounted projected cash flows.
Share capital
Incremental costs directly attributable to the issuance of shares are recognized as a deduction
from equity. When share capital recognized as equity is repurchased, the amount of the
consideration paid, including directly attributable costs, is recognized as a deduction from
equity. Repurchased shares are classified as treasury shares and are presented as a deduction from
stockholders equity.
Provisions
The Company recognizes provisions for liabilities and probable losses that have been incurred as of
the balance sheet date and for which the amount is uncertain but can be reasonably estimated.
Provisions of a long-term nature are stated at present value when the amount and timing of related
cash payments are fixed or reliably determinable. Short-term provisions are stated at face value.
The Company applies the provisions of SOP 96-1, Environmental liabilities and SFAS No. 5,
Accounting for Contingencies and accrues for losses associated with environmental obligations
when such losses are probable and can be reasonably estimated. Additionally, in accordance with SOP
96-1, the Company accrues for certain costs such as compensation and benefits for employees
directly involved in the remediation activities. Measurement of liabilities is based on current
legal requirements and existing technology. Liabilities and probable insurance recoveries, if any,
are recorded separately. The carrying amount of liabilities is regularly reviewed and adjusted for
new facts or changes in law or technology.
Restructuring
The provision for restructuring relates to the estimated costs of initiated reorganizations that
have been approved by the Board of Management. When such reorganizations require discontinuance
and/or closure of lines of activities, the anticipated costs of closure or discontinuance are
included in restructuring provisions.
SFAS No. 146, Accounting for Costs Associated with Exit or Disposal Activities requires that a
liability be recognized for those costs only when the liability is incurred, i.e. when it meets the
definition of a liability. SFAS No. 146 also establishes fair value as the objective for initial
measurement of the liability.
Liabilities related to one-time employee termination benefits are recognized ratably over the
future service period if those employees are required to render services to the Company, if that
period exceeds 60 days or a longer legal notification period.
Employee termination benefits covered by a contract or under an ongoing benefit arrangement
continue to be accounted for under SFAS No. 112, Employers Accounting for Postemployment
Benefits and are recognized when it is probable that the employees will be entitled to the
benefits and the amounts can be reasonably estimated.
140 Philips Annual Report 2008
|
|
|
|
|
|
|
250 Reconciliation of
non-US GAAP
information |
|
254 Corporate governance |
|
262 Ten-year overview
|
|
266 Investor information |
Guarantees
The Company complies with FASB Interpretation No. 45, Guarantors Accounting and Disclosure
Requirements for Guarantees, including Indirect Guarantees of Indebtedness of Others. In
accordance with this interpretation, the Company recognizes a liability at the fair value of the
obligation incurred for guarantees within the scope of the recognition criteria of the
Interpretation, including minimum revenue guarantees.
Accounting standards adopted in 2008
FASB issued the following pronouncements which are applicable to the Company in 2008:
SFAS No. 157 Fair Value Measurements
Effective January 1, 2008, the Company adopted SFAS No. 157, Fair Value Measurements, for all
financial instruments and non-financial instruments accounted for at fair value on a recurring
basis. SFAS 157 establishes a single definition of fair value and a framework for measuring fair
value, sets out a fair value hierarchy to be used to classify the source of information used in
fair value measurement and expands disclosures about fair value measurements required under other
accounting pronouncements. It does not change existing guidance as to whether or not an instrument
is carried at fair value.
SFAS 157 established market and observable inputs as the preferred source of values, followed by
assumptions based on hypothetical transaction in the absence of market inputs.
The valuation techniques required by SFAS 157 are based upon observable and unobservable inputs.
Observable inputs reflect market data obtained from independent sources, while unobservable inputs
reflect the Companys market assumptions. These two types of inputs create the following fair value
hierarchy:
|
|
Level 1 Quoted prices in active markets for identical asset or liabilities. |
|
|
|
Level 2 Observable inputs other than quoted prices included in Level 1, such as quoted prices
for similar assets and liabilities in active markets; quoted prices for identical or similar assets
and liabilities in markets that are not active; or other inputs that are observable or can be
corroborated by observable market data. |
|
|
|
Level 3 Unobservable inputs that are supported by little or no market activity and that are
significant to the fair value of the assets or liabilities. This includes certain pricing models,
discounted cash flow methodologies and similar techniques that use significant unobservable inputs. |
In February 2008, the FASB issued FASB Staff Position No. FAS 157-1 (FSP FAS 157-1), which excludes
SFAS No. 13, Accounting for Leases and certain other accounting pronouncements that address fair
value measurements, from the scope of SFAS 157. In February 2008, the FASB issued FASB Staff
Position No. 157-2 (FSP 157-2), which provides a one-year delayed application of SFAS 157 for
non-financial assets and liabilities, except for items that are recognized or disclosed at fair
value in the financial statements on a recurring basis (at least annually). SFAS 157, as amended by
FSP FAS 157-1 and FSP FAS 157-2, is required to be adopted on January 1, 2009.
In October 2008, the FASB issued FASB Staff Position No. FAS 157-3, Determining the Fair Value of
a Financial Asset in a Market That Is Not Active (FSP 157-3), which clarifies the application of
SFAS 157 when the market for a financial asset is inactive. Specifically, FSP 157-3 clarifies how
(1) managements internal assumptions should be considered in measuring fair value when observable
data are not present, (2) observable market information from an inactive market should be taken
into account, and (3) the use of broker quotes or pricing services should be considered in
assessing the relevance of observable and unobservable data to measure fair value. The guidance in
FSP 157-3 became effective immediately and was applied by the Company upon its adoption of SFAS 157
on January 1, 2008.
Standards after 2008
Philips has decided to move to International Financial Reporting Standards as its sole accounting
standard from January 1, 2009 onwards. The use of US GAAP will be discontinued as from the same
date.
Philips Annual Report 2008 141
|
|
|
|
|
|
|
124 US GAAP financial statements
|
|
180 Sustainability performance |
|
192 IFRS financial statements
|
|
244 Company financial statements |
Notes to the US GAAP financial statements
|
|
|
|
|
Notes to the US GAAP consolidated financial statements of the Philips Group
All amounts in millions of euros unless otherwise stated.
1
Discontinued operations
MedQuist
On August 6, 2008, the Company announced that it had completed the sale of its approximately 70%
ownership interest in MedQuist to CBaySystems Holdings (CBAY) for a consideration of USD 287
million. The consideration was composed of a cash payment of USD 98 million, a promissory note of
USD 26 million, a convertible bond of USD 91 million, and a pre-closing cash dividend of USD 72
million. The promissory note is included in Other receivables, the convertible bond in Other
non-current financial assets.
The financial results attributable to the Companys interest in MedQuist have been presented as
discontinued operations. The decision to proceed with the sale, which was made in 2007, resulted in
an impairment of EUR 325 million in 2007. This charge did not affect equity as it related to the
cumulative translation differences of the USD-denominated investment in MedQuist, which accumulated
within equity since the date of acquisition.
The following table summarizes the results of the MedQuist business included in the consolidated
statements of income as discontinued operations for 2006, 2007 and 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
2007 |
|
2008 |
Sales |
|
|
293 |
|
|
|
244 |
|
|
|
128 |
|
Costs and expenses |
|
|
(304 |
) |
|
|
(271 |
) |
|
|
(132 |
) |
Gain on sale of discontinued operations |
|
|
|
|
|
|
|
|
|
|
5 |
|
Impairment charge |
|
|
|
|
|
|
(360 |
)1) |
|
|
|
|
Income (loss) before taxes |
|
|
(11 |
) |
|
|
(387 |
) |
|
|
1 |
|
Income tax |
|
|
29 |
|
|
|
(8 |
) |
|
|
(3 |
) |
Result of equity- accounted investees |
|
|
|
|
|
|
1 |
|
|
|
|
|
Minority interests |
|
|
|
|
|
|
4 |
|
|
|
1 |
|
Results from discontinued operations |
|
|
18 |
|
|
|
(390 |
) |
|
|
(1 |
) |
|
|
|
|
1) |
|
Including EUR 35 million following the 2007 annual impairment test. |
The following table presents the assets and liabilities of the MedQuist business, classified as
discontinued operations, in the consolidated balance sheets as at December 31, 2007.
|
|
|
|
|
|
|
2007 |
Cash and cash equivalents |
|
|
108 |
|
Accounts receivable |
|
|
41 |
|
Equity-accounted investees |
|
|
4 |
|
Property, plant and equipment |
|
|
16 |
|
Intangible assets including goodwill |
|
|
141 |
|
Other assets |
|
|
23 |
|
Assets of discontinued operations |
|
|
333 |
|
Accounts payable |
|
|
9 |
|
Provisions |
|
|
32 |
|
Other liabilities |
|
|
37 |
|
Minority interest |
|
|
79 |
|
Liabilities of discontinued operations |
|
|
157 |
|
Semiconductors
On September 29, 2006, the Company sold a majority stake in its Semiconductors division to a
private equity consortium led by Kohlberg Kravis Robert & Co. (KKR). The transaction consisted of
the sale of the division for a total consideration of EUR 7,913 million and a simultaneous
acquisition of a minority interest in the recapitalized organization NXP Semiconductors at a cost
of EUR 854 million. A gain of EUR 4,283 million was recorded on the sale, net of taxes, and net of
costs directly associated with this transaction of approximately EUR 367 million.
The operations of the Semiconductors division and the aforementioned gain have been presented as
discontinued operations.
The Companys ownership interest in NXP Semiconductors is 19.8%. The Company cannot exert
significant influence over the operating or financial policies of NXP and the investment is
accounted for as a cost-method investment under other non-current financial assets.
Philips and NXP have continuing relationships through shared research and development activities
and through license agreements. Additionally, through the purchase of semiconductor products by the
Consumer Lifestyle sector, Philips and NXP will have a continuing relationship for the foreseeable
future. The Company assessed the expected future transactions and determined that the cash flows
from these transactions are not significant direct cash flows.
The following table summarizes the results of the Semiconductors division included in the
consolidated statements of income as discontinued operations for the period through its divestment
on September 29, 2006. The 2007 results mainly related to the settlement of pensions and income
taxes. The 2008 results mainly related to the settlement of income taxes, largely operational in
nature.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
2007 |
|
2008 |
Sales |
|
|
3,681 |
|
|
|
|
|
|
|
|
|
Costs and expenses |
|
|
(3,319 |
) |
|
|
|
|
|
|
|
|
Gain (loss) on sale of discontinued
operations |
|
|
4,953 |
|
|
|
(69 |
) |
|
|
(3 |
) |
Income (loss) before taxes |
|
|
5,315 |
|
|
|
(69 |
) |
|
|
(3 |
) |
Income taxes |
|
|
(768 |
) |
|
|
26 |
|
|
|
(4 |
) |
Result of equity- accounted investees |
|
|
(63 |
) |
|
|
|
|
|
|
|
|
Minority interests |
|
|
(49 |
) |
|
|
|
|
|
|
|
|
Results from discontinued operations |
|
|
4,435 |
|
|
|
(43 |
) |
|
|
(7 |
) |
The following table shows the components of
the gain from the sale of the Semiconductors
division, net of tax on December 31, 2006:
|
|
|
|
|
|
|
2006 |
Consideration |
|
|
7,913 |
|
Carrying value of net assets disposed |
|
|
(2,593 |
) |
Cost of disposal |
|
|
(367 |
) |
Gain on disposal before taxes |
|
|
4,953 |
|
Income taxes |
|
|
(670 |
) |
Gain on sale |
|
|
4,283 |
|
Philips Mobile Display Systems
On November 10, 2005, Philips and Toppoly Optoelectronics
Corporation of Taiwan announced that they had
signed a binding letter of intent to merge
Philips Mobile Display Systems (MDS) business
with Toppoly. The company was named TPO, and
the transaction was completed in the first half
of 2006.
Philips separately reported the results
of the MDS business as a discontinued
operation.
The following table summarizes the results
of the MDS business included in the
consolidated statements of income as
discontinued operations for 2006, which
mainly relate to translation differences
upon completion of the transaction.
142 Philips Annual Report 2008
|
|
|
|
|
|
|
250 Reconciliation of
non-US GAAP
information |
|
254 Corporate governance |
|
262 Ten-year overview
|
|
266 Investor information |
|
|
|
|
|
|
|
2006 |
Sales |
|
|
194 |
|
Costs and expenses |
|
|
(165 |
) |
Income (loss) before taxes |
|
|
29 |
|
Income taxes |
|
|
|
|
Results from discontinued operations |
|
|
29 |
|
2
Acquisitions and divestments
2008
During 2008, Philips entered into a number
of acquisitions and completed several
divestments. All business combinations
have been accounted for using the purchase
method of accounting.
The major acquisitions in 2008 consisted of
Genlyte Group Inc. (Genlyte), Respironics Inc.
(Respironics) and VISICU Inc. (VISICU). The
remaining acquisitions, both individually and
in the aggregate, were deemed immaterial in
respect of the SFAS No. 141 disclosure
requirements.
Sales and income from operations related to
activities divested in 2008, included in the
Companys consolidated statement of income for
2008, amounted to EUR 176 million and EUR 6
million loss, respectively.
The most significant acquisitions and
divestments are summarized in the next two
tables and described in the section below.
Acquisitions
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
net |
|
|
other |
|
|
|
|
|
|
net cash |
|
|
assets |
|
|
intangible |
|
|
|
|
|
|
outflow |
|
|
acquired1) |
|
|
assets |
|
|
goodwill |
|
Genlyte |
|
|
1,894 |
|
|
|
(2 |
) |
|
|
860 |
|
|
|
1,036 |
|
Respironics |
|
|
3,196 |
|
|
|
(152 |
) |
|
|
1,186 |
|
|
|
2,162 |
|
VISICU |
|
|
198 |
|
|
|
(10 |
) |
|
|
33 |
|
|
|
175 |
|
|
|
|
1) |
|
Excluding cash acquired |
Divestments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
inflow of |
|
|
|
|
|
|
|
|
|
cash and |
|
|
|
|
|
|
|
|
|
other |
|
|
net assets |
|
|
recognized |
|
|
|
assets1) |
|
|
divested |
|
|
gain |
|
Set-Top Boxes and Connectivity
Solutions |
|
|
74 |
2) |
|
|
(11 |
) |
|
|
63 |
|
Philips Speech Recognition
Systems |
|
|
65 |
3) |
|
|
(20 |
) |
|
|
45 |
|
|
|
|
1) |
|
Net of cash divested |
|
2) |
|
Assets received in lieu of cash (see note 31) |
|
3) |
|
Of which EUR 22 million cash |
Genlyte
On January 22, 2008, Philips completed the
purchase of all outstanding shares of Genlyte,
a leading manufacturer of lighting fixtures,
controls and related products for the
commercial, industrial and residential markets.
Through this acquisition Philips established a
solid platform for further growth in the area
of energy-saving and green lighting technology.
The acquisition created a leading position for
Philips in the North American luminaires
market. Philips paid a total net cash
consideration of EUR 1,894 million. This amount
includes the cost of 331,627 shares previously
acquired in August 2007, the pay-off of certain
debt, and the settlement of
outstanding stock options. The net impact of
the Genlyte acquisitions on Philips liquidity
position in 2008, excluding the pay-off of
debt, was EUR 1,805 million. As of the
acquisition date, Genlyte has been consolidated
as part of the Lighting sector.
The following table summarizes the fair
value of Genlyte assets and liabilities:
|
|
|
|
|
|
|
January 22, 2008 |
|
Total purchase price (net of cash) |
|
|
1,894 |
|
|
|
|
|
|
Allocated to: |
|
|
|
|
Property, plant and equipment |
|
|
191 |
|
Working capital |
|
|
155 |
|
Current financial assets |
|
|
3 |
|
Provisions |
|
|
(52 |
) |
Deferred tax liabilities |
|
|
(291 |
) |
Long-term debt |
|
|
(8 |
) |
In-process R&D |
|
|
11 |
|
Other intangible assets |
|
|
849 |
|
Goodwill |
|
|
1,036 |
|
|
|
|
1,894 |
|
The goodwill recognized is related to the
complementary technological expertise and
talent of the Genlyte workforce and the
synergies expected to be achieved from
integrating Genlyte into the Lighting
sector.
The amount of in-process research and
development acquired and written off in 2008
was EUR 11 million. This amount is included
in the consolidated statement of income
under Research and development expenses.
Other intangible assets, excluding
in-process research and development
comprise:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
amortization |
|
|
|
amount |
|
|
period in years |
|
Core technology and designs |
|
|
81 |
|
|
|
1-8 |
|
Group brands |
|
|
142 |
|
|
|
2-14 |
|
Product brands |
|
|
5 |
|
|
|
2-5 |
|
Customer relationships and patents |
|
|
614 |
|
|
|
9-17 |
|
Order backlog |
|
|
6 |
|
|
|
0.25 |
|
Software |
|
|
1 |
|
|
|
3 |
|
|
|
|
849 |
|
|
|
|
|
Genlyte contributed income from operations
of EUR 49 million to the Group for the
period from January 22 to December 31, 2008.
Respironics
On March 10, 2008, Philips acquired 100% of the
shares of Respironics, a leading provider of
innovative solutions for the global sleep and
respiratory markets. Respironics designs,
develops, manufactures and markets medical
devices used primarily for patients suffering
from Obstructive Sleep Apnea (OSA) and
respiratory disorders. The acquisition of
Respironics added new product categories in OSA
and home respiratory care to the existing
Philips business. This acquisition formed a
solid foundation for the Home Healthcare
Solution business of the Company. Philips
acquired Respironics shares at a net cash
consideration of EUR 3,196 million. As of the
acquisition date, Respironics has been
consolidated as part of the Healthcare sector.
Philips Annual Report 2008 143
|
|
|
|
|
|
|
124 US GAAP financial statements
|
|
180 Sustainability performance |
|
192 IFRS financial statements
|
|
244 Company financial statements |
Notes to the US GAAP financial statements
|
|
|
|
|
The following table summarizes the fair value
of Respironics assets and liabilities:
|
|
|
|
|
|
|
March 10, 2008 |
|
Total purchase price (net of cash) |
|
|
3,196 |
|
|
|
|
|
|
Allocated to: |
|
|
|
|
Property, plant and equipment |
|
|
137 |
|
Other non-current financial assets |
|
|
10 |
|
Working capital |
|
|
215 |
|
Deferred tax liabilities |
|
|
(439 |
) |
Provisions |
|
|
(27 |
) |
Long-term debt |
|
|
(48 |
) |
In-process R&D |
|
|
3 |
|
Other intangible assets |
|
|
1,183 |
|
Goodwill |
|
|
2,162 |
|
|
|
|
3,196 |
|
The goodwill recognized is related to the
complementary technical skills and talent of
the Respironics workforce and the synergies
expected to be achieved from integrating
Respironics into the Healthcare sector.
The amount of in-process research and
development acquired and written off in 2008
was EUR 3 million. This amount is included
in the consolidated statement of income
under Research and development expenses.
Other intangible assets, excluding
in-process research and development
comprise:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
amortization |
|
|
|
amount |
|
|
period in years |
|
Core technology |
|
|
355 |
|
|
|
9-13 |
|
Developed non-core technology |
|
|
21 |
|
|
|
4-7 |
|
Trade name |
|
|
72 |
|
|
|
6 |
|
Customer relationships |
|
|
732 |
|
|
|
16-18 |
|
Other |
|
|
3 |
|
|
|
1-3 |
|
|
|
|
1,183 |
|
|
|
|
|
Respironics contributed income from
operations of EUR 6 million to the Group for
the period from March 10 to December 31,
2008.
VISICU
On February 20, 2008, Philips acquired 100% of
the shares of VISICU, a leading IT company
which develops remote patient monitoring
systems. The acquisition of VISICU will
facilitate the creation of products to provide
increased clinical decision support to hospital
staff, while allowing them to monitor a greater
number of critically ill patients. Philips paid
a net cash consideration of EUR 198 million. As
of the acquisition date, VISICU has been
consolidated as part of the Healthcare sector.
The following table summarizes the fair
value of VISICUs assets and liabilities:
|
|
|
|
|
|
|
February 20, 2008 |
|
Total purchase price (net of cash) |
|
|
198 |
|
|
|
|
|
|
Allocated to: |
|
|
|
|
Working capital |
|
|
(4 |
) |
Deferred tax liabilities |
|
|
(4 |
) |
Defered revenue |
|
|
(2 |
) |
In-process R&D |
|
|
4 |
|
Other intangible assets |
|
|
29 |
|
Goodwill |
|
|
175 |
|
|
|
|
198 |
|
The goodwill recognized is related to the
complementary technological skills and talent
of VISICUs workforce and the synergies
expected to be achieved from integrating VISICU
into the Healthcare sector.
The amount of in-process research and
development acquired and written off in 2008
was EUR 4 million. This amount is included
in the consolidated statement of income
under Research and development expenses.
Other intangible assets, excluding
in-process research and development
comprise:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
amortization |
|
|
|
amount |
|
|
period in years |
|
Core technology |
|
|
20 |
|
|
|
7 |
|
Patents and trademarks |
|
|
1 |
|
|
|
6 |
|
Customer relationships |
|
|
5 |
|
|
|
2-15 |
|
Backlog |
|
|
3 |
|
|
|
1-3 |
|
|
|
|
29 |
|
|
|
|
|
VISICU contributed a loss from operations of
EUR 16 million to the Group for the period
from February 20 to December 31, 2008.
Pro forma disclosures on acquisitions
The following table presents the year-to-date
unaudited pro-forma results of Philips,
assuming Genlyte, Respironics and VISICU had
been consolidated as of January 1, 2008:
Unaudited
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
January-December 2008 |
|
|
|
|
|
|
|
|
|
|
|
pro forma |
|
|
|
Philips |
|
|
pro forma |
|
|
Philips |
|
|
|
Group |
|
|
adjustments1) |
|
|
Group |
|
Sales |
|
|
26,385 |
|
|
|
230 |
|
|
|
26,615 |
|
Income (loss) from
operations |
|
|
317 |
|
|
|
(7 |
) |
|
|
310 |
|
Net income (loss) |
|
|
(186 |
) |
|
|
(7 |
) |
|
|
(193 |
) |
Basic earnings per share -
in euros |
|
|
(0.19 |
) |
|
|
|
|
|
|
(0.19 |
) |
|
|
|
1) |
|
Pro forma adjustments include sales, income
from operations and net income from
continuing operations of the acquired
companies from January 1, 2008 to the date of
acquisition. As Philips finances its
acquisitions with own funds, the pro forma
adjustments exclude the cost of external
funding incurred prior to the acquisition.
The pro forma adjustments reflect the impact
of the purchase-price accounting effects from
January 1, 2008 to the date of acquisition
and elimination
of non-recurring integration costs.
Purchase-price accounting effects primarily
relate to the amortization of intangible
assets (EUR 36 million, excluding the
write-off of research and development assets).
The non-recurring integration costs primarily
relate to the accelerated vesting of stock
options (EUR 255 million) |
144 Philips Annual Report 2008
|
|
|
|
|
|
|
250 Reconciliation of
non-US GAAP
information |
|
254 Corporate governance |
|
262 Ten-year overview
|
|
266 Investor information |
The following table presents the
year-to-date unaudited pro-forma results of
Philips, assuming Genlyte, Respironics and
VISICU had been consolidated as of January
1, 2007:
Unaudited
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
January-December 2007 |
|
|
|
|
|
|
|
|
|
|
|
pro forma |
|
|
|
Philips |
|
|
pro forma |
|
|
Philips |
|
|
|
Group |
|
|
adjustments |
1) |
|
Group |
|
Sales |
|
|
26,793 |
|
|
|
2,142 |
|
|
|
28,935 |
|
Income from operations |
|
|
1,841 |
|
|
|
69 |
|
|
|
1,910 |
|
Net income |
|
|
4,160 |
|
|
|
59 |
|
|
|
4,219 |
|
Basic earnings per share -
in euros |
|
|
3.83 |
|
|
|
|
|
|
|
3.88 |
|
|
|
|
1) |
|
Pro forma adjustments include sales, income
from operations and net income from
continuing operations of the acquired
companies for 2007. As Philips finances its
acquisitions with own funds, the pro forma
adjustments exclude the cost of external
funding incurred in 2007. The pro forma
adjustments also reflect the impact of the
purchase-price accounting effects of 2007.
These effects primarily relate to the
amortization of intangible assets (EUR 256
million, excluding the write-off of research
and development assets) and inventory
step-ups (EUR 78 million). |
Set-Top Boxes and Connectivity Solutions
On April 21, 2008, Philips completed the sale
of its Set-Top Boxes (STB) and Connectivity
Solutions (CS) activities to UK-based
technology provider Pace Micro Technology
(Pace). Philips received 64.5 million Pace
shares, representing a 21.6% shareholding,
with a market value of EUR 74 million at that
date. Philips recognized a gain on this
transaction of EUR 63 million which was
recognized in Other business income. Two days
later, Philips reduced its interest to 17%.
The Pace shares are treated as
available-for-sale securities and presented
under Other non-current financial assets. The
shares are subject to a lock-up period which
expires in April 2009.
Philips Speech Recognition Systems
On September 28, 2008, Philips sold its
speech recognition activities to US-based
Nuance Communications for EUR 65 million.
Philips realized a gain of EUR 45 million on
this transaction which was recognized in
Other business income.
2007
During 2007, Philips entered into a number
of acquisitions and completed several
disposals of activities. All business
combinations have been accounted for using
the purchase method of accounting.
Major acquisitions in 2007 relate to the
acquisitions of Partners in Lighting and
Color Kinetics, currently Philips Solid-State
Lighting Solutions. The remaining
acquisitions, both individually and in the
aggregate, were deemed immaterial in respect
of the SFAS No. 141 disclosure requirements.
Sales and income from operations related to
activities divested in 2007, included in the
Companys consolidated statement of income for
2007, amounted to EUR 262 million and a loss
of EUR 39 million, respectively.
The most significant acquisitions and
divestments are summarized in the next two
tables and described in the section below.
Acquisitions
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
net |
|
|
other |
|
|
|
|
|
|
net cash |
|
|
assets |
|
|
intangible |
|
|
|
|
|
|
outflow |
|
|
acquired |
2) |
|
assets |
|
|
goodwill |
|
Partners in Lighting |
|
|
561 |
|
|
|
47 |
|
|
|
217 |
|
|
|
297 |
|
Color Kinetics |
|
|
515 |
|
|
|
(29 |
) |
|
|
187 |
|
|
|
357 |
|
|
|
|
1) |
|
Excluding cash acquired |
Divestments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
cash |
|
|
net assets |
|
|
recognized |
|
|
|
inflow |
1) |
|
divested |
2) |
|
gain (loss) |
|
LG Display |
|
|
1,548 |
|
|
|
1,040 |
|
|
|
508 |
|
|
|
|
1) |
|
Net of cash divested |
|
2) |
|
Includes the release of cumulative translation differences |
Partners in Lighting (PLI)
On February 5, 2007, Philips acquired 100% of
the shares of PLI, a leading European
manufacturer of home luminaires. Philips
acquired PLI from CVC Capital Partners, a
private equity investment company, at a net
cash consideration of EUR 561 million paid
upon completion of the transaction. As of the
date of acquisition, PLI has been consolidated
within the Lighting sector.
The following table summarizes the fair
value of PLIs assets and liabilities:
|
|
|
|
|
|
|
February 5, 2007 |
|
Total purchase price (net of cash) |
|
|
561 |
|
|
|
|
|
|
Allocated to: |
|
|
|
|
Property, plant and equipment |
|
|
97 |
|
Other non-current financial assets |
|
|
1 |
|
Working capital |
|
|
114 |
|
Deferred tax liabilities |
|
|
(67 |
) |
Long-term debt |
|
|
(50 |
) |
Short-term debt |
|
|
(34 |
) |
Provisions |
|
|
(14 |
) |
Intangible assets |
|
|
217 |
|
Goodwill |
|
|
297 |
|
|
|
|
561 |
|
The goodwill recognized is related to the
complementary technical skills and talent of
PLIs workforce and the synergies expected to
be achieved from integrating PLI into the
Lighting sector.
Intangible assets comprise:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
amortization |
|
|
|
amount |
|
|
period in years |
|
Customer relationships |
|
|
156 |
|
|
|
20 |
|
Trademarks and trade names |
|
|
61 |
|
|
|
20 |
|
|
|
|
217 |
|
|
|
|
|
PLI contributed income from operations of
EUR 24 million to the Group for the period
from February 5 to December 31, 2007.
Color Kinetics
On August 24, 2007, Philips completed the
acquisition of 100% of the shares of Color
Kinetics, a leader in designing and marketing
innovative lighting systems based on Light
Emitting Diode (LED) technology for a net
cash consideration of EUR 515 million. As of
the date of acquisition, Color Kinetics has
been consolidated within the Lighting sector.
Philips Annual Report 2008 145
|
|
|
|
|
|
|
124 US GAAP financial statements
|
|
180 Sustainability performance |
|
192 IFRS financial statements
|
|
244 Company financial statements |
Notes to the US GAAP
financial statements
|
|
|
|
|
The following table summarizes the fair
value of Color Kinetics assets and
liabilities:
|
|
|
|
|
|
|
August 24, 2007 |
|
Total purchase price (net of cash) |
|
|
515 |
|
|
|
|
|
|
Allocated to: |
|
|
|
|
Property, plant and equipment |
|
|
7 |
|
Working capital |
|
|
16 |
|
Deferred tax |
|
|
(52 |
) |
Intangible assets |
|
|
186 |
|
In-process R&D |
|
|
1 |
|
Goodwill |
|
|
357 |
|
|
|
|
515 |
|
The goodwill recognized is related mainly to
the complementary technological expertise of
Color Kinetics workforce and the synergies
expected to be achieved from integrating Color
Kinetics into the Lighting sector.
The amount of in-process research and
development acquired and written off in 2007
was EUR 1 million. This amount is included
in the consolidated statement of income
under Research and development expenses.
Other intangible assets, excluding
in-process research and development
comprise:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
amortization |
|
|
|
|
|
|
|
period |
|
|
|
amount |
|
|
in years |
|
Trademarks and trade names |
|
|
1 |
|
|
|
1 |
|
Developed and core technology |
|
|
113 |
|
|
|
10-20 |
|
Customer relationships |
|
|
68 |
|
|
|
7-18 |
|
Other |
|
|
4 |
|
|
|
2-10 |
|
|
|
|
186 |
|
|
|
|
|
Color Kinetics contributed a loss from
operations of EUR 8 million to the Group for
the period from August 24 to December 31,
2007.
Pro forma disclosures on acquisitions
The following table presents the
year-to-date unaudited pro-forma results of
Philips, assuming PLI and Color Kinetics had
been consolidated as of January 1, 2007:
Unaudited
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
January-December 2007 |
|
|
|
|
|
|
|
|
|
|
|
pro forma |
|
|
|
Philips |
|
|
pro forma |
|
|
Philips |
|
|
|
Group |
|
|
adjustments |
1) |
|
Group |
|
Sales |
|
|
26,793 |
|
|
|
75 |
|
|
|
26,868 |
|
Income from operations |
|
|
1,841 |
|
|
|
|
|
|
|
1,841 |
|
Net income |
|
|
4,160 |
|
|
|
(2 |
) |
|
|
4,158 |
|
Basic earnings per share -
in euros |
|
|
3.83 |
|
|
|
|
|
|
|
3.83 |
|
|
|
|
1) |
|
Pro forma adjustments include sales, income
from operations and net income from
continuing operations of the acquired
companies from January 1, 2007 to the date of
acquisition. As Philips finances its
acquisitions with own funds, the pro forma
adjustments exclude the cost of external
funding incurred prior to the acquisition.
The pro forma adjustments reflect the impact
of the purchase-price accounting effects from
January 1, 2007 to the date of acquisition
and elimination of non-recurring integration
costs. Purchase-price accounting effects
primarily relate to the amortization of
intangible assets (EUR 10 million, excluding
the write-off of research and development
assets). |
The following table presents the
year-to-date unaudited pro-forma results of
Philips, assuming PLI and Color Kinetics had
been consolidated as of January 1, 2006:
Unaudited
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
January-December 2006 |
|
|
|
|
|
|
|
|
|
|
|
pro forma |
|
|
|
Philips |
|
|
pro forma |
|
|
Philips |
|
|
|
Group |
|
|
adjustments |
1) |
|
Group |
|
Sales |
|
|
26,682 |
|
|
|
454 |
|
|
|
27,136 |
|
Income from operations |
|
|
1,198 |
|
|
|
14 |
|
|
|
1,212 |
|
Net income |
|
|
5,381 |
|
|
|
26 |
|
|
|
5,407 |
|
Basic earnings per share -
in euros |
|
|
4.58 |
|
|
|
|
|
|
|
4.60 |
|
|
|
|
1) |
|
Pro forma adjustments include sales, income
from operations and net income from
continuing operations of the acquired
companies for 2006. As Philips finances its
acquisitions with own funds, the pro forma
adjustments exclude the cost of external
funding incurred in 2006. The pro forma
adjustments also reflect the impact of the
purchase-price accounting effects of 2006.
These effects primarily relate to the
amortization of intangible assets (EUR 26
million, excluding the write-off of research
and development assets) and inventory
step-ups (EUR 26 million). |
LG Display
On October 10, 2007, Philips sold 46,400,000
shares of common stock in LG Display to
financial institutions in a capital markets
transaction. This transaction represented 13%
of LG Displays issued share capital and
reduced Philips holding to 19.9%. The
transaction resulted in a gain of EUR 508
million, reported under Results relating to
equity-accounted investees.
2006
During 2006, Philips entered into a number of
acquisitions and completed several
divestments. All acquisitions have been
accounted for using the purchase method of
accounting.
Major acquisitions in 2006 relate to the
acquisitions of Lifeline Systems (Lifeline),
Witt Biomedical, Avent and Intermagnetics. The
remaining acquisitions, both individually and
in the aggregate, were deemed immaterial in
respect of the SFAS No. 141 disclosure
requirements.
Sales and income from operations related to
activities divested in 2006, included in the
Companys consolidated statement of income for
2006, amounted to EUR 975 million and a loss of
EUR 54 million, respectively.
The most significant acquisitions and
divestments are summarized in the next two
tables and described in the section below.
Acquisitions
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
net |
|
|
other |
|
|
|
|
|
|
net cash |
|
|
assets |
|
|
intangible |
|
|
|
|
|
|
outflow |
|
|
acquired |
1) |
|
assets |
|
|
goodwill |
|
Lifeline |
|
|
583 |
|
|
|
(77 |
) |
|
|
319 |
|
|
|
341 |
|
Witt Biomedical |
|
|
110 |
|
|
|
(9 |
) |
|
|
29 |
|
|
|
90 |
|
Avent |
|
|
689 |
|
|
|
(47 |
) |
|
|
392 |
|
|
|
344 |
|
Intermagnetics |
|
|
993 |
|
|
|
(53 |
) |
|
|
313 |
|
|
|
733 |
|
|
|
|
1) |
|
Excluding cash acquired |
Divestments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
cash |
|
|
net assets |
|
|
recognized |
|
|
|
inflow |
1) |
|
divested2) |
|
|
gain |
|
CryptoTec |
|
|
30 |
|
|
|
(1 |
) |
|
|
31 |
|
Philips Enabling Technologies (ETG) |
|
|
45 |
|
|
|
42 |
|
|
|
3 |
|
Philips Sound Solutions (PSS) |
|
|
53 |
|
|
|
10 |
|
|
|
43 |
|
FEI Company |
|
|
154 |
|
|
|
78 |
|
|
|
76 |
|
|
|
|
1) |
|
Net of cash divested |
|
2) |
|
Includes the release of cumulative translation differences |
146 Philips Annual Report 2008
|
|
|
|
|
|
|
250 Reconciliation of
non-US GAAP
information |
|
254 Corporate governance |
|
262 Ten-year overview
|
|
266 Investor information |
Lifeline
On March 22, 2006, Philips completed its
acquisition of Lifeline, a provider of
personal emergency response services. Philips
acquired a 100% interest in Lifeline by
paying USD 47.75 per share in cash. Lifeline
has been consolidated within the Healthcare
sector.
The following table summarizes the fair
value of Lifelines assets and
liabilities:
|
|
|
|
|
|
|
March 22, 2006 |
|
Total purchase price (net of cash) |
|
|
583 |
|
Allocated to: |
|
|
|
|
Property, plant and equipment |
|
|
20 |
|
Other non-current financial assets |
|
|
19 |
|
Working capital |
|
|
8 |
|
Deferred tax liabilities |
|
|
(124 |
) |
Intangible assets |
|
|
319 |
|
Goodwill |
|
|
341 |
|
|
|
|
583 |
|
Intangible assets comprise:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
amortization |
|
|
|
|
|
|
|
period in |
|
|
|
amount |
|
|
years |
|
Trademarks and trade names |
|
|
114 |
|
|
indefinite |
Software |
|
|
9 |
|
|
|
3-5 |
|
Customer relationships |
|
|
196 |
|
|
|
5-20 |
|
|
|
|
319 |
|
|
|
|
|
Witt Biomedical
On April 26, 2006, Philips completed its
acquisition of Witt Biomedical, the largest
independent supplier of hemodynamic monitoring
and clinical reporting systems used in
cardiology catheterization laboratories. As of
the date of aquisition, Witt Biomedical has
been consolidated within the Healthcare
sector. Goodwill on this acquisition is
tax-deductible.
The following table summarizes the fair
value of Witt Biomedicals assets and
liabilities:
|
|
|
|
|
|
|
April 26, 2006 |
|
Total purchase price (net of cash) |
|
|
110 |
|
Allocated to: |
|
|
|
|
Property, plant and equipment |
|
|
1 |
|
Working capital |
|
|
10 |
|
Deferred tax |
|
|
4 |
|
Provisions |
|
|
(24 |
) |
Intangible assets |
|
|
25 |
|
In-process R&D |
|
|
4 |
|
Goodwill |
|
|
90 |
|
|
|
|
110 |
|
Intangible assets comprise:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
amortization |
|
|
|
|
|
|
|
period in |
|
|
|
amount |
|
|
years |
|
Backlog |
|
|
7 |
|
|
|
1 |
|
Developed and core technology |
|
|
11 |
|
|
|
4 |
|
Customer relationships and patents |
|
|
6 |
|
|
|
10 |
|
Other |
|
|
1 |
|
|
|
3 |
|
|
|
|
25 |
|
|
|
|
|
Avent
As of August 31, 2006, Philips completed its
acquisition of Avent, a provider of baby and
infant feeding products in the United Kingdom
and the United States. Philips acquired Avent
for EUR 689 million, which was paid in cash
upon completion of the transaction. As of the
date of acquisition Avent has been consolidated
within the Consumer Lifestyle sector.
The following table summarizes the fair
value of Avents assets and liabilities:
|
|
|
|
|
|
|
August 31, 2006 |
|
Total purchase price (net of cash) |
|
|
689 |
|
|
Allocated to: |
|
|
|
|
Property, plant and equipment |
|
|
35 |
|
Working capital |
|
|
40 |
|
Deferred tax liabilities |
|
|
(122 |
) |
Intangible assets |
|
|
392 |
|
Goodwill |
|
|
344 |
|
|
|
|
689 |
|
Intangible assets comprise:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
amortization |
|
|
|
|
|
|
|
period in |
|
|
|
amount |
|
|
years |
|
Trademarks and trade names |
|
|
242 |
|
|
indefinite |
Customer relationships and patents |
|
|
150 |
|
|
|
5-18 |
|
|
|
|
392 |
|
|
|
|
|
Intermagnetics
On November 9, 2006, Philips acquired
Intermagnetics for USD 27.50 per share, which
was paid in cash upon completion. Additionally,
in connection with the closing, Philips
provided a loan to Intermagnetics of
approximately USD 120 million to pay off debt
and certain other obligations, including
amounts related to the acceleration of
stock-based compensation and expenses incurred
as a result of the transaction. Since the date
of acquisition, Intermagnetics has been
consolidated within the Healthcare sector.
Philips Annual Report 2008 147
|
|
|
|
|
|
|
124 US GAAP financial statements
|
|
180 Sustainability performance |
|
192 IFRS financial statements
|
|
244 Company financial statements |
Notes to the US GAAP
financial statements
|
|
|
|
|
The following table summarizes the fair
value of Intermagnetics assets and
liabilities:
|
|
|
|
|
|
|
November 9, 2006 |
|
Total purchase price (net of cash) |
|
|
993 |
|
|
Allocated to: |
|
|
|
|
Property, plant and equipment |
|
|
45 |
|
Working capital |
|
|
66 |
|
Deferred tax liabilities |
|
|
(96 |
) |
Provisions |
|
|
(9 |
) |
Long-term debt |
|
|
(1 |
) |
Short-term debt |
|
|
(58 |
) |
In-process R&D |
|
|
39 |
|
Other intangible assets |
|
|
274 |
|
Goodwill |
|
|
733 |
|
|
|
|
993 |
|
The amount of in-process research and
development acquired and written off was EUR 39
million. This amount is included in the
consolidated statement of income under Research
and development expenses.
Other intangible assets, excluding
in-process research and development
comprise:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
amortization |
|
|
|
|
|
|
|
period in |
|
|
|
amount |
|
|
years |
|
Core and existing technology |
|
|
181 |
|
|
|
6 |
|
Trademarks and trade names |
|
|
8 |
|
|
|
10 |
|
Customer relationships |
|
|
81 |
|
|
|
9 |
|
Miscellaneous |
|
|
4 |
|
|
|
2 |
|
|
|
|
274 |
|
|
|
|
|
Intermagnetics has developed, designed,
manufactured and supplied superconducting
magnet systems and certain other components
used in magnetic resonance imaging systems to
Philips for use in medical systems. This
pre-existing relationship involved EUR 120
million of Intermagnetics revenues in 2006.
Pro forma disclosures on acquisitions
The following table presents the
year-to-date unaudited pro-forma results of
Philips, assuming Lifeline, Witt Biomedical,
Avent and Intermagnetics had been
consolidated as of January 1, 2006:
Unaudited
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
January-December 2006 |
|
|
|
|
|
|
|
|
|
|
|
pro forma |
|
|
|
Philips |
|
|
pro forma |
|
|
Philips |
|
|
|
Group |
|
|
adjustments |
1) |
|
Group |
|
Sales |
|
|
26,682 |
|
|
|
236 |
|
|
|
26,918 |
|
Income from operations |
|
|
1,198 |
|
|
|
(7 |
) |
|
|
1,191 |
|
Net income |
|
|
5,381 |
|
|
|
(2 |
) |
|
|
5,379 |
|
Basic earnings per share -
in euros |
|
|
4.58 |
|
|
|
|
|
|
|
4.58 |
|
|
|
|
1) |
|
Pro forma adjustments include sales, income
from operations and net income from
continuing operations of the acquired
companies from January 1, 2006 to the date of
acquisition. For that purpose, sales related
to the pre-existing relationship between
Philips and Intermagnetics have been excluded.
As Philips finances its acquisitions with own
funds, the pro forma adjustments exclude the
cost of external funding incurred prior to
acquisition. The pro forma adjustments
reflect the impact of the purchase-price
accounting effects from January 1, 2006 to
the date of acquisition. Purchase-price
accounting effects primarily relate to the
amortization of intangible assets (EUR 72
million, excluding the write-off of research
and development assets) and inventory
step-ups (EUR 24 million). |
CryptoTec
On March 31, 2006, Philips transferred its
CryptoTec activities to Irdeto, a provider of
content security, and a subsidiary of
multimedia group Naspers. Irdeto purchased the
CryptoTec net assets for an amount of EUR 30
million. A EUR 31 million gain on this
transaction has been reported under Other
business income.
Philips Enabling Technologies
On November 6, 2006, Philips sold Philips
Enabling Technologies Group (ETG) to VDL for
EUR 45 million. The gain on this transaction
(EUR 3 million) has been reported under Other
business income.
Philips Sound Solutions
On December 31, 2006, Philips transferred its
Philips Sound Solutions (PSS) business to D&M
Holdings for EUR 53 million. A EUR 43 million
gain on the transaction has been reported under
Other business income.
FEI Company
On December 20, 2006, Philips sold its 24.8 %
interest in FEI Company, a NASDAQ-listed
company, in a public offering. The sale
provided Philips with net proceeds of EUR 154
million. A EUR 76 million gain on this
transaction is included in Results relating to
equity-accounted investees.
3
Income from operations
For information related to sales and income
from operations on a geographical and
sector basis, see Information by sector and
main country that begins on page 133 of
this Annual Report.
Sales composition
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Goods |
|
|
24,107 |
|
|
|
24,270 |
|
|
|
23,568 |
|
Services |
|
|
2,073 |
|
|
|
1,973 |
|
|
|
2,325 |
|
Licenses |
|
|
502 |
|
|
|
550 |
|
|
|
492 |
|
|
|
|
26,682 |
|
|
|
26,793 |
|
|
|
26,385 |
|
Salaries and wages
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Salaries and wages |
|
|
4,613 |
|
|
|
4,607 |
|
|
|
5,098 |
|
Pension costs |
|
|
155 |
|
|
|
111 |
|
|
|
106 |
|
Other social security and similar
charges: |
|
|
|
|
|
|
|
|
|
|
|
|
- Required by law |
|
|
635 |
|
|
|
634 |
|
|
|
750 |
|
- Voluntary |
|
|
104 |
|
|
|
101 |
|
|
|
80 |
|
|
|
|
5,507 |
|
|
|
5,453 |
|
|
|
6,034 |
|
Salaries and wages include an amount of EUR 376
million (2007: EUR 35 million, 2006: EUR 78
million) relating to restructuring charges.
See note 20 for further information on pension costs.
Share-based compensation expense amounted to
EUR 78 million (EUR 58 million, net of tax),
EUR 111 million (EUR 84 million, net of tax)
and EUR 107 million (EUR 78 million, net of
tax) in 2008, 2007, and 2006, respectively.
See note 33 for further information on
Share-based compensation.
For the remuneration of the Board of
Management and Supervisory Board, please
refer to note 34.
148 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
non-US GAAP information
|
|
|
254 |
|
|
Corporate governance
|
|
|
262 |
|
|
Ten-year overview
|
|
|
266 |
|
|
Investor information |
Employees
The average number of employees by
category is summarized as follows (in
FTEs):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Production |
|
|
59,955 |
|
|
|
61,447 |
|
|
|
66,675 |
|
Research & development |
|
|
13,227 |
|
|
|
12,804 |
|
|
|
11,926 |
|
Other |
|
|
27,694 |
|
|
|
28,469 |
|
|
|
34,365 |
|
Permanent employees |
|
|
100,876 |
|
|
|
102,720 |
|
|
|
112,966 |
|
Temporary employees |
|
|
16,225 |
|
|
|
16,660 |
|
|
|
13,493 |
|
Continuing operations |
|
|
117,101 |
|
|
|
119,380 |
|
|
|
126,459 |
|
Discontinued operations1) |
|
|
44,040 |
|
|
|
6,276 |
|
|
|
|
|
|
|
|
1) |
|
Average number of discontinued operations
relates to MDS, Semiconductors and MedQuist.
MDS was reported until June 2006,
Semiconductors until September 2006 and
MedQuist until August 2008. |
In many countries, employees render services
under collective labor agreements, of which a
significant portion expires within a year.
Depreciation and amortization
Depreciation of property, plant and
equipment and amortization of intangibles
are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Depreciation of property, plant
and equipment |
|
|
554 |
|
|
|
562 |
|
|
|
725 |
|
Amortization of internal-use software |
|
|
71 |
|
|
|
76 |
|
|
|
85 |
|
Amortization of other intangible assets |
|
|
152 |
|
|
|
200 |
|
|
|
365 |
|
Write-off of in-process R&D |
|
|
33 |
|
|
|
13 |
|
|
|
15 |
|
|
|
|
810 |
|
|
|
851 |
|
|
|
1,190 |
|
Depreciation of property, plant and equipment
includes an additional write-off in connection
with the retirement of property, plant and
equipment amounting to EUR 40 million (2007:
EUR 28 million, 2006: EUR 20 million).
Included in depreciation of property, plant and
equipment is an amount of EUR 56 million (2007:
EUR 22 million, 2006: EUR 17 million) relating
to impairment charges.
Depreciation of property, plant and
equipment and amortization of software are
primarily included in cost of sales.
Rent
Rent expenses amounted to EUR 322 million
(2007: EUR 334 million, 2006: EUR 392
million).
Selling expenses
Advertising and sales promotion costs totaled
EUR 949 million (2007: EUR 994 million, 2006:
EUR 865 million) and are included in selling
expenses. Shipping and handling costs of EUR
595 million are also included (2007: EUR 533
million, 2006: EUR 558 million).
General and administrative expenses
General and administrative expenses include the
costs related to management and staff
departments in the corporate center, sectors
and country/regional organizations, amounting
to EUR 983 million (2007: EUR 885 million,
2006: EUR 882 million). Additionally, the
pension costs and costs of other postretirement
benefit plans relating to employees, not
allocated to current sector activities,
amounted to a net cost of EUR 33 million (2007:
EUR 34 million, 2006: EUR 87 million).
Research and development expenses
Expenditures for research and development
activities amounted to EUR 1,622 million,
representing 6.1% of Group sales (2007: EUR
1,629 million, 6.1% of Group sales 2006: EUR
1,659 million, 6.2% of Group sales).
For information related to research and
development expenses on a sector basis, see
the section Information by sector and main
country that begins on page 133 of this Annual
Report.
Impairment of goodwill
In 2008, a EUR 234 million goodwill
impairment charge was recorded of which EUR
232 million was related to Lumileds (2007:
EUR nil, 2006: EUR nil).
Other business income
Other business income consists of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Results on disposal of businesses |
|
|
103 |
|
|
|
1 |
|
|
|
106 |
|
Results on disposal of fixed assets |
|
|
107 |
|
|
|
92 |
|
|
|
58 |
|
Remaining business income |
|
|
24 |
|
|
|
53 |
|
|
|
31 |
|
|
|
|
234 |
|
|
|
146 |
|
|
|
195 |
|
Results on the disposal of businesses consisted of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Philips Sound Solutions |
|
|
43 |
|
|
|
|
|
|
|
|
|
CryptoTec |
|
|
31 |
|
|
|
|
|
|
|
|
|
Connected Displays (Monitors) |
|
|
23 |
|
|
|
|
|
|
|
|
|
Set-Top Boxes and Connectivity
Solutions |
|
|
|
|
|
|
|
|
|
|
63 |
|
Philips Speech Recognition Systems |
|
|
|
|
|
|
|
|
|
|
45 |
|
Other |
|
|
6 |
|
|
|
1 |
|
|
|
(2 |
) |
|
|
|
103 |
|
|
|
1 |
|
|
|
106 |
|
The results on the sale of businesses in 2008
are mainly related to the sale of the Set-Top
Boxes (STB) and Connectivity Solutions (CS)
activities to Pace Micro Technology which
resulted in a gain of EUR 63 million, and the
sale of Speech Recognition activities to Nuance
Communications which resulted in a gain of 45
million. The result on the disposal of fixed
assets is mainly related to the sale of fixed
assets in Taiwan with a gain of EUR 39 million.
In 2007, the results on the sale of fixed
assets mainly related to the sale of certain
buildings in Austria and the Netherlands as
well as land in the US. Remaining business
income is mainly attributable to certain
settlements and the finalization of several
divestitures.
The result on the disposal of businesses in
2006 is mainly related to the sale of the
CryptoTec activities which resulted in a gain
of EUR 31 million, the sale of Philips Sound
Solutions PSS to D&M Holding at a gain of EUR
43 million and the sale of the monitor business
in Television at a gain of EUR 23 million. The
result on the disposal of fixed assets is
mainly related to the sale of certain real
estate assets in Austria with a gain of EUR 31
million. The remaining business income consists
of the settlement of certain legal claims.
4
Restructuring and impairment
In 2008, a EUR 520 million charge was recorded
as a result of restructuring projects,
including related asset impairments and
inventory write-downs. Inventory write-downs
were recorded in cost of sales and amounted to
EUR 19 million in 2008. In 2006 and 2007 there
were no inventory write-downs as a result of
restructuring projects. The components of
restructuring program charges recognized in
2006, 2007 and 2008 are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Personnel lay-off costs |
|
|
78 |
|
|
|
35 |
|
|
|
376 |
|
Write-down of assets |
|
|
5 |
|
|
|
4 |
|
|
|
116 |
|
Other restructuring costs |
|
|
4 |
|
|
|
3 |
|
|
|
30 |
|
Release of excess provisions |
|
|
(5 |
) |
|
|
(5 |
) |
|
|
(2 |
) |
|
|
|
82 |
|
|
|
37 |
|
|
|
520 |
|
Philips Annual Report 2008 149
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124
|
|
US GAAP financial statements
|
|
|
180 |
|
|
Sustainability performance
|
|
|
192 |
|
|
IFRS financial statements
|
|
|
244 |
|
|
Company financial statements |
|
|
|
Notes to the US GAAP financial statements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The charges are included in the following
line items in the income statement:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Cost of sales |
|
|
63 |
|
|
|
24 |
|
|
|
275 |
|
Selling expenses |
|
|
8 |
|
|
|
4 |
|
|
|
154 |
|
G&A expenses |
|
|
6 |
|
|
|
4 |
|
|
|
51 |
|
R&D expenses |
|
|
5 |
|
|
|
5 |
|
|
|
40 |
|
|
|
|
82 |
|
|
|
37 |
|
|
|
520 |
|
The most significant new projects in 2008
|
|
In Lighting, over 60 restructuring
projects were active during 2008 and a
total charge of EUR 221 million was
recognized. A significant portion of the
charge related to actions taken to address
the ongoing shift from incandescent bulbs
to energy efficient lighting solutions.
Other main projects within the Lighting
sector included the closure of lamp
phosphor production in Maarheeze (the
Netherlands), the consolidation of
production activities from Fairmont to
Salina (USA), the reorganization of the
wire & lean coiling activities in Turnhout
(Belgium) and Maarheeze (the Netherlands),
the reorganization of R&D activities
within traditional lighting, mainly in
Turnhout (Belgium) and Roosendaal (the
Netherlands), and the reorganization and
staff reductions of the headquarters in
Eindhoven (the Netherlands). Other smaller
projects in Lighting, in various
locations, were aimed
at further increasing organizational
effectiveness and reducing the fixed cost base |
|
|
Consumer Lifestyles main projects
primarily relate to the integration of the
former DAP and CE businesses, the exit of
TV in North America, the restructuring and
subsequent sale of the Television factory
in Juarez (Mexico) and the optimization of
the European supply footprint within
almost all businesses |
|
|
Healthcares restructuring projects were
undertaken to reduce operating costs and
simplify the organization. The projects
affected many locations, most notably
sites in Hamburg (Germany), Helsinki
(Finland) and Andover (USA) |
|
|
Within Innovation and Emerging
Businesses, the restructuring of
Assembleon will adapt the company to
ongoing weakness in the semiconductor
market |
|
|
Within Group Management & Services,
most of the costs relate to the move of
the US country organization
headquarters from New York to Andover,
initiated in 2007 |
While all these projects have been
communicated, the completion of many of
these projects will be during 2009 and early
2010, and will affect approximately 7,000
employees.
The movements in the provisions and
liabilities for restructuring costs in 2008
are presented by sector as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dec. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dec. |
|
|
|
31, |
|
|
acqui- |
|
|
addi- |
|
|
|
|
|
|
|
|
|
|
other |
|
|
31, |
|
|
|
2007 |
|
|
sitions |
|
|
tions |
|
|
utilized |
|
|
released |
|
|
changes1) |
|
|
2008 |
|
Healthcare |
|
|
|
|
|
|
|
|
|
|
68 |
|
|
|
(2 |
) |
|
|
|
|
|
|
(2 |
) |
|
|
64 |
|
Consumer
Lifestyle |
|
|
10 |
|
|
|
|
|
|
|
171 |
|
|
|
(48 |
) |
|
|
|
|
|
|
1 |
|
|
|
134 |
|
Lighting |
|
|
14 |
|
|
|
20 |
|
|
|
132 |
|
|
|
(32 |
) |
|
|
(2 |
) |
|
|
1 |
|
|
|
133 |
|
I&EB |
|
|
1 |
|
|
|
|
|
|
|
18 |
|
|
|
(6 |
) |
|
|
|
|
|
|
|
|
|
|
13 |
|
GM&S |
|
|
19 |
|
|
|
|
|
|
|
17 |
|
|
|
(6 |
) |
|
|
|
|
|
|
(1 |
) |
|
|
29 |
|
|
|
|
44 |
|
|
|
20 |
|
|
|
406 |
|
|
|
(94 |
) |
|
|
(2 |
) |
|
|
(1 |
) |
|
|
373 |
|
|
|
|
1) |
|
Other changes primarily relate to translation differences |
The total restructuring program charges in
2008 of EUR 520 million are presented by
sector as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
write- |
|
|
|
|
|
|
|
|
|
|
|
|
personnel |
|
|
down of |
|
|
other |
|
|
|
|
|
|
|
|
|
costs |
|
|
assets |
|
|
costs |
|
|
released |
|
|
total |
|
Healthcare |
|
|
68 |
|
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
69 |
|
Consumer
Lifestyle |
|
|
156 |
|
|
|
24 |
|
|
|
15 |
|
|
|
|
|
|
|
195 |
|
Lighting |
|
|
126 |
|
|
|
91 |
|
|
|
6 |
|
|
|
(2 |
) |
|
|
221 |
|
I&EB |
|
|
17 |
|
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
18 |
|
GM&S |
|
|
9 |
|
|
|
|
|
|
|
8 |
|
|
|
|
|
|
|
17 |
|
|
|
|
376 |
|
|
|
116 |
|
|
|
30 |
|
|
|
(2 |
) |
|
|
520 |
|
The most significant new projects in 2007
|
|
Within Lighting: restructuring of the
Oss plant in the Netherlands, from mass
manufacturing to a competence center, and
the closure of fluorescent lamp-based LCD
backlighting activities. |
|
|
Within Group Management & Services: the
US country organization headquarters were
moved from New York to Andover. |
The movements in the provisions and liabilities
for restructuring costs in 2007 are presented
by sector as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dec. 31, |
|
|
addi- |
|
|
|
|
|
|
|
|
|
|
other |
|
|
Dec. 31, |
|
|
|
2006 |
|
|
tions |
|
|
utilized |
|
|
released |
|
|
changes1) |
|
|
2007 |
|
Healthcare |
|
|
13 |
|
|
|
1 |
|
|
|
(14 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Consumer
Lifestyle |
|
|
18 |
|
|
|
8 |
|
|
|
(15 |
) |
|
|
(1 |
) |
|
|
|
|
|
|
10 |
|
Lighting |
|
|
45 |
|
|
|
24 |
|
|
|
(51 |
) |
|
|
(4 |
) |
|
|
|
|
|
|
14 |
|
I&EB |
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
GM&S |
|
|
16 |
|
|
|
4 |
|
|
|
|
|
|
|
|
|
|
|
(1 |
) |
|
|
19 |
|
|
|
|
92 |
|
|
|
38 |
|
|
|
(80 |
) |
|
|
(5 |
) |
|
|
(1 |
) |
|
|
44 |
|
|
|
|
1) |
|
Other changes primarily relate to translation differences |
The total restructuring program charges in
2007 of EUR 37 million are presented by
sector as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
write- |
|
|
|
|
|
|
|
|
|
|
|
|
personnel |
|
|
down of |
|
|
other |
|
|
|
|
|
|
|
|
|
costs |
|
|
assets |
|
|
costs |
|
|
released |
|
|
total |
|
Healthcare |
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
Consumer
Lifestyle |
|
|
7 |
|
|
|
|
|
|
|
1 |
|
|
|
(1 |
) |
|
|
7 |
|
Lighting |
|
|
22 |
|
|
|
4 |
|
|
|
2 |
|
|
|
(4 |
) |
|
|
24 |
|
I&EB |
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
GM&S |
|
|
4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 |
|
|
|
|
35 |
|
|
|
4 |
|
|
|
3 |
|
|
|
(5 |
) |
|
|
37 |
|
The most significant new projects in 2006
|
|
Within Lighting: the relocation of parts
of the loss-making activities in Weert,
Netherlands, to low-cost areas, the
relocation in Mexico of all Juarez plant
activities to the Monterrey plant and the
relocation of the standard Lead in Wire
business in the Netherlands (Deurne) to
Poland |
|
|
Within Healthcare: the transfer of
the production of SPECT cameras from
Milpitas to Cleveland |
|
|
Within Consumer Lifestyle: the
restructuring of the Klagenfurt site in
Austria, reduction of the fixed cost base
and providing a more diverse and flexible
supply base. |
150 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
non-US GAAP information
|
|
|
254 |
|
|
Corporate governance
|
|
|
262 |
|
|
Ten-year overview
|
|
|
266 |
|
|
Investor information |
The movements in the provisions and liabilities
for restructuring costs in 2006 are presented
by sector as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dec. 31, |
|
|
addi- |
|
|
|
|
|
|
|
|
|
|
other |
|
|
Dec. 31, |
|
|
|
2005 |
|
|
tions |
|
|
utilized |
|
|
released |
|
|
changes1) |
|
|
2006 |
|
Healthcare |
|
|
|
|
|
|
14 |
|
|
|
(1 |
) |
|
|
|
|
|
|
|
|
|
|
13 |
|
Consumer
Lifestyle |
|
|
26 |
|
|
|
25 |
|
|
|
(29 |
) |
|
|
(3 |
) |
|
|
(1 |
) |
|
|
18 |
|
Lighting |
|
|
6 |
|
|
|
43 |
|
|
|
(2 |
) |
|
|
(2 |
) |
|
|
|
|
|
|
45 |
|
I&EB/
GM&S |
|
|
30 |
|
|
|
|
|
|
|
(11 |
) |
|
|
|
|
|
|
(3 |
) |
|
|
16 |
|
|
|
|
62 |
|
|
|
82 |
|
|
|
(43 |
) |
|
|
(5 |
) |
|
|
(4 |
) |
|
|
92 |
|
|
|
|
1) |
|
Other changes primarily relate to translation differences |
The total restructuring program charges in
2006 of EUR 82 million are presented by
sector as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
write- |
|
|
|
|
|
|
|
|
|
|
|
|
personnel |
|
|
down of |
|
|
other |
|
|
|
|
|
|
|
|
|
costs |
|
|
assets |
|
|
costs |
|
|
released |
|
|
total |
|
Healthcare |
|
|
13 |
|
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
14 |
|
Consumer
Lifestyle |
|
|
24 |
|
|
|
|
|
|
|
1 |
|
|
|
(3 |
) |
|
|
22 |
|
Lighting |
|
|
41 |
|
|
|
5 |
|
|
|
2 |
|
|
|
(2 |
) |
|
|
46 |
|
I&EB /
GM&S
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
78 |
|
|
|
5 |
|
|
|
4 |
|
|
|
(5 |
) |
|
|
82 |
|
5
Financial income and expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Interest income |
|
|
150 |
|
|
|
236 |
|
|
|
140 |
|
Interest expense |
|
|
(339 |
) |
|
|
(279 |
) |
|
|
(246 |
) |
Net interest expense |
|
|
(189 |
) |
|
|
(43 |
) |
|
|
(106 |
) |
|
Sale of securities |
|
|
|
|
|
|
2,549 |
|
|
|
1,197 |
|
Impairment of securities |
|
|
(77 |
) |
|
|
(36 |
) |
|
|
(1,296 |
) |
Foreign exchange results |
|
|
2 |
|
|
|
(1 |
) |
|
|
(13 |
) |
|
Other financial income (expense), net |
|
|
292 |
|
|
|
144 |
|
|
|
(7 |
) |
|
|
|
217 |
|
|
|
2,656 |
|
|
|
(119 |
) |
|
|
|
28 |
|
|
|
2,613 |
|
|
|
(225 |
) |
Interest income decreased by EUR 96 million
during 2008, mainly as a result of lower
average cash balances during 2008, compared to
2007. Interest expense decreased by EUR 33
million during 2008, mainly as a result of
lower interest costs on derivatives related to
hedging of Philips foreign currency funding
positions.
In 2008, income from the sale of securities
totaled EUR 1,197 million. This included a EUR
1,082 million gain from the sale of shares in
TSMC, a EUR 83 million gain on the sale of
shares in LG Display, and a EUR 16 million gain
on the sale of shares in D&M. These gains were
offset by impairment charges amounting to EUR
1,296 million. This included EUR 599 million
for NXP, EUR 596 million for LG Display, EUR 71
million for TPO and EUR 30 million for Pace
Micro Technology. Other financial expense
primarily consisted of a EUR 37 million loss
related to the revaluation of the convertible
bond received from TPV Technology, partially
offset by a EUR 23 million dividend from TSMC.
In 2007, income from the sale of securities
totaled EUR 2,549 million. This included a EUR
2,528 million gain from the sale of shares in
TSMC and a EUR 31 million gain on the sale of
shares in Nuance Communications, partially
offset by a EUR 10 million loss on the sale of
shares in JDS Uniphase. Impairment of
securities consisted of a charge of EUR 36
million for JDS Uniphase. Other financial
income included a EUR 12 million gain related
to the revaluation of the convertible bond
received from TPV Technology and a EUR 128
million cash dividend from TSMC.
In 2006, a EUR 77 million impairment of TPO
was recorded. Other financial income totaled
EUR 292 million, which included a cash
dividend of EUR 223 million from TSMC, a gain
of EUR 97 million upon designation of the
TSMC shares received through a stock dividend
as trading securities and a EUR 29 million
gain as a result of increases in the fair
value of the trading securities held in TSMC.
Additionally, it included a partially
offsetting EUR 61 million loss as a result of
the fair value change in the conversion
option embedded in the convertible bond
received from TPV Technology.
Philips Annual Report 2008 151
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124
|
|
US GAAP financial statements
|
|
|
180 |
|
|
Sustainability performance
|
|
|
192 |
|
|
IFRS financial statements
|
|
|
244 |
|
|
Company financial statements |
|
|
|
Notes to the US GAAP financial statements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6
Income taxes
The tax expense on income before tax amounted
to EUR 286 million (2007: EUR 619 million,
2006: EUR 166 million).
The components of income before taxes and
income tax expense are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Netherlands |
|
|
444 |
|
|
|
2,770 |
|
|
|
142 |
|
Foreign |
|
|
782 |
|
|
|
1,684 |
|
|
|
(50 |
) |
Income before taxes |
|
|
1,226 |
|
|
|
4,454 |
|
|
|
92 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Netherlands: |
|
|
|
|
|
|
|
|
|
|
|
|
Current taxes |
|
|
81 |
|
|
|
(41 |
) |
|
|
20 |
|
Deferred taxes |
|
|
(58 |
) |
|
|
(144 |
) |
|
|
(153 |
) |
|
|
|
23 |
|
|
|
(185 |
) |
|
|
(133 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign: |
|
|
|
|
|
|
|
|
|
|
|
|
Current taxes |
|
|
(273 |
) |
|
|
(360 |
) |
|
|
(289 |
) |
Deferred taxes |
|
|
84 |
|
|
|
(74 |
) |
|
|
136 |
|
|
|
|
(189 |
) |
|
|
(434 |
) |
|
|
(153 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax expense |
|
|
(166 |
) |
|
|
(619 |
) |
|
|
(286 |
) |
Philips operations are subject to income
taxes in various foreign jurisdictions. The
statutory income tax rates vary from 10.0% to
40.7%, which causes a difference between the
weighted average statutory income tax rate and
the Netherlands statutory income tax rate of
25.5% (2007: 25.5%; 2006: 29.6%).
A reconciliation of the weighted average
statutory income tax rate to the effective
income tax rate is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
in % |
|
2006 |
|
|
2007 |
|
|
2008 |
|
Weighted average statutory income tax rate |
|
|
30.1 |
|
|
|
26.9 |
|
|
|
(22.3 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Tax rate effect of: |
|
|
|
|
|
|
|
|
|
|
|
|
Changes in the valuation allowance: |
|
|
|
|
|
|
|
|
|
|
|
|
- utilization of previously reserved loss
carryforwards |
|
|
(1.6 |
) |
|
|
(0.2 |
) |
|
|
(22.5 |
) |
- new loss carryforwards not expected
to be realized |
|
|
2.2 |
|
|
|
0.9 |
|
|
|
107.5 |
|
- additions (releases) |
|
|
3.4 |
|
|
|
(3.5 |
) |
|
|
2.3 |
|
Non-tax-deductible impairment charges |
|
|
|
|
|
|
0.2 |
|
|
|
449.6 |
|
Non-taxable income |
|
|
(16.0 |
) |
|
|
(17.3 |
) |
|
|
(428.0 |
) |
Non-tax-deductible expenses |
|
|
8.9 |
|
|
|
1.2 |
|
|
|
142.5 |
|
Withholding and other taxes |
|
|
1.3 |
|
|
|
(0.2 |
) |
|
|
(7.8 |
) |
Tax rate changes |
|
|
(6.5 |
) |
|
|
2.6 |
|
|
|
1.6 |
|
Uncertain tax positions |
|
|
|
|
|
|
1.8 |
|
|
|
57.7 |
|
Tax incentives and other |
|
|
(8.3 |
) |
|
|
1.5 |
|
|
|
30.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effective income tax rate |
|
|
13.5 |
|
|
|
13.9 |
|
|
|
310.8 |
|
The weighted average statutory income tax
rate decreased in 2008 compared to 2007 due
to a significant change in the country mix of
income tax rates, due to losses in countries
with higher income tax rates and profits in
countries with relatively lower income tax
rates, combined with a lower income before
tax.
The effective income tax rate is higher than
the weighted average statutory income tax rate
in 2008, mainly due to new losses carried
forward not expected to be realized, non-tax
deductible impairment charges, and income tax
expenses due to tax provisions for uncertain
tax positions, which were partly offset by
non-taxable gains on the sale of securities
and other non-taxable income.
Deferred tax assets and liabilities
Deferred tax assets and liabilities relate
to the following balance sheet captions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
2008 |
|
|
|
assets |
|
|
liabilities |
|
|
assets |
|
|
liabilities |
|
Intangible assets |
|
|
110 |
|
|
|
(298 |
) |
|
|
174 |
|
|
|
(1,328 |
) |
Property, plant and equipment |
|
|
126 |
|
|
|
(55 |
) |
|
|
62 |
|
|
|
(206 |
) |
Inventories |
|
|
164 |
|
|
|
(32 |
) |
|
|
163 |
|
|
|
(13 |
) |
Prepaid pension costs |
|
|
18 |
|
|
|
(784 |
) |
|
|
58 |
|
|
|
(763 |
) |
Other receivables |
|
|
52 |
|
|
|
(9 |
) |
|
|
50 |
|
|
|
(9 |
) |
Other assets |
|
|
58 |
|
|
|
(34 |
) |
|
|
82 |
|
|
|
(20 |
) |
Provisions: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- pensions |
|
|
444 |
|
|
|
(9 |
) |
|
|
435 |
|
|
|
|
|
- guarantees |
|
|
13 |
|
|
|
|
|
|
|
10 |
|
|
|
|
|
- termination benefits |
|
|
19 |
|
|
|
|
|
|
|
61 |
|
|
|
|
|
- other postretirement benefits |
|
|
147 |
|
|
|
|
|
|
|
129 |
|
|
|
|
|
- other provisions |
|
|
368 |
|
|
|
(277 |
) |
|
|
825 |
|
|
|
(65 |
) |
Other liabilities |
|
|
192 |
|
|
|
(35 |
) |
|
|
235 |
|
|
|
(75 |
) |
Total deferred
tax assets/liabilities |
|
|
1,711 |
|
|
|
(1,533 |
) |
|
|
2,284 |
|
|
|
(2,479 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tax loss carryforwards (including
tax credit carryforwards) |
|
|
1,014 |
|
|
|
|
|
|
|
988 |
|
|
|
|
|
Net deferred tax position |
|
|
1,192 |
|
|
|
|
|
|
|
793 |
|
|
|
|
|
Valuation allowances |
|
|
(494 |
) |
|
|
|
|
|
|
(568 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net deferred tax assets |
|
|
698 |
|
|
|
|
|
|
|
225 |
|
|
|
|
|
Other provisions include provisions for
restructuring and a EUR 251 million deferred
tax asset position of legal claims for
asbestos.
In assessing the realizability of deferred tax
assets, management considers whether it is more
likely than not that some portion or all of the
deferred tax assets will not be realized. The
ultimate realization of deferred tax assets is
dependent upon the generation of future taxable
income during the periods in which those
temporary differences become deductible.
Management considers the scheduled reversal of
deferred tax liabilities, projected future
taxable income and tax planning strategies in
making this assessment. In order to fully
realize the deferred tax assets arising from
net operating losses, the Company will need to
generate future taxable income in the countries
where the net operating losses were incurred.
Based upon the level of historical taxable
income and projections for future taxable
income over the periods in which the deferred
tax assets are deductible, management believes,
as at December 31, 2008, it is more likely than
not that the Company will realize the benefits
of these deductible differences, net of the
existing valuation allowance.
The valuation allowance for deferred tax assets
was EUR 568 million and EUR 494 million as of
December 31, 2008 and 2007, respectively. The
net changes in the total valuation allowance,
due to re-assessment by management, were an
increase of EUR 74 million, a decrease of EUR
227 million and a decrease of EUR 214 million
for the years ended December 31, 2008, 2007 and
2006, respectively.
152 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
non-US GAAP information
|
|
|
254 |
|
|
Corporate governance
|
|
|
262 |
|
|
Ten-year overview
|
|
|
266 |
|
|
Investor information |
At December 31, 2008, operating loss
carryforwards expire as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2014/ |
|
|
|
|
|
|
|
Total |
|
2009 |
|
|
2010 |
|
|
2011 |
|
|
2012 |
|
|
2013 |
|
|
2018 |
|
|
later |
|
|
unlimited |
|
4,198 |
|
|
14 |
|
|
|
16 |
|
|
|
58 |
|
|
|
12 |
|
|
|
8 |
|
|
|
27 |
|
|
|
852 |
|
|
|
3,211 |
|
The Company also has tax credit carryforwards
of EUR 107 million, which are available to
offset future tax, if any, and which expire
as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2014/ |
|
|
|
|
|
|
|
Total |
|
2009 |
|
|
2010 |
|
|
2011 |
|
|
2012 |
|
|
2013 |
|
|
2018 |
|
|
later |
|
|
unlimited |
|
107 |
|
|
2 |
|
|
|
2 |
|
|
|
5 |
|
|
|
7 |
|
|
|
3 |
|
|
|
12 |
|
|
|
49 |
|
|
|
27 |
|
Classification of the deferred tax assets and liabilities is as follows:
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Deferred tax assets under other current assets |
|
|
399 |
|
|
|
837 |
|
Deferred tax assets under other non-current assets |
|
|
971 |
|
|
|
553 |
|
Deferred tax liabilities under provisions |
|
|
(672 |
) |
|
|
(1,165 |
) |
|
|
|
698 |
|
|
|
225 |
|
Classification of the income tax payable and receivable is as follows:
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Income tax receivable under current receivables |
|
|
52 |
|
|
|
133 |
|
Income tax receivable under non-current
receivables |
|
|
14 |
|
|
|
1 |
|
Income tax payable under accrued liabilities |
|
|
(154 |
) |
|
|
(132 |
) |
Income tax payable under other non-current
liabilities |
|
|
(1 |
) |
|
|
(1 |
) |
Uncertain tax positions
The Company adopted the provisions of FASB
Interpretation No. 48, Accounting for
Uncertainty in Income Taxes, on January 1,
2007. A reconciliation of the beginning and
ending amount of unrecognized tax benefits is
as follows:
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Balance as of January 1: |
|
|
719 |
|
|
|
627 |
|
Additions based on tax positions related to the
current year |
|
|
116 |
|
|
|
67 |
|
Acquisitions |
|
|
|
|
|
|
24 |
|
Additions for tax positions of prior years |
|
|
23 |
|
|
|
15 |
|
Reductions for tax positions of prior years for: |
|
|
|
|
|
|
|
|
- change in judgment |
|
|
(28 |
) |
|
|
(4 |
) |
- settlement during the period |
|
|
(159 |
) |
|
|
(28 |
) |
- lapses of applicable statute of limitation |
|
|
(1 |
) |
|
|
(3 |
) |
- currency differences |
|
|
(43 |
) |
|
|
12 |
|
- provisional payment |
|
|
|
|
|
|
(151 |
) |
Balance as of December 31: |
|
|
627 |
|
|
|
559 |
|
The amount presented as provisional payment
represents a reduction of the balance of
unrecognized tax benefits due to a provisional
tax payment, subject to the resolution of a
disputed matter.
The estimated timing of cash payments
associated with unrecognized tax positions
amounting to EUR 559 million (2007: EUR 627
million) cannot be reliably estimated.
The total amount of unrecognized tax benefits
that, if recognized, would affect the
effective tax rate is EUR 509 million (2007:
EUR 577 million).
Unrecognized tax benefits including
interest and penalties are accounted for
as follows:
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Netted against deferred tax assets |
|
|
143 |
|
|
|
155 |
|
Netted against income tax receivable |
|
|
100 |
|
|
|
|
|
Non-current portion of other liabilities |
|
|
429 |
|
|
|
452 |
|
Estimated interest and penalties relating to
unrecognized tax benefits are classified as a
component of finance charges and income tax
expense, respectively. During the years ended
December 31, 2008, 2007, and 2006, the Company
recognized EUR 7 million, EUR 14 million, and
EUR 6 million respectively in interest and
penalties. The accrued liability for interest
and penalties was EUR 48 million and EUR 45
million at December 31, 2008 and 2007,
respectively.
In many cases, unrecognized tax benefits are
related to tax years that remain subject to
examination by the relevant tax authorities.
The following table summarizes these open
years by major jurisdiction:
Major jurisdiction
|
|
|
|
|
|
|
Open tax years |
|
United States |
|
|
2003-2008 |
|
United Kingdom |
|
|
2001-2008 |
|
Germany |
|
|
1997-2008 |
|
France |
|
|
2000-2008 |
|
Netherlands |
|
|
2007-2008 |
|
Hong Kong |
|
|
2002-2008 |
|
It is reasonably possible that the amount of
unrecognized tax benefits may change in the
next twelve months due to expiring statutes,
audit activity, tax payments, competent
authority proceedings related to transfer
pricing, or final decisions in matters that
are the subject of litigation in various
taxing jurisdictions in which we operate.
7
Investments in equity-accounted investees
Results relating to equity-accounted investees
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Companys participation in income
(loss) |
|
|
(180 |
) |
|
|
271 |
|
|
|
81 |
|
Results on sales of shares |
|
|
79 |
|
|
|
514 |
|
|
|
(2 |
) |
Gains arising from dilution effects |
|
|
14 |
|
|
|
|
|
|
|
12 |
|
Investment impairment/other charges |
|
|
(70 |
) |
|
|
(22 |
) |
|
|
(72 |
) |
|
|
|
(157 |
) |
|
|
763 |
|
|
|
19 |
|
In 2006 and 2008, Philips recorded dilution
gains of EUR 14 million and EUR 12 million
respectively on its share in TPV Technology
(TPV), a Hong Kong based manufacturer of flat
panels.
Detailed information on the other
aforementioned individual line items is set
out below.
Companys participation in income (loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
LG Display |
|
|
(196 |
) |
|
|
260 |
|
|
|
66 |
|
Others |
|
|
16 |
|
|
|
11 |
|
|
|
15 |
|
|
|
|
(180 |
) |
|
|
271 |
|
|
|
81 |
|
Philips Annual Report 2008 153
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124
|
|
US GAAP financial statements
|
|
|
180 |
|
|
Sustainability performance
|
|
|
192 |
|
|
IFRS financial statements
|
|
|
244 |
|
|
Company financial statements |
|
|
|
Notes to the US GAAP financial statements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At the end of February 2008, Philips influence
on LG Displays operating and financial
policies including representation on the LG
Display board was reduced. Consequently, the
19.9% investment in LG Display was transferred
from Investments in equity-accounted investees
to Other non-current financial assets effective
March 1, 2008, as Philips was no longer able to
exercise significant influence. Philips ceased
to apply equity accounting for its LG Display
shares as of that date.
Results on sales of shares
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
FEI Company |
|
|
76 |
|
|
|
|
|
|
|
|
|
LG Display |
|
|
|
|
|
|
508 |
|
|
|
|
|
Others |
|
|
3 |
|
|
|
6 |
|
|
|
(2 |
) |
|
|
|
79 |
|
|
|
514 |
|
|
|
(2 |
) |
2007
In 2007, Philips sold 46,400,000 shares of LG
Display common stock, resulting in a gain of
EUR 508 million. As a result of the sale,
Philips shareholding in LG Display was
reduced from 32.9% to 19.9%.
2006
In 2006, Philips sold its interest of 24.8% in FEI Company (see note 2).
Investment impairment/other charges
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
LG.Philips Displays |
|
|
(61 |
) |
|
|
(22 |
) |
|
|
(9 |
) |
Others |
|
|
(9 |
) |
|
|
|
|
|
|
(63 |
) |
|
|
|
(70 |
) |
|
|
(22 |
) |
|
|
(72 |
) |
2008
The category Others includes an impairment
charge related to our 12.4% interest in TPV.
Philips performed impairment reviews on the
book value of the investment in TPV in 2008.
We concluded that an impairment charge of EUR
59 million was required. The impairment
reviews in 2008 were triggered by the
deteriorating economic environment of the
flat panel industry, the weakening financial
performance of TPV and the stock price
performance of TPV. The valuation of TPV is
based on level 1 of the fair value hierarchy.
The valuation as per December 31, 2008 was
based on the stock price of TPV as of that
date on the Hong Kong Stock Exchange.
2007
The voluntary support of social plans for
employees impacted by the bankruptcy of
certain LG.Philips Displays activities
amounted to EUR 22 million.
2006
The voluntary support of social plans for
employees impacted by the bankruptcy of
certain LG.Philips Displays activities
amounted to EUR 61 million.
Investments in equity-accounted investees
|
|
|
|
|
Investment in equity-accounted investees as of
January 1, 2008 |
|
|
1,886 |
|
Changes: |
|
|
|
|
Acquisitions/additions |
|
|
56 |
|
Sales/repayments |
|
|
(3 |
) |
Transfer to other non-current financial assets |
|
|
(1,601 |
) |
Share in income/value adjustments |
|
|
30 |
|
Dividends received |
|
|
(65 |
) |
Translation and exchange rate differences |
|
|
(19 |
) |
Investments in equity-accounted investees
as of December 31, 2008 |
|
|
284 |
|
The EUR 1,601 million reported on Transfer
to other non-current financial assets
relates to the investment in LG Display.
Included in investments is EUR 25 million
(2007: EUR 404 million), representing the
excess of the Companys investment over its
underlying equity in the net assets of
equity-accounted investees.
The total carrying value of investments
in, and loans to, equity-accounted
investees is summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
2008 |
|
|
|
share- |
|
|
|
|
|
|
share- |
|
|
|
|
|
|
holding % |
|
|
amount |
|
|
holding % |
|
|
amount |
|
LG Display |
|
|
19.9 |
|
|
|
1,607 |
|
|
|
|
|
|
|
|
|
Other equity-accounted
investees |
|
|
|
|
|
|
279 |
|
|
|
|
|
|
|
284 |
|
|
|
|
|
|
|
|
1,886 |
|
|
|
|
|
|
|
284 |
|
The category Other equity-accounted investees
includes the investment in TPV (12.4%, carrying
value EUR 60 million) and InterTrust
Technologies Corporation (49.5%, carrying value
EUR 64 million).
The Company owns TPV bonds that have
convertible rights, that potentially could
result in significant influence.
The investment in equity-accounted investees
are mainly included in the sector Group
Management & Services.
Summarized information of equity-accounted investees
Summarized financial information on the
Companys investments in equity-accounted
investees, on a combined basis, is presented
below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Net sales |
|
|
13,599 |
|
|
|
15,799 |
|
|
|
6,951 |
|
Income (loss) before taxes |
|
|
(626 |
) |
|
|
1,304 |
|
|
|
538 |
|
Income taxes |
|
|
187 |
|
|
|
(169 |
) |
|
|
(109 |
) |
Other income (loss) |
|
|
(36 |
) |
|
|
(1 |
) |
|
|
|
|
Net income (loss) |
|
|
(475 |
) |
|
|
1,134 |
|
|
|
429 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total share in net income (loss) of
equity-accounted investees recognized
in the consolidated statements of
income |
|
|
(180 |
) |
|
|
271 |
|
|
|
81 |
|
|
|
|
|
|
|
|
|
|
|
|
December 31 |
|
|
|
2007 |
|
|
2008 |
|
Current assets |
|
|
6,380 |
|
|
|
2,781 |
|
Non-current assets |
|
|
6,406 |
|
|
|
685 |
|
|
|
|
12,786 |
|
|
|
3,466 |
|
|
|
|
|
|
|
|
|
|
Current liabilities |
|
|
(3,340 |
) |
|
|
(2,134 |
) |
Non-current liabilities |
|
|
(2,429 |
) |
|
|
(184 |
) |
Net asset value |
|
|
7,017 |
|
|
|
1,148 |
|
|
|
|
|
|
|
|
|
|
Investments in equity-accounted investees included
in the consolidated balance sheet |
|
|
1,886 |
|
|
|
284 |
|
154 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
non-US GAAP information
|
|
|
254 |
|
|
Corporate governance
|
|
|
262 |
|
|
Ten-year overview
|
|
|
266 |
|
|
Investor information |
8
Earnings per share
The earnings per share (EPS) data have been calculated as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
2008 |
|
Net income (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations |
|
|
|
|
|
|
899 |
|
|
|
|
|
|
|
4,593 |
|
|
|
|
|
|
|
(178 |
) |
Income (loss) from discontinued operations |
|
|
|
|
|
|
4,482 |
|
|
|
|
|
|
|
(433 |
) |
|
|
|
|
|
|
(8 |
) |
Net income (loss) attributable to holders
of common shares |
|
|
|
|
|
|
5,381 |
|
|
|
|
|
|
|
4,160 |
|
|
|
|
|
|
|
(186 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of shares |
|
|
|
|
|
|
1,174,924,579 |
|
|
|
|
|
|
|
1,086,128,418 |
|
|
|
|
|
|
|
991,420,017 |
|
Plus incremental shares from assumed conversions of: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options and restricted share rights |
|
|
6,817,690 |
|
|
|
|
|
|
|
10,203,409 |
|
|
|
|
|
|
|
6,099,113 |
|
|
|
|
|
Convertible debentures |
|
|
1,042,061 |
|
|
|
|
|
|
|
1,103,117 |
|
|
|
|
|
|
|
200,904 |
|
|
|
|
|
Dilutive potential common shares |
|
|
|
|
|
|
7,859,751 |
|
|
|
|
|
|
|
11,306,526 |
|
|
|
|
|
|
|
6,300,017 |
|
Adjusted weighted average number of shares |
|
|
|
|
|
|
1,182,784,330 |
|
|
|
|
|
|
|
1,097,434,944 |
|
|
|
|
|
|
|
997,720,034 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per share in euros |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations |
|
|
|
|
|
|
0.77 |
|
|
|
|
|
|
|
4.23 |
|
|
|
|
|
|
|
(0.18 |
) |
Income (loss) from discontinued operations |
|
|
|
|
|
|
3.81 |
|
|
|
|
|
|
|
(0.40 |
) |
|
|
|
|
|
|
(0.01 |
) |
Net income (loss) |
|
|
|
|
|
|
4.58 |
|
|
|
|
|
|
|
3.83 |
|
|
|
|
|
|
|
(0.19 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per share in euros |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations |
|
|
|
|
|
|
0.76 |
|
|
|
|
|
|
|
4.19 |
|
|
|
|
|
|
|
(0.18 |
)1) |
Income (loss) from discontinued operations |
|
|
|
|
|
|
3.79 |
|
|
|
|
|
|
|
(0.40 |
) |
|
|
|
|
|
|
(0.01 |
)1) |
Net income (loss) |
|
|
|
|
|
|
4.55 |
|
|
|
|
|
|
|
3.79 |
|
|
|
|
|
|
|
(0.19 |
)1) |
In 2008, 2007 and 2006, respectively 48 million, 27 million and 19 million securities that
could potentially dilute basic EPS were not included in the computation of dilutive EPS
because the effect would have been antidilutive for the periods presented.
|
|
|
1) |
|
In 2008, the incremental shares from assumed conversion are not taken into account as the
effect would be antidilutive. |
9
Receivables
Income taxes receivable (current portion)
totaling EUR 133 million (2007: EUR 52
million) are included under other
receivables.
The changes in the allowance for doubtful
accounts receivable are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Balance as of January 1 |
|
|
369 |
|
|
|
336 |
|
|
|
300 |
|
Additions charged to income |
|
|
52 |
|
|
|
62 |
|
|
|
33 |
|
Deductions from allowance1) |
|
|
(72 |
) |
|
|
(85 |
) |
|
|
(63 |
) |
Other movements2) |
|
|
(13 |
) |
|
|
(13 |
) |
|
|
10 |
|
Balance as of December 31 |
|
|
336 |
|
|
|
300 |
|
|
|
280 |
|
|
|
|
1) |
|
Write-offs for which an allowance was previously provided |
|
2) |
|
Including the effect of translation differences and consolidation changes |
10
Inventories
Inventories are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Raw materials and supplies |
|
|
908 |
|
|
|
976 |
|
Work in process |
|
|
391 |
|
|
|
530 |
|
Finished goods |
|
|
1,968 |
|
|
|
2,066 |
|
Advance payments on work in process |
|
|
(121 |
) |
|
|
(201 |
) |
|
|
|
3,146 |
|
|
|
3,371 |
|
The amounts recorded above are net of allowances for obsolescence.
As of December 31, 2008, the carrying amount
of inventories carried at fair value less
cost-to-sell is EUR 257 million (2007: EUR 190
million).
As discussed under Significant accounting
policies, Reclassification and revisions, the
previously reported inventories balance as of
December 31, 2007 was revised downwards by EUR
57 million to reflect immaterial adjustments
of intercompany profit eliminations on
inventories.
11
Other current assets
Other current assets consist of a current
deferred tax asset of EUR 837 million (2007:
EUR 399 million), derivative instruments of
EUR 253 million (2007: EUR 275 million),
prepaid expenses of EUR 375 million (2007:
EUR 346 million) and other current financial
assets of EUR 121 million (2007: EUR nil).
Philips Annual Report 2008 155
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124
|
|
US GAAP financial statements
|
|
|
180 |
|
|
Sustainability performance
|
|
|
192 |
|
|
IFRS financial statements
|
|
|
244 |
|
|
Company financial statements |
|
|
|
Notes to the US GAAP financial statements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12
Other non-current financial assets
The changes during 2008 are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
cost- |
|
|
|
|
|
|
|
|
|
available- |
|
|
restricted |
|
|
method |
|
|
|
|
|
|
|
|
|
for-sale |
|
|
liquid |
|
|
invest- |
|
|
|
|
|
|
|
|
|
securities |
|
|
assets |
|
|
ments |
|
|
other |
|
|
total |
|
Balance as of
January 1, 2008 |
|
|
1,776 |
|
|
|
101 |
|
|
|
1,027 |
|
|
|
279 |
|
|
|
3,183 |
|
Changes: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reclassifications |
|
|
1,601 |
|
|
|
(27 |
) |
|
|
(3 |
) |
|
|
24 |
|
|
|
1,595 |
|
Acquisitions/
additions |
|
|
75 |
|
|
|
2 |
|
|
|
2 |
|
|
|
82 |
|
|
|
161 |
|
Sales/
redemptions/
reductions |
|
|
(2,530 |
) |
|
|
|
|
|
|
(2 |
) |
|
|
(22 |
) |
|
|
(2,554 |
) |
Value
adjustments/
impairments |
|
|
(323 |
) |
|
|
|
|
|
|
(673 |
) |
|
|
(69 |
) |
|
|
(1,065 |
) |
Translation
and exchange
differences |
|
|
|
|
|
|
(1 |
) |
|
|
|
|
|
|
12 |
|
|
|
11 |
|
Balance as of
December 31,
2008 |
|
|
599 |
|
|
|
75 |
|
|
|
351 |
|
|
|
306 |
|
|
|
1,331 |
|
Investments in available-for-sale securities
The Companys investments in
available-for-sale securities consist of
investments in shares of companies in
various industries.
Major holdings in available-for-sale securities at December 31:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
2008 |
|
|
|
number of |
|
|
|
|
|
number of |
|
|
|
|
|
|
shares |
|
|
fair value |
|
|
shares |
|
|
fair value |
|
D&M Holdings |
|
|
11,126,640 |
|
|
|
32 |
|
|
|
|
|
|
|
|
|
TSMC |
|
|
1,311,490,224 |
|
|
|
1,699 |
|
|
|
|
|
|
|
|
|
LG Display |
|
|
|
|
|
|
|
|
|
|
47,225,000 |
|
|
|
558 |
|
Pace Micro
Technology |
|
|
|
|
|
|
|
|
|
|
50,701,049 |
|
|
|
29 |
|
|
|
|
|
|
|
|
1,731 |
|
|
|
|
|
|
|
587 |
|
During 2008, the Company reduced its
shareholding portfolio of available-for-sale
securities by selling its interests in TSMC
and D&M Holdings (D&M).
In 2007, Philips and TSMC jointly announced
that the companies agreed to a multi-phased
plan to facilitate an orderly exit by Philips
from its shareholding in TSMC. The plan
comprised a private sale transaction to
long-term financial investors in Taiwan, the
offering of shares through a public offering in
the United States (in the form of American
Depositary Shares) and the participation in
stock repurchase programs initiated by TSMC.
Under this agreement, the remaining 1,311
million TSMC shares were sold during 2008 in
various transactions. Philips realized a gain
of EUR 1,082 million on these transactions. In
September 2008, Philips sold its remaining
stake of approximately 13% in D&M, a Japanese
company which manufactures audio-visual
products. The company realized a gain on this
transaction of EUR 16 million. The results on
the TSMC and D&M transactions were recognized
in Financial income and expenses.
During 2008, the Company increased its
shareholding portfolio of available-for-sale
securities primarily as a result of the
reclassification of LG Display from
equity-accounted investees. Additionally,
shares of Pace Micro Technology were received
in conjunction with the divesture of our
Set-Top Boxes and Connectivity Solutions
activities.
Until March 2008, LG Display was presented as
an equity-accounted investee. At the end of
February 2008, Philips influence on LG
Displays operating and financial policies,
including representation on the LG Display
board, was reduced. Consequently, the 19.9%
investment in LG Display was transferred from
investments in equity-accounted investees to
available-for-sale securities effective March
1, 2008, as Philips was no longer able to
exercise significant influence. The investment
in LG Display was reduced on March 12, 2008,
when 24 million shares were sold in a capital
market transaction to third parties. The EUR 83
million gain on this transaction was presented
in Financial income and expense. At December
31, 2008, Philips owned 13.2% of LG Displays
share capital. At year-end the fair value based
on the stock price of LG Display was EUR 596
million below the carrying value (fair value
plus losses recognized in accumulated other
comprehensive income). As this loss was
considered other than temporary, an impairment
charge of EUR 596 million was recorded by
releasing the accumulated amounts under Other
comprehensive income to Financial income and
expense.
In April 2008, the Company obtained 64.5
million shares in Pace in exchange for the
transfer of the Companys Set-Top Boxes and
Connectivity Solutions activities.
Subsequently, 13.8 million shares were sold to
third parties. The EUR 1 million loss on this
transaction was presented under Financial
income and expenses. As of December 31, 2008,
Philips owns 17% of Paces share capital. At
year-end the fair value based on the stock
price of Pace was EUR 30 million below the
carrying value (fair value plus losses
recognized in accumulated other comprehensive
income). As this loss was considered other than
temporary, an impairment charge of EUR 30
million was recorded by releasing the
accumulated amounts under Other comprehensive
income to Financial income and expense.
Cost-method investments
The major cost-method investment as of December
31, 2008 is NXP, for an amount of EUR 255
million, of which the Company holds 19.8% of
the common shares. The interest in NXP resulted
from the sale of a majority stake in the
Semiconductors division in September 2006. The
Companys stake in NXP is considered a non-core
activity that is available for sale. Although
the ultimate method of disposal and the precise
market for non-listed shares are not clear, the
disposal could be effected, for example, by way
of a private transaction to strategic buyers or
other financial parties, or via a public
offering. The Company does not have any
definitive plans to dispose of this interest.
NXP is a privately held company that is not
quoted in an active market. NXP is carried at
cost because the fair value is not readily
determinable. The variability in the range of
reasonable fair value estimates is significant
and the probabilities of the various estimates
within the range of reasonable inputs are not
sufficiently reliable to determine a fair
value. This is mainly due to the nature of the
majority shareholders (private equity firms)
and their potentially volatile investment and
exit strategy, as well as to the nature and
limited availability of the financial
projections of NXP. Triggered by the
deteriorating economic environment of the
semiconductors industry in general and the
weakening financial performance of NXP
specifically, Philips performed impairment
reviews on the carrying value of the investment
in NXP in 2007 and 2008. During 2008,
impairment charges were recognized in the
amount of EUR 599 million, which are presented
in Financial income and expenses. Our
impairment calculations in 2008 indicated a
broad range of valuations. The primary
valuation techniques considered in determining
the estimated fair value ranges comprise
multiplier calculations (EBITDA multiples),
calculations based on the share price
performance of a peer group of listed
(semiconductor) companies and discounted cash
flow methods based on unobservable inputs. The
latter methodology involved estimates of
revenues, expenses, capital spending and other
costs, as well as a discount rate calculated
based on the risk profile of the semiconductor
industry. As a result, the investment is
classified within level 3 of the fair-value
hierarchy, which is measured at fair value on a
non-recurring basis. Taking into account
certain market considerations and the range of
estimated fair values, management determined
that the best estimate of fair value for the
NXP investment was EUR 255 million at December
31, 2008. However, as noted above, the fair
value used for impairment purposes represents
an estimate; the actual fair value of this
interest could materially differ from that
estimate.
Another significant cost-method investment is
an investment in TPO Displays Corp. (TPO). The
Company obtained a 17.4% stake in TPO, after
the merger of MDS with TPO in 2006. The value
of the investment at amortized cost is EUR 32
million, net of impairments. The Company
performed impairment reviews of the TPO
investment, which resulted in an impairment
charge of EUR 71 million in 2008 and
156 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
non-US GAAP information
|
|
|
254 |
|
|
Corporate governance
|
|
|
262 |
|
|
Ten-year overview
|
|
|
266 |
|
|
Investor information |
EUR 77 million in 2006, recognized in Financial
income and expense. The impairment review in
2008 was triggered by the deteriorating
economic environment of the connected displays
industry and the weakening financial
performance of TPO. The valuation was based on
the over-the-counter stock price of TPO,
quoted on the Gre Tai Securities Market in
Taiwan, a market with insufficient trading
volumes and infrequent transactions. The
investment in TPO is classified as level 2 in
the fair value hierarchy.
Other
Included in the category other are two
convertible bonds, one issued by TPV
Technology (TPV) and one issued by CBAY.
The convertible bond issued by TPV has a total
fair value of EUR 142 million as at December
31, 2008. The bond has a maturity date of
September 5, 2010, with an option to convert
the bond into shares of TPV during the period
September 5, 2008 until maturity.
The CBAY convertible bond, which may not be
transferred to a third party before August 6,
2009, has a total fair value EUR 51 million as
of December 31, 2008. The bond has a maturity
date of August 6, 2015.
Philips has an option to convert the bond into
shares of CBAY before the maturity date or to
sell the convertible bond to C-Bay as of August
2012 onwards. CBAY also has the option to
redeem the convertible bonds in 2011, 2012 and
2013 at a certain percentage of the bonds face
value.
13
Non-current receivables
Non-current receivables include receivables
with a remaining term of more than one year,
and the non-current portion of income taxes
receivable amounting to EUR 1 million (2007:
EUR 14 million).
14
Other non-current assets
Other non-current assets in 2008 are
comprised of prepaid pension costs of EUR
2,751 million (2007: EUR 2,703 million),
deferred tax assets of EUR 553 million (2007:
EUR 971 million) and prepaid expenses of EUR
46 million (2007: EUR 52 million).
15
Property, plant and equipment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
prepayments |
|
|
| |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
and |
|
|
no longer |
|
|
|
|
|
|
land and |
|
|
machinery and |
|
|
|
|
|
|
other |
|
|
construction in |
|
|
productively |
|
|
|
|
|
|
buildings |
|
|
installations |
|
|
lease assets |
|
|
equipment |
|
|
progress |
|
|
employed |
|
|
total |
|
Balance as of January 1, 2008: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost |
|
|
2,303 |
|
|
|
3,395 |
|
|
|
88 |
|
|
|
1,732 |
|
|
|
343 |
|
|
|
13 |
|
|
|
7,874 |
|
Accumulated depreciation |
|
|
(935 |
) |
|
|
(2,321 |
) |
|
|
(48 |
) |
|
|
(1,381 |
) |
|
|
|
|
|
|
(9 |
) |
|
|
(4,694 |
) |
Book value |
|
|
1,368 |
|
|
|
1,074 |
|
|
|
40 |
|
|
|
351 |
|
|
|
343 |
|
|
|
4 |
|
|
|
3,180 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Changes in book value: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures |
|
|
101 |
|
|
|
339 |
|
|
|
37 |
|
|
|
277 |
|
|
|
9 |
|
|
|
8 |
|
|
|
771 |
|
Retirements and sales |
|
|
(51 |
) |
|
|
(33 |
) |
|
|
|
|
|
|
(37 |
) |
|
|
(7 |
) |
|
|
|
|
|
|
(128 |
) |
Depreciation |
|
|
(90 |
) |
|
|
(331 |
) |
|
|
(13 |
) |
|
|
(195 |
) |
|
|
|
|
|
|
|
|
|
|
(629 |
) |
Write-downs and impairments |
|
|
(1 |
) |
|
|
(38 |
) |
|
|
|
|
|
|
(17 |
) |
|
|
|
|
|
|
|
|
|
|
(56 |
) |
Translation differences |
|
|
9 |
|
|
|
12 |
|
|
|
9 |
|
|
|
3 |
|
|
|
2 |
|
|
|
|
|
|
|
35 |
|
Changes in consolidation |
|
|
133 |
|
|
|
95 |
|
|
|
25 |
|
|
|
58 |
|
|
|
|
|
|
|
|
|
|
|
311 |
|
Total changes |
|
|
101 |
|
|
|
44 |
|
|
|
58 |
|
|
|
89 |
|
|
|
4 |
|
|
|
8 |
|
|
|
304 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 31, 2008: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost |
|
|
2,353 |
|
|
|
3,434 |
|
|
|
128 |
|
|
|
1,733 |
|
|
|
347 |
|
|
|
48 |
|
|
|
8,043 |
|
Accumulated depreciation |
|
|
(884 |
) |
|
|
(2,316 |
) |
|
|
(30 |
) |
|
|
(1,293 |
) |
|
|
|
|
|
|
(36 |
) |
|
|
(4,559 |
) |
Book value |
|
|
1,469 |
|
|
|
1,118 |
|
|
|
98 |
|
|
|
440 |
|
|
|
347 |
|
|
|
12 |
|
|
|
3,484 |
|
Land with a book value of EUR 185 million,
at December 31, 2008 (2007: EUR 148 million)
is not depreciated.
The expected useful lives of property,
plant and equipment are as follows:
|
|
|
|
|
Buildings |
|
from 5 to 50 years |
Machinery and installations |
|
from 3 to 10 years |
Lease assets |
|
from 1 to 15 years |
Other equipment |
|
from 1 to 10 years |
Capital expenditures include capitalized
interest related to construction in progress
amounting to EUR 3 million in 2008 (2007: EUR
5 million).
Philips Annual Report 2008 157
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124
|
|
US GAAP financial statements
|
|
|
180 |
|
|
Sustainability performance
|
|
|
192 |
|
|
IFRS financial statements
|
|
|
244 |
|
|
Company financial statements |
|
|
|
Notes to the US GAAP financial statements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16
Intangible assets excluding goodwill
The changes during 2008 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
other |
|
|
|
|
|
|
|
|
|
|
intangible |
|
|
|
|
|
|
software |
|
|
assets |
|
|
total |
|
Balance as of
January 1, 2008: |
|
|
|
|
|
|
|
|
|
|
|
|
Cost |
|
|
615 |
|
|
|
2,629 |
|
|
|
3,244 |
|
Accumulated
amortization |
|
|
(404 |
) |
|
|
(686 |
) |
|
|
(1,090 |
) |
Book value |
|
|
211 |
|
|
|
1,943 |
|
|
|
2,154 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Changes in book value: |
|
|
|
|
|
|
|
|
|
|
|
|
Acquisitions/additions |
|
|
118 |
|
|
|
2,106 |
|
|
|
2,224 |
|
Amortization/deductions |
|
|
(85 |
) |
|
|
(380 |
) |
|
|
(465 |
) |
Translation differences |
|
|
5 |
|
|
|
55 |
|
|
|
60 |
|
Other |
|
|
(6 |
) |
|
|
8 |
|
|
|
2 |
|
Total changes |
|
|
32 |
|
|
|
1,789 |
|
|
|
1,821 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of
December 31, 2008: |
|
|
|
|
|
|
|
|
|
|
|
|
Cost |
|
|
702 |
|
|
|
4,784 |
|
|
|
5,486 |
|
Accumulated
amortization |
|
|
(459 |
) |
|
|
(1,052 |
) |
|
|
(1,511 |
) |
Book value |
|
|
243 |
|
|
|
3,732 |
|
|
|
3,975 |
|
Other intangible assets in 2008 consist of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
January 1 |
|
|
|
|
|
|
December 31 |
|
|
|
|
|
|
|
accumulated |
|
|
|
|
|
|
accumulated |
|
|
|
gross |
|
|
amortization |
|
|
gross |
|
|
amortization |
|
Marketing-related |
|
|
168 |
|
|
|
(30 |
) |
|
|
69 |
|
|
|
(24 |
) |
Customer-related |
|
|
1,042 |
|
|
|
(182 |
) |
|
|
2,527 |
|
|
|
(354 |
) |
Contract-based |
|
|
33 |
|
|
|
(10 |
) |
|
|
36 |
|
|
|
(17 |
) |
Technology-based |
|
|
735 |
|
|
|
(374 |
) |
|
|
1,356 |
|
|
|
(518 |
) |
Patents and
trademarks |
|
|
651 |
|
|
|
(90 |
) |
|
|
796 |
|
|
|
(139 |
) |
|
|
|
2,629 |
|
|
|
(686 |
) |
|
|
4,784 |
|
|
|
(1,052 |
) |
The estimated amortization expense for these
other intangible assets for each of the five
succeeding years is:
|
|
|
|
|
2009 |
|
|
391 |
|
2010 |
|
|
372 |
|
2011 |
|
|
334 |
|
2012 |
|
|
308 |
|
2013 |
|
|
279 |
|
The expected weighted average remaining life
of other intangibles is 11.5 years as of
December 31, 2008.
The additions acquired through business
combinations in 2008 consist of the acquired
intangible assets of Respironics of EUR
1,186 million, Genlyte of EUR 860 million, and
VISICU of EUR 33 million.
The acquired intangible assets mainly consist
of customer relationships and patents for
Respironics of EUR 732 million and Genlyte of
EUR 614 million, and core and existing
technology for Respironics of EUR 355 million
and VISICU of EUR 20 million.
The unamortized costs of computer software to
be sold, leased or otherwise marketed amounted
to EUR 102 million (2007: EUR 63 million). The
amounts charged to the income statement for
amortization or impairment of these capitalized
computer software costs amounted to EUR 26
million (2007: EUR 20 million).
17
Goodwill
The changes in 2007 and 2008 were as follows:
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Balance as of January 1: |
|
|
|
|
|
|
|
|
Cost |
|
|
3,853 |
|
|
|
4,249 |
|
Amortization / Impairments |
|
|
(130 |
) |
|
|
(114 |
) |
Book value |
|
|
3,723 |
|
|
|
4,135 |
|
|
|
|
|
|
|
|
|
|
Acquisitions |
|
|
810 |
|
|
|
3,446 |
|
Impairments |
|
|
|
|
|
|
(234 |
) |
Translation differences |
|
|
(398 |
) |
|
|
354 |
|
|
|
|
|
|
|
|
|
|
Balance as of December 31: |
|
|
|
|
|
|
|
|
Cost |
|
|
4,249 |
|
|
|
8,033 |
|
Amortization / Impairments |
|
|
(114 |
) |
|
|
(332 |
) |
Book value |
|
|
4,135 |
|
|
|
7,701 |
|
Acquisitions in 2008 include the goodwill paid
on the acquisition of Respironics for EUR
2,162 million, Genlyte for EUR 1,036 million,
and VISICU for EUR 175 million, and several
smaller acquisitions.
Acquisitions in 2007 include the goodwill paid
on the acquisition of Partners in Lighting for
EUR 297 million, Color Kinetics for EUR 357
million and several smaller acquisitions. In
addition, goodwill changed due to the
finalization of purchase price accounting
related to acquisitions in prior years.
A significant part of goodwill is
allocated to the following reporting
units:
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Home Healthcare Solutions |
|
|
388 |
|
|
|
2,800 |
|
Professional Luminaires |
|
|
353 |
|
|
|
1,445 |
|
Imaging Systems |
|
|
1,210 |
|
|
|
1,274 |
|
Home Healthcare Solutions and Professional
Luminaires increased by the acquisitions of
Respironics and Genlyte, respectively (see note
2) and are the most sensitive to fluctuations
in the key assumptions used in the impairment
tests as set out below.
The key assumptions used in the annual
(performed in Q2) and trigger-based impairment
tests were growth of sales and gross margin,
together with the rates used for discounting
the forecast cash flows. Sales and gross margin
growth are based on managements internal
forecasts that cover an initial period of no
more than five years and then are extrapolated
with stable or declining growth rates, after
which a terminal value is calculated for which
growth rates are capped. The pre-tax discount
rates are determined for each reporting unit
(one level below sector level) and, in the
annual test, ranged from 9.4% to 15.6%.
Due to deteriorating economic circumstances
and the decline of the market capitalization
of the Company, trigger-based impairment tests
were performed in the latter half of the year
using updated assumptions. The trigger-based
tests resulted in goodwill impairment charges
of EUR 234 million, mainly related to Lumileds
as a
158 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
non-US GAAP information
|
|
|
254 |
|
|
Corporate governance
|
|
|
262 |
|
|
Ten-year overview
|
|
|
266 |
|
|
Investor information |
consequence of weaker demand for LED solutions
in the automotive, display and cell phone
markets. The pre-tax discount rate used for
the Lumileds impairment test was 14.6%.
Please refer to Information by sector and
main country that begins on page 133 of this
Annual Report for a specification of goodwill
by sector.
18
Accrued liabilities
Accrued liabilities are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Personnel-related costs: |
|
|
|
|
|
|
|
|
- Salaries and wages |
|
|
433 |
|
|
|
438 |
|
- Accrued holiday entitlements |
|
|
178 |
|
|
|
192 |
|
- Other personnel-related costs |
|
|
169 |
|
|
|
161 |
|
Fixed-asset-related costs: |
|
|
|
|
|
|
|
|
- Gas, water, electricity, rent and other |
|
|
62 |
|
|
|
69 |
|
Taxes: |
|
|
|
|
|
|
|
|
- Income tax payable |
|
|
154 |
|
|
|
132 |
|
- Other taxes payable |
|
|
12 |
|
|
|
16 |
|
Communication & IT costs |
|
|
31 |
|
|
|
23 |
|
Distribution costs |
|
|
109 |
|
|
|
92 |
|
Sales-related costs: |
|
|
|
|
|
|
|
|
- Commissions payable |
|
|
43 |
|
|
|
53 |
|
- Advertising and marketing-related costs |
|
|
66 |
|
|
|
87 |
|
- Other sales-related costs |
|
|
206 |
|
|
|
249 |
|
Material-related accruals |
|
|
134 |
|
|
|
170 |
|
Interest-related accruals |
|
|
110 |
|
|
|
79 |
|
Deferred income |
|
|
564 |
|
|
|
671 |
|
Derivative instruments liabilities (see note 35) |
|
|
144 |
|
|
|
505 |
|
Restructuring-related liabilities |
|
|
20 |
|
|
|
163 |
|
Other accrued liabilities |
|
|
549 |
|
|
|
536 |
|
|
|
|
2,984 |
|
|
|
3,636 |
|
Please refer to note 6 for a specification of income tax payable.
19
Provisions
Provisions are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
2008 |
|
|
|
long- |
|
|
short- |
|
|
long- |
|
|
short- |
|
|
|
term |
|
|
term |
|
|
term |
|
|
term |
|
Provision for defined-benefit
plans (see note 20) |
|
|
745 |
|
|
|
68 |
|
|
|
697 |
|
|
|
64 |
|
Other postretirement benefits
(see note 21) |
|
|
390 |
|
|
|
23 |
|
|
|
330 |
|
|
|
23 |
|
Postemployment benefits and
obligatory severance payments |
|
|
92 |
|
|
|
11 |
|
|
|
73 |
|
|
|
16 |
|
Deferred tax liabilities
(see note 6) |
|
|
671 |
|
|
|
1 |
|
|
|
1,145 |
|
|
|
20 |
|
Product warranty |
|
|
133 |
|
|
|
190 |
|
|
|
107 |
|
|
|
203 |
|
Loss contingencies
(environmental remediation
and product liability) |
|
|
432 |
|
|
|
49 |
|
|
|
153 |
|
|
|
651 |
|
Restructuring-related
provisions |
|
|
22 |
|
|
|
2 |
|
|
|
161 |
|
|
|
49 |
|
Other provisions |
|
|
227 |
|
|
|
33 |
|
|
|
243 |
|
|
|
34 |
|
|
|
|
2,712 |
|
|
|
377 |
|
|
|
2,909 |
|
|
|
1,060 |
|
Product warranty
The provision for product warranty reflects
the estimated costs of replacement and
free-of-charge services that are expected to
be incurred by the Group with respect to
products sold. The changes in the provision
for product warranty are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Balance as of January 1 |
|
|
378 |
|
|
|
365 |
|
|
|
323 |
|
Changes: |
|
|
|
|
|
|
|
|
|
|
|
|
Additions |
|
|
438 |
|
|
|
354 |
|
|
|
333 |
|
Utilizations |
|
|
(443 |
) |
|
|
(369 |
) |
|
|
(357 |
) |
Translation differences |
|
|
(13 |
) |
|
|
(16 |
) |
|
|
(3 |
) |
Changes in consolidation |
|
|
5 |
|
|
|
(11 |
) |
|
|
14 |
|
Balance as of December 31 |
|
|
365 |
|
|
|
323 |
|
|
|
310 |
|
Loss contingencies (environmental remediation
and product liability)
This provision includes
accrued losses recorded with respect to
environmental remediation and product liability
(including asbestos) obligations which are
probable and reasonably estimable. The asbestos
liabilities have been classified as current at
December 31, 2008. Please refer to note 27.
The changes in this provision are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of January 1 |
|
|
287 |
|
|
|
576 |
|
|
|
481 |
|
Changes: |
|
|
|
|
|
|
|
|
|
|
|
|
Additions |
|
|
365 |
|
|
|
15 |
|
|
|
317 |
|
Utilizations |
|
|
(39 |
) |
|
|
(66 |
) |
|
|
(12 |
) |
Translation differences |
|
|
(37 |
) |
|
|
(44 |
) |
|
|
18 |
|
Balance as of December 31 |
|
|
576 |
|
|
|
481 |
|
|
|
804 |
|
Postemployment benefits and obligatory
severance payments
The provision for
postemployment benefits covers benefits
provided to former or inactive employees after
employment but before retirement, including
salary continuation, supplemental unemployment
benefits and disability-related benefits.
The provision for obligatory severance payments
covers the Companys commitment to pay
employees a lump sum upon the employees
dismissal or resignation. In the event that a
former employee has passed away, the Company
may have a commitment to pay a lump sum to the
deceased employees relatives.
Other provisions
Other provisions include provisions for
employee jubilee funds totaling EUR 76
million (2007: EUR 79 million) and expected
losses on existing projects/orders totaling
EUR 13 million (2007: EUR 14 million).
Philips Annual Report 2008 159
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124
|
|
US GAAP financial statements
|
|
|
180 |
|
|
Sustainability performance
|
|
|
192 |
|
|
IFRS financial statements
|
|
|
244 |
|
|
Company financial statements |
|
|
|
Notes to the US GAAP financial statements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20
Pensions
Employee pension plans have been established
in many countries in accordance with the
legal requirements, customs and the local
situation in the countries involved. The
majority of employees in Europe and North
America are covered by defined-benefit
pension plans. The benefits provided by these
plans are based on employees years of
service and compensation levels. The
measurement date for all defined-benefit
pension plans is December 31.
The Companys contributions to the funding of
defined-benefit plans are determined based
upon various factors, including funded status,
legal and tax considerations as well as local
customs.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Summary of pre-tax costs for
pension plans and retiree
healthcare plans |
|
|
|
|
|
|
|
|
|
|
|
|
Defined-benefit plans |
|
|
75 |
|
|
|
27 |
|
|
|
10 |
|
Defined-contribution plans incl.
multi-employer plans |
|
|
80 |
|
|
|
84 |
|
|
|
96 |
|
Retiree medical plans (see note 21) |
|
|
39 |
|
|
|
36 |
|
|
|
47 |
|
|
|
|
194 |
|
|
|
147 |
|
|
|
153 |
|
The Company funds certain defined-benefit
pension plans as claims are incurred. The
projected and accumulated benefit obligations
for both unfunded defined-benefit pension plans
and funded defined-benefit plans with
accumulated benefit obligations in excess of
the fair values of their plan assets, are
presented in the table below. It also provides
the respective aggregates of these fair values:
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Projected benefit obligation |
|
|
4,476 |
|
|
|
5,741 |
|
Accumulated benefit obligation |
|
|
4,356 |
|
|
|
5,623 |
|
Fair value of plan assets |
|
|
3,445 |
|
|
|
4,057 |
|
The table below provides a summary of the
changes in the projected benefit obligations
for defined-benefit pension plans
and the fair value of their assets for 2008 and
2007. It also provides a reconciliation of the
funded status of these plans to the amounts
recognized in the consolidated balance sheets.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
|
|
|
|
2008 |
|
|
|
Netherlands |
|
|
other |
|
|
total |
|
|
Netherlands |
|
|
other |
|
|
total |
|
Projected benefit obligation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Projected benefit obligation at beginning of year |
|
|
12,396 |
|
|
|
8,014 |
|
|
|
20,410 |
|
|
|
11,260 |
|
|
|
7,419 |
|
|
|
18,679 |
|
Service cost |
|
|
147 |
|
|
|
118 |
|
|
|
265 |
|
|
|
135 |
|
|
|
84 |
|
|
|
219 |
|
Interest cost |
|
|
521 |
|
|
|
399 |
|
|
|
920 |
|
|
|
524 |
|
|
|
398 |
|
|
|
922 |
|
Employee contributions |
|
|
|
|
|
|
4 |
|
|
|
4 |
|
|
|
|
|
|
|
4 |
|
|
|
4 |
|
Actuarial (gains) losses |
|
|
(670 |
) |
|
|
(86 |
) |
|
|
(756 |
) |
|
|
(789 |
) |
|
|
(393 |
) |
|
|
(1,182 |
) |
Plan amendments |
|
|
|
|
|
|
4 |
|
|
|
4 |
|
|
|
|
|
|
|
1 |
|
|
|
1 |
|
Settlements |
|
|
(435 |
) |
|
|
(67 |
) |
|
|
(502 |
)1) |
|
|
|
|
|
|
(22 |
) |
|
|
(22 |
) |
Curtailments |
|
|
|
|
|
|
2 |
|
|
|
2 |
|
|
|
|
|
|
|
(1 |
) |
|
|
(1 |
) |
Changes in consolidation |
|
|
|
|
|
|
49 |
|
|
|
49 |
|
|
|
|
|
|
|
106 |
|
|
|
106 |
|
Benefits paid |
|
|
(700 |
) |
|
|
(452 |
) |
|
|
(1,152 |
) |
|
|
(733 |
) |
|
|
(457 |
) |
|
|
(1,190 |
) |
Exchange rate differences |
|
|
|
|
|
|
(564 |
) |
|
|
(564 |
) |
|
|
|
|
|
|
(688 |
) |
|
|
(688 |
) |
Miscellaneous |
|
|
1 |
|
|
|
(2 |
) |
|
|
(1 |
) |
|
|
(3 |
) |
|
|
1 |
|
|
|
(2 |
) |
Projected benefit obligation at end of year |
|
|
11,260 |
|
|
|
7,419 |
|
|
|
18,679 |
|
|
|
10,394 |
|
|
|
6,452 |
|
|
|
16,846 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Present value of funded obligations at end of year |
|
|
11,245 |
|
|
|
6,621 |
|
|
|
17,866 |
|
|
|
10,384 |
|
|
|
5,701 |
|
|
|
16,085 |
|
Present value of unfunded obligations at end of year |
|
|
15 |
|
|
|
798 |
|
|
|
813 |
|
|
|
10 |
|
|
|
751 |
|
|
|
761 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Plan assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of plan assets at beginning of year |
|
|
14,521 |
|
|
|
6,831 |
|
|
|
21,352 |
|
|
|
13,771 |
|
|
|
6,429 |
|
|
|
20,200 |
|
Actual return on plan assets |
|
|
320 |
|
|
|
325 |
|
|
|
645 |
|
|
|
(174 |
) |
|
|
(618 |
) |
|
|
(792 |
) |
Employee contributions |
|
|
|
|
|
|
4 |
|
|
|
4 |
|
|
|
|
|
|
|
4 |
|
|
|
4 |
|
Employer contributions |
|
|
145 |
|
|
|
187 |
|
|
|
332 |
|
|
|
136 |
|
|
|
48 |
|
|
|
184 |
|
Settlements |
|
|
(516 |
) |
|
|
(61 |
) |
|
|
(577 |
)1) |
|
|
|
|
|
|
(22 |
) |
|
|
(22 |
) |
Changes in consolidations |
|
|
|
|
|
|
53 |
|
|
|
53 |
|
|
|
|
|
|
|
88 |
|
|
|
88 |
|
Benefits paid |
|
|
(700 |
) |
|
|
(383 |
) |
|
|
(1,083 |
) |
|
|
(730 |
) |
|
|
(383 |
) |
|
|
(1,113 |
) |
Exchange rate differences |
|
|
|
|
|
|
(525 |
) |
|
|
(525 |
) |
|
|
|
|
|
|
(651 |
) |
|
|
(651 |
) |
Miscellaneous |
|
|
1 |
|
|
|
(2 |
) |
|
|
(1 |
) |
|
|
|
|
|
|
1 |
|
|
|
1 |
|
Fair value of plan assets at end of year |
|
|
13,771 |
|
|
|
6,429 |
|
|
|
20,200 |
|
|
|
13,003 |
|
|
|
4,896 |
|
|
|
17,899 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Funded status |
|
|
2,511 |
|
|
|
(990 |
) |
|
|
1,521 |
|
|
|
2,609 |
|
|
|
(1,556 |
) |
|
|
1,053 |
|
|
|
|
1) |
|
Of which EUR (473) million (PBO) and EUR (560) million (Assets) is discontinued operations |
160 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
non-US GAAP information
|
|
|
254 |
|
|
Corporate governance
|
|
|
262 |
|
|
Ten-year overview
|
|
|
266 |
|
|
Investor information |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
|
|
|
|
2008 |
|
|
|
Netherlands |
|
|
other |
|
|
total |
|
|
Netherlands |
|
|
other |
|
|
total |
|
Amounts recognized in the consolidated
balance sheet |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prepaid pension costs under other non-current assets |
|
|
2,526 |
|
|
|
177 |
|
|
|
2,703 |
|
|
|
2,619 |
|
|
|
132 |
|
|
|
2,751 |
|
Accrued pension costs under other non-current liabilities |
|
|
|
|
|
|
(369 |
) |
|
|
(369 |
) |
|
|
|
|
|
|
(937 |
) |
|
|
(937 |
) |
Provisions for pensions under provisions including
discontinued operations |
|
|
(15 |
) |
|
|
(798 |
) |
|
|
(813 |
) |
|
|
(10 |
) |
|
|
(751 |
) |
|
|
(761 |
) |
Net pension asset (liability) at year-end |
|
|
2,511 |
|
|
|
(990 |
) |
|
|
1,521 |
|
|
|
2,609 |
|
|
|
(1,556 |
) |
|
|
1,053 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts recognized in accumulated other
comprehensive income (before tax) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net actuarial loss |
|
|
105 |
|
|
|
1,083 |
|
|
|
1,188 |
|
|
|
273 |
|
|
|
1,447 |
|
|
|
1,720 |
|
Prior-service cost (credit) |
|
|
(421 |
) |
|
|
36 |
|
|
|
(385 |
) |
|
|
(378 |
) |
|
|
26 |
|
|
|
(352 |
) |
Accumulated other comprehensive income |
|
|
(316 |
) |
|
|
1,119 |
|
|
|
803 |
|
|
|
(105 |
) |
|
|
1,473 |
|
|
|
1,368 |
|
The weighted averages of the assumptions used to calculate the
projected benefit obligations as of December 31 were as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
2008 |
|
|
|
Netherlands |
|
|
other |
|
|
Netherlands |
|
|
other |
|
Discount rate |
|
|
4.8 |
% |
|
|
5.6 |
% |
|
|
5.3 |
% |
|
|
6.0 |
% |
Rate of compensation increase |
|
|
|
* |
|
|
3.9 |
% |
|
|
|
* |
|
|
3.4 |
% |
The weighted averages of the assumptions used to calculate the
net periodic pension cost for the years ended December 31 were
as follows:
20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
2008 |
|
|
|
Netherlands |
|
|
other |
|
|
Netherlands |
|
|
other |
|
Discount rate |
|
|
4.3 |
% |
|
|
5.2 |
% |
|
|
4.8 |
% |
|
|
5.6 |
% |
Expected returns on plan assets |
|
|
5.7 |
% |
|
|
6.1 |
% |
|
|
5.7 |
% |
|
|
6.4 |
% |
Rate of compensation increase |
|
|
|
* |
|
|
3.5 |
% |
|
|
|
* |
|
|
3.9 |
% |
|
|
|
* |
|
The rate of compensation increase for the Netherlands consists of a general compensation increase
and an individual salary increase based on seniority and promotion. The average individual salary
increase for all active participants for the remaining working lifetime is estimated at 0.75%
annually. The assumed rate of general compensation increase for the Netherlands for calculating
the projected benefit obligation amounts to 2.0% (2007: 2.3%).The indexation assumption used to
calculate the projected benefit obligation for the Netherlands is 1.0% (2007: 1.15%). |
Philips Annual Report 2008 161
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124
|
|
US GAAP financial statements
|
|
|
180 |
|
|
Sustainability performance
|
|
|
192 |
|
|
IFRS financial statements
|
|
|
244 |
|
|
Company financial statements |
|
|
|
Notes to the US GAAP financial statements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The components of net periodic pension costs and amounts recognized in Other comprehensive income
were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Netherlands |
|
|
other |
|
|
total |
|
2008 |
|
|
|
|
|
|
|
|
|
|
|
|
Service cost |
|
|
135 |
|
|
|
84 |
|
|
|
219 |
|
Interest cost on the projected benefit obligation |
|
|
524 |
|
|
|
398 |
|
|
|
922 |
|
Expected return on plan assets |
|
|
(769 |
) |
|
|
(380 |
) |
|
|
(1,149 |
) |
Net actuarial (gain) loss recognized |
|
|
(15 |
) |
|
|
68 |
|
|
|
53 |
|
Amortization of prior-service cost |
|
|
(43 |
) |
|
|
9 |
|
|
|
(34 |
) |
Settlement loss |
|
|
|
|
|
|
1 |
|
|
|
1 |
|
Other |
|
|
(3 |
) |
|
|
1 |
|
|
|
(2 |
) |
Net periodic cost (income) |
|
|
(171 |
) |
|
|
181 |
|
|
|
10 |
|
Items recognized in other comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
Current year |
|
|
|
|
|
|
|
|
|
|
|
|
- Net actuarial loss (gain) |
|
|
153 |
|
|
|
434 |
|
|
|
587 |
|
- Prior-service cost (credit) |
|
|
|
|
|
|
(1 |
) |
|
|
(1 |
) |
Reclassified/included in pension costs |
|
|
|
|
|
|
|
|
|
|
|
|
- Amortization of net actuarial gains and losses |
|
|
15 |
|
|
|
(70 |
) |
|
|
(55 |
) |
- Amortization prior-service costs (credits) |
|
|
43 |
|
|
|
(9 |
) |
|
|
34 |
|
|
|
|
211 |
|
|
|
354 |
|
|
|
565 |
|
Recognized in net periodic benefit cost and other comprehensive income |
|
|
40 |
|
|
|
535 |
|
|
|
575 |
|
2007 |
|
|
|
|
|
|
|
|
|
|
|
|
Service cost |
|
|
147 |
|
|
|
118 |
|
|
|
265 |
|
Interest cost on the projected benefit obligation |
|
|
521 |
|
|
|
399 |
|
|
|
920 |
|
Expected return on plan assets |
|
|
(813 |
) |
|
|
(384 |
) |
|
|
(1,197 |
) |
Net acturial (gain) loss recognized |
|
|
(6 |
) |
|
|
79 |
|
|
|
73 |
|
Amortization of prior-service cost |
|
|
(43 |
) |
|
|
14 |
|
|
|
(29 |
) |
Settlement loss |
|
|
|
|
|
|
(7 |
) |
|
|
(7 |
) |
Curtailment gain |
|
|
|
|
|
|
2 |
|
|
|
2 |
|
Net periodic cost (income) |
|
|
(194 |
) |
|
|
221 |
|
|
|
27 |
|
Items recognized in other comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
Current year |
|
|
|
|
|
|
|
|
|
|
|
|
- Net actuarial loss (gain) |
|
|
(174 |
) |
|
|
(139 |
) |
|
|
(313 |
) |
- Prior-service cost (credit) |
|
|
|
|
|
|
(2 |
) |
|
|
(2 |
) |
Reclassified/included in pension costs |
|
|
|
|
|
|
|
|
|
|
|
|
- Amortization of net actuarial gains and losses |
|
|
6 |
|
|
|
(79 |
) |
|
|
(73 |
) |
- Amortization prior-service costs (credits) |
|
|
43 |
|
|
|
(14 |
) |
|
|
29 |
|
|
|
|
(125 |
) |
|
|
(234 |
) |
|
|
(359 |
) |
Recognized in net periodic benefit cost and other comprehensive income |
|
|
(319 |
) |
|
|
(13 |
) |
|
|
(332 |
) |
2006 |
|
|
|
|
|
|
|
|
|
|
|
|
Service cost |
|
|
198 |
|
|
|
129 |
|
|
|
327 |
|
Interest cost on the projected benefit obligation |
|
|
531 |
|
|
|
411 |
|
|
|
942 |
|
Expected return on plan assets |
|
|
(808 |
) |
|
|
(390 |
) |
|
|
(1,198 |
) |
Net amortization of unrecognized net transition assets/liabilities |
|
|
|
|
|
|
1 |
|
|
|
1 |
|
Net actuarial (gain) loss recognized |
|
|
(49 |
) |
|
|
84 |
|
|
|
35 |
|
Amortization of prior-service cost |
|
|
(56 |
) |
|
|
25 |
|
|
|
(31 |
) |
Settlement loss |
|
|
8 |
|
|
|
2 |
|
|
|
10 |
|
Curtailment gain |
|
|
(21 |
) |
|
|
(1 |
) |
|
|
(22 |
) |
Other |
|
|
5 |
|
|
|
23 |
|
|
|
28 |
|
Net periodic cost (income)1) |
|
|
(192 |
) |
|
|
284 |
|
|
|
92 |
|
|
|
|
1) |
|
Of which EUR 17 million (Netherlands EUR (12) million, other EUR 29 million) is related to
discontinued operations |
162 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
non-US GAAP information
|
|
|
254 |
|
|
Corporate governance
|
|
|
262 |
|
|
Ten-year overview
|
|
|
266 |
|
|
Investor information |
The Company also sponsors defined-contribution
and similar types of plans for a significant
number of salaried employees.
The total cost of these plans amounted to EUR
96 million (2007: EUR 84 million, 2006: EUR 80
million). In 2008, the defined-contribution
cost includes contributions to multi-employer
plans of EUR 4 million (2007: EUR 4 million,
2006: EUR 4 million).
Cash flows
The Company expects considerable cash outflows
in relation to employee benefits which are
estimated to amount to EUR 414 million in 2009
(2008 actual: EUR 379 million), consisting of
EUR 248 million employer contributions to
defined-benefit pension plans, EUR 100 million
employer contributions to defined-contribution
pension plans, and EUR 66 million expected cash
outflows in relation to unfunded pension plans.
The employer contributions to defined-benefit
pension plans are expected to amount to EUR 180
million for the Netherlands and EUR 68 million
for other countries.
Estimated future pension benefit payments
The following benefit payments are expected:
|
|
|
|
|
2009 |
|
|
1,136 |
|
2010 |
|
|
1,138 |
|
2011 |
|
|
1,149 |
|
2012 |
|
|
1,162 |
|
2013 |
|
|
1,173 |
|
Years 2014-2018 |
|
|
5,943 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Netherlands |
|
|
other |
|
|
total |
|
The accumulated benefit
obligation for all defined-benefit pension plans was |
|
|
|
|
|
|
|
|
|
|
|
|
2008 |
|
|
10,170 |
|
|
|
6,304 |
|
|
|
16,474 |
|
2007 |
|
|
10,944 |
|
|
|
7,123 |
|
|
|
18,067 |
|
Plan assets: investment policies/strategies
Investment policies are reviewed at least once
per year. The resulting investment plans
determine the strategic asset allocations, the
constraints on any tactical deviation from
such strategic allocations, and the
constraints on amongst others geographical
allocations and credit risk, and will be
reflected in the investment guidelines to the
respective investment managers. In order to
keep the investment strategies in balance with
pension obligations, asset-liability reviews
are carried out at least once every three
years. Generally, plan assets are invested in
global equity and debt markets (with the
exception of debt or equity instruments that
have been issued by the Company or any of its
subsidiaries) and property. Derivatives of
equity and debt instruments may be used to
realize swift changes in investment
portfolios, to hedge against unfavorable
market developments or to fine tune any
matching of assets and liabilities.
Plan assets in the Netherlands
The Companys pension plan asset allocation
in the Netherlands at December 31, 2007 and
2008 was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
2008 |
|
Matching portfolio |
|
|
59 |
|
|
|
|
|
|
|
75 |
|
|
|
|
|
- Debt securities |
|
|
|
|
|
|
59 |
|
|
|
|
|
|
|
75 |
|
Return portfolio |
|
|
41 |
|
|
|
|
|
|
|
25 |
|
|
|
|
|
- Equity securities |
|
|
|
|
|
|
28 |
|
|
|
|
|
|
|
13 |
|
- Real Estate |
|
|
|
|
|
|
8 |
|
|
|
|
|
|
|
4 |
|
- Other |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
8 |
|
|
|
|
|
|
|
|
100 |
|
|
|
|
|
|
|
100 |
|
The objective of the Matching portfolio is to
match the interest rate sensitivity of the
plans real pension liabilities. The Matching
portfolio is mainly invested in
euro-denominated government bonds and
investment grade debt securities and
derivatives. Leverage or gearing
is not permitted. The size of the Matching
portfolio is supposed to be at least 70% of the
fair value of the plans real pension
obligations (on the assumption of 2%
inflation). The objective of the Return
portfolio is to maximize returns within
well-specified risk constraints. The long-term
rate of return on total plan assets is expected
to be 5.95% per annum, based on expected
long-term returns on equity securities, debt
securities, real estate and other investments
of 8.3%, 4.0%, 6.5% and 5.0%, respectively.
Philips Pension Fund in the Netherlands
On November 13, 2007, various officials, on
behalf of the Public Prosecutors office in The
Netherlands, visited a number of offices of the
Philips Pension Fund and the Company in
relation to a widespread investigation into
potential fraud in the real estate sector. The
Company was notified that one former employee
and one employee of an affiliate of the Company
had been detained. This affiliate, Philips Real
Estate Investment Management BV, managed the
real estate portfolio of the Philips Pension
Fund between 2002 and 2007. The investigation
by the public prosecutor is concerned with the
potential involvement of (former) employees of
a number of Dutch companies with respect to
fraud in the context of certain real estate
transactions. Neither Philips Pension Fund nor
any Philips entity is a suspect in this
investigation. The Philips Pension Fund and
Philips are cooperating with the authorities
and have also started their own investigation.
The investigators expect to finalize their
report in early 2009. Formal notifications of
suspected fraud have been filed with the public
prosecutor against the (former) employees
concerned and with our insurers. If any losses
have been suffered, action will be taken to
recover such losses from the responsible
individuals or legal entities. At this time it
is not possible to assess the outcome of this
matter nor the potential consequences. At
present it is managements assessment that this
matter will not cause a decline in plan assets
or an increase in pension costs in any material
respect.
Plan assets in other countries
The pension plan asset allocations in other
countries at December 31, 2007 and December
31, 2008 are shown in the table below. This
table also shows the target allocation for
2009.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
target |
|
|
|
|
|
|
|
|
|
|
|
allocation |
|
Asset category |
|
2007 |
|
|
2008 |
|
|
2009 |
|
|
|
% |
|
|
% |
|
|
% |
|
Equity securities |
|
|
24 |
|
|
|
18 |
|
|
|
20 |
|
Debt securities |
|
|
73 |
|
|
|
73 |
|
|
|
74 |
|
Real estate |
|
|
2 |
|
|
|
3 |
|
|
|
2 |
|
Other |
|
|
1 |
|
|
|
6 |
|
|
|
4 |
|
|
|
|
100 |
|
|
|
100 |
|
|
|
100 |
|
SFAS No. 158
In September 2006, SFAS No. 158 was issued.
This statement requires an employer to
recognize the funded status of a benefit plan -
measured as the difference between plan assets
at fair value and the benefit obligation - in
the balance sheet. The offset of recognizing the
funded status is recorded in accumulated other
comprehensive income (within stockholders
equity). Additionally, the additional minimum
pension liability and related intangible assets
are derecognized upon adoption of this
standard. The incremental effect of applying
FASB Statement No. 158 on Accumulated other
comprehensive income as of December 31, 2006,
amounted to a decrease of EUR 477 million.
21
Postretirement benefits other than pensions
In addition to providing pension benefits, the
Company provides other postretirement benefits,
primarily retiree healthcare benefits, in
certain countries. The Company funds those
other postretirement benefit plans as claims
are incurred.
The table below provides a summary of the
changes in the accumulated postretirement
benefit obligations for 2007 and 2008. It also
provides a reconciliation of the obligations to
the amounts recognized in the consolidated
balance sheets.
All the postretirement benefit plans are
unfunded and therefore no plan asset
disclosures are presented.
Philips Annual Report 2008 163
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124
|
|
US GAAP financial statements
|
|
|
180 |
|
|
Sustainability performance
|
|
|
192 |
|
|
IFRS financial statements
|
|
|
244 |
|
|
Company financial statements |
|
|
|
Notes to the US GAAP financial statements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Netherlands |
|
|
other |
|
|
total |
|
2008 |
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated postretirement benefit obligation |
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated benefit obligation at beginning of year |
|
|
7 |
|
|
|
406 |
|
|
|
413 |
|
Service cost |
|
|
|
|
|
|
3 |
|
|
|
3 |
|
Interest cost |
|
|
|
|
|
|
34 |
|
|
|
34 |
|
Actuarial gains |
|
|
|
|
|
|
(49 |
) |
|
|
(49 |
) |
Benefits paid |
|
|
(4 |
) |
|
|
(20 |
) |
|
|
(24 |
) |
Exchange rate differences |
|
|
|
|
|
|
(36 |
) |
|
|
(36 |
) |
Miscellaneous |
|
|
|
|
|
|
12 |
|
|
|
12 |
|
Accumulated benefit obligation at end of year |
|
|
3 |
|
|
|
350 |
|
|
|
353 |
|
Funded status |
|
|
(3 |
) |
|
|
(350 |
) |
|
|
(353 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts recognized in the consolidated balance sheet |
|
|
|
|
|
|
|
|
|
|
|
|
Current provisions |
|
|
(1 |
) |
|
|
(22 |
) |
|
|
(23 |
) |
Non-current provisions |
|
|
(2 |
) |
|
|
(328 |
) |
|
|
(330 |
) |
Net pension liability at year-end |
|
|
(3 |
) |
|
|
(350 |
) |
|
|
(353 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts recognized in accumulated other comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
Net actuarial loss |
|
|
|
|
|
|
26 |
|
|
|
26 |
|
Prior-service cost |
|
|
|
|
|
|
(3 |
) |
|
|
(3 |
) |
Transition obligation |
|
|
|
|
|
|
18 |
|
|
|
18 |
|
Accumulated other comprehensive income |
|
|
|
|
|
|
41 |
|
|
|
41 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated postretirement benefit obligation |
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated benefit obligation at beginning of year |
|
|
10 |
|
|
|
363 |
|
|
|
373 |
|
Service cost |
|
|
|
|
|
|
3 |
|
|
|
3 |
|
Interest cost |
|
|
|
|
|
|
26 |
|
|
|
26 |
|
Actuarial gains |
|
|
|
|
|
|
47 |
|
|
|
47 |
|
Settlements |
|
|
|
|
|
|
(6 |
) |
|
|
(6 |
) |
Benefits paid |
|
|
(3 |
) |
|
|
(29 |
) |
|
|
(32 |
) |
Exchange rate differences |
|
|
|
|
|
|
(19 |
) |
|
|
(19 |
) |
Miscellaneous |
|
|
|
|
|
|
21 |
|
|
|
21 |
|
Accumulated benefit obligation at end of year |
|
|
7 |
|
|
|
406 |
|
|
|
413 |
|
Funded status |
|
|
(7 |
) |
|
|
(406 |
) |
|
|
(413 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts recognized in the consolidated balance sheet |
|
|
|
|
|
|
|
|
|
|
|
|
Current provisions |
|
|
(3 |
) |
|
|
(20 |
) |
|
|
(23 |
) |
Non-current provisions |
|
|
(4 |
) |
|
|
(386 |
) |
|
|
(390 |
) |
Net pension liability at year-end |
|
|
(7 |
) |
|
|
(406 |
) |
|
|
(413 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts recognized in accumulated other comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
Net actuarial loss |
|
|
|
|
|
|
96 |
|
|
|
96 |
|
Prior-service cost |
|
|
|
|
|
|
(4 |
) |
|
|
(4 |
) |
Transition obligation |
|
|
|
|
|
|
25 |
|
|
|
25 |
|
Accumulated other comprehensive income |
|
|
|
|
|
|
117 |
|
|
|
117 |
|
164 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
non-US GAAP information
|
|
|
254 |
|
|
Corporate governance
|
|
|
262 |
|
|
Ten-year overview
|
|
|
266 |
|
|
Investor information |
The components of the net periodic cost of postretirement benefits other than pensions are:
|
|
|
|
|
|
|
total |
|
2008 |
|
|
|
|
Service cost |
|
|
3 |
|
Interest cost on accumulated postretirement benefit obligation |
|
|
34 |
|
Amortization of unrecognized transition obligation |
|
|
4 |
|
Net actuarial loss recognized |
|
|
6 |
|
Net periodic cost |
|
|
47 |
|
|
|
|
|
|
Items recognized in other comprehensive income |
|
|
|
|
Current year |
|
|
|
|
Net actuarial loss (gain) |
|
|
(64 |
) |
Prior-service cost (credit) |
|
|
1 |
|
Transition obligation |
|
|
(3 |
) |
Reclassified/included in pension costs |
|
|
|
|
Amortization of net actuarial gains and losses |
|
|
(6 |
) |
Amortization of transition amounts |
|
|
(4 |
) |
|
|
|
(76 |
) |
|
|
|
|
|
Recognized in net periodic benefit cost and other comprehensive income |
|
|
(29 |
) |
|
|
|
|
|
2007 |
|
|
|
|
Service cost |
|
|
3 |
|
Interest cost on accumulated postretirement benefit obligation |
|
|
26 |
|
Amortization of unrecognized transition obligation |
|
|
5 |
|
Net actuarial loss recognized |
|
|
2 |
|
Net periodic cost |
|
|
36 |
|
|
|
|
|
|
Items recognized in other comprehensive income |
|
|
|
|
Current year |
|
|
|
|
Net actuarial loss (gain) |
|
|
58 |
|
Prior-service cost (credit) |
|
|
(6 |
) |
Transition obligation |
|
|
(2 |
) |
Reclassified/included in pension costs |
|
|
|
|
Amortization of net actuarial gains and losses |
|
|
(2 |
) |
Amortization of transition amounts |
|
|
(5 |
) |
|
|
|
43 |
|
|
|
|
|
|
Recognized in net periodic benefit cost and other comprehensive income |
|
|
79 |
|
|
|
|
|
|
2006 |
|
|
|
|
Service cost |
|
|
4 |
|
Interest cost on accumulated postretirement benefit obligation |
|
|
26 |
|
Amortization of unrecognized transition obligation |
|
|
5 |
|
Net actuarial loss recognized |
|
|
4 |
|
Net periodic cost |
|
|
39 |
|
Philips Annual Report 2008 165
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124
|
|
US GAAP financial statements
|
|
|
180 |
|
|
Sustainability performance
|
|
|
192 |
|
|
IFRS financial statements
|
|
|
244 |
|
|
Company financial statements |
|
|
|
Notes to the US GAAP
financial statements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The weighted averages of the assumptions
used to calculate the postretirement
benefit obligations as of December 31 were
as follows:
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Discount rate |
|
|
8.5 |
% |
|
|
9.7 |
% |
Compensation increase (where applicable) |
|
|
|
|
|
|
|
|
The weighted averages of the assumptions used
to calculate the net periodic cost for years
ended December 31 were as follows:
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Discount rate |
|
|
7.2 |
% |
|
|
8.5 |
% |
Compensation increase (where applicable) |
|
|
|
|
|
|
|
|
Assumed healthcare cost trend rates at December 31:
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Healthcare cost trend rate assumed for next years |
|
|
9.0 |
% |
|
|
10.0 |
% |
Rate that the cost trend rate will gradually reach |
|
|
7.0 |
% |
|
|
7.5 |
% |
Year of reaching the rate at which it is assumed
to remain |
|
|
2015 |
|
|
|
2016 |
|
Assumed healthcare cost trend rates have a
significant effect on the amounts reported
for the retiree medical plans. A
one-percentage-point change in assumed
healthcare cost trend rates would have the
following effects:
|
|
|
|
|
|
|
|
|
|
|
one- |
|
|
one- |
|
|
|
percentage- |
|
|
percentage- |
|
|
|
point |
|
|
point |
|
|
|
increase |
|
|
decrease |
|
Effect on total of service and interest cost |
|
|
5 |
|
|
|
(4 |
) |
Effect on postretirement benefit obligation |
|
|
36 |
|
|
|
(32 |
) |
Estimated future postretirement benefit payments
The following postretirement benefit payments are expected:
|
|
|
|
|
2009 |
|
|
24 |
|
2010 |
|
|
25 |
|
2011 |
|
|
26 |
|
2012 |
|
|
27 |
|
2013 |
|
|
28 |
|
Years 2014 - 2018 |
|
|
172 |
|
22
Other current liabilities
Other current liabilities are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Advances received from customers on orders
not covered by work in process |
|
|
133 |
|
|
|
148 |
|
Other taxes including social security premiums |
|
|
253 |
|
|
|
251 |
|
Other short-term liabilities |
|
|
123 |
|
|
|
124 |
|
|
|
|
509 |
|
|
|
523 |
|
23
Short-term debt
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Short-term bank borrowings |
|
|
464 |
|
|
|
562 |
|
Other short-term loans |
|
|
32 |
|
|
|
24 |
|
Current portion of long-term debt |
|
|
1,849 |
|
|
|
131 |
|
|
|
|
2,345 |
|
|
|
717 |
|
During 2008, the weighted average interest rate
on the bank borrowings was 8.6% (2007: 7.9%).
In the Netherlands, the Company issues
personnel debentures with a 5-year right of
conversion into common shares of Royal Philips
Electronics. Convertible personnel debentures
may not be converted within a period of 3 years
after the date of issue. These convertible
personnel debentures are available to most
employees in the Netherlands and are purchased
by them with their own funds and are redeemable
on demand. The convertible personnel debentures
become non-convertible debentures at the end of
the conversion period.
Although convertible debentures have the
character of long-term financing, the total
outstanding amounts are classified as current
portion of long-term debt. At December 31,
2008, an amount of EUR 72 million (2007: EUR
103 million) of convertible personnel
debentures was outstanding, with an average
conversion price of EUR 22.95. The conversion
price varies between EUR 14.19 and EUR 31.59
with various conversion periods ending between
January 1, 2008 and December 31, 2012. As of
January 1, 2009, Philips no longer issues those
debentures.
The Company has access to a USD 2.5 billion
commercial paper program which was established
at the beginning of 2001. The Company also has
available a seven-year revolving credit
facility for USD 2.5 billion, established in
December 2004, that could act as a back-up for
the commercial paper program and can also be
used for general corporate purposes. The
Company did not use the commercial paper
program or the revolving credit facility during
2008.
In addition to the USD 2.5 billion revolving
credit facility, Philips has a EUR 500 million
standby roll-over loan agreement in place. The
availability of EUR 450 million out of this EUR
500 million is committed until April 29, 2010.
As of December 31, 2008, Philips did not have
any loans outstanding under these facilities.
As of December 31, 2008 Philips had an undrawn
committed bilateral loan of EUR 250 million in
place which was fully drawn in January 2009.
166 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
non-US GAAP information
|
|
|
254 |
|
|
Corporate governance
|
|
|
262 |
|
|
Ten-year overview
|
|
|
266 |
|
|
Investor information |
24
Long-term debt
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
average |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
amount |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
remaining |
|
|
amount |
|
|
|
range of |
|
|
average rate |
|
|
outstanding |
|
|
|
|
|
|
due after 1 |
|
|
due after 5 |
|
|
term (in |
|
|
outstanding |
|
|
|
interest rates |
|
|
of interest |
|
|
2008 |
|
|
due in 1 year |
|
|
year |
|
|
years |
|
|
years) |
|
|
2007 |
|
Eurobonds |
|
|
6.1-6.1 |
% |
|
|
6.1 |
% |
|
|
750 |
|
|
|
|
|
|
|
750 |
|
|
|
|
|
|
|
2.4 |
|
|
|
2,442 |
|
USD bonds |
|
|
3.3-7.8 |
% |
|
|
5.9 |
% |
|
|
2,522 |
|
|
|
|
|
|
|
2,522 |
|
|
|
1,822 |
|
|
|
14.0 |
|
|
|
357 |
|
Convertible debentures |
|
|
1.7-1.7 |
% |
|
|
1.7 |
% |
|
|
81 |
|
|
|
72 |
|
|
|
9 |
|
|
|
|
|
|
|
2.6 |
|
|
|
103 |
|
Private financing |
|
|
1.0-12.4 |
% |
|
|
4.5 |
% |
|
|
8 |
|
|
|
1 |
|
|
|
7 |
|
|
|
|
|
|
|
1.8 |
|
|
|
9 |
|
Bank borrowings |
|
|
1.0-16.3 |
% |
|
|
5.1 |
% |
|
|
11 |
|
|
|
|
|
|
|
11 |
|
|
|
4 |
|
|
|
3.6 |
|
|
|
4 |
|
Finance Leases |
|
|
1.0-11.3 |
% |
|
|
3.0 |
% |
|
|
135 |
|
|
|
4 |
|
|
|
131 |
|
|
|
46 |
|
|
|
3.9 |
|
|
|
88 |
|
Other long-term debt |
|
|
2.0-16.4 |
% |
|
|
5.2 |
% |
|
|
65 |
|
|
|
54 |
|
|
|
11 |
|
|
|
1 |
|
|
|
1.4 |
|
|
|
58 |
|
|
|
|
|
|
|
|
5.7 |
% |
|
|
3,572 |
|
|
|
131 |
|
|
|
3,441 |
|
|
|
1,873 |
|
|
|
|
|
|
|
3,061 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corresponding data
of previous year |
|
|
|
|
|
|
5.9 |
% |
|
|
3,061 |
|
|
|
1,849 |
|
|
|
1,212 |
|
|
|
416 |
|
|
|
|
|
|
|
3,213 |
|
The following amounts of long-term debt, as
at December 31, 2008, are due in the next
five years:
|
|
|
|
|
2009 |
|
|
131 |
|
2010 |
|
|
75 |
|
2011 |
|
|
1,020 |
|
2012 |
|
|
14 |
|
2013 |
|
|
459 |
|
Total |
|
|
1,699 |
|
Corresponding amount
of previous year |
|
|
2,645 |
|
In March 2008, Philips placed a total of USD
3,100 million of debt which consisted of a
floating rate note for USD 350 million, and 3
fixed rate bonds totaling USD 2,750 million.
The weighted average interest rate of the new
bonds was 5.66% at December 31, 2008. Philips
used the proceeds of this offering to refinance
the EUR 1,691 million worth of notes that
matured in the first half of 2008. As of
December 31, 2008, Philips had outstanding
public bonds of EUR 3,272 million previously
issued mostly in USD or EUR.
The following table provides additional
details regarding the outstanding bonds.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
effective rate |
|
|
2007 |
|
|
2008 |
|
Unsecured Eurobonds |
|
|
|
|
|
|
|
|
|
|
|
|
Due 2/06/08; 7 1/8% |
|
|
7.302 |
% |
|
|
130 |
|
|
|
|
|
Due 5/14/08; 7% |
|
|
7.094 |
% |
|
|
61 |
|
|
|
|
|
Due 5/16/08; 5 3/4% |
|
|
5.817 |
% |
|
|
1,500 |
|
|
|
|
|
Due 5/16/11; 6 1/8% |
|
|
6.122 |
% |
|
|
750 |
|
|
|
750 |
|
Adjustments1) |
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
2,442 |
|
|
|
750 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unsecured USD Bonds |
|
|
|
|
|
|
|
|
|
|
|
|
Due 5/15/25; 7 3/4% |
|
|
8.010 |
% |
|
|
67 |
|
|
|
70 |
|
Due 6/01/26; 7 1/5% |
|
|
7.426 |
% |
|
|
113 |
|
|
|
118 |
|
Due 8/15/13; 7 1/4% |
|
|
7.554 |
% |
|
|
97 |
|
|
|
101 |
|
Due 5/15/25; 7 1/8% |
|
|
7.361 |
% |
|
|
70 |
|
|
|
73 |
|
Due 11/03/11; 3 3/8% |
|
|
3.128 |
% |
|
|
|
|
|
|
248 |
|
Due 11/03/13; 4 5/8% |
|
|
4.949 |
% |
|
|
|
|
|
|
355 |
|
Due 11/03/18; 5 3/4% |
|
|
6.066 |
% |
|
|
|
|
|
|
887 |
|
Due 11/03/38; 6 7/8% |
|
|
7.210 |
% |
|
|
|
|
|
|
710 |
|
Adjustments1) |
|
|
|
|
|
|
10 |
|
|
|
(40 |
) |
|
|
|
|
|
|
|
357 |
|
|
|
2,522 |
|
|
|
|
1) |
|
Adjustments relate to issued bond
discounts, transaction costs and fair value
adjustments for interest rate derivatives. |
The provisions applicable to all corporate
bonds that have been issued by the Company in
March 2008, contain a Change of Control
Triggering Event. This means that if the
Company would experience such an event, it may
be required to offer to purchase the bonds of
that series at a purchase price equal to 101%
of their principal amount, plus accrued and
unpaid interest, if any.
Secured liabilities
In 2008, EUR 3.5 million of long-term and
short-term debt was secured by collateral
of EUR 3.4 million manufacturing assets
(2007: EUR nil).
Philips Annual Report 2008 167
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124
|
|
US GAAP financial statements
|
|
|
180 |
|
|
Sustainability performance
|
|
|
192 |
|
|
IFRS financial statements
|
|
|
244 |
|
|
Company financial statements |
|
|
|
Notes to the US GAAP financial statements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25
Other non-current liabilities
Other non-current liabilities are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Accrued pension costs |
|
|
369 |
|
|
|
937 |
|
Sale-and-leaseback deferred income |
|
|
31 |
|
|
|
31 |
|
Income tax payable |
|
|
1 |
|
|
|
1 |
|
Asset retirement obligations |
|
|
21 |
|
|
|
20 |
|
Uncertain tax positions |
|
|
429 |
|
|
|
452 |
|
Other liabilities |
|
|
83 |
|
|
|
33 |
|
|
|
|
934 |
|
|
|
1,474 |
|
Please refer to note 6 for a specification
of the income tax payable and the uncertain
tax positions.
26
Contractual obligations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
payments due by period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
more |
|
|
|
|
|
|
less than |
|
|
|
|
|
|
|
|
|
|
than 5 |
|
|
|
|
|
|
1 year |
|
|
1-3 years |
|
|
3-5 years |
|
|
years |
|
|
total |
|
Long-term debt |
|
|
127 |
|
|
|
1,027 |
|
|
|
456 |
|
|
|
1,827 |
|
|
|
3,437 |
|
Finance leases |
|
|
4 |
|
|
|
68 |
|
|
|
17 |
|
|
|
46 |
|
|
|
135 |
|
Operating
leases |
|
|
171 |
|
|
|
229 |
|
|
|
137 |
|
|
|
178 |
|
|
|
715 |
|
|
|
|
302 |
|
|
|
1,324 |
|
|
|
610 |
|
|
|
2,051 |
|
|
|
4,287 |
|
For details about uncertain tax positions
amounting to EUR 559 million, see note note 6
of the notes to US GAAP financial statements.
For an explanation of long-term debt, see note
24. For other long-term liabilities, see note
25. Property, plant and equipment includes EUR
135 million (2007: EUR 88 million) for finance
leases and other beneficial rights of use, such
as buildings rights and hire purchase
agreements.
Long-term operating lease commitments totaled
EUR 715 million at December 31, 2008 (2007:
EUR 730 million). These leases expire at
various dates during the next 20 years.
The long-term operating leases are mainly
related to the rental of buildings. A number
of these leases originate from
sale-and-leaseback arrangements. In 2008, a
small sale-and-operational-leaseback
arrangement was concluded. Operating lease
payments for 2008 totaled EUR 16 million
(2007: EUR 14 million, 2006: EUR 20 million).
The remaining minimum payments are as follows:
|
|
|
|
|
2009 |
|
|
16 |
|
2010 |
|
|
12 |
|
2011 |
|
|
8 |
|
2012 |
|
|
8 |
|
2013 |
|
|
8 |
|
Thereafter |
|
|
41 |
|
27
Contingent liabilities
Guarantees
Philips policy is to provide only guarantees
and other letters of support, in writing.
Philips does not stand by other forms of
support. At the end of 2008, the total fair
value of guarantees was EUR 10 million (2007:
EUR 3 million). The following table outlines
the total outstanding off-balance sheet
credit-related guarantees and business-related
guarantees provided by Philips for the benefit
of unconsolidated companies and third parties
as at December 31, 2008.
Expiration per period
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
business- |
|
|
credit- |
|
|
|
|
|
|
related |
|
|
related |
|
|
|
|
|
|
guarantees |
|
|
guarantees |
|
|
total |
|
2008 |
|
|
|
|
|
|
|
|
|
|
|
|
Total amounts committed |
|
|
443 |
|
|
|
42 |
|
|
|
485 |
|
Less than 1 year |
|
|
205 |
|
|
|
18 |
|
|
|
223 |
|
1-5 years |
|
|
78 |
|
|
|
7 |
|
|
|
85 |
|
After 5 years |
|
|
160 |
|
|
|
17 |
|
|
|
177 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
|
|
|
|
|
|
Total amounts committed |
|
|
432 |
|
|
|
45 |
|
|
|
477 |
|
Less than 1 year |
|
|
142 |
|
|
|
5 |
|
|
|
147 |
|
1-5 years |
|
|
95 |
|
|
|
16 |
|
|
|
111 |
|
After 5 years |
|
|
195 |
|
|
|
24 |
|
|
|
219 |
|
Environmental remediation
The Company and its subsidiaries are subject to
environmental laws and regulations. Under these
laws, the Company and/or its subsidiaries may
be required to remediate the effects of the
release or disposal of certain chemicals on the
environment.
In the United States, subsidiaries of the
Company have been named as potentially
responsible parties in state and federal
proceedings for the clean-up of various sites,
including
Superfund sites. The Company applies the
provisions of SOP 96-1, Environmental
Liabilities, and SFAS No. 5, Accounting for
Contingencies, and accrues for losses
associated with environmental obligations when
such losses are probable and reasonably
estimable.
Generally, the costs of future expenditures
for environmental remediation obligations are
not discounted to their present value since
the amounts and the timing of related cash
payments are not reliably determinable.
Potential insurance recoveries are recognized
when recoveries are deemed probable.
Legal proceedings
The Company and certain of its group companies
and former group companies are involved as a
party in legal proceedings, including
regulatory and other governmental proceedings,
including discussions on potential remedial actions, relating to such matters as competition issues,
commercial transactions, product liability,
participations and environmental pollution. In
respect of antitrust laws, the Company and
certain of its group companies and former group
companies are involved in investigations by
competition law authorities in several
jurisdictions and are engaged in litigation in
this respect. Since the ultimate disposition of
asserted claims and proceedings and
investigations cannot be predicted with
certainty, an adverse outcome could have a
material adverse effect on the Companys
consolidated financial position and
consolidated results of operations for a
particular period.
Provided below are disclosures of the more significant cases:
Asbestos
Judicial proceedings have been brought in the
United States, relating primarily to the
activities of the Companys US subsidiary TH
Agriculture & Nutrition L.L.C. (THAN) prior to
1981, involving allegations of personal injury
from alleged asbestos exposure. The claims
generally relate to asbestos used in the
manufacture of unrelated companies products in
the United States and frequently involved
claims for substantial compensatory and
punitive damages. THANs businesses which
allegedly gave rise to these alleged
liabilities were completely sold in 1984 and
its ongoing operations are not material to its
parent, Philips Electronics North America
Corporation (PENAC), or the Company.
During the past several years, certain of the
asserted claims were settled. Additionally,
various alternatives for resolving pending and
future claims were explored, including the
possibility of THAN filing for bankruptcy. In
the fourth quarter of 2008, THAN solicited
votes for the acceptance of a plan of
reorganization from the holders of asbestos
claims. Approximately ninety percent of the
claimants (both in number and value of claims)
voted in favor of the plan, exceeding the
thresholds of seventy-five percent in number
and two-thirds in value which are required for
a prepackaged bankruptcy under section 524(g)
of the Bankruptcy Code. On November 24, 2008,
THAN filed
168 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
non-US GAAP information
|
|
254
|
|
Corporate governance
|
|
262
|
|
Ten-year overview
|
|
266
|
|
Investor information |
a petition, along with a prepackaged plan of
reorganization, in the U.S. Bankruptcy Court
for the Southern District of New York seeking
reorganization under Chapter 11 of the U.S.
Bankruptcy Code. Under the proposed Plan of
Reorganization, which must be approved by the
Bankruptcy Court and the U.S. District Court
for the Southern District of New York, an
Asbestos Personal Injury Trust (the Trust)
would be established in accordance with section
524(g) of the Bankruptcy Code to assume,
liquidate and satisfy all liabilities of THAN
determined to arise from, or relate to pending
and future claims alleging personal injury or
death based on or related to alleged exposure
to asbestos fiber distributed by THAN, a
product containing asbestos fiber distributed
by THAN, or an asbestos-containing product
distributed by THAN. The Trust would be funded
by a contribution of USD 900 million (EUR 639
million) by PENAC and THAN. Additionally, under
the Plan, PENAC will forgive certain debt of
THAN and assume certain liabilities from THAN.
If approved by the Courts, the Plan of
Reorganization will result in a permanent
injunction directing all claims alleging
personal injury or death from exposure to
asbestos distributed by THAN to the Trust and
will bar all related litigation against THAN,
its affiliates (including PENAC and the
Company) and certain third parties. As a result
of THANs bankruptcy filing, an automatic stay
has been implemented, staying, restraining and
enjoining the commencement or continuation of
any and all actions or other proceedings
against THAN. Additionally, on December 3,
2008, the U.S. Bankruptcy Court issued a
preliminary injunction staying, restraining and
enjoining the commencement or continuation of
any and all actions or other proceedings
against PENAC, its affiliates, and certain
third parties, based on or related to alleged
exposure to asbestos fiber distributed by THAN,
a product containing asbestos fiber distributed
by THAN, or an asbestos-containing product
distributed by THAN.
In connection with these matters, a pre-tax
charge to earnings of EUR 326 million was
recorded in 2008. In 2006, a pre-tax charge to
earnings of EUR 334 million was recognized,
representing the cost of disposing of pending
and estimated future claims filed through 2016.
There was no expense recognized in 2007. At
December 31, 2008, the recorded provision for
loss contingencies with respect to asbestos
product liability amounted to EUR 640 million
(EUR 316 million at December 31, 2007). During
2008, costs of EUR 24 million were incurred
with respect to litigation, claims
administration, insurance recoveries, and
bankruptcy related matters (EUR 27 million was
incurred in 2007 and EUR 15 million was
incurred in 2006).
In prior years, legal proceedings were
commenced against certain third-party insurance
carriers which had provided various types of
product liability coverage to PENAC and THAN.
During 2008 and the last several years,
agreements were reached with certain insurance
carriers resolving disputes with respect to the
interpretation and available limits of the
policies, amounts payable to PENAC and THAN,
and terms under which future settlements and
related defense costs are reimbursable. In
conjunction with these settlements, insurance
recoveries of EUR 87 million were recognized in
2008 (EUR 17 million was recognized in 2007 and
EUR 79 million was recognized in 2006).
Insurers paid EUR 113 million in 2008 (EUR 27
million was paid in 2007 and EUR 34 million was
paid in 2006) for asbestos-related defense and
indemnity costs. At December 31, 2008, EUR 121
million was jointly held by PENAC and THAN in
an insurance settlement proceeds trust for
future contribution to the Trust if the Plan of
Reorganization is approved by the Courts.
Additionally, at December 31, 2008, the
recorded receivable from insurance carriers,
for which settlement agreements have been
reached amounted to EUR 36 million (EUR 62.7
million at December 31, 2007) for the
reimbursement of incurred defense and indemnity
costs as well as for probable recoveries of
accrued projected settlement costs with respect
to pending and future claims, which is
reflected in the Companys consolidated balance
sheet. Insurance receivables have not been
recorded from non-settling insurance carriers.
Litigation against non-settling insurance
carriers continues to be pursued. Additionally,
settlement discussions are also being held with
certain carriers.
MedQuist
On January 22, 2008, Philips and four employees
of Philips affiliates that once served on the
board of directors of MedQuist, Inc. were named
as defendants in a lawsuit filed in New Jersey
state court challenging MedQuists exploration
of strategic alternatives, as well as Philips
ultimate sale of its MedQuist stake to an
unaffiliated third party in August 2008. On
July 10, 2008, the defendants moved to dismiss
the complaint and, on November 24, 2008, the
court dismissed the action in its entirety and
with prejudice. In December 2008 the plaintiff
filed a notice of appeal.
LG Display
On December 11, 2006, LG Display Co. Ltd
(formerly LG.Philips LCD Co. Ltd.), a company
in which the Company holds 13% of the common
stock, announced that officials from the Korean
Fair Trade Commission visited the offices of LG
Display and that it had received a subpoena
from the United States Department of Justice
and similar notice from the Japanese Fair Trade
Commission in connection with inquiries by
those regulators into possible anticompetitive
conduct in the LCD industry.
Subsequent to the public announcement of these
inquiries, certain Philips group companies were
named as defendants in a number of class action
antitrust complaints filed in the United States
courts, seeking damages on behalf of purchasers
of products incorporating thin-film transistor
liquid crystal display panels (TFT-LCD panels),
based on alleged anticompetitive conduct by
manufacturers of such panels. Those lawsuits
were consolidated in two master actions in the
United States District Court for the Northern
District of California: one, asserting a claim
under federal antitrust law, on behalf of
direct purchasers of TFT-LCD panels and
products containing such panels, and another,
asserting claims under federal antitrust law,
as well as various state antitrust and unfair
competition laws, on behalf of indirect
purchasers of such panels and products. On
December 5, 2008, following the partial grant
of motions to dismiss consolidated class action
complaints in those master actions, the
plaintiffs filed amended consolidated class
action complaints, asserting essentially the
same legal claims as those alleged in the prior
complaints. The Company and certain other
companies within the Philips group companies
that were named as defendants in various of the
original complaints have entered into
agreements with the plaintiffs that generally
toll the statutes of limitations applicable to
plaintiffs claims, following which the
plaintiffs agreed to dismiss without prejudice
the claims against the Philips defendants. None
of the companies within the Philips group of
companies currently is named as a defendant in
the pending amended complaints, but the
litigation is continuing. In addition, in
February 2007, certain plaintiffs filed
purported class actions in a United States
court against LG Display and certain current
and former employees and directors of LG
Display for damages based on alleged violations
of U.S. federal securities laws. No Philips
group company is named as a defendant in these
actions.
Beginning in November 2008, several
manufacturers of TFT-LCD panels, including LG
Display, and certain executives of two of those
companies entered into plea agreements with the
United States Department of Justice (DOJ),
pursuant to which those companies and
individuals agreed to plead guilty to
participating in a conspiracy to fix the prices
of TFT-LCD panels. On December 15, 2008, LG
Display and its wholly owned subsidiary, LG
Display America Inc., pleaded guilty to
participating in a conspiracy from September
2001 to June 2006 to fix the price of TFT-LCD
panels sold worldwide. Pursuant to that plea,
LG Display was sentenced to pay in five annual
installments a total of USD 400 million in
criminal fines. The DOJ has announced that its
investigation is continuing. On the basis of
current knowledge, the Company cannot determine
whether a loss is probable with respect to
these actions.
CRT Investigations
On November 21, 2007, the Company announced
that competition law authorities in several
jurisdictions have commenced investigations
into possible anticompetitive activities in
the Cathode-Ray Tubes, or CRT industry. As one
of the companies that formerly was active in
the CRT business, Philips is subject to a
number of these ongoing investigations. The
Company has assisted the regulatory
authorities in these investigations. In the
U.S., Philips has been informed that the
Department of Justice has deferred Philips
obligation to respond to the grand jury
subpoena Philips received in November of 2007.
Subsequent to the public announcement of these
investigations, certain Philips group companies
were named as defendants in over 50 class
action antitrust complaints filed in various
federal district courts in the United States.
These actions allege anticompetitive conduct by
manufacturers of CRTs and seek treble damages
on behalf of direct and indirect purchasers of
CRTs and products incorporating CRTs. These
complaints assert claims under federal
antitrust law, as well as various state
antitrust and unfair competition laws and may
involve joint and several liability among the
named defendants. These actions have been
consolidated by the Judicial Panel for
Multidistrict Litigation for pre-trial
proceedings in the United States District Court
for the Northern District of California.
Pursuant to a Stipulation and Order issued by
the District Court on September 12, 2008, a
broad stay of merits discovery has been imposed
and the Court has set a deadline of March 9,
2009 for the filing of separate consolidated
amended complaints by the direct and indirect
purchasers. Philips intends to move to dismiss
such consolidated amended complaints once they
are filed and otherwise will vigorously defend
these lawsuits.
Philips Annual Report 2008 169
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124
|
|
US GAAP financial statements
Notes to the US GAAP
financial statements
|
|
180
|
|
Sustainability performance
|
|
192
|
|
IFRS financial statements
|
|
244
|
|
Company financial statements |
Certain Philips group companies have also been
named as defendants, in a proposed class
proceeding in Ontario, Canada along with
numerous other participants in the industry.
Philips intends to vigorously oppose the claim,
and the proceedings remain at a preliminary
stage. At this time, no class proceeding has
been certified and no statement of defence has
been filed.
These matters are in their initial stages and
due to the considerable uncertainty associated
with these matters, on the basis of current
knowledge, the Company has concluded that
potential losses cannot be reliably estimated
with respect to these matters. An adverse final
resolution of these investigations and
litigation could have a materially adverse
effect on the Companys consolidated financial
position, results of operations and cashflows.
28
Stockholders equity
Common shares
In 2008, the Companys issued share capital was
reduced by 170,414,994 shares, which were
acquired pursuant to the EUR 5 billion share
repurchase program. As of December 31, 2008,
the issued share capital consists of
972,411,769 common shares, each share having a
par value of EUR 0.20, which shares have been
paid-in in full.
Preference shares
The Stichting Preferente Aandelen Philips has
been granted the right to acquire preference
shares in the Company. Such right has not been
exercised. As a means to protect the Company
and its stakeholders against an unsolicited
attempt to acquire (de facto) control of the
Company, the General Meeting of Shareholders in
1989 adopted amendments to the Companys
articles of association that allow the Board of
Management and the Supervisory Board to issue
(rights to acquire) preference shares to a
third party. As of December 31, 2008, no
preference shares have been issued.
Option rights/restricted shares
The Company has granted stock options on
its common shares and rights to receive
common shares in future (see note 33).
Treasury shares
In connection with the Companys share
repurchase programs, shares which have been
repurchased and are held in treasury for (i)
delivery upon exercise of options and
convertible personnel debentures and under
restricted share programs and employee share
purchase programs and (ii) capital reduction
purposes, are accounted for as a reduction of
stockholders equity. Treasury shares are
recorded at cost, representing the market price
on the acquisition date. When issued, shares
are removed from treasury stock on a FIFO
basis.
Any difference between the cost and the cash
received at the time treasury shares are
issued, is recorded in capital in excess of
par value, except in the situation in which
the cash received is lower than cost, and
capital in excess of par has been depleted.
In order to reduce potential dilution
effects, the following transactions
took place:
|
|
|
|
|
|
|
2007 |
|
2008 |
Shares acquired
|
|
27,326,969
|
|
273 |
Average market
price
|
|
EUR 29.65
|
|
EUR 24.61 |
Amount paid
|
|
EUR 810 million
|
|
|
Shares delivered
|
|
11,140,884
|
|
4,541,969 |
Average market
price
|
|
EUR 30.46
|
|
EUR 23.44 |
Amount received
|
|
EUR 199 million
|
|
EUR 52 million |
Total shares in
treasury at end of
year
|
|
52,119,611
|
|
47,577,915 |
Total cost
|
|
EUR 1,393 million
|
|
EUR 1,263 million |
In order to reduce capital stock, the following
transactions took place in 2007 and 2008:
|
|
|
|
|
|
|
2007 |
|
2008 |
Shares acquired
|
|
25,813,898
|
|
146,453,094 |
Average market
price
|
|
EUR 31.87
|
|
EUR 22.52 |
Amount paid
|
|
EUR 823 million
|
|
EUR 3,298 million |
Reduction of capital
stock
|
|
|
|
170,414,994 |
Total shares in
treasury at year-end
|
|
25,813,898
|
|
1,851,998 |
Total cost
|
|
EUR 823 million
|
|
EUR 25 million |
Net income (loss) and proposed distribution
to shareholders
The net loss of 2008 will
be accounted for in retained earnings. A
distribution from retained earnings of EUR
0.70 per common share will be proposed to
the 2009 Annual General Meeting of
Shareholders.
Limitations on the distribution of
stockholders equity
Pursuant to Dutch law
certain limitations exist relating to the
distribution of stockholders equity amounting
to EUR 1,296 million (2007: EUR 2,915
million).
29
Cash from derivatives
The Company has no trading derivatives. A total
of EUR 337 million cash was received with
respect to foreign exchange derivative
contracts related to financing of subsidiaries
(2007: EUR 385 million; 2006: EUR 62 million).
Cash flow from interest-related derivatives is
part of cash flow from operating activities.
During 2008, there was a cash inflow in
relation to these derivatives of EUR 28 million
(2007: EUR 2 million cash outflow; 2006: EUR 1
million cash outflow).
30
Proceeds from other non-current financial assets
In 2008, the sale of TSMC shares, LG Display
shares, D&M and Pace shares generated cash
totaling EUR 2,553 million.
In 2007, the sale of TSMC shares, Nuance
Communications shares and JDS Uniphase shares
generated cash totaling EUR 4,002 million.
In 2006, there were no material proceeds
from the sale of other non-current
financial assets.
31
Assets received in lieu of cash from the sale of businesses
In April 2008, the Company acquired 64.5
million shares in Pace Micro Technology in
exchange for the transfer of the Companys
Set-Top Boxes and Connectivity Solutions
activities which represented a value of EUR 74
million at the date of the closing of that
transaction.
In August 2008, Philips transferred its 69.5%
ownership in Medquist to CBAY. A part of the
consideration was settled through the
issuance of a convertible bond by CBAY which
represented a fair value of EUR 53 million at
the date of the closing of the transaction.
In September 2008, Philips acquired a 33.5%
interest in Prime Technology Ventures III
in exchange for the transfer of seven
incubator activities which represented a
value of EUR 21 million at the date of the
closing of that transaction.
In 2007, the Company only received cash
as consideration in connection with the
sale of businesses.
During 2006, several ownership interests were
received in connection with certain sale and
transfer transactions.
At the beginning of July 2006, Philips
transferred its Optical Pick Up activities to
Arima Devices in exchange for a 12% interest
in Arima Devices valued at EUR 8 million.
170 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
non-US GAAP information
|
|
254
|
|
Corporate governance
|
|
262
|
|
Ten-year overview
|
|
266
|
|
Investor information |
In June 2006, the merger of Philips Mobile
Display Systems with Toppoly Optoelectronics
Corporation of Taiwan to form a new company
named Toppoly Display Corporation was
completed. Philips obtained a 17.5% stake in
this entity as consideration for the
transaction valued at EUR 180 million.
32
Related-party transactions
In the normal course of business, Philips
purchases and sells goods and services to
various related parties in which Philips
typically holds a 50% or less equity interest
and has significant influence. These
transactions are generally conducted on terms
comparable to transactions with third parties.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Purchases of goods and services |
|
|
2,041 |
|
|
|
1,837 |
|
|
|
692 |
|
Sales of goods and services |
|
|
152 |
|
|
|
168 |
|
|
|
174 |
|
Receivables from related parties |
|
|
37 |
|
|
|
26 |
|
|
|
24 |
|
Payables to related parties |
|
|
271 |
|
|
|
289 |
|
|
|
112 |
|
For acquisitions and divestments see note 2.
For remuneration details of the
members of the Board of Management and
the Supervisory Board see note 34.
33
Share-based compensation
The Company has granted stock options on its
common shares and rights to receive common
shares in the future (restricted share rights)
to members of the Board of Management and other
members of the Group Management Committee,
Philips executives and certain selected
employees. The purpose of the share-based
compensation plans is to align the interests of
management with those of shareholders by
providing incentives to improve the Companys
performance on a long-term basis, thereby
increasing shareholder value. Under the
Companys plans, options are granted at fair
market value on the date of grant.
The Company issues restricted share rights that
vest in equal annual installments over a
three-year period, starting one year after the
date of grant. If the grantee still holds the
shares after three years from the delivery
date, Philips will grant 20% additional
(premium) shares, provided the grantee is still
with the Company on the respective delivery
dates.
The Company grants stock options that expire
after 10 years. Generally, the options vest
after 3 years; however, a limited number of
options granted to certain employees of
acquired businesses may contain accelerated
vesting. Of the total stock options that are
outstanding as of December 31, 2008,
approximately 3 million options contain
performance conditions.
In contrast to the year 2001 and certain
prior years, when variable (performance)
stock options were issued, the share-based
compensation grants as from 2002 consider
the performance of the Company versus a peer
group of multinationals.
USD-denominated stock options and
restricted share rights are granted to
employees in the United States only.
Under the terms of employee stock purchase
plans established by the Company in various
countries, substantially all employees in those
countries are eligible to purchase a limited
number of shares of Philips stock at discounted
prices through payroll withholdings, of which
the maximum ranges from 8.5% to 10% of total
salary. Generally, the discount provided to the
employees is in the range of 10% to 20%. A
total of 1,051,206 shares were sold in 2008
under the plan at an average price of EUR 21.82
(2007: 707,717 shares at EUR 29.99, 2006:
1,016,421 shares at EUR 24.70).
In the Netherlands, Philips issues personnel
debentures with a 2-year right of conversion
into common shares of Royal Philips Electronics
starting three years after the date of
issuance, with a conversion price equal to the
share price on that date. The fair value of the
conversion option of EUR 2.13 in 2008 (EUR 4.01
in 2007 and EUR 6.41 in 2006) is recorded as
compensation expense over the period of
vesting. In 2008, 485,331 shares were issued in
conjunction with conversions at an average
price of EUR 19.13 (2007: 2,019,788 shares at
an average price of 18.94, 2006: 1,570,785
shares at an average price of EUR 16.94).
Share-based compensation expense was EUR 78
million, EUR 111 million and EUR 107
million, in 2008, 2007, and 2006,
respectively.
The fair value of the Companys 2008, 2007
and 2006 option grants was estimated using a
Black-Scholes option valuation model and the
following weighted average assumptions:
EUR-denominated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Risk-free interest rate |
|
|
3.63 |
% |
|
|
4.18 |
% |
|
|
3.75 |
% |
Expected dividend yield |
|
|
1.8 |
% |
|
|
1.8 |
% |
|
|
2.4 |
% |
Expected option life |
|
6 yrs |
|
6 yrs |
|
6 yrs |
Expected stock price
volatility |
|
|
39 |
% |
|
|
27 |
% |
|
|
26 |
% |
USD-denominated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Risk-free interest rate |
|
|
4.73 |
% |
|
|
3.96 |
% |
|
|
3.17 |
% |
Expected dividend yield |
|
|
1.8 |
% |
|
|
1.7 |
% |
|
|
2.8 |
% |
Expected option life |
|
6 yrs |
|
6 yrs |
|
6 yrs |
Expected stock price
volatility |
|
|
38 |
% |
|
|
28 |
% |
|
|
27 |
% |
The assumptions were used for these
calculations only and do not necessarily
represent an indication of Managements
expectations of future developments.
The Black-Scholes option valuation model was
developed for use in estimating the fair
value of traded options which have no vesting
restrictions and are fully transferable. In
addition, option valuation models require the
input of subjective assumptions, including
the expected price volatility.
The Company has based its volatility
assumptions on historical experience for a
period that approximates the expected life
of the options. The expected life of the
options is also based upon historical
experience.
The Companys employee stock options have
characteristics significantly different from
those of traded options, and changes in the
assumptions can materially affect the fair
value estimate.
Philips Annual Report 2008 171
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124
|
|
US GAAP financial statements
Notes to the US GAAP
financial statements
|
|
180
|
|
Sustainability performance
|
|
192
|
|
IFRS financial statements
|
|
244
|
|
Company financial statements |
The following tables summarize
information about Philips stock
options as of December 31, 2008
and changes during the year:
Option plans, EUR-denominated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
weighted average |
|
|
|
|
|
|
|
|
|
|
weighted average |
|
|
remaining contractual |
|
|
aggregate intrinsic |
|
|
|
shares |
|
|
exercise price |
|
|
term (in years) |
|
|
value (in millions) |
|
Outstanding at January 1, 2008 |
|
|
34,089,540 |
|
|
|
30.14 |
|
|
|
|
|
|
|
|
|
Granted |
|
|
5,747,981 |
|
|
|
23.42 |
|
|
|
|
|
|
|
|
|
Exercised |
|
|
285,628 |
|
|
|
19.23 |
|
|
|
|
|
|
|
|
|
Forfeited |
|
|
2,896,715 |
|
|
|
33.08 |
|
|
|
|
|
|
|
|
|
Expired |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2008 |
|
|
36,655,178 |
|
|
|
28.94 |
|
|
|
5.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at December 31, 2008 |
|
|
23,511,926 |
|
|
|
30.35 |
|
|
|
3.4 |
|
|
|
|
|
The exercise prices range from EUR 15.28 to 53.75
The weighted average
grant-date fair value of
options granted during 2008,
2007, and 2006 was EUR 5.69,
EUR 8.72 and EUR 9.76,
respectively. The total
intrinsic value of options
exercised during 2008, 2007,
and 2006 was EUR 1 million,
EUR 16 million and EUR 8
million, respectively.
Option plans, USD-denominated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
weighted average |
|
|
|
|
|
|
|
|
|
|
weighted average |
|
|
remaining contractual |
|
|
aggregate intrinsic |
|
|
|
shares |
|
|
exercise price |
|
|
term (in years) |
|
|
value (in millions) |
|
Outstanding at January 1, 2008 |
|
|
18,774,719 |
|
|
|
31.82 |
|
|
|
|
|
|
|
|
|
Granted |
|
|
4,231,921 |
|
|
|
35.47 |
|
|
|
|
|
|
|
|
|
Exercised |
|
|
1,075,063 |
|
|
|
25.15 |
|
|
|
|
|
|
|
|
|
Forfeited |
|
|
884,967 |
|
|
|
35.97 |
|
|
|
|
|
|
|
|
|
Expired |
|
|
42,600 |
|
|
|
18.14 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2008 |
|
|
21,004,010 |
|
|
|
32.75 |
|
|
|
5.7 |
|
|
|
2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at December 31, 2008 |
|
|
11,634,946 |
|
|
|
29.71 |
|
|
|
3.4 |
|
|
|
2 |
|
The exercise prices range from USD 16.41 to 49.71
The weighted average
grant-date fair value of
options granted during 2008,
2007 and 2006 was USD 7.97,
USD 11.99 and USD 12.31,
respectively. The total
intrinsic value of options
exercised during 2008, 2007
and 2006 was USD 13 million,
USD 64 million and USD 46
million, respectively.
The aggregate intrinsic value
in the tables above represents
the total pretax intrinsic
value (the difference between
the Companys closing stock
price on the last trading day
of 2008 and the exercise price,
multiplied by the number of
in-the-money options) that
would have been received by the
option holders if the options
had been exercised on December
31, 2008. At December 31, 2008,
a total of EUR 68 million of
unrecognized compensation cost
related to non-vested stock
options. This cost is expected
to be recognized over a
weighted-average period of 1.8
years. Cash received from
option exercises under the
Companys option plans amounted
to EUR 24 million, EUR 140
million and EUR 120 million in
2008, 2007, and 2006,
respectively. The actual tax
deductions realized as a result
of stock option exercises
totaled EUR 3 million, EUR 36
million and EUR 16 million, in
2008, 2007, and 2006,
respectively.
172 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
non-US GAAP information
|
|
254
|
|
Corporate governance
|
|
262
|
|
Ten-year overview
|
|
266
|
|
Investor information |
A summary of the status of the Companys restricted share
plans as of December 31, 2008 and changes during the year is
presented below:
Restricted share rights, EUR-denominated 1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
weighted average grant-date fair |
|
|
|
shares |
|
|
value |
|
Outstanding at January 1, 2008 |
|
|
2,357,377 |
|
|
|
26.97 |
|
Granted |
|
|
1,209,327 |
|
|
|
21.64 |
|
Vested/Issued |
|
|
1,089,446 |
|
|
|
25.46 |
|
Forfeited |
|
|
78,658 |
|
|
|
27.34 |
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2008 |
|
|
2,398,600 |
|
|
|
24.96 |
|
|
|
|
1) |
|
Excludes 20% additional (premium) shares that may be
received if shares awarded under the restricted share rights
plan are not sold for a three-year period. |
Restricted share rights, USD-denominated 1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
weighted average grant-date fair |
|
|
|
shares |
|
|
value |
|
Outstanding at January 1, 2008 |
|
|
1,717,369 |
|
|
|
35.47 |
|
Granted |
|
|
1,112,307 |
|
|
|
33.38 |
|
Vested/Issued |
|
|
775,093 |
|
|
|
33.44 |
|
Forfeited |
|
|
71,079 |
|
|
|
35.75 |
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2008 |
|
|
1,983,504 |
|
|
|
35.09 |
|
|
|
|
1) |
|
Excludes 20% additional (premium) shares that may be
received if shares awarded under the restricted share rights
plan are not sold for a three-year period. |
At December 31, 2008, a total of EUR 63 million of
unrecognized compensation cost related to non-vested
restricted share rights. This cost is expected to be
recognized over a weighted-average period of 2.3 years.
In December 2006, the Company offered to exchange outstanding
Lumileds Depository Receipts and options for cash and
shared-based instruments settled in cash. The amount to be
paid to settle the obligation, with respect to share-based
instruments, will fluctuate based upon changes in the fair
value of Lumileds. Substantially all of the holders of the
options and the depository receipts accepted the Company
offer. The amount of the share-based payment liability, which
is denominated in US dollars, recorded at December 31, 2007
was EUR 49 million. During 2008, the Company paid EUR 11
million as a part of the settlement of the liability.
Additionally, a release of EUR 27.6 million was recognized to
reflect an adjustment to the value of the liability. The
balance at December 31, 2008 amounted to EUR 10.4 million
which will be settled between 2009 and 2012.
34
Information on remuneration
Remuneration of the Board of Management
Remuneration and pension charges relating to the members of
the Board of Management amounted to EUR 6,992,350 (2007: EUR
8,732,378, 2006: EUR 9,090,403). In 2008, an additional
amount of EUR 619,252 (2007: EUR 739,861, 2006: EUR 645,123)
was awarded in the form of other compensation. When pension
rights are granted to members of the Board of Management,
necessary payments (if insured) and all necessary provisions
are made in accordance with the applicable accounting
principles. In 2008, no (additional) pension benefits were
granted to former members of the Board of Management.
In 2008, the present members of the Board of Management were
granted 259,218 stock options (2007: 318,132 stock options,
2006: 198,027 stock options) and 86,406 restricted share
rights (2007: 106,044 restricted share rights; 2006: 66,009
restricted share rights).
At year-end 2008, the members of the Board of Management held
1,805,672 stock options (year-end 2007: 1,771,097; year-end
2006: 1,355,765) at a weighted average exercise price of EUR
27.31 (year-end 2007: EUR 28.05; year-end 2006: EUR 27.70).
Please refer to the report of the Remuneration Committee
that begins on page 116 of this Annual Report for
further information.
Philips Annual Report 2008 173
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124
|
|
US GAAP financial statements
Notes to the US GAAP
financial statements
|
|
180
|
|
Sustainability performance
|
|
192
|
|
IFRS financial statements
|
|
244
|
|
Company financial statements |
Remuneration of individual members of the Board of
Management
in euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
salary |
|
|
annual incentive1) |
|
|
special payment2) |
|
|
total cash |
|
|
other compensation3) |
|
2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
G.J. Kleisterlee |
|
|
1,100,000 |
|
|
|
490,512 |
|
|
|
|
|
|
|
1,590,512 |
|
|
|
324,346 |
|
P-J. Sivignon |
|
|
687,500 |
|
|
|
217,386 |
|
|
|
|
|
|
|
904,886 |
|
|
|
8,738 |
|
G.H.A. Dutiné |
|
|
618,750 |
|
|
|
200,664 |
|
|
|
|
|
|
|
819,414 |
|
|
|
135,673 |
|
T.W.H.P. van Deursen4) |
|
|
150,000 |
|
|
|
267,984 |
|
|
|
|
|
|
|
417,984 |
|
|
|
20,068 |
|
R.S. Provoost |
|
|
620,000 |
|
|
|
247,607 |
|
|
|
|
|
|
|
867,607 |
|
|
|
26,406 |
|
A. Ragnetti |
|
|
613,750 |
|
|
|
329,571 |
|
|
|
|
|
|
|
943,321 |
|
|
|
37,665 |
|
S.H. Rusckowski5) |
|
|
620,000 |
|
|
|
103,164 |
|
|
|
|
|
|
|
723,164 |
|
|
|
66,356 |
|
|
|
|
4,410,000 |
|
|
|
1,856,888 |
|
|
|
|
|
|
|
6,266,888 |
|
|
|
619,252 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
G.J. Kleisterlee |
|
|
1,087,500 |
|
|
|
1,186,618 |
|
|
|
|
|
|
|
2,274,118 |
|
|
|
304,047 |
|
P-J. Sivignon |
|
|
637,500 |
|
|
|
508,550 |
|
|
|
|
|
|
|
1,146,050 |
|
|
|
25,218 |
|
G.H.A. Dutiné |
|
|
587,500 |
|
|
|
513,691 |
|
|
|
|
|
|
|
1,101,191 |
|
|
|
140,116 |
|
A. Huijser6) |
|
|
|
|
|
|
140,098 |
|
|
|
|
|
|
|
140,098 |
|
|
|
|
|
T.W.H.P. van Deursen |
|
|
587,500 |
|
|
|
380,190 |
|
|
|
|
|
|
|
967,690 |
|
|
|
73,701 |
|
J.A. Karvinen7) |
|
|
|
|
|
|
382,579 |
|
|
|
|
|
|
|
382,579 |
|
|
|
|
|
R.S. Provoost |
|
|
562,500 |
|
|
|
335,551 |
|
|
|
|
|
|
|
898,051 |
|
|
|
22,007 |
|
A. Ragnetti |
|
|
531,250 |
|
|
|
354,893 |
|
|
|
|
|
|
|
886,143 |
|
|
|
37,031 |
|
S.H. Rusckowski8) |
|
|
431,250 |
|
|
|
|
|
|
|
|
|
|
|
431,250 |
|
|
|
137,741 |
|
|
|
|
4,425,000 |
|
|
|
3,802,170 |
|
|
|
|
|
|
|
8,227,170 |
|
|
|
739,861 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
G.J. Kleisterlee |
|
|
1,042,500 |
|
|
|
1,150,560 |
|
|
|
350,000 |
|
|
|
2,543,060 |
|
|
|
300,064 |
|
J.H.M. Hommen9) |
|
|
|
|
|
|
323,018 |
|
|
|
|
|
|
|
323,018 |
|
|
|
|
|
P-J. Sivignon10) |
|
|
568,750 |
|
|
|
219,191 |
|
|
|
300,000 |
|
|
|
1,087,941 |
|
|
|
60,671 |
|
G.H.A. Dutiné |
|
|
540,750 |
|
|
|
433,998 |
|
|
|
|
|
|
|
974,748 |
|
|
|
99,373 |
|
A. Huijser11) |
|
|
150,000 |
|
|
|
507,600 |
|
|
|
|
|
|
|
657,600 |
|
|
|
6,835 |
|
T.W.H.P. van Deursen12) |
|
|
412,500 |
|
|
|
|
|
|
|
|
|
|
|
412,500 |
|
|
|
28,265 |
|
F.A. van Houten13) |
|
|
262,500 |
|
|
|
|
|
|
|
400,000 |
|
|
|
1,174,375 |
|
|
|
21,602 |
|
J.A. Karvinen14) |
|
|
400,000 |
|
|
|
|
|
|
|
|
|
|
|
400,000 |
|
|
|
79,710 |
|
R.S. Provoost15) |
|
|
393,750 |
|
|
|
|
|
|
|
|
|
|
|
393,750 |
|
|
|
34,632 |
|
A. Ragnetti15) |
|
|
356,250 |
|
|
|
|
|
|
|
|
|
|
|
356,250 |
|
|
|
13,971 |
|
|
|
|
4,127,000 |
|
|
|
2,634,367 |
|
|
|
1,050,000 |
|
|
|
8,323,242 |
|
|
|
645,123 |
|
|
|
|
1) |
|
The annual incentives paid are related to the level of performance achieved in the previous
year. |
|
2) |
|
Relating to the divestment of the Semiconductors division. |
|
3) |
|
The stated amounts concern (share of) allowances to members of the Board of Management
that can be considered as remuneration. In a situation where such a share of an allowance
can be considered as (indirect) remuneration (for example, private use of the company car),
then the share is both valued and accounted for here. The method employed by the fiscal
authorities in the Netherlands is the starting point for the value stated. |
|
4) |
|
Salary amount and amount under under other compensation relates to period January 1 March
31, 2008. |
|
5) |
|
Annual incentive figure relates to period of board membership April 1 December 31, 2007. |
|
6) |
|
Annual incentive figure relates to period January 1 March 31, 2006. |
|
7) |
|
Annual incentive figure relates to period April 1 November 30, 2006. |
|
8) |
|
The salary amount as well as the amount under other compensation relates to the period
April 1 December 31, 2007. The annual incentive paid out relates to the period before
board membership and is not stated. |
|
9) |
|
Annual incentive amount relates to period January 1 June 15, 2005. |
|
10) |
|
Annual incentive amount relates to
period June 15 December 31, 2005. |
|
11) |
|
The
salary amount relates to the period January
1 March 31, 2006. |
|
12) |
|
The salary amount as well as the amount under other compensation relates to the period
April 1 December 31, 2006. The annual incentive paid out relates to the period before board
membership and therefore is not stated. |
|
13) |
|
The salary amount as well as the amount under other compensation relates to the period
April 1 September 29, 2006. The total cash amount includes the salary over the period April 1 -
September 29, 2006, the special Semiconductors payment, the annual incentive of EUR 354,375 over
the period April 1 September 29, 2006 and pursuant to the Semiconductors transaction retention
scheme an amount of EUR 157,500. |
|
14) |
|
The salary amount as well as the amount under other compensation relates to the period
April 1 November 30, 2006. The annual incentive paid out relates to the period before board
membership and therefore is not stated. |
|
15) |
|
The salary amount as well as the amount under other compensation relates to the period
April 1 December 31, 2006. The annual incentive paid out relates to the period before board
membership and therefore is not stated. |
174 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
|
|
254
|
|
Corporate governance
|
|
262
|
|
Ten-year overview
|
|
266
|
|
Investor information |
|
|
non-US GAAP information |
|
|
|
|
|
|
|
|
|
|
|
|
The tables below give an overview of
the interests of the members of the
Board of Management under the
restricted share rights plans and the
stock option plans of the Company:
Number of restricted share rights
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
awarded during |
|
|
released during |
|
|
as of Dec. 31, |
|
|
potential |
|
|
|
as of Jan. 1, 2008 |
|
|
2008 |
|
|
2008 |
|
|
20082) |
|
|
premium shares |
|
G.J. Kleisterlee |
|
|
40,644 |
|
|
|
22,401 |
|
|
|
18,882 |
|
|
|
44,163 |
|
|
|
19,121 |
|
P-J. Sivignon |
|
|
25,191 |
|
|
|
12,801 |
|
|
|
11,990 |
|
|
|
26,002 |
|
|
|
9,762 |
|
G.H.A. Dutiné |
|
|
23,424 |
|
|
|
12,801 |
|
|
|
11,290 |
|
|
|
24,935 |
|
|
|
11,546 |
|
R.S. Provoost |
|
|
22,5351) |
|
|
|
12,801 |
|
|
|
10,401 |
|
|
|
24,935 |
|
|
|
10,653 |
|
A. Ragnetti |
|
|
21,8671) |
|
|
|
12,801 |
|
|
|
10,067 |
|
|
|
24,601 |
|
|
|
9,814 |
|
S.H. Rusckowski |
|
|
26,1011) |
|
|
|
12,801 |
|
|
|
12,567 |
|
|
|
26,335 |
|
|
|
11,678 |
|
|
|
|
159,762 |
|
|
|
86,406 |
|
|
|
75,197 |
|
|
|
170,971 |
|
|
|
72,574 |
|
|
|
|
1) |
|
Partly awarded before date of appointment as a member of the Board of Management. |
|
2) |
|
Excluding premium shares |
Stock options
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
share (closing) |
|
|
|
|
|
|
as of Jan. 1, |
|
|
granted during |
|
|
exercised |
|
|
as of Dec. 31, |
|
|
exercise price |
|
|
price on |
|
|
|
|
|
|
2008 |
|
|
2008 |
|
|
during 2008 |
|
|
2008 |
|
|
(in euros) |
|
|
exercise date |
|
|
expiry date |
|
G.J. Kleisterlee |
|
|
52,5001) |
|
|
|
|
|
|
|
|
|
|
|
52,5001) |
|
|
|
42.243) |
|
|
|
|
|
|
|
17.02.2010 |
|
|
|
|
105,000 |
|
|
|
|
|
|
|
|
|
|
|
105,000 |
|
|
|
37.60 |
|
|
|
|
|
|
|
08.02.2011 |
|
|
|
|
115,200 |
|
|
|
|
|
|
|
|
|
|
|
115,200 |
|
|
|
30.17 |
|
|
|
|
|
|
|
07.02.2012 |
|
|
|
|
52,803 |
|
|
|
|
|
|
|
|
|
|
|
52,803 |
|
|
|
16.77 |
|
|
|
|
|
|
|
15.04.2013 |
|
|
|
|
48,006 |
|
|
|
|
|
|
|
|
|
|
|
48,006 |
|
|
|
24.13 |
|
|
|
|
|
|
|
13.04.2014 |
|
|
|
|
48,006 |
|
|
|
|
|
|
|
|
|
|
|
48,006 |
|
|
|
19.41 |
|
|
|
|
|
|
|
18.04.2015 |
|
|
|
|
48,006 |
|
|
|
|
|
|
|
|
|
|
|
48,006 |
|
|
|
26.28 |
|
|
|
|
|
|
|
18.04.2016 |
|
|
|
|
73,926 |
|
|
|
|
|
|
|
|
|
|
|
73,926 |
|
|
|
30.96 |
|
|
|
|
|
|
|
16.04.2017 |
|
|
|
|
|
|
|
|
67,203 |
|
|
|
|
|
|
|
67,203 |
|
|
|
23.11 |
|
|
|
|
|
|
|
14.04.2018 |
|
P-J. Sivignon |
|
|
32,004 |
|
|
|
|
|
|
|
|
|
|
|
32,004 |
|
|
|
22.07 |
|
|
|
|
|
|
|
18.07.2015 |
|
|
|
|
33,003 |
|
|
|
|
|
|
|
|
|
|
|
33,003 |
|
|
|
26.28 |
|
|
|
|
|
|
|
18.04.2016 |
|
|
|
|
42,903 |
|
|
|
|
|
|
|
|
|
|
|
42,903 |
|
|
|
30.96 |
|
|
|
|
|
|
|
16.04.2017 |
|
|
|
|
|
|
|
|
38,403 |
|
|
|
|
|
|
|
38,403 |
|
|
|
23.11 |
|
|
|
|
|
|
|
14.04.2018 |
|
G.H.A. Dutiné |
|
|
124,8001)2) |
|
|
|
|
|
|
|
|
|
|
|
124,8001)2) |
|
|
|
30.17 |
|
|
|
|
|
|
|
07.02.2012 |
|
|
|
|
35,208 |
|
|
|
|
|
|
|
|
|
|
|
35,208 |
|
|
|
16.77 |
|
|
|
|
|
|
|
15.04.2013 |
|
|
|
|
32,004 |
|
|
|
|
|
|
|
|
|
|
|
32,004 |
|
|
|
24.13 |
|
|
|
|
|
|
|
13.04.2014 |
|
|
|
|
32,004 |
|
|
|
|
|
|
|
|
|
|
|
32,004 |
|
|
|
19.41 |
|
|
|
|
|
|
|
18.04.2015 |
|
|
|
|
30,006 |
|
|
|
|
|
|
|
|
|
|
|
30,006 |
|
|
|
26.28 |
|
|
|
|
|
|
|
18.04.2016 |
|
|
|
|
39,600 |
|
|
|
|
|
|
|
|
|
|
|
39,600 |
|
|
|
30.96 |
|
|
|
|
|
|
|
16.04.2017 |
|
|
|
|
|
|
|
|
38,403 |
|
|
|
|
|
|
|
38,403 |
|
|
|
23.11 |
|
|
|
|
|
|
|
14.04.2018 |
|
R.S. Provoost |
|
|
56,8751)2) |
|
|
|
|
|
|
|
|
|
|
|
56,8751)2) |
|
|
|
42.90 |
|
|
|
|
|
|
|
17.10.2010 |
|
|
|
|
29,7501) |
|
|
|
|
|
|
|
|
|
|
|
29,7501) |
|
|
|
37.60 |
|
|
|
|
|
|
|
08.02.2011 |
|
|
|
|
49,2001)2) |
|
|
|
|
|
|
|
|
|
|
|
49,2001)2) |
|
|
|
30.17 |
|
|
|
|
|
|
|
07.02.2012 |
|
|
|
|
16,2501)2) |
|
|
|
|
|
|
|
|
|
|
|
16,2501)2) |
|
|
|
34,78 |
|
|
|
|
|
|
|
16.04.2012 |
|
|
|
|
26,4061) |
|
|
|
|
|
|
|
|
|
|
|
26,4061) |
|
|
|
16.77 |
|
|
|
|
|
|
|
15.04.2013 |
|
|
|
|
8,6671) |
|
|
|
|
|
|
|
|
|
|
|
8,6671) |
|
|
|
22.12 |
|
|
|
|
|
|
|
14.10.2013 |
|
|
|
|
24,0031) |
|
|
|
|
|
|
|
|
|
|
|
24,0031) |
|
|
|
24.13 |
|
|
|
|
|
|
|
13.04.2014 |
|
|
|
|
24,0031) |
|
|
|
|
|
|
|
|
|
|
|
24,0031) |
|
|
|
19.41 |
|
|
|
|
|
|
|
18.04.2015 |
|
|
|
|
30,006 |
|
|
|
|
|
|
|
|
|
|
|
30,006 |
|
|
|
26.28 |
|
|
|
|
|
|
|
18.04.2016 |
|
|
|
|
39,600 |
|
|
|
|
|
|
|
|
|
|
|
39,600 |
|
|
|
30.96 |
|
|
|
|
|
|
|
16.04.2017 |
|
|
|
|
|
|
|
|
38,403 |
|
|
|
|
|
|
|
38,403 |
|
|
|
23.11 |
|
|
|
|
|
|
|
14.04.2018 |
|
Philips Annual Report 2008 175
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124
|
|
US GAAP financial statements
|
|
180
|
|
Sustainability performance
|
|
192
|
|
IFRS financial statements
|
|
244
|
|
Company financial statements |
|
|
Notes to the US GAAP
financial statements |
|
|
|
|
|
|
|
|
|
|
|
|
Stock options
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
exercise price |
|
|
(closing) |
|
|
|
|
|
|
as of Jan. 1, |
|
|
granted |
|
|
exercised |
|
|
as of Dec. 31, |
|
|
(in euros or |
|
|
price on |
|
|
|
|
|
|
2008 |
|
|
during 2008 |
|
|
during 2008 |
|
|
2008 |
|
|
USD) |
|
|
exercise date |
|
|
expiry date |
|
A. Ragnetti |
|
|
30,000 |
1)2) |
|
|
|
|
|
|
|
|
|
|
30,000 |
|
|
|
15.29 |
|
|
|
|
|
|
|
11.02.2013 |
|
|
|
|
17,604 |
1) |
|
|
|
|
|
|
|
|
|
|
17,604 |
|
|
|
16.77 |
|
|
|
|
|
|
|
15.04.2013 |
|
|
|
|
18,405 |
1) |
|
|
|
|
|
|
|
|
|
|
18,405 |
|
|
|
24.13 |
|
|
|
|
|
|
|
13.04.2014 |
|
|
|
|
24,003 |
1) |
|
|
|
|
|
|
|
|
|
|
24,003 |
|
|
|
19.41 |
|
|
|
|
|
|
|
18.04.2015 |
|
|
|
|
27,000 |
|
|
|
|
|
|
|
|
|
|
|
27,000 |
|
|
|
26.28 |
|
|
|
|
|
|
|
18.04.2016 |
|
|
|
|
39,600 |
|
|
|
|
|
|
|
|
|
|
|
39,600 |
|
|
|
30.96 |
|
|
|
|
|
|
|
16.04.2017 |
|
|
|
|
|
|
|
|
38,403 |
|
|
|
|
|
|
|
38,403 |
|
|
|
23.11 |
|
|
|
|
|
|
|
14.04.2018 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
S.H. Rusckowski |
|
|
27,000 |
1)4) |
|
|
|
|
|
|
|
|
|
|
27,000 |
1)4) |
|
$ |
28.78 |
|
|
|
|
|
|
|
13.04.2014 |
|
|
|
|
2,700 |
1)4) |
|
|
|
|
|
|
|
|
|
|
2,700 |
1)4) |
|
$ |
25.43 |
|
|
|
|
|
|
|
27.01.2015 |
|
|
|
|
31,500 |
1)4) |
|
|
|
|
|
|
|
|
|
|
31,500 |
1)4) |
|
$ |
25.28 |
|
|
|
|
|
|
|
18.04.2015 |
|
|
|
|
31,500 |
1)4) |
|
|
|
|
|
|
|
|
|
|
31,500 |
1)4) |
|
$ |
32.25 |
|
|
|
|
|
|
|
18.04.2016 |
|
|
|
|
4,500 |
1)4) |
|
|
|
|
|
|
|
|
|
|
4,500 |
1)4) |
|
$ |
34.56 |
|
|
|
|
|
|
|
16.10.2016 |
|
|
|
|
42,903 |
|
|
|
|
|
|
|
|
|
|
|
42,903 |
|
|
|
30.96 |
|
|
|
|
|
|
|
16.04.2017 |
|
|
|
|
|
|
|
|
38,403 |
|
|
|
|
|
|
|
38,403 |
|
|
|
23.11 |
|
|
|
|
|
|
|
14.04.2018 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,546,454 |
|
|
|
259,218 |
|
|
|
|
|
|
|
1,805,672 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1) |
|
Awarded before date of appointment as a member of the Board of Management |
|
2) |
|
(Partly) sign-on grant |
|
3) |
|
The Supervisory Board
and the Board of
Management have decided
to adjust upwards the
exercise price of all
options to, but not yet
exercised by, members of
the Board of Management
as of July 31, 2000 by
EUR 0.21 per common
share in connection with
the 3% share reduction
program effected
mid-2000 |
|
4) |
|
Awarded under US stock option plan |
See note 33 for further information on stock options and restricted share rights.
The total pension charges
of the members of the
Board of Management in
2008 amount to EUR
725,462 (pension charge
in 2007: EUR 505,208;
2006: EUR 767,161).
The accumulated annual
pension entitlements and
the pension costs of
individual members of the
Board of Management are
as follows (in euros):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
accumulated |
|
|
|
|
|
|
|
|
|
|
annual |
|
|
|
|
|
|
age at |
|
|
pension as of |
|
|
|
|
|
|
December |
|
|
December |
|
|
pension |
|
|
|
31,2008 |
|
|
31, 20081) |
|
|
costs2) |
|
G.J. Kleisterlee3) |
|
|
62 |
|
|
|
719,769 |
|
|
|
(314,893 |
) |
P-J. Sivignon |
|
|
52 |
|
|
|
28,477 |
|
|
|
250,951 |
|
G.H.A. Dutiné |
|
|
56 |
|
|
|
87,864 |
|
|
|
192,153 |
|
R.S. Provoost |
|
|
49 |
|
|
|
66,233 |
|
|
|
192,003 |
|
A. Ragnetti |
|
|
48 |
|
|
|
38,598 |
|
|
|
202,281 |
|
S.H. Rusckowski |
|
|
51 |
|
|
|
13,030 |
|
|
|
235,852 |
|
|
|
|
|
|
|
|
|
|
|
|
758,347 |
4) |
|
|
|
1) |
|
Under final pay or average pay plan |
|
2) |
|
Including costs related to employer contribution in defined-contribution pension plan |
|
3) |
|
As Mr Kleisterlee was born before January 1, 1950 be continued to be a member of the final pay plan with a pensionable age of 60. No further acctual takes place |
|
4) |
|
Mr Van Deursen for the period January April 2008 not included: EUR (32,885) |
176 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
|
|
254
|
|
Corporate governance
|
|
262
|
|
Ten-year overview
|
|
266
|
|
Investor information |
|
|
non-US GAAP information |
|
|
|
|
|
|
|
|
|
|
|
|
Remuneration of the Supervisory Board
The remuneration of
the members of the
Supervisory Board
amounted to EUR
851,250 (2007: EUR
540,000, 2006: EUR
494,500); former
members received no
remuneration.
At year-end 2008,
the present members
of the Supervisory
Board held no stock
options.
The individual
members of the
Supervisory Board
received, by virtue
of the positions
they held, the
following
remuneration (in
euros):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
fee for |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
inter- |
|
|
|
|
|
|
member- |
|
|
commit- |
|
|
continental |
|
|
|
|
|
|
ship |
|
|
tees |
|
|
travel |
1) |
|
total |
|
2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
W. de Kleuver
(Jan.-March) |
|
|
55,000 |
|
|
|
5,125 |
|
|
|
|
|
|
|
60,125 |
|
L. Schweitzer
(Jan.-March) |
|
|
32,500 |
|
|
|
1,500 |
|
|
|
|
|
|
|
34,000 |
|
J-M. Hessels |
|
|
98,750 |
|
|
|
19,125 |
|
|
|
3,000 |
|
|
|
120,875 |
|
J.M. Thompson |
|
|
65,000 |
|
|
|
14,000 |
|
|
|
9,000 |
|
|
|
88,000 |
|
R. Greenbury |
|
|
65,000 |
|
|
|
8,000 |
|
|
|
3,000 |
|
|
|
76,000 |
|
K.A.L.M. van Miert |
|
|
65,000 |
|
|
|
10,000 |
|
|
|
3,000 |
|
|
|
78,000 |
|
C.J.A. van Lede |
|
|
65,000 |
|
|
|
12,500 |
|
|
|
3,000 |
|
|
|
80,500 |
|
E. Kist |
|
|
65,000 |
|
|
|
13,750 |
|
|
|
3,000 |
|
|
|
81,750 |
|
N.L. Wong |
|
|
65,000 |
|
|
|
|
|
|
|
9,000 |
|
|
|
74,000 |
|
J.J. Schiro |
|
|
65,000 |
|
|
|
14,500 |
|
|
|
3,000 |
|
|
|
82,500 |
|
H. von Prondzynski |
|
|
65,000 |
|
|
|
7,500 |
|
|
|
3,000 |
|
|
|
75,500 |
|
|
|
|
706,250 |
|
|
|
106,000 |
|
|
|
39,000 |
|
|
|
851,250 |
|
2007 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
W. de Kleuver |
|
|
75,000 |
|
|
|
10,500 |
|
|
|
|
|
|
|
85,500 |
|
L. Schweitzer |
|
|
41,000 |
|
|
|
4,500 |
|
|
|
|
|
|
|
45,500 |
|
J-M. Hessels |
|
|
41,000 |
|
|
|
7,000 |
|
|
|
|
|
|
|
48,000 |
|
J.M. Thompson |
|
|
41,000 |
|
|
|
9,000 |
|
|
|
|
|
|
|
50,000 |
|
R. Greenbury |
|
|
41,000 |
|
|
|
4,500 |
|
|
|
|
|
|
|
45,500 |
|
K.A.L.M. van Miert |
|
|
41,000 |
|
|
|
4,500 |
|
|
|
|
|
|
|
45,500 |
|
C.J.A. van Lede |
|
|
41,000 |
|
|
|
6,000 |
|
|
|
|
|
|
|
47,000 |
|
E. Kist |
|
|
41,000 |
|
|
|
4,500 |
|
|
|
|
|
|
|
45,500 |
|
N.L. Wong |
|
|
41,000 |
|
|
|
|
|
|
|
|
|
|
|
41,000 |
|
J.J. Schiro |
|
|
41,000 |
|
|
|
4,500 |
|
|
|
|
|
|
|
45,500 |
|
H. von Prondzynski
(Apr.-Dec.) |
|
|
41,000 |
|
|
|
|
|
|
|
|
|
|
|
41,000 |
|
|
|
|
485,000 |
|
|
|
55,000 |
|
|
|
|
|
|
|
540,000 |
|
2006 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
W. de Kleuver |
|
|
75,000 |
|
|
|
10,500 |
|
|
|
|
|
|
|
85,500 |
|
L. Schweitzer |
|
|
41,000 |
|
|
|
4,500 |
|
|
|
|
|
|
|
45,500 |
|
J-M. Hessels |
|
|
41,000 |
|
|
|
7,000 |
|
|
|
|
|
|
|
48,000 |
|
J.M. Thompson |
|
|
41,000 |
|
|
|
4,500 |
|
|
|
|
|
|
|
45,500 |
|
R. Greenbury |
|
|
41,000 |
|
|
|
4,500 |
|
|
|
|
|
|
|
45,500 |
|
K.A.L.M. van Miert |
|
|
41,000 |
|
|
|
4,500 |
|
|
|
|
|
|
|
45,500 |
|
C.J.A. van Lede |
|
|
41,000 |
|
|
|
6,000 |
|
|
|
|
|
|
|
47,000 |
|
E. Kist |
|
|
41,000 |
|
|
|
4,500 |
|
|
|
|
|
|
|
45,500 |
|
N.L. Wong |
|
|
41,000 |
|
|
|
|
|
|
|
|
|
|
|
41,000 |
|
J.J. Schiro |
|
|
41,000 |
|
|
|
4,500 |
|
|
|
|
|
|
|
45,500 |
|
|
|
|
444,000 |
|
|
|
50,500 |
|
|
|
|
|
|
|
494,500 |
|
|
|
|
1) |
|
The fee for
intercontinental
travel was approved
by the General
Meeting of
Shareholders in
2008 |
Supervisory Board
members and Board
of Management
members interests
in Philips shares
Members of the
Supervisory Board
and of the Board of
Management are not
allowed to hold any
interests in
derivative Philips
securities.
Number of shares 1)
|
|
|
|
|
|
|
|
|
|
|
as of December |
|
|
as of December |
|
|
|
31, 2007 |
|
|
31, 2008 |
|
H. von Prondzynski |
|
|
430 |
|
|
|
2,930 |
|
J.M. Thompson |
|
|
1,000 |
|
|
|
1,000 |
|
G.J. Kleisterlee |
|
|
151,916 |
|
|
|
173,039 |
|
P-J. Sivignon |
|
|
10,779 |
|
|
|
22,769 |
|
G.H.A. Dutiné |
|
|
33,633 |
|
|
|
46,418 |
|
R.S. Provoost |
|
|
30,198 |
|
|
|
41,495 |
|
A. Ragnetti |
|
|
20,729 |
|
|
|
31,597 |
|
S.H. Rusckowski |
|
|
26,584 |
|
|
|
40,125 |
|
|
|
|
1) |
|
Reference date for board membership is December 31, 2008 |
35
Fair value of financial assets and liabilities
The estimated fair
value of financial
instruments has
been determined by
the Company using
available market
information and
appropriate
valuation methods.
The estimates
presented are not
necessarily
indicative of the
amounts that will
ultimately be
realized by the
Company upon
maturity or
disposal.
The table below
presents our assets
and liabilities
measured at
December 31, 2008,
at estimated fair
value on a
recurring basis as
required by SFAS
No. 157.
Comparative numbers
are presented in
line with SFAS No.
107, Disclosure
about Fair Value
Instruments. SFAS
No. 107 requires
disclosure of
estimated fair
value of certain
financial
instruments and the
methods and
significant
assumptions used to
estimate their fair
values. Because of
the variety of
valuation
techniques
permitted under
SFAS No. 107
comparisons of fair
values between
entities may not be
meaningful. The use
of different market
assumptions and/or
estimation methods
may have a material
effect on the
estimated fair
value amounts.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2007 |
|
|
December 31, 2008 |
|
|
|
carrying |
|
|
estimated |
|
|
carrying |
|
|
estimated |
|
|
|
amount |
|
|
fair value |
|
|
amount |
|
|
fair value |
|
Level 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other non-current |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
financial assets excl. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
cost-method investments |
|
|
1,965 |
|
|
|
1,965 |
|
|
|
786 |
|
|
|
786 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Level 2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative instruments |
|
|
275 |
|
|
|
275 |
|
|
|
253 |
|
|
|
253 |
|
Other non-current
financial assets |
|
|
191 |
|
|
|
191 |
|
|
|
194 |
|
|
|
194 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative instruments |
|
|
(144 |
) |
|
|
(144 |
) |
|
|
(505 |
) |
|
|
(505 |
) |
|
|
|
322 |
|
|
|
322 |
|
|
|
(58 |
) |
|
|
(58 |
) |
Certain assets are
measured at fair
value on a
non-recurring
basis, and
therefore not
included in the
preceding tables.
The fair value
identified as Level
2 of the fair value
hierarchy is EUR 32
million relating to
TPO Display as
discussed in note
12. The fair value
identified as Level
3 of the fair value
hierarchy is EUR
255 million
relating to NXP as
discussed in note
12.
Philips Annual Report 2008 177
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124
|
|
US GAAP financial statements
|
|
180
|
|
Sustainability performance
|
|
192
|
|
IFRS financial statements
|
|
244
|
|
Company financial statements |
|
|
|
Notes to the US GAAP
financial statements |
|
|
|
|
|
|
|
|
|
|
|
|
Additional
information
required by SFAS
No. 107 is
presented in the
following table:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2007 |
|
|
December 31, 2008 |
|
|
|
carrying |
|
|
estimated |
|
|
carrying |
|
|
estimated |
|
|
|
amount |
|
|
fair value |
|
|
amount |
|
|
fair value |
|
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
|
8,769 |
|
|
|
8,769 |
|
|
|
3,620 |
|
|
|
3,620 |
|
Accounts receivable -
current |
|
|
4,670 |
|
|
|
4,670 |
|
|
|
4,289 |
|
|
|
4,289 |
|
Accounts receivable -
non-current |
|
|
84 |
|
|
|
84 |
|
|
|
50 |
|
|
|
50 |
|
Current financial assets |
|
|
|
|
|
|
|
|
|
|
121 |
|
|
|
121 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable |
|
|
(3,372 |
) |
|
|
(3,372 |
) |
|
|
(2,992 |
) |
|
|
(2,992 |
) |
Debt |
|
|
(3,557 |
) |
|
|
(3,640 |
) |
|
|
(4,158 |
) |
|
|
(4,141 |
) |
The carrying
amounts of cash and
cash equivalents,
accounts receivable
(current and
non-current),
current financial
assets and accounts
payable approximate
fair value because
of the short
maturity of these
instruments. The
fair value of the
debt is estimated
on the basis of the
quoted market
prices, or on the
basis of discounted
cash flow analyses
based upon market
rates plus Philips
spread for the
particular tenors
of borrowing
agreements. Accrued
interest is
included under
accounts payable
and not within the
carrying amount or
estimated fair
value of debt. At
December 31, 2008
total accrued
interest expense
was EUR 79 million
(2007: EUR 110
million). The
accrued interest on
bonds, which is the
main part of the
accrual, was EUR 70
million. (2007: EUR
99 million).
36
Other financial
instruments,
derivatives and
currency risk
The Company does
not purchase or
hold financial
derivative
instruments for
trading purposes.
Assets and
liabilities related
to derivative
instruments are
disclosed in Other
current assets,
note 11, note 12
and note 18
respectively.
Currency
fluctuations may
impact Philips
financial results.
The Company is exposed to currency risk in the following areas:
|
|
Transaction
exposures,
such as
forecasted
sales and
purchases, and
on-balance-sheet receivables
or payables
resulting from
such
transactions; |
|
|
|
Translation exposure of net income in foreign entities; |
|
|
|
Translation
exposure of
foreign-currency intercompany
and external
debt and
deposits; |
|
|
|
Translation
exposure of
equity
invested in
consolidated
foreign
entities; and |
|
|
|
Exposure to
equity
interests in
non-functional-currency
equity-accounted-investees
and
available-for-sale
investments. |
It is Philips
policy that
significant
transaction
exposures are
hedged. The Philips
policy generally
requires committed
foreign-currency
exposures to be
hedged fully using
forwards.
Anticipated
transactions are
hedged using
forwards or options
or a combination
thereof. The policy
for the hedging of
anticipated
exposures
specifying the use
of forwards/options
and the hedge tenor
varies per business
and is a function
of the ability to
forecast cash flows
and the way in
which the
businesses can
adapt to changed
levels of foreign
exchange rates. As
a result, hedging
activities may not
eliminate all
currency risks for
these transaction
exposures.
Generally, the
maximum tenor of
these hedges equals
18 months. The
Company does not
hedge the exposure
arising from
translation
exposure of net
income in foreign
entities.
Translation
exposure of equity
invested in
consolidated
foreign entities
financed by equity
is partially
hedged. If a hedge
is entered into, it
is accounted for as
a net investment
hedge.
The currency of the
external funding
and deposits of the
Company is matched
with the required
financing of
subsidiaries either
directly by
external foreign
currency loans and
deposits, or by
using foreign
exchange swaps. In
certain cases where
group companies
have foreign
currency debt or
liquid assets,
these exposures are
also hedged through
the use of foreign
exchange
derivatives.
Philips does not
currently hedge the
foreign exchange
exposure arising
from
equity-accounted
investees and
available-for-sale
investments.
The Company uses
foreign exchange
derivatives to
manage its currency
risk. The US dollar
and pound sterling
account for a high
percentage of the
Companys foreign
exchange
derivatives.
The Company hedges
certain commodity
price risks using
derivative
instruments to
minimize
significant,
unanticipated
earnings
fluctuations caused
by commodity price
volatility. The
commodity price
derivatives that
Philips enters into
are normally
concluded as cash
flow hedges to
offset forecasted
purchases.
Changes in the
value of foreign
currency accounts
receivable/payable
as well as the
changes in the fair
value of the hedges
of accounts
receivable/payable
are reported in the
income statement
under cost of
sales. The hedges
related to
forecasted
transactions are
recorded as cash
flow hedges. The
results from such
hedges are deferred
within other
comprehensive
income in
stockholders
equity. Currently,
a loss of EUR 28
million is deferred
in stockholders
equity as a result
of these hedges.
During 2008, a loss
of EUR 3 million
was recorded in the
income statement as
a result of
ineffectiveness of
transaction hedges.
Changes in the fair
value of hedges
related to external
and intercompany
debt and deposits
are recognized
within Financial
income and expenses
in the income
statement. The
changes in the fair
value of these
hedges related to
foreign exchange
movements are
largely offset in
the income
statement by
changes in the fair
value of the hedged
items. The Company
recorded a gain of
EUR 11 million in
other comprehensive
income under
currency
translation
differences as a
result of net
investment hedges
of investments in
foreign
subsidiaries during
2008.
Philips has 2
embedded
derivatives within
convertible bonds.
One was issued to
Philips in
September 2005 by
TPV Technology
Ltd., the face
value of the bond
being EUR 149
million and the
value of the option
at year-end EUR 10
million. Changes in
the value of the
embedded derivative
are reported in
Financial income
and expenses during
2008 (EUR 37
million). A further
convertible bond
was issued to
Philips in August
2008 by CBAY, the
face value of the
bond being EUR 65
million and the
value of the option
at year-end less
than EUR 1 million.
Changes in the
value of the
embedded derivative
are reported in
Financial income
and expenses during
2008 (EUR 6
million).
37
Subsequent events
Share repurchase program
On January 26,
2009, the Company
announced that it
had stopped the EUR
5 billion share
repurchase program,
which was announced
on December 19,
2007, until further
notice.
178 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
non-US GAAP information
|
|
254
|
|
Corporate governance
|
|
262
|
|
Ten-year overview
|
|
266
|
|
Investor information |
Philips Annual Report 2008 179
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124
|
|
US GAAP financial statements
|
|
180
|
|
Sustainability performance
|
|
192
|
|
IFRS financial statements
|
|
244
|
|
Company financial statements |
|
|
|
|
|
|
Approach to sustainability reporting |
|
|
|
|
|
|
|
|
Sustainability
performance
Approach to sustainability reporting
In 1999 we
published our first
environmental
annual report. We
expanded our
reporting in 2003
with the launch of
our first
sustainability
annual report,
which provided
details on our
social and economic
performance in
addition to our
environmental
results.
Now, for the first
time, Philips is
reporting on its
annual financial,
social and
environmental
performance in a
single, integrated
report. This
approach reflects
the progress we
have made to embed
sustainability in
our way of doing
business.
Reporting standards
In compiling the
sustainability
performance covered
in this report, we
have followed
relevant best
practice standards
and international
guidelines. Most
important are the
Global Reporting
Initiatives (GRI)
G3 Sustainability
Reporting
Guidelines.
In keeping with G3
we have sharpened
our focus on the
principles of
materiality,
stakeholder
inclusiveness,
sustainability
context and
completeness. As a
result, with regard
to the GRI
Application Levels
system, we see
ourselves currently
positioned at the
B+ level. We cover
a large part of the
G3 Core Indicators,
while our
Management Approach
is explained in
this report and in
our previous
sustainability
reports. A detailed
overview of these
Core Indicators is
provided at the end
of this section.
We signed on to the
United Nations
Global Compact in
March 2007, joining
thousands of
companies from all
regions of the
world,
international labor
and civil society
organizations to
advance 10
universal
principles in the
areas of human
rights, labor, the
environment and
anti-corruption.
Our General
Business
Principles,
Sustainability and
Environmental
Policies, and our
Supplier
Sustainability
Declaration are the
cornerstones that
enable us to live
up to the standards
set by the Global
Compact. This is
closely monitored
and reported, as
illustrated
throughout this
report.
Trends
We continuously
follow external
trends to determine
the issues most
relevant for our
company and those
where we can make a
positive
contribution to
society at large.
In addition to our
own research, we
make use of a
variety of sources,
including the World
Bank, World
Business Council
for Sustainable
Development, World
Economic Forum and
World Health
Organization. As a
member of
organizations like
the World Business
Council for
Sustainable
Development and the
Electronic Industry
Code of Conduct, we
participate in
meetings and task
forces, bringing
new learning to
bear. Our work also
involves tracking
topics of concern
to governments,
regulatory bodies
and
non-governmental
organizations, and
following the
resulting media
coverage.
Stakeholder input on innovations
We also engage
directly with
stakeholders to
gain additional
outside
perspective. One of
the most important
platforms is our
Sustainability
Innovation Day held
during our annual
Corporate Research
Exhibition (CRE).
At the 2008 CRE in
May stakeholders
from governmental
and
non-governmental
organizations
viewed our
innovations
designed to meet
the global energy
and climate change
challenge as well
as other
environmental
topics. The event
was designed to
encourage
participants to
listen to each
other and begin an
ongoing dialogue to
envision innovative
solutions to these
challenges. They
learned about
projects on zero
standby power,
Organic LEDs, green
urban living, air
quality sensing and
the Compact UV for
safe drinking
water, among
others.
Launched in 1959 as
an internal event
intended to help
researchers from
different labs find
synergies in their
work, in 2001
Philips businesses
began bringing
strategic customers
to CRE and
extending
invitations to
other key external
stakeholders in the
following years.
Material issues and our focus
Based on our trend
analysis and
stakeholder input,
we identify the key
material issues for
our company. Using
the materiality
matrix approach, we
have mapped
relevant issues on
a scale from low to
high in terms of
the:
|
|
level of concern to society at large and stakeholders, versus impact on Philips, or |
|
|
|
level of
control or influence we can have on an issue through our operations and products/solutions. |
This is a dynamic
process, as we
continuously
monitor the world
around us.
Currently we
consider the
following items as
material, making a
distinction between
clear risks and
opportunities.
Key material issues
|
|
|
|
|
|
|
|
|
|
|
opportunity |
|
risk |
Health |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- Rising healthcare costs |
|
|
ü |
|
|
|
|
|
- Chronic diseases in developing world |
|
|
ü |
|
|
|
|
|
- Lack of access to affordable healthcare |
|
|
ü |
|
|
|
|
|
- Infectious diseases in developing world |
|
|
ü |
|
|
|
|
|
- Employee health and safety |
|
|
|
|
|
|
ü |
|
|
|
|
|
|
|
|
|
|
Business |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- Demand and credit crisis |
|
|
|
|
|
|
ü |
|
- Offshoring/outsourcing |
|
|
|
|
|
|
ü |
|
- Business integrity |
|
|
|
|
|
|
ü |
|
|
|
|
|
|
|
|
|
|
Societal |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- Aging population in developed world |
|
|
ü |
|
|
|
|
|
- Rising attention for human rights |
|
|
|
|
|
|
ü |
|
|
|
|
|
|
|
|
|
|
Environmental |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- Climate change |
|
|
ü |
|
|
|
|
|
- Energy management |
|
|
ü |
|
|
|
|
|
- Clean technologies |
|
|
ü |
|
|
|
|
|
- Collection and recycling |
|
|
ü |
|
|
|
ü |
|
Based on this, we
develop our
strategy and
vision, as well as
the programs and
policies to drive
the implementation
of our strategy.
Our primary focus
has been on
business
opportunities in
energy efficiency
and healthcare. We
also have programs
in place to manage
risk, including our
General Business
Principles,
Sustainability
Policies and
Supplier
Sustainability
Involvement
Program.
Sustainability programs and targets
All of our programs
are guided by the
Philips General
Business
Principles, which
provide the
fundamental
principles for all
of our business
decisions and
actions.
With our
longstanding
commitment to
reducing the
environmental
impact of our
products and
processes, we have
been establishing
four-year action
programs with
measurable targets
since 1994. We are
currently running
two programs-EcoVision III,
which covers the
years 2006-2009,
and EcoVision4,
which runs through
2012.
EcoVision III is
focused primarily
on reducing the
environmental
footprint of our
manufacturing
processes spanning
a broad range of
parameters (full
details on the
program can be
found at
www.philips.com/sustainability). After
EcoVision III was
launched in 2005,
two major
developments
affected the scope
and relevance of
this program.
Internally, the
divestment of our
Semiconductors
sector in September
2006 significantly
reduced the overall
environmental
impact of most of
the programs
parameters. Outside
the company, the
issue of energy
efficiency emerged
strongly at the
global level.
180 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
non-US GAAP information
|
|
254
|
|
Corporate governance
|
|
262
|
|
Ten-year overview
|
|
266
|
|
Investor information |
These events drove
us to create the
complementary, more
focused EcoVision4
program. Launched
in September 2007,
this latest
EcoVision program
focuses on reducing
the energy
consumption of our
products and
facilities. With
EcoVision4 we have
committed to:
|
|
generate 30% of total revenues from Green Products (up from 15% in 2006) |
|
|
|
double our investment in Green Innovations to a cumulative EUR 1 billion |
|
|
|
further increase the energy efficiency of our operations by 25% and reduce our operational carbon
footprint by 25%, both compared with the base year of 2007. |
We are reporting on
the results of both
programs versus
targets and will
continue to do so
until each program
concludes.
In addition to our
environmental
initiatives we have
been running
programs in other
areas. Our employee
programs include
engagement,
diversity and
inclusion, and
health and safety.
Through our
Supplier
Sustainability
Involvement Program
we have been
embedding
sustainability into
our supply
management
processes since
2003. Further, we
have a targeted
approach to our
social investment
program that
reflects our
business. In
keeping with this
we direct our
efforts toward
projects to upgrade
lighting,
particularly in
schools, and to
healthcare projects
that focus on
children.
Scope of sustainability reporting
The scope of our
sustainability
performance
reporting
encompasses the
consolidated
Philips Group
activities,
following the
consolidation
criteria detailed
in this section.
The consolidated
selected financial
information in this
sustainability
performance chapter
has been prepared
in accordance with
generally accepted
accounting
principles in the
United States of
America (US GAAP).
Comparability and completeness
For comparability
reasons, all
economic,
environmental and
social performance
data exclude the
former activities
of the
Semiconductors
sector, which was
divested in
September 2006.
Environmental data
are measured for
those manufacturing
sites with more
than 50 industrial
employees.
Integration of
newly acquired
manufacturing sites
is scheduled
according to a
defined integration
schedule, in
principle for the
first full
reporting year
after the year of
acquisition. Data
for activities that
are divested during
the reporting year
are not included
for the full-year
reporting.
Social data cover
all employees,
including temporary
employees, but
exclude contract
workers. Reporting
of health and
safety data by new
acquisitions must
start in the first
year after
acquisition. Data
for activities that
are divested during
the reporting year
are not included
for the full-year
reporting.
Data definitions and scope
Green Products
Green Products
offer a significant
environmental
improvement in one
or more Green Focal
Areas: Energy
efficiency,
Packaging,
Hazardous
substances, Weight,
Recycling and
disposal, Lifetime
reliability. In
addition, the life
cycle approach is
used to determine a
products overall
environmental
improvement. It
calculates the
environmental
impact of a product
over its total life
cycle (raw
materials,
manufacturing,
product use and
disposal).
Green Products need
to have a score in
at least one Green
Focal Area that is
significantly
better (at least
10%), compared to
the reference
product, which can
be a competitor or
predecessor product
in the particular
product family.
Because of the
different product
portfolios, sectors
has specified
additional criteria
for Green Products.
Green Innovations
Green Innovations
comprise all R&D
activities directly
contributing to the
development of
Green Products or
Green Technologies.
A wide set of
additional criteria
and boundaries have
been defined, as
the basis for
internal and
external
validation.
Environmental data
All environmental
data from
manufacturing
operations are
reported on a
half-year basis in
our intranet-based
EcoVision reporting
and validation
tool, according to
defined company
guidelines that
include
definitions,
procedures and
calculation
methods.
Internal validation
processes are
followed to ensure
consistent data
quality. The sector
validation officers
provide support to
the data collectors
at site level and
regularly conduct
audits to assess
the robustness of
data reporting
systems.
Tracking and
reporting these
EcoVision data from
manufacturing is
conducted to
measure progress
against our
EcoVision III
program targets.
Reporting on ISO
certification is
based on actively
reporting
manufacturing
units.
Operational carbon footprint
The Philips operational carbon footprint includes:
|
|
Industrial manufacturing and assembly sites |
|
|
|
Non-industrial offices, warehouses, IT centers and R&D facilities |
|
|
|
Business travel lease and rental cars, and airplane travel |
|
|
|
Distribution air, sea and road transport. |
All conversion
factors used to
transform input
data (for example,
amount of
ton-kilometers)
into CO2
emissions are from
the Greenhouse Gas
Protocol, except
for business
travel, where the
providers
supplied CO2
data based on their
own methodology.
The Greenhouse Gas
Protocol
distinguishes three
scopes, the first
two of which are
mandatory to report
on.
|
|
Scope 1
direct CO2
emissions is
completely
reported on
with direct
emissions from
our industrial
and
non-industrial
sites.
Emissions from
industrial
sites, which
consists of
direct
emissions
resulting from
processes and
fossil fuel
combustion on
site, are
reported in
the EcoVision
reporting
system.
Emissions from
industrial
sites that are
not yet
reporting in
EcoVision
following
recent
acquisitions
are calculated
based on
average
CO2
emissions per
square meter
of comparable
sites in the
same sector. |
|
|
|
Scope 2 CO2
emissions
resulting from
the generation
of purchased
electricity
for our
premises is
completely
reported on
with
electricity
use from
industrial and
non-industrial
sites. As
reported in
the EcoVision
reporting
system, this
consists of
indirect
emissions from
purchased
electricity,
steam and
heat. As with
Scope 1,
emissions from
industrial
sites that are
not yet
reporting in
the EcoVision
database
following
recent
acquisition
are
calculated
based on
average
CO2
emissions per
square meter
of compatible
sites in the
same sector. |
|
|
|
Scope 3
other CO2
emissions
related to
activities not
owned or
controlled by
the Company
is reported on
for our
business
travel and
distribution
activities.
Commuting by
our employees,
upstream
distribution
(before
suppliers ship
to us),
outsourced
activities and
emissions
resulting from
product use by
our customers
are not
included. The
calculations
for business
travel by
lease and
rental cars
are based on
actual fuel
usage.
Emissions from
business
travel by
airplane are
calculated by
the supplier
based on
airplane-specific emission
factors, the
number of
take-off and
landing
movements, and
the amount of
climb, cruise
and descent
activities.
Further,
emissions from
air freight
for
distribution
are calculated
based on the
amount of
ton-kilometers
transported
between
airports
(distinguishing
between
short, medium
and long
hauls). For
sea transport,
only data on
transported
volume were
available so
an estimate
had to be made
about the
average weight
of a
container.
Transportation
to and from
ports is not
registered.
This fore and
aft part of
air and sea
transport was
estimated to
be around 3%
of the total
distance,
consisting of
a mix of
modalities,
and was
added to the
total
emissions
accordingly.
CO2
emissions from
road transport
were also
calculated
based on
ton-kilometers.
If data were
incomplete,
the emissions
were estimated
based on
spend. Return
travel is not
included in
the data for
sea and road
distribution. |
Philips Annual Report 2008 181
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124
|
|
US GAAP financial statements
|
|
180
|
|
Sustainability performance
|
|
192
|
|
IFRS financial statements
|
|
244
|
|
Company financial statements |
|
|
|
|
|
|
- Economic indicators |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- Environmental indicators |
|
|
|
|
|
|
|
|
Health and safety
Health and safety
data are reported
monthly and
validated on a
half-yearly basis.
The focus is on
reporting
work-related
injuries, which
predominantly occur
in manufacturing
operations. The
annual number of
cases leading to at
least one lost
workday is reported
per 100 FTEs
(full-time
equivalents).
KPI (Key
Performance
Indicator) targets
are defined yearly
to drive
improvement.
Supplier audits
Supplier audits are
primarily focused
on identified risk
suppliers, based on
identified risk
countries and on
spend of more than
EUR 100,000.
|
|
Based on the
Maplecroft
Human Rights
Risk Indexes,
risk countries
for Supply
Management in
2008 were:
Belarus,
Brazil, China,
South Korea,
Mexico,
Malaysia,
Philippines,
Russia,
Taiwan,
Thailand,
Ukraine and
Vietnam. |
|
|
|
Suppliers of
new ventures
are included
to the extent
that the
integration
process of
these ventures
has been
finalized.
Normative
integration
period is two
years after
closure of the
new venture. |
External assurance
KPMG has provided
limited assurance
on whether the
information in this
section
Sustainability
performance is
fairly stated. We
refer to KPMGs
independent
assurance report on
page 189 of this
Annual Report.
Economic indicators
This section
provides summarized
information on
contributions to
the most important
economic
stakeholders as a
basis to drive
economic growth.
For a full
understanding of
each of these
indicators, please
refer to the
financial
statements and
notes in this
report.
Distribution of direct economic benefits
in millions of euros
|
|
|
|
|
|
|
2008 |
|
Suppliers: goods and services |
|
|
17,890 |
|
Employees: wages and pensions |
|
|
5,098 |
|
Shareholders: dividend |
|
|
720 |
|
Government: corporate income taxes |
|
|
286 |
|
Capital providers: net interest |
|
|
106 |
|
The total amount of
purchased goods and
services totaled
EUR 17.9 billion,
representing 68% of
total revenues of
the Philips Group.
Compared with 2007,
spending both in
absolute terms and
as a percentage of
sales increased,
reflecting the
trend to
outsourcing and
sub-contracting.
in billions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Total supply spend |
|
|
18.4 |
|
|
|
17.6 |
|
|
|
17.9 |
|
In 2008 the
salaries and wages
totaled EUR 5.1
billion. The
increase versus
2007 relates
particularly to
restructuring
charges. In
addition, the
acquisitions at
Healthcare and
Lighting had an
upward effect.
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Total salaries and wages |
|
|
4,613 |
|
|
|
4,607 |
|
|
|
5,098 |
|
Total dividend paid
to shareholders
amounted to EUR 720
million. This
reflects the
increase in
dividend per share
from EUR 0.60 to
EUR 0.70 per common
share, paid in
2008.
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Dividend paid |
|
|
523 |
|
|
|
659 |
|
|
|
720 |
|
Corporate income
taxes decreased
significantly in
2008, mainly due to
substantially lower
income. For a full
understanding,
please refer to
note 6.
in million of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Corporate income taxes |
|
|
166 |
|
|
|
619 |
|
|
|
286 |
|
Environmental indicators
EcoVision4: Green Product sales
Sales from Green
Products increased
12.5% in 2008,
contributing
significantly to
the total revenue
stream. As a
percentage of the
company total,
Green Product sales
rose to 22.6%, up
from 19.8% in 2007.
Excluding the major
new acquisitions in
2008 (Genlyte and
Respironics), the
percentage
increased to 24.9%.
These acquisitions
do not yet have a
process in place to
develop new
products with
significantly
improved
environmental
performance. These
will be included
from 2009 onward.
Green Product sales
in billions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Philips Group |
|
|
4.0 |
|
|
|
5.3 |
|
|
|
6.0 |
|
as a percentage of total published
sales |
|
|
15.0 |
|
|
|
19.8 |
|
|
|
22.6 |
|
as a percentage of comparable total
sales1) |
|
|
15.0 |
|
|
|
19.8 |
|
|
|
24.9 |
|
|
|
|
1) |
|
adjusted for sales from new consolidations |
Consumer Lifestyle
contributed most to
the overall
increase with the
introduction of 61
Green Products in
2008. Further
progress was also
achieved in the
Lighting sector,
where the share of
Green Products
increased.
Green Product sales per sector
as a percentage of total sales 1)
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Healthcare |
|
|
22 |
|
|
|
23 |
|
Consumer Lifestyle |
|
|
8 |
|
|
|
13 |
|
Lighting |
|
|
49 |
|
|
|
53 |
|
Philips Group |
|
|
20 |
|
|
|
25 |
|
|
|
|
1) |
|
adjusted for sales from new consolidations |
Overall,
improvements are
predominantly
realized in our
energy efficiency
Green Focal Area.
New Green Products from each sector include the following examples.
Healthcare
The CliniScape
mobile clinical
assistant is
designed to support
nurses and
physicians in
making more
informed clinical
decisions at the
point of care by
using an
ultra-ergonomic and
always connected
touch-screen device
that integrates
features needed to
enhance patient
safety and reduce
administrative
workload.
Compared to its
predecessor, this
Green Products
environmental
benefits include a
7% reduction in
energy use, 45%
less packaging
weight and an
improvement of the
environmental
impact of the total
life cycle of 21%.
182 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
non-US GAAP information
|
|
254
|
|
Corporate governance
|
|
262
|
|
Ten-year overview
|
|
266
|
|
Investor information |
Consumer Lifestyle
We signed an
exclusive
three-year
agreement with
Starwood Hotels and
Resorts, Inc. to
provide our latest
range of
SmartPower2 energy
efficient hotel
televisions to
Starwoods 460
properties across
North America. The
deal will see these
energy efficient
televisions
installed in new
hotels and existing
Starwood properties
looking to convert
to LCD TV
technology for the
first time.
This agreement is
expected to save
the hotel company
more than EUR 9
million in energy
costs over the
seven-year lifetime
of the equipment,
and reduce energy
consumption by up
to 40% compared
with the
televisions
currently in use.
We continue to
lower the standby
power of our
televisions, and
have brought it
down to 0.15 watts
in all of our TVs.
Ten years ago some
8 to 9 watts were
used for standby
power.
Lighting
In the area of
urban lighting, our
new UrbanLine
luminaire
represents a
breakthrough into
functional outdoor
LED lighting.
UrbanLine delivers
light in a
sustainable and
energy-efficient
manner, while still
fulfilling all the
requirements in
terms of safety and
city
identification.
Featuring
high-power LEDs
combined with smart
optics, UrbanLine
offers an
environmentally
friendly lighting
solution
consuming up to 50%
less energy than
traditional street
lighting by
exploiting the
benefits of white
light.
EcoVision4: Green Innovations
In 2008 Philips
invested
approximately EUR
282 million in
Green Innovations
the R&D spend
related to the
development of new
generations of
Green Products and
Green Technologies.
Healthcare
Philips Healthcare
invested some EUR
54 million,
concentrating on
innovation projects
that consider all
of the Green Focal
Areas and aim to
reduce total life
cycle impact. In
particular the
sector focuses on
reducing energy
consumption, weight
and hazardous
substances. One
example is our
holistic approach
to radiation
management called
DoseWise.
DoseWise is a set
of techniques,
programs and
practices that
ensures optimal
image quality,
while protecting
people in x-ray
environments. Based
on our ALARA (As
Low As Reasonably
Achievable)
principle, this is
a philosophy that
is active in every
level of product
design. And it
includes creative
thinking in three
areas: X-ray Beam
Management, Less
Radiation Time and
More Dose
Awareness.
Consumer Lifestyle
The Consumer
Lifestyle sector
invested about EUR
36 million in Green
Innovations. The
sector is dedicated
to developing new
Green Products with
a sharp focus on
further enhancing
energy efficiency
and closing
material loops, for
example by using
recycled materials
or offering better
recyclability.
Lighting
The Lighting sector
accounts for more
than half of the
total spend on
Green Innovations,
investing some EUR
151 million. The
focus is on
developing new
energy-efficient
lighting solutions,
further enhancing
current Green
Products and
driving toward
technological
breakthroughs, such
as solid-state
lighting.
Research
Within Corporate
Technologies,
Philips Research
invested more than
EUR 41 million,
spread over Green
Innovation projects
focused on meeting
global challenges
related to water,
air, waste and
energy. One example
is a patented
technology in
solid-state
lighting.
For all the
acknowledged
benefits of power
LEDs, including
efficiency,
sustainability and
durability, one of
the major
challenges has been
customer acceptance
of white LED light
for general
lighting. Philips
Lumileds Advanced
Laboratories in San
Jose and Philips
Research in Europe
have addressed this
issue, jointly
developing a new
technology that
ensures consistent
delivery of
uniformly high
color-quality white
LEDs. This
Lumiramic
technology,
patented by
Philips, enables us
to produce white
LEDs that offer
better controlled
warm white light.
EcoVision4:
Operational energy
efficiency and
carbon footprint
Determining our
carbon footprint is
a complex exercise.
In the Philips
Sustainability
Report 2007, we
reported our
operational carbon
footprint for the
first time. Based
on the available
data, some of which
were estimated or
extrapolated, we
calculated our
total operational
footprint to
be approximately
2,350 kilotons
CO2
equivalents.
During 2008 we
further improved
the data by
collecting more
accurate figures
and making less
estimates and
extrapolations. As
a result, we have
recalculated our
total operational
carbon footprint
for 2007 to
approximately 2,127
kilotons
CO2
equivalents, in
order to get a
reliable comparison
between 2007 and
2008.
In absolute
terms, total
CO2
emissions
in 2008 remained
virtually flat
at 2,147
kilotons CO2
equivalents, mainly
due to the major
acquisitions
(Genlyte and
Respironics).
Without these
additions, the
footprint would
have decreased by
nearly 5%.
Operational carbon footprint
in kilotons CO2 equivalents
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Manufacturing |
|
|
940 |
|
|
|
962 |
|
Non-industrial operations |
|
|
260 |
|
|
|
242 |
|
Business travel |
|
|
266 |
|
|
|
244 |
|
Distribution |
|
|
661 |
|
|
|
699 |
|
Total Philips Group |
|
|
2,127 |
|
|
|
2,147 |
|
Our total
operational carbon
footprint can also
be expressed
according to the
three scopes of the
Greenhouse Gas
Protocol.
Operational carbon footprint by Greenhouse Gas Protocol scopes
in kilotons CO2 equivalents
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Scope 1 |
|
|
460 |
|
|
|
484 |
|
Scope 2 |
|
|
740 |
|
|
|
720 |
|
Scope 3 |
|
|
927 |
|
|
|
943 |
|
Total Philips Group |
|
|
2,127 |
|
|
|
2,147 |
|
Operational energy
efficiency and
carbon footprint:
2008 details
The
2008 results can be
attributed to
several factors:
|
|
The major
acquisitions
(Genlyte and
Respironics)
had a
significant
impact on our
total
operational
carbon
footprint,
with an upward
effect of
nearly 6%.
Without these
additions, the
footprint
would have
decreased by
nearly 5%. |
|
|
|
Total CO2
emissions from
manufacturing
increased 2%
in absolute
terms, but
decreased 4%
on a
comparable
basis,
excluding the
acquisitions.
We doubled the
percentage of
electricity
purchased from
renewable
sources up
to 16% in 2008
from 8% in
2007
thereby
reducing
indirect
CO2
emissions.
Further,
optimized
production
reduced direct
and indirect
emissions.
Additional
details
on CO2
emissions from
manufacturing
operations are
provided under
EcoVision III
performance. |
|
|
|
CO2 emissions
from
non-industrial
operations
(offices,
warehouses,
etc.)
decreased 7%
in absolute
terms, and 15%
after
eliminating
the effect of
new
consolidations.
We reduced
facility space
decreasing
total square
meters by 9%
mainly by
centralizing
and
re-allocating
facilities. |
|
|
|
The total
level of CO2
emissions
related to
business
travel, which
represents 11%
of the total,
decreased 8%
in absolute
terms and 11%
on a
comparable
basis,
excluding the
acquisitions.
This reduction
was achieved
through our
strict air
travel policy
and strong
promotion of
videoconferencing. While the
number of
lease cars
increased 5%,
particularly
related to
acquisitions,
total
emissions
from
lease cars
remained
virtually
unchanged, as
CO2
emissions per
car decreased
3%,
attributable
to our green
lease car
policy. |
Philips Annual Report 2008 183
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124
|
|
US GAAP financial statements
|
|
180
|
|
Sustainability performance
Environmental indicators
|
|
192
|
|
IFRS financial statements
|
|
244
|
|
Company financial statements |
|
|
Overall CO2
emissions from
distribution
increased 6%
nominally, and
1% on a
comparable
basis,
excluding the
acquisitions.
Representing
nearly half of
these total
emissions, air
transport was
up 1%
nominally, but
2% lower on a
comparable
basis. Sea
transport
increased 19%,
due to various
reasons like a
targeted shift
from air to
sea transport,
new
acquisitions
and shipments
moving into
our scope
definition,
which includes
all shipments
for which
Philips pays
the transport.
Road transport
increased 2%,
but decreased
7% on a
comparable
basis due to
improved truck
utilization
and higher
value density
of some of our
products. |
Operational carbon footprint for distribution
in kilotons CO2 equivalents
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Air transport |
|
|
306 |
|
|
|
310 |
|
Road transport |
|
|
211 |
|
|
|
217 |
|
Sea transport |
|
|
144 |
|
|
|
172 |
|
Total Philips Group |
|
|
661 |
|
|
|
699 |
|
For
comparison, the
most relevant
ratios for
CO2 emissions
and energy
efficiency are
provided below.
Ratios on carbon emissions and energy use
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Operational CO2 emissions in kilotons
CO2 equivalents |
|
|
2,127 |
|
|
|
2,147 |
|
Operational CO2 intensity in tons CO2 equivalents
per million euro sales |
|
|
79.40 |
|
|
|
81.37 |
|
Operational energy use in terajoules |
|
|
34,953 |
|
|
|
34,924 |
|
Operational energy intensity in terajoules
per million euro sales |
|
|
1.30 |
|
|
|
1.32 |
|
EcoVision III manufacturing targets
Our EcoVision III
environmental
action program
began in 2006 and
will run through
2009. Focused on
reducing the impact
of our production
processes,
EcoVision III set
reduction targets
for all major
environmental
parameters in
manufacturing
compared to the
base year 2005.
Progress against
our EcoVision III
targets is detailed
below.
EcoVision III: Energy use in manufacturing
Absolute energy
usage amounted to
14,584 terajoules
in 2008. Compared
with 2007, energy
consumption at
Philips Group level
decreased 4%.
Further
rationalization of
production at
Lighting resulted
in a 5% decrease in
this sector,
representing nearly
80% of the total
Group. In one of
the major Lighting
sites, the
soda-lime furnace
was shut down,
resulting in less
electricity use.
Total energy consumption in manufacturing
in terajoules
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 |
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Healthcare |
|
|
1,539 |
|
|
|
1,569 |
|
|
|
1,600 |
|
|
|
1,609 |
|
Consumer Lifestyle |
|
|
1,411 |
|
|
|
1,402 |
|
|
|
1,444 |
|
|
|
1,515 |
|
Lighting |
|
|
12,131 |
|
|
|
12,086 |
|
|
|
12,090 |
|
|
|
11,426 |
|
I&EB |
|
|
1,456 |
|
|
|
156 |
|
|
|
35 |
|
|
|
34 |
|
Philips Group |
|
|
16,537 |
|
|
|
15,213 |
|
|
|
15,169 |
|
|
|
14,584 |
|
EcoVision III: CO2 emissions in manufacturing
The Greenhouse Gas
Emissions of our
manufacturing
operations
totaled 825
kilo tons CO2
equivalents in
2008, 4% lower than
2007. Both
direct and indirect
CO2 emissions
related to energy
use decreased. This
is particularly
attributable to the
increased use of
purchased
electricity coming
from renewable
sources, which went
up significantly
from 8% to 16%.
Total CO2 emissions in manufacturing
in kilotons CO2 equivalents
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 |
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Direct CO2 |
|
|
335 |
|
|
|
326 |
|
|
|
321 |
|
|
|
302 |
|
Indirect CO2 |
|
|
551 |
|
|
|
473 |
|
|
|
465 |
|
|
|
434 |
|
Other greenhouse gases |
|
|
144 |
|
|
|
40 |
|
|
|
40 |
|
|
|
61 |
|
From glass production |
|
|
29 |
|
|
|
29 |
|
|
|
29 |
|
|
|
28 |
|
Total |
|
|
1,059 |
|
|
|
868 |
|
|
|
855 |
|
|
|
825 |
|
The Lighting
sector, which
accounts for nearly
80% of total
CO2
emissions, achieved
a 5% reduction.
Total carbon emissions in manufacturing per sector
in kilotons CO2 equivalents
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 |
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Healthcare |
|
|
112 |
|
|
|
114 |
|
|
|
113 |
|
|
|
117 |
|
Consumer Lifestyle |
|
|
65 |
|
|
|
63 |
|
|
|
65 |
|
|
|
65 |
|
Lighting |
|
|
685 |
|
|
|
685 |
|
|
|
675 |
|
|
|
642 |
|
I&EB |
|
|
197 |
|
|
|
6 |
|
|
|
2 |
|
|
|
1 |
|
Philips Group |
|
|
1,059 |
|
|
|
868 |
|
|
|
855 |
|
|
|
825 |
|
EcoVision III: Water usage in manufacturing
Water is used
primarily for
domestic purposes,
with the exception
of Lighting where
it is also used in
manufacturing.
Total water intake
in 2008 was
slightly below 4
million
m3, 6%
lower than in 2007.
This decrease was
primarily realized
in Lighting. In
this sector less
cooling water was
used, while water
saving programs
such as rain buffer
water recycling
(treating the water
from rain for
additional supply),
installing stop
valves for water
taps etc. had a
positive effect on
water consumption.
Water intake
in thousands m3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 |
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Healthcare |
|
|
497 |
|
|
|
406 |
|
|
|
369 |
|
|
|
370 |
|
Consumer Lifestyle |
|
|
695 |
|
|
|
509 |
|
|
|
485 |
|
|
|
456 |
|
Lighting |
|
|
3,094 |
|
|
|
3,217 |
|
|
|
3,350 |
|
|
|
3,134 |
|
I&EB |
|
|
1,112 |
|
|
|
39 |
|
|
|
5 |
|
|
|
6 |
|
Philips Group |
|
|
5,398 |
|
|
|
4,171 |
|
|
|
4,209 |
|
|
|
3,966 |
|
In 2008, 66% of
water was purchased
and 34% was
extracted from
groundwater wells.
184 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of non-US GAAP information |
|
254
|
|
Corporate governance
|
|
262
|
|
Ten-year overview
|
|
266
|
|
Investor information |
EcoVision III: Waste in manufacturing
Total waste
decreased from 128
kilotons in 2007 to
113 kilotons in
2008. Lighting
(68%) and Consumer
Lifestyle (25%)
account for 93% of
our worldwide total
waste. The decrease
was mainly realized
by Consumer
Lifestyle due to
lower production.
Total waste
in kilotons
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 |
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Healthcare |
|
|
8.6 |
|
|
|
8.3 |
|
|
|
7.9 |
|
|
|
8.2 |
|
Consumer Lifestyle |
|
|
35.7 |
|
|
|
35.0 |
|
|
|
40.4 |
|
|
|
27.8 |
|
Lighting |
|
|
82.9 |
|
|
|
80.6 |
|
|
|
79.2 |
|
|
|
77.3 |
|
I&EB |
|
|
5.8 |
|
|
|
1.5 |
|
|
|
0.2 |
|
|
|
0.1 |
|
Philips Group |
|
|
133.0 |
|
|
|
125.4 |
|
|
|
127.7 |
|
|
|
113.4 |
|
Total waste is made
up of actual waste
that is delivered
for either landfill
or incineration,
comprising 17%
non-hazardous and
7% hazardous waste,
and recyclable
waste. Materials
delivered for
recycling via an
external contractor
comprised 87
kilotons, which
equals 76% of total
waste.
EcoVision III: Restricted substances
Emissions of
restricted
substances totaled
1,118 kilos in
2008, a significant
decrease of 18%
versus 2007. With
EcoVision III we
are focusing on a
selection of the
most important
substances in our
processes.
Restricted substances
in kilos
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 |
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Benzene |
|
|
20 |
|
|
|
6 |
|
|
|
52 |
|
|
|
1 |
|
Mercury |
|
|
260 |
|
|
|
197 |
|
|
|
185 |
|
|
|
211 |
|
CFCs/HCFCs1) |
|
|
2,758 |
|
|
|
160 |
|
|
|
157 |
|
|
|
213 |
|
Other restricted substances |
|
|
2,158 |
|
|
|
1,738 |
|
|
|
977 |
|
|
|
693 |
|
Total |
|
|
5,196 |
|
|
|
2,101 |
|
|
|
1,371 |
|
|
|
1,118 |
|
|
|
|
1) |
|
excluding cooling systems |
Benzene
Lighting is the
only sector that
uses benzene in
manufacturing.
During the course
of 2007, 52 kg of
benzene was
reported, and 1 kg
reported in 2008.
This significant
decrease is the
result of an
emissions
elimination program
initiated during
the year.
Mercury
Mercury is used
exclusively by
Lighting. Emissions
increased from 185
kg in 2007 to 211
kg in 2008, due to
a production
increase along with
a product mix
change.
CFCs/HCFCs
In 2008 total
emissions from
CFCs/HCFCs
increased to 213 kg
from 157 kg due to
a change in the
production mix at a
Healthcare site.
Other restricted substances
Emissions of other
restricted
substances totaled
693 kg in 2008,
strongly decreasing
from the year
before, when 977 kg
was emitted. The
decrease relates
particularly to the
phasing out of
certain substances
at Lighting
including the
phasing out of
dimethoxyethane. In
addition, use of
dichloromethane has
been reduced at a
major Healthcare
site.
EcoVision III: Hazardous substances
For hazardous
substances targets
have been set on a
selected number of
substances and not
for the total, as
listed in the
table.
Hazardous substances1)
in kilos
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 |
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
PFCs |
|
|
6,030 |
|
|
|
1,461 |
|
|
|
1,534 |
|
|
|
1,858 |
|
Lead |
|
|
4,297 |
|
|
|
4,257 |
|
|
|
3,958 |
|
|
|
8,074 |
|
Toluene |
|
|
9,091 |
|
|
|
3,091 |
|
|
|
1,029 |
|
|
|
1,107 |
|
Xylene |
|
|
4,022 |
|
|
|
4,493 |
|
|
|
4,166 |
|
|
|
3,358 |
|
Other hazardous
substances |
|
|
149,234 |
|
|
|
106,153 |
|
|
|
131,738 |
|
|
|
125,251 |
|
|
|
|
1) |
|
excluding PFCs
and Non-ODP
refrigerants for
cooling systems,
which are not added
in totals |
PFCs
The increase in
2008 is related to
one site in
Healthcare, due to
increased
production for
certain components
for which no
alternatives are
available.
Lead
The increase in
2008 is related to
the addition of two
new production
lines in one major
Lighting site, as
well as the test of
a new lead solder
recycling process.
Toluene
The increase in
2008 is caused by a
change in
production mix in
one major Lighting
site.
Xylene
The decrease is
attributable to the
closure of a
Lighting factory in
Juarez, Mexico. In
other Lighting
sites, some product
families were
pruned and actions
were taken to
reduce wet painting
and, thereby,
xylene.
Other hazardous substances
Styrene decreased due to divestments in Lighting.
ISO certification
In 2008, 95% of
reporting
manufacturing sites
were certified, in
line with company
policy.
ISO 14001 certification
as a % of all reporting organizations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 |
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Philips Group |
|
|
93 |
|
|
|
93 |
|
|
|
90 |
|
|
|
95 |
|
Incidents
In 2008, seven
issues were
reported in the
following four
categories. They
were related to
water (four),
restricted
substances (one),
soil (one) and fire
(one).
Philips Annual Report 2008 185
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124
|
|
US GAAP financial statements
|
|
180
|
|
Sustainability performance
Social indicators
|
|
192
|
|
IFRS financial statements
|
|
244
|
|
Company financial statements |
Social indicators
In 2008, 90% of
Philips employees
took the Engagement
Survey, giving
their answers to 44
questions on
leadership,
management
capabilities,
alignment with the
companys vision,
identification with
the brand,
communication,
reward and
recognition,
diversity and
inclusion, and
sustainability.
Engagement Index
The Employee
Engagement Index
(EEI) is the single
measure of the
overall level of
employee engagement
at Philips. It is a
combination of
perceptions and
attitudes related
to employee
satisfaction,
commitment and
advocacy.
Employee Engagement Index
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 |
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
% favorable |
|
|
59 |
|
|
|
61 |
|
|
|
64 |
|
|
|
69 |
|
% neutral |
|
|
|
|
|
|
21 |
|
|
|
20 |
|
|
|
17 |
|
% unfavorable |
|
|
|
|
|
|
18 |
|
|
|
16 |
|
|
|
14 |
|
The EEI rose to 69%
in 2008, from 64%
in the previous
year. Our target
for 2008 was to
reach 67% favorable
in our journey
towards 70%
favorable by the
end of 2009.
In the coming
years, we will
continue to review
and update our
targets by using
the
High-Performance
norm the score
achieved by the top
20% of companies
from our partner
Kenexas database.
A look at the results
No less than 83% of
the respondents say
they feel proud to
work for Philips
up from 72% in
2007. Another
positive outcome is
that many more
people now feel
that the company is
making good use of
their talents and
abilities, and
there is open and
honest two-way
communication
within their
organization. Other
aspects that people
clearly appreciate
are our strong
commitment to
sustainability and
a climate in which
diverse
perspectives are
valued and where
there are equal
opportunities for
all.
The scores also
showed that we must
pay more attention
to some areas of
key importance. For
example, employees
confidence in the
companys future
decreased. To
reverse this we are
placing emphasis on
connecting all of
our people with the
long-term ambition
of Philips.
Creating a dialogue
Detailed reports of
the survey results
were sent to
managers with a
team of eight or
more people. In
Deep Dive
sessions beginning
in November 2008,
teams talked about
their results,
discussing
strengths and
weaknesses, and
designing actions
to leverage
strengths and
address areas of
concern. These
Deep Dives will
be tracked and
monitored by
specially trained
HR generalists.
Diversity and inclusion
We continue to
focus on increasing
the opportunities
for women and other
under-represented
groups in key
positions, and on
developing a
diverse talent
pipeline.
as a % of total executives
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 |
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Female executives |
|
|
5 |
|
|
|
6 |
|
|
|
8 |
|
|
|
10 |
|
We reached our
diversity and
inclusion (D&I)
target for 2008,
significantly
increasing the
percentage of women
in executive
positions. Women
now comprise nearly
10% of executives
across the global
Philips
organization,
double the figure
of 5% in 2005 and
we aim to increase
that number to 15%
by 2012.
In 2008 the
percentage of women
in the top
potential pool
reached 23%, up
from 20% in 2007.
Further, we want to
get more talented
local people into
key positions in
our growth markets.
The percentage of
executives from
Asia Pacific stood
at 8% at year-end
2008, versus 7% the
previous year. The
percentage of top
potentials from
Asia Pacific was
14%, a decrease
from 16% in 2007.
As we move forward
with our D&I
initiative, new
targets are being
set to be achieved
by 2012. More
detailed attention
will be given to
growth markets and
to increasing the
numbers for top
potential and
executive
positions. As a
result we will
focus on target
setting for the
BRIC countries, to
monitor progress
more closely.
Developing our people
Employees across
the world can
access detailed
information about
our Global Learning
Curricula and
register for
courses online via
our Global Learning
Portal, Learning @
Philips.
number of employees participating
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 |
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Core Curriculum programs |
|
|
11,000 |
|
|
|
14,500 |
|
|
|
12,000 |
|
|
|
10,000 |
|
Our Core Curriculum
offers learning
opportunities in
the areas of
personal
effectiveness,
people management
and business
acumen. With nearly
10,000 employees
participating in
programs in the
Core Curriculum
during 2008,
enrollment
decreased compared
with 12,000 the
previous year. These
decreases are a
result of travel
restrictions.
Our Functional Core
Curricula includes
courses in Finance,
HRM, IT, Sales,
Marketing, Project
Management and
Supply Management.
Enrollment in the
Functional Core
Curricula was some
7,600 in 2008, a
slight decrease
from 8,000 in 2007.
Many Functional
Curricula are tied
to mandatory
learning plans
designed to
increase our
organizational
capability.
Talent pipeline curriculum
The Talent Pipeline
Curriculum consists
of systematic,
accelerating and
inspiring learning
interventions for
the Philips talent
pool (from high
potentials to
executives).
Our advanced
learning experience
for high
potentials, called
Inspire, is
designed to develop
future leaders who
are able to combine
a thorough
understanding of
their business
environment with
excellent personal
skills. The Octagon
program is the
accelerating
development program
for top potentials,
offering
participants the
opportunity to use
the strategic
insight, knowledge
and skills required
to tackle a major
(cross-sector/cross-
regional/cross-functional) issue, and
round out their
Philips leadership
behavior.
We upgraded the
content of our
Inspire program to
stretch even
further the
development of our
high potentials. In
2008, the Inspire
program facilitated
completion of seven
project
assignments, with
seven more expected
to be completed.
One project
explored potential
business
opportunities for
consumers to move
towards a more
sustainable
lifestyle by
focusing on
developed and
emerging markets.
Eight Octagon
projects were
completed. The
first class of 2008
showed the highest
results in the past
four years in
quality and Net
Promoter Score as
measured by
participants
evaluations. One of
the projects the
top potentials
worked on looked at
how to bring
lighting devices
into rural villages
in India where
electricity is not
available.
Executive education
To help our
executives to
continue to develop
their careers and
strengthen their
leadership skills,
we have been
offering a
curriculum of
internal and
external programs.
These offerings
continue to be
relevant to our
executives.
Participation
remained at the
same levels as
2007, with
approximately 9% of
executives and top
potentials
attending external
business school
programs.
After the 2007
redesign of our
executive induction
program for newly
hired or recently
appointed
executives, results
continue to show
high quality levels
for participants.
In 2008, 13 new
executives went
through the
session.
People Leadership Index
Because managers
contribute
significantly to
the engagement of
their employees, we
have developed the
People Leadership
Index (PLI), which
focuses on overall
people leadership
effectiveness. Our
PLI measuring 10
aspects relating to
management
capabilities
continued to
increase, rising to
69% in 2008 from
64% in 2007. This
is encouraging, as
it shows that our
efforts to improve
our managers
leadership skills
are working.
186 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
non-US GAAP information
|
|
254
|
|
Corporate governance
|
|
262
|
|
Ten-year overview
|
|
266
|
|
Investor information |
General Business Principles
In 2008 a total of
361 complaints were
raised, compared
with 389 in 2007;
392 in 2006; and
318 in 2005.
The number of
complaints in 2006
and 2007 may have
been affected by
two developments:
the global roll-out
of the One Philips
Ethics Hotline in
2006, and an
updated version of
the GBP Directives
approved and
adopted in 2007.
The hotline offers
improved access to
reporting
complaints,
including employee
anonymity and the
ability to call
from outside the
office. The updated
Directives reflect
ongoing
developments in
codes of conduct
and business
integrity
legislation. The
main updates
related to Philips
endorsement of the
UN Global Compact,
policy on HIV/AIDS,
health and safety
policy, integrity
and ethics in
advertising, and in
particular
directives on the
giving of gifts.
As many of the
alleged violations
are currently still
being investigated,
it is not possible
to determine
exactly which if
any of the
Philips General
Business Principles
(GBP) have been
infringed and to
what extent.
However, based on
careful analysis,
it is possible to
draw some
conclusions about
those GBP that are
most frequently
called into
question.
Breakdown of alleged violations GBP
as a % of total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 |
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
1 General commitment, total |
|
|
4.3 |
|
|
|
7.2 |
|
|
|
7.0 |
|
|
|
5.2 |
|
1.0 General commitment |
|
|
2.2 |
|
|
|
4.5 |
|
|
|
3.2 |
|
|
|
3.3 |
|
1.1 Human rights |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.2 Child, bonded and forced labor |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.3 Free market competition |
|
|
|
|
|
|
|
|
|
|
0.5 |
|
|
|
0.5 |
|
1.4 Product safety |
|
|
1.1 |
|
|
|
0.7 |
|
|
|
0.5 |
|
|
|
|
|
1.5 Privacy |
|
|
0.5 |
|
|
|
1.7 |
|
|
|
2.8 |
|
|
|
1.4 |
|
1.6 Environmental protection |
|
|
0.5 |
|
|
|
0.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 Commitment to customers, total |
|
|
|
|
|
|
1.2 |
|
|
|
0.7 |
|
|
|
1.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 Commitment to shareholders, total |
|
|
|
|
|
|
0.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 Commitment to employees, total |
|
|
48.1 |
|
|
|
58.8 |
|
|
|
55.8 |
|
|
|
62.9 |
|
4.0 Commitment to employees |
|
|
6.7 |
|
|
|
2.2 |
|
|
|
2.8 |
|
|
|
7.9 |
|
4.1 Right to organize |
|
|
1.1 |
|
|
|
0.5 |
|
|
|
1.5 |
|
|
|
|
|
4.2 Health and safety |
|
|
1.6 |
|
|
|
5.0 |
|
|
|
2.5 |
|
|
|
3.0 |
|
4.3 Equal and fair treatment |
|
|
34.1 |
|
|
|
47.1 |
|
|
|
44.3 |
|
|
|
49.4 |
|
4.4 Wages and payment |
|
|
4.6 |
|
|
|
4.0 |
|
|
|
4.7 |
|
|
|
2.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 Commitment to suppliers and
business partners, total |
|
|
8.9 |
|
|
|
5.7 |
|
|
|
2.3 |
|
|
|
2.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 Assets and information, total |
|
|
24.2 |
|
|
|
15.6 |
|
|
|
17.0 |
|
|
|
9.9 |
|
6.1 Use and protection of assets |
|
|
19.6 |
|
|
|
12.6 |
|
|
|
15.5 |
|
|
|
7.7 |
|
6.2 Improper disclosure |
|
|
4.6 |
|
|
|
3.0 |
|
|
|
1.5 |
|
|
|
2.2 |
|
6.3 Insider trading |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7 Business integrity, total |
|
|
13.7 |
|
|
|
10.9 |
|
|
|
17.2 |
|
|
|
16.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8 Observance of the General Business
Principles, total |
|
|
0.8 |
|
|
|
0.3 |
|
|
|
|
|
|
|
1.6 |
|
8.1 Sanctions |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8.2 Whistleblower policy |
|
|
0.8 |
|
|
|
0.3 |
|
|
|
|
|
|
|
1.6 |
|
8.3 Compliance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100.0 |
|
|
|
100.0 |
|
|
|
100.0 |
|
|
|
100.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In the table a
breakdown of the
newly filed alleged
violations of the
General Business
Principles are
given per year. For
each category the
number is expressed
as a percentage of
the total. More
information can be
found on
www.philips.com/gbp.
All alleged GBP
violations (and the
status of the
investigations) are
considered by the
Board of Management
and the Audit
Committee of the
Supervisory Board,
which assess any
possible impact on
Philips businesses
and compliance with
applicable laws.
Working conditions
In 2005 the number
of reported
(alleged)
violations related
to GBP 4
(Commitment towards
employees) stood at
48% of the total.
This was followed
by an increase to
63% in 2008.
Another point that
stands out in 2008
is the sharp rise
in the number of
complaints relating
to the general
commitment towards
employees principle
(GBP 4.0). To a
large extent these
originated from
employees of a
number of recently
acquired companies,
where the
pre-acquisition
style of management
was in many
respects
inconsistent with
the underlying
principles of
business conduct
defined in the
Philips GBP.
In 2008 the GBP
most associated
with alleged
violations was
again GBP 4.3
(Equal and fair
treatment). As in
the previous two
years, almost half
of all reported
complaints related
to this principle
(49.4% in 2008
compared with 44.3%
in 2007 and 47.1%
in 2006). More than
two thirds of these
complaints related
to two issues:
respectful
treatment and
discrimination.
Some 35% of the
complaints related
to respectful
treatment and 30%
to discrimination
issues.
Business integrity issues
With regard to
reporting of the
typical business
integrity issues,
the number of
complaints remained
fairly stable in
2008 compared to
2007.
Use and protection of assets
After having been
the second most
frequently received
GBP complaint in
2007 at 15.5% of
the total, there
was a sharp fall in
the number of
complaints relating
to GBP 6.1 (Use and
protection of
assets), with only
7.7% in 2008. A lot
of attention has
been devoted to
this issue, both in
the recent editions
of the GBP
Directives and in
the latest
Corporate IT
Directives. It is
possible that this
has helped to bring
about the necessary
improvement in
discipline with
regard to the
handling of
confidential
information and
Philips assets and
resources.
Supply management
The number of
complaints relating
to supply
management was
virtually the same
in 2008 and 2007.
Only eight
complaints were
lodged in 2008 in
the GBP Complaints
database as alleged
violations of GBP 5
(Commitment to
Suppliers and
Business Partners),
compared with nine
in 2007. The vast
majority of supply
management
allegations are
related to the
conduct of
purchasing. For
more information
see the section on
Supplier indicators
that begins on page
188 of this Annual
Report.
Health and safety
Philips strives for
an injury and
illness-free work
environment, with a
sharp focus on
decreasing the
number of injuries.
This is defined as
a KPI, on which we
set yearly targets
for the company and
our individual
sectors.
In 2008 we recorded
650 Lost Workday
Injuries cases,
occupational injury
cases where the
injured person is
unable to work the
day after the
injury. This is an
18% decrease
compared with 2007.
The rate of Lost
Workday Injuries
also decreased
substantially to
0.68 per 100 FTEs,
compared with 0.81
in 2007.
Lost workday injuries
per 100 FTEs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 |
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Healthcare |
|
|
0.45 |
|
|
|
0.37 |
|
|
|
0.29 |
|
|
|
0.27 |
|
Consumer Lifestyle |
|
|
0.69 |
|
|
|
0.66 |
|
|
|
0.61 |
|
|
|
0.44 |
|
Lighting |
|
|
1.23 |
|
|
|
1.27 |
|
|
|
1.35 |
|
|
|
1.17 |
|
I&EB |
|
|
0.34 |
|
|
|
0.23 |
|
|
|
0.12 |
|
|
|
0.12 |
|
Philips Group |
|
|
0.78 |
|
|
|
0.78 |
|
|
|
0.81 |
|
|
|
0.68 |
|
Reductions were
particularly
realized in the
Lighting sector,
which initiated a
dedicated action
program two years
ago to drive down
injury levels.
Consumer Lifestyle
also achieved a
lower injury rate.
Philips Annual Report 2008 187
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124
|
|
US GAAP financial statements
|
|
180
|
|
Sustainability performance
|
|
192
|
|
IFRS financial statements
|
|
244
|
|
Company financial statements |
|
|
|
|
|
|
- Supplier indicators |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- Independent assurance report |
|
|
|
|
|
|
|
|
Supplier indicators
Supplier sustainability training
In 2008 Philips
Sustainability
Officers held 15
training sessions
in China, India and
the United States,
attended by more
than 400 suppliers.
2008 supplier audits
Before a formal
audit takes place,
a quick scan of the
suppliers site is
conducted to
identify critical
issues where
possible. This
increases the
suppliers
understanding of
our sustainability
requirements and
standards. In 2008
we performed more
than 100 scans in
our supply base.
A total of 572
audits of Bill of
Material (BOM) and
non-product related
(NPR) identified
risk suppliers were
carried out in
2008, comprised of:
|
|
244 initial
audits of new
suppliers,
including
those from
acquisitions,
new sites or
spend growth
exceeding EUR
100,000 |
|
|
|
33 continual conformance audits at suppliers audited in 2005, and |
|
|
|
295
resolution
audits
focusing on
zero-tolerance
issues (for
example: child
labor,
continual
seven-day work
weeks,
immediate life
threatening
situations,
slave labor
conditions and
banned
substances). |
The majority (80%) of BOM-related audits were conducted in China.
Some 60% of initial
audits were
performed by
specialized
external auditing
bodies for reasons
of independence,
professionalism and
capacity.
Summary supplier sustainability audit results
% of newly audited
BOM-sites where the
following types of
non-compliances
were found
|
|
|
|
|
|
|
|
|
|
|
zero |
|
|
limited |
|
|
|
tolerance |
|
|
tolerance |
|
Labor |
|
|
|
|
|
|
|
|
Freely choosen employment |
|
|
1 |
|
|
|
11 |
|
Child labor avoidance |
|
|
|
|
|
|
9 |
|
Working hours |
|
|
15 |
|
|
|
26 |
|
Wages and benefits |
|
|
|
|
|
|
26 |
|
Humane treatment |
|
|
|
|
|
|
2 |
|
Non-discrimination |
|
|
1 |
|
|
|
4 |
|
Freedom of association |
|
|
|
|
|
|
|
|
Collective bargaining |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Health and safety |
|
|
|
|
|
|
|
|
Occupational safety |
|
|
22 |
|
|
|
11 |
|
Emergency preparedness |
|
|
26 |
|
|
|
1 |
|
Occupational injury and illness |
|
|
|
|
|
|
21 |
|
Industrial hygiene |
|
|
14 |
|
|
|
22 |
|
Physically demanding work |
|
|
|
|
|
|
|
|
Machine safeguarding |
|
|
7 |
|
|
|
2 |
|
Dormitory and canteen |
|
|
7 |
|
|
|
4 |
|
|
|
|
|
|
|
|
|
|
Environmental |
|
|
|
|
|
|
|
|
Environmental permits and reporting |
|
|
15 |
|
|
|
2 |
|
Pollution prevention and resource
reduction |
|
|
|
|
|
|
2 |
|
Hazardous substances |
|
|
20 |
|
|
|
29 |
|
Waste water and solid waste |
|
|
9 |
|
|
|
3 |
|
Air emissions |
|
|
1 |
|
|
|
4 |
|
Product content restrictions |
|
|
5 |
|
|
|
2 |
|
|
|
|
|
|
|
|
|
|
Management system |
|
|
|
|
|
|
|
|
Company commitment |
|
|
|
|
|
|
8 |
|
Management accountability |
|
|
|
|
|
|
|
|
Legal and customer requirements |
|
|
|
|
|
|
4 |
|
Risk assessment and management |
|
|
|
|
|
|
13 |
|
Performance objectives |
|
|
|
|
|
|
23 |
|
Training |
|
|
|
|
|
|
5 |
|
Communication |
|
|
|
|
|
|
5 |
|
Worker feedback and participation |
|
|
|
|
|
|
2 |
|
Audits and assessments |
|
|
|
|
|
|
14 |
|
Corrective action process |
|
|
|
|
|
|
4 |
|
Documentation and records |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
Ethics |
|
|
|
|
|
|
|
|
Business integrity |
|
|
|
|
|
|
|
|
No proper advantage |
|
|
|
|
|
|
7 |
|
Disclosure of information |
|
|
|
|
|
|
|
|
Intellectual property |
|
|
2 |
|
|
|
|
|
Fair business, advertising and competition |
|
|
6 |
|
|
|
1 |
|
Protection of identity |
|
|
|
|
|
|
3 |
|
188 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
non-US GAAP information
|
|
254
|
|
Corporate governance
|
|
262
|
|
Ten-year overview
|
|
266
|
|
Investor information |
Supplier audit results
We implemented the
EICC checklist for
audits conducted in
2008. This has led
to a marked
increase in the
number of issues
recorded.
Previously we
focused primarily
on
social/labor-related
issues, while the
checklist includes
a broader range of
parameters.
Management issues
represent a major
part of the
increase in
identified issues.
Findings identified
during initial
audits provide the
base for the yearly
issue overview, and
continual
conformance audit
findings have also
been included for
the first time.
The vast majority of non-compliances (89%) were found in China.
The most frequently
identified issues
coming out of the
277 initial and
continual
conformance audits
were as follows:
|
|
Zero-tolerance
emergency
preparedness
(blocked fire
exits);
occupational
safety
(immediate
threat to
health and
safety);
working
conditions
(exposure to
hazardous
substances);
working hours
(continual
seven-day work
weeks); and
lack of
environmental
permits. |
|
|
|
Limited-tolerance improper
handling/processing of
chemical
waste; working
hours (above
legal
limits/60
hours a week);
wages and
benefits
(below minimum
wages and
absence of
legal overtime
payment);
environmental
performance
objectives do
not meet legal
requirements;
lack of
industrial
hygiene (lack
of personal
protective
equipment);
occupational
injury and
illness (no
medical
treatment
facility). |
Increased speed in resolving zero-tolerance issues
At the Supply
Leadership Meeting
(a forum of the top
100 Philips supply
managers) in May
2008 we focused on
resolving
zero-tolerance
issues, leading to
a breakthrough in
resolution time.
During the last
four months of the
year all
zero-tolerance
issues were solved
within 105 days,
down significantly
from the average
resolution time of
250 days in 2007.
This represents a
60% increase in
speed of
resolution. At
year-end there were
no zero-tolerance
issues older than
three months,
indicating that
ownership within
the Philips Supply
Management
community is now
well engrained.
Those remaining
issues were
identified during
audits performed in
November and
December 2008.
Where no
improvement could
be established, 25
suppliers were
phased out.
Tackling the most frequent zero-tolerances
The most frequently
identified
zero-tolerance
issues related to
occupational health
and safety risks
and continual
seven-day work
weeks. Health and
safety issues can
be resolved
quickly, while
dealing with
working hours often
entails installing
extra shifts with
additional
personnel, which
can take at least a
month.
By helping our
suppliers to see
this as a business
opportunity, more
than 30,000 workers
from our supply
base average at
least one day rest
every week.
Resolving limited-tolerance issues
The top three open
items for
limited-tolerance
concerns are the
lack of management
systems to track
and trace site
environmental
pollution;
environmental
permits; reliable
recording of
working hours. Some
dated back to 2007
due to long lead
time for
implementing
required changes.
Independent assurance report
To the Supervisory
Board and
Shareholders of
Koninklijke Philips
Electronics N.V.:
Introduction
We have been
engaged by
Koninklijke Philips
Electronics N.V. to
provide limited
assurance on the
section
Sustainability
performance in this
Annual Report. The
Board of Management
is responsible for
the preparation and
fair presentation
of the
Sustainability
performance
section. Our
responsibility is
to provide limited
assurance on this
information
contained in this
Annual Report.
Scope
Our engagement was
designed to provide
limited assurance
on whether the
information in the
section
Sustainability
performance on
pages 180 to 189 of
this Annual Report
is fairly stated.
Procedures
performed to obtain
a limited level of
assurance are aimed
at determining the
plausibility of
data and are less
extensive than
those for a
reasonable level of
assurance. Our
procedures included
reviewing systems
and processes for
data management,
assessing the
appropriateness of
the accounting
policies used,
assessing the data
collection and
reporting process
at a limited number
of sites and
evaluating the
overall
presentation of
sustainability
information within
our scope.
We have also
reviewed, to the
extent of our
competence, whether
the section
Sustainability on
pages 62 to 67 is
consistent with the
information in the
section
Sustainability
performance.
Reporting criteria
There are no
generally accepted
standards for
reporting
sustainability
performance.
Koninklijke Philips
Electronics N.V.
applies the
Sustainability
Reporting
Guidelines of the
Global Reporting
Initiative (G3)
together with
internal corporate
guidelines, as
detailed in
Approach to
sustainability
reporting in the
section
Sustainability
performance on
pages 180 to 182.
It is important to
view the
performance data in
the context of this
explanatory
information. We
believe that these
criteria are
suitable in view of
the purpose of our
assurance
engagement.
Standards
We conducted our
engagement in
accordance with the
International
Standard for
Assurance
Engagements (ISAE)
3000: Assurance
Engagements other
than Audits or
Reviews of
Historical
Financial
Information, issued
by the
International
Auditing and
Assurance Standards
Board. Amongst
others, this
standard requires
that the assurance
team members
possess the
specific knowledge,
skills and
professional
competencies needed
to understand and
review the
information and
that they comply
with ethical
requirements.
Conclusion
Based on our work
described in this
report, the
information in the
section
Sustainability
performance on
pages 180 to 189
does not appear to
be unfairly stated
in accordance with
the criteria
described in
Approach to
sustainability
reporting in the
section
Sustainability
performance in this
Annual Report.
We also report, to
the extent of our
competence, that
the section
Sustainability on
pages 62 to 67 is
consistent with the
section
Sustainability
performance.
Amsterdam, 23 February 2009
KPMG Accountants N.V.
M.A. Soeting RA
Philips Annual Report 2008 189
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124
|
|
US GAAP financial statements
|
|
180
|
|
Sustainability performance
Global Reporting Initiative
|
|
192
|
|
IFRS financial statements
|
|
244
|
|
Company financial statements |
Global Reporting Initiative (GRI): G3 performance indicators
The Philips Annual Report 2008 covers our
financial, social and environmental
performance in a single volume. This chart
provides you with a view of performance
indicators covered in the report. Because we
report at Philips Group level, performance
indicators on local issues are not adressed.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
not |
|
|
|
not |
|
page |
|
|
|
|
|
|
applicable |
|
addressed |
|
addressed |
|
number |
Economic
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Economic performance
|
|
EC1
|
|
Direct economic value generated and distributed, including
revenues, operating costs,
employee compensation, donations and other community
investments, retained earnings,
and payments to capital providers and governments
|
|
|
|
ü
|
|
|
|
124-178
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EC2
|
|
Financial implications and other risks and opportunities for
the organizations activities
due to climate change
|
|
|
|
ü
|
|
|
|
|
26-29,
180-185 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EC3
|
|
Coverage of the organizations defined-benefit plan
obligations
|
|
|
|
ü
|
|
|
|
|
160-163 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EC4
|
|
Significant financial assistance received from government
|
|
|
|
|
|
ü |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EC6
|
|
Policy, practices, and proportion of spending on
locally-based suppliers at significant
locations of operation
|
|
|
|
|
|
ü |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EC7
|
|
Procedures for local hiring and proportion of senior
management hired from the local
community at significant locations of operation
|
|
|
|
ü
|
|
|
|
|
37, 64,
187 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EC8
|
|
Development and impact of infrastructure investments and
services provided primarily
for public benefit through commercial, in-kind, or pro bono
engagement
|
|
|
|
ü
|
|
|
|
|
33, 65 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Environment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Materials
|
|
EN1
|
|
Materials used by weight or volume
|
|
|
|
|
|
ü |
|
|
|
|
|
|
EN2
|
|
Percentage of materials used that are recycled input materials
|
|
|
|
|
|
ü |
|
|
|
|
Energy
|
|
EN3
|
|
Direct energy consumption by primary energy source
|
|
|
|
|
|
ü |
|
|
|
|
|
|
EN4
|
|
Indirect energy consumption by primary source
|
|
|
|
|
|
ü |
|
|
|
|
Water
|
|
EN8
|
|
Total water withdrawal by source
|
|
|
|
ü
|
|
|
|
|
185 |
|
Biodiversity
|
|
EN11
|
|
Location and size of land owned, leased, managed in, or
adjacent to, protected
areas and areas of high biodiversity value outside protected
areas
|
|
ü |
|
|
|
|
|
|
|
|
|
|
EN12
|
|
Description of significant impacts of activities, products,
and services on
biodiversity in protected areas and areas of high
biodiversity value outside
protected areas
|
|
ü |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Emissions, effluents, and waste
|
|
EN16
|
|
Total direct and indirect greenhouse gas emissions by weight
|
|
|
|
ü
|
|
|
|
|
185 |
|
|
|
EN17
|
|
Other relevant indirect greenhouse gas emissions by weight
|
|
|
|
ü
|
|
|
|
|
184 |
|
|
|
EN19
|
|
Emissions of ozone-depleting substances by weight
|
|
|
|
ü
|
|
|
|
|
186 |
|
|
|
EN20
|
|
NOx, SOx, and other significant air emissions by type and
weight
|
|
|
|
|
|
ü |
|
|
|
|
|
|
EN21
|
|
Total water discharge by quality and destination
|
|
|
|
|
|
ü |
|
|
|
|
|
|
EN22
|
|
Total weight of waste by type and disposal method
|
|
|
|
ü
|
|
|
|
|
185 |
|
|
|
EN23
|
|
Total number and volume of significant spills
|
|
|
|
ü
|
|
|
|
|
186 |
|
|
|
EN26
|
|
Initiatives to mitigate environmental impacts of products and
services, and
extent of impact mitigation
|
|
|
|
ü
|
|
|
|
|
38-40, 183 |
|
|
|
EN27
|
|
Percentage of products sold and their packaging materials
that are
reclaimed by category
|
|
ü |
|
|
|
|
|
|
|
|
Compliance
|
|
EN28
|
|
Monetary value of significant fines and total number of
non-monetary
sanctions for non-compliance with environmental laws and
regulations
|
|
ü |
|
|
|
|
|
|
|
|
190 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
non-US GAAP information
|
|
254
|
|
Corporate governance
|
|
262
|
|
Ten-year overview
|
|
266
|
|
Investor information |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
not |
|
|
|
not |
|
page |
|
|
|
|
|
|
applicable |
|
addressed |
|
addressed |
|
number |
Product responsibility
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Customer health and safety
|
|
PR1
|
|
Life cycle stages in which health and safety impacts of
products and services
are assessed for improvement, and percentage of significant
products and
services categories subject to such procedures
|
|
|
|
ü
|
|
|
|
|
38-40 |
|
Product and service labeling
|
|
PR3
|
|
Type of product and service information required by
procedures, and
percentage of significant products and services subject to
such information
requirements
|
|
|
|
|
|
ü |
|
|
|
|
Marketing communications
|
|
PR6
|
|
Programs for adherence to laws, standards, and voluntary
codes related to
marketing communications, including advertising, promotion,
and sponsorship
|
|
|
|
ü
|
|
|
|
|
180 |
|
|
|
PR9
|
|
Monetary value of significant fines for non-compliance with
laws and
regulations concerning the provision and use of products and
services
|
|
ü |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Labor practices and decent work |
|
|
|
|
|
|
|
|
|
|
|
|
Employment
|
|
LA1
|
|
Total workforce by employment type, employment contract, and
region
|
|
|
|
ü
|
|
|
|
|
54-55 |
|
|
|
LA2
|
|
Total number and rate of employee turnover by age group,
gender, and region
|
|
|
|
ü
|
|
|
|
|
16-17,187 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Labor / Management relations
|
|
LA4
|
|
Percentage of employees covered by collective bargaining
agreements
|
|
|
|
|
|
ü |
|
|
|
|
|
|
LA5
|
|
Minimum notice period(s) regarding significant operational
changes, including
whether it is specified in collective agreements
|
|
|
|
|
|
ü |
|
|
|
|
Occupational health and safety
|
|
LA7
|
|
Rates of injury, occupational diseases, lost days,
absenteeism and total number
of work-related fatalities, by region
|
|
|
|
ü
|
|
|
|
|
189 |
|
|
|
LA8
|
|
Education, training, counseling, prevention and risk-control
programs in place to
assist workforce members, their families, or community
members regarding
serious diseases
|
|
|
|
|
|
ü |
|
|
|
|
Training and education
|
|
LA10
|
|
Average hours of training per year per employee by employee
category
|
|
|
|
|
|
ü |
|
|
|
|
Diversity and equal opportunity
|
|
LA13
|
|
Ratio of basic salary of men to women by employee category
|
|
|
|
|
|
ü |
|
|
|
|
|
|
LA14
|
|
Composition of governance bodies and breakdown
of employees per category according to gender, age group,
minority group
membership, and other indicators of diversity
|
|
|
|
|
|
ü |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Human rights
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment and procurement
practices
|
|
HR1
|
|
Percentage and total number of significant investment
agreements that include
human rights clauses or that underwent human rights screening
|
|
|
|
ü
|
|
|
|
|
187-189 |
|
|
|
HR2
|
|
Percentage of significant suppliers and contractors that have
undergone
screening on human rights, and actions taken
|
|
|
|
ü
|
|
|
|
|
188-189 |
|
Non-discrimination
|
|
HR4
|
|
Total number of incidents of discrimination, and actions taken
|
|
|
|
ü
|
|
|
|
|
187-189 |
|
Freedom of association and
collective bargaining
|
|
HR5
|
|
Operations identified in which the right to exercise freedom
of association or
collective bargaining may be at significant risk, and actions
taken to support
these rights
|
|
|
|
ü
|
|
|
|
|
187-189 |
|
Child labor
|
|
HR6
|
|
Operations identified as having significant risk of incidents
of child labor, and
measures taken to contribute to the elimination of child labor
|
|
|
|
ü
|
|
|
|
|
187-189 |
|
Forced and compulsary labor
|
|
HR7
|
|
Operations identified as having significant risk of incidents
of forced or
compulsory labor, and measures taken to contribute to the
elimination of
forced or compulsory labor
|
|
|
|
ü
|
|
|
|
|
187-189 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Society
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Community
|
|
SO1
|
|
Nature, scope, and effectiveness of any programs and
practices that assess and
manage the impacts of operations on communities, including
entering,
operating, and exiting
|
|
|
|
ü
|
|
|
|
|
28,32-33 |
|
Ethics
|
|
SO2
|
|
Percentage and total number of business units analyzed for
risks
related to ethics
|
|
|
|
ü
|
|
|
|
|
188-189 |
|
|
|
SO3
|
|
Percentage of employees trained in organizations
anti-corruption policies
and procedures
|
|
|
|
ü
|
|
|
|
|
188-189 |
|
|
|
SO4
|
|
Actions taken in response to incidents of ethics
|
|
|
|
ü
|
|
|
|
|
188-189 |
|
Public policy
|
|
SO5
|
|
Public policy positions and participation in public policy
development
and lobbying
|
|
|
|
ü
|
|
|
|
|
180 |
|
Compliance
|
|
SO8
|
|
Monetary value of significant fines and total number of
non-monetary
sanctions for non-compliance with laws and regulations
|
|
|
|
|
|
ü |
|
|
|
|
Philips Annual Report 2008 191
|
|
|
|
|
|
|
|
|
124 US GAAP financial
statements
|
|
180 Sustainability performance
|
|
192
|
|
IFRS financial statements
|
|
244 Company financial
statements |
|
|
|
|
|
|
IFRS management commentary |
IFRS financial statements
Introduction
This chapter of this Annual Report contains the IFRS management commentary and the audited
consolidated financial statements including the notes thereon prepared in accordance with the
International Financial Reporting Standards as adopted by the European Union and with the statutory
provisions of Part 9, Book 2 of the Dutch Civil Code. Together with the chapter Company financial
statements, this chapter contains the statutory financial statements of the Company.
The IFRS management commentary together with the following chapters, sections and pages of this
Annual Report:
|
|
Who we are that begins on page 14 of this Annual Report; |
|
|
|
We care about... that begins on page 18 of this Annual Report; |
|
|
|
Our group performance that begins on page 42 of this Annual Report; including the management
discussion and analysis; |
|
|
|
Our sector performance that begins on page 70 of this Annual Report; |
|
|
|
Report of the Remuneration Committee that begins on page 116 of this Annual Report; |
|
|
|
Risk management that begins on page 94 of this Annual Report; and |
|
|
|
Corporate governance that begins on page 254 of this Annual
Report, |
|
which are deemed
incorporated and repeated in this chapter by reference, form the management report within the
meaning of section 2:391 of the Dutch Civil Code (and related Decrees). |
The chapters Our group performance and Our sector performance provide an extensive analysis of the
developments during the financial year 2008 and the results. These chapters also provide
information on the business outlook, investments, financing, personnel and research and development
activities. It should be noted that the figures used in these chapters are based on US GAAP because
Philips primary external and internal reporting is currently based on US GAAP. However, the
commentary and analysis set out in these chapters is no different under US GAAP or IFRS, except for
the figures that are referred to.
The section IFRS management commentary provides an analysis in summarized form of the developments
during the financial year 2008 and the results based on IFRS on group and sector level. To further
facilitate understanding of the major differences between US GAAP and IFRS that affect
stockholders equity and net income, this section includes a reconciliation from IFRS to US GAAP in
respect of these items.
The income statement included in the chapter Company financial statements has been prepared in
accordance with section 2:402 of the Dutch Civil Code, which allows a simplified income statement
in the Company financial statements in the event that a comprehensive income statement is included
in the consolidated financial statements.
For Additional information within the meaning of section 2:392 of the Dutch Civil Code, please
refer to the Auditors report on page 243, the Auditors report on page 249, the section Proposed
distribution to shareholders on page 68 of this Annual Report, and note 70 for subsequent events.
The IFRS management commentary is based on the IFRS consolidated financial statements and should be
read in conjunction with these statements. The term EBIT has the same meaning as Income from
operations (IFO), and is used to evaluate the performance of the business.
Please refer to page 44 of this Annual Report for more information about forward-looking
statements, third-party market share data, fair value information, and revisions and
reclassifications.
The Board of Management of the Company hereby declares that, to the best of their knowledge, the
IFRS financial statements and Company financial statements give a true and fair view of the assets,
liabilities, financial position and profit or loss of the Company and the undertakings included in
the consolidation taken as a whole and that the management report referred to above gives a true
and fair view concerning the position as per the balance sheet date, the development and
performance of the business during the financial year of the Company and the undertakings included
in the consolidation taken as a whole, together with a description of the principal risks that they
face.
Board of Management
February 23, 2009
192 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of non-US GAAP information
|
|
254 Corporate governance
|
|
262 Ten-year overview
|
|
266 Investor information |
IFRS management commentary
The year 2008...
|
|
2008 was impacted by the most globally significant economic downturn in many years. For Philips,
this led to a 3% decline in comparable sales and lower earnings. In response, we proactively
expanded and accelerated restructuring programs across all sectors and stepped up our focus on
costs and cash management. |
|
|
|
2008 was nevertheless a year of strategic progress. We continued the reshaping of our portfolio
by investing EUR 5.3 billion in high-growth, high-margin businesses such as Respironics and
Genlyte, and divesting unprofitable activities such as Television in North America and non-core
businesses such as Set-Top Boxes and PC Monitors. |
|
|
|
Healthcare sales grew by 6% on a comparable basis; all businesses contributed to this growth.
Lighting achieved 3% comparable sales growth, driven by energy-efficient lighting solutions.
Consumer Lifestyle sales declined 8% compared to 2007, reflecting the severe economic downturn in
consumer markets in the second half of 2008. |
|
|
|
Emerging markets remained a major focal point and delivered 4% comparable growth in 2008 with
Healthcare and Lighting growing by 12% and 8% respectively. Additionally, we announced and/or
finalized five strategic Healthcare acquisitions in China, Brazil and India. |
|
|
|
EBIT included EUR 1.2 billion of charges related to restructuring and change programs across all
sectors (EUR 535 million), an asbestos-related settlement charge (EUR 264 million), a non-cash
goodwill impairment charge for Lumileds (EUR 299 million) and acquisition-related charges, mainly
in Healthcare and Lighting (EUR 131 million), which were partially offset by EUR 147 million of
gains on the sale of businesses and real estate. |
|
|
|
We generated strong cash flows from operations of EUR 1,648 million despite lower earnings,
driven by rigorous working capital management. In addition, in March we structurally refinanced our
debt prior to the collapse of the financial markets providing Philips with a strong balance
sheet and a solid liquidity position to help weather the turbulent economic situation. |
|
|
|
We reduced our shareholding in LG Display and sold our remaining stake in TSMC, generating EUR
2.5 billion in cash proceeds and realizing a gain of just under EUR 1.4 billion. The economic
downturn led us to take a non-cash value adjustment of EUR 1.3 billion on the majority of our
remaining financial holdings. |
|
|
|
We completed EUR 3.3 billion of the EUR 5 billion share buy-back program announced in 2007.
Additionally, we returned EUR 720 million to shareholders in the form of a dividend payment. |
Key data
in millions of euros unless otherwise stated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20061) |
|
|
20071) |
|
|
2008 |
|
Sales |
|
|
26,682 |
|
|
|
26,793 |
|
|
|
26,385 |
|
EBITA |
|
|
1,528 |
|
|
|
2,094 |
|
|
|
744 |
|
as a % of sales |
|
|
5.7 |
|
|
|
7.8 |
|
|
|
2.8 |
|
EBIT |
|
|
1,336 |
|
|
|
1,867 |
|
|
|
54 |
|
as a % of sales |
|
|
5.0 |
|
|
|
7.0 |
|
|
|
0.2 |
|
Financial income and expenses |
|
|
29 |
|
|
|
2,849 |
|
|
|
88 |
|
Income tax expense |
|
|
(223 |
) |
|
|
(582 |
) |
|
|
(256 |
) |
Results of equity-accounted investees |
|
|
(139 |
) |
|
|
884 |
|
|
|
19 |
|
Income (loss) from continuing
operations |
|
|
1,003 |
|
|
|
5,018 |
|
|
|
(95 |
) |
Discontinued operations |
|
|
4,154 |
|
|
|
(138 |
) |
|
|
3 |
|
Net income (loss) for the period |
|
|
5,157 |
|
|
|
4,880 |
|
|
|
(92 |
) |
Net income (loss) attributable
to stockholders |
|
|
5,153 |
|
|
|
4,873 |
|
|
|
(91 |
) |
Per common share (in euro) basic |
|
|
4.39 |
|
|
|
4.49 |
|
|
|
(0.09 |
) |
Per common share (in euro) diluted |
|
|
4.35 |
|
|
|
4.43 |
|
|
|
(0.09 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net operating capital (NOC) |
|
|
8,956 |
|
|
|
10,802 |
|
|
|
14,069 |
|
Cash flows before financing activities |
|
|
(2,462 |
) |
|
|
5,452 |
|
|
|
(1,606 |
) |
Employees (FTEs) |
|
|
121,732 |
|
|
|
123,801 |
|
|
|
121,398 |
|
of which discontinued operations |
|
|
6,640 |
|
|
|
5,703 |
|
|
|
|
|
|
|
|
1) |
|
Prior-period amounts have been restated to reflect a change in accounting policy
related to pensions (see Significant accounting policies, Change in accounting policy) and revised
to reflect immaterial adjustments of intercompany profit elimination on inventory (see Significant
accounting policies, Reclassifications and revisions) |
Performance of the Group
Sales
In percentage terms, the composition of sales growth in 2008,
compared to 2007, was as follows:
Sales growth composition 2008 versus 2007
in %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
com- |
|
|
|
|
|
|
consoli- |
|
|
|
|
|
|
parable |
|
|
currency |
|
|
dation |
|
|
nominal |
|
|
|
growth |
|
|
effects |
|
|
changes |
|
|
growth |
|
Healthcare |
|
|
5.6 |
|
|
|
(4.5 |
) |
|
|
14.1 |
|
|
|
15.2 |
|
Consumer Lifestyle |
|
|
(8.5 |
) |
|
|
(2.7 |
) |
|
|
(5.2 |
) |
|
|
(16.4 |
) |
Lighting |
|
|
2.6 |
|
|
|
(3.8 |
) |
|
|
17.8 |
|
|
|
16.6 |
|
I&EB |
|
|
(26.6 |
) |
|
|
(0.9 |
) |
|
|
(9.6 |
) |
|
|
(37.1 |
) |
GM&S |
|
|
(24.2 |
) |
|
|
(0.5 |
) |
|
|
|
|
|
|
(24.7 |
) |
Philips Group |
|
|
(2.7 |
) |
|
|
(3.3 |
) |
|
|
4.5 |
|
|
|
(1.5 |
) |
Group sales totaled EUR 26,385 million in 2008, a 2% decline compared to 2007. Adjusted for
unfavorable currency effects of 3% and a positive net impact from portfolio changes, mainly due to
the acquisition of Genlyte and Respironics, comparable sales were 3% lower than in 2007. Excluding
the Television business which we manage for margin rather than scale Group comparable sales
were in line with 2007.
The decline in comparable sales was mainly due to the severe economic downturn, particularly in the
consumer markets. This was predominantly felt within Consumer Lifestyle, which reported an 8%
decline in comparable sales, led by a 12% sales decrease at Television, as well as lower sales in
Audio & Video Multimedia and Peripherals & Accessories.
This decline was partly tempered by 6% comparable sales growth at Healthcare, with higher sales
visible in emerging markets and across all businesses, notably Customer Services, Clinical Care
Systems, and Healthcare Informatics and Patient Monitoring. Additionally, Lighting saw a 3%
comparable sales increase, mainly attributable to strong growth in energy-efficient lighting
solutions, partly offset by lower sales in OEM automotive and consumer-related lighting markets.
Earnings
In 2008, Philips gross margin was EUR 8,467 million, or 32.1% of sales, compared to EUR 9,190
million, or 34.3% of sales, in 2007. Adjusted for the 2008 asbestos-related settlement charge of
EUR 264 million, gross margin declined from 34.3% of sales to 33.1%. The majority of this decline
was due to EUR 297 million restructuring and asset impairment charges, attributable to most
sectors.
Selling expenses increased from EUR 4,975 million in 2007 to
EUR 5,499 million in 2008, largely due to additional acquisition-related selling expenses at
Healthcare and Lighting, as well as EUR 147 million of restructuring charges across all sectors.
These increases were partly offset by lower selling expenses at Group Management & Services. As a
percentage of sales, selling expenses increased from 18.6% in 2007 to 20.8% in 2008, mainly due to
the aforementioned restructuring charges and the impact of lower sales at Consumer Lifestyle.
General and administrative expenses amounted to EUR 1,011 million, an increase of EUR 160 million
compared to 2007, mainly due to EUR 51 million of restructuring charges, primarily within Lighting
and Consumer Lifestyle, and higher costs in Consumer Lifestyle. As a percentage of sales, G&A
expenses increased from 3.2% in 2007 to 3.8% in 2008, largely due to the lower sales in Consumer
Lifestyle and higher restructuring charges across most sectors.
Research and development costs increased from EUR 1,601 million in 2007 to EUR 1,777 million in
2008 due to EUR 40 million of restructuring charges and higher spend in all sectors.
Philips Annual Report 2008 193
|
|
|
|
|
|
|
|
|
124 US GAAP financial
statements
|
|
180 Sustainability performance
|
|
192
|
|
IFRS financial statements
|
|
244 Company financial
statements |
|
|
|
|
|
|
IFRS management commentary |
The following overview shows sales, EBIT and EBITA according to the 2008 sector classification.
Sales, EBIT and EBITA 2008
in millions of euros unless otherwise stated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
sales |
|
|
EBIT |
|
|
% |
|
|
EBITA |
|
|
% |
|
Healthcare |
|
|
7,649 |
|
|
|
645 |
|
|
|
8.4 |
|
|
|
863 |
|
|
|
11.3 |
|
Consumer Lifestyle |
|
|
11,145 |
|
|
|
136 |
|
|
|
1.2 |
|
|
|
152 |
|
|
|
1.4 |
|
Lighting |
|
|
7,106 |
|
|
|
14 |
|
|
|
0.2 |
|
|
|
470 |
|
|
|
6.6 |
|
I&EB |
|
|
337 |
|
|
|
(247 |
) |
|
|
(73.3 |
) |
|
|
(247 |
) |
|
|
(73.3 |
) |
GM&S |
|
|
148 |
|
|
|
(494 |
) |
|
|
|
|
|
|
(494 |
) |
|
|
|
|
Philips Group |
|
|
26,385 |
|
|
|
54 |
|
|
|
0.2 |
|
|
|
744 |
|
|
|
2.8 |
|
Sales, EBIT and EBITA 20071)
in millions of euros unless otherwise stated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
sales |
|
|
EBIT |
|
|
% |
|
|
EBITA |
|
|
% |
|
Healthcare |
|
|
6,638 |
|
|
|
724 |
|
|
|
10.9 |
|
|
|
861 |
|
|
|
13.0 |
|
Consumer Lifestyle |
|
|
13,330 |
|
|
|
837 |
|
|
|
6.3 |
|
|
|
853 |
|
|
|
6.4 |
|
Lighting |
|
|
6,093 |
|
|
|
637 |
|
|
|
10.5 |
|
|
|
711 |
|
|
|
11.7 |
|
I&EB |
|
|
535 |
|
|
|
(104 |
) |
|
|
(19.4 |
) |
|
|
(104 |
) |
|
|
(19.4 |
) |
GM&S |
|
|
197 |
|
|
|
(227 |
) |
|
|
|
|
|
|
(227 |
) |
|
|
|
|
Philips Group |
|
|
26,793 |
|
|
|
1,867 |
|
|
|
7.0 |
|
|
|
2,094 |
|
|
|
7.8 |
|
|
|
|
1) |
|
Prior-period amounts have been restated to reflect a change in accounting policy
related to pensions (see Significant accounting policies, Change in accounting policy) and revised
to reflect immaterial adjustments of intercompany profit elimination on inventory (see Significant
accounting policies, Reclassifications and revisions) |
In 2008, EBIT declined by EUR 1,813 million compared to 2007, to EUR 54 million. EBIT included a
EUR 299 million non-cash goodwill impairment for Lumileds. EBIT and EBITA were both impacted by EUR
535 million restructuring charges and EUR 131 million of acquisition-related charges, as well as a
EUR 264 million asbestos-related settlement charge. 2007 included EUR 37 million of restructuring
charges and EUR 41 million of acquisition-related charges.
Adjusted for the aforementioned charges, EBITA declined from 8.1% of sales to 7.4% in 2008, largely
due to lower sales at Consumer Lifestyle and lower license income at Innovation & Emerging
Businesses.
Healthcares EBITA of EUR 863 million was in line with 2007 and included EUR 63 million of
restructuring charges and EUR 90 million of acquisition-related costs, partially offset by a EUR 45
million gain on the sale of Philips Speech Recognition Services. In 2007, acquisition-related
charges were EUR 11 million. As a percentage of sales, EBITA declined from 13.0% in 2007 to 11.3%
in 2008. However, adjusted for the aforementioned items, EBITA profitability was 12.7% in relation
to sales, broadly in line with 2007.
Consumer Lifestyles EBITA declined from EUR 853 million in 2007 to EUR 152 million in 2008,
largely due to lower sales-driven earnings in all businesses except Health & Wellness and Domestic
Appliances, deteriorating margins within Television, and restructuring charges of EUR 192 million.
The sectors 2008 EBITA included a EUR 42 million gain on the sale of the Set-Top Boxes activity.
EBITA at Lighting declined from EUR 711 million, or 11.7% of sales, in 2007 to EUR 470 million, or
6.6% of sales, in 2008. Additional earnings from acquisitions were offset by EUR 245 million of
restructuring charges, EUR 41 million of acquisition-related charges and margin compression in
mature markets. In 2007, restructuring and acquisition-related charges were EUR 55 million.
The EBITA loss at Innovation & Emerging Businesses amounted to EUR 247 million, compared to a loss
of EUR 104 million in 2007. The decline was mainly due to EUR 81 million lower license income, EUR
18 million restructuring charges at Assembléon, a EUR 13 million loss on the sale of the High Tech
Plastics Optics business, and higher investments in the Healthcare and Lighting & Cleantech
incubator activities.
EBITA at Group Management and Services declined EUR 267 million in 2008 to a loss of EUR 494
million, mainly due to a EUR 264 million
asbestos-related settlement charge. Adjusted for this settlement, GM&S costs saw a year-on-year
decline due to lower brand campaign spending.
Financial income and expense
Financial income declined from EUR 2,849 million in 2007 to EUR 88 million in 2008, mainly due to
the EUR 2,804 million of gains recorded in 2007 related to the sale of shares in TSMC, Nuance and
JDS Uniphase. In 2008, a total gain of EUR 1,406 million was recognized from the sale of stakes in
mainly TSMC and LG Display, mostly offset by non-cash value adjustments amounting to EUR 1,148
million, notably on our financial stakes in NXP and LG Display.
Income taxes
Income taxes amounted to EUR 256 million, compared to EUR 582 million in 2007. The lower tax burden
was mainly due to the lower sector earnings, as well as higher net interest expense.
The tax burden in 2008, however, corresponded to an effective tax rate of 180% on pre-tax income,
compared to 12% in 2007. The 2008 effective tax rate was affected by non-deductible impairment and
value adjustments, increased valuation allowances, higher provisions for uncertain tax positions
and foreign withholding taxes for which a credit could not be realized. These were partially offset
by non-taxable gains resulting from the sale of securities.
For 2009, the effective tax rate excluding non-taxable items is expected to be around 30%.
For further information, please refer to note 42.
Results relating to equity-accounted investees
The results related to equity-accounted investees declined by EUR 865 million in 2008 to EUR 19
million. Philips participation in the net income of equity-accounted investees declined from EUR
246 million in 2007 to EUR 81 million in 2008, which included EUR 66 million from earnings at LG
Display. These earnings were partly offset by a EUR 59 million non-cash value adjustment on the
equity stake in TPV Technology.
During 2008, as a result of the reduction in both Philips shareholding and the number of Philips
board members, LG Display was accounted for as an available-for-sale security instead of an
equity-accounted investee.
In 2007, the EUR 660 million proceeds from the sale of shares were mainly due to the EUR 654
million non-taxable gain on the sale of a 13% stake in LG Display. The proceeds from the sale of
stakes in 2008 were recorded under Financial income and expenses.
Discontinued operations
Philips reports the results of Semiconductors and the MedQuist business separately as discontinued
operations. Consequently, the related results, including transaction gains and losses, are shown
separately in the financial statements under Discontinued operations.
The gain from discontinued operations of EUR 3 million in 2008 was mainly related to MedQuist,
which was sold in 2008 to CBAY.
In 2007, discontinued operations recorded a loss of EUR 138 million, primarily attributable to
impairment charges for MedQuist and results of the Semiconductors business.
Net income
Income from continuing operations declined from EUR 5,018 million in 2007 to a loss of EUR 95
million in 2008. The decline was attributable to lower EBIT in 2008, and lower results in financial
income and expenses, largely due to value adjustments on our financial stakes in NXP and LG
Display.
Net income for the Group including discontinued operations and minority interests amounted to a
loss of EUR 91 million, or EUR 0.09 per common share, in 2008, compared to a profit of EUR 4,873
million, or EUR 4.49 per common share, in 2007.
Cash flows before financing activities
Cash flows before financing activities were EUR 7.1 billion lower than in 2007, primarily due to
higher cash used for the acquisitions of Respironics and Genlyte, as well as lower proceeds from
the sale of stakes in LG Display and TSMC.
Net cash from operating activities amounted to EUR 1,648 million in 2008, below the EUR 1,752
million of cash flow generated in 2007. This decline was mainly due to lower sales driven-earnings
in Consumer Lifestyle, largely offset by lower working capital requirements in most sectors and
positive contributions from acquisitions.
194 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
|
|
254 Corporate governance
|
|
262 Ten-year overview
|
|
266 Investor information |
|
|
non-US GAAP information |
|
|
|
|
|
|
Cash flows from investing activities were an outflow of EUR 3,254 million in 2008, mainly due to
EUR 5,316 million cash used for acquisitions, notably Respironics (EUR 3,196 million), Genlyte (EUR
1,894 million) and VISICU (EUR 198 million), as well as EUR 875 million used for net capital
expenditures. These outflows were partly offset by inflows amounting to EUR 2,576 million from the
sale of other non-current financial assets, mainly TSMC (EUR 1,831 million) and LG Display (EUR 670
million), as well as the maturing of derivatives which led to a net cash inflow of EUR 337 million.
2007 cash flows from investing activities amounted to an inflow of EUR 3,700 million as a result of
EUR 5,745 million of proceeds, mainly from the sale of other non-current financial assets (mainly
TSMC) and businesses (mainly LG Display) and the maturing of currency hedges (EUR 385 million).
These inflows were partly offset by cash used for the acquisitions of PLI (EUR 561 million) and
Color Kinetics (EUR 515 million) and net capital expenditures (EUR 928 million).
Philips sectors
Key data Healthcare
in millions of euros unless otherwise stated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20061) |
|
|
20071) |
|
|
2008 |
|
Sales |
|
|
6,562 |
|
|
|
6,638 |
|
|
|
7,649 |
|
% increase, nominal |
|
|
9 |
|
|
|
1 |
|
|
|
15 |
|
% increase, comparable |
|
|
8 |
|
|
|
4 |
|
|
|
6 |
|
EBITA |
|
|
881 |
|
|
|
861 |
|
|
|
863 |
|
as a % of sales |
|
|
13.4 |
|
|
|
13.0 |
|
|
|
11.3 |
|
EBIT |
|
|
770 |
|
|
|
724 |
|
|
|
645 |
|
as a % of sales |
|
|
11.7 |
|
|
|
10.9 |
|
|
|
8.4 |
|
Net operating capital (NOC) |
|
|
4,640 |
|
|
|
4,758 |
|
|
|
8,785 |
|
Cash flows before financing activities |
|
|
(993 |
) |
|
|
227 |
|
|
|
(2,415 |
) |
Employees (FTEs) |
|
|
27,223 |
|
|
|
29,191 |
|
|
|
35,551 |
|
|
|
|
1) |
|
Prior-period amounts have been restated to reflect a change in accounting policy
related to pensions (see Significant accounting policies, Change in accounting policy) and revised
to reflect immaterial adjustments of intercompany profit elimination on inventory (see Significant
accounting policies, Reclassifications and revisions) |
In 2008, sales amounted to EUR 7,649 million, 15% higher than in 2007 on a nominal basis, largely
thanks to the contributions from acquired companies, notably Respironics. Excluding the 14%
positive impact of portfolio changes and the 5% unfavorable impact of currency effects, comparable
sales grew 6%. All businesses showed positive growth, led by solid sales growth in Customer
Services, Clinical Care Systems, and Healthcare Informatics and Patient Monitoring. Higher sales
within Imaging Systems were supported by X-Ray and Nuclear Medicine, partly tempered by lower sales
at Computed Tomography. Green Product sales amounted to EUR 1,527 million in 2008, up from EUR
1,452 million in 2007, representing 20% of sector sales.
Geographically, double-digit comparable sales growth was achieved in the key emerging markets,
notably in China and Latin America, driven by growth in all businesses. Also, single-digit sales
growth was recognized in the mature markets, across all businesses, notably Imaging Systems and
Clinical Care Systems.
EBITA of EUR 863 million, or 11.3% of sales, was in line with 2007 earnings of EUR 861 million.
Earnings included EUR 90 million of acquisition-related charges and EUR 63 million of restructuring
charges, which were partly offset by a EUR 45 million gain on the sale of Philips Speech
Recognition Systems. EBITA also included additional income from Respironics and higher earnings at
Clinical Care Systems and Healthcare Informatics and Patient Monitoring, partially offset by lower
earnings at Imaging Systems.
Compared to 2007, EBIT declined EUR 79 million to EUR 645 million.
Cash flow before financing activities included net payments totaling EUR 3,456 million, mainly for
the acquisitions of Respironics, VISICU, TOMCAT, Dixtal Biomédica, Shenzhen Goldway, Medel SpA and
Alpha X-Ray Technologies. In 2007, acquisition-related outflows amounted to EUR 245 million, mainly
for the acquisitions of Health Watch, Raytel Cardiac Services, Emergin and VMI Sistemas Medicos.
Excluding these acquisition-related outflows, cash flow before financing activities was EUR 569
million higher than in 2007, largely thanks to improved working capital requirements, notably lower
inventory.
Key data Consumer Lifestyle
in millions of euros unless otherwise stated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20061) |
|
|
20071) |
|
|
2008 |
|
Sales |
|
|
13,108 |
|
|
|
13,330 |
|
|
|
11,145 |
|
of which Television |
|
|
6,559 |
|
|
|
6,270 |
|
|
|
4,980 |
|
Sales growth |
|
|
|
|
|
|
|
|
|
|
|
|
% increase (decrease), nominal |
|
|
4 |
|
|
|
2 |
|
|
|
(16 |
) |
% increase (decrease), comparable |
|
|
6 |
|
|
|
4 |
|
|
|
(8 |
) |
Sales growth excl. Television |
|
|
|
|
|
|
|
|
|
|
|
|
% increase (decrease), nominal |
|
|
0 |
|
|
|
8 |
|
|
|
(13 |
) |
% increase (decrease), comparable |
|
|
(3 |
) |
|
|
10 |
|
|
|
(6 |
) |
EBITA |
|
|
714 |
|
|
|
853 |
|
|
|
152 |
|
of which Television |
|
|
151 |
|
|
|
(71 |
) |
|
|
(426 |
) |
as a % of sales |
|
|
5.4 |
|
|
|
6.4 |
|
|
|
1.4 |
|
EBIT |
|
|
705 |
|
|
|
837 |
|
|
|
136 |
|
of which Television |
|
|
151 |
|
|
|
(71 |
) |
|
|
(426 |
) |
as a % of sales |
|
|
5.4 |
|
|
|
6.3 |
|
|
|
1.2 |
|
Net operating capital (NOC) |
|
|
1,126 |
|
|
|
1,113 |
|
|
|
825 |
|
of which Television |
|
|
(133 |
) |
|
|
(208 |
) |
|
|
(244 |
) |
Cash flows before financing activities |
|
|
(39 |
) |
|
|
754 |
|
|
|
252 |
|
of which Television |
|
|
212 |
|
|
|
(49 |
) |
|
|
(489 |
) |
Employees (FTEs) |
|
|
24,419 |
|
|
|
23,397 |
|
|
|
17,346 |
|
of which Television |
|
|
7,262 |
|
|
|
6,855 |
|
|
|
4,943 |
|
|
|
|
1) |
|
Prior-period amounts have been restated to reflect a change in accounting policy
related to pensions (see Significant accounting policies, Change in accounting policy) |
2008 presented very challenging market conditions for Consumer Lifestyle. Sales amounted to EUR
11,145 million, a nominal decline of 16% compared to 2007. Adjusted for unfavorable currency
effects of 3% and portfolio changes, mainly the divestment of Television in North America and the
sale of the Set-Top Boxes and Mobile Phones businesses, comparable sales declined by 8%.
Year-on-year declines were seen in all businesses, except for 4% comparable growth in Domestic
Appliances and Health & Wellness. Television and Audio & Video Multimedia suffered comparable
double-digit declines. Green Product sales totaled 1,478 million in 2008, a nominal increase of 41%
compared to 2007, amounting to 13% of sector sales.
From a geographical perspective, Western Europe and North America, which account for more than half
of the sectors sales, were heavily impacted by the economic downturn as well as by selective
portfolio and margin management. Sales growth was strong in the key emerging markets, led by
double-digit growth in Brazil. Growth in Asia was driven by solid double-digit growth across the
countries in most businesses, mostly offset by a decline in Television. European emerging markets
declined 14%.
EBITA as a percentage of sales decreased from 6.4% in 2007 to 1.4% in 2008, due to declines in
nearly all businesses, mainly as a result of lower sales. EBITA was impacted by EUR 192 million of
restructuring charges, partially offset by the EUR 42 million gain on the sale of Set-Top Boxes.
EBIT declined from EUR 837 million (6.3% of sales) in 2007 to EUR 136 million (1.2% of sales) in
2008.
Net operating capital was reduced by EUR 288 million at the end of 2008 and amounted to EUR 825
million.
Philips Annual Report 2008 195
|
|
|
|
|
|
|
|
|
124 US GAAP financial
statements
|
|
180 Sustainability performance
|
|
192
|
|
IFRS financial statements
|
|
244 Company financial
statements |
|
|
|
|
|
|
IFRS management commentary |
Cash flows before financing activities declined from EUR 754 million in 2007 to an inflow of EUR
252 million, primarily driven by lower earnings.
Key data Lighting
in millions of euros unless otherwise stated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20061) |
|
|
20071) |
|
|
2008 |
|
Sales |
|
|
5,466 |
|
|
|
6,093 |
|
|
|
7,106 |
|
% increase, nominal |
|
|
14 |
|
|
|
11 |
|
|
|
17 |
|
% increase, comparable |
|
|
8 |
|
|
|
6 |
|
|
|
3 |
|
EBITA |
|
|
620 |
|
|
|
711 |
|
|
|
470 |
|
as a % of sales |
|
|
11.3 |
|
|
|
11.7 |
|
|
|
6.6 |
|
EBIT |
|
|
549 |
|
|
|
637 |
|
|
|
14 |
|
as a % of sales |
|
|
10.0 |
|
|
|
10.5 |
|
|
|
0.2 |
|
Net operating capital (NOC) |
|
|
2,817 |
|
|
|
4,059 |
|
|
|
5,685 |
|
Cash flows before financing activities |
|
|
451 |
|
|
|
(644 |
) |
|
|
(1,137 |
) |
Employees (FTEs) |
|
|
47,739 |
|
|
|
54,323 |
|
|
|
57,166 |
|
|
|
|
1) |
|
Prior-period amounts have been restated to reflect a change in accounting policy
related to pensions (see Significant accounting policies, Change in accounting policy) |
Sales in 2008 grew by 17% in nominal terms, mainly supported by the acquired companies: Genlyte and
Color Kinetics. Adjusted for portfolio changes of 18% and unfavorable currency effects of 4%,
comparable sales grew by 3% compared to 2007. This growth was driven by continued sales growth in
energy-efficient lighting solutions, notably within the Lamps and Professional Luminaires
businesses. Sales were broadly in line with 2007 in the remaining businesses as a result of the
deteriorating economic climate in the latter part of 2008 within the automotive, consumer and
construction industries. Green Product sales grew by 12% in 2008 compared to 2007, reaching EUR
2,970 million. This growth was supported by increased sales of solid-state lighting applications,
which grew by 6% to EUR 470 million, as well as innovative product design and strong growth in
application-based solutions.
Geographically, comparable sales in the mature markets slightly declined compared to 2007, as
higher sales in energy-efficient lighting solutions were more than offset by the deteriorating
economic climate in the automotive, consumer and construction segments in North America and Western
Europe. Emerging market sales increased 8%, with growth in all businesses except Special Lighting
Applications, led by strong double-digit sales growth in India, Eastern Europe and the ASEAN
countries.
EBITA of EUR 470 million, or 6.6% of sales, declined EUR 241 million compared to 2007 and included
EUR 245 million restructuring charges and EUR 41 million of acquisition-related charges. 2008
earnings were also impacted by margin compression in mature markets as a result of slowing demand,
particularly in the automotive and construction segments, partly offset by positive contributions
from acquisitions.
EBIT amounted to EUR 14 million, compared to EUR 637 million in 2007. In addition, a EUR 299
million non-cash goodwill impairment charge for Lumileds was recorded, primarily due to weaker
demand in the automotive, displays and mobile phone segments.
Cash flow before financing activities included cash disbursements of EUR 1,826 million, mainly
related to the acquisition of Genlyte, whereas in 2007 acquisition-related disbursements amounted
to EUR 1,162 million, mainly in connection with the acquisitions of PLI and Color Kinetics.
Excluding these acquisition-related payments, cash flow before financing activities increased by
EUR 171 million compared to 2007 thanks to improved working capital requirements.
Key data I&EB
in millions of euros unless otherwise stated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20061) |
|
|
20071) |
|
|
2008 |
|
Sales |
|
|
1,379 |
|
|
|
535 |
|
|
|
337 |
|
% decrease, nominal |
|
|
(28 |
) |
|
|
(61 |
) |
|
|
(37 |
) |
% increase (decrease), comparable |
|
|
(9 |
) |
|
|
38 |
|
|
|
(27 |
) |
EBITA |
|
|
(92 |
) |
|
|
(104 |
) |
|
|
(247 |
) |
as a % of sales |
|
|
(6.7 |
) |
|
|
(19.4 |
) |
|
|
(73.3 |
) |
EBIT |
|
|
(93 |
) |
|
|
(104 |
) |
|
|
(247 |
) |
as a % of sales |
|
|
(6.7 |
) |
|
|
(19.4 |
) |
|
|
(73.3 |
) |
Net operating capital (NOC) |
|
|
171 |
|
|
|
270 |
|
|
|
150 |
|
Cash flows before financing activities |
|
|
(49 |
) |
|
|
(179 |
) |
|
|
(128 |
) |
Employees (FTEs) |
|
|
8,832 |
|
|
|
5,888 |
|
|
|
5,324 |
|
|
|
|
1) |
|
Prior-period amounts have been restated to reflect a change in accounting policy
related to pensions (see Significant accounting policies, Change in accounting policy) |
In 2008, EBITA amounted to a loss of EUR 247 million, compared to a loss of EUR 104 million in
2007. The higher loss was mainly due to EUR 18 million restructuring charges at Assembléon, a EUR
13 million loss from the sale of High Tech Plastics Optics, as well as higher investments in the
Lighting & Cleantech and Healthcare Incubator activities and decline in income attributable to an
intellectual property transaction in 2007.
Key data GM&S
in millions of euros unless otherwise stated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20061) |
|
|
20071) |
|
|
2008 |
|
Sales |
|
|
167 |
|
|
|
197 |
|
|
|
148 |
|
EBITA |
|
|
(595 |
) |
|
|
(227 |
) |
|
|
(494 |
) |
EBIT |
|
|
(595 |
) |
|
|
(227 |
) |
|
|
(494 |
) |
Net operating capital (NOC) |
|
|
202 |
|
|
|
602 |
|
|
|
(1,376 |
) |
Cash flows before financing activities |
|
|
(1,832 |
) |
|
|
5,294 |
|
|
|
1,822 |
|
Employees (FTEs) |
|
|
6,879 |
|
|
|
5,299 |
|
|
|
6,011 |
|
|
|
|
1) |
|
Prior-period amounts have been restated to reflect a change in accounting policy
related to pensions (see Significant accounting policies, Change in accounting policy) |
EBITA at Group Management & Services decreased by EUR 267 million compared to 2007, mainly due to a
EUR 264 million asbestos-related settlement charge. Reduced global brand campaign expenditures in
2008 were mainly offset by lower pension results compared to 2007.
196 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
|
|
254 Corporate governance
|
|
262 Ten-year overview
|
|
266 Investor information |
|
|
non-US GAAP information |
|
|
|
|
|
|
Reconciliation from IFRS to US GAAP
For transparency purposes for the users of the financial statements, the Company provides the
following reconciliations from IFRS to US GAAP.
Reconciliation of net income from IFRS to US GAAP
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20061) |
|
|
20071) |
|
|
2008 |
|
Net income (loss) attributable to
stockholders, as per the consolidated
statements of income on an IFRS basis |
|
|
5,153 |
|
|
|
4,873 |
|
|
|
(91 |
) |
Adjustments to reconcile to US GAAP: |
|
|
|
|
|
|
|
|
|
|
|
|
- Reversal of capitalized product
development cost |
|
|
(271 |
) |
|
|
(234 |
) |
|
|
(154 |
) |
- Reversal of amortization and
impairments of product
development costs |
|
|
213 |
|
|
|
205 |
|
|
|
300 |
|
- Reversal of additional net pensions
and other charges |
|
|
(90 |
) |
|
|
(74 |
) |
|
|
(54 |
) |
- Impairment of goodwill |
|
|
|
|
|
|
|
|
|
|
67 |
|
- Amortization of intangible assets |
|
|
40 |
|
|
|
27 |
|
|
|
24 |
|
- Financial income and expenses |
|
|
(1 |
) |
|
|
(236 |
) |
|
|
(313 |
) |
- Adjustment of results of equity
accounted investees |
|
|
(18 |
) |
|
|
(121 |
) |
|
|
|
|
- Income tax effect on US GAAP
adjustments |
|
|
57 |
|
|
|
(37 |
) |
|
|
(30 |
) |
- Discontinued operations |
|
|
328 |
|
|
|
(295 |
) |
|
|
(11 |
) |
- Other |
|
|
(30 |
) |
|
|
52 |
|
|
|
76 |
|
Net income (loss) as per the
consolidated statements of income
on a US GAAP basis |
|
|
5,381 |
|
|
|
4,160 |
|
|
|
(186 |
) |
|
|
|
1) |
|
Prior-period amounts have been restated to reflect a change in accounting policy
related to pensions (see Significant accounting policies, Change in accounting policy) and revised
to reflect immaterial adjustments of intercompany profit elimination on inventory (see Significant
accounting policies, Reclassifications and revisions) |
Reconciliation of stockholders equity from IFRS to US GAAP
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
Dec. 31, |
|
|
Dec. 31, |
|
|
|
20071) |
|
|
2008 |
|
Stockholders equity as per the consolidated
balance sheets on an IFRS basis |
|
|
21,741 |
|
|
|
15,544 |
|
Adjustments to reconcile to US GAAP: |
|
|
|
|
|
|
|
|
- Reversal of capitalized product development
cost |
|
|
(518 |
) |
|
|
(357 |
) |
- Reversal of pensions and other
postretirement benefits |
|
|
147 |
|
|
|
889 |
|
- Goodwill amortization/impairment |
|
|
260 |
|
|
|
339 |
|
- Goodwill capitalization (acquisition-related) |
|
|
76 |
|
|
|
81 |
|
- Acquisition-related intangibles |
|
|
(162 |
) |
|
|
(152 |
) |
- Equity-accounted investees |
|
|
69 |
|
|
|
(10 |
) |
- Reversal of result on recognition
of sale-and-leaseback |
|
|
(39 |
) |
|
|
(36 |
) |
- Deferred tax effect |
|
|
79 |
|
|
|
(122 |
) |
- Assets from discontinued operations |
|
|
14 |
|
|
|
|
|
- Other |
|
|
(25 |
) |
|
|
67 |
|
Stockholders equity as per the consolidated
balance sheets on a US GAAP basis |
|
|
21,642 |
|
|
|
16,243 |
|
|
|
|
1) |
|
Prior-period amounts have been restated to reflect a change in accounting policy
related to pensions (see Significant accounting policies, Change in accounting policy) and revised
to reflect immaterial adjustments of intercompany profit elimination on inventory (see Significant
accounting policies, Reclassifications and revisions) |
The major differences between IFRS and US GAAP that affect stockholders equity and net income are
the following:
|
|
IFRS requires capitalization and subsequent amortization of development costs, if the relevant
conditions for capitalization are met, whereas development costs under US GAAP are recorded as an
expense. |
|
|
|
Under IFRS, if the plan assets exceed the defined-benefit obligation, the amount of net asset
recognized is limited to the available future benefits from the plan. The future benefit is
determined as the present value of the estimated future service costs in each year less the
estimated minimum funding contributions required in respect of the future accrual of benefits in
each year. FAS 158 prescribes full recognition of the net assets. Moreover, under US GAAP,
actuarial gains and losses recognized in other comprehensive income are recycled to the statements
of income. Under IFRS, amounts directly recognised in equity are not recycled to the statements of
income. |
|
|
|
Under IFRS an impairment loss is recognized when the carrying amount of the reporting unit
exceeds its recoverable amount. Such an impairment loss is allocated to goodwill first. Under US
GAAP the goodwill of a reporting unit is impaired when the carrying amount of the goodwill exceeds
its implied fair value (two-step process). |
|
|
|
Under IFRS, goodwill is not amortized as from 2004. Since goodwill was no longer amortized as
from 2002 under US GAAP, IFRS has two additional years of goodwill amortization. This is also a
reason for differences in equity-accounted investees between IFRS and US GAAP. |
|
|
|
As a consequence of step-up accounting with IFRS, higher acquisition-related intangibles and
amortization expenses are recorded. |
|
|
|
The composition of equity under IFRS is affected by the exemption in IFRS 1 that allows the
inclusion of the existing negative cumulative translation differences in retained earnings as per
January 1, 2004. In 2007 TSMC and in 2008 LG Display were reclassified from equity-accounted
investee to an available-for-sale financial asset, and due to the above-mentioned difference for
goodwill amortization and as a result of the application of the exemption in IFRS 1, the recycling
of translation gains and losses from equity to the income statement differs when comparing US GAAP
and IFRS. |
|
|
|
IFRS requires up-front profit recognition of operational sale-and-leaseback transactions when the
sale-and-leaseback is on market conditions, whereas US GAAP requires amortization. |
|
|
|
The differences as explained above affect income taxes and therefore deferred income taxes. |
|
|
|
In 2006, the result of discontinued operations was particularly affected by the different
treatment of development costs between US GAAP and IFRS. This resulted in a higher gain upon the
sale of the Semiconductors business under US GAAP than IFRS. In 2007, the difference in results
from discontinued operations was particularly impacted by the impairment of MedQuist, which takes
into account a higher cumulative currency translation loss under US GAAP than IFRS due to the
above-mentioned IFRS 1 exemption. In 2008, the difference in results from discontinued operations
was particularly affected by the different impairment charges in 2007, which resulted in a higher
gain upon the sale of MedQuist. |
Philips Annual Report 2008 197
|
|
|
|
|
|
|
|
|
124 US GAAP financial
statements
|
|
180 Sustainability performance
|
|
192
|
|
IFRS financial statements
|
|
244 Company financial
statements |
|
|
|
|
|
|
Consolidated
statements of income |
IFRS Consolidated statements of income of the Philips Group for the years ended December 31
in millions of euros unless otherwise stated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
|
|
|
|
Sales |
|
|
26,682 |
|
|
|
26,793 |
|
|
|
26,385 |
|
|
|
|
|
Cost of sales |
|
|
(18,402 |
) |
|
|
(17,603 |
) |
|
|
(17,918 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin |
|
|
8,280 |
|
|
|
9,190 |
|
|
|
8,467 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling expenses |
|
|
(4,660 |
) |
|
|
(4,975 |
) |
|
|
(5,499 |
) |
|
|
|
|
General and administrative expenses |
|
|
(907 |
) |
|
|
(851 |
) |
|
|
(1,011 |
) |
|
|
|
|
Research and development expenses |
|
|
(1,556 |
) |
|
|
(1,601 |
) |
|
|
(1,777 |
) |
|
|
|
|
Impairment of goodwill |
|
|
|
|
|
|
|
|
|
|
(301 |
) |
|
|
|
|
Other business income |
|
|
328 |
|
|
|
269 |
|
|
|
261 |
|
|
|
|
|
Other business expense |
|
|
(149 |
) |
|
|
(165 |
) |
|
|
(86 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40 |
|
|
Income from operations |
|
|
1,336 |
|
|
|
1,867 |
|
|
|
54 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
41 |
|
|
Financial income |
|
|
546 |
|
|
|
3,194 |
|
|
|
2,013 |
|
|
|
41 |
|
|
Financial expenses |
|
|
(517 |
) |
|
|
(345 |
) |
|
|
(1,925 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before taxes |
|
|
1,365 |
|
|
|
4,716 |
|
|
|
142 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
42 |
|
|
Income tax expense |
|
|
(223 |
) |
|
|
(582 |
) |
|
|
(256 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) after taxes |
|
|
1,142 |
|
|
|
4,134 |
|
|
|
(114 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
43 |
|
|
Results relating to equity-accounted investees: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- Companys participation in income (loss) |
|
|
(188 |
) |
|
|
246 |
|
|
|
81 |
|
|
|
|
|
- Other results |
|
|
49 |
|
|
|
638 |
|
|
|
(62 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations |
|
|
1,003 |
|
|
|
5,018 |
|
|
|
(95 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
38 |
|
|
Discontinued operations net of income tax |
|
|
4,154 |
|
|
|
(138 |
) |
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) for the period |
|
|
5,157 |
|
|
|
4,880 |
|
|
|
(92 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Attribution of net income (loss) for the period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
44 |
|
|
Net income (loss) attributable to stockholders |
|
|
5,153 |
|
|
|
4,873 |
|
|
|
(91 |
) |
|
|
|
|
Net income (loss) attributable to minority interests |
|
|
4 |
|
|
|
7 |
|
|
|
(1 |
) |
Prior-period amounts have been restated to reflect a change in accounting policy related to
pensions (see Significant accounting policies, Change in accounting policy) and revised to reflect
immaterial adjustments of intercompany profit elimination on inventory (see Significant accounting
policies, Reclassifications and revisions). The accompanying notes are an integral part of these
consolidated financial statements.
198 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
|
|
254 Corporate governance
|
|
262 Ten-year overview
|
|
266 Investor information |
|
|
non-US GAAP information |
|
|
|
|
|
|
IFRS Consolidated statements of recognized income and expenses of the Philips Group
for the years
ended December 31
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Revaluation reserve |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Release revaluation reserve |
|
|
|
|
|
|
(34 |
) |
|
|
(16 |
) |
Reclassification into retained earnings |
|
|
|
|
|
|
34 |
|
|
|
16 |
|
Reclassification into income (loss) |
|
|
(95 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Included in other reserves |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Currency translation differences: |
|
|
|
|
|
|
|
|
|
|
|
|
Net current period change continuing operations |
|
|
(515 |
) |
|
|
(749 |
) |
|
|
(60 |
) |
Net current period change discontinued operations |
|
|
|
|
|
|
(22 |
) |
|
|
4 |
|
Income tax on net current period change |
|
|
(72 |
) |
|
|
(10 |
) |
|
|
5 |
|
Reclassification into income (loss) |
|
|
(10 |
) |
|
|
(67 |
) |
|
|
8 |
|
Available-for-sale securities: |
|
|
|
|
|
|
|
|
|
|
|
|
Net current period change |
|
|
4,768 |
|
|
|
(618 |
) |
|
|
(269 |
) |
Reclassification into income (loss) |
|
|
(98 |
) |
|
|
(2,870 |
) |
|
|
(939 |
) |
Cash flow hedges: |
|
|
|
|
|
|
|
|
|
|
|
|
Net current period change |
|
|
72 |
|
|
|
19 |
|
|
|
(24 |
) |
Income tax on net current period change |
|
|
(15 |
) |
|
|
(3 |
) |
|
|
18 |
|
Reclassification into income (loss) |
|
|
(20 |
) |
|
|
4 |
|
|
|
(50 |
) |
Actuarial gains (losses) on pension plans: |
|
|
|
|
|
|
|
|
|
|
|
|
Net current period change |
|
|
(181 |
) |
|
|
59 |
|
|
|
(1,310 |
) |
Income tax on net current period change |
|
|
51 |
|
|
|
(12 |
) |
|
|
406 |
|
Net income (loss) recognized directly in equity |
|
|
3,885 |
|
|
|
(4,269 |
) |
|
|
(2,211 |
) |
Net income (loss) for the period |
|
|
5,153 |
|
|
|
4,873 |
|
|
|
(91 |
) |
Total recognized income (loss) for the period |
|
|
9,038 |
|
|
|
604 |
|
|
|
(2,302 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Attributable to |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders |
|
|
9,256 |
|
|
|
612 |
|
|
|
(2,224 |
) |
Minority interests |
|
|
(218 |
) |
|
|
(8 |
) |
|
|
(78 |
) |
Total recognized income (loss) for the period |
|
|
9,038 |
|
|
|
604 |
|
|
|
(2,302 |
) |
Prior-period amounts have been restated to reflect a change in accounting policy related to
pensions (see Significant accounting policies, Change in accounting policy) and revised to reflect
immaterial adjustments of intercompany profit elimination on inventory (see Significant accounting
policies, Reclassifications and revisions). The accompanying notes are an integral part of these
consolidated financial statements.
Earnings per share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Weighted average number of common shares outstanding (after deduction
of treasury stock) during the year (in thousands) |
|
|
1,174,925 |
|
|
|
1,086,128 |
|
|
|
991,420 |
|
Adjusted weighted average number of shares (after deduction
of treasury stock) during the year (in thousands) |
|
|
1,183,631 |
|
|
|
1,098,925 |
|
|
|
996,714 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per common share in euros |
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations |
|
|
0.85 |
|
|
|
4.61 |
|
|
|
(0.09 |
) |
Income (loss) from discontinued operations |
|
|
3.54 |
|
|
|
(0.12 |
) |
|
|
|
|
Net income (loss) |
|
|
4.39 |
|
|
|
4.49 |
|
|
|
(0.09 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per common share in euros |
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations |
|
|
0.84 |
|
|
|
4.56 |
|
|
|
(0.09 |
)1) |
Income (loss) from discontinued operations |
|
|
3.51 |
|
|
|
(0.13 |
) |
|
|
|
1) |
Net income (loss) |
|
|
4.35 |
|
|
|
4.43 |
|
|
|
(0.09 |
)1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend paid per common share in euros |
|
|
0.44 |
|
|
|
0.60 |
|
|
|
0.70 |
|
|
|
|
1) |
|
In 2008, the incremental shares from assumed conversion are not taken into account as the effect
would be antidilutive. |
Philips Annual Report 2008 199
|
|
|
|
|
|
|
|
|
124 US GAAP financial
statements
|
|
180 Sustainability performance
|
|
192
|
|
IFRS financial statements
|
|
244 Company financial
statements |
|
|
|
|
|
|
Consolidated
balance sheets |
IFRS Consolidated balance sheets of the Philips Group as of December 31
in millions of euros unless otherwise stated
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
2008 |
|
|
|
|
|
Current assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
|
|
|
|
|
8,769 |
|
|
|
|
|
|
|
3,620 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
45 67 |
|
|
Receivables: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- Accounts receivable net |
|
|
4,209 |
|
|
|
|
|
|
|
3,813 |
|
|
|
|
|
|
|
|
|
- Accounts receivable from related parties |
|
|
26 |
|
|
|
|
|
|
|
24 |
|
|
|
|
|
|
|
|
|
- Other receivables |
|
|
435 |
|
|
|
|
|
|
|
452 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,670 |
|
|
|
|
|
|
|
4,289 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
38 |
|
|
Current assets of discontinued operations |
|
|
|
|
|
|
149 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
46 |
|
|
Inventories net |
|
|
|
|
|
|
3,146 |
|
|
|
|
|
|
|
3,371 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
47 |
|
|
Other current assets |
|
|
|
|
|
|
622 |
|
|
|
|
|
|
|
749 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets |
|
|
|
|
|
|
17,356 |
|
|
|
|
|
|
|
12,029 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-current assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
43 |
|
|
Investments in equity-accounted investees |
|
|
|
|
|
|
1,817 |
|
|
|
|
|
|
|
293 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
48 |
|
|
Other non-current financial assets |
|
|
|
|
|
|
3,183 |
|
|
|
|
|
|
|
1,331 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
49 |
|
|
Non-current receivables |
|
|
|
|
|
|
78 |
|
|
|
|
|
|
|
47 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
38 |
|
|
Non-current assets of discontinued operations |
|
|
|
|
|
|
170 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50 |
|
|
Other non-current assets |
|
|
|
|
|
|
2,610 |
|
|
|
|
|
|
|
1,906 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
42 |
|
|
Deferred tax assets |
|
|
|
|
|
|
1,271 |
|
|
|
|
|
|
|
931 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
51 61 |
|
|
Property, plant and equipment: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- At cost |
|
|
7,897 |
|
|
|
|
|
|
|
8,065 |
|
|
|
|
|
|
|
|
|
- Less accumulated depreciation |
|
|
(4,703 |
) |
|
|
|
|
|
|
(4,569 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,194 |
|
|
|
|
|
|
|
3,496 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
52 |
|
|
Intangible assets excluding goodwill: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- At cost |
|
|
4,609 |
|
|
|
|
|
|
|
6,528 |
|
|
|
|
|
|
|
|
|
- Less accumulated amortization |
|
|
(1,774 |
) |
|
|
|
|
|
|
(2,051 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,835 |
|
|
|
|
|
|
|
4,477 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
53 |
|
|
Goodwill |
|
|
|
|
|
|
3,800 |
|
|
|
|
|
|
|
7,280 |
|
|
|
|
|
|
Total non-current assets |
|
|
|
|
|
|
18,958 |
|
|
|
|
|
|
|
19,761 |
|
|
|
|
|
|
|
|
|
|
|
|
36,314 |
|
|
|
|
|
|
|
31,790 |
|
Prior-period amounts have been restated to reflect a change in accounting policy related to
pensions (see Significant accounting policies, Change in accounting policy) and revised to reflect
immaterial adjustments of intercompany profit elimination on inventory (see Significant accounting
policies, Reclassifications and revisions). The accompanying notes are an integral part of these
consolidated financial statements.
200 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
|
|
254 Corporate governance
|
|
262 Ten-year overview
|
|
266 Investor information |
|
|
non-US GAAP information |
|
|
|
|
|
|
Liabilities and equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
2008 |
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts and notes payable: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
67 |
|
- Trade creditors |
|
|
3,083 |
|
|
|
|
|
|
|
2,880 |
|
|
|
|
|
|
|
|
|
- Accounts payable to related parties |
|
|
289 |
|
|
|
|
|
|
|
112 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,372 |
|
|
|
|
|
|
|
2,992 |
|
|
|
|
|
Current liabilities of discontinued operations |
|
|
|
|
|
|
46 |
|
|
|
|
|
|
|
|
|
|
|
38 |
|
Accrued liabilities |
|
|
|
|
|
|
2,975 |
|
|
|
|
|
|
|
3,634 |
|
|
|
54 |
|
Short-term provisions |
|
|
|
|
|
|
382 |
|
|
|
|
|
|
|
1,043 |
|
|
|
62 56 55 |
|
Other current liabilities |
|
|
|
|
|
|
509 |
|
|
|
|
|
|
|
522 |
|
|
|
57 |
|
Short-term debt |
|
|
|
|
|
|
2,350 |
|
|
|
|
|
|
|
722 |
|
|
|
59 58 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
|
|
|
|
9,634 |
|
|
|
|
|
|
|
8,913 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-current liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term debt |
|
|
|
|
|
|
1,213 |
|
|
|
|
|
|
|
3,466 |
|
|
|
61 59 |
|
Long-term provisions |
|
|
|
|
|
|
2,021 |
|
|
|
|
|
|
|
1,794 |
|
|
|
62 56 55 |
|
Deferred tax liabilities |
|
|
|
|
|
|
652 |
|
|
|
|
|
|
|
584 |
|
|
|
42 |
|
Non-current liabilities of discontinued operations |
|
|
|
|
|
|
32 |
|
|
|
|
|
|
|
|
|
|
|
38 |
|
Other non-current liabilities |
|
|
|
|
|
|
894 |
|
|
|
|
|
|
|
1,440 |
|
|
|
60 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total non-current liabilities |
|
|
|
|
|
|
4,812 |
|
|
|
|
|
|
|
7,284 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contractual obligations and contingent liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
62 61 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Minority interests1) |
|
|
|
|
|
|
127 |
|
|
|
|
|
|
|
49 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders equity: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
63 |
|
Preference shares, par value EUR 0.20 per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- Authorized: 2,000,000,000 shares (2007: 2,500,000,000 shares), issued none |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common shares, par value EUR 0.20 per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- Authorized: 2,000,000,000 shares (2007: 2,500,000,000 shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- Issued and fully paid: 972,411,769 shares (2007: 1,142,826,763 shares) |
|
|
228 |
|
|
|
|
|
|
|
194 |
|
|
|
|
|
|
|
|
|
Capital in excess of par value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retained earnings |
|
|
22,998 |
|
|
|
|
|
|
|
18,439 |
|
|
|
|
|
|
|
|
|
Revaluation reserve |
|
|
133 |
|
|
|
|
|
|
|
117 |
|
|
|
|
|
|
|
|
|
Other reserves |
|
|
598 |
|
|
|
|
|
|
|
(1,918 |
) |
|
|
|
|
|
|
|
|
Treasury shares, at cost 49,429,913 shares (2007: 77,933,509 shares) |
|
|
(2,216 |
) |
|
|
|
|
|
|
(1,288 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21,741 |
|
|
|
|
|
|
|
15,544 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity |
|
|
|
|
|
|
21,868 |
|
|
|
|
|
|
|
15,593 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
36,314 |
|
|
|
|
|
|
|
31,790 |
|
|
|
|
|
|
|
|
1) |
|
Of which discontinued operations EUR 79 million at December 31, 2007. |
Philips Annual Report 2008 201
|
|
|
|
|
|
|
|
|
124 US GAAP financial
statements
|
|
180 Sustainability performance
|
|
192
|
|
IFRS financial statements
|
|
244 Company financial
statements |
|
|
|
|
|
|
Consolidated
statements of cash flows |
IFRS Consolidated statements of cash flows of the Philips Group for the years ended December 31
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
|
|
|
|
Cash flows from operating activities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) attributable to stockholders |
|
|
5,153 |
|
|
|
4,873 |
|
|
|
(91 |
) |
|
|
|
|
(Income) loss from discontinued operations |
|
|
(4,154 |
) |
|
|
138 |
|
|
|
(3 |
) |
|
|
|
|
Minority interests |
|
|
4 |
|
|
|
7 |
|
|
|
(1 |
) |
|
|
|
|
Adjustments to reconcile net income (loss) to net cash provided by operating
activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
990 |
|
|
|
1,083 |
|
|
|
1,528 |
|
|
|
|
|
Impairment of goodwill, equity-accounted investees and available-for-sale securities |
|
|
8 |
|
|
|
39 |
|
|
|
1,509 |
|
|
|
|
|
Net gain on sale of assets |
|
|
(232 |
) |
|
|
(3,385 |
) |
|
|
(1,536 |
) |
|
|
|
|
Loss (income) from equity-accounted investees |
|
|
237 |
|
|
|
(371 |
) |
|
|
(91 |
) |
|
|
|
|
Dividends received from equity-accounted investees |
|
|
|
|
|
|
48 |
|
|
|
65 |
|
|
|
|
|
Dividends paid to minority shareholders |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Increase) decrease in receivables and other current assets |
|
|
(2,067 |
) |
|
|
(435 |
) |
|
|
234 |
|
|
|
|
|
Decrease (increase) in inventories |
|
|
5 |
|
|
|
(378 |
) |
|
|
41 |
|
|
|
|
|
Increase (decrease) in accounts payable, accrued and other liabilities |
|
|
1,042 |
|
|
|
121 |
|
|
|
(185 |
) |
|
|
|
|
(Increase) in non-current receivables/other assets |
|
|
(432 |
) |
|
|
(68 |
) |
|
|
(341 |
) |
|
|
|
|
(Decrease) increase in provisions |
|
|
(59 |
) |
|
|
(108 |
) |
|
|
432 |
|
|
|
|
|
Proceeds from sales of trading securities |
|
|
|
|
|
|
196 |
|
|
|
|
|
|
|
|
|
Other items |
|
|
144 |
|
|
|
(8 |
) |
|
|
87 |
|
|
|
|
|
Net cash provided by operating activities |
|
|
639 |
|
|
|
1,752 |
|
|
|
1,648 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase of intangible assets |
|
|
(101 |
) |
|
|
(118 |
) |
|
|
(121 |
) |
|
|
|
|
Expenditures on development assets |
|
|
(295 |
) |
|
|
(233 |
) |
|
|
(154 |
) |
|
|
|
|
Capital expenditures on property, plant and equipment |
|
|
(698 |
) |
|
|
(658 |
) |
|
|
(770 |
) |
|
|
|
|
Proceeds from disposals of property, plant and equipment |
|
|
107 |
|
|
|
81 |
|
|
|
170 |
|
|
64 |
|
|
Cash from derivatives |
|
|
62 |
|
|
|
385 |
|
|
|
337 |
|
|
|
|
|
Purchase of other non-current financial assets |
|
|
(31 |
) |
|
|
(17 |
) |
|
|
|
|
|
65 |
|
|
Proceeds from other non-current financial assets |
|
|
4 |
|
|
|
4,105 |
|
|
|
2,576 |
|
|
|
|
|
Purchase of businesses, net of cash acquired |
|
|
(2,467 |
) |
|
|
(1,485 |
) |
|
|
(5,316 |
) |
|
|
|
|
Proceeds from sale of interests in businesses |
|
|
318 |
|
|
|
1,640 |
|
|
|
24 |
|
|
|
|
|
Net cash (used for) provided by investing activities |
|
|
(3,101 |
) |
|
|
3,700 |
|
|
|
(3,254 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase (decrease) in short-term debt |
|
|
97 |
|
|
|
(158 |
) |
|
|
18 |
|
|
|
|
|
Principal payments on short-term portion of long-term debt |
|
|
(553 |
) |
|
|
(155 |
) |
|
|
(1,726 |
) |
|
|
|
|
Proceeds from issuance of long-term debt |
|
|
9 |
|
|
|
29 |
|
|
|
2,088 |
|
|
|
|
|
Treasury stock transactions |
|
|
(2,755 |
) |
|
|
(1,448 |
) |
|
|
(3,257 |
) |
|
|
|
|
Dividends paid |
|
|
(523 |
) |
|
|
(639 |
) |
|
|
(698 |
) |
|
|
|
|
Net cash used for financing activities |
|
|
(3,725 |
) |
|
|
(2,371 |
) |
|
|
(3,575 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used for) provided by continuing operations |
|
|
(6,187 |
) |
|
|
3,081 |
|
|
|
(5,181 |
) |
202 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
|
|
254 Corporate governance
|
|
262 Ten-year overview
|
|
266 Investor information |
|
|
non-US GAAP information |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Cash flows from discontinued operations |
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used for) operating activities |
|
|
582 |
|
|
|
(153 |
) |
|
|
(49 |
) |
Net cash provided by investing activities |
|
|
6,532 |
|
|
|
38 |
|
|
|
12 |
|
Net cash provided by financing activities |
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used for) discontinued operations |
|
|
7,114 |
|
|
|
(115 |
) |
|
|
(37 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used for) continuing and discontinued operations |
|
|
927 |
|
|
|
2,966 |
|
|
|
(5,218 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of changes in exchange rates on cash and cash equivalents |
|
|
(197 |
) |
|
|
(112 |
) |
|
|
(39 |
) |
Cash and cash equivalents at the beginning of the year |
|
|
5,293 |
|
|
|
6,023 |
|
|
|
8,877 |
|
Cash and cash equivalents at the end of the year |
|
|
6,023 |
|
|
|
8,877 |
|
|
|
3,620 |
|
Less cash and cash equivalents at the end of the year discontinued operations |
|
|
137 |
|
|
|
108 |
|
|
|
|
|
Cash and cash equivalents at the end of the year continuing operations |
|
|
5,886 |
|
|
|
8,769 |
|
|
|
3,620 |
|
Prior-period amounts have been restated to reflect a change in accounting policy related to
pensions (see Significant accounting policies, Change in accounting policy) and revised to reflect
immaterial adjustments of intercompany profit elimination on inventory (see Significant accounting
policies, Reclassifications and revisions).
Supplemental disclosures to the consolidated statements of cash flows
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
|
|
|
|
Net cash paid during the year for |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pensions |
|
|
1,144 |
|
|
|
449 |
|
|
|
379 |
|
|
|
|
|
Interest |
|
|
211 |
|
|
|
49 |
|
|
|
123 |
|
|
|
|
|
Income taxes |
|
|
632 |
|
|
|
493 |
|
|
|
352 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net gain on sale of assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash proceeds from the sale of assets |
|
|
429 |
|
|
|
5,826 |
|
|
|
2,770 |
|
|
|
|
|
Book value of these assets |
|
|
(249 |
) |
|
|
(2,528 |
) |
|
|
(1,341 |
) |
|
|
|
|
Non-cash gains |
|
|
52 |
|
|
|
87 |
|
|
|
107 |
|
|
|
|
|
|
|
|
232 |
|
|
|
3,385 |
|
|
|
1,536 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-cash investing and financing information |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets received in lieu of cash from the sale of businesses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
66 |
|
Shares/share options/convertible bonds |
|
|
188 |
|
|
|
|
|
|
|
148 |
|
|
|
|
|
Receivables/loans |
|
|
6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of convertible personnel debentures |
|
|
26 |
|
|
|
38 |
|
|
|
9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Treasury stock transactions |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares acquired |
|
|
(2,899 |
) |
|
|
(1,609 |
) |
|
|
(3,298 |
) |
|
|
|
|
Exercise of stock options |
|
|
144 |
|
|
|
161 |
|
|
|
41 |
|
|
|
|
|
Prior-period amounts have been restated to reflect a change in accounting policy related to
pensions (see Significant accounting policies, Change in accounting policy) and revised to reflect
immaterial adjustments of intercompany profit elimination on inventory (see Significant accounting
policies, Reclassifications and revisions). The accompanying notes are an integral part of these
consolidated financial statements. For a number of reasons, principally the effects of translation
differences and consolidation changes, certain items in the statements of cash flows do not
correspond to the differences between the balance sheet amounts for the respective items.
Philips Annual Report 2008 203
|
|
|
|
|
|
|
|
|
124 US GAAP financial
statements
|
|
180 Sustainability performance
|
|
192
|
|
IFRS financial statements
|
|
244 Company financial
statements |
|
|
|
|
|
|
Consolidated
statements of equity |
IFRS Consolidated statements of changes in equity of the Philips Group
in millions of euros unless otherwise stated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
total |
|
|
|
|
|
|
|
|
|
number of |
|
|
|
|
|
|
capital in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
treasury |
|
|
stock- |
|
|
|
|
|
|
|
|
|
shares in |
|
|
common |
|
|
excess of |
|
|
retained |
|
|
revaluation |
|
|
other |
|
|
shares |
|
|
holders |
|
|
minority |
|
|
|
|
|
|
thousands |
|
|
stock |
|
|
par value |
|
|
earnings |
|
|
reserve |
|
|
reserves |
|
|
at cost |
|
|
equity |
|
|
interests1) |
|
|
total equity |
|
Balance as of Dec. 31, 2005 |
|
|
1,201,358 |
|
|
|
263 |
|
|
|
82 |
|
|
|
17,827 |
|
|
|
262 |
|
|
|
804 |
|
|
|
(2,919 |
) |
|
|
16,319 |
|
|
|
353 |
|
|
|
16,672 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in accounting policy2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,084 |
|
|
|
|
|
|
|
(222 |
) |
|
|
|
|
|
|
862 |
|
|
|
|
|
|
|
862 |
|
Prior-period revisions2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(32 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(32 |
) |
|
|
|
|
|
|
(32 |
) |
Balance as of Dec. 31, 2005 -
as restated and revised |
|
|
1,201,358 |
|
|
|
263 |
|
|
|
82 |
|
|
|
18,879 |
|
|
|
262 |
|
|
|
582 |
|
|
|
(2,919 |
) |
|
|
17,149 |
|
|
|
353 |
|
|
|
17,502 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total recognized income
and expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,153 |
|
|
|
(95 |
) |
|
|
3,980 |
|
|
|
|
|
|
|
9,038 |
|
|
|
|
|
|
|
|
|
Dividend paid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(523 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(523 |
) |
|
|
|
|
|
|
|
|
Cancellation of treasury shares |
|
|
|
|
|
|
(35 |
) |
|
|
|
|
|
|
(4,332 |
) |
|
|
|
|
|
|
|
|
|
|
4,367 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase of treasury stock |
|
|
(105,949 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,899 |
) |
|
|
(2,899 |
) |
|
|
|
|
|
|
|
|
Re-issuance of treasury stock |
|
|
11,484 |
|
|
|
|
|
|
|
(245 |
) |
|
|
(112 |
) |
|
|
|
|
|
|
|
|
|
|
528 |
|
|
|
171 |
|
|
|
|
|
|
|
|
|
Share-based compensation plans |
|
|
|
|
|
|
|
|
|
|
122 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
122 |
|
|
|
|
|
|
|
|
|
Income tax share-based
compensation plans |
|
|
|
|
|
|
|
|
|
|
41 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
41 |
|
|
|
|
|
|
|
|
|
|
|
|
(94,465 |
) |
|
|
(35 |
) |
|
|
(82 |
) |
|
|
186 |
|
|
|
(95 |
) |
|
|
3,980 |
|
|
|
1,996 |
|
|
|
5,950 |
|
|
|
(218 |
) |
|
|
5,732 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of Dec. 31, 2006 |
|
|
1,106,893 |
|
|
|
228 |
|
|
|
|
|
|
|
19,065 |
|
|
|
167 |
|
|
|
4,562 |
|
|
|
(923 |
) |
|
|
23,099 |
|
|
|
135 |
|
|
|
23,234 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total recognized income
and expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,907 |
|
|
|
(34 |
) |
|
|
(4,269 |
) |
|
|
|
|
|
|
604 |
|
|
|
|
|
|
|
|
|
Dividend paid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(659 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(659 |
) |
|
|
|
|
|
|
|
|
Purchase of treasury stock |
|
|
(53,141 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,633 |
) |
|
|
(1,633 |
) |
|
|
|
|
|
|
|
|
Re-issuance of treasury stock |
|
|
11,141 |
|
|
|
|
|
|
|
(131 |
) |
|
|
(10 |
) |
|
|
|
|
|
|
|
|
|
|
340 |
|
|
|
199 |
|
|
|
|
|
|
|
|
|
Share-based compensation plans |
|
|
|
|
|
|
|
|
|
|
104 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
104 |
|
|
|
|
|
|
|
|
|
Income tax share-based
compensation plans |
|
|
|
|
|
|
|
|
|
|
27 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27 |
|
|
|
|
|
|
|
|
|
|
|
|
(42,000 |
) |
|
|
|
|
|
|
|
|
|
|
4,238 |
|
|
|
(34 |
) |
|
|
(4,269 |
) |
|
|
(1,293 |
) |
|
|
(1,358 |
) |
|
|
(8 |
) |
|
|
(1,366 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of Dec. 31, 2007 |
|
|
1,064,893 |
|
|
|
228 |
|
|
|
|
|
|
|
23,303 |
|
|
|
133 |
|
|
|
293 |
|
|
|
(2,216 |
) |
|
|
21,741 |
|
|
|
127 |
|
|
|
21,868 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total recognized income
and expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(75 |
) |
|
|
(16 |
) |
|
|
(2,211 |
) |
|
|
|
|
|
|
(2,302 |
) |
|
|
|
|
|
|
|
|
Dividend paid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(720 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(720 |
) |
|
|
|
|
|
|
|
|
Cancellation of treasury stock |
|
|
|
|
|
|
(34 |
) |
|
|
|
|
|
|
(4,062 |
) |
|
|
|
|
|
|
|
|
|
|
4,096 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase of treasury stock |
|
|
(146,453 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3,298 |
) |
|
|
(3,298 |
) |
|
|
|
|
|
|
|
|
Re-issuance of treasury stock |
|
|
4,542 |
|
|
|
|
|
|
|
(71 |
) |
|
|
(7 |
) |
|
|
|
|
|
|
|
|
|
|
130 |
|
|
|
52 |
|
|
|
|
|
|
|
|
|
Share-based compensation plans |
|
|
|
|
|
|
|
|
|
|
106 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
106 |
|
|
|
|
|
|
|
|
|
Income tax share-based
compensation plans |
|
|
|
|
|
|
|
|
|
|
(35 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(35 |
) |
|
|
|
|
|
|
|
|
|
|
|
(141,911 |
) |
|
|
(34 |
) |
|
|
|
|
|
|
(4,864 |
) |
|
|
(16 |
) |
|
|
(2,211 |
) |
|
|
928 |
|
|
|
(6,197 |
) |
|
|
(78 |
) |
|
|
(6,275 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of Dec. 31, 2008 |
|
|
922,982 |
|
|
|
194 |
|
|
|
|
|
|
|
18,439 |
|
|
|
117 |
|
|
|
(1,918 |
) |
|
|
(1,288 |
) |
|
|
15,544 |
|
|
|
49 |
|
|
|
15,593 |
|
|
|
|
1) |
|
Of which discontinued operations EUR 91 million at December 31, 2006 and EUR 79 million at
December 31, 2007 |
|
2) |
|
Prior-period amounts have been restated to reflect a change in accounting policy related to
pensions (see Significant accounting policies, Change in accounting policy) and revised to reflect
immaterial adjustments of intercompany profit elimination on inventory (see Significant accounting
policies, Reclassifications and revisions). |
The accompanying notes are an integral part of these consolidated financial statements.
204 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
|
|
254 Corporate governance
|
|
262 Ten-year overview
|
|
266 Investor information |
|
|
non-US GAAP information |
|
|
|
|
|
|
Changes in other reserves
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
currency |
|
|
|
|
|
|
|
|
|
|
Actuarial gains |
|
|
|
|
|
|
translation |
|
|
available-for-sale |
|
|
|
|
|
|
(losses) on |
|
|
total other |
|
|
|
differences |
|
|
securities |
|
|
cash flow hedges |
|
|
pension plans |
|
|
reserves |
|
Balance as of December 31, 2005 |
|
|
832 |
|
|
|
1 |
|
|
|
(29 |
) |
|
|
|
|
|
|
804 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in accounting policy1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(222 |
) |
|
|
(222 |
) |
Balance as of December 31, 2005 - as restated |
|
|
832 |
|
|
|
1 |
|
|
|
(29 |
) |
|
|
(222 |
) |
|
|
582 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net current period change |
|
|
(515 |
) |
|
|
4,768 |
|
|
|
72 |
|
|
|
(181 |
) |
|
|
4,144 |
|
Income tax on net current period change |
|
|
(72 |
) |
|
|
|
|
|
|
(15 |
) |
|
|
51 |
|
|
|
(36 |
) |
Reclassification into income |
|
|
(10 |
) |
|
|
(98 |
) |
|
|
(20 |
) |
|
|
|
|
|
|
(128 |
) |
|
|
|
(597 |
) |
|
|
4,670 |
|
|
|
37 |
|
|
|
(130 |
) |
|
|
3,980 |
|
Balance as of December 31, 2006 |
|
|
235 |
|
|
|
4,671 |
|
|
|
8 |
|
|
|
(352 |
) |
|
|
4,562 |
|
|
Net current period change continuing operations |
|
|
(749 |
) |
|
|
(618 |
) |
|
|
19 |
|
|
|
59 |
|
|
|
(1,289 |
) |
Net current period change discontinued
operations |
|
|
(22 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(22 |
) |
Income tax on net current period change |
|
|
(10 |
) |
|
|
|
|
|
|
(3 |
) |
|
|
(12 |
) |
|
|
(25 |
) |
Reclassification into income |
|
|
(67 |
) |
|
|
(2,870 |
) |
|
|
4 |
|
|
|
|
|
|
|
(2,933 |
) |
|
|
|
(848 |
) |
|
|
(3,488 |
) |
|
|
20 |
|
|
|
47 |
|
|
|
(4,269 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 31, 2007 |
|
|
(613 |
) |
|
|
1,183 |
|
|
|
28 |
|
|
|
(305 |
) |
|
|
293 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net current period change continuing operations |
|
|
(60 |
) |
|
|
(269 |
) |
|
|
(24 |
) |
|
|
(1,310 |
) |
|
|
(1,663 |
) |
Net current period change discontinued
operations |
|
|
4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 |
|
Income tax on net current period change |
|
|
5 |
|
|
|
|
|
|
|
18 |
|
|
|
406 |
|
|
|
429 |
|
Reclassification into income |
|
|
8 |
|
|
|
(939 |
) |
|
|
(50 |
) |
|
|
|
|
|
|
(981 |
) |
|
|
|
(43 |
) |
|
|
(1,208 |
) |
|
|
(56 |
) |
|
|
(904 |
) |
|
|
(2,211 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 31, 2008 |
|
|
(656 |
) |
|
|
(25 |
) |
|
|
(28 |
) |
|
|
(1,209 |
) |
|
|
(1,918 |
) |
|
|
|
1) |
|
Prior-period amounts have been restated to reflect a change in accounting policy related to
pensions (see Significant accounting policies, Change in accounting policy). |
Philips Annual Report 2008 205
|
|
|
|
|
|
|
|
|
124 US GAAP financial
statements
|
|
180 Sustainability performance
|
|
192
|
|
IFRS financial statements
|
|
244 Company financial
statements |
|
|
|
|
|
|
Information
by sector and main country |
Information by sector and main country
in millions of euros
Sectors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
relating to |
|
|
cash flow |
|
|
|
|
|
|
|
research and |
|
|
|
|
|
|
income from |
|
|
equity- |
|
|
before |
|
|
|
|
|
|
|
development |
|
|
income from |
|
|
operations as a |
|
|
accounted |
|
|
financing |
|
|
|
sales |
|
|
expenses |
|
|
operations |
|
|
% of sales |
|
|
investees |
|
|
activities |
|
2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Healthcare |
|
|
7,649 |
|
|
|
(648 |
) |
|
|
645 |
|
|
|
8.4 |
|
|
|
8 |
|
|
|
(2,415 |
) |
Consumer Lifestyle |
|
|
11,145 |
|
|
|
(509 |
) |
|
|
136 |
|
|
|
1.2 |
|
|
|
|
|
|
|
252 |
|
of which Television |
|
|
4,980 |
|
|
|
(118 |
) |
|
|
(426 |
) |
|
|
(8.6 |
) |
|
|
|
|
|
|
(489 |
) |
Lighting |
|
|
7,106 |
|
|
|
(333 |
) |
|
|
14 |
|
|
|
0.2 |
|
|
|
1 |
|
|
|
(1,137 |
) |
Innovation & Emerging Businesses |
|
|
337 |
|
|
|
(287 |
) |
|
|
(247 |
) |
|
|
(73.3 |
) |
|
|
(2 |
) |
|
|
(128 |
) |
Group Management & Services |
|
|
148 |
|
|
|
|
|
|
|
(494 |
) |
|
|
|
|
|
|
12 |
|
|
|
1,822 |
|
|
|
|
26,385 |
|
|
|
(1,777 |
) |
|
|
54 |
|
|
|
0.2 |
|
|
|
19 |
|
|
|
(1,606 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Healthcare |
|
|
6,638 |
|
|
|
(579 |
) |
|
|
724 |
|
|
|
10.9 |
|
|
|
7 |
|
|
|
227 |
|
Consumer Lifestyle |
|
|
13,330 |
|
|
|
(486 |
) |
|
|
837 |
|
|
|
6.3 |
|
|
|
2 |
|
|
|
754 |
|
of which Television |
|
|
6,270 |
|
|
|
(116 |
) |
|
|
(71 |
) |
|
|
(1.1 |
) |
|
|
|
|
|
|
(49 |
) |
Lighting |
|
|
6,093 |
|
|
|
(279 |
) |
|
|
637 |
|
|
|
10.5 |
|
|
|
|
|
|
|
(644 |
) |
Innovation & Emerging Businesses |
|
|
535 |
|
|
|
(257 |
) |
|
|
(104 |
) |
|
|
(19.4 |
) |
|
|
(9 |
) |
|
|
(179 |
) |
Group Management & Services |
|
|
197 |
|
|
|
|
|
|
|
(227 |
) |
|
|
|
|
|
|
884 |
|
|
|
5,294 |
|
|
|
|
26,793 |
|
|
|
(1,601 |
) |
|
|
1,867 |
|
|
|
7.0 |
|
|
|
884 |
|
|
|
5,452 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Healthcare |
|
|
6,562 |
|
|
|
(515 |
) |
|
|
770 |
|
|
|
11.7 |
|
|
|
9 |
|
|
|
(993 |
) |
Consumer Lifestyle |
|
|
13,108 |
|
|
|
(538 |
) |
|
|
705 |
|
|
|
5.4 |
|
|
|
3 |
|
|
|
(39 |
) |
of which Television |
|
|
6,559 |
|
|
|
(115 |
) |
|
|
151 |
|
|
|
2.3 |
|
|
|
|
|
|
|
212 |
|
Lighting |
|
|
5,466 |
|
|
|
(255 |
) |
|
|
549 |
|
|
|
10.0 |
|
|
|
(4 |
) |
|
|
451 |
|
Innovation & Emerging Businesses |
|
|
1,379 |
|
|
|
(248 |
) |
|
|
(93 |
) |
|
|
(6.7 |
) |
|
|
(12 |
) |
|
|
(49 |
) |
Group Management & Services |
|
|
167 |
|
|
|
|
|
|
|
(595 |
) |
|
|
|
|
|
|
(135 |
) |
|
|
(1,832 |
) |
|
|
|
26,682 |
|
|
|
(1,556 |
) |
|
|
1,336 |
|
|
|
5.0 |
|
|
|
(139 |
) |
|
|
(2,462 |
) |
As of January 2008, Philips activities are organized on a sector basis, with each operating
sector, Healthcare, Lighting and Consumer Lifestyle being responsible for the management of its
business worldwide. The Healthcare sector brings together the former Medical Systems division and
Home Healthcare Solutions (formerly Consumer Healthcare Solutions) which has been transferred
from Innovation & Emerging Businesses. The former Consumer Electronics and Domestic Appliances and
Personal Care divisions have been integrated in the Consumer Lifestyle sector. As a consequence of
the aforementioned, prior-year financials have been restated. Prior-period amounts have also been
restated to reflect a change in accounting policy related to pensions (see Significant accounting
policies, Change in accounting policy). Prior-period Group and Healthcare amounts have been revised
to reflect immaterial adjustments of intercompany profit elimination on inventory (see Significant
accounting policies, Reclassifications and revisions).
The following sectors are included in the table above: Healthcare, Consumer Lifestyle, Lighting,
Innovation & Emerging Businesses (I&EB) and Group Management & Services (GM&S). A short description
of these sectors is as follows:
Healthcare: Consists of the following businesses Imaging Systems, Clinical Care systems, Home
Healthcare Solutions, Healthcare Informatics and Patient Monitoring, and Customer Services.
Consumer Lifestyle: Consists of the following businesses Television, Shaving & Beauty, Audio &
Video Multimedia, Domestic Appliances, Peripherals & Accessories, Health & Wellness, and Licenses.
Lighting: Consists of the following businesses Lamps, Professional Luminaires, Consumer
Luminaires, Lighting Electronics, Automotive, Special Lighting Applications, and Lumileds.
I&EB: Consists of various activities and businesses which mainly support, but are not allocated to,
a specific sector. This includes Corporate Technologies (such as Research, Intellectual Property &
Standards, Molecular Healthcare, the Healthcare, Lifestyle and Lighting & Cleantech Incubators as
well as Applied Technologies), Corporate Investments, New Venture Integration, and Design.
GM&S: Consists of the corporate center, as well as the overhead expenses of regional and country
organizations. Also included are the costs of Philips global brand campaign and pension and other
postretirement benefit costs not directly allocated to the other sectors.
206 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
non-US GAAP information
|
|
254
|
|
Corporate governance
|
|
262
|
|
Ten-year overview
|
|
266
|
|
Investor information |
Sectors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
depreciation of |
|
|
|
|
|
|
|
net operating |
|
|
total liabilities |
|
|
long-lived |
|
|
capital |
|
|
property, plant |
|
|
|
total assets |
|
|
capital |
|
|
excl. debt |
|
|
assets |
|
|
expenditures |
|
|
and equipment |
|
2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Healthcare |
|
|
11,305 |
|
|
|
8,785 |
|
|
|
2,448 |
|
|
|
8,117 |
|
|
|
206 |
|
|
|
139 |
|
Consumer Lifestyle |
|
|
3,621 |
|
|
|
825 |
|
|
|
2,794 |
|
|
|
1,213 |
|
|
|
173 |
|
|
|
170 |
|
of which Television |
|
|
1,000 |
|
|
|
(244 |
) |
|
|
1,244 |
|
|
|
82 |
|
|
|
64 |
|
|
|
68 |
|
Lighting |
|
|
7,177 |
|
|
|
5,685 |
|
|
|
1,477 |
|
|
|
5,135 |
|
|
|
302 |
|
|
|
329 |
|
Innovation & Emerging Businesses |
|
|
506 |
|
|
|
150 |
|
|
|
220 |
|
|
|
211 |
|
|
|
5 |
|
|
|
31 |
|
Group Management & Services |
|
|
9,181 |
|
|
|
(1,376 |
) |
|
|
5,070 |
|
|
|
577 |
|
|
|
84 |
|
|
|
60 |
|
|
|
|
31,790 |
|
|
|
14,069 |
|
|
|
12,009 |
|
|
|
15,253 |
|
|
|
770 |
|
|
|
729 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Healthcare |
|
|
6,744 |
|
|
|
4,758 |
|
|
|
1,911 |
|
|
|
3,987 |
|
|
|
166 |
|
|
|
91 |
|
Consumer Lifestyle |
|
|
4,535 |
|
|
|
1,113 |
|
|
|
3,423 |
|
|
|
1,514 |
|
|
|
164 |
|
|
|
156 |
|
of which Television |
|
|
1,350 |
|
|
|
(208 |
) |
|
|
1,558 |
|
|
|
115 |
|
|
|
59 |
|
|
|
53 |
|
Lighting |
|
|
5,287 |
|
|
|
4,059 |
|
|
|
1,220 |
|
|
|
3,462 |
|
|
|
247 |
|
|
|
217 |
|
Innovation & Emerging Businesses |
|
|
626 |
|
|
|
270 |
|
|
|
|
|
|
|
261 |
|
|
|
53 |
|
|
|
39 |
|
Group Management & Services |
|
|
18,803 |
|
|
|
602 |
|
|
|
4,251 |
|
|
|
605 |
|
|
|
28 |
|
|
|
59 |
|
|
|
|
35,995 |
|
|
|
10,802 |
|
|
|
10,805 |
|
|
|
9,829 |
|
|
|
658 |
|
|
|
562 |
|
Discontinued operations |
|
|
319 |
|
|
|
|
|
|
|
78 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
36,314 |
|
|
|
|
|
|
|
10,883 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Healthcare |
|
|
6,625 |
|
|
|
4,640 |
|
|
|
1,924 |
|
|
|
4,053 |
|
|
|
89 |
|
|
|
77 |
|
Consumer Lifestyle |
|
|
4,499 |
|
|
|
1,126 |
|
|
|
3,365 |
|
|
|
1,568 |
|
|
|
156 |
|
|
|
140 |
|
of which Television |
|
|
1,359 |
|
|
|
(133 |
) |
|
|
1,492 |
|
|
|
121 |
|
|
|
40 |
|
|
|
43 |
|
Lighting |
|
|
3,983 |
|
|
|
2,817 |
|
|
|
1,159 |
|
|
|
2,508 |
|
|
|
343 |
|
|
|
205 |
|
Innovation & Emerging Businesses |
|
|
811 |
|
|
|
171 |
|
|
|
475 |
|
|
|
291 |
|
|
|
4 |
|
|
|
66 |
|
Group Management & Services |
|
|
22,199 |
|
|
|
202 |
|
|
|
4,391 |
|
|
|
646 |
|
|
|
106 |
|
|
|
66 |
|
|
|
|
38,117 |
|
|
|
8,956 |
|
|
|
11,314 |
|
|
|
9,066 |
|
|
|
698 |
|
|
|
554 |
|
Discontinued operations |
|
|
427 |
|
|
|
|
|
|
|
78 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
38,544 |
|
|
|
|
|
|
|
11,392 |
|
|
|
|
|
|
|
|
|
|
|
|
|
As of January 2008, Philips activities are organized on a sector basis, with each operating
sector, Healthcare, Lighting and Consumer Lifestyle being
responsible of the management of its
business worldwide. The Healthcare sector brings together the former Medical Systems division and
Home Healthcare Solutions (formerly Consumer Healthcare Solutions) which has been transferred
from Innovation & Emerging Businesses. The former Consumer Electronics and Domestic Appliances and
Personal Care divisions have been integrated in the Consumer Lifestyle sector. As a consequence of
the aforementioned, prior-year financials have been restated. Prior-period amounts have also been
restated to reflect a change in accounting policy related to pensions (see Significant accounting
policies, Change in accounting policy). Prior-period Group and Healthcare amounts have been revised
to reflect immaterial adjustments of intercompany profit elimination on inventory (see Significant
accounting policies, Reclassifications and revisions).
Philips Annual Report 2008 207
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124
|
|
US GAAP financial statements
|
|
180
|
|
Sustainability performance
|
|
192
|
|
IFRS financial statements
|
|
244
|
|
Company financial statements |
|
|
|
|
|
|
|
|
|
|
|
- Sector and main country |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- Significant IFRS accounting policies |
|
|
|
|
Goodwill assigned to sectors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
carrying value at |
|
|
|
|
|
|
|
|
|
|
translation differences |
|
|
carrying value at |
|
|
|
January 1 |
|
|
acquisitions |
|
|
impairment |
|
|
and other changes |
|
|
December 31 |
|
2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Healthcare |
|
|
2,235 |
|
|
|
2,421 |
|
|
|
|
|
|
|
305 |
|
|
|
4,961 |
|
Consumer Lifestyle |
|
|
425 |
|
|
|
5 |
|
|
|
|
|
|
|
(66 |
) |
|
|
364 |
|
Lighting |
|
|
1,140 |
|
|
|
1,024 |
|
|
|
(301 |
) |
|
|
92 |
|
|
|
1,955 |
|
Innovation & Emerging Businesses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Group Management & Services |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,800 |
|
|
|
3,450 |
|
|
|
(301 |
) |
|
|
331 |
|
|
|
7,280 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Healthcare |
|
|
2,361 |
|
|
|
116 |
|
|
|
|
|
|
|
(242 |
) |
|
|
2,235 |
|
Consumer Lifestyle |
|
|
460 |
|
|
|
7 |
|
|
|
|
|
|
|
(42 |
) |
|
|
425 |
|
Lighting |
|
|
585 |
|
|
|
637 |
|
|
|
|
|
|
|
(82 |
) |
|
|
1,140 |
|
Innovation & Emerging Businesses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Group Management & Services |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,406 |
|
|
|
760 |
|
|
|
|
|
|
|
(366 |
) |
|
|
3,800 |
|
Main countries
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
depreciation of |
|
|
|
|
|
|
|
|
|
|
|
net operating |
|
|
long-lived |
|
|
capital |
|
|
property, plant |
|
|
|
sales |
|
|
total assets |
|
|
capital |
|
|
assets |
|
|
expenditures |
|
|
and equipment |
|
2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Netherlands |
|
|
1,012 |
|
|
|
8,858 |
|
|
|
3,016 |
|
|
|
1,348 |
|
|
|
156 |
|
|
|
151 |
|
United States |
|
|
7,027 |
|
|
|
14,240 |
|
|
|
9,152 |
|
|
|
10,770 |
|
|
|
192 |
|
|
|
82 |
|
Germany |
|
|
2,048 |
|
|
|
978 |
|
|
|
(308 |
) |
|
|
298 |
|
|
|
50 |
|
|
|
46 |
|
France |
|
|
1,692 |
|
|
|
534 |
|
|
|
(77 |
) |
|
|
137 |
|
|
|
55 |
|
|
|
26 |
|
United Kingdom |
|
|
1,016 |
|
|
|
729 |
|
|
|
414 |
|
|
|
524 |
|
|
|
13 |
|
|
|
9 |
|
China |
|
|
1,754 |
|
|
|
1,325 |
|
|
|
(172 |
) |
|
|
242 |
|
|
|
60 |
|
|
|
44 |
|
Other countries |
|
|
11,836 |
|
|
|
5,126 |
|
|
|
2,044 |
|
|
|
1,934 |
|
|
|
244 |
|
|
|
371 |
|
|
|
|
26,385 |
|
|
|
31,790 |
|
|
|
14,069 |
|
|
|
15,253 |
|
|
|
770 |
|
|
|
729 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Netherlands |
|
|
1,159 |
|
|
|
14,115 |
|
|
|
2,155 |
|
|
|
1,367 |
|
|
|
163 |
|
|
|
151 |
|
United States |
|
|
6,725 |
|
|
|
8,133 |
|
|
|
6,747 |
|
|
|
5,159 |
|
|
|
115 |
|
|
|
103 |
|
Germany |
|
|
2,014 |
|
|
|
1,375 |
|
|
|
(255 |
) |
|
|
326 |
|
|
|
50 |
|
|
|
46 |
|
France |
|
|
1,784 |
|
|
|
722 |
|
|
|
(86 |
) |
|
|
147 |
|
|
|
23 |
|
|
|
26 |
|
United Kingdom |
|
|
1,250 |
|
|
|
1,037 |
|
|
|
689 |
|
|
|
719 |
|
|
|
13 |
|
|
|
8 |
|
China |
|
|
1,707 |
|
|
|
1,254 |
|
|
|
(497 |
) |
|
|
189 |
|
|
|
36 |
|
|
|
42 |
|
Other countries |
|
|
12,154 |
|
|
|
9,359 |
|
|
|
2,049 |
|
|
|
1,922 |
|
|
|
258 |
|
|
|
186 |
|
|
|
|
26,793 |
|
|
|
35,995 |
|
|
|
10,802 |
|
|
|
9,829 |
|
|
|
658 |
|
|
|
562 |
|
Discontinued operations |
|
|
|
|
|
|
319 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
36,314 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Netherlands |
|
|
1,088 |
|
|
|
10,790 |
|
|
|
3,697 |
|
|
|
1,299 |
|
|
|
246 |
|
|
|
162 |
|
United States |
|
|
7,153 |
|
|
|
7,888 |
|
|
|
4,558 |
|
|
|
5,229 |
|
|
|
209 |
|
|
|
98 |
|
Germany |
|
|
1,985 |
|
|
|
1,196 |
|
|
|
(405 |
) |
|
|
340 |
|
|
|
57 |
|
|
|
51 |
|
France |
|
|
1,626 |
|
|
|
632 |
|
|
|
342 |
|
|
|
146 |
|
|
|
18 |
|
|
|
32 |
|
United Kingdom |
|
|
1,186 |
|
|
|
1,133 |
|
|
|
714 |
|
|
|
790 |
|
|
|
4 |
|
|
|
6 |
|
China |
|
|
1,740 |
|
|
|
1,141 |
|
|
|
(99 |
) |
|
|
192 |
|
|
|
31 |
|
|
|
42 |
|
Other countries |
|
|
11,904 |
|
|
|
15,337 |
|
|
|
149 |
|
|
|
1,070 |
|
|
|
133 |
|
|
|
163 |
|
|
|
|
26,682 |
|
|
|
38,117 |
|
|
|
8,956 |
|
|
|
9,066 |
|
|
|
698 |
|
|
|
554 |
|
Discontinued operations |
|
|
|
|
|
|
427 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
38,544 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The sales are attributed by country of destination. Prior-period amounts have been revised to
reflect immaterial adjustments of intercompany profit elimination on inventory (see Significant
accounting policies, Reclassifications and revisions).
208 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
non-US GAAP information
|
|
254
|
|
Corporate governance
|
|
262
|
|
Ten-year overview
|
|
266
|
|
Investor information |
Significant IFRS accounting policies
The consolidated financial statements in this section have been prepared in accordance with
International Financial Reporting Standards (IFRS) as adopted by the European Union (EU). All
standards and interpretations issued by the International Accounting Standards Board (IASB) and the
International Financial Reporting Interpretations Committee (IFRIC) effective
year-end 2008 have
been adopted by the EU, except that the EU carved out certain hedge accounting provisions of IAS
39. Philips does not utilize this carve-out permitted by the EU. Consequently, the accounting
policies applied by Philips also comply fully with IFRS issued by the IASB.
The consolidated financial statements have been prepared under the historical cost convention,
unless otherwise indicated.
Basis of consolidation
The consolidated financial statements include the accounts of
Koninklijke Philips Electronics N.V. (the Company) and all subsidiaries that fall under its power
to govern the financial and operating policies of an entity so as to obtain benefits from its
activities. The existence and effect of potential voting rights that are currently exercisable are
considered when assessing whether the Company controls another entity. Subsidiaries are fully
consolidated from the date that control commences until the date that control ceases. All
intercompany balances and transactions have been eliminated in the consolidated financial
statements. Unrealized losses are eliminated in the same way as unrealized gains, but only to the
extent that there is no evidence of impairment.
The purchase method of accounting is used to account for the acquisition of subsidiaries by the
Company. The cost of an acquisition is measured as the fair value of the assets given, equity
instruments issued and liabilities incurred or assumed at the date of exchange, plus costs directly
attributable to the business combination, irrespective of the extent of any minority interest. The
excess of the cost of acquisition over the fair value of the Companys share of the identifiable
net assets of the subsidiary acquired is recognized as goodwill. The minority interests are
disclosed separately in the consolidated statements of income as part of profit allocation and in
the consolidated balance sheets as a separate component of equity.
Foreign currencies
The consolidated financial statements are presented in euros, which is the Companys functional and
presentation currency. The financial statements of entities that use a functional currency other
than the euro, are translated into euros. Assets and liabilities are translated using the exchange
rates on the respective balance sheet dates. Items in the statements of income and statements of
cash flows are translated into euros using the average rates of exchange for the periods involved.
The resulting translation adjustments are recorded as a separate component of equity. Cumulative
translation adjustments are recognized as income or expense upon partial or complete disposal or
liquidation of a foreign entity. The functional currency of foreign entities is generally the local
currency, unless the primary economic environment requires the use of another currency. Gains and
losses arising from the translation or settlement of foreign currency-denominated monetary assets
and liabilities into the functional currency are recognized in income in the period in which they
arise. However, currency differences on intercompany loans that have the nature of a permanent
investment are accounted for as translation differences in a separate component of equity. Changes
in the fair value of monetary securities denominated in foreign currency classified as available
for sale are split into translation differences resulting from changes in the amortized cost of the
security and other changes in the carrying amount of the security. Translation differences related
to changes in the amortized cost are recognized in profit or loss, and other changes in the
carrying amount are recognized in equity.
Translation differences on non-monetary financial assets and liabilities such as equities held at
fair value through profit or loss are reported as part of the fair value gain or loss. Translation
differences on non-monetary financial assets such as equities classified as available for sale are
included in other reserves in equity.
Use of estimates
The preparation of financial statements requires management to make estimates and assumptions that
affect amounts reported in the consolidated financial statements in order to conform to IFRS. These
estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of
contingent liabilities at the date of the consolidated financial statements, and the reported
amounts of revenues and expenses during the reporting period. We evaluate these estimates and
judgments on an ongoing basis and base our estimates on experience, current and expected future
conditions, third-party evaluations and various other assumptions that we believe are reasonable
under the circumstances. The results of these estimates form the basis for making judgements about
the carrying values of assets and liabilities as well as identifying and assessing the accounting
treatment with respect to commitments and contingencies. Actual results could differ materially
from the estimates and assumptions.
Estimates significantly impact goodwill and other intangibles acquired, tax on activities disposed,
impairments, financial instruments, assets and liabilities from employee benefit plans, other
provisions and tax and other contingencies. The fair values of acquired identifiable intangibles
are based on an assessment of future cash flows. Impairment analyses of goodwill and
indefinite-lived intangible assets are performed annually and whenever a triggering event has
occurred to determine whether the carrying value exceeds the recoverable amount. These analyses are
based on estimates of future cash flows.
The fair value of financial instruments that are not traded in an active market is determined by
using valuation techniques. The Company uses its judgment to select from a variety of common
valuation methods including the discounted cash flow method and option valuation models and to make
assumptions that are mainly based on market conditions existing at each balance sheet date.
Actuarial assumptions are established to anticipate future events and are used in calculating
pension and other postretirement benefit expense and liability. These factors include assumptions
with respect to interest rates, expected investment returns on plan assets, rates of increase in
health care costs, rates of future compensation increases, turnover rates, and life expectancy.
Accounting changes
In the absence of explicit transition requirements for new accounting pronouncements, the Company
accounts for any change in accounting principle retrospectively.
Change in accounting policy
As of January 1, 2008, the Company changed its pension accounting policy by adopting the option
available under IAS 19 Employee Benefits, paragraph 93A. Under this option, actuarial gains and
losses are recorded directly in equity and disclosed in the Statements of Recognized Income and
Expense and therefore recognized immediately on the balance sheet. The Company believes that
recognizing actuarial gains and losses when they occur, results in a better presentation of the
financial position of the pension obligation in the balance sheet since the amount recognized as a
provision at balance sheet date reflects the best estimate of the present obligation. The Company
also believes that recognizing the actuarial gains and losses directly in equity provides more
relevant information.
In addition, Philips early-adopted IFRIC Interpretation 14 Limit on a Defined Benefit Asset on
January 1, 2008.
The impact of the change of accounting policy has been retrospectively applied in accordance with
IAS 8 Accounting Policies, Changes in Accounting Estimates and Errors. The financial
quantification of this change is disclosed in note 56.
Philips Annual Report 2008 209
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124
|
|
US GAAP financial statements
|
|
180
|
|
Sustainability performance
|
|
192
|
|
IFRS financial statements
Significant IFRS accounting policies
|
|
244
|
|
Company financial statements |
Reclassifications and revisions
Certain items previously reported under specific financial statement captions have been
reclassified to conform to the current year presentation.
Prior-period amounts have been revised to adjust for certain intercompany profit eliminations on
inventories in Healthcare related to prior years. These adjustments are not material to the
consolidated financial statements in any of the prior periods. The table below outlines the impact
of these adjustments:
|
|
|
|
|
|
|
|
|
in millions of euros unless otherwise stated |
|
2006 |
|
|
2007 |
|
Decrease in income before taxes |
|
|
(3 |
) |
|
|
(11 |
) |
Decrease in income tax expense |
|
|
1 |
|
|
|
3 |
|
Decrease in net income |
|
|
(2 |
) |
|
|
(8 |
) |
Decrease in net income per common
share in euros |
|
|
|
|
|
|
|
|
- basic |
|
|
(0.00 |
) |
|
|
(0.01 |
) |
- diluted |
|
|
(0.00 |
) |
|
|
(0.01 |
) |
The effect on retained earnings as of December 31, 2005 is a decrease of EUR 32 million.
Discontinued operations and non-current assets held for sale
Non-current assets (disposal groups
comprising assets and liabilities) that are expected to be recovered primarily through sale rather
than through continuing use are classified as held for sale.
A discontinued operation is a component of an entity that either has been disposed of, or that is
classified as held for sale, and (a) represents a separate major line of business or geographical
area of operations; and (b) is a part of a single coordinated plan to dispose of a separate major
line of business or geographical area of operations; or (c) is a subsidiary acquired exclusively
with a view to resale.
Non-current assets held for sale and discontinued operations are carried at the lower of carrying
amount or fair value less costs to sell. Any gain or loss from disposal of a business, together
with the results of these operations until the date of disposal, is reported separately as
discontinued operations. The financial information of discontinued operations is excluded from the
respective captions in the consolidated financial statements and related notes for all years
presented.
Cash flow statements
Cash flow statements are prepared using the indirect method. Cash flows in foreign currencies have
been translated into euros using the weighted average rates of exchange for the periods involved.
Cash flows from derivative instruments that are accounted for as fair value hedges or cash flow
hedges are classified in the same category as the cash flows from the hedged items. Cash flows from
other derivative instruments are classified consistent with the nature of the instrument.
Segments
Operating segments are components of the Companys business activities about which separate
financial information is available that is evaluated regularly by the chief operating decision
maker (the Board of Management of the Company). The Board of Management decides how to allocate
resources and assesses performance. Reportable segments comprise: Healthcare, Consumer Lifestyle,
Lighting, and Television. Segment accounting policies are the same as the accounting policies as
applied to the Group.
Earnings per share
The Company presents basic and diluted earnings per share (EPS) data for its common shares. Basic
EPS is calculated by dividing the net income attributable to shareholders of the Company by the
weighted average number of common shares outstanding during the period. Diluted EPS is determined
by adjusting the profit or loss attributable to shareholders and the weighted average number of
common shares outstanding for the effects of all dilutive potential common shares, which comprise
convertible personnel debentures, restricted shares and share options granted to employees.
Revenue recognition
Revenue for sale of goods is recognized when the significant risks and rewards of ownership have
been transferred to the buyer, recovery of the consideration is probable, the associated costs and
possible return of the goods can be estimated reliably, there is no continuing involvement with
goods, and the amount of revenue can be measured reliably.
Transfer of risks and rewards varies depending on the individual terms of the contract of sale. For
consumer-type products in the Sectors Lighting and Consumer Lifestyle, these criteria are generally
met at the time the product is shipped and delivered to the customer and, depending on the delivery
conditions, title and risk have passed to the customer and acceptance of the product, when
contractually required, has been obtained, or, in cases where such acceptance is not contractually
required, when management has established that all aforementioned conditions for revenue
recognition have been met. Examples of the above-mentioned delivery conditions are Free on Board
point of delivery and Costs, Insurance Paid point of delivery, where the point of delivery may
be the shipping warehouse or any other point of destination as agreed in the contract with the
customer and where title and risk in the goods pass to the customer.
Revenues of transactions that have separately identifiable components are recognized based on their
relative fair values. These transactions mainly occur in the Healthcare sector and include
arrangements that require subsequent installation and training activities in order to become
operable for the customer. However, since payment for the equipment is typically contingent upon
the completion of the installation process, revenue recognition is deferred until the installation
has been completed and the product is ready to be used by the customer in the way contractually
agreed.
Revenues are recorded net of sales taxes, customer discounts, rebates and similar charges. For
products for which a right of return exists during a defined period, revenue recognition is
determined based on the historical pattern of actual returns, or in cases where such information is
not available, revenue recognition is postponed until the return period has lapsed. Return policies
are typically based on customary return arrangements in local markets.
For products for which a residual value guarantee has been granted or a buy-back arrangement has
been concluded, revenue recognition takes place in accordance with the requirements for lease
accounting of IAS 17 Leases. Shipping and handling costs billed to customers are recognized as
revenues. Expenses incurred for shipping and handling costs of internal movements of goods are
recorded as cost of sales. Shipping and handling costs related to sales to third parties are
recorded as selling expenses and disclosed separately. Service revenue related to repair and
maintenance activities for goods sold is recognized ratably over the service period or as services
are rendered.
A provision for product warranty is made at the time of revenue recognition and reflects the
estimated costs of replacement and free-of-charge services that will be incurred by the Company
with respect to the products. The customer has the option to purchase such an extension, which is
subsequently billed to the customer. Revenue recognition occurs on a straight-line basis over the
contract period.
Royalty income, which is generally earned based upon a percentage of sales or a fixed amount per
product sold, is recognized on an accrual basis.
Government grants are recognized as income as qualified expenditures are made, except for grants
relating to purchases of assets, which are deducted from the cost of the assets.
Employee benefit accounting
The net pension asset or liability recognized in the balance sheet in respect of defined-benefit
postemployment plans is the fair value of plan assets less the present value of the projected
defined-benefit obligation at the balance sheet date, together with adjustments for projected
unrecognized past service costs. The projected defined- benefit obligation is calculated annually
by qualified actuaries using the projected unit credit method. Recognized assets are limited to the
present value of any reductions in future contributions or any future refunds, in accordance with
IFRIC Interpretation 14 The Limit on a Defined Benefit Asset, Minimum Funding Requirements and
their Interaction.
For the Companys major plans, a full discount rate curve of high-quality corporate bonds
(Bloomberg AA Composite) is used to determine the defined-benefit obligation whereas for the other
plans, a single-point discount rate is used based on the plans maturity. Plans in countries
without a deep corporate bond market use a discount rate based on the local sovereign curve and the
plans maturity.
Pension costs in respect of defined-benefit postemployment plans primarily represent the increase
of the actuarial present value of the obligation for postemployment benefits based on employee
service during the year and the interest on this obligation in respect of employee service in
previous years, net of the expected return on plan assets.
210 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
non-US GAAP information
|
|
254
|
|
Corporate governance
|
|
262
|
|
Ten-year overview
|
|
266
|
|
Investor information |
Actuarial gains and losses arise mainly from changes in actuarial assumptions and differences
between actuarial assumptions and what has actually occurred. The Company recognizes all actuarial
gains and losses directly in equity through the statement of recognized income and expense.
To the extent that postemployment benefits vest immediately following the introduction of a change
to a defined-benefit plan, the resulting past service costs are recognized immediately.
Obligations for contributions to defined-contribution pension plans are recognized as an expense in
the income statement as incurred.
In certain countries, the Company also provides postretirement benefits other than pensions. The
costs relating to such plans consist primarily of the present value of the benefits attributed on
an equal basis to each year of service, interest cost on the accumulated postretirement benefit
obligation, which is a discounted amount, and amortization of the unrecognized transition
obligation.
Share-based payment
The Company recognizes the estimated fair value, measured as of grant date of equity instruments
granted to employees as compensation expense over the vesting period on a straight-line basis,
taking into account expected forfeitures. The Company uses the Black-Scholes option-pricing model
to determine the fair value of the equity instruments.
The fair value of the amount payable to employees in respect of share appreciation rights, which
are settled in cash, is recognized as an expense, with a corresponding increase in liabilities,
over the vesting period. The liability is remeasured at each reporting date and at settlement date.
Any changes in fair value of the liability are recognized as personnel expense in the statement of
income.
Income tax
Income tax comprises current and deferred tax. Income tax is recognized in the statement of income
except to the extent that it relates to an item recognized directly within equity, in which case
the tax effect is recognized in equity as well. Current tax is the expected tax payable on the
taxable income for the year, using tax rates enacted or substantially enacted at the balance sheet
date, and any adjustment to tax payable in respect of previous years. Deferred tax assets and
liabilities are recognized, using the balance sheet method, for the expected tax consequences of
temporary differences between the tax base of assets and liabilities and their carrying amounts for
financial reporting purposes. Deferred tax is not recognized for the following temporary
differences: the initial recognition of goodwill, the initial recognition of assets and liabilities
in a transaction that is not a business combination and that affects neither accounting nor taxable
profit, and differences relating to investments in subsidiaries to the extent that they probably
will not reverse in the foreseeable future. Measurement of deferred tax assets and liabilities is
based upon the enacted or substantially enacted tax rates expected to apply to taxable income in
the years in which those temporary differences are expected to be recovered or settled. Deferred
tax assets, including assets arising from loss carry-forwards, are recognized if it is probable
that the asset will be realized. Deferred tax assets are reviewed each reporting date and reduced
to the extent that it is no longer probable that sufficient taxable income will be available to
allow all or part of the asset to be recovered. Deferred tax assets and liabilities are not
discounted.
Deferred tax liabilities for withholding taxes are recognized for subsidiaries in situations where
the income is to be paid out as dividend in the foreseeable future, and for undistributed earnings
of unconsolidated companies to the extent that these withholding taxes are not expected to be
refundable and deductible. Changes in tax rates are reflected in the period when the change has
been enacted or substantively enacted by the balance sheet date.
Leases
Leases in which a significant portion of the risks and rewards of ownership are retained by the
lessor are classified as operating leases. Payments made under operating leases are recognized in
the statement of income on a straight-line basis over the term of the lease. Leases in which the
Company has substantially all the risks and rewards of ownership are classified as finance leases.
Finance leases are capitalized at the leases commencement at the lower of the fair value of the
leased property and the present value of the minimum lease payments. Each lease payment is
allocated between the liability and finance charges so as to achieve a constant rate of interest on
the finance balance outstanding. The corresponding rental obligations, net of finance charges, are
included in other short-term and other non-current liabilities. The property, plant and equipment
acquired under finance leases is depreciated over the shorter of the useful life of the assets and
the lease term.
Derivative financial instruments
The Company uses derivative financial instruments principally to manage its foreign currency risks
and, to a more limited extent, for managing interest rate and commodity price risks. All derivative
financial instruments are classified as current assets or liabilities based on their maturity dates
and are accounted for at trade date. Embedded derivatives are separated from the host contract and
accounted for separately if required by IAS 39 Financial Instruments: Recognition and Measurement.
The Company measures all derivative financial instruments based on fair values derived from market
prices of the instruments or from option pricing models, as appropriate. Gains or losses arising
from changes in fair value of derivatives are recognized in the statement of income, except for
derivatives that are highly effective and qualify for cash flow or net investment hedge accounting.
Changes in the fair value of a derivative that is highly effective and that is designated and
qualifies as a fair value hedge, along with the loss or gain on the hedged asset, or liability or
unrecognized firm commitment of the hedged item that is attributable to the hedged risk, are
recorded in the statement of income.
Changes in the fair value of a derivative that is highly effective and that is designated and
qualifies as a cash flow hedge, are recorded in equity, until statement of income is affected by
the variability in cash flows of the designated hedged item. To the extent that the hedge is
ineffective, changes in the fair value are recognized in the statement of income.
The Company formally assesses, both at the hedges inception and on an ongoing basis, whether the
derivatives that are used in hedging transactions are highly effective in offsetting changes in
fair values or cash flows of hedged items. When it is established that a derivative is not highly
effective as a hedge or that it has ceased to be a highly effective hedge, the Company discontinues
hedge accounting prospectively. When hedge accounting is discontinued because it has been
established that the derivative no longer qualifies as an effective fair value hedge, the Company
continues to carry the derivative on the balance sheet at its fair value, and no longer adjusts the
hedged asset or liability for changes in fair value.
When hedge accounting is discontinued because it is expected that a forecasted transaction will not
occur, the Company continues to carry the derivative on the balance sheet at its fair value, and
gains and losses that were accumulated in equity are recognized immediately in the income
statement. If there is a delay and it is expected that the transaction will still occur, the amount
in equity remains there until the forecasted transaction affects income. In all other situations in
which hedge accounting is discontinued, the Company continues to carry the derivative at its fair
value on the balance sheet, and recognizes any changes in its fair value in the statement of
income. For interest rate swaps designated as a fair value hedge of an interest bearing asset or
liability that are unwound, the amount of the fair value adjustment to the asset or liability for
the risk being hedged is released to the income statement over the remaining life of the asset or
liability based on the recalculated effective yield.
Foreign currency differences arising on the retranslation of a financial liability designated as a
hedge of a net investment in a foreign operation are recognized directly as a separate component of
equity, to the extent that the hedge is effective. To the extent that the hedge is ineffective,
such differences are recognized in the statement of income.
Non-derivative financial instruments
Non-derivative financial instruments are recognized initially at fair value when the Company
becomes a party to the contractual provisions of the instrument. They are derecognized if the
Companys contractual rights to the cash flows from the financial instruments expire or if the
Company transfers the financial instruments to another party without retaining control or
substantially all risks and rewards of the instruments. Regular way purchases and sales of
financial instruments are accounted for at trade date. Dividend and interest income are recognized
when earned. Gains or losses, if any, are recorded in financial income and expenses.
Cash and cash equivalents
Cash and cash equivalents include all cash balances and short-term highly liquid investments with
an original maturity of three months or less that are readily convertible into known amounts of
cash. They are stated at face value which approximates fair value.
Receivables
Trade accounts receivable are carried at the lower of amortized cost or the present value of
estimated future cash flows, taking into account
Philips
Annual Report 2008 211
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124
|
|
US GAAP financial statements
|
|
180
|
|
Sustainability performance
|
|
192
|
|
IFRS financial statements
Significant IFRS accounting
policies
|
|
244
|
|
Company financial statements |
discounts given or agreed. The present value of estimated future cash flows is determined through
the use of allowances for uncollectible amounts. As soon as individual trade accounts receivable
can no longer be collected in the normal way and are expected to result in a loss, they are
designated as doubtful trade accounts receivable and valued at the expected collectible amounts.
They are written off when they are deemed to be uncollectible because of bankruptcy or other forms
of receivership of the debtors. The allowance for the risk of non-collection of trade accounts
receivable takes into account credit-risk concentration, collective debt risk based on average
historical losses, and specific circumstances such as serious adverse economic conditions in a
specific country or region.
In the event of sale of receivables and factoring, the Company derecognizes receivables when the
Company has given up control or continuing involvement.
Long-term receivables are initially recognized at their present value using an appropriate interest
rate. Any discount is amortized to income over the life of the receivable using the effective
yield.
Investments in equity-accounted investees
Investments in companies in which the Company does not have the ability to directly or indirectly
control the financial and operating decisions, but does possess the ability to exercise significant
influence, are accounted for using the equity method. Generally, in the absence of demonstrable
proof of significant influence, it is presumed to exist if at least 20% of the voting stock is
owned. The Companys share of the net income of these companies is included in results relating to
equity-accounted investees in the consolidated statements of income. When the Companys share of
losses exceeds its interest in an equity-accounted investee, the carrying amount of that interest
(including any long-term loans) is reduced to nil and recognition of further losses is discontinued
except to the extent that the Company has incurred legal or constructive obligations or made
payments on behalf of an associate. Unrealized gains on transactions between the Company and its
equity-accounted investees are eliminated to the extent of the Companys interest in the
associates. Unrealized losses are also eliminated unless the transaction provides evidence of an
impairment of the asset transferred.
Investments in equity-accounted investees include loans from the Company to these investees.
Investments in equity-accounted investees also included goodwill identified on acquisition, net of
any accumulated impairment loss.
Accounting for capital transactions of a consolidated subsidiary or an equity-accounted investee
The Company recognizes dilution gains or losses arising from the sale or issuance of stock by a
consolidated subsidiary or an equity-accounted investee in the income statement, unless the
Company or the subsidiary either has reacquired or plans to reacquire such shares. In such
instances, the result of the transaction will be recorded directly in equity.
The dilution gains or losses are presented in a separate line in the income statement if they
relate to consolidated subsidiaries. Dilution gains and losses related to equity-accounted
investees are presented under Results relating to equity-accounted investees in the consolidated
statement of income.
Other non-current financial assets
Other non-current financial assets include available-for-sale securities, held-to-maturity
securities, loans and cost-method investments.
The Company classifies its investments in equity securities that have readily determinable fair
values as either available-for-sale or for trading purposes. Trading securities are acquired and
held principally for the purpose of selling them in the short term and are presented as Other
current assets. Trading securities are recorded at fair value with changes in the fair value
recorded in financial income and expense.
Held-to-maturity securities are those debt securities which the Company has the ability and intent
to hold until maturity. Held-to-maturity debt securities are recorded at amortized cost, adjusted
for the amortization or accretion of premiums or discounts using the effective interest method.
All securities not included in trading or held-to-maturity are classified as available-for-sale.
Available-for-sale securities are recorded at fair value. Unrealized holding gains and losses, net
of the related tax effect, on available-for-sale equity securities are reported as a separate
component of equity until realized. Realized gains and losses from the sale of available-for-sale
securities are determined on a first-in, first-out basis. For available-for-sale securities hedged
under a fair value hedge, the changes in the fair value that are attributable to the risk which is
being hedged are recognized in the income statement rather than in equity.
Loans receivable are stated at amortized cost, less the related allowance for impaired loans
receivable.
Investments in privately held companies that are not equity-accounted investees, and do not have a
quoted market price in an active market and whose fair value could not be reliably determined are
carried at cost.
Impairment of financial assets
A financial asset is considered to be impaired if objective evidence indicates that one or more
events have had a negative effect on the estimated future cash flows of that asset. In case of
available-for-sale securities, a significant or prolonged decline in the fair value of the security
below its cost is considered an indicator that the securities are impaired. If any such evidence
exists for available-for-sale financial assets, the cumulative loss measured as the difference
between the acquisition cost and the current fair value, less any impairment loss on that financial
asset previously recognized in the income statement is removed from equity and recognized in the
income statement.
If objective evidence indicates that cost-method investments need to be tested for impairment,
calculations are based on information derived from business plans and other information available
for estimating their fair value. Any impairment loss is charged to the income statement.
An impairment loss related to financial assets is reversed if and to the extent there has been a
change in the estimates used to determine the recoverable amount. The loss is reversed only to the
extent that the assets carrying amount does not exceed the carrying amount that would have been
determined, if no impairment loss had been recognized. Reversals of impairment are recognized in
net income except for reversals of impairment of available-for-sale equity securities, which are
recognized in equity.
Inventories
Inventories are stated at the lower of cost or net realizable value, less advance payments on work
in progress. The cost of inventories comprises all costs of purchase, costs of conversion and other
costs incurred in bringing the inventories to their present location and condition. The costs of
conversion of inventories include direct labor and fixed and variable production overheads, taking
into account the stage of completion and the normal capacity of production facilities. Costs of
idle facility and waste are expensed. The cost of inventories is determined using the first-in,
first-out (FIFO) method. Inventory is reduced for the estimated losses due to obsolescence. This
reduction is determined for groups of products based on purchases in the recent past and/or
expected future demand.
Property, plant and equipment
Property, plant and equipment is stated at cost, less accumulated depreciation. Assets manufactured
by the Company include direct manufacturing costs, production overheads and interest charges
incurred for qualifying assets during the construction period. Government grants are deducted from
the cost of the related asset. Depreciation is calculated using the straight-line method over the
useful life of the asset. Depreciation of special tooling is generally also based on the
straight-line method. Gains and losses on the sale of property, plant and equipment are included in
other business income. Costs related to repair and maintenance activities are expensed in the
period in which they are incurred unless leading to an extension of the original lifetime or
capacity.
Plant and equipment under finance leases and leasehold improvements are amortized using the
straight-line method over the shorter of the lease term or the estimated useful life of the asset.
The gain realized on sale and operating leaseback transactions that are concluded based upon market
conditions is recognized at the time of the sale.
The Company capitalizes interest as part of the cost of assets that take a substantial period of
time to get ready for use.
212 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
non-US GAAP information
|
|
254
|
|
Corporate governance
|
|
262
|
|
Ten-year overview
|
|
266
|
|
Investor information |
Intangible assets other than goodwill
Acquired definite-lived intangible assets are amortized using the straight-line method over their
estimated useful life. The useful lives are evaluated every year. Brands acquired from third
parties that are expected to generate cash inflows during a period without a foreseeable limit, are
regarded as intangible assets with an indefinite useful life. These brands are not amortized, but
tested for impairment annually or whenever an impairment trigger indicates that the asset may be
impaired. Patents and trademarks acquired from third parties either separately or as part of the
business combination are capitalized at cost and amortized over their remaining useful lives.
The Company expenses all research costs as incurred. Expenditure on development activities, whereby
research findings are applied to a plan or design for the production of new or substantially
improved products and processes, is capitalized as an intangible asset if the product or process is
technically and commercially feasible and the Company has sufficient resources and the intention to
complete development.
The development expenditure capitalized includes the cost of materials, direct labor and an
appropriate proportion of overheads. Other development expenditures and expenditures on research
activities are recognized in the income statement as an expense as incurred. Capitalized
development expenditure is stated at cost less accumulated amortization and impairment losses.
Amortization of capitalized development expenditure is charged to the income statement on a
straight-line basis over the estimated useful lives of the intangible assets. The useful lives for
the intangible development assets are from three to five years.
Costs relating to the development and purchase of software for both internal use and software
intended to be sold are capitalized and subsequently amortized over the estimated useful life of
three years.
Impairment of non-financial assets other than goodwill, inventories and deferred tax assets
Non-financial assets other than goodwill, inventories and deferred tax assets are reviewed for
impairment whenever events or changes in circumstances indicate that the carrying amount of an
asset may not be recoverable. Recoverability of assets to be held and used is recognized and
measured by a comparison of the carrying amount of an asset with the greater of its value in use
and its fair value less cost to sell. Value in use is measured as the present value of future cash
flows expected to be generated by the asset. If the carrying amount of an asset is not recoverable,
an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds
the recoverable amount. The review for impairment is carried out at the level where discrete cash
flows occur that are independent of other cash flows.
An impairment loss related to intangible assets other than goodwill, tangible fixed assets,
inventories and equity-accounted investees is reversed if and to the extent there has been a change
in the estimates used to determine the recoverable amount. The loss is reversed only to the extent
that the assets carrying amount does not exceed the carrying amount that would have been
determined, net of depreciation or amortization, if no impairment loss had been recognized.
Reversals of impairment are recognized in the statement of income.
Goodwill
Goodwill represents the excess of the cost of an acquisition over the fair value of the Companys
share of the net identifiable assets of the acquired subsidiary/equity-accounted investee at the
date of acquisition. Goodwill is measured at cost less accumulated impairment losses. In respect of
equity-accounted investees, the carrying amount of goodwill is included in the carrying amount of
the investment.
Impairment of goodwill
Goodwill is not amortized but tested for impairment annually and whenever impairment indicators
require. In most cases the Company identified its cash generating units as one level below that of
an operating sector. Cash flows at this level are substantially independent from other cash flows
and this is the lowest level at which goodwill is monitored by the Board of Management. The Company
performed and completed annual impairment tests in the same quarter of all years presented in the
consolidated statements of income. A goodwill impairment loss is recognized in the statement of
income whenever and to the extent that the carrying amount of a cash-generating unit exceeds the
recoverable amount of that unit.
Share capital
Incremental costs directly attributable to the issuance of shares are recognized as a deduction
from equity. When share capital recognized as equity is repurchased, the amount of the
consideration paid, including directly attributable costs, is recognized as a deduction from
equity. Repurchased shares are classified as treasury shares and are presented as a deduction from
stockholders equity.
Debt and other liabilities
Debt and liabilities other than provisions are stated at amortized cost. However, loans that are
hedged under a fair value hedge are remeasured for the changes in the fair value that are
attributable to the risk that is being hedged.
Provisions
Provisions are recognized if, as a result of a past event, the Company has a present legal or
constructive obligation that can be estimated reliably, and it is probable that an outflow of
economic benefits will be required to settle the obligation.
Provisions are measured at the present value of the expenditures expected to be required to settle
the obligation using a pre-tax discount rate that reflects current market assessments of the time
value of money and the risks specific to the obligation. The increase in the provision due to
passage of time is recognized as interest expense.
The Company accrues for losses associated with environmental obligations when such losses are
probable and can be estimated reliably. Measurement of liabilities is based on current legal and
constructive requirements. Liabilities and expected insurance recoveries, if any, are recorded
separately. The carrying amount of liabilities is regularly reviewed and adjusted for new facts and
changes in law.
Restructuring
The provision for restructuring relates to the estimated costs of initiated reorganizations that
have been approved by the Board of Management, and which involve the realignment of certain parts
of the industrial and commercial organization. When such reorganizations require discontinuance
and/or closure of lines of activities, the anticipated costs of closure or discontinuance are
included in restructuring provisions. A liability is recognized for those costs only when the
Company has a detailed formal plan for the restructuring and has raised a valid expectation with
those affected that it will carry out the restructuring by starting to implement that plan or
announcing its main features to those affected by it.
Guarantees
The Company recognizes a liability at the fair value of the obligation at the inception of a
financial guarantee contract. The guarantee is subsequently measured at the higher of the best
estimate of the obligation or the amount initially recognized.
IFRS accounting standards adopted as from 2008
IAS 23 (Amendment) Borrowing costs
The Company has early adopted the amendment to IAS 23 on January 1, 2008. The amendment removes the
option of immediately recognizing as an expense borrowing costs that relate to assets that take a
substantial period of time to get ready for use or sale. The adoption of this amendment did not
have any impact on the Companys IFRS financial statements as the Company already capitalizes
borrowing costs relating to assets that take a substantial period of time to get ready for use or
sale.
Amendments to IAS 39 Reclassification of Financial Instruments Recognition and Measurement and
IFRS 7 Financial instruments disclosures
The amendments to IAS 39 and IFRS 7 which were issued in October 2008, permit an entity to
reclassify non-derivative financial assets (other than those designated at fair value through
profit or loss by the entity upon initial recognition) out of the fair value through profit or loss
category in particular circumstances. The amendment also permits an entity to transfer from the
available-for-sale category to the loans and receivables category a financial asset that would have
met the definition of loans and receivables (if the financial asset had not been designated as
available for sale), if the entity has the intention and ability to hold that financial asset for
the foreseeable future. These amendments were adopted by the Company on July 1, 2008. Any
reclassification of a financial asset in periods beginning on or after November 1, 2008 took effect
only from the date when the reclassification is made. The application of these amendments did not
have any impact on the Companys consolidated financial statements.
Philips Annual Report 2008 213
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124
|
|
US GAAP financial statements
|
|
180
|
|
Sustainability performance
|
|
192
|
|
IFRS financial statements
Significant IFRS accounting policies
|
|
244
|
|
Company financial statements |
IFRIC Interpretation 11 Group and Treasury Share Transactions
IFRIC 11 requires a share-based payment arrangement in which an entity receives goods or services
as consideration for its own equity instruments to be accounted for as an equity-settled
share-based payment transaction, regardless of how the equity instruments are obtained. IFRIC 11
was applied by the Company in its 2008 financial statements. The application of IFRIC 11 did not
have any impact on the Companys consolidated financial statements.
IFRIC Interpretation 12 Service Concession Arrangements
IFRIC 12 provides guidance on certain recognition and measurement issues that arise in accounting
for public-to-private service concession arrangements. IFRIC 12 was applied by the Company on
January 1, 2008. IFRIC 12 did not have a material impact on the Companys consolidated financial
statements.
IFRIC Interpretation 14 The Limit on a Defined Benefit Asset, Minimum Funding Requirements and
their Interaction
IFRIC 14 addresses (1) when refunds or reductions in future contributions should be regarded as
available in the context of paragraph 58 of IAS 19 Employee Benefits; (2) how a minimum funding
requirement might affect the availability of reductions in future contributions; and (3) when a
minimum funding requirement might give rise to a liability. This interpretation was applied by the
Company on January 1, 2008. The effect of the application of this Interpretation is disclosed in
Note 56 to the IFRS financial statements.
IFRS accounting standards effective as from 2009 and onwards
A number of amendments and revisions
to standards and interpretations are not yet effective for the year ended December 31, 2008, and
have not been applied in preparing these consolidated financial statements:
Amendments to IAS 1 Presentation of Financial Statements
The amendments to IAS 1 mainly concern the presentation of changes in equity, in which changes as a
result of the transaction with shareholders should be presented separately and for which a
different format of the overview of the changes in equity can be selected. Furthermore, an opening
balance sheet of the corresponding period is presented where restatements have occurred. Philips
has chosen to present all non-owner changes in equity in two statements (a separate income
statement and a statement of comprehensive income). This Standard is applicable to the Company on
January 1, 2009.
Amendments to IAS 32 Financial instruments: Presentation and IAS 1 Presentation of Financial
Statements Puttable Financial Instruments and Obligations Arising on Liquidation
The amendments to IAS 32 and IAS 1 are relevant to entities that have issued financial instruments
that are (i) puttable financial instruments or (ii) instruments, or components of instruments, that
impose on the entity an obligation to deliver to another party a pro-rata share of the net assets
of the entity on liquidation. Under the revised IAS 32, subject to specified criteria being met,
these instruments will be classified equity. These amendments are applicable to the Company on
January 1, 2009. The Company expects that application of this amendment will not have a material
impact on the Companys consolidated financial statements.
Amendment to IAS 39 Financial Instruments: Recognition and Measurement Eligible Hedged Items
The amendment to IAS 39 provides additional guidance on the designation of a hedged item. The
amendment clarifies how the existing principles underlying hedge accounting should be applied in
two particular situations. It clarifies the designation of a one-sided risk in a hedged item and
inflation in a financial hedged item. This amendment is applicable to the Company on January 1,
2010. The application of this amendment will not have a material impact on the Companys
consolidated financial statements.
Amendments to IFRS 1 and IAS 27 Cost of an investment on first-time adoption
The amendments to IFRS 1 and IAS 27, which will be applicable to the Company on January 1, 2009,
allows first-time adopters to use a deemed cost of either fair value or the carrying amount under
previous accounting practice to measure the initial cost of investments in subsidiaries, jointly
controlled entities and associates in the separate financial statements. The amendment also removed
the definition of the cost method from IAS 27 and replaced with a requirement to present dividends
as income in the separate financial statements of the investor. This standard does not have any
impact on the Companys consolidated financial statements.
Revision to IFRS 1 First-time Adoption of IFRSs
The revision to IFRS 1 improves the structure of the Standard but does contain any technical
changes. The revisions are designed to make the Standard clearer and easier to follow and to better
accommodate future changes to the Standard. This revision is applicable to the Company on January
1, 2010 but will not have an impact on the Companys consolidated financial statements.
Amendments to IFRS 2 Share-based Payment Vesting Conditions and Cancellations
The amendments to IFRS 2, which will be applicable to the Company on January 1, 2009, clarify the
definition of vesting conditions and the accounting treatment of cancellations by the counterparty
to a shared-based arrangement. The Company expects that this amendment will not have a material
impact on the Companys consolidated financial statements.
Revision to IFRS 3 Business Combinations
The revised standard incorporates the following changes that are likely to be relevant to the
Companys operations:
|
|
The definition of a business has been broadened, which is likely to result in more acquisitions
being treated as business combinations. |
|
|
|
Contingent consideration will be measured at fair value, with the subsequent changes therein
recognized in statement of income. |
|
|
|
Transaction costs, other than share and debt issue costs, will be expensed as incurred. |
|
|
|
Any pre-existing interest in the acquiree will be measured at fair value with gain or loss
recognized in the income statement. |
|
|
|
Any non-controlling (minority) interest will be measured at either fair value, or at its
proportionate interest in the identifiable assets and liabilities of the acquiree, on a
transaction-by-transaction basis. |
The revision to IFRS 3 is mandatory for the Companys business combinations beginning January 1,
2010 and will have no impact on prior periods.
Amendments to IAS 27 Consolidated and Separate Financial Statements
The amendments to IAS 27 require accounting for changes in ownership interest by the Company in a
subsidiary, while maintaining control, to be recognized as an equity transaction. When the Company
loses control of a subsidiary, any interest retained in the former subsidiary will be measured at
fair value with the gain or loss recognized in the statement of income. The amendments to IAS 27
will be applicable to the Company on January 1, 2010. These are not expected to have significant
impact on the consolidated financial statements.
Improvements to IFRS 2008
The improvements published under the IASBs annual improvement process are intended to deal with
non-urgent, minor amendments to the standards. Most of the improvements are applicable to the
Company on January 1, 2010, some on January 1, 2009.
The improvements to IFRS 2008 relate mainly to the following:
|
|
Disclosure requirements: Classification as held for sale of the assets and liabilities of a
subsidiary where the parent is commited to a plan to sell its controlling interest but intends to
retain a non-controlling interest. |
|
|
|
Reclass to inventories of PP&E previously held for rental when the assets cease to be rented and
are held for sale, and the recognition of the proceeds of disposal of such assets as revenue. |
|
|
|
Recognition of a government grant arising from government loans at below-market interest. |
|
|
|
Recognition of advertising and promotional expenditure as an asset is not permitted beyond the
point at which the entity has the right to access the goods purchased or services received. |
|
|
|
Classification of property under construction for investment purposes as investment property
under IAS 40. |
The Company has not yet determined the potential impact of those improvements.
IFRIC Interpretation 13 Customer Loyalty Programmes
IFRIC 13 addresses recognition and measurement of the obligation to provide free or discounted
goods or services in the future. This interpretation will be applicable to the Company on January
1, 2009. The application of this interpretation will not have a material impact on the Companys
consolidated financial statements.
214 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
non-US GAAP information
|
|
254
|
|
Corporate governance
|
|
262
|
|
Ten-year overview
|
|
266
|
|
Investor information |
IFRIC Interpretation 15 Agreements for the Construction of Real Estate
IFRIC 15 applies to the accounting for revenue and associated expenses by entities that undertake
the construction of real estate directly or through subcontractors. Agreements in the scope of this
Interpretation are agreements for the construction of real estate. In addition to the construction
of real estate, such agreements may include the delivery of other goods or services. This
Interpretation will be applicable to the Company on January 1, 2009. The application of this
interpretation will not have a material impact on the Companys consolidated financial statements.
IFRIC 16 Hedges of a Net Investment in Foreign Operations
IFRIC 16 applies to an entity that hedges the foreign currency risk arising from its net
investments in foreign operations and wishes to qualify for hedge accounting in accordance with IAS
39. It does not apply to other types of hedge accounting. The main expected change in practice is
to eliminate the possibility of an entity applying hedge accounting for a hedge of the foreign
exchange differences between the functional currency of a foreign operation and the presentation
currency of the parents consolidated financial statements. This interpretation is applicable to
the Company on January 1, 2009. The current accounting practice of Philips is consistent with this
amendment.
IFRIC 17 Distributions of Non-cash Assets to Owners
IFRIC 17 clarifies that dividends payable should be recognized when the dividend is appropriately
authorized and is no longer at the discretion of the entity and should measure the dividend payable
at the fair value of the net assets to be distributed. It also provides that an entity should
recognize the difference between the dividend paid and the carrying amount of the net assets
distributed in the statements of income. IFRIC 17 is applicable to the Company on January 1, 2010.
The application of this interpretation will not have a material impact on the Companys
consolidated financial statements.
IFRIC 18 Transfers of Assets from Customers
IFRIC 18 clarifies the requirements of IFRS for agreements in which an entity receives from a
customer an item of property, plant and equipment that the entity must then use either to connect
the customer to a network or to provide the customer with ongoing access to a supply of goods or
services (such as a supply of electricity, gas or water). The interpretation is applicable on
January 1, 2010. The application of this IFRIC will not have a material impact on the Companys
consolidated financial statements.
Philips Annual Report 2008 215
|
|
|
|
|
|
|
124
US GAAP financial statements
|
|
180
Sustainability performance
|
|
192
IFRS financial statements
Notes to the IFRS financial
statements
|
|
244
Company financial statements |
Notes to the IFRS consolidated
financial statements of the Philips
Group
All amounts in millions of euros unless
otherwise stated. The US GAAP notes 33 and 34
are deemed incorporated and repeated herein
by reference
38
Discontinued operations
MedQuist
On August 6, 2008, the Company announced that
it had completed the sale of its approximately
70% ownership interest in MedQuist to
CBaySystems Holdings (CBAY) for a consideration
of USD 287 million. The consideration was
composed of a cash payment of USD 98 million, a
promissory note of USD 26 million, a
convertible bond of USD 91 million, and a
pre-closing cash dividend of USD 72 million.
The promissory note is included in Other
receivables, the convertible bond in Other
non-current financial assets.
The financial results attributable to the
Companys interest in MedQuist have been
presented as discontinued operations. The
decision to proceed with the sale, which was
made in 2007, resulted in an impairment of EUR
16 million in 2007. This charge did not affect
equity as it related to the cumulative
translation differences of the USD-denominated
investment in MedQuist, which accumulated
within equity since the adoption of IFRS.
The following table summarizes the results of
the MedQuist business included in the
consolidated statements of income as
discontinued operations for 2006, 2007 and
2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Sales |
|
|
293 |
|
|
|
244 |
|
|
|
128 |
|
Costs and expenses |
|
|
(304 |
) |
|
|
(271 |
) |
|
|
(131 |
) |
Gain on sale of discontinued operations |
|
|
|
|
|
|
|
|
|
|
15 |
|
Impairment charge |
|
|
|
|
|
|
(63 |
)1) |
|
|
|
|
Income (loss) before taxes |
|
|
(11 |
) |
|
|
(90 |
) |
|
|
12 |
|
Income taxes |
|
|
29 |
|
|
|
(8 |
) |
|
|
(3 |
) |
Result of equity-accounted investees |
|
|
|
|
|
|
1 |
|
|
|
|
|
Minority interests |
|
|
|
|
|
|
4 |
|
|
|
1 |
|
Results from discontinued operations |
|
|
18 |
|
|
|
(93 |
) |
|
|
10 |
|
|
|
|
1) |
|
Including EUR 47 million following the 2007 annual impairment test. |
The following table presents the assets and
liabilities of the MedQuist business,
classified as discontinued operations, in the
consolidated balance sheets as at December 31,
2007:
|
|
|
|
|
|
|
2007 |
|
Cash and cash equivalents |
|
|
108 |
|
Accounts receivable |
|
|
41 |
|
Equity-accounted investees |
|
|
4 |
|
Property, plant and equipment |
|
|
16 |
|
Intangible assets including goodwill |
|
|
127 |
|
Other assets |
|
|
23 |
|
Assets of discontinued operations |
|
|
319 |
|
|
|
|
|
|
Accounts payable |
|
|
9 |
|
Provisions |
|
|
32 |
|
Other liabilities |
|
|
37 |
|
Liabilities of discontinued operations |
|
|
78 |
|
Semiconductors
On September 29, 2006, the Company sold a
majority stake in its Semiconductors division
to a private equity consortium led by Kohlberg
Kravis Robert & Co. (KKR). The transaction
consisted of the sale of the division for a
total consideration of EUR 7,913 million and a
simultaneous acquisition of a minority interest
in the recapitalized organization NXP
Semiconductors (NXP) at a cost of EUR 854
million. A gain of EUR 3,683 million was
recorded on the sale, net of taxes, and net of
costs directly associated with this transaction
of approximately EUR 68 million.
The operations of the Semiconductors division
and the aforementioned gain have been presented
as discontinued operations.
The Companys ownership interest in NXP is
19.8%. The Company cannot exert significant
influence over the operating or financial
policies of NXP and, accordingly, the
investment is accounted for under Other
non-current financial assets.
Philips and NXP have continuing relationships
through shared research and development
activities and through license agreements.
Additionally, through the purchase of
semiconductor products for the Consumer
Lifestyle sector, Philips and NXP will have a
continuing relationship for the foreseeable
future. The Company assessed the expected
future transactions and determined that the
cash flows from these transactions are not
significant direct cash flows.
The following table summarizes the results of
the Semiconductors division included in the
consolidated statements of income as
discontinued operations for the period through
its divestment on September 29, 2006. The 2007
results mainly relate to the settlement of the
transaction and various local income taxes.
The 2008 results mainly related to the
settlement of income taxes, largely
operational in nature.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Sales |
|
|
3,681 |
|
|
|
|
|
|
|
|
|
Costs and expenses |
|
|
(3,000 |
) |
|
|
(65 |
) |
|
|
|
|
Gain (loss) on sale of discontinued
operations |
|
|
4,323 |
|
|
|
15 |
|
|
|
(3 |
) |
Income (loss) before taxes |
|
|
5,004 |
|
|
|
(50 |
) |
|
|
(3 |
) |
Income taxes |
|
|
(790 |
) |
|
|
5 |
|
|
|
(4 |
) |
Result of equity- accounted investees |
|
|
(63 |
) |
|
|
|
|
|
|
|
|
Minority interests |
|
|
(49 |
) |
|
|
|
|
|
|
|
|
Results from discontinued operations |
|
|
4,102 |
|
|
|
(45 |
) |
|
|
(7 |
) |
Prior-period amounts have been restated to
reflect a change in accounting policy
related to pensions (see Significant
accounting policies, Change in accounting
policy).
The following table shows the components of
the gain from the sale of the Semiconductors
division, net of tax on December 31, 2006:
|
|
|
|
|
|
|
2006 |
|
Consideration |
|
|
7,913 |
|
Carrying value of net assets disposed |
|
|
(3,522 |
) |
Cost of disposal |
|
|
(68 |
) |
Gain on disposal before taxes |
|
|
4,323 |
|
Income taxes |
|
|
(640 |
) |
Gain on sale |
|
|
3,683 |
|
Philips Mobile Display Systems
On November 10, 2005, Philips and Toppoly
Optoelectronics Corporation of Taiwan
announced that they had signed a binding
letter of intent to merge Philips Mobile
Display Systems (MDS) business with
Toppoly. The Company was named TPO, and the
transaction was completed in the first half
of 2006.
Philips separately reported the results
of the MDS business as a discontinued
operation.
216 Philips Annual Report 2008
|
|
|
|
|
|
|
250 Reconciliation of
|
|
254 Corporate governance
|
|
262 Ten-year overview
|
|
266 Investor information |
non-US GAAP information |
|
|
|
|
|
|
The following table summarizes the results
of the MDS business included in the
consolidated statements of income as
discontinued operations for 2006, which
mainly relate to translation differences
upon completion of the transaction.
|
|
|
|
|
|
|
2006 |
|
Sales |
|
|
194 |
|
Costs and expenses |
|
|
(160 |
) |
Income (loss) from operations |
|
|
34 |
|
Financial income and expenses |
|
|
|
|
Income (loss) before taxes |
|
|
34 |
|
Income taxes |
|
|
|
|
Results from discontinued operations |
|
|
34 |
|
39
Acquisitions and divestments
2008
During 2008, Philips entered into a number
of acquisitions and completed several
divestments. All business combinations
have been accounted for using the purchase
method of accounting.
The major acquisitions in 2008 consisted of
Genlyte Group Inc. (Genlyte), Respironics Inc.
(Respironics) and VISICU Inc. (VISICU). The remaining
acquisitions, both individually and in the
aggregate, were deemed immaterial in
respect of the IFRS 3 disclosure
requirements.
Sales and income from operations related to
activities divested in 2008, included in the
Companys consolidated statement of income
for 2008, amounted to EUR 176 million and
nil, respectively.
The most significant acquisitions and
divestments are summarized in the next two
tables and described in the section below.
Acquisitions
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
net |
|
|
other |
|
|
|
|
|
|
net cash |
|
|
assets |
|
|
intangible |
|
|
|
|
|
|
outflow |
|
|
acquired1) |
|
|
assets |
|
|
goodwill |
|
Genlyte |
|
|
1,894 |
|
|
|
10 |
|
|
|
860 |
|
|
|
1,024 |
|
Respironics |
|
|
3,196 |
|
|
|
(152 |
) |
|
|
1,186 |
|
|
|
2,162 |
|
VISICU |
|
|
198 |
|
|
|
(10 |
) |
|
|
33 |
|
|
|
175 |
|
|
|
|
1) |
|
Excluding cash acquired |
Divestments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
inflow of |
|
|
|
|
|
|
|
|
|
cash and |
|
|
net assets |
|
|
recognized |
|
|
|
other assets1) |
|
|
divested |
|
|
gain (loss) |
|
Set-Top Boxes &
Connectivity Solutions |
|
|
742) |
|
|
|
(32 |
) |
|
|
42 |
|
Philips Speech Recognition
Systems |
|
|
653) |
|
|
|
(20 |
) |
|
|
45 |
|
|
|
|
1) |
|
Net of cash divested |
|
2) |
|
Assets received in lieu of cost (see note 66) |
|
3) |
|
Of which EUR 22 million cash |
Genlyte
On January 22, 2008, Philips completed the
purchase of all outstanding shares of Genlyte,
a leading manufacturer of lighting fixtures,
controls and related products for the
commercial, industrial and residential markets.
Through this acquisition Philips established a
solid platform for further growth in the area
of energy-saving and green lighting technology.
The acquisition created a leading position for
Philips in the North American luminaires
market. Philips paid total net cash
consideration of EUR 1,894 million. This amount
includes the cost of 331,627 shares previously
acquired in August 2007, the pay-off of certain
debt and the settlement of outstanding stock
options. The net impact of the Genlyte
acquisition on Philips liquidity position in
2008, excluding the pay-off of debt, was EUR
1,805 million. As of the acquisition date,
Genlyte has been consolidated as part of the
Lighting sector.
The condensed balance sheet of Genlyte
determined in accordance with IFRS,
immediately before and after the acquisition
date:
|
|
|
|
|
|
|
|
|
|
|
before |
|
|
after acquisition |
|
|
|
acquisition date |
|
|
date |
|
Assets and liabilities |
|
|
|
|
|
|
|
|
Goodwill |
|
|
254 |
|
|
|
1,024 |
|
Other intangible assets |
|
|
102 |
|
|
|
860 |
|
Property, plant and equipment |
|
|
129 |
|
|
|
191 |
|
Working capital |
|
|
134 |
|
|
|
160 |
|
Other current financial assets |
|
|
|
|
|
|
3 |
|
Deferred tax liabilities |
|
|
(12 |
) |
|
|
(300 |
) |
Provisions |
|
|
(18 |
) |
|
|
(36 |
) |
Cash |
|
|
57 |
|
|
|
57 |
|
|
|
|
|
|
|
|
|
|
|
|
|
646 |
|
|
|
1,959 |
|
Financed by |
|
|
|
|
|
|
|
|
Group equity |
|
|
568 |
|
|
|
1,951 |
|
Loans |
|
|
78 |
|
|
|
8 |
|
|
|
|
646 |
|
|
|
1,959 |
|
The goodwill recognized is related to the
complementary technological expertise and
talent of the Genlyte workforce and the
synergies expected to be achieved from
integrating Genlyte into the Lighting sector.
Other intangible assets are comprised of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
amortization |
|
|
|
amount |
|
|
period in years |
|
Core technology and designs |
|
|
81 |
|
|
|
1-8 |
|
In-process R&D |
|
|
11 |
|
|
|
5 |
|
Group brands |
|
|
142 |
|
|
|
2-14 |
|
Product brands |
|
|
5 |
|
|
|
2-5 |
|
Customer relationships and patents |
|
|
614 |
|
|
|
9-17 |
|
Order backlog |
|
|
6 |
|
|
|
0.25 |
|
Software |
|
|
1 |
|
|
|
3 |
|
|
|
|
860 |
|
|
|
|
|
Genlyte contributed income from operations
of EUR 34 million to the Group for the
period from January 22 to December 31, 2008.
Respironics
On March 10, 2008, Philips acquired 100% of the
shares of Respironics, a leading provider of
innovative solutions for the global sleep and
respiratory markets. Respironics designs,
develops, manufactures and markets medical
devices used
primarily for patients suffering from
Obstructive Sleep Apnea (OSA) and respiratory
disorders. The acquisition of Respironics added
new product categories in OSA and home
respiratory care to the existing Philips
business. This acquisition formed a solid
foundation for the Home Healthcare Solutions
business of the Company. Philips acquired
Respironics shares for a net cash
consideration of EUR 3,196 million. As of the
acquisition date, Respironics has been
consolidated as part of the Healthcare sector.
Philips Annual Report 2008 217
|
|
|
|
|
|
|
124
US GAAP financial statements
|
|
180
Sustainability performance
|
|
192
IFRS financial statements
Notes to the IFRS financial
statements
|
|
244
Company financial statements |
The condensed balance sheet of Respironics
determined in accordance with IFRS,
immediately before and after the acquisition
date:
|
|
|
|
|
|
|
|
|
|
|
before |
|
|
after acquisition |
|
|
|
acquisition date |
|
|
date |
|
Assets and liabilities |
|
|
|
|
|
|
|
|
Goodwill |
|
|
165 |
|
|
|
2,162 |
|
Other intangible assets |
|
|
39 |
|
|
|
1,186 |
|
Property, plant and equipment |
|
|
123 |
|
|
|
137 |
|
Working capital |
|
|
214 |
|
|
|
215 |
|
Other non-current financial assets |
|
|
11 |
|
|
|
10 |
|
Provisions |
|
|
(27 |
) |
|
|
(27 |
) |
Deferred tax assets/liabilities |
|
|
35 |
|
|
|
(439 |
) |
Cash |
|
|
135 |
|
|
|
135 |
|
|
|
|
695 |
|
|
|
3,379 |
|
|
|
|
|
|
|
|
|
|
Financed by |
|
|
|
|
|
|
|
|
Group equity |
|
|
647 |
|
|
|
3,331 |
|
Loans |
|
|
48 |
|
|
|
48 |
|
|
|
|
695 |
|
|
|
3,379 |
|
The goodwill recognized is related to the
complementary technical skills and talent of
the Respironics workforce and the synergies
expected to be achieved from integrating
Respironics into the Healthcare sector.
Other intangible assets are comprised of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
amortization |
|
|
|
amount |
|
|
period in years |
|
Core technology |
|
|
355 |
|
|
|
9-13 |
|
Developed non-core technology |
|
|
21 |
|
|
|
4-7 |
|
In-process R&D |
|
|
3 |
|
|
|
3 |
|
Trade name |
|
|
72 |
|
|
|
6 |
|
Customer relationships |
|
|
732 |
|
|
|
16-18 |
|
Other |
|
|
3 |
|
|
|
1-3 |
|
|
|
|
1,186 |
|
|
|
|
|
Respironics contributed income from
operations of EUR 10 million to the Group for
the period from March 10 to December 31,
2008.
VISICU
On February 20, 2008, Philips acquired 100% of
the shares of VISICU, a leading IT company
which develops remote patient monitoring
systems. The acquisition of VISICU will
facilitate the creation of products to provide
increased clinical decision support to hospital
staff, while allowing them to monitor a greater
number of critically ill patients. Philips paid
a total net cash consideration of EUR 198
million. As of the acquisition date, VISICU has
been consolidated as part of the Healthcare
sector.
The condensed balance sheet of VISICU
determined in accordance with IFRS,
immediately before and after the acquisition
date:
|
|
|
|
|
|
|
|
|
|
|
before |
|
|
after acquisition |
|
|
|
acquisition date |
|
|
date |
|
Assets |
|
|
|
|
|
|
|
|
Goodwill |
|
|
|
|
|
|
175 |
|
Other intangible assets |
|
|
|
|
|
|
33 |
|
Property, plant and equipment |
|
|
1 |
|
|
|
|
|
Working capital |
|
|
(2 |
) |
|
|
(4 |
) |
Other non-current financial assets |
|
|
3 |
|
|
|
|
|
Deferred tax assets/ liabilities |
|
|
7 |
|
|
|
(4 |
) |
Deferred Revenue |
|
|
(25 |
) |
|
|
(2 |
) |
Cash |
|
|
74 |
|
|
|
74 |
|
|
|
|
58 |
|
|
|
272 |
|
|
|
|
|
|
|
|
|
|
Financed by |
|
|
|
|
|
|
|
|
Group equity |
|
|
58 |
|
|
|
272 |
|
Loans |
|
|
|
|
|
|
|
|
|
|
|
58 |
|
|
|
272 |
|
The goodwill recognized is related to the
complementary technological skills and talent
of VISICUs workforce and the synergies
expected to be achieved from integrating VISICU
into the Healthcare sector.
Other intangible assets are comprised of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
amortization |
|
|
|
amount |
|
|
period in years |
|
Core technology |
|
|
20 |
|
|
|
7 |
|
In-process R&D |
|
|
4 |
|
|
|
3 |
|
Patents and trademarks |
|
|
1 |
|
|
|
6 |
|
Customer relationships |
|
|
5 |
|
|
|
2-15 |
|
Backlog |
|
|
3 |
|
|
|
1-3 |
|
|
|
|
33 |
|
|
|
|
|
VISICU contributed a loss from operations of
EUR 13 million to the Group for the period
from February 20 to December 31, 2008.
Pro forma disclosures on acquisitions
The following table presents the year-to-date
unaudited pro-forma results of Philips,
assuming Genlyte, Respironics and VISICU had
been consolidated as of January 1, 2008:
Unaudited
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
January-December 2008 |
|
|
|
|
|
|
|
|
|
|
|
pro forma |
|
|
|
Philips |
|
|
pro forma |
|
|
Philips |
|
|
|
Group |
|
|
adjustments1) |
|
|
Group |
|
Sales |
|
|
26,385 |
|
|
|
230 |
|
|
|
26,615 |
|
Income from operations |
|
|
54 |
|
|
|
(29 |
) |
|
|
25 |
|
Net income (loss) |
|
|
(91 |
) |
|
|
(13 |
) |
|
|
(104 |
) |
Earnings per share in
euros |
|
|
(0.09 |
) |
|
|
|
|
|
|
(0.10 |
) |
|
|
|
1) |
|
Pro forma adjustments include sales,
income from operations and net income from
continuing operations of the acquired
companies from January 1, 2008 to the date
of acquisition. As Philips finances its
acquisitions with own funds, the pro forma
adjustments exclude the cost of external
funding incurred prior to the acquisition.
The pro forma adjustments also reflect the
impact of the purchase-price accounting
effects from January 1, 2008 to the date
of acquisition and the elimination of
non-recurring integration costs incurred
by the Company. Purchase-price accounting
effects primarily relate to the
amortization of intangible assets (EUR 36
million).The non-recurring integration
costs primarly relate to the accelarated
vesting of stock options (EUR 255
million). |
218 Philips Annual Report 2008
|
|
|
|
|
|
|
250 Reconciliation of
|
|
254 Corporate governance
|
|
262 Ten-year overview
|
|
266 Investor information |
non-US GAAP information |
|
|
|
|
|
|
The following table presents the year-to-date
unaudited pro-forma results of Philips,
assuming Genlyte, Respironics and VISICU had
been consolidated as of January 1, 2007:
Unaudited
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
pro forma |
|
|
|
Philips |
|
|
pro forma |
|
|
Philips |
|
|
|
Group |
|
|
adjustments1) |
|
|
Group |
|
Sales |
|
|
26,793 |
|
|
|
2,142 |
|
|
|
28,935 |
|
Income from operations |
|
|
1,867 |
|
|
|
61 |
|
|
|
1,928 |
|
Net income |
|
|
4,873 |
|
|
|
66 |
|
|
|
4,939 |
|
Earnings per share in
euros |
|
|
4.49 |
|
|
|
|
|
|
|
4.55 |
|
|
|
|
1) |
|
Pro forma adjustments include sales,
income from operations and net income
from continuing operations of the
acquired companies for 2007. As Philips
finances its acquisitions with own funds,
the pro forma adjustments exclude the
cost of external funding incurred in
2007. The pro forma adjustments also
reflect the impact of the purchase-price
accounting effects of 2007. These effects
primarly relate to the amortization of
intangible assets (EUR 256 million) and
inventory step-ups (EUR 78 million). |
Set-Top Boxes and Connectivity Solutions
On April 21, 2008, Philips completed the sale
of its Set-Top Boxes (STB) and Connectivity
Solutions (CS) activities to UK-based
technology provider Pace Micro Technology
(Pace). Philips received 64.5 million Pace
shares, representing a 21.6% shareholding,
with a market value of EUR 74 million at that
date. Philips recognized a gain on this
transaction of EUR 42 million which was
recognized in Other business income. Two days
later, Philips reduced its interest to 17%.
The Pace shares are treated as
available-for-sale securities and presented
under Other non-current financial assets. The
shares are subject to a lock-up period which
expires in April 2009.
Philips Speech Recognition Systems
On September 28, 2008, Philips sold its
speech recognition activities to US-based
Nuance Communications for EUR 65 million.
Philips realized a gain of EUR 45 million on
this transaction which was recognized in
Other business income.
2007
During 2007, Philips entered into a number
of acquisitions and completed several
disposals of activities. All business
combinations have been accounted for using
the purchase method of accounting.
Major acquisitions in 2007 were Partners in
Lighting and Color Kinetics, currently Philips
Solid-State Lighting Solutions. The remaining
acquisitions, both individually and in the
aggregate, were deemed immaterial in respect of
the IFRS 3 disclosure requirements.
Sales and income from operations related to
activities divested in 2007, included in the
Companys consolidated statement of income
2007, amounted to EUR 262 million and a loss of
EUR 39 million respectively.
The most significant acquisitions and
divestments are summarized in the next two
tables and described in the section below.
Acquisitions
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
net |
|
|
other |
|
|
|
|
|
|
net cash |
|
|
assets |
|
|
intangible |
|
|
|
|
|
|
outflow |
|
|
acquired1) |
|
|
assets |
|
|
goodwill |
|
Partners in Lighting |
|
|
561 |
|
|
|
47 |
|
|
|
217 |
|
|
|
297 |
|
Color Kinetics |
|
|
515 |
|
|
|
(29 |
) |
|
|
187 |
|
|
|
357 |
|
|
|
|
1) |
|
Excluding cash acquired |
Divestments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
net assets |
|
|
recognized |
|
|
|
cash inflow1) |
|
|
divested2) |
|
|
gain (loss) |
|
LG Display |
|
|
1,548 |
|
|
|
895 |
|
|
|
653 |
|
|
|
|
1) |
|
Net of cash divested |
|
2) |
|
Includes the release of cumulative translation differences |
Partners in Lighting (PLI)
On February 5, 2007, Philips acquired PLI, a
leading European manufacturer of home
luminaires. Philips acquired 100% of the shares
of PLI from CVC Capital Partners, a private
equity investment company, at a net cash
consideration of EUR 561 million paid upon
completion of the transaction. As of the date
of acquisition, PLI has been consolidated
within the Lighting sector.
The condensed balance sheet of PLI
determined in accordance with IFRS,
immediately before and after acquisition
date:
|
|
|
|
|
|
|
|
|
|
|
before |
|
|
after acquisition |
|
|
|
acquisition date |
|
|
date |
|
Assets and liabilities |
|
|
|
|
|
|
|
|
Goodwill |
|
|
293 |
|
|
|
297 |
|
Other intangible assets |
|
|
|
|
|
|
217 |
|
Property, plant and equipment |
|
|
76 |
|
|
|
97 |
|
Other non-current financial assets
(liabilities) |
|
|
(30 |
) |
|
|
1 |
|
Working capital |
|
|
75 |
|
|
|
114 |
|
Provisions |
|
|
|
|
|
|
(14 |
) |
Deferred tax liabilities |
|
|
8 |
|
|
|
(67 |
) |
Cash |
|
|
23 |
|
|
|
23 |
|
|
|
|
445 |
|
|
|
668 |
|
|
|
|
|
|
|
|
|
|
Financed by |
|
|
|
|
|
|
|
|
Group equity |
|
|
(46 |
) |
|
|
584 |
|
Loans |
|
|
491 |
|
|
|
84 |
|
|
|
|
445 |
|
|
|
668 |
|
The goodwill recognized is related to the
complementary technical skills and talent of
PLIs workforce and the synergies expected to
be achieved from integrating PLI into the
Lighting sector.
Other intangible assets comprise:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
amortization |
|
|
|
amount |
|
|
period in years |
|
Customer relationships and patents |
|
|
156 |
|
|
|
20 |
|
Trademarks and trade names |
|
|
61 |
|
|
|
20 |
|
|
|
|
217 |
|
|
|
|
|
PLI contributed income from operations of
EUR 24 million to the Group for the period
from February 5 to December 31, 2007.
Color Kinetics
On August 24, 2007, Philips completed the
acquisition of 100% of the shares of Color
Kinetics, a leader in designing and marketing
innovative lighting systems based on Light
Emitting Diode (LED) technology for a net cash
consideration of EUR 515 million. As of the
date of acquisition, Color Kinetics has been
consolidated within the Lighting sector.
Philips Annual Report 2008 219
|
|
|
|
|
|
|
124
US GAAP financial statements
|
|
180
Sustainability performance
|
|
192
IFRS financial statements
Notes to the IFRS financial
statements
|
|
244
Company financial statements |
The condensed balance sheet of Color Kinetics
determined in accordance with IFRS,
immediately before and after acquisition
date:
|
|
|
|
|
|
|
|
|
|
|
before |
|
|
after |
|
|
|
acquisition date |
|
|
acquisition date |
|
Assets and liabilities |
|
|
|
|
|
|
|
|
Goodwill |
|
|
|
|
|
|
357 |
|
Other intangible assets |
|
|
|
|
|
|
187 |
|
Property, plant and equipment |
|
|
7 |
|
|
|
7 |
|
Working capital |
|
|
10 |
|
|
|
16 |
|
Deferred tax |
|
|
|
|
|
|
(52 |
) |
Cash |
|
|
71 |
|
|
|
71 |
|
|
|
|
88 |
|
|
|
586 |
|
|
|
|
|
|
|
|
|
|
Financed by |
|
|
|
|
|
|
|
|
Group equity |
|
|
88 |
|
|
|
586 |
|
|
|
|
88 |
|
|
|
586 |
|
The goodwill recognized is related mainly
to the complementary expertise of the Color
Kinetics workforce and the synergies
expected to be achieved from integrating
Color Kinetics into the Lighting sector.
Other intangible assets comprise:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
amortization |
|
|
|
amount |
|
|
period in years |
|
Trade marks and trade names |
|
|
1 |
|
|
|
1 |
|
Developed and core technology |
|
|
113 |
|
|
|
10-20 |
|
In-process research and patents |
|
|
1 |
|
|
|
0.5 |
|
Customer relationships |
|
|
68 |
|
|
|
7-18 |
|
Other |
|
|
4 |
|
|
|
2-10 |
|
|
|
|
187 |
|
|
|
|
|
Color Kinetics reported a loss from
operations of EUR 8 million to the Group for
the period from August 24 to December 31,
2007.
Pro forma disclosures on acquisitions
The following table presents the
year-to-date unaudited pro-forma results of
Philips, assuming PLI and Color Kinetics had
been consolidated as of January 1, 2007:
Unaudited
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
January-December 2007 |
|
|
|
|
|
|
|
|
|
|
|
pro forma |
|
|
|
Philips |
|
|
pro forma |
|
|
Philips |
|
|
|
Group |
|
|
adjustments1) |
|
|
Group |
|
Sales |
|
|
26,793 |
|
|
|
75 |
|
|
|
26,868 |
|
Income from operations |
|
|
1,867 |
|
|
|
|
|
|
|
1,867 |
|
Net income |
|
|
4,873 |
|
|
|
(2 |
) |
|
|
4,871 |
|
Earnings per share in
euros |
|
|
4.49 |
|
|
|
|
|
|
|
4.48 |
|
|
|
|
3) |
|
Pro forma adjustments include sales,
income from operations and net income from
continuing operations of the acquired
companies from January 1, 2007 to the date
of acquisition. As Philips finances its
acquisitions with own funds, the pro forma
adjustments exclude the cost of external
funding incurred prior to the acquisition.
The pro forma adjustments also reflect the
impact of the purchase-price
accounting effects from January 1, 2007 to the
date of acquisition and the elimination of
non-recurring post-merger integration costs
incurred by the Company. Purchase-price
accounting effects primarily relate to the
amortization of intangible assets (EUR 10
million). |
The following table presents the
year-to-date unaudited pro-forma results of
Philips, assuming PLI and Color Kinetics had
been consolidated as of January 1, 2006:
Unaudited
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
pro forma |
|
|
|
Philips |
|
|
pro forma |
|
|
Philips |
|
|
|
Group |
|
|
adjustments1) |
|
|
Group |
|
Sales |
|
|
26,682 |
|
|
|
454 |
|
|
|
27,136 |
|
Income from operations |
|
|
1,336 |
|
|
|
14 |
|
|
|
1,350 |
|
Net income |
|
|
5,153 |
|
|
|
26 |
|
|
|
5,179 |
|
Earnings per share in
euros |
|
|
4.39 |
|
|
|
|
|
|
|
4.41 |
|
|
|
|
1) |
|
Pro forma adjustments include sales,
income from operations and net income from
continuing operations of the acquired
companies of 2006. As Philips finances its
acquisitions with own funds, the pro forma
adjustments exclude the cost of external
funding incurred in 2006. The pro forma
adjustments also reflect the impact of the
purchase-price accounting effects of 2006.
These effects primarily relate to the
amortization of intangible assets (EUR 26
million) and inventory step-ups (EUR 26
million). |
LG Display
On October 10, 2007, Philips sold 46,400,000
shares of common stock in LG Display to
financial institutions in a capital markets
transaction. This transaction represented 13%
of LG Displays issued share capital and
reduced Philips holding to 19.9%. The
transaction resulted in a gain of EUR 654
million, reported under Results relating to
equity-accounted investees.
2006
During 2006, Philips entered into a number of
acquisitions and completed several
divestments. All acquisitions have been
accounted for using the purchase method of
accounting.
Major acquisitions in 2006 were Lifeline, Witt
Biomedical, Avent and Intermagnetics. The
remaining acquisitions, both individually and
in the aggregate, were deemed immaterial in
respect of the IFRS 3 disclosure requirements.
Sales and income from operations related to
activities divested in 2006, included in the
Companys consolidated statement of income for
2006, amounted to EUR 975 million and a loss
of EUR 21 million respectively.
The most significant acquisitions and
divestments are summarized in the next two
tables and described in the section below.
Acquisitions
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
net |
|
|
other |
|
|
|
|
|
|
net cash |
|
|
assets |
|
|
intangible |
|
|
|
|
|
|
outflow |
|
|
acquired1) |
|
|
assets |
|
|
goodwill |
|
Lifeline |
|
|
583 |
|
|
|
(77 |
) |
|
|
319 |
|
|
|
341 |
|
Witt Biomedical |
|
|
110 |
|
|
|
(2 |
) |
|
|
29 |
|
|
|
83 |
|
Avent |
|
|
689 |
|
|
|
(47 |
) |
|
|
392 |
|
|
|
344 |
|
Intermagnetics |
|
|
993 |
|
|
|
(50 |
) |
|
|
313 |
|
|
|
730 |
|
|
|
|
1) |
|
Excluding cash acquired |
Divestments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
net assets |
|
|
recognized |
|
|
|
cash inflow1) |
|
|
divested2) |
|
|
gain |
|
CryptoTec |
|
|
30 |
|
|
|
4 |
|
|
|
26 |
|
Philips Enabling
Technologies (ETG) |
|
|
45 |
|
|
|
38 |
|
|
|
7 |
|
Philips Sound
Solutions (PSS) |
|
|
53 |
|
|
|
41 |
|
|
|
12 |
|
FEI Company |
|
|
154 |
|
|
|
51 |
|
|
|
103 |
|
|
|
|
1) |
|
Net of cash divested |
|
2) |
|
Includes the release of cumulative translation differences |
220 Philips Annual Report 2008
|
|
|
|
|
|
|
250 Reconciliation of
|
|
254 Corporate governance
|
|
262 Ten-year overview
|
|
266 Investor information |
non-US GAAP information |
|
|
|
|
|
|
Lifeline
On March 22, 2006, Philips completed its
acquisition of Lifeline, a leader in
personal emergency response services.
Philips acquired a 100% interest in Lifeline
by paying USD 47.75 per share in cash. As of
the date of acquisition Lifeline is
consolidated as part of the Healthcare
sector.
The condensed balance sheet of Lifeline
determined in accordance with IFRS,
immediately before and after acquisition
date:
|
|
|
|
|
|
|
|
|
|
|
before |
|
|
after acquisition |
|
|
|
acquisition date |
|
|
date |
|
Assets and liabilities |
|
|
|
|
|
|
|
|
Goodwill |
|
|
15 |
|
|
|
341 |
|
Other intangible assets |
|
|
18 |
|
|
|
319 |
|
Property, plant and equipment |
|
|
34 |
|
|
|
20 |
|
Other non-current financial assets |
|
|
22 |
|
|
|
19 |
|
Working capital |
|
|
27 |
|
|
|
8 |
|
Deferred tax liabilities |
|
|
(6 |
) |
|
|
(124 |
) |
Cash |
|
|
17 |
|
|
|
14 |
|
|
|
|
127 |
|
|
|
597 |
|
|
|
|
|
|
|
|
|
|
Financed by |
|
|
|
|
|
|
|
|
Group equity |
|
|
84 |
|
|
|
597 |
|
Loans |
|
|
43 |
|
|
|
|
|
|
|
|
127 |
|
|
|
597 |
|
Other intangible assets comprise:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
amortization |
|
|
|
amount |
|
|
period in years |
|
Trademarks and trade names |
|
|
114 |
|
|
indefinite |
|
Software |
|
|
9 |
|
|
|
3-5 |
|
Customer relationships |
|
|
196 |
|
|
|
5-20 |
|
|
|
|
319 |
|
|
|
|
|
Witt Biomedical
On April 26, 2006, Philips completed its
acquisition of Witt Biomedical, the largest
independent supplier of hemodynamic monitoring
and clinical reporting systems used in
cardiology catheterization laboratories. As of
the date of acquisition, Witt Biomedical has
been consolidated within the Healthcare sector.
The condensed balance sheet of Witt
Biomedical determined in accordance with
IFRS, immediately before and after
acquisition date:
|
|
|
|
|
|
|
|
|
|
|
before |
|
|
after acquisition |
|
|
|
acquisition date |
|
|
date |
|
Assets and liabilities |
|
|
|
|
|
|
|
|
Goodwill |
|
|
|
|
|
|
83 |
|
Other intangible assets |
|
|
|
|
|
|
29 |
|
Property, plant and equipment |
|
|
1 |
|
|
|
1 |
|
Working capital |
|
|
13 |
|
|
|
17 |
|
Provisions |
|
|
(4 |
) |
|
|
(24 |
) |
Deferred tax |
|
|
|
|
|
|
4 |
|
Cash |
|
|
5 |
|
|
|
5 |
|
|
|
|
15 |
|
|
|
115 |
|
|
|
|
|
|
|
|
|
|
Financed by |
|
|
|
|
|
|
|
|
Group equity |
|
|
15 |
|
|
|
115 |
|
|
|
|
15 |
|
|
|
115 |
|
Other intangible assets comprise:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
amortization |
|
|
|
amount |
|
|
period in years |
|
In-process research and
development |
|
|
4 |
|
|
|
3 |
|
Developed and core technology |
|
|
11 |
|
|
|
4 |
|
Customer relationships |
|
|
6 |
|
|
|
10 |
|
Backlog |
|
|
7 |
|
|
|
1 |
|
Other |
|
|
1 |
|
|
|
3 |
|
|
|
|
29 |
|
|
|
|
|
Avent
As of August 31, 2006, Philips completed its
acquisition of Avent, a leading provider of
baby and infant feeding products in the
United Kingdom and the United States. Philips
acquired Avent for EUR 689 million, which was
paid in cash upon completion of the
transaction. As of the date of acquisition,
Avent has been consolidated within the
Consumer Lifestyle sector.
The condensed balance sheet of Avent
determined in accordance with IFRS,
immediately before and after acquisition
date:
|
|
|
|
|
|
|
|
|
|
|
before |
|
|
after acquisition |
|
|
|
acquisition date |
|
|
date |
|
Assets and liabilities |
|
|
|
|
|
|
|
|
Goodwill |
|
|
367 |
|
|
|
344 |
|
Other intangible assets |
|
|
|
|
|
|
392 |
|
Property, plant and equipment |
|
|
36 |
|
|
|
35 |
|
Working capital |
|
|
26 |
|
|
|
40 |
|
Deferred tax liabilities |
|
|
|
|
|
|
(122 |
) |
Cash |
|
|
23 |
|
|
|
22 |
|
|
|
|
452 |
|
|
|
711 |
|
|
|
|
|
|
|
|
|
|
Financed by |
|
|
|
|
|
|
|
|
Group equity |
|
|
(35 |
) |
|
|
711 |
|
Loans |
|
|
487 |
1) |
|
|
|
|
|
|
|
452 |
|
|
|
711 |
|
|
|
|
1) |
|
Includes preference share capital |
Other intangible assets comprise:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
amortization |
|
|
|
amount |
|
|
period in years |
|
Trademarks and trade names |
|
|
242 |
|
|
indefinite |
|
Customer relationships and patents |
|
|
150 |
|
|
|
5-18 |
|
|
|
|
392 |
|
|
|
|
|
Intermagnetics
On November 9, 2006, Philips acquired
Intermagnetics for USD 27.50 per share, which
was paid in cash upon completion. Additionally,
in connection with the closing, Philips
provided a loan to Intermagnetics of
approximately USD 120 million to pay off debt
and certain other obligations, including
amounts related to the acceleration of
stock-based compensation and expenses incurred
as a result of the
transaction. Since the date of the transaction,
Intermagnetics has been consolidated within the
Healthcare sector.
Philips Annual Report 2008 221
|
|
|
|
|
|
|
124
US GAAP financial statements
|
|
180
Sustainability performance
|
|
192
IFRS financial statements
Notes to the IFRS financial
statements
|
|
244
Company financial statements |
The condensed balance sheet of Intermagnetics
determined in accordance with IFRS,
immediately before and after acquisition
date:
|
|
|
|
|
|
|
|
|
|
|
before |
|
|
after |
|
|
|
acquisition date |
|
|
acquisition date |
|
Assets and liabilities |
|
|
|
|
|
|
|
|
Goodwill |
|
|
132 |
|
|
|
730 |
|
Other intangible assets |
|
|
34 |
|
|
|
313 |
|
Property, plant and equipment |
|
|
35 |
|
|
|
45 |
|
Working capital |
|
|
67 |
|
|
|
66 |
|
Provisions |
|
|
|
|
|
|
(6 |
) |
Deferred tax liabilities |
|
|
(6 |
) |
|
|
(96 |
) |
Cash |
|
|
19 |
|
|
|
24 |
|
|
|
|
281 |
|
|
|
1,076 |
|
|
|
|
|
|
|
|
|
|
Financed by |
|
|
|
|
|
|
|
|
Group equity |
|
|
137 |
|
|
|
1,017 |
|
Loans |
|
|
144 |
|
|
|
59 |
|
|
|
|
281 |
|
|
|
1,076 |
|
Other intangible assets comprise:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
amortization |
|
|
|
amount |
|
|
period in years |
|
Core and existing technology |
|
|
181 |
|
|
|
6 |
|
In-process R&D |
|
|
39 |
|
|
|
3 |
|
Trademarks and trade names |
|
|
8 |
|
|
|
10 |
|
Customer relationships |
|
|
81 |
|
|
|
9 |
|
Miscellaneous |
|
|
4 |
|
|
|
2 |
|
|
|
|
313 |
|
|
|
|
|
Pro forma disclosures on acquisitions
The following table presents the
year-to-date pro forma unaudited results of
Philips, assuming Lifeline, Witt Biomedical,
Avent and Intermagnetics had been
consolidated as of January 1, 2006:
Unaudited
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Philips |
|
|
pro forma |
|
|
pro forma |
|
|
|
Group |
|
|
adjustments1) |
|
|
Philips Group |
|
Sales |
|
|
26,682 |
|
|
|
236 |
|
|
|
26,918 |
|
Income from operations |
|
|
1,336 |
|
|
|
(17 |
) |
|
|
1,319 |
|
Net income |
|
|
5,153 |
|
|
|
(11 |
) |
|
|
5,142 |
|
Earnings per share in euros |
|
|
4.39 |
|
|
|
|
|
|
|
4.38 |
|
|
|
|
1) |
|
Pro forma adjustments include sales,
income from operations and net income from
continuing operations of the acquired
companies from January 1, 2006 to the date
of acquisition. For that purpose, sales
related to the pre-existing relationship
between Philips and Intermagnetics have
been excluded. As Philips finances its
acquisitions with own funds, the pro forma
adjustments exclude the cost of external
funding incurred prior to the acquisition.
The pro forma adjustments also reflect the
impact of the purchase-price accounting
effects from January 1, 2006 to the date
of acquisition and the elimination of
non-recurring post-merger integration
costs incurred by the Company.
Purchase-price accounting effects
primarily relate to the amortization of
intangible assets (EUR 81 million) and
inventory step-ups (EUR 24 million). |
CryptoTec
On March 31, 2006, Philips transferred its
CryptoTec activities to Irdeto, a world leader
in content security and a subsidiary of
multimedia group Naspers. Irdeto purchased the
CryptoTec assets for an amount of EUR 30
million. The gain on this transaction of EUR 26
million has been reported under Other Business
income.
Philips Enabling Technologies
On November 6, 2006, Philips sold Philips
Enabling Technologies Group (ETG) to VDL.
The recognized gain on this transaction (EUR
7 million) has been reported under Other
business expense.
Philips Sound Solutions
On December 31, 2006, Philips sold its Philips
Sound Solutions (PSS) business to D&M Holding
for EUR 53 million. The transaction resulted in
EUR 12 million gain, reported under Other
business income.
FEI Company
On December 20, 2006, Philips sold its 24.8%
interest in FEI Company, a NASDAQ listed
company, in a public offering. The sale
provided Philips with net proceeds of EUR 154
million and a non-taxable gain of EUR 103
million. The gain is included in Results
relating to equity-accounted investees.
40
Income from operations
For information related to sales and income
from operations on a geographical and sector
basis, see Information by sector and main
country that begins on page 206 of this
Annual Report.
Sales composition
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Goods |
|
|
24,107 |
|
|
|
24,270 |
|
|
|
23,568 |
|
Services |
|
|
2,073 |
|
|
|
1,973 |
|
|
|
2,325 |
|
Licenses |
|
|
502 |
|
|
|
550 |
|
|
|
492 |
|
|
|
|
26,682 |
|
|
|
26,793 |
|
|
|
26,385 |
|
Salaries and wages
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Salaries and wages |
|
|
4,613 |
|
|
|
4,607 |
|
|
|
5,094 |
|
Pension costs |
|
|
76 |
|
|
|
41 |
|
|
|
75 |
|
Other social security and similar
charges: |
|
|
|
|
|
|
|
|
|
|
|
|
- Required by law |
|
|
640 |
|
|
|
642 |
|
|
|
749 |
|
- Voluntary |
|
|
91 |
|
|
|
89 |
|
|
|
63 |
|
|
|
|
5,420 |
|
|
|
5,379 |
|
|
|
5,981 |
|
Salaries and wages include an amount of EUR 372
million (2007: EUR 35 million, 2006: EUR 78
million) relating to restructuring charges.
See note 56 for further information on pension costs.
Share-based compensation expense amounted to
EUR 78 million (EUR 106 million, net of tax),
EUR 111 million (EUR 84 million, net of tax)
and EUR 107 million (EUR 78 million, net of
tax) in 2008, 2007, and 2006, respectively.
See note 33 for futher information on
share-based compensation.
For remuneration details of the
members of the Board of Management and
the Supervisory Board, see note 34.
Employees
The average number of employees by
category is summarized as follows (in
FTEs):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Production |
|
|
59,955 |
|
|
|
61,447 |
|
|
|
66,675 |
|
Research & development |
|
|
13,227 |
|
|
|
12,804 |
|
|
|
11,926 |
|
Other |
|
|
27,694 |
|
|
|
28,469 |
|
|
|
34,365 |
|
Permanent employees |
|
|
100,876 |
|
|
|
102,720 |
|
|
|
112,966 |
|
Temporary employees |
|
|
16,225 |
|
|
|
16,660 |
|
|
|
13,493 |
|
Continuing operations |
|
|
117,101 |
|
|
|
119,380 |
|
|
|
126,459 |
|
Discontinued operations1) |
|
|
44,040 |
|
|
|
6,276 |
|
|
|
|
|
|
|
|
1) |
|
Average number of discontinued
operations relates to MDS, Semiconductors
and MedQuist. MDS was reported until June
2007, Semiconductors until September 2007
and MedQuist until August 2008 |
222 Philips Annual Report 2008
|
|
|
|
|
|
|
250 Reconciliation of
|
|
254 Corporate governance
|
|
262 Ten-year overview
|
|
266 Investor information |
non-US GAAP information |
|
|
|
|
|
|
Depreciation and amortization
Depreciation of property, plant and
equipment and amortization of intangibles
are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Depreciation of property, plant and
equipment |
|
|
554 |
|
|
|
562 |
|
|
|
729 |
|
Amortization of internal-use software |
|
|
71 |
|
|
|
76 |
|
|
|
92 |
|
Amortization of other intangibles: |
|
|
|
|
|
|
|
|
|
|
|
|
- Amortization of other intangible
assets |
|
|
192 |
|
|
|
227 |
|
|
|
389 |
|
- Amortization of development costs |
|
|
173 |
|
|
|
218 |
|
|
|
318 |
|
|
|
|
990 |
|
|
|
1,083 |
|
|
|
1,528 |
|
Depreciation of property, plant and equipment
includes an additional write-off in connection
with the retirement of property, plant and
equipment amounting to EUR 40 million (2007:
EUR 28 million, 2006: EUR 20 million).
Included in depreciation of property, plant and
equipment is an amount of EUR 57 million (2007:
EUR 22 million, 2006: EUR 17 million) relating
to impairment charges.
Depreciation of property, plant and equipment
and amortization of software and other
intangible assets are primarily included in
cost of sales. Amortization of development
cost is included in research and development
expenses.
Total depreciation and amortization
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Healthcare |
|
|
257 |
|
|
|
333 |
|
|
|
486 |
|
Consumer Lifestyle |
|
|
317 |
|
|
|
303 |
|
|
|
365 |
|
Lighting |
|
|
255 |
|
|
|
332 |
|
|
|
540 |
|
Innovation & Emerging Businesses |
|
|
82 |
|
|
|
44 |
|
|
|
68 |
|
Group Management & Services |
|
|
79 |
|
|
|
71 |
|
|
|
69 |
|
|
|
|
990 |
|
|
|
1,083 |
|
|
|
1,528 |
|
Impairment of goodwill
In 2008, EUR 301 million goodwill impairment
charges were recorded of which EUR 299 million
was related to Lumileds (2007: EUR nil, 2006:
EUR nil).
Other business income (expense)
Other business income (expense) consists of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Result on disposal of businesses: |
|
|
|
|
|
|
|
|
|
|
|
|
- income |
|
|
130 |
|
|
|
35 |
|
|
|
136 |
|
- expense |
|
|
(64 |
) |
|
|
(65 |
) |
|
|
(45 |
) |
Result on disposal of fixed assets: |
|
|
|
|
|
|
|
|
|
|
|
|
- income |
|
|
108 |
|
|
|
107 |
|
|
|
72 |
|
- expense |
|
|
(18 |
) |
|
|
(24 |
) |
|
|
(16 |
) |
Result on remaining businesses: |
|
|
|
|
|
|
|
|
|
|
|
|
- income |
|
|
90 |
|
|
|
127 |
|
|
|
53 |
|
- expense |
|
|
(67 |
) |
|
|
(76 |
) |
|
|
(25 |
) |
|
|
|
179 |
|
|
|
104 |
|
|
|
175 |
|
Results on the disposal of businesses consisted of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Automotive Playback Modules |
|
|
|
|
|
|
(30 |
) |
|
|
|
|
Philips Sound Solutions |
|
|
12 |
|
|
|
|
|
|
|
|
|
CryptoTec |
|
|
26 |
|
|
|
|
|
|
|
|
|
Connected Displays (Monitors) |
|
|
23 |
|
|
|
|
|
|
|
|
|
Set-Top Boxes and Connectivity
Solutions |
|
|
|
|
|
|
|
|
|
|
42 |
|
Philips Speech Recognition Systems |
|
|
|
|
|
|
|
|
|
|
45 |
|
Other |
|
|
5 |
|
|
|
|
|
|
|
4 |
|
|
|
|
66 |
|
|
|
(30 |
) |
|
|
91 |
|
The results on the disposal of businesses in
2008 are mainly related to the sale of the
Set-Top Boxes and Connectivity Solutions
activities to Pace Micro Technology which
resulted in a gain of EUR 42 million, and the
sale of Speech Recognition activities to Nuance
Communications which resulted in a gain of EUR
45 million. The result on the disposal of fixed
assets is mainly related to the sale of fixed
assets in Taiwan with a gain of EUR 39 million.
The result on the disposal of businesses in
2007 mainly related to the sale of Automotive
Playback Modules which resulted in a loss of
EUR 30 million. The result on the sale of
fixed assets mainly related to the sale of
certain buildings in Austria and the
Netherlands as well as land in the US. The
other business results are mainly attributable
to certain settlements and the finalization of
several divestitures.
The result on the disposal of businesses in
2006 is related mainly to the sale of the
CryptoTec activities which delivered a gain of
EUR 26 million, the sale of Philips Sound
Solutions PSS to D&M Holding at a gain of EUR
12 million and the sale of Television at a
gain of EUR 23 million. The result on the
disposal of fixed assets is mainly related to
the sale of certain real estate assets in
Austria with a gain of EUR 31 million. Other
business income consists of the settlement of
certain legal claims and some releases of
provisions.
41
Financial income and expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Interest income |
|
|
150 |
|
|
|
236 |
|
|
|
141 |
|
Interest expense |
|
|
(339 |
) |
|
|
(279 |
) |
|
|
(246 |
) |
Net interest expense |
|
|
(189 |
) |
|
|
(43 |
) |
|
|
(105 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Sale of securities |
|
|
|
|
|
|
2,804 |
|
|
|
1,406 |
|
Impairment of securities |
|
|
(77 |
) |
|
|
(36 |
) |
|
|
(1,148 |
) |
Foreign exchange results |
|
|
2 |
|
|
|
(1 |
) |
|
|
(13 |
) |
Other financial income (expenses), net |
|
|
293 |
|
|
|
125 |
|
|
|
(52 |
) |
|
|
|
218 |
|
|
|
2,892 |
|
|
|
193 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
29 |
|
|
|
2,849 |
|
|
|
88 |
|
Interest income decreased by EUR 95 million
during 2008, mainly as a result of lower
average cash balances during 2008, compared to
2007. Interest expense decreased by EUR 33
million during 2008, mainly as a result of
lower interest costs on derivatives related to
hedging of Philips foreign currency funding
positions.
In 2008, income from the sale of securities
totaled EUR 1,406 million. This included EUR
1,205 million gain from the sale of shares in
TSMC, EUR 158 million gain on the sale of
shares in LG Display, and EUR 20 million gain
on the sale of shares in D&M. These gains were
offset by impairment charges amounting to EUR
1,148 million. This included EUR 599 million
for NXP, EUR 448 million for LG Display, EUR 71
million for TPO and EUR 30 million for Pace
Micro Technology. Furthermore, other financial
expense primarily
consisted of a EUR 37 million loss related to
the revaluation of the convertible bond
received from TPV Technology and a EUR 23
million dividend from TSMC.
Philips Annual Report 2008 223
|
|
|
|
|
|
|
124
US GAAP financial statements
|
|
180
Sustainability performance
|
|
192
IFRS financial statements
Notes to the IFRS financial
statements
|
|
244
Company financial statements |
In 2007, income from the sale of securities
totaled EUR 2,804 million. This included EUR
2,783 million gain from the sale of shares in
TSMC, EUR 31 million gain on the sale of shares
in Nuance Communications, and EUR 10 million
loss on the sale of shares in JDS Uniphase.
These gains were offset by an impairment of EUR
36 million for JDS Uniphase. Furthermore, other
financial income included a EUR 12 million gain
related to the revaluation of the convertible
bond received from TPV Technology and a EUR 128
million cash dividend from TSMC.
In 2006, a EUR 77 million impairment of TPO was
recorded. This is offset by other financial
income of EUR 293 million, which included a
cash dividend of EUR 223 million from TSMC, a
gain of EUR 97 million upon designation of the
TSMC shares received through a stock dividend
as trading securities and a EUR 29 million gain
as a result of increases in the fair value of
the trading securities held in TSMC. This is
offset by a EUR 61 million loss as a result of
the fair value change in the conversion option
embedded in the convertible bond received from
TPV Technology.
42
Income taxes
The tax expense on income before tax amounted
to EUR 256 million (2007: EUR 582 million,
2006: EUR 223 million).
The components of income before taxes and
income tax expense are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Netherlands |
|
|
364 |
|
|
|
2,968 |
|
|
|
330 |
|
Foreign |
|
|
1,001 |
|
|
|
1,748 |
|
|
|
(188 |
) |
Income before taxes |
|
|
1,365 |
|
|
|
4,716 |
|
|
|
142 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Netherlands: |
|
|
|
|
|
|
|
|
|
|
|
|
Current taxes |
|
|
81 |
|
|
|
(41 |
) |
|
|
20 |
|
Deferred taxes |
|
|
(23 |
) |
|
|
(155 |
) |
|
|
(120 |
) |
|
|
|
58 |
|
|
|
(196 |
) |
|
|
(100 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign: |
|
|
|
|
|
|
|
|
|
|
|
|
Current taxes |
|
|
(274 |
) |
|
|
(360 |
) |
|
|
(289 |
) |
Deferred taxes |
|
|
(7 |
) |
|
|
(26 |
) |
|
|
133 |
|
|
|
|
(281 |
) |
|
|
(386 |
) |
|
|
(156 |
) |
Income tax expense |
|
|
(223 |
) |
|
|
(582 |
) |
|
|
(256 |
) |
Deferred tax expense
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Previously unrecognized tax losses
carried forwards realized |
|
|
20 |
|
|
|
5 |
|
|
|
21 |
|
Current year tax losses carried
forward not realized |
|
|
(26 |
) |
|
|
(38 |
) |
|
|
(98 |
) |
Temporary differences
(not recognized) recognized |
|
|
(42 |
) |
|
|
156 |
|
|
|
(2 |
) |
Prior year results |
|
|
44 |
|
|
|
25 |
|
|
|
(7 |
) |
Tax rate changes |
|
|
64 |
|
|
|
(99 |
) |
|
|
(1 |
) |
Origination and reversal
of temporary differences |
|
|
(90 |
) |
|
|
(230 |
) |
|
|
100 |
|
|
|
|
(30 |
) |
|
|
(181 |
) |
|
|
13 |
|
Philips operations are subject to income
taxes in various foreign jurisdictions. The
statutory income tax rates vary from 10.0%
to 40.7%, which causes a difference between
the weighted average statutory income tax
rate and the
Netherlands statutory income tax rate of
25.5%. (2007: 25.5%; 2006: 29.6%).
A reconciliation of the weighted average
statutory income tax rate to the effective
income tax rate is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
in % |
|
2006 |
|
|
2007 |
|
|
2008 |
|
Weighted average statutory income
tax rate |
|
|
25.4 |
|
|
|
26.4 |
|
|
|
(18.5 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Tax rate effect of: |
|
|
|
|
|
|
|
|
|
|
|
|
Changes related to: |
|
|
|
|
|
|
|
|
|
|
|
|
- utilization of previously reserved loss
carryforwards |
|
|
(1.5 |
) |
|
|
(0.1 |
) |
|
|
(14.5 |
) |
- new loss carryforwards not
expected to be realized |
|
|
1.9 |
|
|
|
0.8 |
|
|
|
69.3 |
|
- addition (releases) |
|
|
3.1 |
|
|
|
(3.3 |
) |
|
|
1.6 |
|
Non-tax deductible impairment charges |
|
|
|
|
|
|
0.2 |
|
|
|
283.1 |
|
Non-taxable income |
|
|
(14.4 |
) |
|
|
(16.3 |
) |
|
|
(315.0 |
) |
Non-tax-deductible expenses |
|
|
8.0 |
|
|
|
1.1 |
|
|
|
91.9 |
|
Withholding and other taxes |
|
|
1.2 |
|
|
|
(0.2 |
) |
|
|
(5.1 |
) |
Tax rate changes |
|
|
(4.7 |
) |
|
|
2.1 |
|
|
|
1.0 |
|
Tax expenses due to other liabilities |
|
|
|
|
|
|
1.6 |
|
|
|
37.2 |
|
Tax incentives and other |
|
|
(2.7 |
) |
|
|
|
|
|
|
49.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effective tax rate |
|
|
16.3 |
|
|
|
12.3 |
|
|
|
180.2 |
|
The weighted average statutory income tax
rate decreased in 2008 compared to 2007 due
to a significant change in country mix of
income tax rates, due to losses in countries
with higher income tax rates and profits in
countries with relatively lower income tax
rates, combined with a lower income before
tax.
The effective income tax rate is higher than
the weighted average statutory income tax rate
in 2008, mainly due to new losses carried
forward not expected to be realized,
non-tax-deductible impairment charges, and
income tax expenses due to tax provisions for
uncertain tax positions, which were partly
offset by non-taxable gains on the sale of
securities and other non-taxable income.
224 Philips Annual Report 2008
|
|
|
|
|
|
|
250 Reconciliation of
|
|
254 Corporate governance
|
|
262 Ten-year overview
|
|
266 Investor information |
non-US GAAP information |
|
|
|
|
|
|
Deferred tax assets and liabilities
Net deferred tax assets relate to the following balance sheet captions,
and tax loss carryforwards (including tax credit carryforwards), of which
the movements during the years 2008 and 2007 respectively are as follows:
42
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
balance Dec. 31, |
|
|
recognized in |
|
|
recognized in |
|
|
acquisitions/ |
|
|
|
|
|
|
balance Dec. 31, |
|
|
|
2007 |
|
|
income |
|
|
equity |
|
|
deconsolidations |
|
|
other |
|
|
2008 |
|
Intangible assets |
|
|
(371 |
) |
|
|
(170 |
) |
|
|
|
|
|
|
(768 |
) |
|
|
11 |
|
|
|
(1,298 |
) |
Property, plant and equipment |
|
|
65 |
|
|
|
(185 |
) |
|
|
|
|
|
|
(26 |
) |
|
|
|
|
|
|
(146 |
) |
Inventories |
|
|
132 |
|
|
|
|
|
|
|
|
|
|
|
9 |
|
|
|
6 |
|
|
|
147 |
|
Prepaid pension costs |
|
|
(685 |
) |
|
|
(83 |
) |
|
|
243 |
|
|
|
|
|
|
|
15 |
|
|
|
(510 |
) |
Other receivables |
|
|
21 |
|
|
|
19 |
|
|
|
|
|
|
|
3 |
|
|
|
(2 |
) |
|
|
41 |
|
Other assets |
|
|
34 |
|
|
|
12 |
|
|
|
10 |
|
|
|
1 |
|
|
|
4 |
|
|
|
61 |
|
Provisions: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- pensions |
|
|
353 |
|
|
|
(120 |
) |
|
|
182 |
|
|
|
5 |
|
|
|
12 |
|
|
|
432 |
|
- guarantees |
|
|
13 |
|
|
|
(3 |
) |
|
|
|
|
|
|
(2 |
) |
|
|
1 |
|
|
|
9 |
|
- termination benefits |
|
|
19 |
|
|
|
42 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
61 |
|
- other postretirement benefits |
|
|
116 |
|
|
|
10 |
|
|
|
(16 |
) |
|
|
|
|
|
|
(2 |
) |
|
|
108 |
|
- other provisions |
|
|
129 |
|
|
|
589 |
|
|
|
(24 |
) |
|
|
32 |
|
|
|
25 |
|
|
|
751 |
|
Other liabilities |
|
|
93 |
|
|
|
(12 |
) |
|
|
|
|
|
|
|
|
|
|
(5 |
) |
|
|
76 |
|
Tax loss carryforwards (including tax
credit carryforwards) |
|
|
700 |
|
|
|
(86 |
) |
|
|
|
|
|
|
24 |
|
|
|
(23 |
) |
|
|
615 |
|
Net deferred tax assets |
|
|
619 |
|
|
|
13 |
|
|
|
395 |
|
|
|
(722 |
) |
|
|
42 |
|
|
|
347 |
|
Other provisions include a EUR 251 million deferred tax asset position of legal claims for
asbestos.
The column other includes foreign currency translation differences of
EUR 56 million (assets) which were recognized in equity and balance
sheet changes amounting to EUR 14 million (liabilities).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
balance Dec. 31, |
|
|
recognized in |
|
|
recognized in |
|
|
acquisitions/ |
|
|
|
|
|
|
balance Dec. 31, |
|
|
|
2006 |
|
|
income |
|
|
equity |
|
|
deconsolidations |
|
|
other |
|
|
2007 |
|
Intangible assets |
|
|
(492 |
) |
|
|
85 |
|
|
|
|
|
|
|
38 |
|
|
|
(2 |
) |
|
|
(371 |
) |
Property, plant and equipment |
|
|
26 |
|
|
|
47 |
|
|
|
|
|
|
|
(1 |
) |
|
|
(7 |
) |
|
|
65 |
|
Inventories |
|
|
150 |
|
|
|
(15 |
) |
|
|
|
|
|
|
|
|
|
|
(3 |
) |
|
|
132 |
|
Prepaid pension costs |
|
|
(529 |
) |
|
|
(122 |
) |
|
|
(46 |
) |
|
|
22 |
|
|
|
(10 |
) |
|
|
(685 |
) |
Other receivables |
|
|
48 |
|
|
|
(28 |
) |
|
|
|
|
|
|
|
|
|
|
1 |
|
|
|
21 |
|
Other assets |
|
|
346 |
|
|
|
(185 |
) |
|
|
|
|
|
|
(127 |
) |
|
|
|
|
|
|
34 |
|
Provisions: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- pensions |
|
|
331 |
|
|
|
50 |
|
|
|
8 |
|
|
|
|
|
|
|
(36 |
) |
|
|
353 |
|
- guarantees |
|
|
15 |
|
|
|
(2 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13 |
|
- termination benefits |
|
|
23 |
|
|
|
(4 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19 |
|
- other postretirement benefits |
|
|
68 |
|
|
|
54 |
|
|
|
2 |
|
|
|
|
|
|
|
(8 |
) |
|
|
116 |
|
- other provisions |
|
|
318 |
|
|
|
(182 |
) |
|
|
|
|
|
|
(7 |
) |
|
|
|
|
|
|
129 |
|
Other liabilities |
|
|
52 |
|
|
|
22 |
|
|
|
14 |
|
|
|
|
|
|
|
5 |
|
|
|
93 |
|
Tax loss carryforwards (including tax
credit carryforwards) |
|
|
449 |
|
|
|
99 |
|
|
|
|
|
|
|
26 |
|
|
|
126 |
|
|
|
700 |
|
Net deferred tax assets |
|
|
805 |
|
|
|
(181 |
) |
|
|
(22 |
) |
|
|
(49 |
) |
|
|
66 |
|
|
|
619 |
|
The column other includes foreign currency translation differences of
EUR 36 million (liabilities) which were recognized in equity, balance
sheet changes amounting to EUR 105 million (assets) which are part of the
tax loss carryforward line item, and discontinued operations of EUR 3
million (liabilities) which were recognized in the profit and loss
account.
Philips Annual Report 2008 225
|
|
|
|
|
|
|
124
US GAAP financial statements
|
|
180
Sustainability performance
|
|
192
IFRS financial statements
Notes to the IFRS financial
statements
|
|
244
Company financial statements |
Deferred tax assets and liabilities relate to
the following balance sheet captions, as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
assets |
|
|
liabilities |
|
|
net |
|
2008 |
|
|
|
|
|
|
|
|
|
|
|
|
Intangible assets |
|
|
112 |
|
|
|
(1,410 |
) |
|
|
(1,298 |
) |
Property, plant & equipment |
|
|
62 |
|
|
|
(208 |
) |
|
|
(146 |
) |
Inventories |
|
|
160 |
|
|
|
(13 |
) |
|
|
147 |
|
Prepaid pension costs |
|
|
52 |
|
|
|
(562 |
) |
|
|
(510 |
) |
Other receivables |
|
|
49 |
|
|
|
(8 |
) |
|
|
41 |
|
Other assets |
|
|
82 |
|
|
|
(21 |
) |
|
|
61 |
|
Provisions: |
|
|
|
|
|
|
|
|
|
|
|
|
- Pensions |
|
|
432 |
|
|
|
|
|
|
|
432 |
|
- Guarantees |
|
|
10 |
|
|
|
(1 |
) |
|
|
9 |
|
- Termination benefits |
|
|
61 |
|
|
|
|
|
|
|
61 |
|
- Other postretirement |
|
|
108 |
|
|
|
|
|
|
|
108 |
|
- Other |
|
|
803 |
|
|
|
(52 |
) |
|
|
751 |
|
Other liabilities |
|
|
152 |
|
|
|
(76 |
) |
|
|
76 |
|
|
|
|
2,083 |
|
|
|
(2,351 |
) |
|
|
(268 |
) |
Set-off of deferred tax positions |
|
|
(1,767 |
) |
|
|
1,767 |
|
|
|
|
|
|
|
|
316 |
|
|
|
(584 |
) |
|
|
(268 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
assets |
|
|
liabilities |
|
|
net |
|
2007 |
|
|
|
|
|
|
|
|
|
|
|
|
Intangible assets |
|
|
43 |
|
|
|
(414 |
) |
|
|
(371 |
) |
Property, plant & equipment |
|
|
120 |
|
|
|
(55 |
) |
|
|
65 |
|
Inventories |
|
|
164 |
|
|
|
(32 |
) |
|
|
132 |
|
Prepaid pension costs |
|
|
18 |
|
|
|
(703 |
) |
|
|
(685 |
) |
Other receivables |
|
|
36 |
|
|
|
(15 |
) |
|
|
21 |
|
Other assets |
|
|
60 |
|
|
|
(26 |
) |
|
|
34 |
|
Provisions: |
|
|
|
|
|
|
|
|
|
|
|
|
- Pensions |
|
|
353 |
|
|
|
|
|
|
|
353 |
|
- Guarantees |
|
|
13 |
|
|
|
|
|
|
|
13 |
|
- Termination benefits |
|
|
19 |
|
|
|
|
|
|
|
19 |
|
- Other postretirement |
|
|
116 |
|
|
|
|
|
|
|
116 |
|
- Other |
|
|
422 |
|
|
|
(293 |
) |
|
|
129 |
|
Other liabilities |
|
|
128 |
|
|
|
(35 |
) |
|
|
93 |
|
|
|
|
1,492 |
|
|
|
(1,573 |
) |
|
|
(81 |
) |
Set-off of deferred tax positions |
|
|
(921 |
) |
|
|
921 |
|
|
|
|
|
|
|
|
571 |
|
|
|
(652 |
) |
|
|
(81 |
) |
In assessing the realizability of deferred tax
assets, management considers whether it is
probable that some portion or all of the
deferred tax assets will not be realized. The
ultimate realization of deferred tax assets is
dependent upon the generation of future
taxable income during the periods in which
those temporary differences become deductible.
Management considers the scheduled reversal of
deferred tax liabilities, projected future
taxable income and tax planning strategies in
making this assessment. In order to fully
realize the deferred tax asset, the Company
will need to generate future taxable income in
the countries where the net operating losses
were incurred. Based upon the level of
historical taxable income and projections for
future taxable income over the periods in
which the deferred tax assets are deductible,
management believes as at December 31, 2008,
it is probable that the Company will realize
all or some portion of the recognized benefits
of these deductible differences.
At December 31, 2008, operating loss carryforwards expire as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2014/ |
|
|
|
|
|
|
un- |
|
Total |
|
2009 |
|
|
2010 |
|
|
2011 |
|
|
2012 |
|
|
2013 |
|
|
2018 |
|
|
later |
|
|
limited |
|
4,198 |
|
|
14 |
|
|
|
16 |
|
|
|
58 |
|
|
|
12 |
|
|
|
8 |
|
|
|
27 |
|
|
|
852 |
|
|
|
3,211 |
|
The Company also has tax credit carryforwards
of EUR 107 million, which are available to
offset future tax, if any, and which expire as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2014/ |
|
|
|
|
|
|
un- |
|
Total |
|
2009 |
|
|
2010 |
|
|
2011 |
|
|
2012 |
|
|
2013 |
|
|
2018 |
|
|
later |
|
|
limited |
|
107 |
|
|
2 |
|
|
|
2 |
|
|
|
5 |
|
|
|
7 |
|
|
|
3 |
|
|
|
12 |
|
|
|
49 |
|
|
|
27 |
|
At December 31, 2008, operating loss and tax
credit carryforwards for which no deferred tax
assets have been recognized in the balance
sheet, expire as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2014 |
|
|
|
|
|
|
un- |
|
Total |
|
2009 |
|
|
2010 |
|
|
2011 |
|
|
2012 |
|
|
2013 |
|
|
/2018 |
|
|
later |
|
|
limited |
|
1,404 |
|
|
9 |
|
|
|
14 |
|
|
|
58 |
|
|
|
11 |
|
|
|
8 |
|
|
|
35 |
|
|
|
77 |
|
|
|
1,192 |
|
Classification of the income tax payable and receivable is as follows:
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Income tax receivable under current receivables |
|
|
52 |
|
|
|
133 |
|
Income tax receivable under non-current
receivables |
|
|
14 |
|
|
|
1 |
|
Income tax payable under accrued liabilities |
|
|
(154 |
) |
|
|
(132 |
) |
Income tax payable under non-current liabilities |
|
|
(1 |
) |
|
|
(1 |
) |
43
Investments in equity-accounted investees
Results relating to investments in equity-accounted investees
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Companys participation in income (loss) |
|
|
(188 |
) |
|
|
246 |
|
|
|
81 |
|
Results on sales of shares |
|
|
106 |
|
|
|
660 |
|
|
|
(2 |
) |
Gains and losses from dilution effects |
|
|
13 |
|
|
|
|
|
|
|
12 |
|
Investment impairment / other charges |
|
|
(70 |
) |
|
|
(22 |
) |
|
|
(72 |
) |
|
|
|
(139 |
) |
|
|
884 |
|
|
|
19 |
|
In 2006 and 2008, Philips recorded dilution
gains of EUR 13 million and EUR 12 million
respectively on its share in TPV Technology
(TPV), a Hong Kong-based manufacturer of flat
panels.
Detailed information on the other
aforementioned individual line items is set
out below.
Companys participation in income (loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
LG Display |
|
|
(192 |
) |
|
|
241 |
|
|
|
66 |
|
Others |
|
|
4 |
|
|
|
5 |
|
|
|
15 |
|
|
|
|
(188 |
) |
|
|
246 |
|
|
|
81 |
|
At the end of February 2008, Philips
influence on LG Displays operating and
financial policies including representation on
the LG Display board was reduced.
Consequently, the 19.9% investment in LG
Display was transferred from Investments in
equity-accounted investees to Other
non-current financial assets effective March
1, 2008 as Philips was no longer able to
exercise significant influence. Philips ceased
to apply equity accounting for its LG Display
shares as of that date.
226 Philips Annual Report 2008
|
|
|
|
|
|
|
250 Reconciliation of
|
|
254 Corporate governance
|
|
262 Ten-year overview
|
|
266 Investor information |
non-US GAAP information |
|
|
|
|
|
|
Results on sales of shares
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
FEI Company |
|
|
103 |
|
|
|
|
|
|
|
|
|
LG Display |
|
|
|
|
|
|
654 |
|
|
|
|
|
Others |
|
|
3 |
|
|
|
6 |
|
|
|
(2 |
) |
|
|
|
106 |
|
|
|
660 |
|
|
|
(2 |
) |
2007
In 2007, Philips sold 46,400,000 shares of LG
Display common stock, resulting in a gain of
EUR 654 million. As a result of the sale,
Philips shareholding in LG Display was
reduced from 32.9% to 19.9%.
2006
In 2006, Philips sold its remaining interest
of 24.8% in FEI Company (see note 39).
Investment impairment/other charges
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
LG.Philips Displays |
|
|
(61 |
) |
|
|
(22 |
) |
|
|
(9 |
) |
Others |
|
|
(9 |
) |
|
|
|
|
|
|
(63 |
) |
|
|
|
(70 |
) |
|
|
(22 |
) |
|
|
(72 |
) |
2008
The category Others includes an impairment
charge related to our 12.4% interest in TPV.
Philips performed impairment reviews on the
book value of the investment in TPV in 2008.
We concluded that an impairment charge of EUR
59 million was required. The impairment
reviews in 2008 were triggered by the
deteriorating economic environment of the
flat panel industry, the weakening financial
performance of TPV and the stock price
performance of TPV. The valuation as per
December 31, 2008 was based on the stock
price of TPV as of that date on the Hong Kong
Stock Exchange.
2007
The voluntary support of social plans for
employees impacted by the bankruptcy of
certain LG.Philips Displays activities
amounted to EUR 22 million.
2006
The voluntary support of social plans for
employees impacted by the bankruptcy of
certain LG.Philips Displays activities
amounted to EUR 61 million.
Investments in equity-accounted investees
The changes during 2008 are as follows:
|
|
|
|
|
Investments in equity-accounted investees |
|
investments |
|
Investments in equity-accounted investees as of
January 1, 2008 |
|
|
1,817 |
|
Changes: |
|
|
|
|
Acquisitions/additions |
|
|
62 |
|
Sales/repayments |
|
|
(3 |
) |
Transfer to other non-current financial assets |
|
|
(1,531 |
) |
Share in income/value adjustments |
|
|
30 |
|
Dividends received |
|
|
(65 |
) |
Translation and exchange rate differences |
|
|
(17 |
) |
Investments in equity-accounted investees
as of December 31, 2008 |
|
|
293 |
|
The EUR 1,531 million reported on Transfer
to other non-current financial assets
relates to the investment in LG Display.
Included in investments is EUR 25 million
(2007: EUR 339 million), representing the
excess of the Companys investment over its
underlying equity in the net assets of the
equity-accounted investees.
The total carrying value of investments
in, and loans to, equity-accounted
investees is summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
2008 |
|
|
|
share- |
|
|
|
|
|
|
share- |
|
|
|
|
|
|
holding % |
|
|
amount |
|
|
holding % |
|
|
amount |
|
LG Display |
|
|
19.9 |
|
|
|
1,535 |
|
|
|
|
|
|
|
|
|
Other investments in
equity-accounted
investees |
|
|
|
|
|
|
282 |
|
|
|
|
|
|
|
293 |
|
|
|
|
|
|
|
|
1,817 |
|
|
|
|
|
|
|
293 |
|
The category Other equity-accounted investees
includes the investment in TPV (12.4%, carrying
value EUR 60 million) and InterTrust
Technologies Corporation (49.5%, carrying value
EUR 64 million).
The Company owns TPV bonds which have
convertible rights that potentially could
result in significant influence.
The investments in equity-accounted
investees are mainly included in the Group
Management & Services sector.
Summarized information of investments in
equity-accounted investees
Summarized
financial information on the Companys
investments in equity-accounted investees, on
a combined basis, is presented below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Net sales |
|
|
13,599 |
|
|
|
15,799 |
|
|
|
6,951 |
|
Income (loss) before taxes |
|
|
(613 |
) |
|
|
1,233 |
|
|
|
538 |
|
Income taxes |
|
|
189 |
|
|
|
(154 |
) |
|
|
(109 |
) |
Other income (loss) |
|
|
(37 |
) |
|
|
(1 |
) |
|
|
|
|
Net income (loss) |
|
|
(461 |
) |
|
|
1,078 |
|
|
|
429 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total share in net income of equity-
accounted investees recognized in the
consolidated statements of income |
|
|
(188 |
) |
|
|
246 |
|
|
|
81 |
|
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
|
|
2007 |
|
|
2008 |
|
Current assets |
|
|
6,116 |
|
|
|
2,781 |
|
Non-current assets |
|
|
6,766 |
|
|
|
685 |
|
|
|
|
12,882 |
|
|
|
3,466 |
|
Current liabilities |
|
|
(3,339 |
) |
|
|
(2,134 |
) |
Non-current liabilities |
|
|
(2,578 |
) |
|
|
(184 |
) |
Net asset value |
|
|
6,965 |
|
|
|
1,148 |
|
|
|
|
|
|
|
|
|
|
Investments in equity- accounted investees included
in the consolidated balance sheet |
|
|
1,817 |
|
|
|
293 |
|
Philips Annual Report 2008 227
|
|
|
|
|
|
|
124
US GAAP financial statements
|
|
180
Sustainability performance
|
|
192
IFRS financial statements
Notes to the IFRS financial
statements
|
|
244
Company financial statements |
44
Earnings per share
The earnings per share (EPS) data have been calculated as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
2008 |
|
Income (loss) from continuing operations |
|
|
|
|
|
|
999 |
|
|
|
|
|
|
|
5,011 |
|
|
|
|
|
|
|
(94 |
) |
Incom (loss) from discontinued operations |
|
|
|
|
|
|
4,154 |
|
|
|
|
|
|
|
(138 |
) |
|
|
|
|
|
|
3 |
|
Net income (loss) attributable to holders
of common shares |
|
|
|
|
|
|
5,153 |
|
|
|
|
|
|
|
4,873 |
|
|
|
|
|
|
|
(91 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of shares |
|
|
|
|
|
|
1,174,924,579 |
|
|
|
|
|
|
|
1,086,128,418 |
|
|
|
|
|
|
|
991,420,017 |
|
Plus incremental shares from assumed conversions
of: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options and restricted share rights |
|
|
7,531,636 |
|
|
|
|
|
|
|
11,669,275 |
|
|
|
|
|
|
|
5,191,635 |
|
|
|
|
|
Convertible debentures |
|
|
1,174,299 |
|
|
|
|
|
|
|
1,127,690 |
|
|
|
|
|
|
|
102,249 |
|
|
|
|
|
Dilutive potential common shares |
|
|
|
|
|
|
8,705,935 |
|
|
|
|
|
|
|
12,796,965 |
|
|
|
|
|
|
|
5,293,884 |
|
Adjusted weighted average number of shares |
|
|
|
|
|
|
1,183,630,514 |
|
|
|
|
|
|
|
1,098,925,383 |
|
|
|
|
|
|
|
996,713,901 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per share in euros |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations |
|
|
|
|
|
|
0.85 |
|
|
|
|
|
|
|
4.61 |
|
|
|
|
|
|
|
(0.09 |
) |
Income (loss) from discontinued operations |
|
|
|
|
|
|
3.54 |
|
|
|
|
|
|
|
(0.12 |
) |
|
|
|
|
|
|
|
|
Net income (loss) attributable to stockholders |
|
|
|
|
|
|
4.39 |
|
|
|
|
|
|
|
4.49 |
|
|
|
|
|
|
|
(0.09 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per share in euros |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations |
|
|
|
|
|
|
0.84 |
|
|
|
|
|
|
|
4.56 |
|
|
|
|
|
|
|
(0.09 |
)1) |
Income (loss) from discontinued operations |
|
|
|
|
|
|
3.51 |
|
|
|
|
|
|
|
(0.13 |
) |
|
|
|
|
|
|
1 |
) |
Net income (loss) attributable to stockholders |
|
|
|
|
|
|
4.35 |
|
|
|
|
|
|
|
4.43 |
|
|
|
|
|
|
|
(0.09 |
)1) |
In 2008, 2007 and 2006, respectively 48 million, 27 million and 19 million securities that
could potentially dilute basic EPS were not included in the computation of dilutive EPS
because the effect would have been antidilutive for the periods presented.
|
|
|
1) |
|
In 2008, the incremental shares from assumed conversion are not taken into account as the
effect would be antidilutive. |
45
Receivables
The accounts receivable, net, split per sector are as follows:
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Healthcare |
|
|
1,425 |
|
|
|
1,586 |
|
Consumer Lifestyle |
|
|
1,770 |
|
|
|
1,258 |
|
Lighting |
|
|
796 |
|
|
|
851 |
|
I&EB |
|
|
151 |
|
|
|
85 |
|
GM&S |
|
|
67 |
|
|
|
33 |
|
|
|
|
4,209 |
|
|
|
3,813 |
|
The ageing analysis of accounts receivable, net, is set out below:
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
not overdue |
|
|
3,453 |
|
|
|
2,953 |
|
overdue 1-30 days |
|
|
495 |
|
|
|
479 |
|
overdue 31-180 days |
|
|
261 |
|
|
|
321 |
|
overdue > 180 days |
|
|
|
|
|
|
60 |
|
|
|
|
4,209 |
|
|
|
3,813 |
|
A large part of the overdues of trade
accounts receivable relates to public sector
customers with slow payment approval
processes. Provisions primarily relate to
items overdue for more than 180 days.
Income taxes receivable (current portion)
totaling EUR 133 million (2007: EUR 52
million) are included in other receivables.
The changes in the allowance for doubtful
accounts receivable are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Balance as of January 1 |
|
|
369 |
|
|
|
336 |
|
|
|
300 |
|
Additions charged to income |
|
|
52 |
|
|
|
62 |
|
|
|
33 |
|
Deductions from allowance1) |
|
|
(72 |
) |
|
|
(85 |
) |
|
|
(63 |
) |
Other movements2) |
|
|
(13 |
) |
|
|
(13 |
) |
|
|
10 |
|
Balance as of December 31 |
|
|
336 |
|
|
|
300 |
|
|
|
280 |
|
|
|
|
1) |
|
Write-offs for which an allowance was previously provided |
|
2) |
|
Including the effect of translation differences and consolidation changes |
46
Inventories
Inventories are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Raw materials and supplies |
|
|
908 |
|
|
|
976 |
|
Work in process |
|
|
391 |
|
|
|
530 |
|
Finished goods |
|
|
1,968 |
|
|
|
2,066 |
|
Advance payments on work in process |
|
|
(121 |
) |
|
|
(201 |
) |
|
|
|
3,146 |
|
|
|
3,371 |
|
The amounts recorded above are net of allowances for obsolescence.
As of December 31, 2008, the carrying amount
of inventories carried at fair value less
cost-to-sell is EUR 257 million (2007: EUR 190
million).
228 Philips Annual Report 2008
|
|
|
|
|
|
|
250
Reconciliation of
non-US GAAP information
|
|
254
Corporate governance
|
|
262
Ten-year overview
|
|
266
Investor information |
As discussed under Significant accounting
policies , Reclassification and revisions,
the previously reported inventories balance
as of December 31, 2007 was adjusted
downwards by EUR 57 million to correct
intercompany profit eliminations.
47
Other current assets
Other current assets include assets for
derivative financial instruments of EUR 253
million (2007: EUR 275 million), prepaid
expenses of EUR 375 million (2007: EUR 347
million) and other current financial assets of
EUR 121 million (2007: EUR nil).
48
Other non-current financial assets
The changes during 2008 are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
cost- |
|
|
|
|
|
|
|
|
|
available- |
|
|
restricted |
|
|
method |
|
|
|
|
|
|
|
|
|
for-sale |
|
|
liquid |
|
|
invest- |
|
|
|
|
|
|
|
|
|
securities |
|
|
assets |
|
|
ments |
|
|
other |
|
|
total |
|
Balance as of
January 1, 2008 |
|
|
1,776 |
|
|
|
101 |
|
|
|
1,027 |
|
|
|
279 |
|
|
|
3,183 |
|
Changes: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reclassifications |
|
|
1,531 |
|
|
|
(27 |
) |
|
|
(3 |
) |
|
|
24 |
|
|
|
1,525 |
|
Acquisitions/
additions |
|
|
75 |
|
|
|
2 |
|
|
|
2 |
|
|
|
82 |
|
|
|
161 |
|
Sales/
redemptions/
reductions |
|
|
(2,530 |
) |
|
|
|
|
|
|
(2 |
) |
|
|
(22 |
) |
|
|
(2,554 |
) |
Value
adjustments/
impairments |
|
|
(253 |
) |
|
|
|
|
|
|
(673 |
) |
|
|
(69 |
) |
|
|
(995 |
) |
Translation and
exchange
differences |
|
|
|
|
|
|
(1 |
) |
|
|
|
|
|
|
12 |
|
|
|
11 |
|
Balance as of
December 31, 2008
|
|
|
599 |
|
|
|
75 |
|
|
|
351 |
|
|
|
306 |
|
|
|
1,331 |
|
Investments in available-for-sale securities
The Companys investments in
available-for-sale securities consist of
investments in common stock of companies in
various industries.
Major holdings in available-for-sale securities at December 31:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
|
|
number of |
|
|
|
|
|
|
number of |
|
|
|
|
|
|
shares |
|
|
fair value |
|
|
shares |
|
|
fair value |
|
D&M
Holdings
Inc. |
|
|
11,126,640 |
|
|
|
32 |
|
|
|
|
|
|
|
|
|
TSMC |
|
|
1,311,490,224 |
|
|
|
1,699 |
|
|
|
|
|
|
|
|
|
LG Display |
|
|
|
|
|
|
|
|
|
|
47,225,000 |
|
|
|
558 |
|
Pace Micro
Technology
Plc. |
|
|
|
|
|
|
|
|
|
|
50,701,049 |
|
|
|
29 |
|
|
|
|
|
|
|
|
1,731 |
|
|
|
|
|
|
|
587 |
|
During 2008, the Company reduced its
shareholding portfolio of available-for-sale
securities by selling its interests in TSMC
and D&M Holdings (D&M).
In 2007, Philips and TSMC jointly announced
that the companies agreed to a multi-phased
plan to facilitate an orderly exit by Philips
from its shareholding in TSMC. The plan
comprised a private sale transaction to
long-term financial investors in Taiwan, the offering of
shares through a public offering in the United
States (in the form of American Depositary
Shares) and the participation in stock
repurchase programs initiated by TSMC. Under
this agreement, the remaining 1,311 million TSMC shares were sold
during 2008 in various transactions. Philips
realized a gain of EUR 1,205 million on these
transactions. In September 2008, Philips sold
its remaining stake of approximately 13% in
D&M, a Japanese company which manufactures
audio-visual products. The gain on this
transaction was EUR 20 million. The results on
the TSMC and D&M transactions were recognized
in Financial income and expenses.
During 2008, the Company increased its
shareholding portfolio of available-for-sale
securities, primarily as a result of the
reclassification of LG Display from
Investments in equity-accounted investees.
Additionally shares of Pace Micro Technology
(Pace) were received in conjunction with the
divesture of our Set-Top Boxes and
Connectivity Solutions activities.
Until March 2008, LG Display was presented as
an equity-accounted investee. At the end of
February 2008, Philips influence on LG
Displays operating and financial policies
including representation on the LG Display
board, was reduced. Consequently, the 19.9%
investment in LG Display was transferred from
investments in equity-accounted investees to
available-for-sale securities effective March
1, 2008, as Philips was no longer able to
exercise significant influence. The investment
in LG Display was reduced on March 12, 2008,
when 24 million shares were sold in a capital
market transaction to third parties. The EUR
158 million gain on this transaction was
presented in Financial income and expense. At
December 31, 2008, Philips owned 13.2% of LG
Displays share capital. At year-end the fair
value based on the stock price of LG Display
was EUR 448 million below the carrying value
(fair value plus losses recognized in
accumulated other comprehensive income). As
this loss was considered significant, an
impairment charge of EUR 448 million was
recorded, by releasing the accumulated amounts
under Other comprehensive income to Financial
income and expense.
In April 2008, the Company obtained 64.5
million shares in Pace in exchange for the
transfer of the Companys Set-Top Boxes and
Connectivity Solutions activities.
Subsequently, 13.8 million shares were sold to
third parties. The EUR 1 million loss on this
transaction was presented under Financial
income and expenses. As of December 31, 2008,
Philips owns 17% of Paces share capital. At
year-end the fair value based on the stock
price of Pace was EUR 30 million below the
carrying value (fair value plus losses
recognized in accumulated other comprehensive
income). As this loss was considered
significant, an impairment charge of EUR 30
million was recorded, by releasing the
accumulated amounts under Other comprehensive
income to Financial income and expense.
Cost-method investments
The major cost-method investment as of December
31, 2008 is NXP, for an amount of EUR 255
million, of which the Company holds 19.8% of
the common shares. The interest in NXP resulted
from the sale of a majority stake in the
Semiconductors division in September 2006. The
Companys stake in NXP is considered a non-core
activity that is available for sale. Although
the ultimate method of disposal and the precise
market for non-listed shares are not clear, the
disposal could be effected, for example, by way
of a private transaction to strategic buyers or
other financial parties, or via a public
offering. The Company does not have any
definitive plans to dispose of this interest.
NXP is a privately held company that is not
quoted in an active market. NXP is carried at
cost because the fair value cannot be reliably
determined. The variability in the range of
reasonable fair value estimates is significant
and the probabilities of the various estimates
within the range of reasonable inputs are not
sufficiently reliable to determine a
fair value. This is mainly due to the nature of
the majority shareholders (private equity
firms) and their potentially volatile
investment and exit strategy, as well as to the
nature and limited availability of the
financial projections of NXP. Triggered by the
deteriorating economic environment of the
semiconductors industry in general and the
weakening financial performance of NXP
specifically, Philips performed impairment
reviews on the carrying value of the investment
in NXP in 2007 and 2008. During 2008,
impairment charges were recognized in the
amount of EUR 599 million, which are presented
in Financial income and expenses.
In accordance with IAS 39, Financial
Instruments: Recognition and Measurement,
paragraph 66, if there is objective evidence
that an impairment loss has been incurred for
an unquoted equity investment carried at cost,
the amount of the impairment loss is measured
as the difference between the carrying amount
of the investment and the present value of the
estimated discounted future cash-flows.
Philips Annual Report 2008 229
|
|
|
|
|
|
|
124
US GAAP financial statements
|
|
180
Sustainability performance
|
|
192
IFRS financial statements
Notes to the IFRS financial
statements
|
|
244
Company financial statements |
The discounted future cash-flows have been
estimated using various valuation techniques
including multiplier calculations (EBITDA
multiples), calculations based on the share
price performance of a peer group of listed
(semiconductor) companies and discounted
cash-flow models based on unobservable inputs.
The latter methodology involved estimates of
revenues, expenses, capital spending and other
costs, as well as a discount rate calculated
based on the risk profile of the semiconductor
industry. Taking into account certain market
considerations and the range of estimated fair
values, management determined that the best
estimate of future cash-flows for the NXP
investment was EUR 255 million at December 31,
2008. However, the resulting estimated
discounted cash-flow amount used for impairment
purposes represents an estimate; the actual
cash-flows of this interest could materially
differ from that estimate.
Another significant cost-method investment is
that in TPO Displays Corp. (TPO). The Company
obtained a 17.4% stake in TPO after the merger
of MDS with TPO in 2006. The value of the
investment at amortized cost is EUR 32 million,
net of impairments. The Company performed
impairment reviews of the TPO investment, which
resulted in an impairment charge of EUR 71
million in 2008 and EUR 77 million in 2006,
recognized in Financial income and expense. The
impairment review in 2008 was triggered by the
deteriorating economic environment of the
connected displays industry and the weakening
financial performance of TPO. The valuation was
based on the over-the-counter stock price of
TPO, quoted on the Gre Tai Securities Market in
Taiwan, a market with insufficient trading
volumes and infrequent transactions.
Other
Included in the category other are two
convertible bonds, one issued by TPV Technology
(TPV) and one issued by CBAY.
The convertible bond issued by TPV has a total
fair value of EUR 142 million as at December
31, 2008. The bond has a maturity date of
September 5, 2010, with an option to convert
the bond into shares of TPV during the period
September 5, 2008 until maturity.
The CBAY convertible bond, which may not be
transferred to a third party before August 6,
2009, has a total fair value EUR 51 million as
at December 31, 2008. The bond has a maturity
date of August 6, 2015. Philips has an option
to convert the bond into shares of CBAY before
the maturity date or to sell the convertible
bond to CBAY as of August 2012 onwards. CBAY
also has options to redeem the convertible
bonds in 2011, 2012 and 2013 at a certain
percentage of the bonds face value.
49
Non-current receivables
Non-current receivables include receivables
with a remaining term of more than one year,
and the non-current portion of income taxes
receivable amounting to EUR 1 million (2007:
EUR 14 million).
50
Other non-current assets
Other non-current assets in 2008 are
comprised of prepaid pension costs of EUR
1,858 million (2007: EUR 2,558 million) and
prepaid expenses of EUR 48 million (2007: EUR
52 million).
51
Property, plant and equipment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
prepayments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
and |
|
|
no longer |
|
|
|
|
|
|
land and |
|
|
machinery and |
|
|
|
|
|
|
other |
|
|
construction |
|
|
productively |
|
|
|
|
|
|
buildings |
|
|
installations |
|
|
lease assets |
|
|
equipment |
|
|
in progress |
|
|
employed |
|
|
total |
|
Balance as of January 1, 2008: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost |
|
|
2,303 |
|
|
|
3,404 |
|
|
|
88 |
|
|
|
1,746 |
|
|
|
343 |
|
|
|
13 |
|
|
|
7,897 |
|
Accumulated depreciation |
|
|
(934 |
) |
|
|
(2,324 |
) |
|
|
(48 |
) |
|
|
(1,388 |
) |
|
|
|
|
|
|
(9 |
) |
|
|
(4,703 |
) |
Book value |
|
|
1,369 |
|
|
|
1,080 |
|
|
|
40 |
|
|
|
358 |
|
|
|
343 |
|
|
|
4 |
|
|
|
3,194 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in book value: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures |
|
|
101 |
|
|
|
339 |
|
|
|
37 |
|
|
|
276 |
|
|
|
9 |
|
|
|
8 |
|
|
|
770 |
|
Retirements and sales |
|
|
(51 |
) |
|
|
(33 |
) |
|
|
|
|
|
|
(36 |
) |
|
|
(7 |
) |
|
|
|
|
|
|
(127 |
) |
Depreciation |
|
|
(90 |
) |
|
|
(332 |
) |
|
|
(13 |
) |
|
|
(197 |
) |
|
|
|
|
|
|
|
|
|
|
(632 |
) |
Write-downs and impairments |
|
|
(1 |
) |
|
|
(39 |
) |
|
|
|
|
|
|
(17 |
) |
|
|
|
|
|
|
|
|
|
|
(57 |
) |
Translation differences |
|
|
9 |
|
|
|
12 |
|
|
|
9 |
|
|
|
3 |
|
|
|
2 |
|
|
|
|
|
|
|
35 |
|
Changes in consolidation |
|
|
133 |
|
|
|
95 |
|
|
|
25 |
|
|
|
60 |
|
|
|
|
|
|
|
|
|
|
|
313 |
|
Total changes |
|
|
101 |
|
|
|
42 |
|
|
|
58 |
|
|
|
89 |
|
|
|
4 |
|
|
|
8 |
|
|
|
302 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 31, 2008: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost |
|
|
2,353 |
|
|
|
3,443 |
|
|
|
128 |
|
|
|
1,746 |
|
|
|
347 |
|
|
|
48 |
|
|
|
8,065 |
|
Accumulated depreciation |
|
|
(883 |
) |
|
|
(2,321 |
) |
|
|
(30 |
) |
|
|
(1,299 |
) |
|
|
|
|
|
|
(36 |
) |
|
|
(4,569 |
) |
Book value |
|
|
1,470 |
|
|
|
1,122 |
|
|
|
98 |
|
|
|
447 |
|
|
|
347 |
|
|
|
12 |
|
|
|
3,496 |
|
Land with a book value of EUR 185 million at December 31, 2008 (2007: EUR 148 million) is not
depreciated.
The expected useful lives of property, plant and equipment are as follows:
|
|
|
Buildings
|
|
from 5 to 50 years |
Machinery and installations
|
|
from 3 to 10 years |
Lease assets
|
|
from 1 to 15 years |
Other equipment
|
|
from 1 to 10 years |
Capital expenditures include capitalized
interest related to construction in progress
amounting to EUR 3 million (2007: EUR 5
million).
230 Philips Annual Report 2008
|
|
|
|
|
|
|
250
Reconciliation of
non-US GAAP information
|
|
254
Corporate governance
|
|
262
Ten-year overview
|
|
266
Investor information |
52
Intangible assets excluding goodwill
The changes during 2008 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
other |
|
|
|
|
|
|
|
|
|
|
|
|
intangible |
|
|
product |
|
|
|
|
|
|
|
|
|
assets |
|
|
development |
|
|
software |
|
|
total |
|
Balance as of
January 1,
2008: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost |
|
|
2,848 |
|
|
|
1,146 |
|
|
|
615 |
|
|
|
4,609 |
|
Accumulated
amortization |
|
|
(743 |
) |
|
|
(627 |
) |
|
|
(404 |
) |
|
|
(1,774 |
) |
Book value |
|
|
2,105 |
|
|
|
519 |
|
|
|
211 |
|
|
|
2,835 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Changes in
book value: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additions |
|
|
3 |
|
|
|
154 |
|
|
|
118 |
|
|
|
275 |
|
Acquisitions |
|
|
2,093 |
|
|
|
15 |
|
|
|
|
|
|
|
2,108 |
|
Amortization/
deductions |
|
|
(389 |
) |
|
|
(234 |
) |
|
|
(92 |
) |
|
|
(715 |
) |
Impairment
losses |
|
|
|
|
|
|
(84 |
) |
|
|
|
|
|
|
(84 |
) |
Translation
differences |
|
|
64 |
|
|
|
9 |
|
|
|
5 |
|
|
|
78 |
|
Other |
|
|
8 |
|
|
|
(22 |
) |
|
|
(6 |
) |
|
|
(20 |
) |
Total changes |
|
|
1,779 |
|
|
|
(162 |
) |
|
|
25 |
|
|
|
1,642 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of
December 31,
2008: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost |
|
|
5,021 |
|
|
|
805 |
|
|
|
702 |
|
|
|
6,528 |
|
Accumulated
amortization |
|
|
(1,137 |
) |
|
|
(448 |
) |
|
|
(466 |
) |
|
|
(2,051 |
) |
Book Value |
|
|
3,884 |
|
|
|
357 |
|
|
|
236 |
|
|
|
4,477 |
|
Other intangible assets in 2008 consist of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
January 1 |
|
|
December 31 |
|
|
|
|
|
|
|
accumulated |
|
|
|
|
|
|
accumulated |
|
|
|
gross |
|
|
amortization |
|
|
gross |
|
|
amortization |
|
Marketing-
related |
|
|
179 |
|
|
|
(31 |
) |
|
|
81 |
|
|
|
(26 |
) |
Customer-
related |
|
|
1,124 |
|
|
|
(195 |
) |
|
|
2,619 |
|
|
|
(380 |
) |
Contract-
based |
|
|
33 |
|
|
|
(10 |
) |
|
|
36 |
|
|
|
(17 |
) |
Technology-
based |
|
|
861 |
|
|
|
(417 |
) |
|
|
1,489 |
|
|
|
(575 |
) |
Patents and
trademarks |
|
|
651 |
|
|
|
(90 |
) |
|
|
796 |
|
|
|
(139 |
) |
|
|
|
2,848 |
|
|
|
(743 |
) |
|
|
5,021 |
|
|
|
(1,137 |
) |
The estimated amortization expense for these
other intangible assets for each of the five
succeeding years are:
|
|
|
|
|
2009 |
|
|
417 |
|
2010 |
|
|
399 |
|
2011 |
|
|
361 |
|
2012 |
|
|
335 |
|
2013 |
|
|
306 |
|
The expected weighted average remaining
life of other intangible assets is 11.1
years as of December 31, 2008.
The additions acquired through business
combinations in 2008 consist of the acquired
intangible assets of Respironics of EUR 1,186
million, Genlyte of EUR 860 million, and VISICU
of EUR 33 million. The acquired intangible
assets mainly consist of customer relationships
and patents of Respironics of EUR 732 million
and Genlyte EUR 614 million, and core
technology of Respironics of EUR 355 million
and VISICU of EUR 20 million.
The unamortized costs of computer software to
be sold, leased or otherwise marketed
amounted to EUR 95 million (2007: EUR 63
million). The amounts charged to the income
statement for amortization or impairment of
these capitalized computer software costs
amounted to EUR 33 million (2007: EUR 20
million)
53
Goodwill
The changes in 2007 and 2008 were as follows:
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Balance as of January 1: |
|
|
|
|
|
|
|
|
Cost |
|
|
3,822 |
|
|
|
4,173 |
|
Amortization / Impairments |
|
|
(416 |
) |
|
|
(373 |
) |
Book value |
|
|
3,406 |
|
|
|
3,800 |
|
|
|
|
|
|
|
|
|
|
Changes in book value: |
|
|
|
|
|
|
|
|
Acquisitions |
|
|
760 |
|
|
|
3,450 |
|
Impairments |
|
|
|
|
|
|
(301 |
) |
Translation differences |
|
|
(366 |
) |
|
|
331 |
|
|
|
|
|
|
|
|
|
|
Balance as of December 31: |
|
|
|
|
|
|
|
|
Cost |
|
|
4,173 |
|
|
|
7,952 |
|
Amortization / Impairments |
|
|
(373 |
) |
|
|
(672 |
) |
Book value |
|
|
3,800 |
|
|
|
7,280 |
|
Acquisitions in 2008 include goodwill related
to the acquisitions of Respironics for EUR
2,162 million, Genlyte for EUR 1,024 million,
VISICU for EUR 175 million, and several smaller
acquisitions. Acquisitions in 2007 include
goodwill related to the acquisitions of
Partners in Lighting for EUR 297 million and
Color Kinetics for EUR 358 million and several
smaller acquisitions. In addition, goodwill
changed due to the finalization of purchase
price accounting related to acquisitions in
prior years.
A significant part of goodwill is allocated to the following businesses:
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Home Healthcare Solutions |
|
|
385 |
|
|
|
2,804 |
|
Professional Luminaires |
|
|
348 |
|
|
|
1,427 |
|
Imaging Systems |
|
|
1,141 |
|
|
|
1,197 |
|
Philips Annual Report 2008 231
|
|
|
|
|
|
|
124
US GAAP financial statements
|
|
180
Sustainability performance
|
|
192
IFRS financial statements
Notes to the IFRS financial
statements
|
|
244
Company financial statements |
Home Healthcare Solutions and Professional
Luminaires increased by the acquisitions of
Respironics and Genlyte, respectively (see note
39) and are the most sensitive to fluctuations
in the key assumptions used in the impairment
tests as set out below.
The key assumptions used in the annual
(performed in Q2) and trigger-based impairment
tests were growth of sales and gross margin,
together with the rates used for discounting
the forecast cash flows. Sales and gross margin
growth are based on managements internal
forecasts that cover an initial period of no
more than five years and then are extrapolated
with stable or declining growth rates, after
which a terminal value is calculated for which
growth rates are capped. The pre-tax discount
rates are determined for each cash-generating
unit (typically one level below sector level)
and, in the annual test, ranged from 9.4% to
15.6%.
Due to deteriorating economic circumstances
and the decline of the market capitalization
of the company, trigger-based impairment tests
were performed in the latter half of the year
using updated assumptions. The pre-tax
discount rates for Home Healthcare Solutions,
Professional Luminaires and Imaging Systems
were 12.2%, 14.0% and 10.5%, respectively and
the growth rate cap applied to the terminal
value was 2.7%.
The trigger-based tests resulted in goodwill
impairment charges of EUR 301 million, mainly
related to Lumileds as a consequence of weaker
demand for LED solutions in the automotive,
display and cell phone markets. The pre-tax
discount rate used for the Lumileds impairment
test was 14.6%.
Please refer to the Information by sector
and main country that begins on page 206 of
this Annual Report for a specification of
goodwill by sector.
54
Accrued liabilities
Accrued liabilities are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Personnel-related costs: |
|
|
|
|
|
|
|
|
- Salaries and wages |
|
|
433 |
|
|
|
438 |
|
- Accrued holiday entitlements |
|
|
178 |
|
|
|
192 |
|
- Other personnel-related costs |
|
|
169 |
|
|
|
161 |
|
Fixed-asset-related costs: |
|
|
|
|
|
|
|
|
- Gas, water, electricity, rent and other |
|
|
62 |
|
|
|
69 |
|
Taxes: |
|
|
|
|
|
|
|
|
- Income tax payable |
|
|
154 |
|
|
|
132 |
|
- Other taxes payable |
|
|
12 |
|
|
|
16 |
|
Communication & IT costs |
|
|
31 |
|
|
|
23 |
|
Distribution costs |
|
|
109 |
|
|
|
92 |
|
Sales-related costs: |
|
|
|
|
|
|
|
|
- Commission payable |
|
|
43 |
|
|
|
53 |
|
- Advertising and marketing-related costs |
|
|
66 |
|
|
|
87 |
|
- Other sales-related costs |
|
|
206 |
|
|
|
249 |
|
Material-related costs |
|
|
134 |
|
|
|
170 |
|
Interest-related accruals |
|
|
110 |
|
|
|
79 |
|
Deferred income |
|
|
556 |
|
|
|
664 |
|
Derivative instruments liabilities (see note 68) |
|
|
144 |
|
|
|
505 |
|
Restructuring-related liabilities |
|
|
20 |
|
|
|
165 |
|
Other accrued liabilities |
|
|
548 |
|
|
|
539 |
|
|
|
|
2,975 |
|
|
|
3,634 |
|
Please refer to note 42 for a specification on the income tax payable.
55
Provisions
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
|
|
long- |
|
|
short- |
|
|
long- |
|
|
short- |
|
|
|
term |
|
|
term |
|
|
term |
|
|
term |
|
Provisions for defined-benefit
plans (see note 56) |
|
|
750 |
|
|
|
68 |
|
|
|
699 |
|
|
|
64 |
|
Other postretirement benefits
(see note 56) |
|
|
396 |
|
|
|
23 |
|
|
|
329 |
|
|
|
23 |
|
Postemployment benefits and
obligatory severance payments |
|
|
92 |
|
|
|
11 |
|
|
|
73 |
|
|
|
16 |
|
Product warranty |
|
|
133 |
|
|
|
190 |
|
|
|
107 |
|
|
|
203 |
|
Loss contingencies (environmental
remediation and product liability) |
|
|
402 |
|
|
|
49 |
|
|
|
178 |
|
|
|
634 |
|
Restructuring-related provisions |
|
|
22 |
|
|
|
2 |
|
|
|
161 |
|
|
|
40 |
|
Other provisions |
|
|
226 |
|
|
|
39 |
|
|
|
247 |
|
|
|
63 |
|
|
|
|
2,021 |
|
|
|
382 |
|
|
|
1,794 |
|
|
|
1,043 |
|
Product warranty
The provision for product warranty reflects
the estimated costs of replacement and
free-of-charge services that will be incurred
by the Group with respect to products sold.
The changes in the provision for product
warranty are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Balance as of January 1 |
|
|
378 |
|
|
|
365 |
|
|
|
323 |
|
Changes: |
|
|
|
|
|
|
|
|
|
|
|
|
Additions |
|
|
438 |
|
|
|
354 |
|
|
|
333 |
|
Utilizations |
|
|
(443 |
) |
|
|
(369 |
) |
|
|
(357 |
) |
Translation differences |
|
|
(13 |
) |
|
|
(16 |
) |
|
|
(3 |
) |
Changes in consolidation |
|
|
5 |
|
|
|
(11 |
) |
|
|
14 |
|
Balance as of December 31 |
|
|
365 |
|
|
|
323 |
|
|
|
310 |
|
Loss contingencies (environmental remediation and product liability)
This provision
includes accrued losses recorded with respect
to environmental remediation and product
liability (including asbestos) obligations
which are probable and can be estimated
reliably. The asbestos liabilities have been
classified as current at December 31, 2008.
Please refer to note 62.
The changes in this provision are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Balance as of January 1 |
|
|
287 |
|
|
|
510 |
|
|
|
451 |
|
Changes: |
|
|
|
|
|
|
|
|
|
|
|
|
Additions |
|
|
304 |
|
|
|
16 |
|
|
|
318 |
|
Utilizations |
|
|
(39 |
) |
|
|
(66 |
) |
|
|
(15 |
) |
Releases |
|
|
(5 |
) |
|
|
29 |
|
|
|
37 |
|
Translation differences |
|
|
(37 |
) |
|
|
(38 |
) |
|
|
21 |
|
Balance as of December 31 |
|
|
510 |
|
|
|
451 |
|
|
|
812 |
|
Postemployment benefits and obligatory severance payments
The provision for
postemployment benefits covers benefits
provided to former or inactive employees after
employment but before retirement, including
salary continuation, supplemental unemployment
benefits and disability-related benefits.
The provision for obligatory severance payments
covers the Companys commitment to pay
employees a lump sum upon the employees
dismissal or resignation. In the event that a
former employee has passed away, the Company
may have a commitment to pay a lump sum to the
deceased employees relatives.
Other provisions
Other provisions include provisions for
employee jubilee funds totaling EUR 76 million
(2007: EUR 79 million) and expected
losses on existing projects/orders totaling EUR
13 million (2007: EUR 14 million).
232 Philips Annual Report 2008
|
|
|
|
|
|
|
250
Reconciliation of
non-US GAAP information
|
|
254
Corporate governance
|
|
262
Ten-year overview
|
|
266
Investor information |
56
Pensions and postretirement benefits other than pensions
Change in accounting policy
As a result of the change in the pension accounting policy by adopting the option available
under IAS 19 paragraph 93A, previously unrecognized actuarial gains and losses are recognized in
full and recorded in the Statement of recognized income and expenses (Sorie). IFRIC 14, which
was early adopted on January 1, 2008, clarified the extent to which a defined-benefit asset
could be recognized in the financial statements. The combined impact of these two changes in
accounting policy at January 1, 2006, reduced the overall net pension liability recognized in
the financial statements by EUR 1,216 million (pre-tax). The financial quantification of this
change is disclosed in the following table:
Change in accounting policy Balance sheet impact
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
effect of accounting |
|
|
|
|
|
|
previous policy |
|
|
policy changes |
|
|
new policy |
|
January 1, 2006 |
|
|
|
|
|
|
|
|
|
|
|
|
Prepaid pension costs under non-current assets |
|
|
95 |
|
|
|
1,559 |
|
|
|
1,654 |
|
Accrued pension costs under non-current liabilities |
|
|
(687 |
) |
|
|
(248 |
) |
|
|
(935 |
) |
Provision for pensions under non-current provisions |
|
|
(703 |
) |
|
|
(126 |
) |
|
|
(829 |
) |
Provision for other post retirement benefits under non-current provisions |
|
|
(446 |
) |
|
|
31 |
|
|
|
(415 |
) |
Deferred income tax asset |
|
|
2,123 |
|
|
|
45 |
|
|
|
2,168 |
|
Deferred income tax liabilities |
|
|
(274 |
)1) |
|
|
(400 |
) |
|
|
(674 |
) |
Stockholders equity |
|
|
16,287 |
1) |
|
|
862 |
|
|
|
17,149 |
|
December 31, 2006 |
|
|
|
|
|
|
|
|
|
|
|
|
Prepaid pension costs under non-current assets |
|
|
343 |
|
|
|
1,823 |
|
|
|
2,166 |
|
Accrued pension costs under non-current liabilities |
|
|
(298 |
) |
|
|
(127 |
) |
|
|
(425 |
) |
Provision for pensions under non-current provisions |
|
|
(677 |
) |
|
|
(115 |
) |
|
|
(792 |
) |
Provision for other post retirement benefits under non-current provisions |
|
|
(372 |
) |
|
|
35 |
|
|
|
(337 |
) |
Deferred income tax asset |
|
|
1,449 |
|
|
|
37 |
|
|
|
1,486 |
|
Deferred income tax liabilities |
|
|
(251 |
)1) |
|
|
(430 |
) |
|
|
(681 |
) |
Stockholders equity |
|
|
21,876 |
1) |
|
|
1,223 |
|
|
|
23,099 |
|
December 31, 2007 |
|
|
|
|
|
|
|
|
|
|
|
|
Prepaid pension costs under non-current assets |
|
|
331 |
|
|
|
2,227 |
|
|
|
2,558 |
|
Accrued pension costs under non-current liabilities |
|
|
(261 |
) |
|
|
(98 |
) |
|
|
(359 |
) |
Provision for pensions under non-current provisions |
|
|
(676 |
) |
|
|
(74 |
) |
|
|
(750 |
) |
Provision for other post retirement benefits under non-current provisions |
|
|
(364 |
) |
|
|
(32 |
) |
|
|
(396 |
) |
Deferred income tax asset |
|
|
1,271 |
|
|
|
|
|
|
|
1,271 |
|
Deferred income tax liabilities |
|
|
(126 |
)1) |
|
|
(526 |
) |
|
|
(652 |
) |
Stockholders equity |
|
|
20,245 |
1) |
|
|
1,496 |
|
|
|
21,741 |
|
Change in accounting policy Income statement impact
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
effect of |
|
|
|
|
|
|
|
|
|
|
accounting |
|
|
|
|
|
|
previous policy |
|
|
policy changes |
|
|
new policy |
|
December 31, 2006 |
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales |
|
|
(18,451 |
)1) |
|
|
49 |
|
|
|
(18,402 |
) |
Selling expenses |
|
|
(4,679 |
) |
|
|
19 |
|
|
|
(4,660 |
) |
General and administrative expenses |
|
|
(1,174 |
) |
|
|
267 |
|
|
|
(907 |
) |
Research and development expenses |
|
|
(1,603 |
) |
|
|
47 |
|
|
|
(1,556 |
) |
Discontinued operations |
|
|
4,010 |
|
|
|
144 |
|
|
|
4,154 |
|
Income tax expense |
|
|
(188 |
)1) |
|
|
(35 |
) |
|
|
(223 |
) |
Net income |
|
|
4,662 |
|
|
|
491 |
|
|
|
5,153 |
|
December 31, 2007 |
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales |
|
|
(17,689 |
)1) |
|
|
21 |
|
|
|
(17,668 |
) |
Selling expenses |
|
|
(4,985 |
) |
|
|
10 |
|
|
|
(4,975 |
) |
General and administrative expenses |
|
|
(1,124 |
) |
|
|
338 |
|
|
|
(786 |
) |
Research and development expenses |
|
|
(1,617 |
) |
|
|
16 |
|
|
|
(1,601 |
) |
Discontinued operations |
|
|
(73 |
) |
|
|
(65 |
) |
|
|
(138 |
) |
Income tax expense |
|
|
(488 |
)1) |
|
|
(94 |
) |
|
|
(582 |
) |
Net income |
|
|
4,647 |
|
|
|
226 |
|
|
|
4,873 |
|
|
|
|
1) |
|
Prior-period amounts have been revised to reflect immaterial adjustments of intercompany
profit elimination on inventory (see Significant accounting policies, Reclassifications and
revisions). |
Philips Annual Report 2008 233
|
|
|
|
|
|
|
124
US GAAP financial statements
|
|
180
Sustainability performance
|
|
192
IFRS financial statements
Notes to the IFRS financial
statements
|
|
244
Company financial statements |
Defined-benefit plans
Employee pension plans have been established in
many countries in accordance with the legal
requirements, customs and the local situation
in the countries involved. The majority of
employees in Europe and North America are
covered by defined-benefit plans. The benefits
provided by these plans are based on employees
years of service and compensation levels. The
measurement date for all defined-benefit plans
is December 31.
The Companys contributions to the funding of
defined-benefit pension plans are determined
based upon various factors, including funded
status, legal and tax considerations as well
as local customs.
Summary of pre-tax costs for pensions and other post retirement benefits
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Defined-benefit plans |
|
|
(10 |
) |
|
|
(38 |
) |
|
|
(21 |
) |
Defined-contribution plans including
multi-employer plans |
|
|
80 |
|
|
|
84 |
|
|
|
96 |
|
Retiree medical plans |
|
|
30 |
|
|
|
29 |
|
|
|
31 |
|
|
|
|
100 |
|
|
|
75 |
|
|
|
106 |
|
The table below provides a summary of the
changes in the projected benefit obligations
for defined-benefit pension plans and the fair
value of their assets for 2008 and 2007. It
also provides a reconciliation of the funded
status of these plans to the amounts recognized
in the consolidated balance sheets.
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Projected benefit obligation at the beginning of year |
|
|
20,410 |
|
|
|
18,679 |
|
Service cost |
|
|
265 |
|
|
|
219 |
|
Interest cost |
|
|
920 |
|
|
|
922 |
|
Employee contributions |
|
|
4 |
|
|
|
4 |
|
Actuarial (gains) or losses |
|
|
(756 |
) |
|
|
(1,182 |
) |
Plan amendments |
|
|
4 |
|
|
|
1 |
|
Settlements |
|
|
(502 |
) |
|
|
(22 |
) |
Curtailments |
|
|
2 |
|
|
|
(1 |
) |
Changes in consolidation |
|
|
49 |
|
|
|
106 |
|
Benefits paid |
|
|
(1,152 |
) |
|
|
(1,190 |
) |
Exchange rate differences |
|
|
(564 |
) |
|
|
(688 |
) |
Miscellaneous |
|
|
(1 |
) |
|
|
(2 |
) |
Projected benefit obligation at end of year |
|
|
18,679 |
|
|
|
16,846 |
|
|
|
|
|
|
|
|
|
|
Present value of funded obligations at end of year |
|
|
17,866 |
|
|
|
16,085 |
|
Present value of unfunded obligations at end
of year |
|
|
813 |
|
|
|
761 |
|
Movement in plan assets:
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Fair value of plan assets at beginning of year |
|
|
21,352 |
|
|
|
20,200 |
|
Expected return on plan assets |
|
|
1,216 |
|
|
|
1,161 |
|
Actuarial gains and (losses) on plan assets |
|
|
(571 |
) |
|
|
(1,955 |
) |
Employee contributions |
|
|
4 |
|
|
|
4 |
|
Employer contributions |
|
|
332 |
|
|
|
184 |
|
Settlements |
|
|
(577 |
) |
|
|
(22 |
) |
Changes in consolidation |
|
|
53 |
|
|
|
88 |
|
Benefits paid |
|
|
(1,083 |
) |
|
|
(1,113 |
) |
Exchange rate differences |
|
|
(525 |
) |
|
|
(649 |
) |
Miscellaneous |
|
|
(1 |
) |
|
|
1 |
|
Fair value of plan assets at end of year |
|
|
20,200 |
|
|
|
17,899 |
|
|
|
|
|
|
|
|
|
|
Funded status |
|
|
1,521 |
|
|
|
1,053 |
|
Unrecognized prior-service cost |
|
|
5 |
|
|
|
3 |
|
Unrecognized net assets |
|
|
(145 |
) |
|
|
(893 |
) |
Net balance sheet position |
|
|
1,381 |
|
|
|
163 |
|
The unrecognized net assets in 2008 are
primarily related to the capped prepaid
pension asset in the Netherlands, in 2007
primarily to the capped prepaid in Brazil.
The classification of the net balance is as follows:
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Prepaid pension costs under other non-current
assets |
|
|
2,558 |
|
|
|
1,858 |
|
Accrued pension costs under other non-current
liabilities |
|
|
(359 |
) |
|
|
(932 |
) |
Provision for pensions under provisions |
|
|
(818 |
) |
|
|
(763 |
) |
|
|
|
1,381 |
|
|
|
163 |
|
Cumulative amount of actuarial (gains) and
losses recognized in the statement of
recognized income and expense (pre tax):
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Balance as of January 1 |
|
|
518 |
|
|
|
343 |
|
New consolidations |
|
|
(2 |
) |
|
|
|
|
Net actuarial loss (gain) |
|
|
(220 |
) |
|
|
623 |
|
Change in the effect of the cap on prepaid |
|
|
47 |
|
|
|
748 |
|
Balance as of December 31 |
|
|
343 |
|
|
|
1,714 |
|
Plan assets in the Netherlands
The Companys pension plan asset allocation
in the Netherlands at December 31, 2007 and
2008 was as follows:
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
|
|
actual |
|
|
actual |
|
|
|
% |
|
|
% |
|
Matching portfolio: |
|
|
59 |
|
|
|
75 |
|
- Debt securities |
|
|
59 |
|
|
|
75 |
|
Return portfolio: |
|
|
41 |
|
|
|
25 |
|
- Equity securities |
|
|
28 |
|
|
|
13 |
|
- Real estate |
|
|
8 |
|
|
|
4 |
|
- Other |
|
|
5 |
|
|
|
8 |
|
|
|
|
100 |
|
|
|
100 |
|
234 Philips Annual Report 2008
|
|
|
|
|
|
|
250
Reconciliation of
non-US GAAP information
|
|
254
Corporate governance
|
|
262
Ten-year overview
|
|
266
Investor information |
The objective of the Matching portfolio is to
match the interest rate sensitivity of the
plans real pension liabilities. The Matching
portfolio is mainly invested in
euro-denominated government bonds and
investment grade debt securities and
derivatives. Leverage or gearing is not
permitted. The size of the Matching portfolio
is supposed to be at least 70% of the fair
value of the plans real pension obligations
(on the assumption of 2% inflation). The
objective of the Return portfolio is to
maximize returns within well-specified risk
constraints. The long-term rate of return on
total plan assets is expected to be 5.95% per
annum, based on expected long-term returns on
equity securities, debt securities, real estate
and other investments of 8.3%, 4.0%, 6.5% and
5.0%, respectively.
Philips Pension Fund in the Netherlands
On November 13, 2007, various officials, on
behalf of the Public Prosecutors office in The
Netherlands, visited a number of offices of the
Philips Pension Fund and the Company in
relation to a widespread investigation into
potential fraud in the real estate sector. The
Company was notified that one former employee
and one employee of an affiliate of the Company
had been detained. This affiliate, Philips Real
Estate Investment Management BV, managed the
real estate portfolio of the Philips Pension
Fund between 2002 and 2007. The investigation
by the public prosecutor is concerned with the
potential involvement of (former) employees of
a number of Dutch companies with respect to
fraud in the context of certain real estate
transactions. Neither the Philips Pension Fund
nor any Philips entity is a suspect in this
investigation. The Philips Pension Fund and
Philips are cooperating with the authorities
and have also started their own investigation.
The investigators expect to finalize their
report in early 2009. Formal notifications of
suspected fraud have been filed with the public
prosecutor against the (former) employees
concerned and with our insurers. If any losses
have been suffered, action will be taken to
recover such losses from the responsible
individuals or legal entities. At this time it
is not possible to assess the outcome of this
matter nor the potential consequences. At
present, it is managements assessment that
this matter will not cause a decline in plan
assets or an increase in pension costs in any
material respect.
Plan assets in other countries
The Companys pension plan asset allocation
in other countries at December 31, 2007 and
December 31,2008 is shown in the table
below. This table also shows the target
allocation for 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
|
2009 |
|
|
|
actual |
|
|
actual |
|
|
target |
|
|
|
% |
|
|
% |
|
|
% |
|
Equity securities |
|
|
24 |
|
|
|
18 |
|
|
|
20 |
|
Debt securities |
|
|
73 |
|
|
|
73 |
|
|
|
74 |
|
Real estate |
|
|
2 |
|
|
|
3 |
|
|
|
2 |
|
Other |
|
|
1 |
|
|
|
6 |
|
|
|
4 |
|
|
|
|
100 |
|
|
|
100 |
|
|
|
100 |
|
Plan assets include property occupied by the
Philips Group with a fair value of EUR 12
million (2007: EUR 12 million).
Pension expense of defined-benefit plans
recognized in the income statement:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Service cost |
|
|
327 |
|
|
|
265 |
|
|
|
219 |
|
Interest cost on the projected benefit
obligation |
|
|
942 |
|
|
|
920 |
|
|
|
922 |
|
Expected return on plan assets |
|
|
(1,214 |
) |
|
|
(1,216 |
) |
|
|
(1,161 |
) |
Prior-service cost |
|
|
6 |
|
|
|
9 |
|
|
|
2 |
|
Settlement loss |
|
|
3 |
|
|
|
(12 |
) |
|
|
|
|
Curtailment benefit |
|
|
(25 |
) |
|
|
2 |
|
|
|
|
|
Other |
|
|
(4 |
) |
|
|
(6 |
) |
|
|
(3 |
) |
|
|
|
35 |
|
|
|
(38 |
) |
|
|
(21 |
) |
of which discontinued operations |
|
|
45 |
|
|
|
|
|
|
|
|
|
Amounts recognized in the Statement of
recognized income and expenses (Sorie):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Actuarial (gains) and losses |
|
|
71 |
|
|
|
(182 |
) |
|
|
623 |
|
Change in the effect of the cap
on prepaids |
|
|
43 |
|
|
|
47 |
|
|
|
748 |
|
Total recognized in Sorie |
|
|
114 |
|
|
|
(135 |
) |
|
|
1,371 |
|
|
Total recognized in net periodic
pension cost and Sorie |
|
|
149 |
|
|
|
(173 |
) |
|
|
1,350 |
|
|
Actual return on plan assets |
|
|
1,050 |
|
|
|
645 |
|
|
|
(794 |
) |
The pension expense of defined-benefit
plans is recognized in the following line
items:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Cost of sales |
|
|
(9 |
) |
|
|
5 |
|
|
|
(23 |
) |
Selling expenses |
|
|
32 |
|
|
|
31 |
|
|
|
24 |
|
General and administrative expenses |
|
|
(10 |
) |
|
|
(75 |
) |
|
|
(23 |
) |
Research and development expenses |
|
|
(23 |
) |
|
|
1 |
|
|
|
1 |
|
|
|
|
(10 |
) |
|
|
(38 |
) |
|
|
(21 |
) |
The Company also sponsors defined-contribution
and similar types of plans for a significant
number of salaried employees. The total cost of
these plans amounted to EUR 96 million (2007:
EUR 84 million, 2006: EUR 80 million). In 2008,
the defined-contribution cost includes
contributions to multi-employer plans of EUR 4
million (2007: EUR 4 million; 2006: EUR 4
million).
Cash flows
Philips expects considerable cash outflows in
relation to employee benefits which are
estimated to amount to EUR 414 million in
2009, consisting of EUR 248 million employer
contributions to defined-benefit pension
plans, EUR 100 million employer contributions
to defined-contribution pension plans, and
EUR 66 million expected cash outflows in
relation to unfunded pension plans. The
employer contributions to defined-benefit
pension plans are expected to amount to EUR
180 million for the Netherlands and EUR 68
million for other countries.
Expected returns per asset class are based on
the assumption that asset valuations tend to
return to their respective long-term
equilibria. The Expected Return on Assets for
any funded plan equals the average of the
expected returns per asset class weighted by
their portfolio weights in accordance with the
funds strategic asset allocation.
The weighted averages of the assumptions
used to calculate the projected benefit
obligations as of December 31 were as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
|
|
Nether- |
|
|
|
|
|
|
Nether- |
|
|
|
|
|
|
lands |
|
|
other |
|
|
lands |
|
|
other |
|
Discount rate |
|
|
4.8 |
% |
|
|
5.6 |
% |
|
|
5.3 |
% |
|
|
6.0 |
% |
Rate of
compensation
increase |
|
|
* |
|
|
|
3.9 |
% |
|
|
* |
|
|
|
3.4 |
% |
Philips Annual Report 2008 235
|
|
|
|
|
|
|
124
US GAAP financial statements
|
|
180
Sustainability performance
|
|
192
IFRS financial statements
Notes to the IFRS financial
statements
|
|
244
Company financial statements |
The weighted averages of the assumptions used
to calculate the net periodic pension cost
for years ended December 31:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
2008 |
|
|
|
Nether- |
|
|
|
|
|
|
Nether- |
|
|
|
|
|
|
lands |
|
|
other |
|
|
lands |
|
|
other |
|
Discount rate |
|
|
4.3 |
% |
|
|
5.2 |
% |
|
|
4.8 |
% |
|
|
5.6 |
% |
Expected returns
on plan assets |
|
|
5.7 |
% |
|
|
6.1 |
% |
|
|
5.7 |
% |
|
|
6.4 |
% |
Rate of
compensation
increase |
|
|
* |
|
|
|
3.5 |
% |
|
|
* |
|
|
|
3.9 |
% |
|
|
|
* |
|
The rate of compensation increase for the
Netherlands consists of a general
compensation increase and an individual
salary increase based on merit, seniority
and promotion. The average individual
salary increase for all active
participants for the remaining working
lifetime is 0.75% annually. The assumed
rate of general compensation increase for
the Netherlands for calculating the
projected benefit obligations, amounts to
2.0% (2007: 2.3%). The indexation
assumption used to calculate the projected
benefit obligations for the Netherlands is
1.0% (2007: 1.15%). |
Historical data
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Present value of defined-benefit obligations |
|
|
20,410 |
|
|
|
18,679 |
|
|
|
16,846 |
|
Fair value of plan assets |
|
|
21,352 |
|
|
|
20,200 |
|
|
|
17,899 |
|
Surplus |
|
|
942 |
|
|
|
1,521 |
|
|
|
1,053 |
|
Experience adjustments in % on: |
|
|
|
|
|
|
|
|
|
|
|
|
- defined-benefit obligations (gain) loss |
|
|
(0.9 |
%) |
|
|
(0.8 |
%) |
|
|
1.2 |
% |
- fair value of plan assets (gain) loss |
|
|
0.8 |
% |
|
|
2.8 |
% |
|
|
10.9 |
% |
Defined-benefit plans: other postretirement benefits
In addition to providing pension benefits, the
Company provides other postretirement benefits,
primarily retiree healthcare benefits, in
certain countries. The Company funds those
other postretirement benefit plans as claims
are incurred.
Movements in the net liability for other defined-benefit obligations:
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Accumulated benefit obligation at the
beginning of year |
|
|
373 |
|
|
|
413 |
|
Service cost |
|
|
3 |
|
|
|
3 |
|
Interest cost |
|
|
26 |
|
|
|
34 |
|
Actuarial gains |
|
|
47 |
|
|
|
(49 |
) |
Plan amendments |
|
|
(5 |
) |
|
|
|
|
Settlements |
|
|
(6 |
) |
|
|
|
|
Changes in consolidation |
|
|
27 |
|
|
|
|
|
Benefits paid |
|
|
(32 |
) |
|
|
(24 |
) |
Exchange rate differences |
|
|
(19 |
) |
|
|
(36 |
) |
Miscellaneous |
|
|
(1 |
) |
|
|
12 |
|
Accumulated benefit obligation at end of year |
|
|
413 |
|
|
|
353 |
|
|
|
|
|
|
|
|
|
|
Present value of funded obligations at end of year |
|
|
|
|
|
|
|
|
Present value of unfunded obligations at end of
year |
|
|
413 |
|
|
|
353 |
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Funded status |
|
|
(413 |
) |
|
|
(353 |
) |
Unrecognized prior-service cost |
|
|
(6 |
) |
|
|
1 |
|
Net balances |
|
|
(419 |
) |
|
|
(352 |
) |
|
|
|
|
|
|
|
|
|
Classification of the net balance is as follows: |
|
|
|
|
|
|
|
|
- Provision for other postretirement benefits |
|
|
(419 |
) |
|
|
(352 |
) |
Cumulative amount of actuarial (gains) and
losses recognized in the statement of
recognized income and expense (pre tax):
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Balance as of January 1 |
|
|
2 |
|
|
|
59 |
|
New consolidations |
|
|
7 |
|
|
|
|
|
Net actuarial loss (gain) |
|
|
50 |
|
|
|
(60 |
) |
Balance as of December 31 |
|
|
59 |
|
|
|
(1 |
) |
Other postretirement benefit expense
recognized in the income statement:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Service cost |
|
|
4 |
|
|
|
3 |
|
|
|
3 |
|
Interest cost on accumulated
postretirement benefits |
|
|
26 |
|
|
|
26 |
|
|
|
34 |
|
Prior-service cost |
|
|
|
|
|
|
|
|
|
|
(6 |
) |
|
|
|
30 |
|
|
|
29 |
|
|
|
31 |
|
of which discontinued operations |
|
|
|
|
|
|
|
|
|
|
|
|
Amounts recognized in the Statement of
recognized income and expenses (Sorie):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Actuarial (gains) and losses |
|
|
(12 |
) |
|
|
50 |
|
|
|
(60 |
) |
Total recognized in Sorie |
|
|
(12 |
) |
|
|
50 |
|
|
|
(60 |
) |
Total recognized in net periodic
pension cost and Sorie |
|
|
18 |
|
|
|
79 |
|
|
|
(29 |
) |
The expense for other postretirement
benefits is recognized in the following
line items in the income statement:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Cost of sales |
|
|
3 |
|
|
|
2 |
|
|
|
4 |
|
Selling expenses |
|
|
3 |
|
|
|
2 |
|
|
|
3 |
|
General and administrative expenses |
|
|
24 |
|
|
|
24 |
|
|
|
24 |
|
Research and development expenses |
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
|
30 |
|
|
|
29 |
|
|
|
31 |
|
The weighted average assumptions used to
calculate the postretirement benefit
obligations other than pensions as of December
31 were as follows:
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Discount rate |
|
|
8.5 |
% |
|
|
9.7 |
% |
Compensation increase (where applicable) |
|
|
|
|
|
|
|
|
236 Philips Annual Report 2008
|
|
|
|
|
|
|
250
Reconciliation of
non-US GAAP information
|
|
254
Corporate governance
|
|
262
Ten-year overview
|
|
266
Investor information |
The weighted average assumptions used to
calculate the net cost for years ended
December 31:
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Discount rate |
|
|
7.2 |
% |
|
|
8.5 |
% |
Compensation increase (where applicable) |
|
|
|
|
|
|
|
|
Assumed healthcare cost trend rates at December 31:
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Healthcare cost trend rate assumed for next year |
|
|
9.0 |
% |
|
|
10.0 |
% |
Rate that the cost trend rate will gradually reach |
|
|
7.0 |
% |
|
|
7.5 |
% |
Year of reaching the rate at which it is assumed to
remain |
|
|
2015 |
|
|
|
2016 |
|
Sensitivity analysis
Assumed healthcare trend rates have a
significant effect on the amounts reported
for the healthcare plans. A one
percentage-point change in assumed healthcare
cost trend rates would have the following
effects as at December 31, 2008:
|
|
|
|
|
|
|
|
|
|
|
increase |
|
|
decrease |
|
|
|
with 1% |
|
|
by 1% |
|
Effect on total of service and interest cost |
|
|
5 |
|
|
|
(4 |
) |
Effect on postretirement benefit obligation |
|
|
36 |
|
|
|
(32 |
) |
Historical data
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Present value of defined-benefit obligation |
|
|
373 |
|
|
|
413 |
|
|
|
353 |
|
Fair value of plan assets |
|
|
|
|
|
|
|
|
|
|
|
|
(Deficit) surplus |
|
|
(373 |
) |
|
|
(413 |
) |
|
|
(353 |
) |
Experience adjustments in % on |
|
|
|
|
|
|
|
|
|
|
|
|
- defined-benefit obligations (gain) loss |
|
|
(1.6 |
%) |
|
|
(0.2 |
%) |
|
|
(0.1 |
%) |
57
Other current liabilities
Other current liabilities are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Advances received from customers on orders not
covered by work in process |
|
|
133 |
|
|
|
148 |
|
Other taxes including social security premiums |
|
|
253 |
|
|
|
251 |
|
Other short-term liabilities |
|
|
123 |
|
|
|
123 |
|
|
|
|
509 |
|
|
|
522 |
|
58
Short-term debt
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Short-term bank borrowings |
|
|
464 |
|
|
|
562 |
|
Other short-term loans |
|
|
32 |
|
|
|
24 |
|
Current portion of long-term debt |
|
|
1,854 |
|
|
|
136 |
|
|
|
|
2,350 |
|
|
|
722 |
|
During 2008, the weighted average
interest rate on the bank borrowings was
8.6% (2007: 7.9%).
In the Netherlands, the Company issues
personnel debentures with a 5-year right of
conversion into common shares of Royal Philips
Electronics. Convertible personnel debentures
may not be converted within a period of 3 years
after the date of issue. These convertible
personnel debentures are available to most
employees in the Netherlands and are purchased
by them with their own funds and are redeemable
on demand. The convertible personnel debentures
become non-convertible debentures at the end of
the conversion period.
Although convertible debentures have the
character of long-term financing, the total
outstanding amounts are classified as current
portion of long-term debt. At December 31,
2008, an amount of EUR 72 million (2007: EUR
103 million) of convertible personnel
debentures was outstanding, with an average
conversion price of EUR 22.95. The conversion
price varies between EUR 14.19 and EUR 31.59
with various conversion periods ending between
January 1, 2008 and December 31, 2012. As of
January 1, 2009, Philips no longer issues those
debentures.
The Company has access to a USD 2.5 billion
commercial paper program which was established
at the beginning of 2001. The Company also has
available a seven year revolving credit
facility for USD 2.5 billion, established in
December 2004, that could act as back-up for
the commercial paper program and can also be
used for general corporate purposes. The
Company did not use the commercial paper
program or the revolving credit facility during
2008.
In addition to the USD 2.5 billion revolving
credit facility, Philips has a EUR 500 million
standby roll-over loan agreement in place. The
availability of EUR 450 million out of this EUR
500 million is committed until April 29, 2010.
As of December 31, 2008, Philips did not have
any loans outstanding under these facilities.
As of December 31, 2008 Philips had an undrawn
committed bilateral loan of EUR 250 million in
place which was fully drawn in January 2009.
Philips Annual Report 2008 237
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124
|
|
US GAAP financial statements
|
|
|
180 |
|
|
Sustainability performance
|
|
|
192 |
|
|
IFRS financial statements
Notes to the IFRS financial
statements
|
|
|
244 |
|
|
Company financial statements |
59
Long-term debt
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
average |
|
|
amount |
|
|
|
range of |
|
|
average rate of |
|
|
amount |
|
|
|
|
|
|
due after 1 |
|
|
due after 5 |
|
|
remaining term |
|
|
outstanding |
|
|
|
interest rates |
|
|
interest |
|
|
outstanding |
|
|
due in 1 year |
|
|
year |
|
|
years |
|
|
(in years) |
|
|
2007 |
|
Eurobonds |
|
|
6.1-6.1 |
% |
|
|
6.1 |
% |
|
|
750 |
|
|
|
|
|
|
|
750 |
|
|
|
|
|
|
|
2.4 |
|
|
|
2,442 |
|
USD bonds |
|
|
3.3-7.8 |
% |
|
|
5.9 |
% |
|
|
2,547 |
|
|
|
|
|
|
|
2,547 |
|
|
|
1,841 |
|
|
|
14.0 |
|
|
|
357 |
|
Convertible
debentures |
|
|
1.7-1.7 |
% |
|
|
1.7 |
% |
|
|
81 |
|
|
|
72 |
|
|
|
9 |
|
|
|
|
|
|
|
2.6 |
|
|
|
103 |
|
Private
financing |
|
|
1.0-12.4 |
% |
|
|
4.5 |
% |
|
|
8 |
|
|
|
1 |
|
|
|
7 |
|
|
|
|
|
|
|
1.8 |
|
|
|
9 |
|
Bank
borrowings |
|
|
1.0-16.3 |
% |
|
|
5.1 |
% |
|
|
11 |
|
|
|
|
|
|
|
11 |
|
|
|
4 |
|
|
|
3.6 |
|
|
|
4 |
|
Finance Leases |
|
|
1.0-11.3 |
% |
|
|
3.0 |
% |
|
|
140 |
|
|
|
9 |
|
|
|
131 |
|
|
|
46 |
|
|
|
3.9 |
|
|
|
94 |
|
Other
long-term debt |
|
|
2.0-16.4 |
% |
|
|
5.2 |
% |
|
|
65 |
|
|
|
54 |
|
|
|
11 |
|
|
|
1 |
|
|
|
1.4 |
|
|
|
58 |
|
|
|
|
|
|
|
|
5.7 |
% |
|
|
3,602 |
|
|
|
136 |
|
|
|
3,466 |
|
|
|
1,892 |
|
|
|
|
|
|
|
3,067 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corresponding
data of previous
year |
|
|
|
|
|
|
5.9 |
% |
|
|
3,067 |
|
|
|
1,854 |
|
|
|
1,213 |
|
|
|
416 |
|
|
|
|
|
|
|
3,222 |
|
The following amounts of long-term debt as of December
31, 2008, are due in the next five years:
|
|
|
|
|
2009 |
|
|
136 |
|
2010 |
|
|
75 |
|
2011 |
|
|
1,020 |
|
2012 |
|
|
14 |
|
2013 |
|
|
465 |
|
Total |
|
|
1,710 |
|
Corresponding amount of previous year |
|
|
2,651 |
|
In March 2008, Philips placed a total of USD 3,100
million of debt which consisted of a floating rate note
for USD 350 million, and 3 fixed rate bonds totaling USD
2,750 million. The weighted average interest rate of the
new bonds was 5.66% at December 31, 2008. Philips used
the proceeds of this offering to refinance the EUR 1,691
million worth of notes that matured in the first half of
2008. As of December 31, 2008, Philips had outstanding
public bonds of EUR 3,297 million previously issued
mostly in USD or EUR.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
effective |
|
|
|
|
|
|
|
|
|
rate |
|
|
2007 |
|
|
2008 |
|
Unsecured Eurobonds |
|
|
|
|
|
|
|
|
|
|
|
|
Due 2/06/08; 7 1/8% |
|
|
7.302 |
% |
|
|
130 |
|
|
|
|
|
Due 5/14/08; 7% |
|
|
7.094 |
% |
|
|
61 |
|
|
|
|
|
Due 5/16/08; 5 3/4% |
|
|
5.817 |
% |
|
|
1,500 |
|
|
|
|
|
Due 5/16/11; 6 1/8% |
|
|
6.122 |
% |
|
|
750 |
|
|
|
750 |
|
Adjustments1) |
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
2,442 |
|
|
|
750 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unsecured USD Bonds |
|
|
|
|
|
|
|
|
|
|
|
|
Due 5/15/25; 7 3/4% |
|
|
7.429 |
% |
|
|
67 |
|
|
|
70 |
|
Due 6/01/26; 7 1/5% |
|
|
6.885 |
% |
|
|
113 |
|
|
|
118 |
|
Due 8/15/13; 7 1/4% |
|
|
6.382 |
% |
|
|
97 |
|
|
|
101 |
|
Due 5/15/25; 7 1/8% |
|
|
6.794 |
% |
|
|
70 |
|
|
|
73 |
|
Due 11/03/11; 3 3/8% |
|
|
3.128 |
% |
|
|
|
|
|
|
248 |
|
Due 11/03/13; 4 5/8% |
|
|
4.949 |
% |
|
|
|
|
|
|
355 |
|
Due 11/03/18; 5 3/4% |
|
|
6.066 |
% |
|
|
|
|
|
|
887 |
|
Due 11/03/38; 6 7/8% |
|
|
7.210 |
% |
|
|
|
|
|
|
710 |
|
Adjustments1) |
|
|
|
|
|
|
10 |
|
|
|
(15 |
) |
|
|
|
|
|
|
|
357 |
|
|
|
2,547 |
|
|
|
|
1) |
|
Adjustments relate to issued bond discounts,
transaction costs and fair value adjustments for
interest rate derivatives. |
The provisions applicable to all corporate bonds that
have been issued by the Company in March 2008, contain a
Change of Control Triggering Event. This means that if
the Company would experience such an event with respect
to a series of corporate bonds the Company may be
required to offer to purchase the bonds of that series at
a purchase price equal to 101% of their principal amount,
plus accrued and unpaid interest, if any.
Secured liabilities
In 2008, EUR 3.5 million of long-term and short-term
debt was secured by collateral of EUR 3.4 million
manufacturing assets (2007: EUR nil).
60
Other non-current liabilities
Other non-current liabilities are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Accrued pension costs |
|
|
359 |
|
|
|
932 |
|
Income tax payable |
|
|
1 |
|
|
|
1 |
|
Asset retirement obligations |
|
|
21 |
|
|
|
20 |
|
Other tax liability |
|
|
429 |
|
|
|
452 |
|
Other liabilities |
|
|
84 |
|
|
|
35 |
|
|
|
|
894 |
|
|
|
1,440 |
|
Please refer to note 42 for a specification on the
income tax payable and the other tax liability.
61
Contractual obligations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
payments due by period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
more |
|
|
|
|
|
|
less than |
|
|
|
|
|
|
|
|
|
|
than 5 |
|
|
|
|
|
|
1 year |
|
|
1-3 years |
|
|
3-5 years |
|
|
years |
|
|
total |
|
Long-term debt |
|
|
127 |
|
|
|
1,027 |
|
|
|
462 |
|
|
|
1,846 |
|
|
|
3,462 |
|
Finance leases |
|
|
9 |
|
|
|
68 |
|
|
|
17 |
|
|
|
46 |
|
|
|
140 |
|
Operating
leases |
|
|
166 |
|
|
|
229 |
|
|
|
137 |
|
|
|
178 |
|
|
|
710 |
|
|
|
|
302 |
|
|
|
1,324 |
|
|
|
616 |
|
|
|
2,070 |
|
|
|
4,312 |
|
238 Philips Annual Report2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
non-US GAAP information
|
|
|
254 |
|
|
Corporate governance
|
|
|
262 |
|
|
Ten-year overview
|
|
|
266 |
|
|
Investor information |
For an explanation of long-term debt, see note 59 for
other long-term liabilities, see note 60. Property,
plant and equipment includes EUR 140 million (2007: EUR
94 million) for finance leases and other beneficial
rights of use, such as buildings rights and hire
purchase agreements.
Long-term operating lease commitments totaled EUR 710
million (2007: EUR 724 million). These leases expire at
various dates during the next 20 years.
The long-term operating leases are mainly related to the
rental of buildings. A number of these leases originate
from sale-and-leaseback arrangements. In 2008, a small
sale-and-operational-leaseback has been concluded.
Operating lease payments for 2008 totaled EUR 16 million
(2007: EUR 14 million, 2006: EUR 20 million).
The remaining minimum payments are as follows:
|
|
|
|
|
2009 |
|
|
16 |
|
2010 |
|
|
12 |
|
2011 |
|
|
8 |
|
2012 |
|
|
8 |
|
2013 |
|
|
8 |
|
Thereafter |
|
|
41 |
|
62
Contingent liabilities
Guarantees
Philips policy is to provide only guarantees and other
letters of support, in writing. Philips does not stand by
other forms of support. At the end of 2008, the total
fair value of guarantees was EUR 10 million (2007: EUR 3
million). The following table outlines the total
outstanding off-balance sheet credit-related guarantees
and business- related guarantees provided by Philips for
the benefit of unconsolidated companies and third parties
as at December 31, 2008.
Expiration per period
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
business- |
|
|
credit- |
|
|
|
|
|
|
related |
|
|
related |
|
|
|
|
|
|
guarantees |
|
|
guarantees |
|
|
total |
|
2008 |
|
|
|
|
|
|
|
|
|
|
|
|
Total amounts committed |
|
|
443 |
|
|
|
42 |
|
|
|
485 |
|
Less than 1 year |
|
|
205 |
|
|
|
18 |
|
|
|
223 |
|
1-5 years |
|
|
78 |
|
|
|
7 |
|
|
|
85 |
|
After 5 years |
|
|
160 |
|
|
|
17 |
|
|
|
177 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
|
|
|
|
|
|
Total amounts committed |
|
|
432 |
|
|
|
45 |
|
|
|
477 |
|
Less than 1 year |
|
|
142 |
|
|
|
5 |
|
|
|
147 |
|
1-5 years |
|
|
95 |
|
|
|
16 |
|
|
|
111 |
|
After 5 years |
|
|
195 |
|
|
|
24 |
|
|
|
219 |
|
Environmental remediation
The Company and its subsidiaries are subject to
environmental laws and regulations. Under these laws,
the Company and/or its subsidiaries may be required to
remediate the effects of the release or disposal of
certain chemicals on the environment.
In the United States, subsidiaries of the Company have
been named as potentially responsible parties in state
and federal proceedings for the clean-up of various
sites. The Company accrues for losses associated with
environmental obligations when such losses are probable
and reliably estimable.
Legal proceedings
The Company and certain of its group companies and
former group companies are involved as a party in legal
proceedings, including regulatory and other governmental
proceedings,
including discussions on potential remedial actions, relating to such matters as competition issues,
commercial transactions, product liability,
participations and environmental pollution. In respect
of
antitrust laws, the Company and certain of its (former)
group companies are involved in investigations by
competition law authorities in several jurisdictions and
are engaged in litigation in this respect. Since the
ultimate disposition of asserted claims and proceedings
and investigations cannot be predicted with certainty, an
adverse outcome could have a material adverse effect on
the Companys consolidated financial position and
consolidated results of operations for a particular
period.
Provided below are disclosures of the more significant cases:
Asbestos
Judicial proceedings have been brought in the United
States, relating primarily to the activities of the
Companys US subsidiary TH Agriculture & Nutrition L.L.C.
(THAN) prior to 1981, involving allegations of personal
injury from alleged asbestos exposure. The claims
generally relate to asbestos used in the manufacture of
unrelated companies products in the United States and
frequently involved claims for substantial compensatory
and punitive damages. THANs businesses which allegedly
gave rise to these alleged liabilities were completely
sold in 1984 and its ongoing operations are not material
to its parent, Philips Electronics North America
Corporation (PENAC), or the Company.
During the past several years, certain of the asserted
claims were settled. Additionally, various alternatives
for resolving pending and future claims were explored,
including the possibility of THAN filing for bankruptcy.
In the fourth quarter of 2008, THAN solicited votes for
the acceptance of a plan of reorganization from the
holders of asbestos claims. Approximately ninety percent
of the claimants (both in number and value of claims)
voted in favor of the plan, exceeding the thresholds of
seventy-five percent in number and two-thirds in value
which are required for a prepackaged bankruptcy under
section 524(g) of the Bankruptcy Code. On November 24,
2008, THAN filed a petition, along with a prepackaged
plan of reorganization, in the U.S. Bankruptcy Court for
the Southern District of New York seeking reorganization
under Chapter 11 of the U.S. Bankruptcy Code. Under the
proposed Plan of Reorganization, which must be approved
by the Bankruptcy Court and the U.S. District Court for
the Southern District of New York, an Asbestos Personal
Injury Trust (the Trust) would be established in
accordance with section 524(g) of the Bankruptcy Code to
assume, liquidate and satisfy all liabilities of THAN
determined to arise from, or relate to pending and future
claims alleging personal injury or death based on or
related to alleged exposure to asbestos fiber distributed
by THAN, a product containing asbestos fiber distributed
by THAN, or an asbestos-containing product distributed by
THAN. The Trust would be funded by a contribution of USD
900 million (EUR 639 million) by PENAC and THAN.
Additionally, under the Plan, PENAC will forgive certain
debt of THAN and assume certain liabilities from THAN. If
approved by the Courts, the Plan of Reorganization will
result in a permanent injunction directing all claims
alleging personal injury or death from exposure to
asbestos distributed by THAN to the Trust and will bar
all related litigation against THAN, its affiliates
(including PENAC and the Company) and certain third
parties. As a result of THANs bankruptcy filing, an
automatic stay has been implemented, staying, restraining
and enjoining the commencement or continuation of any and
all actions or other proceedings against THAN.
Additionally, on December 3, 2008, the U.S. Bankruptcy
Court issued a preliminary injunction staying,
restraining and enjoining the commencement or
continuation of any and all actions or other proceedings
against PENAC, its affiliates, and certain third parties,
based on or related to alleged exposure to asbestos fiber
distributed by THAN, a product containing asbestos fiber
distributed by THAN, or an asbestos-containing product
distributed by THAN.
In connection with these matters, a charge to income from
operations in the amount of EUR 353 million was recorded
in 2008. In 2006, a charge to income from operations in
the amount of EUR 252 million was recognized,
representing the cost of disposing of pending and
estimated future claims filed through 2016. The charge
recognized in 2007 was EUR 4 million. At December 31,
2008, the recorded provision for loss contingencies with
respect to asbestos product liability amounted to EUR 624
million (EUR 261 million at December 31, 2007). During
2008, costs of EUR 24 million were incurred with respect
to litigation, claims administration, insurance
recoveries, and bankruptcy related matters (EUR 27
million was incurred in 2007 and EUR 15 million was
incurred in 2006).
In prior years, legal proceedings were commenced against
certain third-party insurance carriers which had provided
various types of product liability coverage to PENAC and
THAN. During 2008 and the last several years, agreements
were reached with certain insurance carriers resolving
disputes with respect to the interpretation and
Philips Annual Report 2008 239
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124
|
|
US GAAP financial statements
|
|
|
180 |
|
|
Sustainability performance
|
|
|
192 |
|
|
IFRS financial statements
Notes to the IFRS financial
statements
|
|
|
244 |
|
|
Company financial statements |
available limits of the policies, amounts payable to
PENAC and THAN, and terms under which future settlements
and related defense costs are reimbursable. In
conjunction with these settlements, insurance recoveries
of EUR 89 million were recognized in 2008 (EUR 16 million
was recognized in 2007 and EUR 70 million was recognized
in 2006). Insurers paid EUR 113 million in 2008 (EUR 27
million was paid in 2007 and EUR 34 million was paid in
2006) for asbestos-related defense and indemnity costs.
At December 31, 2008, EUR 121 million was jointly held by
PENAC and THAN in an insurance settlement proceeds trust
for future contribution to the Trust if the Plan of
Reorganization is approved by the Courts. Additionally,
at December 31, 2008, the recorded receivable from
insurance carriers, for which settlement agreements have
been reached amounted to EUR 34 million (EUR 56 million
at December 31, 2007) for the reimbursement of incurred
defense and indemnity costs as well as for probable
recoveries of accrued projected settlement costs with
respect to pending and future claims, which is reflected
in the Companys consolidated balance sheet. Insurance
receivables have not been recorded from non-settling
insurance carriers. Litigation against non-settling
insurance carriers continues to be pursued. Additionally,
settlement discussions are also being held with certain
carriers.
MedQuist
On January 22, 2008, Philips and four employees of
Philips affiliates that once served on the board of
directors of MedQuist, Inc. were named as defendants in a
lawsuit filed in New Jersey state court challenging
MedQuists exploration of strategic alternatives, as well
as Philips ultimate sale of its MedQuist stake to an
unaffiliated third party in August 2008. On July 10,
2008, the defendants moved to dismiss the complaint and,
on November 24, 2008, the court dismissed the action in
its entirety and with prejudice. In December 2008 the
plaintiff filed a notice of appeal.
LG Display
On December 11, 2006, LG Display Co. Ltd (formerly
LG.Philips LCD Co. Ltd.), a company in which the Company
holds 13% of the common stock, announced that officials
from the Korean Fair Trade Commission visited the offices
of LG Display and that it had received a subpoena from
the United States Department of Justice and similar
notice from the Japanese Fair Trade Commission in
connection with inquiries by those regulators into
possible anticompetitive conduct in the LCD industry.
Subsequent to the public announcement of these inquiries,
certain Philips group companies were named as defendants
in a number of class action antitrust complaints filed in
the United States courts, seeking damages on behalf of
purchasers of products incorporating thin-film transistor
liquid crystal display panels (TFT-LCD panels), based on
alleged anticompetitive conduct by manufacturers of such
panels. Those lawsuits were consolidated in two master
actions in the United States District Court for the
Northern District of California: one, asserting a claim
under federal antitrust law, on behalf of direct
purchasers of TFT-LCD panels and products containing such
panels, and another, asserting claims under federal
antitrust law, as well as various state antitrust and
unfair competition laws, on behalf of indirect purchasers
of such panels and products. On December 5, 2008,
following the partial grant of motions to dismiss
consolidated class action complaints in those master
actions, the plaintiffs filed amended consolidated class
action complaints, asserting essentially the same legal
claims as those alleged in the prior complaints. The
Company and certain other companies within the Philips
group companies that were named as defendants in various
of the original complaints have entered into agreements
with the plaintiffs that generally toll the statutes of
limitations applicable to plaintiffs claims, following
which the plaintiffs agreed to dismiss without prejudice
the claims against the Philips defendants. None of the
companies within the Philips group of companies currently
is named as a defendant in the pending amended
complaints, but the litigation is continuing. In
addition, in February 2007, certain plaintiffs filed
purported class actions in a United States court against
LG Display and certain current and former employees and
directors of LG Display for damages based on alleged
violations of U.S. federal securities laws. No Philips
group company is named as a defendant in these actions.
Beginning in November 2008, several manufacturers of
TFT-LCD panels, including LG Display, and certain
executives of two of those companies entered into plea
agreements with the United States Department of Justice
(DOJ), pursuant to which those companies and individuals
agreed to plead guilty to participating in a conspiracy
to fix the prices of TFT-LCD panels. On December 15,
2008, LG Display and its wholly owned subsidiary, LG
Display America Inc., pleaded guilty to participating in
a conspiracy from September 2001 to June 2006 to fix the
price of TFT-LCD panels sold worldwide. Pursuant to that
plea, LG Display was sentenced to pay in five annual
installments a
total of USD 400 million in criminal fines. The DOJ has
announced that its investigation is continuing. On the
basis of current knowledge, the Company cannot determine
whether a loss is probable with respect to these actions.
CRT Investigations
On November 21, 2007, the Company announced that
competition law authorities in several jurisdictions have
commenced investigations into possible anticompetitive
activities in the Cathode-Ray Tubes, or CRT industry. As
one of the companies that formerly was active in the CRT
business, Philips is subject to a number of these ongoing
investigations. The Company has assisted the regulatory
authorities in these investigations. In the U.S., Philips
has been informed that the Department of Justice has
deferred Philips obligation to respond to the grand jury
subpoena Philips received in November of 2007.
Subsequent to the public announcement of these
investigations, certain Philips group companies were
named as defendants in over 50 class action antitrust
complaints filed in various federal district courts in
the United States. These actions allege anticompetitive
conduct by manufacturers of CRTs and seek treble damages
on behalf of direct and indirect purchasers of CRTs and
products incorporating CRTs. These complaints assert
claims under federal antitrust law, as well as various
state antitrust and unfair competition laws and may
involve joint and several liability among the named
defendants. These actions have been consolidated by the
Judicial Panel for Multidistrict Litigation for pre-trial
proceedings in the United States District Court for the
Northern District of California. Pursuant to a
Stipulation and Order issued by the District Court on
September 12, 2008, a broad stay of merits discovery has
been imposed and the Court has set a deadline of March 9,
2009 for the filing of separate consolidated amended
complaints by the direct and indirect purchasers. Philips
intends to move to dismiss such consolidated amended
complaints once they are filed and otherwise will
vigorously defend these lawsuits.
Certain Philips group companies have also been named as
defendants, in a proposed class proceeding in Ontario,
Canada along with numerous other participants in the
industry. Philips intends to vigorously oppose the claim,
and the proceedings remain at a preliminary stage. At
this time, no class proceeding has been certified and no
statement of defence has been filed.
These matters are in their initial stages and due to the
considerable uncertainty associated with these matters,
on the basis of current knowledge, the Company has
concluded that potential losses cannot be reliably
estimated with respect to these matters. An adverse final
resolution of these investigations and litigation could
have a materially adverse effect on the Companys
consolidated financial position, results of operations
and cash flows.
63
Stockholders equity
Common shares
In 2008, the Companys issued share capital was reduced
by 170,414,994 shares, which were acquired pursuant to
the EUR 5 billion share repurchase program. As of
December 31, 2008, the issued share capital consists of
972,411,769 common shares, each share having a par value
of EUR 0.20 which shares have been paid-in in full.
Preference shares
The Stichting Preferente Aandelen Philips has been
granted the right to acquire preference shares in the
Company. Such right has not been exercised. As a means to
protect the Company and its stakeholders against an
unsolicited attempt to acquire (de facto) control of the
Company, the General Meeting of Shareholders in 1989
adopted amendments to the Companys articles of
association that allow the Board of Management and the
Supervisory Board to issue (rights to acquire) preference
shares to a third party. As of December 31, 2008, no
preference shares have been issued.
Option rights/restricted shares
The Company has granted stock options on its common
shares and rights to receive common shares in future
(see note 33).
Treasury shares
In connection with the Companys share repurchase
programs, shares which have been repurchased and are held
in treasury for (i) delivery upon exercise of options and
convertible personnel debentures and under restricted
share programs and employee share purchase
programs, and (ii) capital reduction purposes, are
accounted for as a reduction of stockholders equity.
Treasury shares are recorded at cost, representing the
market price on the acquisition date. When issued, shares
are removed from treasury stock on a FIFO basis.
240 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
non-US GAAP information
|
|
|
254 |
|
|
Corporate governance
|
|
|
262 |
|
|
Ten-year overview
|
|
|
266 |
|
|
Investor information |
Any difference between the cost and the cash received at
the time treasury shares are issued, is recorded in
capital in excess of par value, except in the situation
in which the cash received is lower than cost and capital
in excess of par has been depleted.
In order to reduce potential dilution effects, the
following transactions took place:
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Shares acquired |
|
|
27,326,969 |
|
|
|
273 |
|
Average market price |
|
|
EUR 29.65 |
|
|
|
EUR 24.61 |
|
Amount paid |
|
|
EUR 810 million |
|
|
|
|
|
Shares delivered |
|
|
11,140,884 |
|
|
|
4,541,969 |
|
Average market price |
|
|
30.46 |
|
|
|
EUR 23.44 |
|
Amount received |
|
|
EUR 199 million |
|
|
|
EUR 52 million |
|
|
Total shares in treasury at
end of year |
|
|
52,119,611 |
|
|
|
47,577,915 |
|
Total cost |
|
|
EUR 1,393 million |
|
|
|
EUR 1,263 million |
|
In order to reduce share capital, the following
transactions took place in 2007 and 2008:
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Shares acquired |
|
|
25,813,898 |
|
|
|
146,453,094 |
|
Average market
price |
|
|
EUR 31.87 |
|
|
|
EUR 22.52 |
|
Amount paid |
|
|
EUR 823 million |
|
|
|
EUR 3,298 million |
|
Reduction of capital
stock |
|
|
|
|
|
|
170,414,994 |
|
Total shares in
treasury at year-end |
|
|
25,813,898 |
|
|
|
1,851,998 |
|
Total cost |
|
|
EUR 823 million |
|
|
|
EUR 25 million |
|
Net income (loss) and distribution from retained earnings
The net loss of 2008 will be accounted for in retained
earnings. A distribution from retained earnings of EUR
0.70 per common share will be proposed to the 2009 Annual
General Meeting of Shareholders.
Limitations in the distribution of stockholders equity
Pursuant to Dutch law limitations exist relating to the
distribution of stockholders equity of EUR 1,296 million
(2007: EUR 2,915 million). Such limitations relate to
common stock of EUR 194 million (2007: EUR 228 million)
as well as to legal reserves required by Dutch law
included under revaluation reserves of EUR 117 million
(2007: EUR 133 million) and retained earnings of EUR 985
million (2007: EUR 1,343 million). In 2007 the
limitations were also affected by unrealized gains on
available-for-sale securities (EUR 1,183 million) and
cash flow hedges (EUR 28 million), which were both
included in other reserves. In general, gains related to
available-for-sale securities, cash flow hedges and
currency translation differences (which have been
negative for the last two years) reduce the distributable
stockholders equity. By their nature, losses relating to
available-for-sale securities, cash flow hedges and
currency
translation differences (as of December 31, 2008 an
aggregated amount of EUR 709 million) automatically
reduce stockholders equity, and thereby distributable
amounts.
The legal reserve required by Dutch law of EUR 985
million (2007: EUR 1,343 million) included under
retained earnings relates to investments in affiliated
companies.
Other reserves are composed of currency translation
losses of EUR 656 million (2007: losses of EUR 613
million), unrealized losses on available-for-sales
securities of EUR 25 million (2007: gains of EUR 1,183
million), unrealized losses on cash flow hedges of EUR 28
million (2007: gains of EUR 28 million) and actuarial
losses on pension plans of EUR 1,209 million (2007:
losses of EUR 305 million). The movement in unrealized
results on available-for-sales securities are especially
due to the sale of shares (TSMC and LG Display) and the
recognition of impairment charges (see note 48).
64
Cash from derivatives
The Company has no trading derivatives. A total of EUR
337 million cash was received with respect to foreign
exchange derivative contracts related to financing of
subsidiaries (2007: EUR 385 million; 2006: EUR 62
million). Cash flow from interest-related derivatives is
part of cash flow from operating activities. During 2008,
there was a cash inflow in relation to these derivatives
of EUR 28 million (2007: EUR 2 million cash outflow;
2006: EUR 1 million cash outflow).
65
Proceeds from other non-current financial assets
In 2008, the sale of TSMC shares, LG Display shares, D&M
and Pace shares generated cash totaling EUR 2,553
million.
In 2007, the sale of TSMC shares, Nuance Communications
shares and JDS Uniphase shares generated cash totaling
EUR 4,002 million.
In 2006, there were no material proceeds from the sale
of other non-current financial assets.
66
Assets received in lieu of cash from the sale of businesses
In April 2008, the Company acquired 64.5 million shares
in Pace Micro Technology in exchange for the transfer of
the Companys Set-Top Boxes and Connectivity Solutions
activities which represented a value of EUR 74 million at
the date of the closing of that transaction.
In August 2008, Philips transferred its 69.5% ownership
in MedQuist to CBAY. A part of the consideration was
settled through the issuance of a convertible bond by
CBAY which represented a fair value of EUR 53 million at
the date of the closing of the transaction.
In September 2008, Philips acquired a 33.5% interest in Prime
Technology Ventures III in exchange for the transfer of
seven incubator activities which represented a value of
EUR 21 million at the date of the closing of that
transaction.
In 2007, the Company only received cash as consideration
in connection with the sale of businesses.
During 2006, several ownership interests were received in
connection with certain sale and transfer transactions.
During July 2006, Philips transferred its Optical Pick
Up activities to Arima Devices receiving a 12%
interest in Arima Devices of EUR 8 million.
In June 2006, the merger was completed of Philips Mobile
Display Systems with Toppoly Optoelectronics Corporation
of Taiwan to form a new company named TPO. Philips
obtained a 17.5% stake in TPO as a consideration for the
transaction valued at EUR 180 million.
67
Related-party transactions
In the normal course of business, Philips purchases and
sells goods and services to various related parties in
which Philips typically holds a 50% or less equity
interest and has significant
influence. These transactions are generally conducted
with terms comparable to transactions with third parties.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Purchases of goods and services |
|
|
2,041 |
|
|
|
1,837 |
|
|
|
692 |
|
Sales of goods and services |
|
|
152 |
|
|
|
168 |
|
|
|
174 |
|
Receivables from related parties |
|
|
37 |
|
|
|
26 |
|
|
|
24 |
|
Payables to related parties |
|
|
271 |
|
|
|
289 |
|
|
|
112 |
|
For acquisitions and divestments see note 39.
For remuneration details of the members of the
Board of Management and the Supervisory Board see
note 34.
For employee benefit plans see note 56.
Philips Annual Report 2008 241
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124
|
|
US GAAP financial statements
|
|
|
180 |
|
|
Sustainability performance
|
|
|
192 |
|
|
IFRS financial statements
Notes to the IFRS financial
statements
|
|
|
244 |
|
|
Company financial statements |
68
Fair value of financial assets and liabilities
The estimated fair value of financial instruments has
been determined by the Company using available market
information and appropriate valuation methods. The
estimates presented are not necessarily indicative of the
amounts that will ultimately be realized by the Company
upon maturity or disposal. The use of different market
assumptions and/or estimation methods may have a material
effect on the estimated fair value amounts.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2007 |
|
|
December 31, 2008 |
|
|
|
carrying |
|
|
estimated |
|
|
carrying |
|
|
estimated |
|
|
|
amount |
|
|
fair value |
|
|
amount |
|
|
fair value |
|
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
|
8,769 |
|
|
|
8,769 |
|
|
|
3,620 |
|
|
|
3,620 |
|
Accounts receivable -
current |
|
|
4,670 |
|
|
|
4,670 |
|
|
|
4,289 |
|
|
|
4,289 |
|
Accounts receivable -
non-current |
|
|
78 |
|
|
|
78 |
|
|
|
47 |
|
|
|
47 |
|
Other non-current financial
assets excluding
cost-method investments |
|
|
2,156 |
|
|
|
2,156 |
|
|
|
980 |
|
|
|
980 |
|
Main listed investments in
equity-accounted investees |
|
|
1,638 |
|
|
|
2,688 |
|
|
|
60 |
|
|
|
60 |
|
Derivative instruments -
assets |
|
|
275 |
|
|
|
275 |
|
|
|
253 |
|
|
|
253 |
|
Other current financial
assets |
|
|
|
|
|
|
|
|
|
|
121 |
|
|
|
121 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable |
|
|
(3,372 |
) |
|
|
(3,372 |
) |
|
|
(2,992 |
) |
|
|
(2,992 |
) |
Debt |
|
|
(3,563 |
) |
|
|
(3,646 |
) |
|
|
(4,188 |
) |
|
|
(4,146 |
) |
Derivative instruments -
liabilities |
|
|
(144 |
) |
|
|
(144 |
) |
|
|
(505 |
) |
|
|
(505 |
) |
The following methods and assumptions were used to
estimate the fair value of financial instruments:
Cash and cash equivalents, accounts receivable -
current and accounts payable
The carrying amounts
approximate fair value because of the short maturity of
these instruments.
Other financial assets
For other financial assets, fair value is based upon
the estimated market prices.
Accounts receivable non-current
The fair value is estimated on the basis of
discounted cash flow analyses.
Debt
The fair value is estimated on the basis of the quoted
market prices for certain issues, or on the basis of
discounted cash flow analyses based upon market rates
plus Philips spread for the particular tenors of the
borrowing arrangements. Accrued interest is included
under accounts payable and not within the carrying amount
or estimated fair value of debt. At December 31, 2008,
accrued interest expenses were EUR 79 million (2007: EUR
110 million). The accrued interest on bonds, which is the
main part of the accrual, was EUR 70 million (2007: EUR
99 million).
69
Other financial instruments, derivatives and currency risk
The Company does not purchase or hold financial
derivative instruments for trading purposes. Assets and
liabilities related to derivative instruments are
disclosed in note 47, note 48 and note 54 respectively.
Currency fluctuations may impact Philips financial
results.
The Company is exposed to currency risk in the following areas:
|
|
Transaction exposures, such as forecasted sales
and purchases, and on-balance-sheet receivables or
payables resulting from such transactions; |
|
|
Translation exposure of net income in foreign entities; |
|
|
Translation exposure of foreign-currency
intercompany and external debt and deposits; |
|
|
Translation exposure of equity invested in
consolidated foreign entities; and |
|
|
Exposure to equity interests in
non-functional-currency
equity-accounted-investees and available-for-sale
investments. |
It is Philips policy that significant transaction
exposures are hedged. The Philips policy generally
requires committed foreign-currency exposures to be
hedged fully using forwards. Anticipated transactions are
hedged using forwards or options or a combination
thereof. The policy for the hedging of anticipated
exposures specifying the use of forwards/options and the
hedge tenor varies per business and is a function of the
ability to forecast cash flows and the way in which the
businesses can adapt to changed levels of foreign
exchange rates. As a result, hedging activities may not
eliminate all currency risks for these transaction
exposures. Generally, the maximum tenor of these hedges
equals 18 months. The Company does not hedge the exposure
arising from translation exposure of net income in
foreign entities. Translation exposure of equity invested
in consolidated foreign entities financed by equity is
partially hedged. If a hedge is entered into, it is
accounted for as a net investment hedge.
The currency of the external funding and deposits of the
Company is matched with the required financing of
subsidiaries either directly by external foreign currency
loans and deposits, or by using foreign exchange swaps.
In certain cases where group companies have foreign
currency debt or liquid assets, these exposures are also
hedged through the use of foreign exchange derivatives.
Philips does not currently hedge the foreign exchange
exposure arising from equity-accounted investees and
available-for-sale investments.
The Company uses foreign exchange derivatives to manage
its currency risk. The US dollar and pound sterling
account for a high percentage of the Companys foreign
exchange derivatives.
The Company hedges certain commodity price risks using
derivative instruments to minimize significant,
unanticipated earnings fluctuations caused by commodity
price volatility. The commodity price derivatives that
Philips enters into are normally concluded as cash flow
hedges to offset forecasted purchases.
Changes in the value of foreign currency accounts
receivable/payable as well as the changes in the fair
value of the hedges of accounts receivable/payable are
reported in the income statement under cost of sales. The
hedges related to forecasted transactions are recorded as
cash flow hedges. The results from such hedges are
deferred within other comprehensive income in
stockholders equity. Currently, a loss of EUR 28 million
is deferred in stockholders equity as a result of these
hedges. During 2008, a loss of EUR 3 million was recorded
in the income statement in the line cost of sales in the
line cost of sales as a result of ineffectiveness of
transaction hedges.
Changes in the fair value of hedges related to external
and intercompany debt and deposits are recognized within
Financial income and expenses in the income statement.
The changes in the fair value of these hedges related to
foreign exchange movements are largely offset in the
income statement by changes in the fair value of the
hedged items. The Company recorded a gain of EUR 11
million in other comprehensive income under currency
translation differences as a result of net investment
hedges of investments in foreign subsidiaries during
2008.
242 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
non-US GAAP information
|
|
|
254 |
|
|
Corporate governance
|
|
|
262 |
|
|
Ten-year overview
|
|
|
266 |
|
|
Investor information |
Philips has 2 embedded derivatives within convertible
bonds. One was issued to Philips in September 2005 by TPV
Technology Ltd., the face value of the bond being EUR 149
million and the value of the option at year-end EUR 10
million. Changes in the value of the embedded derivative
are reported in Financial income and expenses during 2008
(EUR 37 million). A further convertible bond was issued
to Philips in August 2008 by CBAY, the face value of the
bond being EUR 65 million and the value of the option at
year-end less than EUR 1 million. Changes in the value of
the embedded derivative are reported in Financial income
and expenses during 2008 (EUR 6 million).
Please refer to the section Details of treasury risks
that begins on page 102 of this Annual Report, which is
deemed incorporated and repeated herein by reference.
70
Subsequent events
Share repurchase program
On January 26, 2009, the Company announced that it
stopped the EUR 5 billion share repurchase program,
which was announced on December 19, 2007, until further
notice.
Auditors report
To the Supervisory Board and Shareholders of
Koninklijke Philips Electronics N.V.:
Report on the consolidated financial statements
We have audited the accompanying consolidated financial
statements 2008 which are part of the financial
statements of Koninklijke Philips Electronics N.V.,
Eindhoven, the Netherlands, which comprise the
consolidated balance sheet as at December 31, 2008, the
statement of income, statement of changes in equity and
cash flow statement for the year then ended, and a
summary of significant accounting policies and other
explanatory notes as set out on page 198 to 243.
Managements responsibility
The Board of Management is responsible for the
preparation and fair presentation of the consolidated
financial statements in accordance with International
Financial Reporting Standards as adopted by the European
Union and with Part 9 of Book 2 of the Netherlands Civil
Code, and for the preparation of the Management report in
accordance with Part 9 of Book 2 of the Netherlands Civil
Code. This responsibility includes: designing,
implementing and maintaining internal control relevant to
the preparation and fair presentation of the consolidated
financial statements that are free from material
misstatement, whether due to fraud or error; selecting
and applying appropriate accounting policies; and making
accounting estimates that are reasonable in the
circumstances.
Auditors responsibility
Our responsibility is to express an opinion on the
consolidated financial statements based on our audit. We
conducted our audit in accordance with Dutch law. This
law requires that we comply with ethical requirements
and plan and perform the audit to obtain reasonable
assurance whether the consolidated financial statements
are free from material misstatement.
An audit involves performing procedures to obtain audit
evidence about the amounts and disclosures in the
consolidated financial statements. The procedures
selected depend on the auditors judgment, including the
assessment of the risks of material misstatement of the
consolidated financial statements, whether due to fraud
or error. In making those risk assessments, the auditor
considers internal control relevant to the entitys
preparation and fair presentation of the consolidated
financial statements in order to design audit procedures
that are appropriate in the circumstances, but not for
the purpose of expressing an opinion on the effectiveness
of the entitys internal control. An audit also includes
evaluating the appropriateness of accounting policies
used and the reasonableness of accounting estimates made
by management, as well as evaluating the overall
presentation of the consolidated financial statements.
We believe that the audit evidence we have obtained is
sufficient and appropriate to provide a basis for our
audit opinion.
Opinion
In our opinion, the consolidated financial statements
give a true and fair view of the financial position of
Koninklijke Philips Electronics N.V. as at December 31,
2008, and of its result and its cash flows for the year
then ended in accordance with International Financial
Reporting Standards as adopted by the European Union and
with Part 9 of Book 2 of the Netherlands Civil Code.
Report on other legal and regulatory requirements
Pursuant to the legal requirement under 2:393 sub 5 part
f of the Netherlands Civil Code, we report, to the extent
of our competence, that the Management report as set out
on page 192 to 197 is consistent with the consolidated
financial statements as required by 2:391 sub 4 of the
Netherlands Civil Code.
Amsterdam, February 23, 2009
KPMG Accountants N.V.
M.A. Soeting RA
Philips Annual Report 2008 243
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124
|
|
US GAAP financial statements
|
|
|
180 |
|
|
Sustainability performance
|
|
|
192 |
|
|
IFRS financial statements
|
|
|
244 |
|
|
Company financial statements |
Company financial statements
Balance sheets of Koninklijke Philips Electronics N.V. as of December 31
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20072) |
|
|
|
|
|
|
2008 |
|
|
|
|
|
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
|
7,519 |
|
|
|
|
|
|
|
2,675 |
|
|
|
|
|
|
A |
|
|
Receivables |
|
|
17,149 |
|
|
|
|
|
|
|
1,356 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24,668 |
|
|
|
|
|
|
|
4,031 |
|
|
|
|
|
Non-current assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
B |
|
|
Investments in affiliated companies |
|
|
17,095 |
|
|
|
|
|
|
|
17,957 |
|
|
|
|
|
|
C |
|
|
Other non-current financial assets |
|
|
2,735 |
|
|
|
|
|
|
|
946 |
|
|
|
|
|
|
|
|
|
Property, plant and equipment |
|
|
1 |
|
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19,831 |
|
|
|
|
|
|
|
18,904 |
|
|
|
|
|
|
|
|
|
|
|
|
44,499 |
|
|
|
|
|
|
|
22,935 |
|
|
|
|
|
Liabilities and stockholders equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
D |
|
|
Other current liabilities |
|
|
482 |
|
|
|
|
|
|
|
1,034 |
|
|
|
|
|
|
E |
|
|
Short-term debt |
|
|
21,099 |
|
|
|
|
|
|
|
2,979 |
|
|
|
|
|
|
F |
|
|
Short-term provisions |
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21,586 |
|
|
|
|
|
|
|
4,013 |
|
|
|
|
|
Non-current liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
G |
|
|
Long-term debt |
|
|
1,123 |
|
|
|
|
|
|
|
3,311 |
|
|
|
|
|
|
F |
|
|
Long-term provisions |
|
|
49 |
|
|
|
|
|
|
|
67 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,172 |
|
|
|
|
|
|
|
3,378 |
|
|
H |
|
|
Stockholders equity: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preference shares, par value EUR 0.20 per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- Authorized: 2,000,000,000 shares (2007: 2,500,000,000 shares)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- Issued: none
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common shares, par value EUR 0.20 per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- Authorized: 2,000,000,000 shares (2007: 2,500,000,000 shares)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- Issued and fully paid: 972,411,769 shares (2007: 1,142,826,763 shares) |
|
|
228 |
|
|
|
|
|
|
|
194 |
|
|
|
|
|
|
|
|
|
Capital in excess of par value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Legal reserve: revaluation |
|
|
133 |
|
|
|
|
|
|
|
117 |
|
|
|
|
|
|
|
|
|
Legal reserve: available-for-sale securities |
|
|
1,183 |
|
|
|
|
|
|
|
(25 |
) |
|
|
|
|
|
|
|
|
Legal reserve: cash flow hedges |
|
|
28 |
|
|
|
|
|
|
|
(28 |
) |
|
|
|
|
|
|
|
|
Legal reserve: affiliated companies |
|
|
1,343 |
|
|
|
|
|
|
|
985 |
|
|
|
|
|
|
|
|
|
Legal reserve: currency translation differences |
|
|
(613 |
) |
|
|
|
|
|
|
(656 |
) |
|
|
|
|
|
|
|
|
Retained earnings |
|
|
16,782 |
|
|
|
|
|
|
|
16,336 |
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
|
4,873 |
|
|
|
|
|
|
|
(91 |
)1) |
|
|
|
|
|
|
|
|
Treasury shares, at cost: 49,429,913 shares (2007: 77,933,509 shares) |
|
|
(2,216 |
) |
|
|
|
|
|
|
(1,288 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21,741 |
|
|
|
|
|
|
|
15,544 |
|
|
|
|
|
|
|
|
|
|
|
|
44,499 |
|
|
|
|
|
|
|
22,935 |
|
|
|
|
1) |
|
Prepared before appropriation of results. The net loss of 2008 will be accounted for in
retained earnings. A distribution from retained earnings of EUR 0.70 per common share
will be proposed to the Annual General Meeting of Shareholders. |
|
2) |
|
Prior-period amounts have been restated and revised; see Significant IFRS accounting
policies, sections Change in accounting policy and Reclassifications and revisions for
more details. |
244 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
non-US GAAP information
|
|
|
254 |
|
|
Corporate governance
|
|
|
262 |
|
|
Ten-year overview
|
|
|
266 |
|
|
Investor information |
Statements of income of Koninklijke Philips Electronics N.V. for the years ended December 31
in millions of euros
|
|
|
|
|
|
|
|
|
|
|
2007 |
1) |
|
2008 |
|
Income (loss) after taxes from affiliated companies |
|
|
999 |
|
|
|
(729 |
) |
Other income after taxes |
|
|
3,874 |
|
|
|
638 |
|
Net income (loss) |
|
|
4,873 |
|
|
|
(91 |
) |
|
|
|
1) |
|
Prior-period amounts have been restated and revised; see Significant IFRS accounting
policies, sections Change in accounting policy and Reclassifications and revisions for
more details. |
Statement of changes in equity of Koninklijke Philips Electronics N.V.
in millions of euros unless otherwise stated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
legal reserves |
|
|
|
outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
total |
|
|
|
number of |
|
|
|
|
|
|
capital in |
|
|
|
|
|
|
available |
|
|
|
|
|
|
|
|
|
|
currency |
|
|
|
|
|
|
net |
|
|
treasury |
|
|
stock- |
|
|
|
shares in |
|
|
common |
|
|
excess of |
|
|
|
|
|
|
for-sale |
|
|
cash flow |
|
|
affiliated |
|
|
translation |
|
|
retained |
|
|
income |
|
|
shares at |
|
|
holders |
|
|
|
thousands |
|
|
stock |
|
|
par value |
|
|
revaluation |
|
|
securities |
|
|
hedges |
|
|
companies |
|
|
differences |
|
|
earnings |
|
|
(loss) |
|
|
cost |
|
|
equity |
|
Balance as of
January 1, 2008 |
|
|
1,064,893 |
|
|
|
228 |
|
|
|
|
|
|
|
133 |
|
|
|
1,183 |
|
|
|
28 |
|
|
|
1,343 |
|
|
|
(613 |
) |
|
|
15,546 |
|
|
|
4,655 |
|
|
|
(2,216 |
) |
|
|
20,287 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in
accounting policy |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,270 |
|
|
|
226 |
|
|
|
|
|
|
|
1,496 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prior-period revisions |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(34 |
) |
|
|
(8 |
) |
|
|
|
|
|
|
(42 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of
January 1, 2008 - as
restated and revised1) |
|
|
1,064,893 |
|
|
|
228 |
|
|
|
|
|
|
|
133 |
|
|
|
1,183 |
|
|
|
28 |
|
|
|
1,343 |
|
|
|
(613 |
) |
|
|
16,782 |
|
|
|
4,873 |
|
|
|
(2,216 |
) |
|
|
21,741 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(91 |
) |
|
|
|
|
|
|
(91 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Release revaluation
reserve |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(16 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net current
period change |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(269 |
) |
|
|
(24 |
) |
|
|
(358 |
) |
|
|
(56 |
) |
|
|
3,201 |
|
|
|
(4,153 |
) |
|
|
|
|
|
|
(1,659 |
) |
Income tax on net
current period change |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18 |
|
|
|
|
|
|
|
5 |
|
|
|
406 |
|
|
|
|
|
|
|
|
|
|
|
429 |
|
Reclassification into
income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(939 |
) |
|
|
(50 |
) |
|
|
|
|
|
|
8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(981 |
) |
Dividend paid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(720 |
) |
|
|
|
|
|
|
(720 |
) |
Cancellation of
treasury shares |
|
|
|
|
|
|
(34 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(4,062 |
) |
|
|
|
|
|
|
4,096 |
|
|
|
|
|
Purchase of treasury
stock |
|
|
(146,453 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3,298 |
) |
|
|
(3,298 |
) |
Re-issuance of treasury
stock |
|
|
4,542 |
|
|
|
|
|
|
|
(71 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(7 |
) |
|
|
|
|
|
|
130 |
|
|
|
52 |
|
Share-based
compensation plans |
|
|
|
|
|
|
|
|
|
|
106 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
106 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax share-based
compensation plans |
|
|
|
|
|
|
|
|
|
|
(35 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(35 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of
December 31, 2008 |
|
|
922,982 |
|
|
|
194 |
|
|
|
|
|
|
|
117 |
|
|
|
(25 |
) |
|
|
(28 |
) |
|
|
985 |
|
|
|
(656 |
) |
|
|
16,336 |
|
|
|
(91 |
) |
|
|
(1,288 |
) |
|
|
15,544 |
|
|
|
|
1) |
|
The balance as of January 1, 2008 has been restated and revised; see Significant IFRS
accounting policies, sections Change in accounting policy and Reclassifications and revisions
for more details. |
Philips Annual Report
2008 245
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124
|
|
US GAAP financial statements
|
|
|
180 |
|
|
Sustainability performance
|
|
|
192 |
|
|
IFRS financial statements
|
|
|
145 |
|
|
Company financial statements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- Introduction |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- Notes to the Company financial statements |
Introduction
Statutory financial statements
The chapters IFRS financial statements and Company
financial statements contain the statutory financial
statements of Koninklijke Philips Electronics N.V. (the
Company).
Accounting policies applied
The financial statements of the Company included in this
chapter are prepared in accordance with Part 9 of Book 2
of the Dutch Civil Code. Section 362 (8), Book 2, Dutch
Civil Code, which allows companies that apply IFRS as
adopted by the European Union in their consolidated
financial statements to use the same measurement
principles in their company financial statements. The
Company has prepared these Company financial statements
using this provision.
The accounting policies are described in the section
Significant IFRS accounting policies that begins on page
209 of this Annual Report.
Subsidiaries are accounted for using the net equity
value in these Company financial statements.
Presentation of Company financial statements
The balance sheet presentation deviates from Dutch
regulations and is more in line with common practice in
the US in order to achieve optimal transparency for
Dutch and US shareholders.
Under this format, the order of presentation of assets
and liabilities is based on the decreasing degree of
liquidity, which is common practice in the US.
The income statement has been prepared in accordance
with Section 2:402 of the Dutch Civil Code, which allows
a simplified income statement in the Company financial
statements in the event a comprehensive income statement
is included in the consolidated statements.
Additional information
For Additional information within the meaning of
Section 2:392 of the Dutch Civil Code, please refer to
the Auditors report on page 243, the Auditors report on
page 249 and the section Proposed distribution to
shareholders on page 68 of this Annual Report.
Notes to the Company financial statements
All amounts in millions of euros unless otherwise stated
A
Receivables
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Trade accounts receivable |
|
|
169 |
|
|
|
104 |
|
Affiliated companies |
|
|
16,481 |
|
|
|
613 |
|
Other receivables |
|
|
97 |
|
|
|
87 |
|
Advances and prepaid expenses |
|
|
61 |
|
|
|
42 |
|
Deferred tax assets |
|
|
65 |
|
|
|
32 |
|
Derivative instruments assets |
|
|
276 |
|
|
|
478 |
|
|
|
|
17,149 |
|
|
|
1,356 |
|
An amount of EUR 45 million included in receivables is
due after one year (2007: EUR 65 million).
Until June 2008, cash transactions with US-based group
companies were executed through Koninklijke Philips
Electronics N.V. (KPENV), which resulted in significant
individual short-term intercompany receivables and
payables. As from that date, and in line with the
standard practice in other countries, these intercompany
receivables and payables are periodically cleared via
Philips Electronics North America Corporation, a
subsidiary of KPENV. Consequently, the intercompany
receivables stated under Affiliated companies are
significantly lower compared to previous years.
B
Investments in affiliated companies
The investments in affiliated companies are included in
the balance sheet based on either their net asset value
in accordance with the aforementioned accounting
principles of the consolidated financial statements, or
at amortized cost.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
equity |
|
|
|
|
|
|
|
|
|
investments |
|
|
loans |
|
|
total |
|
Balance as of
January 1, 20081) |
|
|
16,089 |
|
|
|
1,006 |
|
|
|
17,095 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Changes: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transferred to other
non-current financial assets |
|
|
(1,524 |
) |
|
|
|
|
|
|
(1,524 |
) |
Acquisitions/additions |
|
|
2,453 |
|
|
|
4,140 |
|
|
|
6,593 |
|
Sales/redemptions |
|
|
(189 |
) |
|
|
(151 |
) |
|
|
(340 |
) |
After-tax income (loss)
from affiliated companies |
|
|
(729 |
) |
|
|
|
|
|
|
(729 |
) |
Dividends received |
|
|
(2,216 |
) |
|
|
|
|
|
|
(2,216 |
) |
Translation differences |
|
|
(161 |
) |
|
|
234 |
|
|
|
73 |
|
Other |
|
|
(995 |
) |
|
|
|
|
|
|
(995 |
) |
Balance as of
December 31, 2008 |
|
|
12,728 |
|
|
|
5,229 |
|
|
|
17,957 |
|
|
|
|
1) |
|
The balance as of January 1, 2008 has been restated
and revised; see Significant IFRS accounting
policies, sections Change in accounting policy and
Reclassifications and revisions for more details. |
246 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
non-US GAAP information
|
|
|
254 |
|
|
Corporate governance
|
|
|
262 |
|
|
Ten-year overview
|
|
|
266 |
|
|
Investor information |
A list of subsidiaries and affiliated companies, prepared
in accordance with the relevant legal requirements (Dutch
Civil Code, Book 2, Sections 379 and 414), is deposited
at the office of the Commercial Register in Eindhoven,
Netherlands.
The transfer to Other non-current financial assets mainly
relates to the financial interest in LG Display. At the
end of February 2008, Philips influence on LG Displays
operating and financial policies including representation
on the LG Display board, was reduced. Consequently, the
19.9% investment in LG Display was transferred from
Investments in affiliated companies to Other non-current
financial assets effective March 1, 2008, as Philips was
no longer able to exercise significant influence. Philips
ceased to apply equity accounting for its LG Display
shares as of that date.
The line Acquisitions/additions especially reflects the
impact of equity injections and intercompany funding
provided by the Company to US-based group companies.
These transactions enabled the group companies to finance
the three major acquisitions in 2008 (Genlyte group Inc.,
Respironics Inc. and VISICU Inc.).
The line Other especially reflects actuarial gains and
losses related to defined-benefit plans of group
companies.
C
Other non-current financial assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
other |
|
|
|
|
|
|
investments |
|
|
receivables |
|
|
total |
|
Balance as of
January 1, 2008 |
|
|
2,730 |
|
|
|
5 |
|
|
|
2,735 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Changes: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transferred from
Investments in affiliated
companies |
|
|
1,524 |
|
|
|
|
|
|
|
1,524 |
|
Acquisitions/additions |
|
|
79 |
|
|
|
50 |
|
|
|
129 |
|
Sales/redemptions |
|
|
(2,515 |
) |
|
|
|
|
|
|
(2,515 |
) |
Value adjustments/
impairments |
|
|
(925 |
) |
|
|
(2 |
) |
|
|
(927 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of
December 31, 2008 |
|
|
893 |
|
|
|
53 |
|
|
|
946 |
|
Other non-current financial assets include
available-for-sale securities and cost method investments
that generate income unrelated to the normal business
operations.
The transfer from investments in affiliated companies
mainly relates to the interest in LG Display (see note
B).
Sales/redemptions reflect the reduction of Philips
interest in TSMC, LG Display and D&M Holdings.
Value adjustments/impairments mainly relate to the
interests in LG Display, TPO Displays, Pace Micro
Technology and NXP.
D
Other current liabilities
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Income tax payable |
|
|
25 |
|
|
|
12 |
|
Other short-term liabilities |
|
|
85 |
|
|
|
107 |
|
Deferred income and accrued expenses |
|
|
227 |
|
|
|
209 |
|
Derivative instruments liabilities |
|
|
145 |
|
|
|
706 |
|
|
|
|
482 |
|
|
|
1,034 |
|
E
Short-term debt
Short-term debt includes the current portion of
outstanding long-term debt of EUR 126 million (2007: EUR
1,840 million) and debt to other group companies totaling
EUR 2,792 million (2007: EUR 19,193 million).
Institutional financing amounts to EUR 61 million (2007:
EUR 66 million).
Debt to other group companies is significantly lower
compared to previous years as a result of the adoption of
a new practice to clear cash transactions with US-based
subsidiaries (see note A for a further explanation).
F
Provisions
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Pensions |
|
|
5 |
|
|
|
|
|
Deferred tax liabilities |
|
|
37 |
|
|
|
48 |
|
Other |
|
|
12 |
|
|
|
19 |
|
Total provisions |
|
|
54 |
|
|
|
67 |
|
of which long-term |
|
|
49 |
|
|
|
67 |
|
of which short-term |
|
|
5 |
|
|
|
|
|
Philips Annual Report 2008 247
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124
|
|
US GAAP financial statements
|
|
|
180 |
|
|
Sustainability performance
|
|
|
192 |
|
|
IFRS financial statements
|
|
|
145 |
|
|
Company financial statements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- Notes to the Company financial statements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- Auditors report |
G
Long-term debt
Long-term debt and short-term-debt are uncollateralized.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
average |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
remaining |
|
|
amount |
|
|
|
(range of) |
|
|
average |
|
|
amount |
|
|
due in |
|
|
due after |
|
|
due after |
|
|
term |
|
|
out-standing |
|
|
|
interest rates |
|
|
interest rate |
|
|
outstanding |
|
|
1 year |
|
|
1 year |
|
|
5 years |
|
|
(in years) |
|
|
2007 |
|
Eurobonds |
|
|
6.1 |
% |
|
|
6.1 |
% |
|
|
750 |
|
|
|
|
|
|
|
750 |
|
|
|
|
|
|
|
2.4 |
|
|
|
2,442 |
|
USD bonds |
|
|
3.3-7.8 |
% |
|
|
5.9 |
% |
|
|
2,547 |
|
|
|
|
|
|
|
2,547 |
|
|
|
1,841 |
|
|
|
14.0 |
|
|
|
357 |
|
Convertible debentures |
|
|
1.7 |
% |
|
|
1.7 |
% |
|
|
81 |
|
|
|
72 |
|
|
|
9 |
|
|
|
|
|
|
|
2.6 |
|
|
|
103 |
|
Intercompany financing |
|
|
2.2-4.9 |
% |
|
|
3.0 |
% |
|
|
718 |
|
|
|
718 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,161 |
|
Other long-term debt |
|
|
4.7-16.4 |
% |
|
|
5.9 |
% |
|
|
59 |
|
|
|
54 |
|
|
|
5 |
|
|
|
|
|
|
|
1.4 |
|
|
|
61 |
|
|
|
|
|
|
|
|
|
|
|
|
4,155 |
|
|
|
844 |
|
|
|
3,311 |
|
|
|
1,841 |
|
|
|
|
|
|
|
5,124 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corresponding data
previous year |
|
|
|
|
|
|
|
|
|
|
5,124 |
|
|
|
4,001 |
|
|
|
1,123 |
|
|
|
357 |
|
|
|
|
|
|
|
4,769 |
|
The following amounts of the long-term debt as of
December 31, 2008, are due in the next five years:
|
|
|
|
|
2009 |
|
|
844 |
|
2010 |
|
|
8 |
|
2011 |
|
|
1,001 |
|
2012 |
|
|
3 |
|
2013 |
|
|
458 |
|
|
|
|
2,314 |
|
Corresponding amount previous year |
|
|
4,767 |
|
Convertible debentures include Philips personnel
debentures. For more information, please refer to
note 58 and note 59.
H
Stockholders equity
Common shares
In 2008, the Companys issued share capital was reduced by
170,414,994 shares, which were acquired pursuant to the
EUR 5 billion share repurchase program. As of December
31, 2008, the issued share capital consists of
972,411,769 common shares, each share having a par value
of EUR 0.20, which shares have been paid-in in full.
Preference shares
The Stichting Preferente Aandelen Philips has been
granted the right to acquire preference shares in the
Company. Such right has not been exercised. As a means to
protect the Company and its stakeholders against an
unsolicited attempt to (de facto) take over control of
the Company, the General Meeting of Shareholders in 1989
adopted amendments to the Companys articles of
association that allow the Board of Management and the
Supervisory Board to issue (rights to acquire) preference
shares to a third party. As of December 31, 2008, no
preference shares have been issued.
Option rights/restricted shares
The Company has granted stock options on its common
shares and rights to receive common shares in the
future. Please refer to note 33, which is deemed
incorporated and repeated herein by reference.
Treasury shares
In connection with the Companys share repurchase
programs, shares which have been repurchased and are held
in treasury for (i) delivery upon exercise of options and
convertible personnel debentures and under, restricted
share programs and employee share purchase programs, and
(ii) capital reduction purposes are accounted for as a
reduction of stockholders equity. Treasury shares are
recorded at cost, representing the market price on the
acquisition date. When issued, shares are removed from
treasury stock on a FIFO basis.
Any difference between the cost and the cash received
at the time treasury shares are issued, is recorded in
capital in excess of par value, except in the situation
in which the cash received is lower than cost, and
capital in excess of par has been depleted.
In order to reduce potential dilution effects, the
following transactions took place:
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Shares acquired |
|
|
27,326,969 |
|
|
|
273 |
|
Average market
price |
|
|
EUR 29.65 |
|
|
|
EUR 24.61 |
|
Amount paid |
|
|
EUR 810 million |
|
|
|
|
|
Shares delivered |
|
|
11,140,884 |
|
|
|
4,541,969 |
|
Average market
price |
|
|
EUR 30.46 |
|
|
|
EUR 23.44 |
|
Amount received |
|
|
EUR 199 million |
|
|
|
EUR 52 million |
|
Total shares in
treasury at year-end |
|
|
52,119,611 |
|
|
|
47,577,915 |
|
Total cost |
|
|
EUR 1,393 million |
|
|
|
EUR 1,263 million |
|
In order to reduce capital stock, the following
transactions took place in 2007 and 2008:
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Shares acquired |
|
|
25,813,898 |
|
|
|
146,453,094 |
|
Average market
price |
|
|
EUR 31.87 |
|
|
|
EUR 22.52 |
|
Amount paid |
|
|
EUR 823 million |
|
|
|
EUR 3,298 million |
|
Reduction of capital
stock |
|
|
|
|
|
|
170,414,994 |
|
Total shares in
treasury at year-end |
|
|
25,813,898 |
|
|
|
1,851,998 |
|
Total cost |
|
|
EUR 823 million |
|
|
|
EUR 25 million |
|
Net income (loss) and distribution to shareholders
The net loss of 2008 will be accounted for in
retained earnings.
A distribution of EUR 0.70 per
common share will be proposed to the 2009 Annual
General Meeting of Shareholders.
248 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
non-US GAAP information
|
|
|
254 |
|
|
Corporate governance
|
|
|
262 |
|
|
Ten-year overview
|
|
|
266 |
|
|
Investor information |
Legal reserves
As of December 31, 2008, legal reserves relate to the
revaluation of assets and liabilities of acquired
companies in the context of multi-stage acquisitions of
EUR 117 million (2007: EUR 133 million), unrealized
losses on available-for-sale securities of EUR 25 million
(2007: gains of EUR 1,183 million), unrealized losses on
cash flow hedges of EUR 28 million (2007: gains of EUR 28
million), affiliated companies of EUR 985 million
(2007: EUR 1,343 million) and currency translation losses
of EUR 656 million (2007: losses of EUR 613 million).
The movement in unrealized results on available-for-sales
securities are especially due to the sale of shares (TSMC
and LG Display) and the recognition of impairment charges
(see note 48). The item affiliated companies relates to
the wettelijke reserve deelnemingen, which is required
by Dutch law.
Limitations in the distribution of stockholders equity
Pursuant to Dutch law, limitations exist relating to the
distribution of stockholders equity of EUR 1,296 million
(2007: EUR 2,915 million). At December 31, 2008, such
limitations relate to common stock of EUR 194 million
(2007: EUR 228 million) as well as to legal reserves
included under affiliated companies of EUR 985 million
(2007: EUR 1,343 million) and revaluation of EUR 117
million (2007: EUR 1,344 million).
In general, gains related to available-for-sale
securities, cash flow hedges and currency translation
differences reduce the distributable stockholders
equity. By their nature, losses relating to
available-for-sale securities, cash flow hedges and
currency translation differences automatically reduce
stockholders equity, and thereby distributable amounts.
I
Net income
Net income in 2008 amounted to a loss of EUR 91
million (2007: a profit of EUR 4,873 million).
J
Employees
The number of persons employed by the Company at year-end
2008 was 11 (2007: 13) and included the members of the
Board of Management and most members of the Group
Management Committee.
For the remuneration of past and present members of both
the Board of Management and the Supervisory Board, please
refer to note 34, which is deemed incorporated and
repeated herein by reference.
K
Obligations not appearing in the balance sheet
General guarantees as referred to in Section 403, Book
2, of the Dutch Civil Code, have been given by the
Company on behalf of several group companies in the
Netherlands. The liabilities of these companies to third
parties and equity-accounted investees totaled EUR 1,249
million as of year-end 2008 (2007: EUR 1,232 million).
Guarantees totaling EUR 266 million (2007: EUR 256
million) have also been given on behalf of other group
companies, and guarantees totaling EUR 42 million (2007:
EUR 44 million) on behalf of unconsolidated companies
and third parties. The Company is the head of a fiscal
unity that contains the most significant Dutch
wholly-owned group companies. The company is therefore
jointly and severally liable for the tax liabilities of
the tax entity as a whole. For additional information,
please refer to note 62.
L
Audit fees
For a summary of the audit fees, please refer to the
Report of the Supervisory Board, table Aggregated fees
KPMG in the section Report of Audit Committee.
M
Subsequent events
On January 26, 2009, the Company announced that it had
stopped the EUR 5 billion share repurchase program,
which was announced on December 19, 2007, until further
notice.
February 23, 2009
The Supervisory Board
The Board of Management
Auditors report
To the Supervisory Board and Shareholders of
Koninklijke Philips Electronics N.V.:
Report on the Company financial statements
We have audited the accompanying Company financial
statements 2008 which are part of the financial
statements 2008 of Koninklijke Philips Electronics N.V.,
Eindhoven, the Netherlands, which comprise the balance
sheet as at December 31, 2008, statement of income and
the statement of changes in equity for the year then
ended, and the notes as set out on page 244 to 249.
Managements responsibility
The Board of Management is responsible for the
preparation and fair presentation of the Company
financial statements and for the preparation of the
Management report, both in accordance with Part 9 of Book
2 of the Dutch Civil Code. This responsibility includes:
designing, implementing and maintaining internal control
relevant to the preparation and fair presentation of the
Company financial statements that are free from material
misstatement, whether due to fraud or error; selecting
and applying appropriate accounting policies; and making
accounting estimates that are reasonable in the
circumstances.
Auditors responsibility
Our responsibility is to express an opinion on the
Company financial statements based on our audit. We
conducted our audit in accordance with Dutch law. This
law requires that we comply with ethical requirements and
plan and perform the audit to obtain reasonable assurance
whether the Company financial statements are free from
material misstatement.
An audit involves performing procedures to obtain audit
evidence about the amounts and disclosures in the Company
financial statements. The procedures selected depend on
the auditors judgment, including the assessment of the
risks of material misstatement of the Company financial
statements, whether due to fraud or error. In making
those risk assessments, the auditor considers internal
control relevant to the entitys preparation and fair
presentation of the Company financial statements in order
to design audit procedures that are appropriate in the
circumstances, but not for the purpose of expressing an
opinion on the effectiveness of the entitys internal
control. An audit also includes evaluating the
appropriateness of accounting policies used and the
reasonableness of accounting estimates made by
management, as well as evaluating the overall
presentation of the Company financial statements.
We believe that the audit evidence we have obtained is
sufficient and appropriate to provide a basis for our
audit opinion.
Opinion
In our opinion, the Company financial statements give a
true and fair view of the financial position of
Koninklijke Philips Electronics N.V. as at December 31,
2008, and of its result for the year then ended in
accordance with Part 9 of Book 2 of the Dutch Civil
Code.
Report on other legal and regulatory requirements
Pursuant to the legal requirement under 2:393 sub 5 part
f of the Dutch Civil Code, we report, to the extent of
our competence, that the Management report as set out on
page 192 to 197, is consistent with the Company
financial statements as required by 2:391 sub 4 of the
Dutch Civil Code.
Amsterdam, February 23, 2009
KPMG Accountants N.V.
M.A. Soeting RA
Philips Annual Report 2008 249
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124
|
|
US GAAP financial statements
|
|
|
180 |
|
|
Sustainability performance
|
|
|
192 |
|
|
IFRS financial statements
|
|
|
244 |
|
|
Company financial statements |
Reconciliation of non-US GAAP information
Explanation of Non-US GAAP measures
Koninklijke Philips Electronics N.V. (the Company)
believes that an understanding of sales performance is
enhanced when the effects of currency movements and
acquisitions and divestments (changes in consolidation)
are excluded. Accordingly, in addition to presenting
nominal growth, comparable growth is provided.
Comparable sales exclude the effects of currency
movements and changes in consolidation. As indicated in
the Accounting Policies, sales and income are translated
from foreign currencies into the Companys reporting
currency, the euro, at the exchange rate on transaction
dates during the respective years. As a result of
significant currency movements during the years
presented, the effects of translating foreign currency
sales amounts into euros had a material impact that has
been excluded in arriving at the comparable sales in
euros. Currency effects have been calculated by
translating previous years foreign currency sales
amounts into euros at the following years exchange rates
in comparison with the sales in euros as historically
reported. Years under review were characterized by a
number of acquisitions and divestments, as a result of
which activities were consolidated or deconsolidated. The
effect of consolidation changes has also been excluded in
arriving at the comparable sales. For the purpose of
calculating comparable sales growth, when a previously
consolidated entity is sold or contributed to a venture
that is not consolidated by the Company, relevant sales
are excluded from impacted prior-year periods. Similarly,
when an entity is acquired, relevant sales are excluded
from impacted periods.
The Company uses the term EBITA to evaluate the
performance of the Philips Group and its operating
divisions. Referencing EBITA will make the underlying
performance of our businesses more transparent by
factoring out the amortization of intangible assets,
which arises when acquisitions are consolidated. EBITA
represents income from continuing operations excluding
results attributable to minority interest holders,
results relating to equity-accounted investees, income
taxes, financial income and expenses, amortization and
impairment on intangible assets (excluding software), and
write-off of in-process R&D.
The Company believes that an understanding of the Philips
Groups financial condition is enhanced by the disclosure
of net operating capital (NOC), as this figure is used by
Philips management to evaluate the capital efficiency of
the Philips Group and its operating sectors. NOC is
defined as: total assets excluding assets from
discontinued operations less: (a) cash and cash
equivalents, (b) deferred tax assets, (c) other
(non)-current financial assets, (d)
investments in equity-accounted investees, and after
deduction of: (e) provisions excluding deferred tax
liabilities, (f) accounts and notes payable, (g) accrued
liabilities, (h) current/non-current liabilities, and (i)
trading securities.
Net debt is defined as the sum of long- and short-term
debt minus cash and cash equivalents. The net debt
position as a percentage of the sum of total group
equity (stockholders equity and minority interests)
and net debt is presented to express the financial
strength of the Company. This measure is widely used by
investment analysts and is therefore included in the
disclosure.
Cash flows before financing activities, being the sum
total of net cash from operating activities and net cash
from investing activities, and free cash flow, being net
cash from operating activities minus net capital
expenditures, are presented separately to facilitate the
readers understanding of the Companys funding
requirements.
250 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250 |
|
Reconciliation of
non-US GAAP information |
|
|
254 |
|
|
Corporate governance
|
|
|
262 |
|
|
Ten-year overview
|
|
|
266 |
|
|
Investor information |
Sales growth composition per sector
in %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
comparable growth |
|
|
currency effects |
|
|
consolidation changes |
|
|
nominal growth |
|
2008 versus 2007 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Healthcare |
|
|
5.6 |
|
|
|
(4.5 |
) |
|
|
14.1 |
|
|
|
15.2 |
|
Consumer Lifestyle |
|
|
(8.5 |
) |
|
|
(2.7 |
) |
|
|
(5.2 |
) |
|
|
(16.4 |
) |
Lighting |
|
|
2.6 |
|
|
|
(3.8 |
) |
|
|
17.8 |
|
|
|
16.6 |
|
Innovation & Emerging Businesses |
|
|
(26.6 |
) |
|
|
(0.9 |
) |
|
|
(9.6 |
) |
|
|
(37.1 |
) |
Group Management & Services |
|
|
(24.2 |
) |
|
|
(0.5 |
) |
|
|
|
|
|
|
(24.7 |
) |
Philips Group |
|
|
(2.7 |
) |
|
|
(3.3 |
) |
|
|
4.5 |
|
|
|
(1.5 |
) |
2007 versus 2006 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Healthcare |
|
|
3.7 |
|
|
|
(5.2 |
) |
|
|
2.7 |
|
|
|
1.2 |
|
Consumer Lifestyle |
|
|
3.8 |
|
|
|
(2.4 |
) |
|
|
0.3 |
|
|
|
1.7 |
|
Lighting |
|
|
6.0 |
|
|
|
(3.1 |
) |
|
|
8.6 |
|
|
|
11.5 |
|
Innovation & Emerging Businesses |
|
|
38.4 |
|
|
|
(3.1 |
) |
|
|
(96.5 |
) |
|
|
(61.2 |
) |
Group Management & Services |
|
|
30.8 |
|
|
|
(2.3 |
) |
|
|
(10.5 |
) |
|
|
18.0 |
|
Philips Group |
|
|
4.9 |
|
|
|
(3.3 |
) |
|
|
(1.2 |
) |
|
|
0.4 |
|
2006 versus 2005 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Healthcare |
|
|
8.2 |
|
|
|
(1.1 |
) |
|
|
2.0 |
|
|
|
9.1 |
|
Consumer Lifestyle |
|
|
6.5 |
|
|
|
0.1 |
|
|
|
(2.7 |
) |
|
|
3.9 |
|
Lighting |
|
|
8.3 |
|
|
|
(0.3 |
) |
|
|
6.5 |
|
|
|
14.5 |
|
Innovation & Emerging Businesses |
|
|
(8.6 |
) |
|
|
(0.4 |
) |
|
|
(18.5 |
) |
|
|
(27.5 |
) |
Group Management & Services |
|
|
14.1 |
|
|
|
(0.5 |
) |
|
|
8.9 |
|
|
|
22.5 |
|
Philips Group |
|
|
6.4 |
|
|
|
(0.3 |
) |
|
|
(1.2 |
) |
|
|
4.9 |
|
Sales growth composition per market cluster
in %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
comparable growth |
|
|
currency effects |
|
|
consolidation changes |
|
|
nominal growth |
|
2008 versus 2007 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Western Europe |
|
|
(7.1 |
) |
|
|
(1.5 |
) |
|
|
0.8 |
|
|
|
(7.8 |
) |
North America |
|
|
(2.3 |
) |
|
|
(6.9 |
) |
|
|
15.4 |
|
|
|
6.2 |
|
Other mature |
|
|
(8.7 |
) |
|
|
(3.2 |
) |
|
|
7.7 |
|
|
|
(4.2 |
) |
Total mature |
|
|
(5.5 |
) |
|
|
(3.6 |
) |
|
|
6.9 |
|
|
|
(2.2 |
) |
Key emerging |
|
|
7.2 |
|
|
|
(3.7 |
) |
|
|
0.7 |
|
|
|
4.2 |
|
Other emerging |
|
|
(0.3 |
) |
|
|
(1.9 |
) |
|
|
(2.8 |
) |
|
|
(5.0 |
) |
Total emerging |
|
|
3.8 |
|
|
|
(2.8 |
) |
|
|
(0.9 |
) |
|
|
0.1 |
|
Philips Group |
|
|
(2.7 |
) |
|
|
(3.3 |
) |
|
|
4.5 |
|
|
|
(1.5 |
) |
2007 versus 2006 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Western Europe |
|
|
5.2 |
|
|
|
(0.2 |
) |
|
|
(1.0 |
) |
|
|
4.0 |
|
North America |
|
|
(0.4 |
) |
|
|
(7.5 |
) |
|
|
2.0 |
|
|
|
(5.9 |
) |
Other mature |
|
|
2.2 |
|
|
|
(4.8 |
) |
|
|
0.1 |
|
|
|
(2.5 |
) |
Total mature |
|
|
2.8 |
|
|
|
(3.6 |
) |
|
|
0.4 |
|
|
|
(0.4 |
) |
Key emerging |
|
|
7.6 |
|
|
|
(3.6 |
) |
|
|
(7.7 |
) |
|
|
(3.7 |
) |
Other emerging |
|
|
13.7 |
|
|
|
(0.8 |
) |
|
|
(1.8 |
) |
|
|
11.1 |
|
Total emerging |
|
|
10.2 |
|
|
|
(2.5 |
) |
|
|
(5.3 |
) |
|
|
2.4 |
|
Philips Group |
|
|
4.9 |
|
|
|
(3.3 |
) |
|
|
(1.2 |
) |
|
|
0.4 |
|
2006 versus 2005 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Western Europe |
|
|
6.0 |
|
|
|
0.2 |
|
|
|
(3.1 |
) |
|
|
3.1 |
|
North America |
|
|
5.9 |
|
|
|
(1.1 |
) |
|
|
1.1 |
|
|
|
5.9 |
|
Other mature |
|
|
10.4 |
|
|
|
(4.5 |
) |
|
|
(2.0 |
) |
|
|
3.9 |
|
Total mature |
|
|
6.3 |
|
|
|
(0.8 |
) |
|
|
(1.3 |
) |
|
|
4.2 |
|
Key emerging |
|
|
2.7 |
|
|
|
0.7 |
|
|
|
(2.1 |
) |
|
|
1.3 |
|
Other emerging |
|
|
12.6 |
|
|
|
0.1 |
|
|
|
1.7 |
|
|
|
14.4 |
|
Total emerging |
|
|
6.5 |
|
|
|
0.5 |
|
|
|
(0.6 |
) |
|
|
6.4 |
|
Philips Group |
|
|
6.4 |
|
|
|
(0.3 |
) |
|
|
(1.2 |
) |
|
|
4.9 |
|
Philips Annual Report 2008 251
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124
|
|
US GAAP financial statements
|
|
|
180 |
|
|
Sustainability performance
|
|
|
192 |
|
|
IFRS financial statements
|
|
|
244 |
|
|
Company financial statements |
Composition of net debt to group equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Long-term debt |
|
|
3,006 |
|
|
|
1,212 |
|
|
|
3,441 |
|
Short-term debt |
|
|
863 |
|
|
|
2,345 |
|
|
|
717 |
|
Total debt |
|
|
3,869 |
|
|
|
3,557 |
|
|
|
4,158 |
|
Cash and cash equivalents |
|
|
(5,886 |
) |
|
|
(8,769 |
) |
|
|
(3,620 |
) |
Net debt (cash)
(total debt less cash and cash equivalents) |
|
|
(2,017 |
) |
|
|
(5,212 |
) |
|
|
538 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Minority interests |
|
|
40 |
|
|
|
42 |
|
|
|
46 |
|
Stockholders equity |
|
|
22,963 |
|
|
|
21,642 |
|
|
|
16,243 |
|
Group equity |
|
|
23,003 |
|
|
|
21,684 |
|
|
|
16,289 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net debt and group equity |
|
|
20,986 |
|
|
|
16,472 |
|
|
|
16,827 |
|
Net debt divided by net debt and group equity (in %) |
|
|
(10 |
) |
|
|
(32 |
) |
|
|
3 |
|
Group equity divided by net debt and group equity (in %) |
|
|
110 |
|
|
|
132 |
|
|
|
97 |
|
Composition of cash flows
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Cash flows from operating activities |
|
|
330 |
|
|
|
1,519 |
|
|
|
1,495 |
|
Cash flows from investing activities |
|
|
(2,802 |
) |
|
|
3,930 |
|
|
|
(3,101 |
) |
Cash flows before financing activities |
|
|
(2,472 |
) |
|
|
5,449 |
|
|
|
(1,606 |
) |
Cash flows from operating activities |
|
|
330 |
|
|
|
1,519 |
|
|
|
1,495 |
|
Net capital expenditures |
|
|
(688 |
) |
|
|
(698 |
) |
|
|
(722 |
) |
Free cash flows |
|
|
(358 |
) |
|
|
821 |
|
|
|
773 |
|
EBITA to Income from operations or EBIT
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Philips |
|
|
|
|
|
|
Consumer |
|
|
|
|
|
|
|
|
|
|
|
|
Group |
|
|
Healthcare |
|
|
Lifestyle |
|
|
Lighting |
|
|
I&EB |
|
|
GM&S |
|
2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EBITA |
|
|
931 |
|
|
|
863 |
|
|
|
281 |
|
|
|
538 |
|
|
|
(226 |
) |
|
|
(525 |
) |
Amortization of intangibles (excl. software) |
|
|
(365 |
) |
|
|
(220 |
) |
|
|
(16 |
) |
|
|
(129 |
) |
|
|
|
|
|
|
|
|
Write off of acquired in-process R&D |
|
|
(15 |
) |
|
|
(5 |
) |
|
|
|
|
|
|
(10 |
) |
|
|
|
|
|
|
|
|
Impairment of goodwill |
|
|
(234 |
) |
|
|
|
|
|
|
|
|
|
|
(234 |
) |
|
|
|
|
|
|
|
|
Income from operations (or EBIT) |
|
|
317 |
|
|
|
638 |
|
|
|
265 |
|
|
|
165 |
|
|
|
(226 |
) |
|
|
(525 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EBITA |
|
|
2,054 |
|
|
|
862 |
|
|
|
848 |
|
|
|
722 |
|
|
|
(81 |
) |
|
|
(297 |
) |
Amortization of intangibles (excl. software) |
|
|
(200 |
) |
|
|
(137 |
) |
|
|
(16 |
) |
|
|
(46 |
) |
|
|
(1 |
) |
|
|
|
|
Write off of acquired in-process R&D |
|
|
(13 |
) |
|
|
(12 |
) |
|
|
|
|
|
|
(1 |
) |
|
|
|
|
|
|
|
|
Income from operations (or EBIT) |
|
|
1,841 |
|
|
|
713 |
|
|
|
832 |
|
|
|
675 |
|
|
|
(82 |
) |
|
|
(297 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EBITA |
|
|
1,383 |
|
|
|
857 |
|
|
|
692 |
|
|
|
608 |
|
|
|
(75 |
) |
|
|
(699 |
) |
Amortization of intangibles (excl. software) |
|
|
(152 |
) |
|
|
(111 |
) |
|
|
(9 |
) |
|
|
(31 |
) |
|
|
(1 |
) |
|
|
|
|
Write off of acquired in-process R&D |
|
|
(33 |
) |
|
|
(33 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations (or EBIT) |
|
|
1,198 |
|
|
|
713 |
|
|
|
683 |
|
|
|
577 |
|
|
|
(76 |
) |
|
|
(699 |
) |
252 Philips Annual Report 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Reconciliation of
non-US GAAP information
|
|
|
254 |
|
|
Corporate governance
|
|
|
262 |
|
|
Ten-year overview
|
|
|
266 |
|
|
Investor information |
Net operating capital to total assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Philips |
|
|
|
|
|
|
Consumer |
|
|
|
|
|
|
|
|
|
|
|
|
Group |
|
|
Healthcare |
|
|
Lifestyle |
|
|
Lighting |
|
|
I&EB |
|
|
GM&S |
|
2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net operating capital (NOC) |
|
|
14,867 |
|
|
|
8,830 |
|
|
|
728 |
|
|
|
5,648 |
|
|
|
153 |
|
|
|
(492 |
) |
Eliminate liabilities comprised in NOC: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- payables/liabilities |
|
|
8,624 |
|
|
|
2,086 |
|
|
|
2,428 |
|
|
|
1,230 |
|
|
|
229 |
|
|
|
2,651 |
|
- intercompany accounts |
|
|
|
|
|
|
30 |
|
|
|
77 |
|
|
|
37 |
|
|
|
(33 |
) |
|
|
(111 |
) |
- provisions1) |
|
|
2,804 |
|
|
|
311 |
|
|
|
286 |
|
|
|
224 |
|
|
|
26 |
|
|
|
1,957 |
|
Include assets not comprised in NOC: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- investments in equity-accounted investees |
|
|
284 |
|
|
|
68 |
|
|
|
2 |
|
|
|
17 |
|
|
|
129 |
|
|
|
68 |
|
- other current financial assets |
|
|
121 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
121 |
|
- other non-current financial assets |
|
|
1,331 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,331 |
|
- deferred tax assets |
|
|
1,390 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,390 |
|
- liquid assets |
|
|
3,620 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,620 |
|
Total assets |
|
|
33,041 |
|
|
|
11,325 |
|
|
|
3,521 |
|
|
|
7,156 |
|
|
|
504 |
|
|
|
10,535 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net operating capital (NOC) |
|
|
10,529 |
|
|
|
4,802 |
|
|
|
890 |
|
|
|
3,886 |
|
|
|
246 |
|
|
|
705 |
|
Eliminate liabilities comprised in NOC: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- payables/liabilities |
|
|
7,799 |
|
|
|
1,679 |
|
|
|
3,061 |
|
|
|
1,053 |
|
|
|
237 |
|
|
|
1,769 |
|
- intercompany accounts |
|
|
|
|
|
|
29 |
|
|
|
79 |
|
|
|
48 |
|
|
|
(18 |
) |
|
|
(138 |
) |
- provisions2) |
|
|
2,417 |
|
|
|
217 |
|
|
|
283 |
|
|
|
137 |
|
|
|
30 |
|
|
|
1,750 |
|
Include assets not comprised in NOC: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- investments in equity-accounted investees |
|
|
1,886 |
|
|
|
52 |
|
|
|
|
|
|
|
9 |
|
|
|
111 |
|
|
|
1,714 |
|
- other non-current financial assets |
|
|
3,183 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,183 |
|
- deferred tax assets |
|
|
1,370 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,370 |
|
- liquid assets |
|
|
8,769 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,769 |
|
|
|
|
35,953 |
|
|
|
6,779 |
|
|
|
4,313 |
|
|
|
5,133 |
|
|
|
606 |
|
|
|
19,122 |
|
Discontinued operations |
|
|
333 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets |
|
|
36,286 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net operating capital (NOC) |
|
|
8,473 |
|
|
|
4,699 |
|
|
|
910 |
|
|
|
2,527 |
|
|
|
128 |
|
|
|
209 |
|
Eliminate liabilities comprised in NOC: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- payables/ liabilities |
|
|
8,129 |
|
|
|
1,688 |
|
|
|
2,939 |
|
|
|
989 |
|
|
|
437 |
|
|
|
2,076 |
|
- intercompany accounts |
|
|
|
|
|
|
32 |
|
|
|
86 |
|
|
|
50 |
|
|
|
(28 |
) |
|
|
(140 |
) |
- provisions3) |
|
|
2,684 |
|
|
|
229 |
|
|
|
340 |
|
|
|
146 |
|
|
|
79 |
|
|
|
1,890 |
|
Include assets not comprised in NOC: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- investments in equity-accounted investees |
|
|
2,974 |
|
|
|
47 |
|
|
|
9 |
|
|
|
7 |
|
|
|
170 |
|
|
|
2,741 |
|
- other non-current financial assets |
|
|
8,055 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,055 |
|
- trading securities |
|
|
192 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
192 |
|
- deferred tax assets |
|
|
1,627 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,627 |
|
- liquid assets |
|
|
5,886 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,886 |
|
|
|
|
38,020 |
|
|
|
6,695 |
|
|
|
4,284 |
|
|
|
3,719 |
|
|
|
786 |
|
|
|
22,536 |
|
Discontinued operations |
|
|
431 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets |
|
|
38,451 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1) |
|
Provisions on balance sheet EUR 3,969 million, excluding deferred tax liabilities EUR 1,165
million |
|
2) |
|
Provisions on balance sheet EUR 3,089 million, excluding deferred tax liabilities EUR 672
million |
|
3) |
|
Provisions on balance sheet EUR 3,281 million, excluding deferred tax liabilities EUR 597
million |
Philips Annual Report 2008 253
|
|
|
|
|
|
|
124
US GAAP financial statements
|
|
180
Sustainability performance
|
|
192
IFRS financial statements
|
|
244
Company financial statements |
Corporate governance
Corporate governance of the Philips Group
Introduction
Koninklijke Philips Electronics N.V., a company
organized under Dutch law (the Company), is
the parent company of the Philips Group
(Philips or the Group). The Company, which
started as a limited partnership with the name
Philips & Co in 1891, was converted into the
company with limited liability N.V. Philips
Gloeilampenfabrieken on September 11, 1912. On
May 6, 1994, the name was changed to Philips
Electronics N.V., and on April 1, 1998, the
name was changed to Koninklijke Philips
Electronics N.V. Its shares have been listed on
the Amsterdam Stock Exchange, Euronext
Amsterdam, since 1913. The shares have been
traded in the United States since 1962 and have
been listed on the New York Stock Exchange
since 1987.
Over the last decades the Company has pursued a
consistent policy to enhance and improve its
corporate governance in line with US, Dutch and
international (codes of) best practices. The
Company has incorporated a fair disclosure
practice in its investor relations policy, has
strengthened the accountability of its
executive management and its independent
supervisory directors, and has increased the
rights and powers of shareholders and the
communication with investors. The Company is
required to comply with, inter alia, Dutch
Corporate Governance rules, the US
Sarbanes-Oxley Act, New York Stock Exchange
rules and related regulations, insofar as
applicable to the Company. A summary of
significant differences between the Companys
corporate governance structure and the New York
Stock Exchange corporate governance standards
is published on the Companys website
(www.philips.com/investor).
Philips pursues a consistent policy to
enhance and improve its corporate
governance in line with US, Dutch and
international (codes of) best practice
In this report, the Company addresses its
overall corporate governance structure and
states to what extent it applies the provisions
of the Dutch Corporate Governance Code of
December 9, 2003 (the Dutch Corporate
Governance Code). This report also includes
the information which the Company is required
to disclose pursuant to the Royal Decree
Article 10 Takeover Directive. The Supervisory
Board and the Board of Management, which are
responsible for the corporate governance
structure of the Company, are of the opinion
that the vast majority of the principles and
best practice provisions of the Dutch Corporate
Governance Code that are addressed to the Board
of Management and the Supervisory Board,
interpreted and implemented in line with the
best practices followed by the Company, are
being applied. Some recommendations are not
(fully) applied, and the reasons for
these deviations are set out hereinafter.
Deviations from aspects of the corporate
governance structure of the Company that are
described in this report, when deemed necessary
in the interests of the Company, will be
disclosed in the Annual Report. Substantial
changes in the Companys corporate governance
structure including substantial amendments to
the Rules of Procedure of the Supervisory Board
and the Board of Management respectively and
in the Companys compliance with the Dutch
Corporate Governance Code are submitted to the
General Meeting of Shareholders for discussion
under a separate agenda item.
Also in connection with the implementation of
the Dutch Corporate Governance Code and new
Dutch legislation, the 2005 General Meeting of
Shareholders resolved to amend the articles of
association of the Company. Pursuant to the
amendment of the articles of association, the
Companys priority shares have been withdrawn
and the thresholds for overruling the binding
recommendation for appointments of members of
the Board of Management and the Supervisory
Board have been changed. Furthermore the
articles of association now also contain
detailed provisions on dealing with conflicts
of interests of members of the Board of
Management and stipulate that resolutions that
are so far-reaching that they would
significantly change the identity or nature of
the Company or the enterprise shall be subject
to the approval of the General Meeting of
Shareholders. The articles of association were
amended in 2008 to address legislative changes
such as the implementation of the Dutch Act on
Electronic Means of Communications and the
Transparancy Directive and new legislation in
the area of share repurchases.
Board of Management
Introduction
The executive management of Philips is
entrusted to its Board of Management under the
chairmanship of the President/Chief Executive
Officer and consists of at least three members
(currently six). The members of the Board of
Management have collective powers and
responsibilities. They share responsibility for
the management of the Company, the deployment
of its strategy and policies, and the
achievement of its objectives and results. The
Board of Management has, for practical
purposes, adopted a division of
responsibilities indicating the functional and
business areas monitored and reviewed by the
individual members. According to the Companys
corporate objectives and Dutch law, the Board
of Management is guided by the interests of the
Company and its affiliated enterprises within
the Group, taking into consideration the
interests of the Companys stakeholders, and is
accountable for the performance of its
assignment to the Supervisory Board and the
General Meeting of Shareholders. The Board of
Management follows its own Rules of Procedure,
which set forth procedures for meetings,
resolutions, minutes and (vice) chairmanship.
These Rules of Procedure are published on the
Companys website.
(Term of) Appointment, individual data
and conflicts of interests
Members of the Board of Management and the
President/CEO are elected by the General
Meeting of Shareholders upon a binding
recommendation drawn up by the Supervisory
Board after consultation with the
President/CEO. This binding recommendation may
be overruled by a resolution of the General
Meeting of Shareholders adopted by a simple
majority of the votes cast
and representing at least one-third of the
issued share capital. If a simple majority of
the votes cast is in favor of the resolution
to overrule the binding recommendation, but
such majority does not represent at least
one-third of the issued share capital, a new
meeting may be convened at which the
resolution may be passed by a simple majority
of the votes cast, regardless of the portion
of the issued share capital represented by
such majority.
Board members and the President are
appointed by the Shareholders Meeting
Members of the Board of Management and the
President/CEO are appointed for a maximum
term of four years, it being understood that
this maximum term expires at the end of the
General Meeting of Shareholders to be held in
the fourth year after the year of their
appointment. Reappointment is possible for
consecutive maximum terms of four years or,
if applicable, until a later retirement date
or other contractual termination date in the
fourth year, unless the General Meeting of
Shareholders resolves otherwise. Members may
be suspended by the Supervisory Board and the
General Meeting of Shareholders and dismissed
by the latter.
Individual data on the members of the Board of
Management are published in the chapter Our
leadership that begins on page 110 of this
Annual Report. The acceptance by a member of
the Board of Management of membership of the
supervisory board of another company requires
the approval of the Supervisory Board. The
Supervisory Board is required to be notified
of other important positions (to be) held by a
member of the Board of Management. No member
of the Board of Management holds more than two
supervisory board memberships of listed
companies, or is a chairman of such
supervisory board, other than of a Group
company or participating interest of the
Company.
254 Philips Annual Report 2008
|
|
|
|
|
|
|
250
Reconciliation of
non-US GAAP information
|
|
254
Corporate governance
|
|
262
Ten-year overview
|
|
266
Investor information |
The Company has formalized its rules to avoid
conflicts of interests between the Company and
members of the Board of Management. The
articles of association state that in the event
of a legal act or a lawsuit between the Company
and a member of the Board of Management,
certain of such members relatives, or certain
(legal) entities in which a member of the Board
of Management has an interest, and insofar as
the legal act is of material significance to
the Company and/or to the respective member of
the Board of Management, the respective member
of the Board of Management shall not take part
in the decision-making in respect of the
lawsuit or the legal act. Resolutions
concerning
such legal acts or lawsuits require the
approval of the Supervisory Board.
Strict rules to avoid conflicts of interest
between Philips and its board members are
in place
Legal acts as referred to above shall be
mentioned in the Annual Report for the
financial year in question. The Rules of
Procedure of the Board of Management establish
further rules on the reporting of (potential)
conflicts of interests. No legal acts as
referred to above have occurred during the
financial year 2008.
Relationship between Board of
Management and Supervisory Board
The Board of Management is supervised by the
Supervisory Board and provides the latter with
all information the Supervisory Board needs to
fulfill its own responsibilities. Major
decisions of the Board of Management require
the approval of the Supervisory Board; these
include decisions concerning (a) the
operational and financial objectives of the
Company, (b) the strategy designed to achieve
the objectives, and, if necessary, (c) the
parameters to be applied in relation to the
strategy.
Risk management approach
Within Philips, risk management forms an
integral part of business management. The Board
of Management is responsible for managing the
significant risks that the Company is facing
and has implemented a risk management and
internal control system that is designed to
provide reasonable assurance that strategic
objectives are met by creating focus, by
integrating management control over the
Companys operations, by ensuring compliance
with applicable laws and regulations and by
safeguarding the reliability of the financial
reporting and its disclosures. The Board of
Management reports on and accounts for internal
risk management and control systems to the
Supervisory Board and its Audit Committee. The
Company has designed its internal control
system in accordance with the recommendations
of the Committee of Sponsoring Organizations of
the Treadway Commission (COSO).
The Companys risk management approach is
embedded in the periodic business planning and
review cycle and forms an integral part of
business management. On the basis of risk
assessments, management determines the risks
and appropriate risk responses related to the
achievement of business objectives and
critical business processes. Risk factors and
the risk management approach as well as the
sensitivity of the Companys results to
external factors and variables are described
in more detail in the chapter Risk management
of this Annual Report. Significant changes and
improvements in the Companys risk management
and internal control system have been
discussed with the Supervisory Boards Audit
Committee and the external auditor and are
disclosed in that chapter as well.
With respect to financial reporting a
structured self-assessment and monitoring
process is used company-wide to assess,
document, review and monitor compliance with
internal control over financial reporting.
Internal representations received from
management, regular management reviews, reviews
of the design and effectiveness of internal
controls and reviews in corporate and
divisional audit committees are integral parts
of the Companys risk management approach. On
the basis thereof, the Board of Management
confirms that internal controls over financial
reporting provide a reasonable level of
assurance that the financial reporting does not
contain any material inaccuracies,
and confirms that these controls have properly
functioned in 2008 and that there are no
indications that they will not continue to do
so. The financial statements fairly represent
the financial condition and result of
operations of the Company and provide the
required disclosures.
It should be noted that the above does not
imply that these systems and procedures
provide certainty as to the realization of
operational and financial business objectives,
nor can they prevent all misstatements,
inaccuracies, errors, fraud and noncompliances
with rules and regulations.
In view of the above the Board of Management
believes that it is in compliance with the
requirements of recommendation II.1.4. of
the Dutch Corporate Governance Code, taking
into account the recommendation of the
Corporate Governance Code Monitoring
Committee in its 2005-report on the
application thereof. This statement should
not be construed as a statement in response
to the requirements of section 404 of the US
Sarbanes-Oxley Act. The statement as to
compliance with Section 404 is set forth in
the section Managements report on internal
control over financial reporting of this
Annual Report.
Philips has a financial code of ethics which
applies to certain senior officers, including
the CEO and CFO, and to employees performing
an accounting or financial function (the
financial code of ethics has been published on
the Companys website). The Company, through
the Supervisory Boards Audit Committee, also
has appropriate procedures in place for the
receipt, retention and treatment of complaints
received by the Company regarding accounting,
internal accounting controls or auditing
matters and the confidential, anonymous
submission by employees of concerns regarding
questionable accounting or auditing matters.
Internal whistleblowers have the
opportunity, without jeopardizing their
position, to report on irregularities of a
general, operational or financial nature and
to report complaints about members of the
Board of Management to the Chairman of the
Supervisory Board.
In view of the requirements under the US
Securities Exchange Act, procedures are in
place to enable the CEO and the CFO to
provide certifications with respect to the
Annual Report on Form 20-F.
A Disclosure Committee is in place, which
advises the various officers and departments
involved, including the CEO and the CFO, on
the timely review, publication and filing of
periodic and current (financial) reports.
Apart from the certification by the CEO and
CFO under US law, each individual member of
the Supervisory Board and the Board of
Management must under Dutch law, sign the IFRS
and Company financial statements being
disclosed and submitted to the General Meeting
of Shareholders for adoption. If one or more
of their signatures is missing, this shall be
stated, and the reasons given for this. The
Board of Management issues the statement on
page 192 pursuant to requirements of Dutch
civil and securities laws.
Amount and composition of the
remuneration of the Board of
Management
The remuneration of the individual members of the Board of
Management is determined by the Supervisory
Board on the proposal of the Remuneration
Committee of the Supervisory Board, and is
consistent with the policies thereon as adopted
by the General Meeting of Shareholders. The
remuneration policy applicable to the Board of
Management was adopted by the 2004 General
Meeting of Shareholders, and lastly amended by
the 2008 General Meeting of Shareholders and is
published on the Companys website. A full and
detailed description of the composition of the
remuneration of the individual members of the
Board of Management is included in the chapter
Supervisory Board report that begins on page
114 of this Annual Report.
The remuneration structure promotes the
interests of Philips in the medium and
long-term
The remuneration structure, including severance
pay, is such that it promotes the interests of
the Company in the medium and long-term, does
not encourage members of the Board of
Management to act in their own interests and
neglect the interests of the Company, and does
not reward failing members of the Board of
Management upon termination of their
employment. The level and structure of
remuneration shall be determined in the light
of factors such as the results, the share price
performance and other developments relevant to
the Company. Deviations on elements of the
remuneration policy in extraordinary
circumstances, when deemed necessary in the
interest of the Company, will be disclosed in
the Annual Report or, in case of an
appointment, in good time prior to the
appointment of the person concerned.
The main elements of the contract of
employment of a new member of the Board of
Management including the amount of the
(fixed) base salary, the structure and amount
of the variable remuneration component, any
severance plan, pension arrangements and the
general performance criteria shall be made
public no later than at the time of issuance
of the notice convening the General Meeting of
Shareholders in which a proposal for
appointment of that member
Philips Annual Report 2008 255
|
|
|
|
|
|
|
124
US GAAP financial statements
|
|
180
Sustainability performance
|
|
192
IFRS financial statements
|
|
244
Company financial statements |
of the Board of Management has been placed on
the agenda. From August 1, 2003 onwards, for
new members of the Board of Management the term
of their contract of employment is set at a
maximum period of four years, and in case of
termination, severance payment is limited to a
maximum of one years base salary subject to
mandatory Dutch law, to the extent applicable;
if the maximum of one-years salary would be
manifestly unreasonable for a member of the
Board of Management who is dismissed during his
first term of office, the member of the Board
of Management shall be eligible for a severance
payment not exceeding twice the annual salary.
The Company does not grant personal loans,
guarantees or the like to members of the Board
of Management, and no such (remissions of)
loans and guarantees were granted to such
members in 2008, nor are outstanding as per
December 31, 2008.
In 2003, Philips adopted a Long-Term Incentive
Plan (LTIP or the Plan) consisting of a mix
of restricted shares rights and stock options
for members of the Board of Management, the
Group Management Committee, Philips executives
and other key employees. This Plan was approved
by the 2003 General Meeting of Shareholders.
Future substantial changes to the Plan
applicable to members of the Board of
Management will be submitted to the General
Meeting of Shareholders for approval. As from
2002, the Company grants fixed stock options
that expire after ten years to members of the
Board of Management (and other grantees). The
options vest after three years and may not be
exercised in the first three years after they
have been granted. Options are granted at fair
market value, based on the closing price of
Euronext Amsterdam on the date of grant, and
neither the exercise price nor the other
conditions regarding the granted options can be
modified during the term of the options, except
in certain exceptional circumstances in
accordance with established market practice.
The value of the options granted to members of
the Board of Management and other personnel and
the method followed in calculating this value
are stated in the notes to the annual accounts.
Philips is one of the first companies to have
introduced restricted shares as part of the
LTIP. A grantee will receive the restricted
shares in three equal installments in three
successive years, provided he/she is still with
Philips on the respective delivery dates. If
the grantee still holds the shares after three
years from the delivery date, Philips will
grant 20% additional (premium) shares, provided
he/she is still with Philips. The Plan is
designed to stimulate long-term investment in
Philips shares. To further align the interests
of members of the Board of Management and
shareholders, restricted shares granted to
these members of the Board of Management shall
be retained for a period of at least five
years, or until at least the end of employment,
if this period is shorter.
The actual number of long-term incentives (both
stock options and restricted shares rights)
that are to be granted to the members of the
Board of Management will be determined by the
Supervisory Board and depends on the
achievement of the set team targets in the
areas of responsibility monitored by the
individual members of the Board of Management
and on the share performance of Philips. The
share performance of Philips is measured on the
basis of the Philips Total Shareholder Return
(TSR) compared to the TSR of a peer group of 12
leading multinational electronics/electrical
equipment companies over a three-year period;
the composition of this group is described in
the chapter Report of the Supervisory Board of
this Annual Report. The TSR performance of
Philips and the companies in the peer group is
divided into three groups: top 4, middle 4 and
bottom 4. Based on this relative TSR position,
the Supervisory Board establishes a multiplier
which varies from 1.2 to 0.8 and depends on the
group in which the Philips TSR result falls.
Every individual grant, the size of which
depends on the positions and performance of the
individuals, will be multiplied by the
TSR-multiplier.
The so-called ultimum remedium clause and claw
back clause of best practice provisions
II.2.10 and II.2.11 of the new Dutch Corporate
Governance Code as presented by the Corporate
Governance Code Monitoring Committee in its
report of December 2008, is applicable to
Annual Incentive payments and LTIP grants over
the year 2009 onwards to all members of the
Board of Management. In respect of the LTIP
grants, the ultimum remedium clause can be
applied to the performance related actual
number of stock options and restricted share
rights that is (unconditionally) granted.
Members of the Board of Management hold shares
in the Company for the purpose of long-term
investment and are required to refrain from
short-term transactions in Philips
securities. According to the Philips Rules of
Conduct on Inside Information, members of the
Board of Management are only allowed to trade
in Philips securities (including the exercise
of stock options) during windows of ten
business days following the publication of
annual and quarterly results (provided the
person involved has no inside information
regarding
Philips at that time) unless an exemption is
available. Furthermore, the Rules of Procedure
of the Board of Management contain provisions
concerning ownership of and transactions in
non-Philips securities by members of the Board
of Management and the annual notification to
the Philips Compliance Officer of any changes
in a members holdings of securities related to
Dutch listed companies. In order to avoid the
impression that the Company should or could
take corrective action in respect of a certain
transaction in securities in another company by
a member of the Board of Management and the
unnecessary administrative burden, the
Supervisory Board and the Board of Management
consider this annual notification to be in line
with best practices and sufficient to reach an
adequate level of transparency; however, it
does not fully comply with the Dutch Corporate
Governance Code recommendation II.2.6 which
requires notification on a quarterly basis.
Members of the Board of Management are
prohibited from trading, directly or
indirectly, in securities in any of the
companies belonging to the above-mentioned peer
group of 12 leading multinational
electronics/electrical equipment companies.
Indemnification of members of the Board of
Management and Supervisory Board
Unless the law provides otherwise, the members
of the Board of Management and of the
Supervisory Board shall be reimbursed by the
Company for various costs and expenses, such as
the reasonable costs of defending claims, as
formalized in the articles of association.
Under certain circumstances, described in the
articles of association, such as an act or
failure to act by a member of the Board of
Management or a member of the Supervisory Board
that can be characterized as intentional
(opzettelijk), intentionally reckless
(bewust roekeloos) or seriously culpable
(ernstig verwijtbaar), there will be no
entitlement to this reimbursement. The Company
has also taken out liability insurance (D&O -
Directors & Officers) for the persons
concerned.
Supervisory Board
Introduction
The Supervisory Board supervises the policies
of the Board of Management and the general
course of affairs of Philips and advises the
executive management thereon. The Supervisory
Board, in the two-tier corporate structure
under Dutch law, is a separate body that is
independent of the Board of Management. Its
independent character is also reflected in the
requirement that members of the Supervisory
Board can be neither a member of the Board of
Management nor an employee of the Company. The
Supervisory Board considers all its members to
be independent under the applicable US
Securities and Exchange Commission standards
and pursuant to the Dutch Corporate Governance
Code.
The Supervisory Board is a separate body
independent of the Board of Management
The Supervisory Board, acting in the interests
of the Company and the Group and taking into
account the relevant interest of the Companys
stakeholders, supervises and advises the Board
of Management in performing its management
tasks and setting the direction of the Groups
business, including (a) achievement of the
Companys objectives, (b) corporate strategy
and the risks inherent in the business
activities, (c) the structure and operation of
the internal risk management and control
systems, (d) the financial reporting process,
and (e) compliance with legislation and
regulations. Major management decisions and the
Groups strategy are discussed with and
approved by the Supervisory Board. In its
report, the Supervisory Board describes its
activities in the financial year, the number of
committee meetings and the main items
discussed.
Rules of Procedure of the Supervisory Board
The Supervisory Boards Rules of Procedure set
forth its own governance rules (including
meetings, items to be discussed, resolutions,
appointment and re-election, committees,
conflicts of interests, trading in securities,
profile of the Supervisory Board). Its
composition follows the profile, which aims for
an appropriate combination of knowledge and
experience among its members encompassing
marketing, technological, manufacturing,
financial, economic, social and legal aspects
of international business and government and
public administration in relation to the global
and multi-product character of the Groups
businesses. The Supervisory Board further aims
to have available appropriate experience within
Philips by having one former Philips executive
as a member. In line with US and Dutch best
practices, the Chairman of the Supervisory
Board should be independent under the
applicable US standards and pursuant to the
256 Philips Annual Report 2008
|
|
|
|
|
|
|
250
Reconciliation of
non-US GAAP information
|
|
254
Corporate governance
|
|
262
Ten-year overview
|
|
266
Investor information |
Dutch Corporate Governance Code; because this
provision does not exclude a former Philips
executive from being Chairman of the
Supervisory Board, but only if he or she meets
these standards, it is not fully in line with
recommendation III.4.2 of the Dutch Corporate
Governance Code. Under certain circumstances
and in view of the position and
responsibilities of the Chairman of the
Supervisory Board the Company believes that it
could be in the best interests of the Company
that a member of the Board of Management, who
resigned such position more than five years
ago, be Chairman of the Supervisory Board.
The Rules of Procedure of the Supervisory
Board are published on the Companys website.
They include the charters of its committees,
to which the plenary Supervisory Board, while
retaining overall responsibility, has assigned
certain tasks: the Corporate Governance and
Nomination & Selection Committee, the Audit
Committee and the Remuneration Committee. A
maximum of one member of each committee need
not be independent as defined by the Dutch
Corporate Governance Code. Each committee
reports, and submits its minutes for
information, to the Supervisory Board.
The Supervisory Board is assisted by the
General Secretary of the Company. The General
Secretary sees to it that correct procedures
are followed and that the Supervisory Board
acts in accordance with its statutory
obligations and its obligations under the
articles of association. Furthermore the
General Secretary assists the Chairman of the
Supervisory Board in the actual organization
of the affairs of the Supervisory Board
(information, agenda, evaluation, introductory
program) and is the contact person for
interested parties who want to make concerns
known to the Supervisory Board. The General
Secretary shall, either on the recommendation
of the Supervisory Board or otherwise, be
appointed by the Board of Management and may
be dismissed by the Board of Management, after
the approval of the Supervisory Board has been
obtained.
(Term of) Appointment, individual data
and conflicts of interests
The Supervisory Board consists of at least
three members (currently nine), including a
Chairman, Vice-Chairman and Secretary. The
so-called Dutch structure regime does not
apply to the Company itself. Members are
currently elected by the General Meeting of
Shareholders for fixed terms of four years,
upon a binding recommendation from the
Supervisory Board. According to the Companys
articles of association, this binding
recommendation may be overruled by a resolution
of the General Meeting of Shareholders adopted
by a simple majority of the votes cast and
representing at least one-third of the issued
share capital. If a simple majority of the
votes cast is in favor of the resolution to
overrule the binding recommendation, but such
majority does not represent at least one-third
of the issued share capital, a new meeting may
be convened at which the resolution may be
passed by a simple majority of the votes cast,
regardless of the portion of the issued share
capital represented by such majority.
Members of the Supervisory Board are
appointed by the Shareholders Meeting
Members may be suspended and dismissed by the
General Meeting of Shareholders. In the event
of inadequate performance, structural
incompatibility of interests, and in other
instances in which resignation is deemed
necessary in the opinion of the Supervisory
Board, the Supervisory Board shall submit to
the General Meeting of Shareholders a proposal
to dismiss the respective member of the
Supervisory Board. There is no age limit
applicable, and members may be re-elected
twice. The date of expiration of the terms of
Supervisory Board members is put on the
Companys website. Individual data on the
members of the Supervisory Board are published
in the Annual Report, and updated on the
Companys website.
After their appointment, all members of the
Supervisory Board shall follow an introductory
program, which covers general financial and
legal affairs, financial reporting by the
Company, any specific aspects that are unique
to the Company and its business activities,
and the responsibilities of a Supervisory
Board member. Any need for further training or
education of
members will be reviewed annually, also on the
basis of an annual evaluation survey.
In accordance with policies adopted by the
Supervisory Board, no member of the
Supervisory Board shall hold more than five
supervisory board memberships of Dutch listed
companies, the chairmanship of a supervisory
board counting as two regular memberships.
In compliance with the Dutch Corporate
Governance Code, the Company has formalized
strict rules to avoid conflicts of interests
between the Company and members of the
Supervisory Board; all information about a
conflict of interests situation is to be
provided to the Chairman of the Supervisory
Board. No decisions to enter into material
transactions in which there are conflicts of
interest with members of the Supervisory Board
have occurred during the financial year 2008.
Meetings of the Supervisory Board
The Supervisory Board meets at least six times
per year, including a meeting on strategy. The
Supervisory Board, on the advice of its Audit
Committee, also discusses, in any event at
least once a year, the risks of the business,
and the result of the assessment by the Board
of Management of the structure and operation of
the internal risk management and control
systems, as well as any significant changes
thereto. The members of the Board of Management
attend meetings of the Supervisory Board except
in matters such as the desired profile,
composition and competence of the Supervisory
Board, the Board of Management and the Group
Management Committee, as well as the
remuneration and performance of individual
members of the Board of Management and the
Group Management Committee and the conclusions
that must be drawn on the basis thereof. In
addition to these items, the Supervisory Board,
being responsible for the quality of its own
performance, discusses, at least once a year on
its own, without the members of the Board of
Management being present, both its own
functioning and that of the individual members,
and the conclusions that must be drawn on the
basis thereof. The President/ CEO and other
members of the Board of Management have regular
contacts with the Chairman and other members of
the Supervisory Board. The Board of Management
is required to keep the Supervisory Board
informed of all facts and developments
concerning Philips that the Supervisory Board
may need in order to function as required and
to properly carry out its duties, to consult it
on important matters and to submit certain
important decisions to it for its prior
approval. The Supervisory Board and its
individual members each have their own
responsibility to request from the Board of
Management and the external auditor all
information that the Supervisory Board needs in
order to be able to carry out its duties
properly as a supervisory body. If the
Supervisory Board considers it necessary, it
may obtain information from officers and
external advisers of the Company. The Company
provides the necessary means for this purpose.
The Supervisory Board may also require that
certain officers and external advisers attend
its meetings.
The Chairman of the Supervisory Board
The Supervisory Boards Chairman will see to it
that: (a) the members of the Supervisory Board
follow their introductory program, (b) the
members of the Supervisory Board receive in
good time all information which is necessary
for the proper performance of their duties, (c)
there is sufficient time for
consultation and decision-making by the
Supervisory Board, (d) the committees of the
Supervisory Board function properly, (e) the
performance of the Board of Management members
and Supervisory Board members is assessed at
least once a year, and (f) the Supervisory
Board elects a Vice-Chairman.
Remuneration of the Supervisory Board and share ownership
The remuneration of the individual members of
the Supervisory Board, as well as the
additional remuneration for its Chairman and
the members of its committees is determined by
the General Meeting of Shareholders. The
remuneration of a Supervisory Board member is
not dependent on the results of the Company.
Further details are published in the chapter
Report of the Supervisory Board of this Annual
Report. The Company shall not grant its
Supervisory Board members any personal loans,
guarantees or similar arrangements. No such
(remissions of) loans and guarantees were
granted to such members in 2008, nor were any
outstanding as per December 31, 2008.
Shares or rights to shares shall not be granted
to a Supervisory Board member. In accordance
with the Rules of Procedure of the Supervisory
Board, any shares in the Company held by a
Supervisory Board member are long-term
investments. The Supervisory Board has adopted
a policy on ownership (and notification) of
transactions in non-Philips securities by
members of the Supervisory Board. This policy
is included in the Rules of Procedure of the
Supervisory Board. In order to avoid the
impression that the Company should or could
take corrective action in respect of a certain
transaction in securities in another company by
a member of the Supervisory Board and the
unnecessary administrative burden, the
Supervisory Board considers an annual
notification of changes in a members holdings
of securities related to Dutch listed companies
to the Philips Compliance Officer to be in line
with best practices and sufficient to reach an
adequate level of transparency; however, it is
not fully in compliance with the Dutch
Corporate Governance Code, recommendation
III.7.3, which requires notification on a
quarterly basis.
Philips Annual Report 2008 257
|
|
|
|
|
|
|
124
US GAAP financial statements
|
|
180
Sustainability performance
|
|
192
IFRS financial statements
|
|
244
Company financial statements |
The Corporate Governance and Nomination &
Selection Committee
The Corporate Governance and Nomination &
Selection Committee consists of at least the
Chairman and Vice-Chairman of the Supervisory
Board. The Committee reviews the corporate
governance principles applicable to the Company
at least once a year, and advises the
Supervisory Board on any changes to these
principles as it deems appropriate. It also (a)
draws up selection criteria and appointment
procedures for members of the Supervisory
Board, the Board of Management and the Group
Management
Committee; (b) periodically assesses the size
and composition of the Supervisory Board, the
Board of Management and the Group Management
Committee, and makes the proposals for a
composition profile of the Supervisory Board,
if appropriate; (c) periodically assesses the
functioning of individual members of the
Supervisory Board, the Board of Management and
the Group Management Committee, and reports on
this to the Supervisory Board. The Committee
also consults with the President/ CEO and the
Board of Management on candidates to fill
vacancies on the Supervisory Board, the Board
of Management and the Group Management
Committee, and advises the Supervisory Board on
the candidates for appointment. It further
supervises the policy of the Board of
Management on the selection criteria and
appointment procedures for Philips Executives.
The Remuneration Committee
The Remuneration Committee meets at least twice
a year and is responsible for preparing
decisions of the Supervisory Board on the
remuneration of individual members of the Board
of Management and the Group Management
Committee.
The Remuneration Committee prepares an annual
remuneration report. The remuneration report
contains an account of the manner in which the
remuneration policy has been implemented in the
past financial year, as well as an overview of
the implementation of the remuneration policy
planned by the Supervisory Board for the next
year(s). The Supervisory Board aims to have
appropriate experience available within the
Remuneration Committee. Although currently
these functions are not combined, the
Supervisory Board is of the opinion that,
considering the functions and tasks of the
Chairman of the Remuneration Committee and the
position and responsibilities of the Chairman
of the Supervisory Board, it could be desirable
that these functions may be combined in view of
the role of the Chairman of the Remuneration
Committee towards the President/CEO and other
members of the Board of Management in the
procedures for determining the remuneration
policy and the remuneration of the individual
members of the Board of Management. No more
than one member of the Remuneration Committee
shall be an executive board member of another
Dutch listed company.
In performing its duties and responsibilities
the Remuneration Committee is assisted by a
remuneration expert acting on the basis of a
protocol ensuring that the expert acts on the
instructions of the Remuneration Committee and
on an independent basis in which conflicts of
interests are avoided.
The Audit Committee
The Audit Committee meets at least four times a
year, before the publication of the annual and
quarterly results. All of the members of the
Audit Committee are considered to be
independent under the applicable US Securities
and Exchange Commission rules and at least one
of the members of the Audit Committee, which
currently consists of four members of the
Supervisory Board, is a financial expert as set
out in the Dutch Corporate Governance Code and
each member is financially literate. In
accordance with this code, a financial expert
has relevant knowledge and experience of
financial administration and accounting at the
company in question. The Supervisory Board
considers the fact of being compliant with the
Dutch Corporate Governance Code, in combination
with the knowledge and experience available in
the Audit Committee as well as the possibility
to take advice from internal and external
experts and advisors, to be sufficient for the
fulfillment of the tasks and responsibilities
of the Audit Committee. The Supervisory Board
has determined that none of the members of the
Audit Committee is designated as an Audit
Committee financial expert as defined under the
regulations of the US Securities and Exchange
Commission. The Audit Committee may not be
chaired by the Chairman of
the Supervisory Board or by a (former) member
of the Board of Management.
All members of the Audit Committee are independent
The tasks and functions of the Audit
Committee, as described in its charter, which
is published on the Companys website as part
of the Rules of Procedure of the Supervisory
Board, include the duties recommended in the
Dutch Corporate Governance Code. More
specifically, the Audit Committee assists the
Supervisory Board in
fulfilling its oversight responsibilities for
the integrity of the Companys financial
statements, the financial reporting process,
the system of internal business controls and
risk management, the internal and external
audit process, the internal and external
auditors qualifications, its independence and
its performance, as well as the Companys
process for monitoring compliance with laws and
regulations and the General Business Principles
(GBP). It reviews the Companys annual and
interim financial statements, including
non-financial information, prior to publication
and advises the Supervisory Board on the
adequacy and appropriateness of internal
control policies and internal audit programs
and their findings.
In reviewing the Companys annual and interim
statements, including non-financial
information, and advising the Supervisory
Board on internal control policies and
internal audit programs, the Audit Committee
reviews matters relating to accounting
policies and compliance with accounting
standards, compliance with statutory and legal
requirements and regulations, particularly in
the financial domain. Important findings and
identified risks are examined thoroughly by
the Audit Committee in order to allow
appropriate measures to be taken. With regard
to the internal audit, the Audit Committee, in
cooperation with the external auditor, reviews
the internal audit charter, audit plan, audit
scope and its coverage in relation to the
scope of the external audit, staffing,
independence and organizational structure of
the internal audit function.
With regard to the external audit, the Audit
Committee reviews the proposed audit scope,
approach and fees, the independence of the
external auditor, its performance and its
(re-)appointment, audit and permitted non-audit
services provided by the external auditor in
conformity with the Philips Policy on Auditor
Independence, as well as any changes to this
policy. The Audit Committee also considers the
report of the external auditor and its report
with respect to the annual financial
statements. According to the procedures, the
Audit Committee acts as the principal contact
for the external auditor if the auditor
discovers irregularities in the content of the
financial reports. It also advises on the
Supervisory Boards statement to shareholders
in the annual accounts. The Audit Committee
periodically discusses the Companys policy on
business controls, the GBP including the
deployment thereof, overviews on tax, IT,
litigation, environmental exposures, financial
exposures in the area of treasury, real estate,
pensions, and the Groups major areas of risk.
The Companys external auditor, in general,
attends all Committee meetings and the Audit
Committee meets separately at least on a
quarterly basis with each of the President/CEO,
the CFO, the internal auditor and the external
auditor.
Group Management Committee
The Group Management Committee consists of the
members of the Board of Management and certain
key officers.
Members other than members of the Board of
Management are appointed by the Supervisory
Board. The task of the Group Management
Committee, the highest consultative body
within Philips, is to ensure that business
issues and practices are shared across Philips
and to implement common policies.
General Meeting of Shareholders
Introduction
A General Meeting of Shareholders is held at
least once a year to discuss the Annual Report,
including the report of the Board of
Management, the annual financial statements
with explanatory notes thereto and additional
information required by law, and the Report of
the Supervisory Board, any proposal concerning
dividends or other distributions, the
appointment of members of the Board of
Management and Supervisory Board (if any),
important management decisions as required by
Dutch law, and any other matters proposed by
the Supervisory Board, the Board of Management
or shareholders in accordance with the
provisions of the Companys articles of
association. The Annual Report, the financial
statements and other regulated information such
as defined in the Dutch Act on Financial
Supervision, will solely be published in
English. As a separate agenda item and in
application of Dutch law, the General Meeting
of Shareholders discusses the discharge of the
members of the Board of Management and the
Supervisory Board from responsibility for the
performance of their respective duties in the
preceding financial year. However, this
discharge only covers matters that are known to
the Company and the General Meeting of
Shareholders when the resolution is adopted.
The General Meeting of Shareholders is held in
Eindhoven, Amsterdam, Rotterdam, The Hague,
Utrecht or Haarlemmermeer (Schiphol Airport) no
later than six months after the end of the
financial year.
258 Philips Annual Report 2008
|
|
|
|
|
|
|
250
Reconciliation of
non-US GAAP information
|
|
254
Corporate governance
|
|
262
Ten-year overview
|
|
266
Investor information |
Meetings are convened by public notice, via the
Companys website or other electronic means of
communication and by letter or by the use of
electronic means of communication, to
registered shareholders. Extraordinary General
Meetings of Shareholders may be convened by the
Supervisory Board or the Board of Management if
deemed necessary and must be held if
shareholders jointly representing at least 10%
of the outstanding share capital make a written
request to that effect to the Supervisory Board
and the Board of Management, specifying in
detail the business to be dealt with. The
agenda of the General Meeting of Shareholders
shall contain such business as may be placed
thereon by the Board of Management or the
Supervisory Board, and agenda items will be
explained where necessary in writing. In
accordance with the articles of association and
Dutch law, requests from shareholders for items
to be included on the agenda will
generally be honored, subject to the Companys
rights to refuse to include the requested
agenda item under Dutch law, provided that such
requests are made in writing at least 60 days
before a General Meeting of Shareholders to the
Board of Management and the Supervisory Board
by shareholders representing at least 1% of the
Companys outstanding capital or, according to
the official price list of Euronext Amsterdam,
representing a value of at least 50 million
euros. Written requests may be submitted
electronically and shall comply with conditions
stipulated by the Board of Management, which
conditions are posted on the Companys website.
Main powers of the General Meeting of Shareholders
All outstanding shares carry voting rights. The
main powers of the General Meeting of
Shareholders are to appoint, suspend and
dismiss members of the Board of Management and
of the Supervisory Board, to adopt the annual
accounts, declare dividends and to discharge
the Board of Management and the Supervisory
Board from responsibility for the performance
of their respective duties for the previous
financial year, to appoint the external auditor
as required by Dutch law, to adopt amendments
to the articles of association and proposals to
dissolve or liquidate the Company, to issue
shares or rights to shares, to restrict or
exclude pre-emptive rights of shareholders and
to repurchase or cancel outstanding shares.
Following common corporate practice in the
Netherlands, the Company each year requests
limited authorization to issue (rights to)
shares, to restrict or exclude pre-emptive
rights and to repurchase shares. In compliance
with Dutch law, decisions of the Board of
Management that are so far-reaching that they
would greatly change the identity or nature of
the Company or the business require the
approval of the General Meeting of
Shareholders. This includes resolutions to (a)
transfer the business of the Company, or almost
the entire business of the Company, to a third
party (b) enter into or discontinue long-term
cooperation by the Company or a subsidiary with
another legal entity or company or as a fully
liable partner in a limited partnership or
ordinary partnership, if this cooperation or
its discontinuation is of material significance
to the Company or (c) acquire or dispose of a
participating interest in the capital of a
company to the value of at least one third of
the amount of the assets according to the
balance sheet and notes thereto or, if the
Company prepares a consolidated balance sheet,
according to the consolidated balance sheet and
notes thereto as published in the last adopted
annual accounts of the Company, by the Company
or one of its subsidiaries. Thus the Company
applies principle IV.1 of the Dutch Corporate
Governance Code within the framework of the
articles of association and Dutch law and in
the manner as described in this corporate
governance report.
The Board of Management and Supervisory Board
are also accountable, at the Annual General
Meeting of Shareholders, for the policy on the
additions to reserves and dividends (the level
and purpose of the additions to reserves, the
amount of the dividend and the type of
dividend). This subject is dealt with and
explained as a separate agenda item at the
General Meeting of Shareholders. Philips aims
for a sustainable and stable dividend
distribution to shareholders in the long term.
A resolution to pay a dividend is dealt with as
a separate agenda item at the General Meeting
of Shareholders.
The Board of Management and the Supervisory
Board are required to provide the General
Meeting of Shareholders with all requested
information, unless this would be prejudicial
to an overriding interest of the Company. If
the Board of Management and the Supervisory
Board invoke an overriding interest in refusing
to provide information, reasons must be given.
If a serious private bid is made for a business
unit or a participating interest and the value
of the bid exceeds a certain threshold
(currently one third of the amount of the
assets according to the balance sheet and notes
thereto or, if the Company prepares a
consolidated balance sheet, according to the
consolidated balance sheet and notes thereto as
published
in the last adopted annual accounts of the
Company), and such bid is made public, the
Board of Management shall, at its earliest
convenience, make public its position on the
bid and the reasons for this position.
Repurchase and issue of (rights to) own shares
The 2008 General Meeting of Shareholders has
resolved to authorize the Board of Management,
subject to the approval of the Supervisory
Board, to acquire shares in the Company within
the limits of the articles of association and
within a certain price range until September
27, 2009. In view of the Companys plans to
repurchase and cancel up to approximately EUR 5
billion worth of its own shares, the 2008
General Meeting of Shareholders resolved to
renew this authorization, each time the
cancellation of a tranche of shares has become
effective. The renewed authorization allows the
Board of Management to purchase additional
shares in the Company up to 10% of the number
of shares issued by the Company at the time the
relevant tranche of shares has been cancelled.
All repurchases of shares under any renewed
authorization are subject to the same terms of
the original authorization referred to above
and any renewed authorization shall expire on
September 27, 2009.
In addition, the 2008 General Meeting of
Shareholders resolved to authorize the Board of
Management, subject to the approval of the
Supervisory Board, to issue shares or grant
rights to acquire shares in the Company as well
as to restrict or exclude the pre-emption right
accruing to shareholders until September 27,
2009. The latter authorization is limited to a
maximum of 10% of the number of shares issued
plus 10% of the issued capital in connection
with or on the occasion of mergers and
acquisitions.
Logistics of the General Meeting of
Shareholders and provision of information
Introduction
The Company may set a registration date for the
exercise of the voting rights and the rights
relating to General Meetings of Shareholders.
Shareholders registered at such date are
entitled to attend the meeting and to exercise
the other shareholder rights (in the meeting in
question) notwithstanding subsequent sale of
their shares thereafter. This date will be
published in advance of every General Meeting
of Shareholders. Shareholders who are entitled
to attend a General Meeting of Shareholders may
be represented by proxies.
Information which is required to be published
or deposited pursuant to the provisions of
company law and securities law applicable to
the Company, is placed and updated on the
Companys website, or hyperlinks are
established. The Board of Management and
Supervisory Board shall ensure that the
General Meeting of Shareholders is informed by
means of a shareholders circular published
on the Companys website of facts and
circumstances relevant to the proposed
resolutions.
Resolutions adopted at a General Meeting of
Shareholders shall be recorded by a civil law
notary and co-signed by the chairman of the
meeting; such resolutions shall also be
published on the Companys website within one
day after the meeting. A summary of the
discussions during the General Meeting of
Shareholders, in the language of the meeting,
is made available to shareholders, on request,
no later than three months after the meeting.
Shareholders shall have the
opportunity to respond to this summary for
three months, after which a final summary is
adopted by the chairman of the meeting in
question. Such summary shall be made available
on the Companys website.
Philips was one of the key companies in the establishment of the Shareholders Communication
Channel
Proxy voting and the Shareholders Communication Channel
Philips was one of the key companies in the
establishment of the Shareholders Communication
Channel, a project of Euronext Amsterdam, banks
in the Netherlands and several major Dutch
companies to simplify contacts between a
participating company and shareholders that
hold their shares through a Dutch securities
account with a participating bank. The Company
uses the Shareholders Communication Channel to
distribute a voting instruction form for the
Annual General Meeting of Shareholders. By
returning this form, shareholders grant power
to an independent proxy holder who will vote
according to the instructions expressly given
on the voting instruction form. The
Shareholders Communication Channel can also be
used, under certain conditions, by
participating Philips shareholders to
distribute either by mail or by placing it on
the Companys or Shareholders Communication
Channels website information directly
related to the agenda of the General Meeting of
Shareholders to other participating Philips
shareholders.
Philips Annual Report 2008 259
|
|
|
|
|
|
|
124
US GAAP financial statements
|
|
180
Sustainability performance
|
|
192
IFRS financial statements
|
|
244
Company financial statements |
Preference shares and the Stichting
Preferente Aandelen Philips
As a means to protect the Company and its
stakeholders against an unsolicited attempt to
obtain (de facto) control of the Company, the
General Meeting of Shareholders in 1989 adopted
amendments to the Companys articles of
association that allow the Board of Management
and the Supervisory Board to issue (rights to)
preference shares to a third party. As a
result, the Stichting Preferente Aandelen
Philips (the Foundation) was created, which
was granted the right to acquire preference
shares in the Company. The mere notification
that the Foundation wishes to exercise its
rights, should a third party ever seem likely
in the judgment of the Foundation to gain a
controlling interest in the Company, will
result in the preference shares being
effectively issued. The Foundation may exercise
this right for as many preference shares as
there are ordinary shares in the Company
outstanding at that time. No preference shares
have been issued as of December 31, 2008. In
addition, the Foundation has the right to file
a petition with the Enterprise Chamber of the
Amsterdam Court of Appeal to commence in
inquiry
procedure within the meaning of section 2:344
Dutch Civil Code, which right was granted in
2008.
The object of the Foundation is to represent
the interests of the Company, the enterprises
maintained by the Company and its affiliated
companies within the Group, in such a way that
the interests of Philips, those enterprises and
all parties involved with them are safeguarded
as effectively as possible, and that they are
afforded maximum protection against influences
which, in conflict with those interests, may
undermine the autonomy and identity of Philips
and those enterprises, and also to do anything
related to the above ends or conducive to them.
In the event of (an attempt at) a hostile
takeover this arrangement will allow the
Company and its Board of Management and
Supervisory Board to determine its position in
relation to the bidder and its plans, seek
alternatives and defend Philips interests and
those of its stakeholders from a position of
strength. The members of the self-electing
Board of the Foundation are Messrs S.D. de
Bree, F.J.G.M. Cremers and M.W. den Boogert. In
2008 Messrs G.J. Kleisterlee and J-M. Hessels
resigned as board members. Consequently, no
Philips board members or officers are
represented in the board of the Foundation.
The Company does not have any other
anti-takeover measures in the sense of other
measures which exclusively or almost
exclusively have the purpose of frustrating
future public bids for the shares in the
capital of the Company in case no agreement is
reached with the Board of Management on such
public bid. Furthermore the Company does not
have measures which specifically have the
purpose of preventing a bidder who has
acquired 75% of the shares in the capital of
the Company from appointing or dismissing
members of the Board of Management and
subsequently amending the articles of
association of the Company. It should be noted
that also in the event of (an attempt at) a
hostile takeover, the Board of Management and
the Supervisory Board are authorized to
exercise in the interests of Philips all
powers attributed to them.
Audit of the financial reporting and
the position of the external auditor
The annual financial statements are prepared
by the Board of Management and reviewed by the
Supervisory Board upon the advice of its Audit
Committee and the external auditor. Upon
approval by the Supervisory Board, the
accounts are signed by all members of both the
Board of Management and the Supervisory Board
and are published together with the final
opinion of the external auditor. The Board of
Management is responsible, under the
supervision of the Supervisory Board, for the
quality and completeness of such publicly
disclosed financial reports. The annual
financial statements are presented for
discussion and adoption to the Annual General
Meeting of Shareholders, to be convened
subsequently. Philips, under US securities
regulations, separately files its Annual
Report on Form 20-F, incorporating major parts
of the Annual Report as prepared under the
requirements of Dutch law.
Internal controls and disclosure policies
Comprehensive internal procedures, compliance
with which is supervised by the Supervisory
Board, are in place for the preparation and
publication of the Annual Report, the annual
accounts, the quarterly figures and ad hoc
financial information. As from 2003, the
internal assurance process for business risk
assessment has been strengthened and the
review frequency has been upgraded to a
quarterly review cycle, in line with emerging
best practices in this area.
As part of these procedures, a Disclosure
Committee has been appointed by the Board of
Management to oversee the Companys disclosure
activities and to assist the Board of
Management in fulfilling its responsibilities
in this respect. The Committees purpose is to
ensure that the Company implements and
maintains internal procedures for the timely
collection, evaluation and disclosure, as
appropriate, of information potentially
subject to public disclosure under the legal,
regulatory and stock exchange requirements to
which the Company is subject. Such procedures
are designed to capture information that is
relevant to an assessment of the need to
disclose developments and risks that pertain
to the Companys various businesses, and their
effectiveness for this purpose will be
reviewed periodically.
Auditor information
In accordance with the procedures laid down in
the Philips Policy on Auditor Independence and
as mandatorily required by Dutch law, the
external auditor of the Company is appointed by
the General Meeting of Shareholders on the
proposal of the Supervisory Board, after the
latter has been advised by the Audit Committee
and the Board of Management. Under this Auditor
Policy, once every three years the Supervisory
Board and the Audit Committee conduct a
thorough assessment of the functioning of the
external auditor. The main conclusions of this
assessment shall be communicated to the General
Meeting of Shareholders for the purposes of
assessing the nomination for the appointment of
the external auditor. The current auditor of
the Company, KPMG Accountants N.V., was
appointed by the 1995 General Meeting of
Shareholders. In 2002, when the Auditor Policy
was adopted, the appointment of KPMG
Accountants N.V. was confirmed by the
Supervisory Board for an additional three
years. The 2008 General Meeting of Shareholders
resolved to re-appoint KPMG Accountants N.V. as
auditor. Mr M.A. Soeting is the current partner
of KPMG Accountants N.V. in charge of the audit
duties for Philips. In accordance with the
rotation schedule determined in accordance with
the Auditor Policy, he will be replaced by
another partner of the auditing firm ultimately
in 2012. The external auditor shall attend the
Annual General Meeting of Shareholders.
Questions may be put to him at the meeting
about his report. The Board of Management and
the Audit Committee of the Supervisory Board
shall report on their dealings with the
external auditor to the Supervisory Board on an
annual basis, particularly with regard to the
auditors independence. The Supervisory Board
shall take this into account when deciding upon
its nomination for the appointment of an
external auditor.
The external auditor is appointed by
the Shareholders Meeting
The external auditor attends, in principle, all
meetings of the Audit Committee. The findings
of the external auditor, the audit approach and
the risk analysis are also discussed at these
meetings. The external auditor attends the
meeting of the Supervisory Board at which the
report of the external auditor with respect to
the audit of the annual accounts is discussed,
and at which the annual accounts are approved.
In its audit report on the annual accounts to
the Board of Management and the Supervisory
Board, the external auditor refers to the
financial reporting risks and issues that were
identified during the audit, internal control
matters, and any other matters, as appropriate,
requiring communication under the auditing
standards generally accepted in the Netherlands
and the US.
Auditor policy
The Company maintains a policy of auditor
independence, and this policy restricts the use
of its auditing firm for non-audit
services, in line with US Securities and
Exchange Commission rules under which the
appointed external auditor must be independent
of the Company both in fact and appearance. The
policy is laid down in the comprehensive policy
on auditor independence published on the
Companys website.
260 Philips Annual Report 2008
|
|
|
|
|
|
|
250
Reconciliation of
non-US GAAP information
|
|
254
Corporate governance
|
|
262
Ten-year overview
|
|
266
Investor information |
Investor Relations
Introduction
The Company is continually striving to
improve relations with its shareholders. In
addition to communication with its
shareholders at the Annual General Meeting of
Shareholders, Philips elaborates its
financial results during (public) conference
calls, which are broadly accessible. It
publishes informative annual and quarterly
reports and press releases, and informs
investors via its extensive website. The
Company is strict in its compliance with
applicable rules and regulations on fair and
non-selective disclosure and equal treatment
of shareholders.
Each year the Company organizes major Philips
analysts days and participates in several
broker conferences, announced in advance on the
Companys website and by means of press
releases. Shareholders can follow in real time,
by means of webcasting or telephone lines, the
meetings and presentations organized by the
Company. It is Philips policy to post
presentations to analysts and shareholders on
the Companys website. These meetings and
presentations will not take place shortly
before the publication of annual and quarterly
financial information. While strictly complying
with the rules and regulations on fair and
non-selective disclosure and equal treatment of
shareholders, in view of the number of meetings
with analysts and presentations to analysts or
investors, not all of these meetings and
presentations are announced in advance by means
of a press release and on the Companys website
or can be followed in real time. For this
reason the Company cannot fully apply the
literal text of recommendation IV.3.I. of the
Dutch Corporate Governance Code.
Philips is continually striving to
improve relations with its
shareholders
Furthermore, the Company engages in bilateral
communications with investors. These
communications either take place at the
initiative of the Company or at the initiative
of individual investors. During these
communications the Company is generally
represented by its Investor Relations
department, however, on a limited number of
occasions the
Investor Relations department is accompanied by
one or more members of the board of management.
The subject matter of the bilateral
communications ranges from singular queries
from investors to more elaborate discussions on
the back of disclosures that the Company has
made such as its annual and quarterly reports.
Also here, the Company is strict in its
compliance with applicable rules and
regulations on fair and non-selective
disclosure and equal treatment of shareholders.
The Company shall not, in advance, assess,
comment upon or correct, other than factually,
any analysts reports and valuations. No fee(s)
will be paid by the Company to parties for the
carrying-out of research for analysts reports
or for the production or publication of
analysts reports, with the exception of
credit-rating agencies.
Major shareholders and other information for shareholders
As per December 31, 2008, no person is known to
the Company to be the owner of more than 5% of
its common shares. The common shares are held
by shareholders worldwide in bearer and
registered form. Outside the United States,
common shares are held primarily in bearer
form. As per December 31, 2008, approximately
90% of the common shares were held in bearer
form. In the United States shares are held
primarily in the form of registered shares of
New York Registry (Shares of New York Registry)
for which Citibank, N.A., 388 Greenwich Street,
New York, New York 10013 is the transfer agent
and registrar. As per December 31, 2008,
approximately 10% of the total number of
outstanding common shares were represented by
shares of New York Registry issued in the name
of approximately 1,472 holders of record,
including Cede & Co, acting as nominee for the
Depository Trust Company holding the shares
(indirectly) for individual investors as
beneficiaries.
Only bearer shares are traded on the stock
market of Euronext Amsterdam. Only shares of
New York Registry are traded on the New York
Stock Exchange. Bearer shares and registered
shares may be exchanged for each other. Since
certain shares are held by brokers and other
nominees, these numbers may not be
representative of the actual number of United
States beneficial holders or the number of
Shares of New York Registry beneficially held
by US residents.
Philips shares have been listed on
the Amsterdam stock exchange since
1913
The provisions applicable to all corporate
bonds that have been issued by the Company in
March 2008, contain a Change of Control
Triggering Event. This means that if the
Company would experience such an event with
respect to a series of corporate bonds the
Company may be required to offer to purchase
the bonds of that series at a purchase price
equal to 101% of their principal amount, plus
accrued and unpaid interest, if any.
Corporate seat and head office
The statutory seat of the Company is Eindhoven,
the Netherlands, and the statutory list of all
subsidiaries and affiliated companies, prepared
in accordance with the relevant legal
requirements (Dutch Civil Code, Book 2,
Sections 379 and 414), forms part of the notes
to the consolidated financial statements and is
deposited at the office of the Commercial
Register in Eindhoven, the Netherlands (file
no. 17001910).
The executive offices of the Company are
located at the Breitner Center, Amstelplein
2, 1096 BC Amsterdam, the Netherlands,
telephone 31 (0)20 59 77 777.
Compliance with the Dutch Corporate Governance Code
In accordance with the Dutch Order of Council
of December 23, 2004, the Company fully
complies with the Dutch Corporate Governance
Code by applying its principles and best
practice provisions that are addressed to the
Board of Management and the Supervisory Board
or by explaining why it deviates therefrom. The
Company fully applies such principles and best
practice provisions, with the exception of the
following four recommendations that are not
fully applied for the reasons set out above:
|
|
recommendation II.2.6 and III.7.3: with effect from January 1, 2005, the Company requires a
notification to the Philips Compliance Officer of transactions in securities in Dutch listed
companies by members of the Supervisory Board and the Board of Management on a yearly basis
(instead of on a quarterly basis as the Dutch Corporate Governance Code recommends); |
|
|
recommendation III.4.2: the Company requires the Chairman of the Supervisory Board to be
independent under the applicable US standards and pursuant to the Dutch Corporate Governance Code,
but does not exclude that a former member of the Board of Management who left the Company more than
five years ago may be Chairman of the Supervisory Board (as the Dutch Corporate Governance Code
does); |
|
|
recommendation III.5.11: the Company does not exclude that the function of Chairman of the
Supervisory Board may be combined with the function of Chairman of the Remuneration Committee
although this is currently not the case; and |
|
|
recommendation IV.3.1: while strictly complying with the rules and regulations on fair and
non-selective disclosure and equal treatment of shareholders, in view of the number of meetings
with analysts and presentations to analysts or investors, not all of these meetings and
presentations are announced in advance by means of a press release and on the Companys website or
can be followed in real time. |
February 23, 2009
Philips Annual Report 2008 261
|
|
|
|
|
|
|
124
US GAAP financial statements
|
|
180
Sustainability performance
|
|
192
IFRS financial statements
|
|
244
Company financial statements |
The Philips Group in the last ten years
All amounts based on US GAAP and in millions of euros unless otherwise stated.
Due to factors such as consolidations and divestments, the amounts, percentages and ratios are not
directly comparable.
General data
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1999 |
|
|
2000 |
|
|
20011) |
|
|
20021) 2) |
|
|
20031) 2) 3) |
|
|
20041) 2) 3) 4) |
|
|
20051) 2) 3) 4) |
|
|
20061) 2) 3) 4) |
|
|
20073) 4) |
|
|
2008 |
|
Sales |
|
|
31,459 |
|
|
|
37,862 |
|
|
|
31,725 |
|
|
|
26,788 |
|
|
|
23,614 |
|
|
|
24,488 |
|
|
|
25,445 |
|
|
|
26,682 |
|
|
|
26,793 |
|
|
|
26,385 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage increase over
previous year |
|
|
3 |
|
|
|
20 |
|
|
|
(16 |
) |
|
|
(2 |
) |
|
|
(10 |
) |
|
|
4 |
|
|
|
4 |
|
|
|
5 |
|
|
|
|
|
|
|
(2 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing
operations |
|
|
1,595 |
|
|
|
9,577 |
|
|
|
(2,331 |
) |
|
|
(2,863 |
) |
|
|
219 |
|
|
|
3,163 |
|
|
|
2,872 |
|
|
|
899 |
|
|
|
4,593 |
|
|
|
(178 |
) |
Discontinued operations1) 2) 3) |
|
|
|
|
|
|
|
|
|
|
(144 |
) |
|
|
(343 |
) |
|
|
490 |
|
|
|
(328 |
) |
|
|
(11 |
) |
|
|
4,482 |
|
|
|
(433 |
) |
|
|
(8 |
) |
Cumulative effect of a change
in accounting principle |
|
|
|
|
|
|
85 |
|
|
|
|
|
|
|
|
|
|
|
(14 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
|
1,590 |
|
|
|
9,662 |
|
|
|
(2,475 |
) |
|
|
(3,206 |
) |
|
|
695 |
|
|
|
2,835 |
|
|
|
2,861 |
|
|
|
5,381 |
|
|
|
4,160 |
|
|
|
(186 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Free cash flow |
|
|
337 |
|
|
|
(136 |
) |
|
|
(801 |
) |
|
|
1,093 |
|
|
|
848 |
|
|
|
779 |
|
|
|
648 |
|
|
|
(358 |
) |
|
|
821 |
|
|
|
773 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Turnover rate of net operating
capital |
|
|
3.2 |
|
|
|
3.12 |
|
|
|
2.15 |
|
|
|
3.07 |
|
|
|
4.48 |
|
|
|
5.31 |
|
|
|
4.95 |
|
|
|
3.11 |
|
|
|
2.64 |
|
|
|
1.72 |
|
Total employees at year-end
(in thousands) |
|
|
227 |
|
|
|
219 |
|
|
|
189 |
5) |
|
|
170 |
5) |
|
|
164 |
5) |
|
|
162 |
5) |
|
|
159 |
5) |
|
|
122 |
5) |
|
|
124 |
5) |
|
|
121 |
|
|
|
|
1) |
|
Discontinued operations from 2001 onwards reflects the effect of the sale of MDS in 2006, for
which previous years have been restated |
|
2) |
|
Discontinued operations from 2002 onwards reflects the effect of the sale of Semiconductors
in 2006, for which previous years have been restated |
|
3) |
|
Discontinued operations from 2003 onwards reflects the effect of classifying the MedQuist
business as a discontinued operation, for which previous years have been restated |
|
4) |
|
The years 2004 through 2007 have been revised to reflect adjusted intercompany profit
elimination in inventory (see Significant accounting policies, Reclassifications and
revisions) |
|
5) |
|
Including discontinued operations |
|
6) |
|
In manufacturing |
262 Philips Annual Report 2008
|
|
|
|
|
|
|
250
Reconciliation of
non-US GAAP information
|
|
254
Corporate governance
|
|
262
Ten-year overview
|
|
266
Investor information |
Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1999 |
|
|
2000 |
|
|
20011) |
|
|
20021) 2) |
|
|
20031) 2) 3) 4) |
|
|
20041) 2) 3) 4) |
|
|
20051) 2) 3) 4) |
|
|
20061) 2) 3) 4) |
|
|
20073) 4) |
|
|
2008 |
|
EBIT |
|
|
1,553 |
|
|
|
4,258 |
|
|
|
(1,251 |
) |
|
|
943 |
|
|
|
924 |
|
|
|
1,731 |
|
|
|
1,549 |
|
|
|
1,198 |
|
|
|
1,841 |
|
|
|
317 |
|
as a % of sales |
|
|
4.9 |
|
|
|
11.2 |
|
|
|
(3.9 |
) |
|
|
3.5 |
|
|
|
3.9 |
|
|
|
7.1 |
|
|
|
6.1 |
|
|
|
4.5 |
|
|
|
6.9 |
|
|
|
1.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EBITA |
|
|
1,768 |
|
|
|
4,600 |
|
|
|
(810 |
) |
|
|
1,464 |
|
|
|
1,018 |
|
|
|
1,836 |
|
|
|
1,643 |
|
|
|
1,383 |
|
|
|
2,054 |
|
|
|
931 |
|
as a % of sales |
|
|
5.6 |
|
|
|
12.1 |
|
|
|
(2.6 |
) |
|
|
5.5 |
|
|
|
4.3 |
|
|
|
7.5 |
|
|
|
6.5 |
|
|
|
5.2 |
|
|
|
7.7 |
|
|
|
3.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income taxes |
|
|
(208 |
) |
|
|
(563 |
) |
|
|
428 |
|
|
|
(133 |
) |
|
|
(38 |
) |
|
|
(226 |
) |
|
|
(524 |
) |
|
|
(166 |
) |
|
|
(619 |
) |
|
|
(286 |
) |
as a % of income
before taxes |
|
|
(14 |
) |
|
|
(9 |
) |
|
|
20 |
|
|
|
(10 |
) |
|
|
(5.6 |
) |
|
|
(11.6 |
) |
|
|
(31.7 |
) |
|
|
(13.5 |
) |
|
|
(13.9 |
) |
|
|
(310.9 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing
operations |
|
|
1,595 |
|
|
|
9,577 |
|
|
|
(2,331 |
) |
|
|
(2,863 |
) |
|
|
219 |
|
|
|
3,163 |
|
|
|
2,872 |
|
|
|
899 |
|
|
|
4,593 |
|
|
|
(178 |
) |
as a % of stockholders equity
(ROE) |
|
|
10.9 |
|
|
|
48.5 |
|
|
|
(11.2 |
) |
|
|
(15.3 |
) |
|
|
1.7 |
|
|
|
22.7 |
|
|
|
18.4 |
|
|
|
4.3 |
|
|
|
21.0 |
|
|
|
(1.0 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
|
1,590 |
|
|
|
9,662 |
|
|
|
(2,475 |
) |
|
|
(3,206 |
) |
|
|
695 |
|
|
|
2,835 |
|
|
|
2,861 |
|
|
|
5,381 |
|
|
|
4,160 |
|
|
|
(186 |
) |
|
Capital employed |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1999 |
|
|
2000 |
|
|
20011) |
|
|
20021) 2) |
|
|
20031) 2) 3) |
|
|
20041) 2) 3) 4) |
|
|
20051) 2) 3) 4) |
|
|
20061) 2) 3) 4) |
|
|
20073) 4) |
|
|
2008 |
|
Cash and cash equivalents |
|
|
2,331 |
|
|
|
1,089 |
|
|
|
890 |
|
|
|
1,858 |
|
|
|
2,946 |
|
|
|
4,205 |
|
|
|
5,143 |
|
|
|
5,886 |
|
|
|
8,769 |
|
|
|
3,620 |
|
Receivables and other
current assets |
|
|
6,453 |
|
|
|
6,806 |
|
|
|
6,540 |
|
|
|
4,906 |
|
|
|
4,437 |
|
|
|
5,028 |
|
|
|
5,436 |
|
|
|
5,990 |
|
|
|
5,690 |
|
|
|
5,875 |
|
Assets of discontinued operations |
|
|
|
|
|
|
|
|
|
|
426 |
|
|
|
7,381 |
|
|
|
6,838 |
|
|
|
4,661 |
|
|
|
4,484 |
|
|
|
431 |
|
|
|
333 |
|
|
|
|
|
Inventories |
|
|
4,268 |
|
|
|
5,279 |
|
|
|
4,240 |
|
|
|
2,817 |
|
|
|
2,468 |
|
|
|
2,466 |
|
|
|
2,753 |
|
|
|
2,834 |
|
|
|
3,146 |
|
|
|
3,371 |
|
Non-current financial assets/
equity-accounted investees |
|
|
7,400 |
|
|
|
11,306 |
|
|
|
11,033 |
|
|
|
4,995 |
|
|
|
4,096 |
|
|
|
6,235 |
|
|
|
6,067 |
|
|
|
11,029 |
|
|
|
5,069 |
|
|
|
1,615 |
|
Non-current receivables/assets |
|
|
2,326 |
|
|
|
2,713 |
|
|
|
3,080 |
|
|
|
2,823 |
|
|
|
2,782 |
|
|
|
3,035 |
|
|
|
3,438 |
|
|
|
3,661 |
|
|
|
3,810 |
|
|
|
3,400 |
|
Property, plant and equipment |
|
|
7,332 |
|
|
|
9,041 |
|
|
|
7,474 |
|
|
|
3,001 |
|
|
|
2,843 |
|
|
|
2,768 |
|
|
|
2,999 |
|
|
|
3,084 |
|
|
|
3,180 |
|
|
|
3,484 |
|
Intangible assets |
|
|
1,563 |
|
|
|
3,290 |
|
|
|
5,519 |
|
|
|
4,424 |
|
|
|
2,579 |
|
|
|
2,307 |
|
|
|
3,541 |
|
|
|
5,536 |
|
|
|
6,289 |
|
|
|
11,676 |
|
Total assets |
|
|
31,673 |
|
|
|
39,524 |
|
|
|
39,202 |
|
|
|
32,205 |
|
|
|
28,989 |
|
|
|
30,705 |
|
|
|
33,861 |
|
|
|
38,451 |
|
|
|
36,286 |
|
|
|
33,041 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property, plant and equipment: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures for the year |
|
|
1,662 |
|
|
|
3,170 |
|
|
|
2,069 |
|
|
|
720 |
|
|
|
663 |
|
|
|
661 |
|
|
|
637 |
|
|
|
694 |
|
|
|
661 |
|
|
|
771 |
|
Depreciation for the year |
|
|
1,548 |
|
|
|
1,789 |
|
|
|
1,908 |
|
|
|
795 |
|
|
|
641 |
|
|
|
635 |
|
|
|
542 |
|
|
|
554 |
|
|
|
562 |
|
|
|
725 |
|
Capital expenditures : depreciation |
|
|
1.1 |
|
|
|
1.8 |
|
|
|
1.1 |
|
|
|
0.9 |
|
|
|
1.0 |
|
|
|
1.0 |
|
|
|
1.2 |
|
|
|
1.3 |
|
|
|
1.2 |
|
|
|
1.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inventories as a % of sales |
|
|
13.6 |
|
|
|
13.9 |
|
|
|
13.4 |
|
|
|
10.7 |
|
|
|
10.5 |
|
|
|
10.1 |
|
|
|
10.8 |
|
|
|
10.6 |
|
|
|
11.7 |
|
|
|
12.8 |
|
Outstanding trade receivables,
in days sales |
|
|
39 |
|
|
|
42 |
|
|
|
42 |
|
|
|
36 |
|
|
|
43 |
|
|
|
41 |
|
|
|
44 |
|
|
|
45 |
|
|
|
44 |
|
|
|
42 |
|
Philips Annual Report 2008 263
|
|
|
|
|
|
|
124
US GAAP financial statements
|
|
180
Sustainability performance
|
|
192
IFRS financial statements
|
|
244
Company financial statements |
Financial structure
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1999 |
|
|
2000 |
|
|
20011) |
|
|
20021) 2) |
|
|
20031) 2) 3) |
|
|
20041) 2) 3) 4) |
|
|
20051) 2) 3) 4) |
|
|
20061) 2) 3) 4) |
|
|
20073) 4) |
|
|
2008 |
|
Other liabilities |
|
|
8,262 |
|
|
|
8,764 |
|
|
|
8,047 |
|
|
|
6,854 |
|
|
|
6,292 |
|
|
|
7,142 |
|
|
|
8,433 |
|
|
|
8,129 |
|
|
|
7,799 |
|
|
|
8,625 |
|
Liabilities of discontinued operations |
|
|
|
|
|
|
|
|
|
|
196 |
|
|
|
1,166 |
|
|
|
1,345 |
|
|
|
1,529 |
|
|
|
1,627 |
|
|
|
169 |
|
|
|
157 |
|
|
|
d |
|
Debt |
|
|
3,314 |
|
|
|
4,027 |
|
|
|
7,866 |
|
|
|
7,109 |
|
|
|
5,876 |
|
|
|
4,513 |
|
|
|
4,487 |
|
|
|
3,869 |
|
|
|
3,557 |
|
|
|
4,158 |
|
Provisions |
|
|
3,056 |
|
|
|
3,557 |
|
|
|
3,731 |
|
|
|
2,978 |
|
|
|
2,646 |
|
|
|
2,627 |
|
|
|
2,622 |
|
|
|
3,281 |
|
|
|
3,089 |
|
|
|
3,969 |
|
Total provisions and liabilities |
|
|
14,632 |
|
|
|
16,348 |
|
|
|
19,840 |
|
|
|
18,107 |
|
|
|
16,159 |
|
|
|
15,811 |
|
|
|
17,169 |
|
|
|
15,448 |
|
|
|
14,602 |
|
|
|
16,752 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Minority interests |
|
|
333 |
|
|
|
469 |
|
|
|
202 |
|
|
|
179 |
|
|
|
67 |
|
|
|
59 |
|
|
|
58 |
|
|
|
40 |
|
|
|
42 |
|
|
|
46 |
|
Stockholders equity |
|
|
16,708 |
|
|
|
22,707 |
|
|
|
19,160 |
|
|
|
13,919 |
|
|
|
12,763 |
|
|
|
14,835 |
|
|
|
16,634 |
|
|
|
22,963 |
|
|
|
21,642 |
|
|
|
16,243 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity and liabilities |
|
|
31,673 |
|
|
|
39,524 |
|
|
|
39,202 |
|
|
|
32,205 |
|
|
|
28,989 |
|
|
|
30,705 |
|
|
|
33,861 |
|
|
|
38,451 |
|
|
|
36,286 |
|
|
|
33,041 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net debt : group equity ratio |
|
|
5:95 |
|
|
|
11:89 |
|
|
|
26:74 |
|
|
|
27:73 |
|
|
|
19:81 |
|
|
|
2:98 |
|
|
|
(4):104 |
|
|
|
(10):110 |
|
|
|
(32):132 |
|
|
|
3:97 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Market capitalization at year-end |
|
|
44,942 |
|
|
|
50,098 |
|
|
|
42,532 |
|
|
|
21,309 |
|
|
|
29,648 |
|
|
|
25,003 |
|
|
|
31,536 |
|
|
|
31,624 |
|
|
|
31,436 |
|
|
|
12,765 |
|
Sustainability
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1999 |
|
|
2000 |
|
|
2001 |
|
|
2002 |
|
|
2003 |
|
|
2004 |
|
|
2005 |
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Green Product sales, as a % of total sales |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.0 |
|
|
|
19.8 |
|
|
|
22.6 |
|
Green Innovation spending, in millions of euros |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
282 |
|
Operational carbon footprint, in kilotons CO2-e |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,127 |
|
|
|
2,147 |
|
Energy consumption, in TJ6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16,537 |
|
|
|
15,213 |
|
|
|
15,169 |
|
|
|
14,584 |
|
CO2 emissions in manufacturing, in
kilotons CO2-e6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,059 |
|
|
|
868 |
|
|
|
855 |
|
|
|
825 |
|
Water intake, in thousands m3 6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,398 |
|
|
|
4,171 |
|
|
|
4,209 |
|
|
|
3,966 |
|
Total waste, in kilotons6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
133.0 |
|
|
|
125.4 |
|
|
|
127.7 |
|
|
|
113.4 |
|
ISO 14001 certification %6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
93 |
|
|
|
93 |
|
|
|
90 |
|
|
|
95 |
|
Engagement Index, % positive score |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
59 |
|
|
|
61 |
|
|
|
64 |
|
|
|
69 |
|
Female executives, in % of total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 |
|
|
|
6 |
|
|
|
8 |
|
|
|
10 |
|
Lost Workday Injuries, per 100 FTEs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.78 |
|
|
|
0.78 |
|
|
|
0.81 |
|
|
|
0.68 |
|
264 Philips Annual Report 2008
|
|
|
|
|
|
|
250
Reconciliation of
non-US GAAP information
|
|
254
Corporate governance
|
|
262
Ten-year overview
|
|
266
Investor information |
Key figures per share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1999 |
|
|
2000 |
|
|
20011) |
|
|
20021) 2) |
|
|
20031) 2) 3) |
|
|
20041) 2) 3) 4) |
|
|
20051) 2) 3) 4) |
|
|
20061) 2) 3) 4) |
|
|
20073) 4) |
|
|
2008 |
|
Sales per common share |
|
|
22.83 |
|
|
|
28.84 |
|
|
|
24.82 |
|
|
|
21.01 |
|
|
|
18.49 |
|
|
|
19.13 |
|
|
|
20.36 |
|
|
|
22.71 |
|
|
|
24.67 |
|
|
|
26.62 |
|
EBITA per common share diluted |
|
|
1.27 |
|
|
|
3.47 |
|
|
|
(0.63 |
) |
|
|
1.14 |
|
|
|
0.79 |
|
|
|
1.43 |
|
|
|
1.31 |
|
|
|
1.17 |
|
|
|
1.87 |
|
|
|
0.93 |
|
Income (loss) from continuing
operations per share |
|
|
1.16 |
|
|
|
7.29 |
|
|
|
(1.82 |
) |
|
|
(2.25 |
) |
|
|
0.17 |
|
|
|
2.47 |
|
|
|
2.30 |
|
|
|
0.77 |
|
|
|
4.23 |
|
|
|
(0.18 |
) |
Dividend paid per common share |
|
|
0.25 |
|
|
|
0.30 |
|
|
|
0.36 |
|
|
|
0.36 |
|
|
|
0.36 |
|
|
|
0.36 |
|
|
|
0.40 |
|
|
|
0.44 |
|
|
|
0.60 |
|
|
|
0.70 |
|
Total shareholder return
per common share |
|
|
19.70 |
|
|
|
5.57 |
|
|
|
(5.28 |
) |
|
|
(16.32 |
) |
|
|
6.81 |
|
|
|
(3.28 |
) |
|
|
7.14 |
|
|
|
2.76 |
|
|
|
1.55 |
|
|
|
(14.99 |
) |
Stockholders equity
per common share |
|
|
12.55 |
|
|
|
17.69 |
|
|
|
15.04 |
|
|
|
10.91 |
|
|
|
9.97 |
|
|
|
11.57 |
|
|
|
13.85 |
|
|
|
20.75 |
|
|
|
20.32 |
|
|
|
17.60 |
|
Price/earnings ratio |
|
|
29.16 |
|
|
|
5.35 |
|
|
|
(18.30 |
) |
|
|
(7.74 |
) |
|
|
134.99 |
|
|
|
7.90 |
|
|
|
11.41 |
|
|
|
37.10 |
|
|
|
6.98 |
|
|
|
(76.83 |
) |
Share price at year-end |
|
|
33.75 |
|
|
|
39.02 |
|
|
|
33.38 |
|
|
|
16.70 |
|
|
|
23.15 |
|
|
|
19.51 |
|
|
|
26.25 |
|
|
|
28.57 |
|
|
|
29.52 |
|
|
|
13.83 |
|
Highest share price during the year |
|
|
33.90 |
|
|
|
57.25 |
|
|
|
44.20 |
|
|
|
35.40 |
|
|
|
24.86 |
|
|
|
26.20 |
|
|
|
26.70 |
|
|
|
29.31 |
|
|
|
32.99 |
|
|
|
28.94 |
|
Lowest share price during the year |
|
|
14.66 |
|
|
|
31.21 |
|
|
|
18.03 |
|
|
|
13.25 |
|
|
|
12.65 |
|
|
|
17.89 |
|
|
|
18.53 |
|
|
|
21.89 |
|
|
|
26.71 |
|
|
|
12.09 |
|
Average share price |
|
|
22.77 |
|
|
|
46.37 |
|
|
|
31.66 |
|
|
|
25.58 |
|
|
|
18.79 |
|
|
|
21.45 |
|
|
|
21.59 |
|
|
|
26.57 |
|
|
|
29.73 |
|
|
|
21.42 |
|
Common shares
outstanding
at year-end 1) |
|
|
1,332 |
|
|
|
1,284 |
|
|
|
1,274 |
|
|
|
1,276 |
|
|
|
1,281 |
|
|
|
1,282 |
|
|
|
1,201 |
|
|
|
1,107 |
|
|
|
1,065 |
|
|
|
923 |
|
Weighted average shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- basic 1) |
|
|
1,378 |
|
|
|
1,313 |
|
|
|
1,278 |
|
|
|
1,275 |
|
|
|
1,277 |
|
|
|
1,280 |
|
|
|
1,250 |
|
|
|
1,175 |
|
|
|
1,086 |
|
|
|
991 |
|
- diluted 1) |
|
|
1,389 |
|
|
|
1,327 |
|
|
|
1,287 |
|
|
|
1,279 |
|
|
|
1,281 |
|
|
|
1,284 |
|
|
|
1,253 |
|
|
|
1,183 |
|
|
|
1,097 |
|
|
|
998 |
|
Philips Annual Report 2008 265
|
|
|
|
|
|
|
124
US GAAP financial statements
|
|
180
Sustainability performance
|
|
192
IFRS financial statements
|
|
244
Company financial statements |
The Philips investment proposition-
Our strategy-
We believe that demand for healthcare
(especially outside the hospital), a
healthy lifestyle and energy-efficient
high- quality lighting will grow by 6% per
annum and generate double-digit EBITA
margins. We have therefore realigned and
focused our portfolio on leading
businesses in these markets. We have
divested our portfolio of semiconductor
and electronic components businesses
(including participations) and used half
the proceeds to acquire
leadership-strengthening companies, with
Genlyte and Respironics as the key
examples in 2008; the other half was used
for reducing debt and for return to
shareholders.
Based on our sense and simplicity brand
promise, combining advanced end-user
insights with our rich technological
heritage, we build competitive advantageby
bringing meaningful innovations to our
customers and end-users. In doing this, we
will make Philips, already one of the
oldest and strongest global brands, the
preferred brand in health and well-being.
Key financial targets-
Our main strategic financial target to
double EBITA per common share compared to
the level of 2007 is supported by a number
of specific financial objectives as follows:
|
|
Realize average annual comparable
sales growth of 6% |
|
|
Increase Group EBITA margin to 10-11%
of sales of which
- Healthcare 15-17%
- Consumer Lifestyle 8-10%
- Lighting 12-14% |
|
|
Generate a return on invested capital of 12-13% |
Sustainability-
We seek to make constant progress in the
sustainability of our business. A clear
example of how we are driving business
growth through sustainability is evident in
our current EcoVision4 program:
EcoVision4 targets-
over the period 2007 2012
|
|
Double revenues from Green
Products to 30% of total sales |
|
|
Double investment in Green
Innovations to a cumulative
EUR 1 billion |
|
|
Improve our operational energy efficiency
by 25% and reduce CO2 emissions by 25% |
266 Philips Annual Report 2008
|
|
|
|
|
|
|
250
Reconciliation of
non-US GAAP information
|
|
254
Corporate governance
|
|
262
Ten-year overview
|
|
266
Investor information |
Investor information
The year 2008
A challenging year in 2008
In common with many of our peers, the
progressively challenging economic environment
has had an adverse impact on our share price,
on our 2008 financial results and consequently
on progress towards our targets. Nevertheless,
we have continued to execute on all key
strategic objectives including the creation
of our Consumer Lifestyle sector, actions to
improve margins in our Television business,
the successful integration of Genlyte and
Respironics, the significant increase in sales
of energy-efficient lighting, including LED
solutions, and the repurchase of EUR 3.3
billion of our own shares. During the second
half of the year we have taken proactive
measures to address the deteriorating market
conditions. We increased our focus on cash and
risk management and accelerated our
restructuring and change programs, which meant
that we entered 2009 with a solid balance
sheet.
Net income and EPS
Net income of the Philips Group showed a
loss of EUR 186 million, or EUR 0.19 per
common share, compared to a profit of EUR
4,160 million, or EUR 3.79 per common
share, in 2007.
Philips Annual Report 2008 267
|
|
|
|
|
|
|
124
US GAAP financial statements
|
|
180
Sustainability performance
|
|
192
IFRS financial statements
|
|
244
Company financial statements |
|
|
|
|
|
|
|
|
|
ex-dividend date
|
|
record date
|
|
payment date |
Amsterdam shares |
|
March 30, 2009
|
|
April 1, 2009
|
|
April 7, 2009 |
New York shares |
|
March 30, 2009
|
|
April 1, 2009
|
|
April 7, 2009 |
Dividend policy
Our aim is to sustainably grow our dividend
over time. Philips present dividend policy is
based on an annual pay-out ratio of 40 to 50%
of continuing net income.
Continuing net income, or net income excluding
material non-recurring items and discontinued
operations, is the base figure used to
calculate the dividend payout for the year.
For 2008, the key exclusions used to arrive at
continuing net income include the gains on the
sale of shares in LG Display and TSMC,
non-cash value decreases in our remaining
financial stakes, restructuring and the impact
of settlement charges.
Proposed distribution
Consistent with its policy to sustainably grow
its dividend, Philips will submit a proposal to
the 2009 General Meeting of Shareholders to
declare a distribution in cash of EUR 0.70 per
common share. Philips shares will be traded
ex-dividend as of March 30, 2009.
In compliance with the listing requirements of
the New York Stock Exchange and the stock
market of Euronext Amsterdam, the record date
will be April 1, 2009. The distribution as
proposed to the 2009 General Meeting of
Shareholders will be payable as of April 7,
2009, to all shareholders. The distribution to
holders of New York registry shares will be
made in USD at the USD/EUR rate fixed by the
European Central Bank on April 2, 2009. The
dividend paid over the last ten years is shown
in the graph dividend.
Share information
Market capitalization
Philips market capitalization was EUR 12.8
billion at year-end 2008. The highest closing
price for Philips shares in 2008 was EUR 28.94
on January 2, 2008 and the lowest was EUR 12.09
on December 5, 2008, both in Amsterdam.
Share capital structure
In 2008, Philips issued share capital
decreased by 170 million to a level of 972
million common shares. The basic shares
outstanding were reduced from 1,065 million at
the end of December 2007 to 923 million shares
at the end of 2008. As of December
31, 2008, the shares held in treasury amounted
to 49.4 million shares, of which 47.6 million
are held by Philips to cover long-term
incentive and employee stock purchase plans.
No person or group, other than the Company, is
known to Philips to be the owner of more than
5% of the common shares.
268 Philips Annual Report 2008
|
|
|
|
|
|
|
250
Reconciliation of
non-US GAAP information
|
|
254
Corporate governance
|
|
262
Ten-year overview
|
|
266
Investor information |
Share repurchase programs for
capital reduction purposes
In each of the last four years Philips has
started share repurchase programs, which, in
aggregate, reduced the shares outstanding by
28% from 1,282 million to 923 million at
December 31, 2008. All shares have been
purchased for capital reduction purposes. In
the first half of 2005, Philips repurchased
EUR 500 million worth of its own shares and
then an additional EUR 1.5 billion by February
2006.
On July 17, 2006, Philips announced a further
EUR 1.5 billion share repurchase program which
was expanded to EUR 4.0 billion on August 3,
2006. Philips completed EUR 2.4 billion in 2006
of this program.
Philips planned to execute the remaining EUR
1.6 billion via a program using a second
trading line on Euronext Amsterdam, which
started on January 22, 2007. Through this
second trading line EUR 0.8 billion worth of
shares were purchased in 2007.
In December 2007, the Dutch parliament adopted
an amendment to Dutch tax legislation,
effective January 1, 2008, that increased the
amount that companies may spend on repurchasing
shares free of withholding tax. Subsequently,
Philips announced that it planned to repurchase
EUR 5 billion worth of common Philips shares.
As a consequence of this new share repurchase
program, which includes the portion of the
second trading line program that had
yet to be completed, Philips terminated its
second trading line.
At the end of 2008 share repurchases totaling
EUR 3.3 billion, or two-thirds of the planned
EUR 5.0 billion, had been completed. Given the
economic conditions in 2008, we announced on
January 26, 2009 that, in line with our
prudent financial management, we would suspend
the share repurchase program until further
notice.
Further details on the current and previous
share repurchase programs can be found on
the Investor Relations website. For more
information see the section Corporate
governance of the Philips Group that begins
on page 254 of this Annual Report.
In 2008 the Company started the procedure for
the cancellation of Philips shares acquired
pursuant to the EUR 5.0 billion share
repurchase program. The cancellation has been
effected in several tranches. The number of
shares cancelled in 2008 was 170,414,994.
Based on a survey at the end of 2008 and
information provided by several large
custodians, the shareholder portfolio
information is included in the graphs
Shareholder by region and Shareholders by
style.
Impact of share repurchases on share count
in millions of shares
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2004 |
|
|
2005 |
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Shares issued |
|
|
1,316 |
|
|
|
1,316 |
|
|
|
1,143 |
|
|
|
1,143 |
|
|
|
972 |
|
Shares in treasury |
|
|
35 |
|
|
|
115 |
|
|
|
36 |
|
|
|
78 |
|
|
|
49 |
|
Shares outstanding |
|
|
1,282 |
|
|
|
1,201 |
|
|
|
1,107 |
|
|
|
1,065 |
|
|
|
923 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares repurchased |
|
|
|
|
|
|
72 |
|
|
|
102 |
|
|
|
26 |
|
|
|
146 |
|
Shares cancelled |
|
|
|
|
|
|
|
|
|
|
173 |
|
|
|
|
|
|
|
170 |
|
Philips Annual Report 2008 269
|
|
|
|
|
|
|
124
US GAAP financial statements
|
|
180
Sustainability performance
|
|
192
IFRS financial statements
|
|
244
Company financial statements |
Philips acquisitions
|
|
|
|
|
|
|
Closing of major acquisitions announced in 2007 |
|
|
January 22, 2008
|
|
Genlyte
|
|
Professional Luminaires
|
|
Create #1 lighting company in North America and
channel for adoption of green technologies |
February 20, 2008
|
|
VISICU
|
|
Healthcare IT
|
|
Combine clinical IT with patient monitors to provide
more effective clinical decision support to hospital staff |
March 10, 2008
|
|
Respironics
|
|
Home Healthcare
|
|
Become a leader in Home Healthcare and provide
strategic platform for further growth |
|
|
|
|
|
|
|
Announcement of acquisitions in 2008 |
|
|
March 26, 2008
|
|
TOMCAT Systems
|
|
Healthcare IT
|
|
Expand use of IT in cardiology business to improve
patient outcome and hospital efficiency |
April 11, 2008
|
|
Goldway
|
|
Patient Monitoring
|
|
Grow presence in China and platform to other
emerging markets |
May 13, 2008
|
|
Dixtal
|
|
Patient Monitoring
|
|
Further bolster presence in emerging markets and
broaden presence in economy to mid-range products |
September 8, 2008
|
|
Alpha X-ray
|
|
Cardiovascular X-ray
|
|
Strengthen footprint in emerging market and add offering
in economy segment to portfolio |
|
|
|
|
|
|
|
November 21, 2008
|
|
Meditronics
|
|
General X-ray
|
|
Expansion of industrial and commercial footprint in India |
|
|
|
|
|
|
|
December 15, 2008
|
|
Aerosol therapy
business of Medel
|
|
Home Healthcare
|
|
Build industrial and commercial presence, strengthen
emerging market footprint |
Risk management
Taking risks is an inherent part of
entrepreneurial behavior. A structured risk
management process encourages management to
take risks in a controlled manner. Philips has
a structured risk management process in place
that recognizes different risk categories at
Strategic, Market, Operational, Financial and
Compliance level. A more extensive explanation
is published in the Risk management chapter
that begins on page 94 of this Annual Report.
Philips rating
Philips existing long-term debt is rated A3
(with stable outlook) by Moodys and A- (with
stable outlook) by Standard & Poors. It is
our objective to manage our financial ratios
to be in line with A3 / A-. There is no
assurance that we will be able to achieve this
goal and ratings are subject to change at any
time.
Credit rating summary
|
|
|
|
|
|
|
|
|
Long-term |
|
Short-term |
|
Outlook |
Standard and Poors
|
|
A-
|
|
A-2
|
|
Stable |
Moodys
|
|
A3
|
|
P-2
|
|
Stable |
270 Philips Annual Report 2008
|
|
|
|
|
|
|
250
Reconciliation of
non-US GAAP information
|
|
254
Corporate governance
|
|
262
Ten-year overview
|
|
266
Investor information |
Listings and performance in relation to market indices
|
|
|
|
|
Share listings |
|
Amsterdam, New-York |
|
Ticker code |
|
PHIA, PHG |
No. of shares issued at Dec 31, 2008 |
|
972 million |
No. of shares outstanding at Dec 31, 2008 |
|
923 million |
Market capitalization at year-end 2008 |
|
12.8 billion |
Industry classification |
|
|
|
|
MSCI: Capital Goods |
|
|
20105010 |
|
ICB1): Consumer Electronics |
|
|
3743 |
|
Members of indices
AEX, NYSE, DJSI, STOXX50, and others |
|
|
|
|
|
|
|
1) |
|
ICB classification based on 2007 sales split |
Share price development in Amsterdam, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
in euros |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PHIA |
|
Jan |
|
|
Feb |
|
|
Mar |
|
|
Apr |
|
|
May |
|
|
Jun |
|
|
Jul |
|
|
Aug |
|
|
Sep |
|
|
Oct |
|
|
Nov |
|
|
Dec |
|
High |
|
|
28.94 |
|
|
|
26.97 |
|
|
|
26.24 |
|
|
|
25.24 |
|
|
|
25.31 |
|
|
|
25.00 |
|
|
|
22.36 |
|
|
|
23.33 |
|
|
|
22.94 |
|
|
|
19.68 |
|
|
|
16.02 |
|
|
|
14.19 |
|
Low |
|
|
24.18 |
|
|
|
25.73 |
|
|
|
23.63 |
|
|
|
23.11 |
|
|
|
23.93 |
|
|
|
21.61 |
|
|
|
19.42 |
|
|
|
20.95 |
|
|
|
18.48 |
|
|
|
12.71 |
|
|
|
12.47 |
|
|
|
12.09 |
|
Average |
|
|
26.49 |
|
|
|
26.33 |
|
|
|
24.94 |
|
|
|
24.88 |
|
|
|
24.59 |
|
|
|
23.38 |
|
|
|
21.18 |
|
|
|
22.39 |
|
|
|
20.92 |
|
|
|
15.35 |
|
|
|
13.79 |
|
|
|
13.48 |
|
Average daily
volume, in
millions
of shares |
|
|
12.1 |
|
|
|
7.0 |
|
|
|
7.7 |
|
|
|
7.9 |
|
|
|
5.2 |
|
|
|
5.9 |
|
|
|
7.7 |
|
|
|
4.6 |
|
|
|
7.9 |
|
|
|
12.8 |
|
|
|
7.9 |
|
|
|
6.1 |
|
Share price development in New York, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
in USD |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PHG |
|
Jan |
|
|
Feb |
|
|
Mar |
|
|
Apr |
|
|
May |
|
|
Jun |
|
|
Jul |
|
|
Aug |
|
|
Sep |
|
|
Oct |
|
|
Nov |
|
|
Dec |
|
High |
|
|
42.34 |
|
|
|
40.35 |
|
|
|
40.09 |
|
|
|
39.50 |
|
|
|
39.13 |
|
|
|
38.51 |
|
|
|
35.34 |
|
|
|
34.68 |
|
|
|
32.92 |
|
|
|
26.75 |
|
|
|
20.87 |
|
|
|
20.15 |
|
Low |
|
|
35.64 |
|
|
|
37.30 |
|
|
|
37.43 |
|
|
|
36.31 |
|
|
|
37.60 |
|
|
|
33.80 |
|
|
|
31.13 |
|
|
|
32.20 |
|
|
|
25.60 |
|
|
|
15.89 |
|
|
|
14.79 |
|
|
|
14.88 |
|
Average |
|
|
39.06 |
|
|
|
38.83 |
|
|
|
38.71 |
|
|
|
38.21 |
|
|
|
38.26 |
|
|
|
36.24 |
|
|
|
33.36 |
|
|
|
33.45 |
|
|
|
29.99 |
|
|
|
20.36 |
|
|
|
17.50 |
|
|
|
18.28 |
|
Average daily
volume, in
millions
of shares |
|
|
1.5 |
|
|
|
0.9 |
|
|
|
1.3 |
|
|
|
1.0 |
|
|
|
0.6 |
|
|
|
0.6 |
|
|
|
0.9 |
|
|
|
0.5 |
|
|
|
1.0 |
|
|
|
1.4 |
|
|
|
1.0 |
|
|
|
1.0 |
|
Philips Annual Report 2008 271
|
|
|
|
|
|
|
124
US GAAP financial statements
|
|
180
Sustainability performance
|
|
192
IFRS financial statements
|
|
244
Company financial statements |
Shareholder services
Holders of shares listed on Euronext
Non-US shareholders and other non-US
interested parties can obtain copies of the
Annual Report 2008 free of charge from:
Royal Philips Electronics
Annual Report Office
Breitner Center, HBT 11-15
P.O. Box 77900, 1070 MX Amsterdam, Netherlands
Telephone: +31-20-59 77500
Website: www.philips.com/annualreport/orderform
E-mail: annual.report@philips.com
Communications concerning share transfers,
lost certificates, dividends and change of
address should be directed to:
ABN AMRO,
Issuing Institutions Department
Kemelstede
2, 4817 ST Breda, Netherlands
Telephone: +31-76-57 99482,
Fax: +31-76-57 99359
Holders of American Depository Receipts (ADRs)
Holders of shares of New York Registry and
other interested parties in the US can obtain,
free of charge, copies of the Annual Report
2008 from the Transfer and Register Agent:
Citibank Shareholder Service
P.O. Box 43077 Providence, Rhode Island
02940-3077
Telephone: 1-877-CITI-ADR (toll-free)
Telephone: 1-781-575-4555 (outside of US)
Fax: 1-201-324-3284
Website: www.citibank.com/adr
E-mail: citibank@shareholders-online.com
Communications concerning share transfers,
lost certificates, dividends and change of
address should be directed to Citibank. The
Annual Report on Form 20-F (which incorporates
major parts of
this Annual Report) is filed electronically
with the US Securities and Exchange
Commission.
International direct investment program
There is a dividend reinvestment and direct
stock purchase plan designed for the US market.
This program provides existing shareholders and
interested investors with an economic and
convenient way to purchase and sell Philips New
York registry shares and to reinvest cash
dividends. Philips does not administer or
sponsor the program and assumes no obligation
or liability for the operation of the plan. For
further information on this program and for
enrolment forms:
Citibank Shareholder Service
Telephone: 1-877-248-4237 (1-877-CITI-ADR)
Monday through Friday 8:30 AM EST through 6:00 PM EST
Website: www.citibank.com/adr
or by writing to:
Citibank Shareholder Service
International Direct Investment Program
P.O. Box 2502, Jersey City, NJ 07303-2502
Shareholders Communication Channel
Philips is continually striving to improve
relations with its shareholders. For instance,
Philips was one of the key companies in the
establishment of the Shareholders
Communication Channel a project of Euronext
Amsterdam, banks in the Netherlands and
several major Dutch companies to simplify
contacts between a participating company and
its shareholders.
Philips will use the Shareholders Communication
Channel to distribute the Agenda for this
years Annual General Meeting of Shareholders
as well as an instruction form to enable proxy
voting at that meeting.
For the Annual General Meeting of
Shareholders on March 27, 2009, a record date
of March 5, 2009, will apply. Those persons
who on March 5, 2009, hold shares in the
Company and are registered as such in one of
the registers designated by the Board of
Management for the
Annual General Meeting of Shareholders will
be entitled to participate and vote at the
meeting.
272 Philips Annual Report 2008
|
|
|
|
|
|
|
250
Reconciliation of
non-US GAAP information
|
|
254
Corporate governance
|
|
262
Ten-year overview
|
|
266
Investor information |
Investor relations activities
From time to time the Company engages in
communications with investors via road shows,
one-on-one meetings, group meetings, broker
conferences and analysts days. The purpose of
these meetings is to inform the market on the
results, strategy and decisions made, as well
as to receive feedback from our shareholders.
Also, the Company engages in bilateral
communications with investors. These
communications either take place at the
initiative of the Company or at the initiative
of individual investors. During these
communications the Company is generally
represented by its Investor Relations
department. However, on a limited number of
occasions the Investor Relations department is
accompanied by one or more members of the Board
of Management. The subject matter of the
bilateral communications ranges from individual
queries from investors to more elaborate
discussions on the back of disclosures that the
Company has made such as its annual and
quarterly reports. The Company is strict in its
compliance with applicable rules and
regulations on fair and non-selective
disclosure and equal treatment of shareholders.
More information on the activities of
Investor Relations can be found in the
chapter Corporate governance that begins
on page 254 of this Annual Report.
Analysts coverage
Philips is covered by approximately 35
analysts who frequently issue reports
on the company.
Financial calendar
|
|
|
Annual General Meeting of Shareholders |
|
|
Record date Annual General Meeting
of Shareholders
|
|
March 5, 2009 |
Annual General Meeting of
Shareholders
|
|
March 27, 2009 |
|
|
|
Quarterly reports 2009 |
|
|
First quarterly report 2009
|
|
April 14, 2009 |
Second quarterly report 2009
|
|
July 13, 2009 |
Third quarterly report 2009
|
|
October 12, 2009 |
Fourth quarterly report 2009
|
|
January 25, 20101) |
|
|
|
Sector analysts days 2009 |
|
|
Analyst day 1
|
|
May 7, 20091) |
Analyst day 2
|
|
September 24, 20091) |
Analyst day 3
|
|
December 16, 20091) |
|
|
|
2010 |
|
|
Publication of 2009 results
|
|
January 25, 20101) |
Publication of the Annual Report 2009
|
|
February 22, 20101) |
Annual General Meeting of |
|
|
Shareholders
|
|
March 25, 20101) |
|
|
|
1) |
|
Subject to final confirmation |
How to reach us
Investor Relations contact
Royal Philips Electronics
Breitner Center, HBT 11-8
P.O. Box 77900, 1070 MX Amsterdam, Netherlands
Telephone: +31-20-59 77221
Website: www.philips.com/investor E-mail:
investor.relations@philips.com
Stewart McCrone
Senior Vice President Investor Relations
Telephone: +31-20-59 77222
Raymond Schras
Manager Investor Relations
Telephone: +31-20-59 77447
Sustainability contact
Philips Corporate Sustainability
Office Building VS-4C.226
P.O. Box 218 5600 MD Eindhoven, The Netherlands
Tel: +31 (0)40 27 83651
Fax: +31 (0)40 27 86161
Website: www.philips.com/sustainability
E-mail: philips.sustainability@philips.com
Philips Annual Report 2008 273
Definitions
Cash flow before financing activities: the
sum of net cash flow from operating
activities and net cash flow from
investing activities
Comparable sales: excludes the effect of
currency movements and acquisitions and
divestments (changes in consolidation).
Philips believes that comparable sales
information enhances understanding of
sales performance.
Continuing net income: recurring net
income from continuing operations, or net
income excluding discontinued operations
and excluding material non-recurring
items
Dividend yield: the annual dividend payment
divided by Philips market capitalization.
All references to dividend yield are as of
December 31 of the previous year (the yield
on the dividend paid in 2008 uses the
market capitalization as of December 31,
2007).
EBITA IFRS: earnings before interest,
tax and amortization (EBITA) represents
income from continuing operations
excluding results attributable to minority
interest holders, results relating to
equity-accounted investees, income taxes,
financial income and expenses,
amortization and impairment on intangible
assets (excluding software and capitalized
development expenses). Philips believes
that EBITA information makes the
underlying performance of its businesses
more transparent by factoring out the
amortization of intangible assets, which
arises when acquisitions are consolidated.
EBITA US GAAP: earnings before interest,
tax and amortization (EBITA) represents
income from continuing operations excluding
results attributable to minority interest
holders, results relating to
equity-accounted investees, income taxes,
financial income and expenses, amortization
and impairment on intangible assets
(excluding software) and write-off of
in-process R&D. Philips believes that EBITA
information makes the underlying
performance of its businesses more
transparent by factoring out the
amortization of intangible assets, which
arises when acquisitions are consolidated.
EBITA per common share: EBITA divided
by the weighted average number of
shares outstanding (basic). The same
principle is used for the definition
of net income or stockholders equity
per common share, replacing EBITA.
Employee Engagement Index (EEI):
measures the level of employee
loyalty and satisfaction; expressed
as the % of employees giving a
favorable score
Free cash flow: net cash flow from
operating activities minus net capital
expenditures
FTE employee: abbreviation for full-time equivalent employee
Income as a % of stockholders equity
(ROE): measures income from continuing
operations as a percentage of average
stockholders equity. ROE rates Philips
overall profitability by evaluating how
much profit the company generates with
the money shareholders have invested.
Income from continuing operations: net
income from continuing operations, or net
income excluding discontinued operations
This report is printed on Magno Satin manufactured at Sappi Fine Paper
Mills which are ISO 9001:2000 and ISO 14001 certified and EMAS registered.
The pulp used for Magno is bleached chlorine free. The pulp is made from
timber that is sourced from sustainably managed forests. Sappi Fine Paper
Europe (SFPE) has a Group Chain of Custody Certification for its entire
European operations under both the Forest Stewardship Council (FSC) and
the Programme for the Endorsement of Forest Certification Systems (PEFC)
schemes.
274 Philips Annual Report 2008
Reflecting our commitment to simplicity in our external reporting, as of 2009 we will apply IFRS
(International Financial Reporting Standards) only, eliminating a whole layer of complexity from
our financial reporting. And we will continue to shift our publishing focus from print towards the
internet, further improving our website based upon end-user insights and feedback. This will enable
us to offer visitors a more engaging, dynamic and informative interaction, as well as being kinder
to the environment.
Please send an e-mail to annual.report@philips.com if you would like to be notified when next
years Annual Report 2009 website, covering both our financial and our social and environmental
performance, goes live. You can also let us know if you would still like to receive a printed copy
of our Annual Report 2009.
Stay up to date!
Go to News or Feeds for up-to-the-minute news about Philips.
Like to know more about Philips?
Visit our Investor Relations site to find out the latest developments regarding your investment.
Interested in working for Philips? Check out our Careers site.
|
|
|
© 2009 Koninklijke Philips Electronics N.v.
|
|
www.philips.com/annualreport2008 |
All rights reserved. |
|
|
|
|
|
9922
130 09144 |
|
|
Press Information
February 23, 2009
PHILIPS PUBLISHES 2008 ANNUAL REPORT
Amsterdam, The Netherlands Royal Philips Electronics (AEX: PHI, NYSE: PHG) today published its
Annual Report for 2008, and expects to file its 2008 Form 20-F with the US Securities and Exchange
Commission later today (www.sec.gov).
The 2008 Annual Report is available to investors and other interested parties via this internet
link. Hard copies of the 2008 Annual Report can be obtained via annual.report@philips.com.
For more information, please contact:
Arent Jan Hesselink
Philips Corporate Communications:
Tel: +31 20 59 77415
Email: arentjan.hesselink@philips.com
About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified Health and
Well-being company, focused on improving peoples lives through timely innovations. As a world
leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into
people-centric solutions, based on fundamental customer insights and the brand promise of sense
and simplicity. Headquartered in the Netherlands, Philips employs approximately 121,000 employees
in more than 60 countries worldwide. With sales of EUR 26 billion in 2008, the company is a market
leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new
lighting applications, as well as lifestyle products for personal well-being and pleasure with
strong leadership positions in flat TV, male shaving and grooming, portable entertainment and oral
healthcare. News from Philips is located at www.philips.com/newscenter.